Citrus Sinensis ID: 015247
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 410 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | yes | no | 0.992 | 0.711 | 0.734 | 1e-174 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.792 | 0.455 | 0.707 | 1e-141 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.729 | 0.592 | 0.531 | 2e-90 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.729 | 0.582 | 0.526 | 9e-90 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.729 | 0.582 | 0.528 | 2e-89 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.729 | 0.576 | 0.523 | 2e-88 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.726 | 0.240 | 0.458 | 4e-72 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.712 | 0.195 | 0.462 | 6e-72 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.712 | 0.196 | 0.458 | 1e-71 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.712 | 0.196 | 0.458 | 1e-71 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 610 bits (1573), Expect = e-174, Method: Compositional matrix adjust.
Identities = 302/411 (73%), Positives = 343/411 (83%), Gaps = 4/411 (0%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCVFGRE ++ +E+K+ + S VG SV +G + + + E +K EE
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIAD--DVEKKKNEEANG 58
Query: 61 DGEKKP-RGERKRS-KSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSF 118
D E+K +G+R+RS K NPRLSN KH RGEQVAAGWP WL+ CGEALNGW+PR+AD+F
Sbjct: 59 DKERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL+LRRLDHPNV+
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV 238
KLEGLVTSRMSCSLYLVF YM+HDLAGLA+SP VKF+E +VKC M QL+SGLEHCH+ GV
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGV 238
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
LHRDIKGSNLLIDD GVLKIADFGLA+ FDPNHK PMTSRVVTLWYR PELLLGATDYGV
Sbjct: 239 LHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGV 298
Query: 299 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358
G+DLWSAGCILAELLAG+PIMPGRTEVEQLHKIYKLCGSPSE+YWKK K + ++KPRE
Sbjct: 299 GIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPRE 358
Query: 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
PYKR I+ETFKDFPPSSLPLI+ LL+I+P +R TA+ AL SE + C
Sbjct: 359 PYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYAC 409
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 230/325 (70%), Positives = 276/325 (84%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
R+ ++ RG QV AGWP WL +V GEA+NGWIPR+ADSFEK++KIGQGTYS+VYKA+D
Sbjct: 123 RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARD 182
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
+ T ++VALKKVRF N++P+SV+FMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F
Sbjct: 183 LETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFE 242
Query: 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 257
YMEHDLAGLA++P + F+E Q+KCYM QLL GLEHCH+ GVLHRDIKGSNLL+D + LK
Sbjct: 243 YMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLK 302
Query: 258 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317
I DFGLA+F+ + K P+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL GKP
Sbjct: 303 IGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKP 362
Query: 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP 377
IMPGRTEVEQLHKI+KLCGSPSEEYWK SKLP+AT+FKP++PYKRC+ ETFK P S+L
Sbjct: 363 IMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALA 422
Query: 378 LIETLLAIDPAERLTATVALNSEVI 402
L+E LLA++P R T AL SE
Sbjct: 423 LVEVLLAVEPDARGTTASALESEFF 447
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (853), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 168/316 (53%), Positives = 220/316 (69%), Gaps = 17/316 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 169 LRRLDHPNVIKLEGLVTS--------------RMSCSLYLVFHYMEHDLAGLAASPEVKF 214
L++L H NVI+L+ +VTS + +Y+VF YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274
T PQ+KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+ E EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 335 CGSPSEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
CGSP E+ W SK+P FKP P KR ++E F+ F +L L+E +L +DPA+R++A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 394 TVALNSEVIFQDRTLC 409
AL++E + D C
Sbjct: 317 KDALDAEYFWTDPLPC 332
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 9e-90, Method: Compositional matrix adjust.
Identities = 167/317 (52%), Positives = 219/317 (69%), Gaps = 18/317 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK+ T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 169 LRRLDHPNVIKLEGLVTS---------------RMSCSLYLVFHYMEHDLAGLAASPEVK 213
L++L H NVI+L+ +VTS + S+Y+VF YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273
FT PQ+KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA F +H
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKPI+ G+ E EQL KI++
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 334 LCGSPSEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
LCG+P E W +K+P FKP+ P KR ++E+FK F +L L+E +L +DP++R++
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 393 ATVALNSEVIFQDRTLC 409
A AL++E + D C
Sbjct: 316 AKDALDAEYFWTDPLPC 332
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 167/316 (52%), Positives = 217/316 (68%), Gaps = 17/316 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 169 LRRLDHPNVIKLEGLVTS--------------RMSCSLYLVFHYMEHDLAGLAASPEVKF 214
L++L H NVI L+ +VTS + +Y+VF YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274
T PQ+KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL GKPI+PG+TE EQL+KIY+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 335 CGSPSEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
CGSP E W SK+P K P KR ++E ++ F +L L+E +L +DP++R+ A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 394 TVALNSEVIFQDRTLC 409
AL++E + D C
Sbjct: 317 KDALDAEYFWTDPLPC 332
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 166/317 (52%), Positives = 216/317 (68%), Gaps = 18/317 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY A++ T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 169 LRRLDHPNVIKLEGLVTS---------------RMSCSLYLVFHYMEHDLAGLAASPEVK 213
L++L H NVI+L+ +VTS + S+Y+VF YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273
FT PQ+KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA F +H
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKPI+PG+ E EQL KI+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 334 LCGSPSEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+CG+P E W +K+P FKP KR ++E FK F +L L+E +L +DPA+R++
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 393 ATVALNSEVIFQDRTLC 409
A AL++E + D C
Sbjct: 316 AQDALDAEYFWSDPLPC 332
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 4e-72, Method: Compositional matrix adjust.
Identities = 142/310 (45%), Positives = 190/310 (61%), Gaps = 12/310 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 702 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 760
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V+F+E +K
Sbjct: 761 LRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIK 820
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
+M QL+ GLE+CH LHRDIK SN+L+++ G +K+ADFGLA + P T++V+
Sbjct: 821 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVI 880
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 881 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 940
Query: 341 EYWKKS-KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
W KLP KP++ Y+R ++E F P +L L++ +L +DP++R TA L S
Sbjct: 941 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQS 1000
Query: 400 EVIFQDRTLC 409
+ +D +C
Sbjct: 1001 D-FLKDVDVC 1009
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 271 bits (693), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 140/303 (46%), Positives = 188/303 (62%), Gaps = 11/303 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 719 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 777
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E +K
Sbjct: 778 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 837
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
+M QL+ GLE+CH LHRDIK SN+L+++ G +K+ADFGLA ++ P T++V+
Sbjct: 838 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 897
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 898 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 957
Query: 341 EYWKKS-KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
W KLP KP++ Y+R ++E F P ++L L++ +L +DP++R TA L S
Sbjct: 958 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1017
Query: 400 EVI 402
+ +
Sbjct: 1018 DFL 1020
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 139/303 (45%), Positives = 188/303 (62%), Gaps = 11/303 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E +K
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 833
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
+M QL+ GL++CH LHRDIK SN+L+++ G +K+ADFGLA ++ P T++V+
Sbjct: 834 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 893
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 894 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 953
Query: 341 EYWKKS-KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
W KLP KP++ Y+R ++E F P ++L L++ +L +DP++R TA L S
Sbjct: 954 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1013
Query: 400 EVI 402
+ +
Sbjct: 1014 DFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 139/303 (45%), Positives = 188/303 (62%), Gaps = 11/303 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E +K
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 833
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
+M QL+ GL++CH LHRDIK SN+L+++ G +K+ADFGLA ++ P T++V+
Sbjct: 834 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 893
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 894 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 953
Query: 341 EYWKKS-KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
W KLP KP++ Y+R ++E F P ++L L++ +L +DP++R TA L S
Sbjct: 954 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1013
Query: 400 EVI 402
+ +
Sbjct: 1014 DFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 410 | ||||||
| 255542430 | 571 | Serine/threonine-protein kinase cdk9, pu | 0.992 | 0.712 | 0.828 | 0.0 | |
| 356505916 | 573 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.701 | 0.819 | 0.0 | |
| 356535133 | 580 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.703 | 0.787 | 0.0 | |
| 225451183 | 582 | PREDICTED: probable serine/threonine-pro | 0.987 | 0.695 | 0.781 | 0.0 | |
| 147788188 | 576 | hypothetical protein VITISV_038843 [Viti | 0.987 | 0.703 | 0.779 | 0.0 | |
| 356576745 | 580 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.703 | 0.782 | 0.0 | |
| 356573056 | 572 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.702 | 0.799 | 0.0 | |
| 449435738 | 564 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.723 | 0.765 | 0.0 | |
| 7671528 | 599 | CRK1 protein [Beta vulgaris subsp. vulga | 0.992 | 0.679 | 0.739 | 0.0 | |
| 357512159 | 569 | Cdc2-like protein kinase [Medicago trunc | 0.970 | 0.699 | 0.748 | 1e-180 |
| >gi|255542430|ref|XP_002512278.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] gi|223548239|gb|EEF49730.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/409 (82%), Positives = 370/409 (90%), Gaps = 2/409 (0%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV GREVSSGIVSES+EV + SVESS + + KT VE+QN+ES+K+++
Sbjct: 1 MGCVLGREVSSGIVSESREVKHPSVESSRTLDNDSATKTDTSSFVEIQNEESQKEDKS-- 58
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+G+KK + ER+RS+ NPRLSN PKHLRGEQVAAGWPPWL+AVCGEALNGWIPRRAD+FEK
Sbjct: 59 EGDKKSKAERRRSRPNPRLSNPPKHLRGEQVAAGWPPWLSAVCGEALNGWIPRRADTFEK 118
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDK+G GTYSNVYKA+D+L+GKIVALKKVRFDNLEPESVKFMAREILILRRLDH NV+KL
Sbjct: 119 IDKVGSGTYSNVYKARDLLSGKIVALKKVRFDNLEPESVKFMAREILILRRLDHLNVVKL 178
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
EGLVTSRMSCSLYLVF YMEHDLAGLA SP VKFTE QVKCYMHQLLSGLEHCHN GVLH
Sbjct: 179 EGLVTSRMSCSLYLVFEYMEHDLAGLAVSPGVKFTESQVKCYMHQLLSGLEHCHNRGVLH 238
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RDIKGSNLLID++G+L+IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV
Sbjct: 239 RDIKGSNLLIDNEGILRIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 298
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360
DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS+EYWKKSKLP+ATLF+PREPY
Sbjct: 299 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKSKLPHATLFRPREPY 358
Query: 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
KRCI+ETFKDFPPSSLPLIETLLAIDPAER TAT AL SE + C
Sbjct: 359 KRCIRETFKDFPPSSLPLIETLLAIDPAERQTATAALKSEFFTTEPYAC 407
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505916|ref|XP_003521735.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/409 (81%), Positives = 360/409 (88%), Gaps = 7/409 (1%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVS GI+SE KE S ES RKVG VS G+VVEVQN E +EK
Sbjct: 1 MGCVISREVSKGIISEVKEEKGLSGESK-RKVGGVSGSK--GEVVEVQNGE----KEKGG 53
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+G ++ GER+RSK+NPRLSN PKHLRGEQVAAGWPPWLTAVCGEAL+GWIPR+AD+FEK
Sbjct: 54 EGVQRSCGERRRSKANPRLSNPPKHLRGEQVAAGWPPWLTAVCGEALSGWIPRKADTFEK 113
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKAKDM+TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV+KL
Sbjct: 114 IDKIGQGTYSNVYKAKDMMTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVVKL 173
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTEPQVKCYMHQLLSGLEHCHN VLH
Sbjct: 174 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPGIRFTEPQVKCYMHQLLSGLEHCHNRHVLH 233
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RDIKGSNLLID++G LKIADFGLAS FDPNHKHPMTSRVVTLWYRPPELLLGATDY VGV
Sbjct: 234 RDIKGSNLLIDNEGTLKIADFGLASIFDPNHKHPMTSRVVTLWYRPPELLLGATDYSVGV 293
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360
DLWSAGCIL ELLAGKPIMPGRTEVEQLHKIYKLCGSPS+EYWKKSKLPNAT FKPR+PY
Sbjct: 294 DLWSAGCILGELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKSKLPNATSFKPRDPY 353
Query: 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
KR I+ETFKDFPPS+LPLI+TLLAIDP ER TA+ AL SE + C
Sbjct: 354 KRHIRETFKDFPPSALPLIDTLLAIDPVERKTASDALRSEFFTTEPYAC 402
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535133|ref|XP_003536103.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/410 (78%), Positives = 354/410 (86%), Gaps = 2/410 (0%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVSSGIVSE KE N SV S++KV S + + V QN E K+E
Sbjct: 1 MGCVISREVSSGIVSEVKEEKNLSV-GSNKKVDEASTSGAEENAVVAQNGEKEKEENGGG 59
Query: 61 DGE-KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
D ++P+GER+RSK NPRLSN PKHL+GEQVAAGWPPWLTAVCGEAL+GWIPR+AD+FE
Sbjct: 60 DDRVRRPKGERRRSKPNPRLSNPPKHLQGEQVAAGWPPWLTAVCGEALSGWIPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKD LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK
Sbjct: 120 KIDKIGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
LEGLVTSRMS SLYLVF YM HDLAGLAASP++KFTEPQVKCY+HQLLSGLEHCH+ VL
Sbjct: 180 LEGLVTSRMSLSLYLVFDYMVHDLAGLAASPDIKFTEPQVKCYIHQLLSGLEHCHSRNVL 239
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 299
HRDIKGSNLLID++G+LKIADFGLASFFDPN + PMT+RVVTLWYRP ELLLGAT+YG
Sbjct: 240 HRDIKGSNLLIDNEGILKIADFGLASFFDPNRRQPMTNRVVTLWYRPLELLLGATEYGAA 299
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359
+DLWS GCIL ELLAGKPI+PGRTEVEQLHKIYKLCGSPS+EYWKKSK+PNATLFKPR P
Sbjct: 300 IDLWSVGCILGELLAGKPILPGRTEVEQLHKIYKLCGSPSDEYWKKSKMPNATLFKPRHP 359
Query: 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
YKRCI ETFKDFPPS+LPLI+TLLAIDPAER +AT AL SE + C
Sbjct: 360 YKRCITETFKDFPPSALPLIDTLLAIDPAERKSATDALRSEFFTTEPYAC 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451183|ref|XP_002273085.1| PREDICTED: probable serine/threonine-protein kinase At1g54610 [Vitis vinifera] gi|298204939|emb|CBI34246.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/417 (78%), Positives = 362/417 (86%), Gaps = 12/417 (2%)
Query: 1 MGCVFGREV-SSGIVSES-------KEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDES 52
MGCV GREV S+ +VSE+ KE + S +S+RK+ +V+ K+ VEV N E+
Sbjct: 1 MGCVLGREVLSNVVVSEANGAEKSIKEKRSNSSVNSNRKLDDVTKKS--DSKVEVGNGET 58
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+K+E+ DG ++PRG++K+ +SNPRLSNLP H+RGEQVAAGWP WL+ V G ALNGWIP
Sbjct: 59 QKEEK--TDGSQRPRGDKKKLRSNPRLSNLPNHVRGEQVAAGWPSWLSDVAGPALNGWIP 116
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
RRAD+F+K+DKIGQGTYSNVYKA+DMLTGKIVALKKVRFDNLEPESVKFMAREI+ILRRL
Sbjct: 117 RRADTFQKLDKIGQGTYSNVYKARDMLTGKIVALKKVRFDNLEPESVKFMAREIVILRRL 176
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
DHPNV+KLEGLVTSR+SCSLYLVF YMEHDLAGLAASP +KFTEPQVKCYM QLLSGLEH
Sbjct: 177 DHPNVVKLEGLVTSRLSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMKQLLSGLEH 236
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
CHN GVLHRDIKGSNLL+D+ GVLKIADFGLA+ FDPN+KHPMTSRVVTLWYRPPELLLG
Sbjct: 237 CHNRGVLHRDIKGSNLLLDNGGVLKIADFGLAAIFDPNYKHPMTSRVVTLWYRPPELLLG 296
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
A DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS+EYWKK +LPNAT
Sbjct: 297 ANDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKYRLPNAT 356
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
LFKPREPYKRCI ETFKDFPPSSLPLIETLLAIDP ER TAT ALN E C
Sbjct: 357 LFKPREPYKRCIAETFKDFPPSSLPLIETLLAIDPVERRTATAALNCEFFTTKPYAC 413
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788188|emb|CAN73716.1| hypothetical protein VITISV_038843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/417 (77%), Positives = 362/417 (86%), Gaps = 12/417 (2%)
Query: 1 MGCVFGREV-SSGIVSES-------KEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDES 52
MGCV GREV S+ +VSE+ KE + S +S+RK+ +V+ K+ VEV N E+
Sbjct: 1 MGCVLGREVLSNVVVSEANGAEKSIKEKRSNSSVNSNRKLDDVTKKS--DSKVEVGNGET 58
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+K+E+ DG ++PRG++K+ +SNP+LSNLP H+RGEQVAAGWP WL+ V G ALNGWIP
Sbjct: 59 QKEEK--TDGSQRPRGDKKKLRSNPKLSNLPNHVRGEQVAAGWPSWLSDVAGPALNGWIP 116
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
RRAD+F+K+DKIGQGTYSNVYKA+DMLTGKIVALKKVRFDNLEPESVKFMAREI+ILRRL
Sbjct: 117 RRADTFQKLDKIGQGTYSNVYKARDMLTGKIVALKKVRFDNLEPESVKFMAREIVILRRL 176
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
DHPNV+KLEGLVTSR+SCSLYLVF YMEHDLAGLAASP +KFTEPQVKCYM QLLSGLEH
Sbjct: 177 DHPNVVKLEGLVTSRLSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMKQLLSGLEH 236
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
CHN GVLHRDIKGSNLL+D+ GVLKIADFGLA+ FDPN+KHPMTSRVVTLWYRPPELLLG
Sbjct: 237 CHNRGVLHRDIKGSNLLLDNGGVLKIADFGLAAIFDPNYKHPMTSRVVTLWYRPPELLLG 296
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
A DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS+EYWKK +LPNAT
Sbjct: 297 ANDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKYRLPNAT 356
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
LFKPREPYKRCI ETFKDFPPSSLPLIETLLAIDP ER TAT ALN E C
Sbjct: 357 LFKPREPYKRCIAETFKDFPPSSLPLIETLLAIDPVERRTATAALNCEFFTTKPYAC 413
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576745|ref|XP_003556490.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/410 (78%), Positives = 356/410 (86%), Gaps = 2/410 (0%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVSSGIV E KE + SVES+ +KV VS ++ + VE QN E K+E
Sbjct: 1 MGCVISREVSSGIVYEVKEDKSSSVESN-KKVDQVSTGRVEENAVEAQNGEKEKEENGGG 59
Query: 61 DGE-KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
D + ++ +GERKRSK NPRLSN KHL+GEQ+AAGWP WLTAVCGE L+GWIPR+AD+FE
Sbjct: 60 DDQVRRLKGERKRSKPNPRLSNPTKHLQGEQLAAGWPAWLTAVCGEVLSGWIPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKD LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK
Sbjct: 120 KIDKIGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
LEGLVTSRMS SLYLVF YM HDLAGLAASP++KFTEPQVKCYMHQLLSGLEHCH+ +L
Sbjct: 180 LEGLVTSRMSLSLYLVFDYMVHDLAGLAASPDIKFTEPQVKCYMHQLLSGLEHCHSQNIL 239
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 299
HRDIKGSNLLID++G+LKIADFGLASFFDPN + PMT+RVVTLWYRP ELLLGAT+YG
Sbjct: 240 HRDIKGSNLLIDNEGILKIADFGLASFFDPNRRQPMTNRVVTLWYRPLELLLGATEYGAA 299
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359
+DLWS GCIL ELLAGKPI+PGRTEVEQLHKIYKLCGSPS+EYWKKSK+PNATLFKPREP
Sbjct: 300 IDLWSVGCILGELLAGKPILPGRTEVEQLHKIYKLCGSPSDEYWKKSKMPNATLFKPREP 359
Query: 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
YKRCI+ETFKDFPPS+LPLI+TLLAIDPAER +AT AL SE + C
Sbjct: 360 YKRCIRETFKDFPPSALPLIDTLLAIDPAERKSATNALRSEFFTTEPYAC 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573056|ref|XP_003554681.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/409 (79%), Positives = 353/409 (86%), Gaps = 7/409 (1%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVS G++S+ KE + S ES RKV VS +VVEVQN E K++
Sbjct: 1 MGCVISREVSKGVISDVKEERDLSGESK-RKVDGVSGSK--DEVVEVQNGEKEKEKGGEG 57
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
RG+R+RSK+NPRLSN PKHLR EQVAAGWPPWLTAVCGEAL GWIPR+AD+FEK
Sbjct: 58 ----VQRGKRRRSKANPRLSNPPKHLRWEQVAAGWPPWLTAVCGEALGGWIPRKADTFEK 113
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKAKDM+TGKIVALKKVRFDN EPESVKFMAREILILRRLDHPNV+KL
Sbjct: 114 IDKIGQGTYSNVYKAKDMMTGKIVALKKVRFDNWEPESVKFMAREILILRRLDHPNVVKL 173
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTEPQVKCYMHQLLSGLEHCHN VLH
Sbjct: 174 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPGIRFTEPQVKCYMHQLLSGLEHCHNRRVLH 233
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RDIKGSNLLID++G LKIADFGLAS FDPN+KHPMTSRVVTLWYRPPELLLGATDYGVGV
Sbjct: 234 RDIKGSNLLIDNEGTLKIADFGLASIFDPNNKHPMTSRVVTLWYRPPELLLGATDYGVGV 293
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360
DLWSAGCIL ELLAGKPIMPGRTEVEQLHKIYKLCGSPS+EYWKKS LPNATLFKP EPY
Sbjct: 294 DLWSAGCILGELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKSNLPNATLFKPLEPY 353
Query: 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
KR I+ETFKDFPPS+LPLI+TLLAIDP ER TA+ AL SE + C
Sbjct: 354 KRRIRETFKDFPPSALPLIDTLLAIDPVERKTASDALRSEFFTTEPYAC 402
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435738|ref|XP_004135651.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/413 (76%), Positives = 352/413 (85%), Gaps = 5/413 (1%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDE----SRKKE 56
MGC+ RE SS V + + + SR G + V+ + + V V +E ++++E
Sbjct: 1 MGCLVSREASSRSVEAPVDKGKRNQITESRVQGEI-VQEKEVERVSVNVEEHVNVNKEEE 59
Query: 57 EKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRAD 116
+K + +PR ER++S+ PR +NLP H +GEQVAAGWP WLTAVCGEALNGWIPR+AD
Sbjct: 60 QKADVVQDRPRAERRKSRKVPRPTNLPNHSQGEQVAAGWPSWLTAVCGEALNGWIPRKAD 119
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+FEKIDKIGQGTYSNVYKAKD+LTGKIVALKKVRFDNLEPESVKFMAREILILRRL+H N
Sbjct: 120 TFEKIDKIGQGTYSNVYKAKDILTGKIVALKKVRFDNLEPESVKFMAREILILRRLNHNN 179
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
V+KLEGLVTSRMSCSLYLVF YMEHDLAGLAA+P +KFTE QVKC+M QLLSGLEHCHN
Sbjct: 180 VVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAANPSIKFTESQVKCFMQQLLSGLEHCHNR 239
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
VLHRDIKGSNLLID GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY
Sbjct: 240 RVLHRDIKGSNLLIDSGGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 299
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356
GVGVDLWSAGCILAELLAG+PIMPGRTEVEQLHKIYKLCGSPS+EYWK++KLPNATLFKP
Sbjct: 300 GVGVDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSDEYWKRAKLPNATLFKP 359
Query: 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
R+PYKRCI+ETFKDFPPSSLPLIETLLAIDPAER TAT ALNSE + C
Sbjct: 360 RDPYKRCIKETFKDFPPSSLPLIETLLAIDPAERKTATDALNSEFFMTEPLAC 412
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7671528|emb|CAB89490.1| CRK1 protein [Beta vulgaris subsp. vulgaris] gi|7688002|emb|CAB89665.1| CRK1 protein [Beta vulgaris subsp. vulgaris] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/434 (73%), Positives = 360/434 (82%), Gaps = 27/434 (6%)
Query: 1 MGCVFGREV---SSGIVSESKEVSNFSVESSSRKVGNVSVKTI--------DGDVVEVQ- 48
MGCVFG+E +E N ES RKV ++ V + DG+ V+
Sbjct: 1 MGCVFGKESLAPEGRERGGRREKENLGTESG-RKV-DLPVADVVSGWDTGKDGENGGVEL 58
Query: 49 NDESRKKEEK--VVDGE-----------KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGW 95
ND +K EEK DGE +KPRGER+R+K+NPRLSN PK++ GEQVAAGW
Sbjct: 59 NDGGKKDEEKNGEEDGEEKREGEGKGRSQKPRGERRRTKANPRLSNPPKNVHGEQVAAGW 118
Query: 96 PPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE 155
P WL+AV GEA++GW+PRRAD+FEKIDKIGQGTYSNVYKA+D LTGKIVALKKVRFDNLE
Sbjct: 119 PSWLSAVAGEAIDGWVPRRADTFEKIDKIGQGTYSNVYKARDSLTGKIVALKKVRFDNLE 178
Query: 156 PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT 215
PESVKFMAREILILRRLDHPNV+KLEGLVTSRMSCSLYLVF YMEHDLAGLAASP++KFT
Sbjct: 179 PESVKFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPDIKFT 238
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275
EPQVKCYMHQL+SGLEHCHN GVLHRDIKGSNLL+D+ G+LKIADFGLA+FFDPN KHPM
Sbjct: 239 EPQVKCYMHQLISGLEHCHNRGVLHRDIKGSNLLLDNGGILKIADFGLATFFDPNKKHPM 298
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335
TSRVVTLWYR PELLLGATDYGVG+DL SAGCILAELLAG+PIMPGRTEVEQLHKIYKLC
Sbjct: 299 TSRVVTLWYRAPELLLGATDYGVGIDLRSAGCILAELLAGRPIMPGRTEVEQLHKIYKLC 358
Query: 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395
GSPS+EYWKKSKLPNAT+FKPREPYKRCI+ETF+DFPPS+L LI++LLAIDPAER TAT
Sbjct: 359 GSPSDEYWKKSKLPNATIFKPREPYKRCIRETFRDFPPSALSLIDSLLAIDPAERKTATD 418
Query: 396 ALNSEVIFQDRTLC 409
ALNS+ + C
Sbjct: 419 ALNSDFFSTEPLAC 432
|
Source: Beta vulgaris subsp. vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512159|ref|XP_003626368.1| Cdc2-like protein kinase [Medicago truncatula] gi|355501383|gb|AES82586.1| Cdc2-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1644), Expect = e-180, Method: Compositional matrix adjust.
Identities = 306/409 (74%), Positives = 345/409 (84%), Gaps = 11/409 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV GR+ SS S + + + V+ +S + + +VVE++ND+ +K ++ V
Sbjct: 1 MGCVIGRQASSNKGSGA-QTNRIKVDEAS--AATTASNGEEKNVVEIENDQKKKSDDSV- 56
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+RSK NPRLSN PKHLRGEQVAAGWP WLTAVCGEAL GWIPR+AD+FEK
Sbjct: 57 -------QRSRRSKPNPRLSNPPKHLRGEQVAAGWPSWLTAVCGEALTGWIPRKADTFEK 109
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKA D +TGK+VALKKVRFDNLEPES+KFMAREI+ILRRLDHPNVIKL
Sbjct: 110 IDKIGQGTYSNVYKAIDSMTGKVVALKKVRFDNLEPESIKFMAREIIILRRLDHPNVIKL 169
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTE Q+KCYM+QLLSGLEHCHN VLH
Sbjct: 170 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPVIRFTESQIKCYMNQLLSGLEHCHNRRVLH 229
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RDIKGSNLLID++G+LKIADFGLASFFDPN+ +PMTSRVVTLWYRPPELLLGATDYGVG+
Sbjct: 230 RDIKGSNLLIDNEGILKIADFGLASFFDPNYMNPMTSRVVTLWYRPPELLLGATDYGVGI 289
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360
DLWSAGCIL ELL GKPIMPGRTEVEQLHKIYKLCGSPS+EYWKKSKLPNATLFKPREPY
Sbjct: 290 DLWSAGCILGELLVGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKSKLPNATLFKPREPY 349
Query: 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
KRCI+ETFK FPPS+LPLI+ LLAIDP ER TA+ AL SE + C
Sbjct: 350 KRCIRETFKGFPPSALPLIDKLLAIDPVERETASDALRSEFFTTEPYAC 398
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 410 | ||||||
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.995 | 0.712 | 0.721 | 1.4e-160 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.995 | 0.688 | 0.657 | 5.4e-145 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.990 | 0.585 | 0.651 | 1.2e-138 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.770 | 0.544 | 0.765 | 2e-134 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.787 | 0.452 | 0.712 | 1.9e-129 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.787 | 0.462 | 0.695 | 4.2e-127 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.802 | 0.464 | 0.669 | 3e-124 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.807 | 0.539 | 0.670 | 3e-124 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.775 | 0.429 | 0.710 | 9.2e-123 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.836 | 0.532 | 0.652 | 1.1e-119 |
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1564 (555.6 bits), Expect = 1.4e-160, P = 1.4e-160
Identities = 296/410 (72%), Positives = 336/410 (81%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRXXXXXXX 60
MGCVFGRE ++ +E+K+ + S VG SV +G V+ ++ +
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNG-VIADDVEKKKNEEANGD 59
Query: 61 XXXXXPRGERKRS-KSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
+G+R+RS K NPRLSN KH RGEQVAAGWP WL+ CGEALNGW+PR+AD+FE
Sbjct: 60 KERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL+LRRLDHPNV+K
Sbjct: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
LEGLVTSRMSCSLYLVF YM+HDLAGLA+SP VKF+E +VKC M QL+SGLEHCH+ GVL
Sbjct: 180 LEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVL 239
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 299
HRDIKGSNLLIDD GVLKIADFGLA+ FDPNHK PMTSRVVTLWYR PELLLGATDYGVG
Sbjct: 240 HRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVG 299
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359
+DLWSAGCILAELLAG+PIMPGRTEVEQLHKIYKLCGSPSE+YWKK K + ++KPREP
Sbjct: 300 IDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREP 359
Query: 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
YKR I+ETFKDFPPSSLPLI+ LL+I+P +R TA+ AL SE + C
Sbjct: 360 YKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYAC 409
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1351 (480.6 bits), Expect = 5.4e-145, Sum P(2) = 5.4e-145
Identities = 277/421 (65%), Positives = 315/421 (74%)
Query: 2 GCVFGR--EVSSGIVSESKEVSNFSV---ESSSRKVGNVSVKTIDGDVV----EVQNDES 52
G V G EVS+ I S +V+N SV E++ V +G+ V +V + +
Sbjct: 12 GSVSGSRDEVSTRIESNRHQVNNVSVTKTETTESTSAVVVASASNGEEVRNHEDVVDQKK 71
Query: 53 RXXXXXXXXXXXXPRGERKRSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWI 111
+GERKRSK +PR SN PK+L GEQVAAGWP WL+ VCGEAL+GW+
Sbjct: 72 ENGFVVTEAKERKSKGERKRSKPPDPRRSNPPKNLLGEQVAAGWPSWLSEVCGEALSGWL 131
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
PR+ADSFEKIDKIG GTYSNVYKAKD LTG IVALKKVR D E ES+KFMAREILILRR
Sbjct: 132 PRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCDVNERESLKFMAREILILRR 191
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
LDHPNVIKLEGLVTSRMS SLYLVF YM+HDLAGLAASPE+KFTE QVKCYM QLLSGLE
Sbjct: 192 LDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEIKFTEQQVKCYMKQLLSGLE 251
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
HCHN GVLHRDIKGSNLLIDD GVL+I DFGLA+FFD + + MT+RVVTLWYR PELL
Sbjct: 252 HCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKRQEMTNRVVTLWYRSPELLH 311
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
G +Y VGVDLWSAGCILAELLAG+ IMPGR EVEQLH+IYKLCGSPSEEYWKK +LP+
Sbjct: 312 GVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQLHRIYKLCGSPSEEYWKKIRLPST 371
Query: 352 ---TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408
KP YKR I+E +KDF P +L L++TLLA+DPAER TAT L S+ +
Sbjct: 372 HKHAHHKPLPQYKRRIREVYKDFSPEALSLLDTLLALDPAERQTATDVLMSDFFTTEPLA 431
Query: 409 C 409
C
Sbjct: 432 C 432
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1357 (482.7 bits), Expect = 1.2e-138, P = 1.2e-138
Identities = 277/425 (65%), Positives = 319/425 (75%)
Query: 1 MGCVFGR----EVSSGIVSE---SKEVSNFSVE---SSSRKVGNVSVKTIDGDVVEVQ-- 48
MGCV G+ E S E SK S F V +SSR+ + +K DVV V+
Sbjct: 1 MGCVCGKPSAIEDSKDSPRERFSSKSSSEFRVSRPVASSRREEPLRIKE-RSDVVSVRPV 59
Query: 49 --NDESRXXXXXXXXXXXX--PRGERKRSKSNPRLS-NLPKHLRGEQVAAGWPPWLTAVC 103
N +S R E + S +S + K GE VAAGWPPWL +V
Sbjct: 60 LSNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVA 119
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
GEA+ GW+PRRADSFEK+DKIGQGTYSNVY+A+D+ KIVALKKVRFDNLEPESV+FMA
Sbjct: 120 GEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 179
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYM 223
REI ILRRLDHPN+IKLEGLVTSRMSCSLYLVF YMEHDLAGLA+ P +KF+E QVKCY+
Sbjct: 180 REIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKCYL 239
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
QLL GL+HCH+ GVLHRDIKGSNLLID+ GVLKIADFGLASFFDP P+TSRVVTLW
Sbjct: 240 QQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTLW 299
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
YRPPELLLGAT YG VDLWSAGCILAEL AGKPIMPGRTEVEQLHKI+KLCGSP+E+YW
Sbjct: 300 YRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYW 359
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403
KS+LP+AT+FKP +PYKR + ETFK+FP +L L+ETLL+++P +R TAT AL SE F
Sbjct: 360 VKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSE-FF 418
Query: 404 QDRTL 408
R L
Sbjct: 419 STRPL 423
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.0e-134, P = 2.0e-134
Identities = 242/316 (76%), Positives = 276/316 (87%)
Query: 94 GWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN 153
GWPPWL A CG+++ PRRA ++EK++KIGQGTYSNVYKAKD+L+GKIVALKKVRFDN
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 154 LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK 213
LE ESVKFMAREIL+LRRL+HPNVIKL+GLVTSR+SCSLYLVF YMEHDL+GLAA+ +K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273
F PQVKC+M QLLSGLEHCH+ GVLHRDIKGSNLLID+DG+LKIADFGLA+F+DP K
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
MTSRVVTLWYRPPELLLGAT YG GVDLWSAGCI+AELLAGKP+MPGRTEVEQLHKI+K
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
LCGSPS+ YWKK +LPNATLFKP+ PYKRC+ E F F PSS+ L+ETLL IDPA+R T+
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 394 TVALNSEVIFQDRTLC 409
T ALNSE + C
Sbjct: 390 TSALNSEFFTTEPLPC 405
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
Identities = 230/323 (71%), Positives = 276/323 (85%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
R+ ++ RG QV AGWP WL +V GEA+NGWIPR+ADSFEK++KIGQGTYS+VYKA+D
Sbjct: 123 RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARD 182
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
+ T ++VALKKVRF N++P+SV+FMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F
Sbjct: 183 LETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFE 242
Query: 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 257
YMEHDLAGLA++P + F+E Q+KCYM QLL GLEHCH+ GVLHRDIKGSNLL+D + LK
Sbjct: 243 YMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLK 302
Query: 258 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317
I DFGLA+F+ + K P+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL GKP
Sbjct: 303 IGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKP 362
Query: 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP 377
IMPGRTEVEQLHKI+KLCGSPSEEYWK SKLP+AT+FKP++PYKRC+ ETFK P S+L
Sbjct: 363 IMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALA 422
Query: 378 LIETLLAIDPAERLTATVALNSE 400
L+E LLA++P R T AL SE
Sbjct: 423 LVEVLLAVEPDARGTTASALESE 445
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
Identities = 226/325 (69%), Positives = 279/325 (85%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
RL N+ ++L EQVAAGWP WL+ V GEA++GW+P R+D+FEK++KIGQGTYSNV++A +
Sbjct: 81 RLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVE 140
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
TG+IVALKKVRFDN EPESVKFMAREILILRRL+HPN+IKLEGL+TS++SC++ LVF
Sbjct: 141 TETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFE 200
Query: 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 257
YMEHDL GL +SP++KFT PQ+KCYM QLLSGL+HCH+ GV+HRDIKGSNLL+ ++G+LK
Sbjct: 201 YMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILK 260
Query: 258 IADFGLASFFDPN-HKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
+ADFGLA+F + + HK P+TSRVVTLWYRPPELLLGATDYG VDLWS GC+ AELL G
Sbjct: 261 VADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLG 320
Query: 316 KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSS 375
KPI+ GRTEVEQLHKI+KLCGSP E+YWKKSKLP+A LFKP++ Y C++ET KD +
Sbjct: 321 KPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETE 380
Query: 376 LPLIETLLAIDPAERLTATVALNSE 400
+ LIETLL+IDP +R TA+ AL S+
Sbjct: 381 INLIETLLSIDPHKRGTASSALVSQ 405
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1221 (434.9 bits), Expect = 3.0e-124, P = 3.0e-124
Identities = 223/333 (66%), Positives = 283/333 (84%)
Query: 72 RSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYS 130
RS+S + RL NL K+L EQVAAGWP WL+ V GEA++GW+P R+D+FEK++KIGQGTYS
Sbjct: 84 RSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYS 143
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190
+V++A++ TG+IVALKKVRFDN EPESV+FMAREILILR+L+HPN+IKLEG+VTS++SC
Sbjct: 144 SVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSC 203
Query: 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250
S++LVF YMEHDL GL +SP++ FT PQ+KCYM QLLSGL+HCH GV+HRDIKGSNLL+
Sbjct: 204 SIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLV 263
Query: 251 DDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 309
+++G+LK+ADFGLA+F + + +K P+TSRVVTLWYRPPELLLGAT+YG VDLWS GC+
Sbjct: 264 NNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVF 323
Query: 310 AELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFK 369
AELL GKP++ GRTEVEQLHKI+KLCGSP E+YWKKSKLP+A LFKP++ Y C++ET K
Sbjct: 324 AELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLK 383
Query: 370 --DFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ + LIETLL+I P +R TA+ AL S+
Sbjct: 384 LKGLSDADINLIETLLSIQPHKRGTASTALVSQ 416
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1221 (434.9 bits), Expect = 3.0e-124, P = 3.0e-124
Identities = 222/331 (67%), Positives = 273/331 (82%)
Query: 79 LSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDM 138
+SN+P+ E +AAGWP WLT+V GEA+ GW+PRRADSFEK+DKIGQGTYS VYKA+D+
Sbjct: 102 ISNVPRSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDL 161
Query: 139 LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198
TGKIVA+KKVRF N++PESV+FMAREI ILR+LDHPNV+KL+ LVTS++S SL+LVF Y
Sbjct: 162 ETGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEY 221
Query: 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKI 258
MEHDL+GLA P VKFTEPQ+KC+M QLL GLEHCH+ G+LHRDIKGSNLL+++DGVLKI
Sbjct: 222 MEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKI 281
Query: 259 ADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI 318
DFGLASF+ P+ P+TSRVVTLWYR PELLLG+T+YG +DLWS GCILAEL KPI
Sbjct: 282 GDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPI 341
Query: 319 MPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPL 378
MPGRTEVEQ+HKI+KLCGSPSEE+W +K P AT +KP+ PYKR + ETFK+ SSL L
Sbjct: 342 MPGRTEVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDL 401
Query: 379 IETLLAIDPAERLTATVALNSEVIFQDRTLC 409
++ LL+++P +R +A+ L SE + C
Sbjct: 402 LDKLLSVEPEKRCSASSTLLSEFFTTEPLPC 432
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1207 (429.9 bits), Expect = 9.2e-123, P = 9.2e-123
Identities = 226/318 (71%), Positives = 264/318 (83%)
Query: 83 PKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK 142
PK +QVAAGWP WL +V GE+L W PRRA++FEK++KIGQGTYS+VY+A+D+L K
Sbjct: 178 PKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNK 237
Query: 143 IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202
IVALKKVRFD + ESVKFMAREI+++RRLDHPNV+KLEGL+T+ +S SLYLVF YM+HD
Sbjct: 238 IVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHD 297
Query: 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262
L GL++ P VKFTEPQVKCYM QLLSGLEHCH+ GVLHRDIKGSNLLID GVLKIADFG
Sbjct: 298 LLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFG 357
Query: 263 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 322
LA+FFDP +TS VVTLWYRPPELLLGA+ YGVGVDLWS GCIL EL AGKPI+PG+
Sbjct: 358 LATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGK 417
Query: 323 TEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETL 382
TEVEQLHKI+KLCGSP+E YW+K KLP++ FK PY+R + E FKDFP S L L+ETL
Sbjct: 418 TEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETL 477
Query: 383 LAIDPAERLTATVALNSE 400
L+IDP R +A AL SE
Sbjct: 478 LSIDPDHRSSADRALESE 495
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 225/345 (65%), Positives = 270/345 (78%)
Query: 66 PRGERKRSKSNPRLSNLPKHLRGE-QVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKI 124
P E KR S + P+ + E ++AAGWP WL +V GEAL W PRRA +FEK++KI
Sbjct: 85 PPEELKREPSVV-IPPSPETVSKEAELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKI 143
Query: 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLV 184
GQGTYS+VYKA+D+ KIVALK+VRFD + ESVKFMAREI+++RRLDHPNV+KLEGL+
Sbjct: 144 GQGTYSSVYKARDLTNNKIVALKRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLI 203
Query: 185 TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIK 244
T+ +S SLYLVF YM+HDL GLA+ P +KF+EPQVKCYM QLLSGL HCH+ GVLHRDIK
Sbjct: 204 TASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIK 263
Query: 245 GSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 304
GSNLLID +GVLKIADFGLA+FFDP + P+TSRVVTLWYRPPELLLGA YGVGVDLWS
Sbjct: 264 GSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWS 323
Query: 305 AGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCI 364
GCIL EL +GKPI+ G+TEVEQLHKI+KLCGSP+E+YW+K KLP + F+P PY R +
Sbjct: 324 TGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRV 383
Query: 365 QETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409
E FKD P + L L+E LL+IDP R +A AL SE + C
Sbjct: 384 AEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYFRTEPFAC 428
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZVM9 | Y1461_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7347 | 0.9926 | 0.7115 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 410 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-159 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-120 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-111 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-106 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-105 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-103 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-103 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-100 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-98 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-98 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-90 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-85 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-84 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-83 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-82 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-81 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-80 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-79 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-78 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-76 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-75 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-73 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-73 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-73 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-72 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-70 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-70 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-65 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-64 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-63 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-62 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-62 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-61 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-61 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-61 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-59 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-58 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-57 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-57 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-56 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-53 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-52 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-51 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-51 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-50 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-49 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-48 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-47 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-46 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-38 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 448 bits (1156), Expect = e-159
Identities = 162/285 (56%), Positives = 214/285 (75%), Gaps = 2/285 (0%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+EKI +IG+GTY VYKA++ TG++VALKK+R +N + REI +L++L HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
++L+ +VTS+ S+Y+VF YM+HDL GL SPEVKFTE Q+KCYM QLL GL++ H+NG
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
+LHRDIKGSN+LI++DGVLK+ADFGLA + + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 298 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATLFKP 356
VD+WS GCILAEL GKPI G TE+EQL KI++LCGSP++E W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 357 REPYKRCIQETFKDF-PPSSLPLIETLLAIDPAERLTATVALNSE 400
++PYKR ++E FK PS+L L++ LL +DP +R++A AL E
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 350 bits (901), Expect = e-120
Identities = 126/283 (44%), Positives = 181/283 (63%), Gaps = 7/283 (2%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+EK++K+G+GTY VYKA+D TG+IVALKK+R DN E E + A REI +L+ L HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
++KL ++ + LYLVF Y + DL + +K M+QLL GL +CH++
Sbjct: 60 IVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
+LHRD+K N+LI+ DGVLK+ADFGLA F T VVTLWYR PE+LLG+ Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHY 176
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATLFK 355
VD+WS GCI AE++ GKP+ PG +E++QL KI+++ G+P+EE W +KLP+
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P+ P K +++ P + L+ +L +PA+R++A AL
Sbjct: 237 PKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 327 bits (841), Expect = e-111
Identities = 130/288 (45%), Positives = 182/288 (63%), Gaps = 11/288 (3%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMA-REILILRRLDH 174
+EK K+G+GTY+ VYKA+D TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
PN+I L + + + + LVF +ME DL + + T +K YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGA 293
+N +LHRD+K +NLLI DGVLK+ADFGLA F PN K MT +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGA 177
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNAT 352
YGVGVD+WS GCI AELL P +PG ++++QL KI++ G+P+EE W + LP+
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
FKP P +++ F +L L++ LL ++P +R+TA AL
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-106
Identities = 137/303 (45%), Positives = 188/303 (62%), Gaps = 19/303 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+E + K+G+GT+ VYKA+ + TG++VALKK+ N E + A REI IL++L H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKH 66
Query: 175 PNVIKLEGLV------TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLS 228
PNV+ L + + R S+Y+V YM+HDL+GL +P VK TE Q+KCYM QLL
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHP-------MTSR 278
G+ + H N +LHRDIK +N+LID+ G+LKIADFGLA +D PN K T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP 338
VVT WYRPPELLLG Y VD+W GC+ AE+ +PI+ G+++++QLH I+KLCG+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 339 SEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+EE W LP Y R ++E F P L L+ LL++DP +RLTA+ AL
Sbjct: 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 398 NSE 400
Sbjct: 307 EHP 309
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 312 bits (802), Expect = e-105
Identities = 143/300 (47%), Positives = 189/300 (63%), Gaps = 11/300 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I +IG+GTY VYKA+D TG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
LR+L+H N++ L+ +VT + + YLVF YM+HDL GL S V F+E +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
+M QLL GL +CH LHRDIK SN+L+++ G +K+ADFGLA ++ P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYRPPELLLG YG +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 341 EYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
W KLP KP++ Y+R ++E F P +L L++ +L +DP++R TA ALNS
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 141/294 (47%), Positives = 192/294 (65%), Gaps = 7/294 (2%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
FEK+++IG+GTY VY+A+D +G+IVALKKVR DN E + + + REI +L L HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
+++L+ +V + S++LV Y E DLA L + F+E QVKC M QLL GL++ H N
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
++HRD+K SNLL+ D G LKIADFGLA + PMT +VVTLWYR PELLLG T Y
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATLFK 355
+D+W+ GCILAELLA KP++PG++E+EQL I +L G+P+E W S LP F
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 356 -PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408
P++PY ++ F + L L+ LL DP +R TA AL S F+++ L
Sbjct: 247 LPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS-YFKEKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 306 bits (785), Expect = e-103
Identities = 130/293 (44%), Positives = 186/293 (63%), Gaps = 8/293 (2%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRR 171
R D +EK+++I +GTY VY+A+D TG+IVALKK++ + E E + REI IL +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
L HPN++ ++ +V +Y+V Y+EHDL L + + F + +VKC M QLLSG+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPELL 290
H H+N +LHRD+K SNLL+++ G+LKI DFGLA + P P T VVTLWYR PELL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYRAPELL 178
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLP 349
LGA +Y +D+WS GCI AELL KP+ PG++E++QL+KI+KL G+P+E+ W S+LP
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238
Query: 350 NATLFKPREPYKRCIQETFKDFPPS--SLPLIETLLAIDPAERLTATVALNSE 400
A + +++ F S L+ LL DPA+R++A AL
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 140/313 (44%), Positives = 184/313 (58%), Gaps = 26/313 (8%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA- 163
+ +EK+ KIGQGT+ V+KA+ T +IVALKKV +N E E A
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITAL 59
Query: 164 REILILRRLDHPNVIKL------EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP 217
REI IL+ L H NV+ L + +R S YLVF + EHDLAGL ++ VKFT
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119
Query: 218 QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHP 274
++K M LL+GL + H N +LHRD+K +N+LI DG+LK+ADFGLA F + +
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
T+RVVTLWYRPPELLLG DYG +D+W AGCI+AE+ PIM G TE QL I +L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 335 CGSPSEEYW---------KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAI 385
CGS + E W KK +LP K +E K +++ P +L LI+ LL +
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD------PHALDLIDKLLVL 293
Query: 386 DPAERLTATVALN 398
DPA+R+ A ALN
Sbjct: 294 DPAKRIDADTALN 306
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 2e-98
Identities = 125/281 (44%), Positives = 175/281 (62%), Gaps = 4/281 (1%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++K+ KIG+GTY VYKA+D LTG+IVA+KK++ K REI +L+ L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
IKL + + LYLVF +M+ DL L + E +K Y++QLL GL CH++G
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
+LHRD+K NLLI+ +GVLK+ADFGLA F + P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177
Query: 298 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATLFKP 356
VD+WS GCI AELL+ +P+ PG++E++QL KI++ G+P E W K + L F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ + + F + P +L L+ +L DP +R+TA AL
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 293 bits (752), Expect = 7e-98
Identities = 124/285 (43%), Positives = 163/285 (57%), Gaps = 7/285 (2%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + +IG+G + V+KAKD TG+ VALKKV LE REI L+ HP V
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+KL L LV YM DL+ + E E QVK YM LL G+ + H NG
Sbjct: 62 VKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
++HRD+K +NLLI DGVLKIADFGLA F + +V T WYR PELL GA Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 298 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLP--NATLF 354
GVDLW+ GCI AELL G P+ PG ++EQL +++ G+P+EE W + LP N F
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
+P ++E F D P +L L++ LL DP++RL+A AL
Sbjct: 240 PESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 2e-90
Identities = 130/291 (44%), Positives = 187/291 (64%), Gaps = 22/291 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
++K++KIG+GTY VYKA+D LTG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+++L +V S LYLVF +++ DL + +SP P +K Y++QLL G+ +CH+
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM---TSRVVTLWYRPPELLLG 292
+ VLHRD+K NLLID +G LK+ADFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGV----PVRTYTHEVVTLWYRAPEILLG 173
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNA 351
+ Y VD+WS GCI AE++ +P+ PG +E++QL +I++ G+P E+ W + LP+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 352 TLFKPREP-YKRCIQETFKDFP---PSSLPLIETLLAIDPAERLTATVALN 398
+KP P + R Q+ K P L L+ +L DPA+R++A AL
Sbjct: 233 --YKPTFPKWAR--QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (676), Expect = 2e-86
Identities = 114/292 (39%), Positives = 169/292 (57%), Gaps = 20/292 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLD- 173
+E++ +IG+G Y VYKA+D+ TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 174 --HPNVIKL----EGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQL 226
HPN+++L G T R L LVF +++ DLA L+ P+ +K M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
L G++ H++ ++HRD+K N+L+ DG +KIADFGLA + +TS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRA 174
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
PE+LL ++ Y VD+WS GCI AEL +P+ G +E +QL KI+ + G PSEE W ++
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ F P R + + L L++ +L +P +R++A AL
Sbjct: 234 VSLPRSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 2e-85
Identities = 107/282 (37%), Positives = 157/282 (55%), Gaps = 33/282 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E ++K+G+G++ VY A+D TGK+VA+K ++ ++ + + + REI IL++L HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
++L + LYLV Y E DL L + +E + + Y+ Q+LS LE+ H+
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
G++HRD+K N+L+D+DG +K+ADFGLA DP K +T+ V T Y PE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356
G VD+WS G IL ELL GKP PG +QL +++K G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFP------------- 217
Query: 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P + I KD I LL DP +RLTA AL
Sbjct: 218 --PPEWDISPEAKDL-------IRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 4e-84
Identities = 106/287 (36%), Positives = 146/287 (50%), Gaps = 29/287 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E + K+G G++ VYKAK TGKIVA+K ++ + + + + REI ILRRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
++L LYLV Y E DL + +E + K Q+L GLE+ H+N
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
G++HRD+K N+L+D++GV+KIADFGLA +T+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK-LCGSPSEEYWKKSKLPNATLFK 355
G VD+WS G IL ELL GKP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS------ 230
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
E KD I+ L DP++R TA L
Sbjct: 231 ----------EEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 1e-83
Identities = 110/292 (37%), Positives = 163/292 (55%), Gaps = 16/292 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHP 175
+E + IG G Y V A D TG+ VA+KK+ FD+L K + REI +LR L H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHE 59
Query: 176 NVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
N+I L ++ +Y+V ME DL + SP+ T+ ++ +++Q+L GL++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWYRPPELL 290
H+ V+HRD+K SN+L++ + LKI DFGLA DP+ +T VVT WYR PELL
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
L ++ Y +D+WS GCI AELL KP+ PGR ++QL+ I ++ G+PSEE K
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238
Query: 351 A----TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
A + + + F P ++ L+E +L DP +R+TA AL
Sbjct: 239 ARNYLKSLPKKPKKP--LSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 3e-82
Identities = 124/292 (42%), Positives = 179/292 (61%), Gaps = 22/292 (7%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F+K++KIG+GTY VYKA++ LTG++VALKK+R D E E V A REI +L+ L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++KL ++ + LYLVF ++ DL + ASP P +K Y+ QLL GL CH
Sbjct: 60 NIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM---TSRVVTLWYRPPELLL 291
++ VLHRD+K NLLI+ +G +K+ADFGLA F P+ T VVTLWYR PE+LL
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----PVRTYTHEVVTLWYRAPEILL 173
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPN 350
G Y VD+WS GCI AE++ + + PG +E++QL +I++ G+P E W + LP+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233
Query: 351 ATLFKPREPYKRCIQETFKDFPP----SSLPLIETLLAIDPAERLTATVALN 398
+KP P + ++ F P L+ +L DP +R++A AL
Sbjct: 234 ---YKPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 1e-81
Identities = 121/319 (37%), Positives = 177/319 (55%), Gaps = 32/319 (10%)
Query: 118 FEKIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-----------FMA-R 164
+ + +G+GTY V KA D LTGKIVA+KKV+ + + K F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
E+ I+ + H N++ L + + LV M DL + +++ TE QVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDR-KIRLTESQVKCILL 126
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS------FFDPNHKHP---- 274
Q+L+GL H +HRD+ +N+ I+ G+ KIADFGLA + D K
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 275 ---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
MTS+VVTLWYR PELL+GA Y VD+WS GCI AELL GKP+ PG E++QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 332 YKLCGSPSEEYW-KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390
++L G+P+E+ W + KLP T F PR+P + ++ F + ++ L+++LL ++P ER
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 391 LTATVALNSEVIFQDRTLC 409
++A AL E D C
Sbjct: 305 ISAKEALKHEYFKSDPLPC 323
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 8e-80
Identities = 121/284 (42%), Positives = 171/284 (60%), Gaps = 8/284 (2%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N+++L ++ S L LVF Y + DL S VK +M QLL GL CH+
Sbjct: 60 NIVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+ VLHRD+K NLLI+ +G LK+ADFGLA F + ++ VVTLWYRPP++L GA
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL 176
Query: 296 YGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATL 353
Y +D+WSAGCI AEL AG+P+ PG +QL +I++L G+P+EE W SKLP+
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ + K + L++ LL +P +R++A AL
Sbjct: 237 YPMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 6e-79
Identities = 124/295 (42%), Positives = 176/295 (59%), Gaps = 17/295 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D++EK++KIG+GTY VYKA+D TGK+VALKK R + ++ E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 175 -PNVIKL---EGLVTSRMSCSLYLVFHYMEHDLA----GLAASPEVKFTEPQVKCYMHQL 226
+++L E + SLYLVF Y++ DL P +K +M+QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFD-PNHKHPMTSRVVTLWY 284
L G+ HCH +GV+HRD+K NLL+D G+LKIAD GL F P + T +VTLWY
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWY 177
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE+LLG+T Y VD+WS GCI AE+ +P+ PG +E++QL I+KL G+P+E+ W
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 345 K-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
SKL + F +P + D P L L++ +L DPA+R++A AL
Sbjct: 238 GVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 4e-78
Identities = 114/288 (39%), Positives = 176/288 (61%), Gaps = 14/288 (4%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLDH 174
+F++++K+G+GTY+ VYK ++ TG+IVALK++ D E P + REI +++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP--QVKCYMHQLLSGLEH 232
N+++L ++ + L LVF YM+ DL + V+ VK + +QLL G+
Sbjct: 58 ENIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLL 291
CH N VLHRD+K NLLI+ G LK+ADFGLA +F P + ++ VVTLWYR P++LL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLL 173
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPN 350
G+ Y +D+WS GCI+AE++ G+P+ PG +QL KI+++ G+P+E W S+LP
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
PR P + +Q+ F P + L+ LL ++P R++A AL
Sbjct: 234 YKPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 1e-76
Identities = 121/288 (42%), Positives = 184/288 (63%), Gaps = 15/288 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+ KI+KIG+GTY VYK ++ TG+IVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQ-VKCYMHQLLSGLEHCH 234
++ L+ ++ LYL+F ++ DL L + P+ ++ + + VK Y++Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
+ VLHRD+K NLLID+ GV+K+ADFGLA +F P + T VVTLWYR PE+LLG+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--THEVVTLWYRAPEVLLGS 176
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNAT 352
Y VD+WS G I AE+ KP+ G +E++QL +I+++ G+P+E+ W + LP+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD-- 234
Query: 353 LFKPREP--YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+K P K ++ K+ L L+E +L DPA+R++A ALN
Sbjct: 235 -YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 6e-75
Identities = 124/294 (42%), Positives = 186/294 (63%), Gaps = 10/294 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D +EK++KIG+GTY VYKA+D +T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHC 233
N+++L+ +V S LYLVF Y++ DL + +SP+ +K Y++Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 234 HNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H++ VLHRD+K NLLID LK+ADFGLA F + T VVTLWYR PE+LLG
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLG 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNA 351
+ Y VD+WS GCI AE++ KP+ PG +E+++L KI+++ G+P+EE W + LP+
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405
P+ P K + P+ + L+ +L +DP++R+TA AL E F+D
Sbjct: 238 KSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY-FKD 289
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 1e-73
Identities = 111/311 (35%), Positives = 156/311 (50%), Gaps = 30/311 (9%)
Query: 118 FEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+E IG+GTY VYKA K+ GK A+KK + D + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL----AASPEVKFTEPQVKCYMHQLLSGL 230
NV+ L + S+YL+F Y EHDL + + V VK + Q+L+G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 231 EHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR--VVTLWY 284
+ H+N VLHRD+K +N+L+ + GV+KI D GLA F+ K VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLC 335
R PELLLGA Y +D+W+ GCI AELL +PI GR +QL +I+++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 336 GSPSEEYW----KKSKLPNATLFKPREPYKRC----IQETFKDFPPSSLPLIETLLAIDP 387
G+P+E+ W K + + Y E K L+ LL DP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 388 AERLTATVALN 398
+R+TA AL
Sbjct: 302 TKRITAEEALE 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 5e-73
Identities = 110/288 (38%), Positives = 175/288 (60%), Gaps = 16/288 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRL-DH 174
++ I ++G GT+ +VY A++ TG++VA+KK+ +F + E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK-FTEPQVKCYMHQLLSGLEHC 233
PN++KL+ + R + LY VF YME +L L + K F+E ++ ++Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H +G HRD+K NLL+ V+KIADFGLA + + P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KLPNAT 352
T Y VD+W+ GCI+AEL +P+ PG +E++QL+KI + G+P+++ W + KL +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 353 LFK--PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
F+ P + + + P ++ LI+ +L DP +R TA+ AL
Sbjct: 234 GFRFPQFAPTS--LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 6e-73
Identities = 106/288 (36%), Positives = 158/288 (54%), Gaps = 9/288 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E + +G+G Y V K ++ TG+IVA+KK + + + K RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQ-VKCYMHQLLSGLEHC 233
N++ L R LYLVF Y+E L L ASP P V+ Y+ QLL + +C
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYC 116
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H++ ++HRDIK N+L+ + GVLK+ DFG A P+T V T WYR PELL+G
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG--SPSEEYWKKSKLPNA 351
T+YG VD+W+ GCI+AELL G+P+ PG ++++QL+ I K G PS + S A
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 352 TLFKPREPYKRCIQETF-KDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ P ++ + +L ++ L +DP ERLT L
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 1e-72
Identities = 114/300 (38%), Positives = 174/300 (58%), Gaps = 32/300 (10%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ ++++K+DK+G+G+Y+ VYK + LTG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLA------GLAASPEVKFTEPQVKCYMHQL 226
H N++ L ++ ++ + L LVF Y++ DL G S V+ ++ QL
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQL 112
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA---SFFDPNHKHPMTSRVVTLW 283
L GL +CH VLHRD+K NLLI + G LK+ADFGLA S P+ + ++ VVTLW
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PSKTY--SNEVVTLW 168
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEEY 342
YRPP++LLG+T+Y +D+W GCI E+ G+P+ PG T+V +QLHKI+++ G+P+EE
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 343 WKK-SKLPN----ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
W S P + F P P D P L L +P +R++A A+
Sbjct: 229 WPGVSSNPEFKPYSFPFYPPRPL--INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 120/297 (40%), Positives = 170/297 (57%), Gaps = 27/297 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD---NLEPESVKFMAREILILRRL-D 173
+E + K+G+G Y V+KA D T ++VALKK+ FD N F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDL-----AGLAASPEVKFTEPQVKCY-MHQLL 227
HPN++KL ++ + +YLVF YME DL A + E K Y M+QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI--------LEDVHKRYIMYQLL 117
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA---SFFDPNHKHP-MTSRVVTLW 283
L++ H+ V+HRD+K SN+L++ D +K+ADFGLA S + N ++P +T V T W
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
YR PE+LLG+T Y GVD+WS GCIL E+L GKP+ PG + + QL KI ++ G PS E
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 344 K--KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ KS L ++ + E +L L++ LL +P +RLTA AL
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 6e-70
Identities = 112/286 (39%), Positives = 160/286 (55%), Gaps = 19/286 (6%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK--KVRFDNLEPESVKFMAREILILRRL-DHPNV 177
+ KIG+GT+S V KA+ TGK A+K K F +LE + REI LRRL HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
++L ++ R + L LVF M+ +L L + E +VK YM+QLL L+H H NG
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
+ HRDIK N+LI DD +LK+ADFG S K P T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG--SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 298 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL---F 354
+D+W+ GC+ E+L+ P+ PG E++Q+ KI+ + G+P E KK + + F
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYNF 236
Query: 355 KPREP--YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++ ++ + + L L++ LLA DP ER+TA AL
Sbjct: 237 PSKKGTGLRKLLP----NASAEGLDLLKKLLAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-65
Identities = 109/299 (36%), Positives = 157/299 (52%), Gaps = 28/299 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRLD 173
++ I+ IG G Y V A D +GK VA+KK+ FD P K RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 174 HPNVIKLEGLVTSRMS--CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
H N+I + ++ + +Y+V ME DL + S + TE ++ +++QLL GL+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLK 121
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLWYRPPE 288
+ H+ V+HRD+K SNLL+++D L+I DFG+A + HK+ MT V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-- 346
LLL +Y +D+WS GCI AE+L + + PG+ V QL I + GSPSEE +
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 347 --------KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
LP K P+ + F P +L L+ +L DP ER+T AL
Sbjct: 242 DRVRKYIQNLPR----KQPVPWS----KIFPKASPEALDLLSQMLQFDPEERITVEQAL 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 6e-65
Identities = 103/295 (34%), Positives = 156/295 (52%), Gaps = 21/295 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +EK+ KIG+G+Y V+K ++ TG+IVA+KK +P K REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++ L + R L+LVF Y +H L L +P E +K + Q L + CH
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ +HRD+K N+LI G +K+ DFG A T V T WYR PELL+G T
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDT 176
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS---------PSEEYWKK 345
YG VD+W+ GC+ AELL G+P+ PG+++V+QL+ I K G + +++K
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+P REP ++ F + +L ++ L +DP ERL+ L
Sbjct: 237 LSIPEPE---TREP----LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 1e-64
Identities = 111/282 (39%), Positives = 160/282 (56%), Gaps = 11/282 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
IG+G Y V AK+ T + VA+KK+ FDN K REI +LR LDH NVI ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI--DAKRTLREIKLLRHLDHENVIAIK 70
Query: 182 GLV--TSRMSCS-LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV 238
++ R + + +Y+V+ M+ DL + S + ++ + +++QLL GL++ H+ V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
LHRD+K SNLL++ + LKI DFGLA MT VVT WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTT 188
Query: 299 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358
+D+WS GCI AELL KP+ PG+ V QL I +L GSPSEE + A +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 359 PY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
PY ++ F P ++ L+E +L DP++R+T AL
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 9e-63
Identities = 109/291 (37%), Positives = 169/291 (58%), Gaps = 17/291 (5%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K+DK+G+GTY+ V+K + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 174 HPNVIKLEGLV-TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
H N++ L ++ T R L LVF Y++ DL + + VK +M QLL GL +
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
CH +LHRD+K NLLI++ G LK+ADFGLA K ++ VVTLWYRPP++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLG 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
+T+Y +D+W GCIL E+ G+P+ PG T E+LH I++L G+P+EE W P T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGIT 232
Query: 353 LFKPREPY--KRCIQETFKDFPP----SSLPLIETLLAIDPAERLTATVAL 397
+ Y + + + P + L+ +LL + R++A AL
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 3e-62
Identities = 108/286 (37%), Positives = 162/286 (56%), Gaps = 7/286 (2%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K+DK+G+GTY+ VYK + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
H N++ L ++ + S L LVF Y++ DL VK ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H VLHRD+K NLLI++ G LK+ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGS 179
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
TDY +D+W GCI E+ G+P+ PG T EQLH I+++ G+P+EE W L N
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILSNEEF 238
Query: 354 FKPREP--YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
P C+ L+ LL + +R++A A+
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 9e-62
Identities = 106/280 (37%), Positives = 154/280 (55%), Gaps = 11/280 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G G + V A+D LTG+ VA+KK+ P K RE+ +L+ L H N+I L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 184 VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQ-VKCYMHQLLSGLEHCHNNGVLHRD 242
S + +Y V + DL L S + E Q ++ +++Q+L GL++ H+ GV+HRD
Sbjct: 78 FISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 243 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDL 302
+K SN+LI+++ LKI DFGLA DP MT V T +YR PE++L Y V VD+
Sbjct: 134 LKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDI 189
Query: 303 WSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY-- 360
WSAGCI AE+L GKP+ PG+ V Q I L G+P ++ N F P
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249
Query: 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
E FK+ PS++ L+E +L DP +R++A AL
Sbjct: 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 1e-61
Identities = 117/293 (39%), Positives = 169/293 (57%), Gaps = 20/293 (6%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLD 173
A S+ ++K+G+G+Y+ VYK + G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
H N++ L ++ ++ + L VF YM DLA V+ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H +LHRD+K NLLI G LK+ADFGLA + P+ + +S VVTLWYRPP++LLG
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLG 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEEYWKK-SKLPN 350
ATDY +D+W AGCI E+L G+P PG ++V EQL KI+ + G P+E+ W SKLPN
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 351 ATLFKPREPYKRCIQETFKDF------PPSSLPLIETLLAIDPAERLTATVAL 397
+KP E + C + + PP + L +L + P +R++A AL
Sbjct: 238 ---YKP-EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-61
Identities = 107/290 (36%), Positives = 160/290 (55%), Gaps = 16/290 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLD 173
D ++ + +G G Y V A D TG+ VA+KK+ F + K RE+ +L+ +D
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 174 HPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
H NVI L + T S +YLV H M DL + K ++ ++ ++Q+L G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRG 130
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
L++ H+ G++HRD+K SN+ +++D LKI DFGLA D MT V T WYR PE+
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 186
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+L Y VD+WS GCI+AELL GK + PG ++QL +I L G+P EE +K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 350 NATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+A + P K+ +E F P ++ L+E +L +DP +R+TA AL
Sbjct: 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 3e-61
Identities = 105/301 (34%), Positives = 160/301 (53%), Gaps = 32/301 (10%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILR 170
++ + IG+G Y V A TG VA+KK+ P + REI ILR
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 171 RLDHPNVIKLEGLVTSRMSCSL---YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
R H N+I + ++ S Y+V ME DL L + + + ++ +++Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQIL 116
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWYR 285
GL++ H+ VLHRD+K SNLL++ + LKI DFGLA DP H H +T V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
PE++L + Y +D+WS GCILAE+L+ +P+ PG+ + QL+ I + G+PS+E
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 346 SKLPNA-----TL-FKPREPYKRCIQETFKDFP---PSSLPLIETLLAIDPAERLTATVA 396
A +L FKP+ P+ + FP P +L L++ +L +P +R+T A
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 397 L 397
L
Sbjct: 290 L 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 3e-60
Identities = 110/287 (38%), Positives = 157/287 (54%), Gaps = 12/287 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DH 174
+E + +IG G Y VYKA+D +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 175 PNVIKLEGL-VTSRM--SCSLYLVFHYMEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGL 230
PN+++L + TSR + LVF +++ DL L P +K M Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
+ H N ++HRD+K N+L+ G +K+ADFGLA + + + +T VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
L +T Y VD+WS GCI AE+ KP+ G +E +QL KI+ L G P E+ W +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
F PR P R +Q + S L+ +L +P +R++A AL
Sbjct: 239 RGAFSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-59
Identities = 76/191 (39%), Positives = 114/191 (59%), Gaps = 6/191 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+G + VY A+D TGK VA+K ++ ++ + + REI IL++L+HPN++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 184 VTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRD 242
LYLV Y E L L E K +E ++ + Q+L GLE+ H+NG++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 243 IKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVD 301
+K N+L+D D+G +K+ADFGL+ + K + + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 302 LWSAGCILAEL 312
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 93/230 (40%), Positives = 148/230 (64%), Gaps = 4/230 (1%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K++K+G+GTY+ V+K + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
H N++ L +V + S L LVF Y++ DL + VK +++Q+L GL +C
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H VLHRD+K NLLI++ G LK+ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGS 179
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
++Y +D+W GCI E+ +G+P+ PG T ++LH I++L G+P+EE W
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 2e-57
Identities = 108/293 (36%), Positives = 154/293 (52%), Gaps = 17/293 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLT--GKIVALKKVR--FDNLEPESVKFMAREILILRRL- 172
+E I ++GQG Y V A++ T + VA+KK+ F K RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 173 DHPNVIKLEGL--VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
H N+ L + V LYL ME DL + S T+ + +++Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGL 118
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP---MTSRVVTLWYRPP 287
++ H+ VLHRD+K NLL++ D LKI DFGLA F N MT V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E++L Y +D+WS GCILAELL KP+ G+ V+QL++I ++ G+P EE +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 348 LPNATLF---KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
P A + P P K + F + P +L L+E LLA DP +R++ AL
Sbjct: 239 SPKAQNYIRSLPNIPKKP-FESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 106/295 (35%), Positives = 167/295 (56%), Gaps = 25/295 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+E + +G+G+Y V K K TG+IVA+KK ++ + + VK +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
++ L + R LYLVF +++H L L P E +V+ Y+ Q+L G+E CH+
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS 118
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-PNHKHPMTSRVVTLWYRPPELLLGAT 294
+ ++HRDIK N+L+ GV+K+ DFG A P + T V T WYR PELL+G T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDT 176
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE---EYWKKS----- 346
YG VD+W+ GC++ E+L G+P+ PG ++++QL+ I K G+ E ++K+
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 347 -KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+LP K EP ++ F L L + L IDP +R +++ L+ E
Sbjct: 237 MRLPEV---KEIEPLEK----RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 5e-57
Identities = 115/296 (38%), Positives = 168/296 (56%), Gaps = 18/296 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ADS+EK++K+G+G+Y+ VYK K + GK+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
H N++ L ++ ++ + L LVF Y+ DL VK ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-PNHKHPMTSRVVTLWYRPPELLL 291
H +LHRD+K NLLI D G LK+ADFGLA P+H + ++ VVTLWYRPP++LL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVVTLWYRPPDVLL 176
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIYKLCGSPSEEYWKK-SKLP 349
G+T+Y +D+W GCI E++ G PG +++ QL +I+ + G+P+E+ W LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236
Query: 350 NATLFKPRE----PYKRCIQETFK-DFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ FKP K Q K + + L LL P RL+A AL+ E
Sbjct: 237 H---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 1e-56
Identities = 88/288 (30%), Positives = 137/288 (47%), Gaps = 38/288 (13%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+ + + +G+G++ +VY A D TG+++A+K V E ++ + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
+++ G +L + ++E+ L+ L K EP ++ Y Q+L GL +
Sbjct: 61 IVRYYGSERDEEKNTLNI---FLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAY 116
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLL 291
H+NG++HRDIKG+N+L+D DGV+K+ADFG A T V T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYWKKSKLPN 350
G +YG D+WS GC + E+ GKP L+KI P +P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE--------IPE 227
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ E KDF + L DP +R TA L
Sbjct: 228 ------------HLSEEAKDF-------LRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 9e-56
Identities = 109/291 (37%), Positives = 164/291 (56%), Gaps = 22/291 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G G+ V+ A D K VA+KK+ +P+SVK REI I+RRLDH N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 184 VTSRMS------------CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ S S+Y+V YME DLA + + +E + +M+QLL GL+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLK 128
Query: 232 HCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPE 288
+ H+ VLHRD+K +N+ I+ +D VLKI DFGLA DP+ HK ++ +VT WYR P
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK--S 346
LLL +Y +D+W+AGCI AE+L GKP+ G E+EQ+ I + EE + +
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+P+ EP +R +++ P +L +E +L +P +RLTA AL
Sbjct: 249 VIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 114/291 (39%), Positives = 165/291 (56%), Gaps = 17/291 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLD--- 173
+E + +IG+G Y V+KA+D+ G + VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 174 HPNVIKLEGLVT-SRM--SCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSG 229
HPNV++L + T SR L LVF +++ DL L PE +K M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
L+ H++ V+HRD+K N+L+ G +K+ADFGLA + + + +TS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KL 348
LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W + L
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 349 P-NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P A K +P I++ D L+ L +PA+R++A AL+
Sbjct: 240 PRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 107/294 (36%), Positives = 163/294 (55%), Gaps = 18/294 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+P R + + ++G G Y +V A D TG+ VA+KK+ K RE+ +L+
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 171 RLDHPNVIKLEGLVTSRMSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
+ H NVI L + TS +S YLV YM+ DL + P +E +V+ ++Q+
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQM 126
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
L GL++ H+ G++HRD+K NL +++D LKI DFGLA D MT VVT WYR
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRA 182
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
PE++L Y VD+WS GCI+AE+L GK + G+ ++QL +I K+ G P E+ +K
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242
Query: 347 KLPNATLF---KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ A + P+ P ++ F P ++ L+E +L +D +RLTAT AL
Sbjct: 243 EDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 104/289 (35%), Positives = 156/289 (53%), Gaps = 13/289 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHP 175
E IG G + V+ D GK VALKK+ F NL S K + RE+ +L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHD 59
Query: 176 NVIK-LEGLVTSRMSC--SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
NV+ L+ L + +Y+V M+ DL + SP+ + VK +++Q+L GL++
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+ G+LHRDIK NLL++ + VLKI DFGLA +P+ MT VVT +YR PE+L+G
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
+ Y VD+WS GCI AELL + + ++ ++QL I L G+PS E +S A
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM-RSACEGAR 237
Query: 353 LFKPREPYK-RCIQETFKDFPPSS---LPLIETLLAIDPAERLTATVAL 397
R P+K + + ++ + L+ +L DP +R++A AL
Sbjct: 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 105/287 (36%), Positives = 161/287 (56%), Gaps = 19/287 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
IG+G+Y V A D TG+ VA+KK+ F+++ ++ + + REI +LR L HP++++++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHPDIVEIK 65
Query: 182 GLV---TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV 238
++ + R +Y+VF ME DL + + + T + +++QLL L++ H V
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANV 124
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRVVTLWYRPPELLLGA--T 294
HRD+K N+L + D LKI DFGLA +F D T V T WYR PEL G+ +
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFS 183
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y +D+WS GCI AE+L GKP+ PG+ V QL I L G+PS E + + A +
Sbjct: 184 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243
Query: 355 ----KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ ++P + F + P +L L+E LLA DP +R TA AL
Sbjct: 244 LSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 6e-51
Identities = 105/299 (35%), Positives = 154/299 (51%), Gaps = 12/299 (4%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR 164
+ LN I + ++ + +G G Y +V A D TG VA+KK+ K R
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
E+ +L+ + H NVI L + T S +YLV H M DL + K T+ V+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQ 123
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
++Q+L GL++ H+ ++HRD+K SNL +++D LKI DFGLA D MT V
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVA 179
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
T WYR PE++L Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 341 EYWKKSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
E KK +A + K F P ++ L+E +L +D +R+TA AL
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 7e-50
Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
FE ++KIG+G + VYKA+ TGK VA+K ++ + E + + EI IL++ HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
+K G + L++V + L L S TE Q+ +LL GLE+ H+N
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
G++HRDIK +N+L+ DG +K+ DFGL++ + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356
D+WS G EL GKP ++ L KI + L
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGL--- 217
Query: 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
R P K + FKDF ++ L +P +R TA L
Sbjct: 218 RNPEKWS--DEFKDF-------LKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 102/288 (35%), Positives = 158/288 (54%), Gaps = 12/288 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D + + ++G G Y V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
NVI L + T +S YLV +M DL L K +E +++ ++Q+L GL+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLK 132
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
+ H G++HRD+K NL +++D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVIL 188
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y VD+WS GCI+AE+L GKP+ G ++QL +I K+ G+PS+E+ +K + +A
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 352 TLFKPREP--YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ + P K+ + + P ++ ++E +L +D R+TA AL
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-49
Identities = 104/289 (35%), Positives = 154/289 (53%), Gaps = 12/289 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ FE + +G+G Y V K + T +IVA+KK + D+ E E VK RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N+++L+ R LYLVF Y+E ++ L +V+ Y++QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
N ++HRDIK NLLI + VLK+ DFG A T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS-PSEE---YWKKSKLPN 350
YG VD+WS GCIL EL G+P+ PG +E++QL I K+ G P+E+ ++ +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF-- 234
Query: 351 ATLFKPREPYKRCIQETFKDFPPS-SLPLIETLLAIDPAERLTATVALN 398
L P + + ++ + L L++ LL ++P +R LN
Sbjct: 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 3e-49
Identities = 115/310 (37%), Positives = 166/310 (53%), Gaps = 40/310 (12%)
Query: 123 KIGQGTYSNVYKAK--DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
K+G+GTY +VYKAK D + ALK++ + + REI +LR L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDL--------AGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
+ + S ++L+F Y EHDL A A V+ VK ++Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 233 CHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYR 285
H N VLHRD+K +N+L+ + G +KIAD G A F+ K P+ VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYR 182
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLCG 336
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +I+ + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 337 SPSEEYWKK-SKLP-NATLFKP--REPYKRC----IQETFKDFPPS-SLPLIETLLAIDP 387
P+++ W+ K+P ++TL K R Y C E K P S + L++ LL +DP
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 388 AERLTATVAL 397
+R+T+ A+
Sbjct: 303 IKRITSEQAM 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 74/203 (36%), Positives = 120/203 (59%), Gaps = 10/203 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ D IG+G + VYK ++ TG VA+K++ + ++ E++K + +EI +L+ L HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
+K G + + S SLY++ Y E+ L + F E V Y++Q+L GL + H
Sbjct: 62 VKYIGSIET--SDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL--GAT 294
GV+HRDIK +N+L DGV+K+ADFG+A+ + K + V T ++ PE++ GA+
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGAS 177
Query: 295 DYGVGVDLWSAGCILAELLAGKP 317
D+WS GC + ELL G P
Sbjct: 178 ---TASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 6e-48
Identities = 101/295 (34%), Positives = 165/295 (55%), Gaps = 19/295 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P R ++ + +G G Y +V A D + VA+KK+ F +L + RE+ +
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRL 67
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
L+ + H NVI L + T S +YLV + M DL + K ++ V+ ++
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIY 125
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
QLL GL++ H+ G++HRD+K SN+ +++D L+I DFGLA D MT V T WY
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++L Y VD+WS GCI+AELL GK + PG ++QL +I ++ G+PS E K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 345 KSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
K +A + P+ ++ +++ F+ P ++ L+E +L +D +R++A+ AL
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 96/305 (31%), Positives = 134/305 (43%), Gaps = 65/305 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRLD 173
D F+ IG+G++S V AK+ T K A+K + R E + VK++ E +L RL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 174 -HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK----FTEPQVKCYMHQLL 227
HP +IKL T + +LY V Y + +L ++ E + Y ++L
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQY-----IRKYGSLDEKCTRFYAAEIL 112
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--------------- 272
LE+ H+ G++HRD+K N+L+D D +KI DFG A DPN
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 273 HPMTSR----VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328
R V T Y PELL G DLW+ GCI+ ++L GKP G E
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
Query: 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA 388
KI KL EY P +FPP + LIE LL +DP
Sbjct: 232 QKILKL------EY----SFPP-------------------NFPPDAKDLIEKLLVLDPQ 262
Query: 389 ERLTA 393
+RL
Sbjct: 263 DRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 7e-47
Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 46/294 (15%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E I +IG+G++ VY + GK+ LK++ N+ + + E+ IL++L+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 178 IKL-EGLVTSRMSCSLYLVFHYMEH----DLAGL---AASPEVKFTEPQVKCYMHQLLSG 229
IK E L +V ME+ DL+ F E Q+ + QL
Sbjct: 62 IKYYESFEEK---GKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPE 288
L++ H+ +LHRDIK N+ + +G++K+ DFG++ + + VV T +Y PE
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPE 173
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
L Y D+WS GC+L EL K G +E KI K + +
Sbjct: 174 LCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG---------QYPPI 223
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
P+ Y ++ L+ +LL DP ER + L S I
Sbjct: 224 PS--------QYSSELRN-----------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 161 bits (407), Expect = 4e-46
Identities = 111/317 (35%), Positives = 164/317 (51%), Gaps = 54/317 (17%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
K+G+GTY +VYKA KD K ALK++ + + REI +LR L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDL--------AGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
+ + S ++L+F Y EHDL A A ++ VK ++Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 233 CHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYR 285
H N VLHRD+K +N+L+ + G +KIAD G A F+ K P+ VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYR 182
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLCG 336
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +I+ + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 337 SPSEEYW----------------KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIE 380
P+++ W +++ N++L K E +K ++ K F L++
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHK--VKPDSKVF-----LLLQ 295
Query: 381 TLLAIDPAERLTATVAL 397
LL +DP +R+T+ AL
Sbjct: 296 KLLTMDPTKRITSEQAL 312
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 4e-46
Identities = 87/305 (28%), Positives = 135/305 (44%), Gaps = 34/305 (11%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHP 175
S+ + K+G+G++ VY A+D K+VALK + + + V+ REI IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 176 -NVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASP--EVKFTEPQVKCYMHQLLSGLE 231
N++KL SLYLV Y++ L L + +E + + Q+LS LE
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 232 HCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPN-----HKHPMTSRVVTLWYR 285
+ H+ G++HRDIK N+L+D D V+K+ DFGLA ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 286 PPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
PE+LLG + D+WS G L ELL G P G + K
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK---------I 226
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403
+ I + D ++ LLA DP RL+++ L+ +++
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDL-------LKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 404 QDRTL 408
+
Sbjct: 280 HLKLK 284
|
Length = 384 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 100/318 (31%), Positives = 164/318 (51%), Gaps = 43/318 (13%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D +TG+ VA+KK+ F N K RE+++
Sbjct: 14 VLKR---YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVL 68
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
++ ++H N+I L + T + S +YLV M+ +L + ++ ++ ++
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLY 125
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-----SFFDPNHKHPMTSRV 279
Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA SF MT V
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------MTPYV 178
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
VT +YR PE++LG Y VD+WS GCI+ E++ G + PG ++Q +KI + G+PS
Sbjct: 179 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 340 EEYWKK--SKLPNATLFKPREPYKRCIQETFKD--FPPSSLP-----------LIETLLA 384
+E+ + + N +P+ +E F D FPP S L+ +L
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYA-GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 385 IDPAERLTATVALNSEVI 402
IDP +R++ AL I
Sbjct: 297 IDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-43
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V + TGK+ A+K ++ ++ + V+ E IL R++HP ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 183 LVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+ LYLV Y +L S E +F+E + + Y +++ LE+ H+
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
G+++RD+K N+L+D DG +K+ DFGLA + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGK-G 169
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
YG VD WS G +L E+L GKP E KI K L
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------------LKDPL------- 210
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396
+ + +D LI LL DP +RL + A
Sbjct: 211 ---RFPEFLSPEARD-------LISGLLQKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 93/293 (31%), Positives = 132/293 (45%), Gaps = 36/293 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E++ +GQG+ VYK + TGKI ALKK+ D + E K + RE+ LR + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
V+K G + +V YM+ LA L K EP + Q+L GL++ H
Sbjct: 60 YVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH 116
Query: 235 NN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
++HRDIK SNLLI+ G +KIADFG++ + T V T+ Y PE + G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGE 175
Query: 294 TDYGVGVDLWSAGCILAELLAGK-PIMP-GRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
+ Y D+WS G L E GK P +P G+ +L + +C P
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL--MQAICDGPP------------ 220
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
P P + E F+DF I L DP +R +A L I +
Sbjct: 221 ----PSLPAEEFSPE-FRDF-------ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 90/288 (31%), Positives = 132/288 (45%), Gaps = 38/288 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ ++KIG+G VYKA D TGK VA+KK+R E + EILI++ HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 178 IKLEG--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+ LV L++V YM+ L + V+ EPQ+ ++L GLE+ H
Sbjct: 78 VDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ V+HRDIK N+L+ DG +K+ADFG A+ S V T ++ PE++
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVIKR-K 191
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
DYG VD+WS G + E+ G+P + L I G P L N +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP--------PLKNPEKW 242
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
P FKDF + L DP +R +A L +
Sbjct: 243 SP----------EFKDF-------LNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 86/291 (29%), Positives = 143/291 (49%), Gaps = 42/291 (14%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+KIG GT+ VY A ++ TG+++A+K++R + +P+++K +A E+ +L L HPN++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQ--VKCYMHQLLSGLEHCHNNGV 238
G+ R V+ +ME+ G L E + ++ Y QLL GL + H++G+
Sbjct: 66 GVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL----WYRPPELLLGAT 294
+HRDIK +N+ +D +GV+K+ DFG A N+ M V +L Y PE++ G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 295 DYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKI-YKLCGSPSEEYWKKSKLPNA 351
G G D+WS GC++ E+ GK E++ +I + +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH------------- 223
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
KP P + KDF ++ L DP +R TA+ L +
Sbjct: 224 ---KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 97/303 (32%), Positives = 154/303 (50%), Gaps = 25/303 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++++ IG G V A D + G VA+KK+ K RE+++L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
I L + T + S +YLV M+ A L ++ ++ ++Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G++HRD+K SN+++ D LKI DFGLA N MT VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG- 196
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK--SKLPNA 351
Y VD+WS GCI+ EL+ G I G ++Q +K+ + G+PS E+ + + N
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 352 TLFKPREPYKRCIQETFKD--FPPSS----------LPLIETLLAIDPAERLTATVALNS 399
+P+ P +E F D FP S L+ +L IDP +R++ AL
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 400 EVI 402
I
Sbjct: 316 PYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 72/219 (32%), Positives = 118/219 (53%), Gaps = 23/219 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKL 180
+G G++ +VY+ ++ G A+K+V + E+VK + +EI +L +L HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHCHNNG 237
G T R +LY+ ++E G A K F EP ++ Y Q+L GLE+ H+
Sbjct: 68 LG--TEREEDNLYI---FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT-----SRVVTLWYRPPELLLG 292
+HRDIKG+N+L+D +GV+K+ADFG+A K + S + ++ PE++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
YG+ D+WS GC + E+ GKP V + KI
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 96/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
I L + T + S +YLV M+ A L +++ ++ ++Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G++HRD+K SN+++ D LKI DFGLA MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 354 FKPREPYKRCIQETF-KDFPPSSLP---------------LIETLLAIDPAERLTATVAL 397
+ R Y TF K FP S P L+ +L IDPA+R++ AL
Sbjct: 253 VENRPKYAGL---TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 398 NSEVI 402
I
Sbjct: 310 QHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 91/302 (30%), Positives = 153/302 (50%), Gaps = 23/302 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
I L + T + S +Y+V M+ A L +++ ++ ++Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G++HRD+K SN+++ D LKI DFGLA MT VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG- 199
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y VD+WS GCI+ E++ G + PG ++Q +K+ + G+P E+ KK + T
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 354 FKPREPYK-RCIQETFKD--FPPSS----------LPLIETLLAIDPAERLTATVALNSE 400
+ R Y ++ F D FP S L+ +L ID ++R++ AL
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 401 VI 402
I
Sbjct: 320 YI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 72/224 (32%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E ++ IG+G++ V K + GKI+ K++ + N+ + + + E+ ILR L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQVKCYMHQLLSGLEHC 233
++ + R + +LY+V Y E DLA L E + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 234 HN-----NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPP 287
HN N VLHRD+K +N+ +D + +K+ DFGLA H V T +Y P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSP 179
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
E L + Y D+WS GC++ EL A P R +++ KI
Sbjct: 180 EQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 87/289 (30%), Positives = 139/289 (48%), Gaps = 35/289 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKV--------RFDNLEPESVKFMAREILILRRLDHP 175
IG+GTY VY A ++ TG+++A+K+V R D+ + + VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N+++ G T+ S++L Y+ G +F E V+ + Q+L GL + H+
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP--NHKHPMTSRVVTLWYRPPELLLGA 293
G+LHRD+K NLL+D DG+ KI+DFG++ D ++ M+ + W P + +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y VD+WS GC++ E+ AG+ P E E + ++KL K P
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL--------GNKRSAP---- 231
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
P P + + P +L + I+P R TA L I
Sbjct: 232 --PIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 86/283 (30%), Positives = 126/283 (44%), Gaps = 48/283 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK---FMAREILILRRLDHPNVIKL 180
I +G Y V+ AK TG I A+K ++ ++ ++ R+IL + P V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 181 -EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV 238
+ +LYLV Y+ DLA L + E + Y+ +++ LE+ H+NG+
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI 114
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-------TSRVV-TLWYRPPELL 290
+HRD+K N+LID +G LK+ DFGL S + R+V T Y PE++
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGL-SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
LG + VD WS GCIL E L G P G T E I L G + W +
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNG---KIEWPE----- 222
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
+ ++ LI LL DP +RL A
Sbjct: 223 -----------------DVEVSDEAIDLISKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 9e-35
Identities = 98/303 (32%), Positives = 151/303 (49%), Gaps = 30/303 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
IG G++ VY+A + T + VA+KKV D ++ RE+LI++ L+H N+I L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDY 127
Query: 184 VTSR--------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
+ M V YM+H A P VK Y +QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
L + H+ + HRD+K NLLID + LK+ DFG A + S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
L+LGAT+Y +DLWS GCI+AE++ G PI G++ V+QL +I ++ G+P+E+ K+
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN- 299
Query: 349 PNATLFKPREPYKRCIQETF-KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407
PN K + + +++ F K P ++ I L +P +RL AL R
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359
Query: 408 LCL 410
C+
Sbjct: 360 PCI 362
|
Length = 440 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 74/205 (36%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
+F+ KIG+G +S VYKA +L G++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 175 PNVIK-LEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQVKCYMHQLLSG 229
PNVIK L + + L +V + DL+ + + E + Y QL S
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
LEH H+ ++HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 177
Query: 290 LLGATDYGVGVDLWSAGCILAELLA 314
+ Y D+WS GC+L E+ A
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 80/263 (30%), Positives = 125/263 (47%), Gaps = 16/263 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKK-VRFDNLEPESVKFMAREILILRRLDHPN 176
FE + IG+G + V + T K+ A+K + +E SV+ + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG---LAASPEVKFTEPQVKCYMHQLLSGLEHC 233
++ L + + ++YLV + L G S +VKF+E QVK ++ +++ LE+
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G++HRDIK N+L+D+ G + I DF +A+ P+ TS T Y PE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ 174
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPG--RTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y V VD WS G E L GK G RT +Q+ + W +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 352 TLFKPREPYKR--CIQETFKDFP 372
R+P KR + K+ P
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 8e-33
Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 56/298 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I +IG GTY +VYKA+D+ TG++VA+K ++ + + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 176 NVIKLEGLVTSR------MSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
N++ G R M SL ++ L +E Q+ +
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-----------SELQIAYVCRE 109
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTL 282
L GL + H G +HRDIKG+N+L+ +DG +K+ADFG+++ + R + T
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTP 165
Query: 283 WYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
++ PE+ Y D+W+ G EL +P M LH + L
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD------LHPMRALFLISKS 219
Query: 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ KL + + P F DF I+ L DP +R TAT L
Sbjct: 220 NF-PPPKLKDKEKWSP----------VFHDF-------IKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-32
Identities = 81/274 (29%), Positives = 137/274 (50%), Gaps = 46/274 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRF----DNLEPESVKFMAREILILRRLDHPNVIK 179
+G G +S+ Y+A+D+ TG ++A+K+V + + + E V+ + +EI ++ RL+HP++I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQVKCYMHQLLSGLEHCHN 235
+ G +L++ + +AG + S + F E + Y QLL GL + H
Sbjct: 68 MLGATCEDSHFNLFVEW------MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 236 NGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVV-----------TLW 283
N ++HRD+KG+NLLID G L+IADFG A+ + ++ T+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAA--------RLAAKGTGAGEFQGQLLGTIA 173
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC---GSPSE 340
+ PE+L G YG D+WS GC++ E+ KP L I+K+ +PS
Sbjct: 174 FMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS- 231
Query: 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPS 374
+P R+ RC++ +D PPS
Sbjct: 232 -------IPEHLSPGLRDVTLRCLELQPEDRPPS 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 78/258 (30%), Positives = 128/258 (49%), Gaps = 24/258 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+GQG + VY D+ TG+ +A+K+V FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQVKCYMHQLLSGLEHCHNN 236
G + + S++ ME+ + G + ++K TE + Y Q+L G+E+ H+N
Sbjct: 70 YGCLRDDETLSIF-----MEY-MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT 294
++HRDIKG+N+L D G +K+ DFG + + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
YG D+WS GC + E+L KP E E + I+K+ P+ +LP+
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN-----PQLPSHVSP 234
Query: 355 KPREPYKRCIQETFKDFP 372
R +R E K P
Sbjct: 235 DARNFLRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 55/298 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F ++ IG+G++ VYKA D T ++VA+K + + E E ++ + +EI L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEH 232
+ K G L+++ ME+ G + +K E + + ++L GLE+
Sbjct: 60 YITKYYGSFLKG--SKLWII---MEY-CGGGSCLDLLKPGKLDETYIAFILREVLLGLEY 113
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYRPPEL 289
H G +HRDIK +N+L+ ++G +K+ADFG++ M+ R V T ++ PE+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEV 169
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+ + Y D+WS G EL G+P + LH P
Sbjct: 170 IKQ-SGYDEKADIWSLGITAIELAKGEPPL------SDLH-------------------P 203
Query: 350 NATLFK-PREPYKR----CIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
LF P+ + FKDF + L DP ER +A L + I
Sbjct: 204 MRVLFLIPKNNPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLD 173
D +E I+ IG G + VY A + + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
HPNV+K L+LV Y+ D+ + E + + ++L G
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKG 114
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDP--NHKHPMTSRVVTLWYRP 286
LE+ H+NG +HRDIK N+L+ +DG +KIADFG+ AS D + + V T +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKP 317
PE++ Y D+WS G EL G
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 67/208 (32%), Positives = 115/208 (55%), Gaps = 19/208 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F+ ++K+G+G+Y +VYKA TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 176 NVIKLEGLVTSRMSCS-LYLVFHYMEHDLAG----LAASPEVKFTEPQVKCYMHQLLSGL 230
++K G S + L++V ME+ AG + TE ++ ++Q L GL
Sbjct: 59 YIVKYYG---SYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-FFDPNHKHPMTSRVVTLWYRPPEL 289
E+ H+N +HRDIK N+L++++G K+ADFG++ D K + + T ++ PE+
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEV 170
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKP 317
+ Y D+WS G E+ GKP
Sbjct: 171 IQE-IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-30
Identities = 67/224 (29%), Positives = 122/224 (54%), Gaps = 23/224 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-------VKFMAREILILRRLDHPN 176
IG G++ +VY + +G+++A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHC 233
+++ G S + + +L ++E+ G A+ F E V+ ++ Q+L GL +
Sbjct: 68 IVQYLG---SSLD-ADHLNI-FLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN------HKHPMTSRVVTLWYRPP 287
HN G++HRDIKG+N+L+D+ G +KI+DFG++ + N + + + W P
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
++ T Y D+WS GC++ E+L GK P T+++ + KI
Sbjct: 183 --VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
E K+G+G + VYK T VA+K ++ E E +F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
HPN+++L G+ T LY+V YM DL K T + Q+ G+E+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT--SRVVTLWYRPPELL 290
+ +HRD+ N L+ ++ V+KI+DFGL+ + + ++ W PE L
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESL 176
Query: 291 LGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYK 333
+ D+WS G +L E+ L +P PG + E L +
Sbjct: 177 KDGK-FTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 70/238 (29%), Positives = 111/238 (46%), Gaps = 33/238 (13%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
FE ++ IG+GTY VYKA+ TG++VA+K + ++ + + + E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSN 61
Query: 174 HPNVIKLEGLVTSRMSCS----LYLVFHYMEH----DLA-GLAASPEVKFTEPQVKCYMH 224
HPN+ G + L+LV DL GL + + E + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILR 120
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVT 281
+ L GL + H N V+HRDIKG N+L+ + +K+ DFG+++ D + R + T
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD----STLGRRNTFIGT 176
Query: 282 LWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKI 331
++ PE++ Y D+WS G EL GKP + P R L KI
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 15/226 (6%)
Query: 119 EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
K+G+G + VYK K VA+K ++ D E + +F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
PNV+KL G+ T LY+V YME DL K + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL-WYRPPELLLG 292
+ +HRD+ N L+ ++ V+KI+DFGL+ + + + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 293 ATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
+ D+WS G +L E+ G+ P M +E L Y+L
Sbjct: 178 GK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL 222
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 99/313 (31%), Positives = 134/313 (42%), Gaps = 72/313 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V+ +D TG++ A+K +R D ++ + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLL 227
P ++KL S LYLV YM DL L +V F E + Y+ +L+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELV 111
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD------------------- 268
L+ H G +HRDIK N+LID DG +K+ADFGL +
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 269 ------PNHKHPMT---SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 319
+HK S V T Y PE+L G T YG+ D WS G IL E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 320 PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLI 379
T E +KI WK+S L P +P P ++ LI
Sbjct: 231 YSDTLQETYNKIIN---------WKES------LRFPPDP----------PVSPEAIDLI 265
Query: 380 ETLLAIDPAERLT 392
LL DP +RL
Sbjct: 266 CRLLC-DPEDRLG 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKI-----VALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
K+G+G + VYK L GK VA+K ++ D E E F+ +E ++++L HPN
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPN 57
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DL-------AGLAASPEVK-FTEPQVKCYMHQLL 227
V++L G+ T LYLV YME DL + SPE + + + Q+
Sbjct: 58 VVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYR 285
G+E+ + +HRD+ N L+ +D V+KI+DFGL+ + + + ++ W
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174
Query: 286 PPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
PE L + D+WS G +L E+ L P
Sbjct: 175 APESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 119 EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
K+G+G + VYK VA+K ++ D E + +F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLSGLEH 232
PN++KL G+ T L +V YM DL L + + + + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL-WYRPPELLL 291
+ +HRD+ N L+ ++ V+KI+DFGL+ + + + + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 292 GATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
+ D+WS G +L E+ G+ P M +E L K Y+L
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL 223
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-27
Identities = 77/250 (30%), Positives = 125/250 (50%), Gaps = 23/250 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR---EILILRRLDHPNVIKL 180
+GQG + VY D+ TG+ +A K+V+FD PE+ K ++ EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQVKCYMHQLLSGLEHCHNN 236
G + R +L + YM G + ++K TE + Y Q+L G+ + H+N
Sbjct: 70 YGCLRDRAEKTLTIFMEYM----PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT 294
++HRDIKG+N+L D G +K+ DFG + R V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-E 184
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
YG D+WS GC + E+L KP E E + I+K+ P+ +LP+
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-----NPQLPSHISE 236
Query: 355 KPREPYKRCI 364
R+ + CI
Sbjct: 237 HARD-FLGCI 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 12/219 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F+ + K+G+G+Y +VYK K + + ALK+V ++ + + EI IL ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHC 233
I + L +V Y DL+ + + K E ++ QLL GL+
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLG 292
H +LHRD+K +N+L+ + ++KI D G++ K M + T Y PE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKG 175
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 -RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 28/208 (13%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+GTY VY A+D+ T +A+K++ + V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 184 VTSRMSCSLYLVFH-YMEH----DLAGLAASP--EVKFTEPQVKCYMHQLLSGLEHCHNN 236
S S F +ME L+ L S +K E + Y Q+L GL++ H+N
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 237 GVLHRDIKGSNLLIDD-DGVLKIADFG----LASFFDPNHKHPMTSRVV-TLWYRPPELL 290
++HRDIKG N+L++ GV+KI+DFG LA +P T TL Y PE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYMAPEVI 181
Query: 291 -LGATDYGVGVDLWSAGCILAELLAGKP 317
G YG D+WS GC + E+ GKP
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHC 233
I+ +G + +LV ME+ L + EV E ++ H L GL +
Sbjct: 77 TIEYKGCYLREHTA--WLV---MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H++ +HRDIK N+L+ + G +K+ADFG AS P + S V T ++ PE++L A
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVIL-A 185
Query: 294 TD---YGVGVDLWSAGCILAELLAGKP 317
D Y VD+WS G EL KP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 79/253 (31%), Positives = 125/253 (49%), Gaps = 22/253 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+GQG + VY D TG+ +A+K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQVKCYMHQLLSGLEHCHNN 236
G + M +L + +MEH + G + ++K TE + Y Q+L G+ + H+N
Sbjct: 70 YGCLRDPMERTLSI---FMEH-MPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPELLLGAT 294
++HRDIKG+N+L D G +K+ DFG + M S T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-E 184
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
YG D+WS GC + E+L KP E E + I+K+ P+ LP
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-----NPVLPPHVSD 236
Query: 355 KPREPYKRCIQET 367
R+ KR E
Sbjct: 237 HCRDFLKRIFVEA 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D FE I +G G++ V + +GK ALK + ++ + V+ + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYME-------HDLAGLAASPEVKFTEPQVKCYMHQLL 227
P ++ L G + + +LYLV Y+ +G +F EP + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVV 111
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW---- 283
LE+ H+ +++RD+K NLL+D DG +KI DFG A R TL
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTLCGTPE 163
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317
Y PE++L YG VD W+ G ++ E+LAG P
Sbjct: 164 YLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 82/256 (32%), Positives = 122/256 (47%), Gaps = 34/256 (13%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
KIG+G +S VY+A +L G VALKKV+ FD ++ ++ +EI +L++L+HPNVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHCHNNGV 238
++ L DL+ + + + E V Y QL S LEH H+ V
Sbjct: 69 ASFIEDNELNIVLELA-DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
+HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE + Y
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYNF 185
Query: 299 GVDLWSAGCILAELLAGK----------------------PIMPGRTEVEQLHKIYKLCG 336
D+WS GC+L E+ A + P +P E+L ++ +C
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245
Query: 337 SPSEEYWKKSKLPNAT 352
+P E K P+ T
Sbjct: 246 NPDPE-----KRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 36/264 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EIL++R HPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPN 77
Query: 177 VIKLEGLVTSRMSC-SLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEH 232
++ + S + L++V Y LAG + + V T E Q+ + L LE
Sbjct: 78 IVNY---LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+N V+HRDIK N+L+ DG +K+ DFG + P ++ V T ++ PE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVT- 188
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
YG VD+WS G + E++ G+P + L+ I AT
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------AT 229
Query: 353 LFKPREPYKRCIQETFKDFPPSSL 376
P + F+DF L
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 72/198 (36%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIK-L 180
KIG+G +S VY+A +L K VALKKV+ F+ ++ ++ + +EI +L++L+HPNVIK L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHCHNN 236
+ + L +V + DL+ + + + E V Y QL S +EH H+
Sbjct: 69 DSFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
V+HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE + Y
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGY 183
Query: 297 GVGVDLWSAGCILAELLA 314
D+WS GC+L E+ A
Sbjct: 184 NFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 45/277 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPNVIKLEG 182
+G+G + V + TGK+ A KK+ L+ + MA E IL ++ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 183 LVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
++ L + +H G F E + Y Q++ GLEH H
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHLH 112
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+++RD+K N+L+DD G ++I+D GLA + R T Y PE+L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y VD ++ GC L E++AG+ R E + ++ + + EY P+
Sbjct: 171 -YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY------PD---- 219
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
F P + L E LL DP +RL
Sbjct: 220 ---------------KFSPEAKDLCEALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 84/281 (29%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPN 176
+ I +G + +VY AK TG A+K ++ ++ + +VK R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
V KL S+ LYLV Y+ D A L + E K Y+ +++ G+E H
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQ 115
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
G++HRDIK NLLID G LK+ DFGL+ N K V T Y PE +LG D
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-----VGTPDYLAPETILGVGD 170
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
+ D WS GC++ E L G P T I W + +
Sbjct: 171 DKMS-DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-----RRINWPEEVKEFCS--- 221
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396
P ++ LI LL +DPA+RL A
Sbjct: 222 -----------------PEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 80/297 (26%), Positives = 138/297 (46%), Gaps = 49/297 (16%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--- 174
+++++ IG+G Y VY+ K + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQVKCYMHQLL 227
PN+ K G L R L+++ ME+ G + A P E + + ++L
Sbjct: 62 PNITKYYGSYLKGPR----LWII---MEYAEGGSVRTLMKAGP---IAEKYISVIIREVL 111
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
L++ H GV+HRDIK +N+L+ + G +K+ DFG+A+ + N T V T ++ P
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAP 170
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E++ Y D+WS G + E+ G P ++V+ + + KSK
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLI---------PKSK 218
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
P Y + ++E + L +P ERL+A L S+ I
Sbjct: 219 PPRL----EDNGYSKLLRE-----------FVAACLDEEPKERLSAEELLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 69/250 (27%), Positives = 122/250 (48%), Gaps = 16/250 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E I KIG+G++ +Y AK + +K++ + + + +E+++L ++ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+ + + + L++V Y + DL + V F+E Q+ + Q+ GL+H H+
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 236 NGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+LHRDIK N+ + +G V K+ DFG+A + + + T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG------SPSEEYWKKSKL 348
Y D+WS GC+L EL K G + QL + K+C SP+ +S +
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQGYFAPISPNFSRDLRSLI 234
Query: 349 PNATLFKPRE 358
PR+
Sbjct: 235 SQLFKVSPRD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
I+ +G + +LV Y + L + E ++ H L GL + H++
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD- 295
++HRDIK N+L+ + G +K+ADFG AS P + S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVILAMDEG 199
Query: 296 -YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
Y VD+WS G EL KP + + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
I+ G + +LV Y + L + E ++ H L GL + H++
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD- 295
++HRD+K N+L+ + G++K+ DFG AS P + V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMDEG 189
Query: 296 -YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP--SEEYWKKSKLPNAT 352
Y VD+WS G EL KP + + L+ I + SP +W
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHW--------- 239
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408
E F++F S L I P +R T+ V L + ++R
Sbjct: 240 ------------SEYFRNFVDSCLQKI-------PQDRPTSEVLLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-24
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
D +E I ++G G + VYKA+ TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
PN++ L L+++ + + L + E TEPQ++ Q+L L
Sbjct: 62 PNIVGL--YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYRPPELL 290
H++ V+HRD+K N+L+ DG +K+ADFG+++ +K + R + T ++ PE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSA----KNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 291 LGATD----YGVGVDLWSAGCILAELLAGKP 317
T Y D+WS G L EL +P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 87/278 (31%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 64 KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAV-----CGEALNGWIPRRADSF 118
+ R + P L+ LP R +A P + + +G P A S
Sbjct: 15 TARHTTKSRPRRRPDLT-LPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSL 73
Query: 119 ---EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E++++IG G VYK TG++ ALK V + N E + + REI ILR ++HP
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHP 132
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
NV+K + + + ++ +M+ L G + E + Q+LSG+ + H
Sbjct: 133 NVVKCHDMFDH--NGEIQVLLEFMDGGSLEGTHIA-----DEQFLADVARQILSGIAYLH 185
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFG----LASFFDPNHKHPMTSRVVTLWYRPPE-- 288
++HRDIK SNLLI+ +KIADFG LA D P S V T+ Y PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSVGTIAYMSPERI 240
Query: 289 ---LLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGR 322
L GA D G D+WS G + E G+ P GR
Sbjct: 241 NTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A D TG+ VA+KK+ D + + + + E++I+R HPN++++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 183 --LVTSRMSCSLYLVFHYMEHDLAGLAAS---PEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
LV L++V ++E G A + + E Q+ +L L H G
Sbjct: 84 SYLVGDE----LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG 135
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPELLLGAT 294
V+HRDIK ++L+ DG +K++DFG + P K S V T ++ PE ++
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMAPE-VISRL 190
Query: 295 DYGVGVDLWSAGCILAELLAGKP 317
YG VD+WS G ++ E++ G+P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 9/223 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
F+ +G+G + V ++ TG I A+K ++ L E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P + +L + +LYLV Y DL L E +F E + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL-- 291
H G +HRDIK N+LID G +K+ADFG A+ N V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 292 ---GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
G YGV D WS G I E++ G+ T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 86/288 (29%), Positives = 141/288 (48%), Gaps = 23/288 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG VY A D+ TG+ VA++++ NL+ + K + EIL++R +PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPN 78
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEHC 233
++ L + + L++V Y LAG + + V T E Q+ + L LE
Sbjct: 79 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
YG VD+WS G + E++ G+P P E L +Y + + + E KL + +
Sbjct: 192 A-YGPKVDIWSLGIMAIEMIEGEP--PYLNE-NPLRALYLIATNGTPELQNPEKL--SAI 245
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAI-DPAERLTATVALNSE 400
F R+ RC+ + + L L I P LT +A E
Sbjct: 246 F--RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 67/233 (28%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D E + ++G G V K TGKI+A+K +R + + K + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA-SPEVK--FTEPQVKCYMHQLLSGLEH 232
++ G + + + + YM D L EV+ E + +L GL +
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 233 CHNN-GVLHRDIKGSNLLIDDDGVLKIADFG--------LASFFDPNHKHPMTSRVVTLW 283
H ++HRD+K SN+L++ G +K+ DFG LA F V T
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----------VGTSS 164
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGK-----PIMPGRTEVEQLHKI 331
Y PE + G DY V D+WS G L EL G+ P E L I
Sbjct: 165 YMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 12/221 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
FE ++KIG+G++ V+K ++ A+K++ + + E +L +LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 178 IK-LEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
I+ E + L +V Y E H L L E QV + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+ +LHRDIK NL +D +KI D G+A N T V T +Y PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-LCE 174
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
Y D+W+ G +L E GK + + KI +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-23
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 19/232 (8%)
Query: 112 PRRADSFEKID---------KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKF 161
P AD F K D +IG G++ VY A + T ++VA+KK+ + + E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
+ +E+ L++L HPN I+ +G + +LV Y + L + E ++
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
H L GL + H++ ++HRDIK N+L+ + G +K+ADFG AS P S V T
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGT 180
Query: 282 LWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
++ PE++L + Y VD+WS G EL KP + + L+ I
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 4e-23
Identities = 67/204 (32%), Positives = 111/204 (54%), Gaps = 15/204 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EIL++R +PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPN 77
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEHC 233
++ L + + L++V Y LAG + + V T E Q+ + L L+
Sbjct: 78 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190
Query: 294 TDYGVGVDLWSAGCILAELLAGKP 317
YG VD+WS G + E++ G+P
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 74/230 (32%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F+ + ++GQG Y V+ AK TG+IVALK+++ L V+ + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
++KL L + LYL Y+ D L + V +E + YM ++ ++ H
Sbjct: 63 LVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHE 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
G +HRD+K N LID G +K+ DFGL+ + + S V + Y PE+L G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPEVLRG-KG 174
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
Y VD WS GC+L E L G P G T E + YWK+
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-23
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 118 FEKIDKIGQGTY--SNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ I +G+G + + +Y+ + +V K+V L + + EI+IL L HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQVKCYMHQLLSGL 230
N+I + + ME+ G + F E V Y+ Q++S +
Sbjct: 60 NIIAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPEL 289
+ H G+LHRDIK N+ + G++K+ DFG++ ++ M VV T +Y PEL
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPEL 172
Query: 290 LLGATDYGVGVDLWSAGCILAELL 313
G Y D+W+ GC+L ELL
Sbjct: 173 CQGV-KYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 78/252 (30%), Positives = 131/252 (51%), Gaps = 22/252 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG V+ A D+ TG+ VA+K++ NL+ + K + EIL+++ L +PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEHC 233
++ L + + L++V Y LAG + + V T E Q+ + L LE
Sbjct: 78 IVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
YG VD+WS G + E++ G+P P E L +Y + + + E KL + +
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEP--PYLNE-NPLRALYLIATNGTPELQNPEKL--SPI 244
Query: 354 FKPREPYKRCIQ 365
F R+ RC++
Sbjct: 245 F--RDFLNRCLE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 78/261 (29%), Positives = 110/261 (42%), Gaps = 55/261 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V + TG I A+KK+R + LE E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLL 227
P V+K + S LYL+ Y+ D+ L + FTE + + Y+ + +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETI 111
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH---------------- 271
++ H G +HRDIK NLL+D G +K++DFGL + +H
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 272 ----KHPMTS-RVVTLW----------------YRPPELLLGATDYGVGVDLWSAGCILA 310
PM+S R W Y PE+ L T Y D WS G I+
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMY 230
Query: 311 ELLAGKPIMPGRTEVEQLHKI 331
E+L G P E KI
Sbjct: 231 EMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ K+ KIG+G++ K GK +K++ + P+ + +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
++ + + + +LY+V Y E DL + A V F E Q+ + Q+ L+H H+
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+LHRDIK N+ + DG +K+ DFG+A + + T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 296 YGVGVDLWSAGCILAELLAGK 316
Y D+W+ GC+L E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 62/211 (29%), Positives = 109/211 (51%), Gaps = 17/211 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDH 174
+ FE I +IG GTY +VYKA+++ TG++ A+K ++ LEP E + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
N++ G R L++ + D+ + +E Q+ + L GL
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGL 119
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL- 289
+ H+ G +HRDIKG+N+L+ D+G +K+ADFG+++ S + T ++ PE+
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVA 178
Query: 290 -LLGATDYGVGVDLWSAGCILAELLAGKPIM 319
+ Y D+W+ G EL +P M
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 120 KIDKIGQGTYSNVYKAK-DML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
I ++G+G + V + D L TG+ VA+K + E F REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHY-----MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
N++K +G+ SL L+ Y + L + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLWYR 285
++ + +HRD+ N+L++ + ++KI+DFGLA + K P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELL 313
PE L + D+WS G L EL
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR----FDNLEPESVKFMAREILILRRLDHPNVIK 179
+G G + V K + ALK V+ + + E + E IL +HP ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
L T + +Y++ Y F E + Y+ ++ E+ HN G++
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGV 298
+RD+K NLL+D +G +K+ DFG A K T T Y PE++L Y
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILN-KGYDF 171
Query: 299 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
VD WS G +L ELL G+P P + E +IY
Sbjct: 172 SVDYWSLGILLYELLTGRP--PFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+++IG+G++ V+K D T ++VA+K + + E E ++ + +EI +L + D P V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYME--HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
K G + L+++ Y+ L L A P F E Q+ + ++L GL++ H+
Sbjct: 65 TKYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHS 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+HRDIK +N+L+ + G +K+ADFG+A T W P ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQSA 177
Query: 296 YGVGVDLWSAGCILAELLAGKP 317
Y D+WS G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDH 174
D E+I +G GT+ V+ +D ++ ALK + + + + + + E +L+ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLS 228
P +I+L T LY++ Y + G L S +F+ Y +++
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEY----VPGGELFSYLRNSG--RFSNSTGLFYASEIVC 112
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW----Y 284
LE+ H+ +++RD+K N+L+D +G +K+ DFG A + R TL Y
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--------KLRDRTWTLCGTPEY 164
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
PE ++ + + VD W+ G ++ E+L G P KI
Sbjct: 165 LAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 22/236 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+G+G + VY D TG+ +A+K+V FD E+ V + EI +L+ L H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQVKCYMHQLLSGLEHCHNN 236
G + L + YM G + ++K TE + Y Q+L G+ + H+N
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT 294
++HRDIKG+N+L D G +K+ DFG + + V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-E 184
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
YG D+WS C + E+L KP E E + I+K+ P+ K LP+
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-----KPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 18/233 (7%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILR 170
P +D++E I+ IG+GTY V+K + G A+K + +++ E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 171 RL-DHPNVIKLEGLVTSRMSCS---LYLVFHYME----HDLAGLAASPEVKFTEPQVKCY 222
L DHPNV+K G+ + + L+LV DL + EP +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
+H+ L GL+H H N +HRD+KG+N+L+ +G +K+ DFG+++ + + + V T
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTP 188
Query: 283 WYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
++ PE++ + Y D+WS G EL G P + + L KI
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 71/238 (29%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL--- 167
+ D++E I+ IG+GTY VYK + G + A+K L+P + + EI
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDP--ISDVDEEIEAEY 69
Query: 168 -ILRRL-DHPNVIKLEGLVTSRMSCS---LYLVFHY-----MEHDLAGLAASPEVKFTEP 217
IL+ L +HPNV+K G+ L+LV + + GL + + E
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEA 128
Query: 218 QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277
+ ++ L GL+H HNN ++HRD+KG+N+L+ +G +K+ DFG+++ TS
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 278 RVVTLWYRPPELLLGATDYGVG----VDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
V T ++ PE++ Y D+WS G EL G P + V+ L KI
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K++KIG+G++ V+K D T K+VA+K + + E E ++ + +EI +L + D P V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
K G + L+++ Y+ A P E Q+ + ++L GL++ H+
Sbjct: 65 TKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK 121
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
+HRDIK +N+L+ + G +K+ADFG+A D K + V T ++ PE ++ + Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQSAY 178
Query: 297 GVGVDLWSAGCILAELLAGKP 317
D+WS G EL G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+++IG+G++ VYK D T ++VA+K + + E E ++ + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHCH 234
+ G + L+++ Y L G +A +K E + + ++L GL++ H
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ +HRDIK +N+L+ + G +K+ADFG+A T W P + A
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 295 DYGVGVDLWSAGCILAELLAGKP 317
D+ D+WS G EL G+P
Sbjct: 179 DF--KADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-----LEPESVKFMAREILILRRLDHPNVI 178
+G+G Y VY G+++A+K+V D E E K + E+ +L+ L H N++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSLKHVNIV 65
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF---TEPQVKCYMHQLLSGLEHCHN 235
+ G T ++ + +ME G +S +F EP Y Q+L G+ + HN
Sbjct: 66 QYLG--TCLDDNTISI---FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-----DPNHKHPMTSRVVTLWYRPPELL 290
N V+HRDIKG+N+++ +G++K+ DFG A H + + S T ++ PE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-V 179
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKP 317
+ + YG D+WS GC + E+ GKP
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
+E I ++G GTY +VYKA+++ TG++ A+K ++ LEP + + +EI +++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC---YM-HQLLSGLEH 232
++ G SR L++ Y G + T P + Y+ + L GL +
Sbjct: 68 IVAYFGSYLSREK--LWICMEY----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+ G +HRDIKG+N+L+ D+G +K+ADFG+A+ S + T ++ PE+
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAAV 180
Query: 293 ATDYGVG--VDLWSAGCILAELLAGKPIM 319
+ G D+W+ G EL +P M
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 45/294 (15%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F + +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
V+ L ++ + L L FH AG F E + Y ++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--------FEEGRAVFYAAEIC 112
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
GLE H +++RD+K N+L+DD G ++I+D GLA + RV T+ Y P
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAP 170
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E++ Y D W+ GC+L E++AG+ R + + ++ +L EEY +K
Sbjct: 171 EVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK-- 227
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
F P + L + LL DP ERL EV
Sbjct: 228 -----------------------FSPDARSLCKMLLCKDPKERLGCQGGGAREV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLE--------PESVKFMAREIL 167
+ ++ +G G + VYK + G ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 168 ILR-RLDHPNVIK-----LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVK---FTEP 217
I++ +L HPN+++ LE LY+V +E L S + K FTE
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 218 QVKCYMHQLLSGLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276
++ Q++ L + H ++HRD+ +N+++ +D + I DFGLA P K +T
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LT 171
Query: 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317
S V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 172 SVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ ++G+G +V K + TG I ALK + D P+ K + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL-------LS 228
++K G S S+ + Y E G S K + + L L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG--------LASFFDPNHKHPMTSRVV 280
GL + H+ ++HRDIK SN+L+ G +K+ DFG LA F
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-----------TG 165
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMP 320
T +Y PE + G Y + D+WS G L E+ + P P
Sbjct: 166 TSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
IG+GT+ VY+ + T +I A+K + + + + + V E IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 183 LVTSRMSCS-LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
L S + S LYLV YM E +F+E + K Y+ +L+ LEH H +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVG 299
D+K N+L+D G + + DFGL+ N T+ T Y PE+LL Y
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 300 VDLWSAGCILAELLAG 315
VD WS G ++ E+ G
Sbjct: 178 VDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 53/288 (18%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
V+ L ++ + L L FH G F E + Y ++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--------FDEERAVFYAAEIT 112
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
GLE H +++RD+K N+L+DD G ++I+D GLA + RV T+ Y P
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAP 170
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E ++ Y D W GC++ E++ GK SP + +K K
Sbjct: 171 E-VVKNERYTFSPDWWGLGCLIYEMIEGK--------------------SPFRQRKEKVK 209
Query: 348 LPNATLFKPREPYKRCI---QETFKD-FPPSSLPLIETLLAIDPAERL 391
RE +R + QE + + F ++ + LL DP RL
Sbjct: 210 ---------REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I ++G G + VYKA++ TG + A K + D E ++ EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-----EVKFTEPQVKCYMHQLLSGL 230
N++KL L +L+++ + AG A E TEPQ++ Q L L
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT-----SRVVTLWYR 285
+ H N ++HRD+K N+L DG +K+ADFG+++ K+ T S + T ++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWM 170
Query: 286 PPELLLGATD----YGVGVDLWSAGCILAELLAGKP 317
PE+++ T Y D+WS G L E+ +P
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 18/227 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + K+G G + V+ T K VA+K ++ + PE+ +E I++
Sbjct: 3 IPR--ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLS 228
+L H +++L + + +Y+V YM L L + K PQ+ Q+
Sbjct: 57 KLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ + + +HRD+ N+L+ ++ V KIADFGLA + + + + PE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 289 LLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
A +YG + D+WS G +L E++ G+ PG T E L ++
Sbjct: 175 ----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
E KIG+G+ V A++ +G+ VA+K + D + + + + E++I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+++ + + L+++ +++ S + + E Q+ +L L + H+ G
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPELLLGAT 294
V+HRDIK ++L+ DG +K++DFG + P K S V T ++ PE ++ T
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPE-VISRT 192
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
YG VD+WS G ++ E++ G+P + V+ + +L SP KL NA
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP------PKLKNAHKI 243
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
P +DF +E +L +P ER TA L+ + Q
Sbjct: 244 SP----------VLRDF-------LERMLTREPQERATAQELLDHPFLLQ 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 34/256 (13%)
Query: 165 EILILRRLDHPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYM 223
E ++L+ ++HP+VI++ + LV+ ++C +V + DL Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TL 282
Q+L GL + H ++HRD+K N+ I+D + I D G A F P + T+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTV 220
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLA----------GKPIMPGRTEVEQLHKIY 332
PE+L Y D+WSAG +L E+LA P ++ L KI
Sbjct: 221 ETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 333 KLCGSPSEEYWKKSKLPNATLFKP--------REPYKR--CIQETFKDFPPSSLPLIETL 382
EE+ + P + L + R+PY R C Q + P L+ +
Sbjct: 280 STLKVHPEEF---PRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLVHKM 334
Query: 383 LAIDPAERLTATVALN 398
L D A R +A LN
Sbjct: 335 LTFDAAMRPSAEEILN 350
|
Length = 357 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 51/280 (18%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL-DHPNVIK 179
IG+G + VY + TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 180 LEGLVTS--RMSCSLYLV------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ + ++S L L+ +H +H + F+E +++ Y +++ GLE
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV----------FSEAEMRFYAAEIILGLE 111
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H HN V++RD+K +N+L+D+ G ++I+D GLA F H + V T Y PE+L
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQ 168
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y D +S GC+L +LL G SP ++ K K
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGH--------------------SPFRQHKTKDKHEID 208
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ E F P L+E LL D RL
Sbjct: 209 RMTLTMAV------ELPDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 7/213 (3%)
Query: 124 IGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+GQG++ V+ + + G++ A+K ++ L+ E IL ++HP ++KL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
+ LYL+ ++ S EV FTE VK Y+ +L L+H H+ G+++
Sbjct: 64 H--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RD+K N+L+D++G +K+ DFGL S +H+ S T+ Y PE ++ +
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSA 179
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
D WS G ++ E+L G G+ E + I K
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 72/248 (29%), Positives = 122/248 (49%), Gaps = 21/248 (8%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A + TGK VA+KK+ D + + + + E++I+R H NV+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEHCHNNGVL 239
+ + L++V ++E G A + V T E Q+ +L L + HN GV+
Sbjct: 87 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPELLLGATDY 296
HRDIK ++L+ DG +K++DFG + P K S V T ++ PE ++ Y
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMAPE-VISRLPY 195
Query: 297 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA--TLF 354
G VD+WS G ++ E++ G+P ++ + +I ++ K S + L
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 355 KPREPYKR 362
REP +R
Sbjct: 256 LVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDH 174
+ + +G+G++ + + + + A+K++R P+S V+ +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK-FTEPQVKCYMHQLLSGLEH 232
PN++ + + LY+V Y + DL K F E + + Q+ G++H
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT---SRVVTLWYRPPEL 289
H VLHRDIK N+ + +G +K+ DFG A P + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEI 171
Query: 290 LLGATDYGVGVDLWSAGCILAEL 312
Y D+WS GCIL EL
Sbjct: 172 WENMP-YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR----FDNLEPESVKFMAREILILRRLD 173
F + +G+G + V A+ TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG---LAASPEVKFTEPQVKCYMHQLLSGL 230
HP ++ L + V ME+ G + +V F+EP+ Y ++ GL
Sbjct: 61 HPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGL 114
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM--TSRVVTLWYRP-- 286
++ H N +++RD+K NLL+D +G +KIADFGL K M R T P
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEF 167
Query: 287 --PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 326
PE+L T Y VD W G ++ E+L G+ PG E E
Sbjct: 168 LAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 56/208 (26%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 117 SFEKIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRL 172
S KI++ IG G + V + + L GK VA+K ++ E + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
DHPN+I LEG+VT S + ++ +ME+ L + +FT Q+ + + +G++
Sbjct: 63 DHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-----DPNHKHPMTSRVVTLWYRP 286
+ +HRD+ N+L++ + V K++DFGL+ F DP + + ++ W P
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLA 314
+ + D+WS G ++ E+++
Sbjct: 181 EAIAY--RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 53/291 (18%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL-DHPNVIK 179
IG+G + VY + TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 180 LE-GLVTSRMSCSLY-------LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ T C + L +H +H + F+E +++ Y +++ GLE
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV----------FSEKEMRFYATEIILGLE 111
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H HN V++RD+K +N+L+D+ G ++I+D GLA F H + V T Y PE+L
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQ 168
Query: 292 GATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
T Y D +S GC+L +LL G P +T+ + H+I ++ + + E LP+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVNVE------LPD 220
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
+ F P L+E LL D ++RL EV
Sbjct: 221 S-------------------FSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I ++G G + VYKAK+ TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-----EVKFTEPQVKCYMHQLLSGL 230
++KL G + + F G A + TEPQ++ Q+L L
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------CPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLWYRPPE 288
++ H+ ++HRD+K N+L+ DG +K+ADFG+++ N K S + T ++ PE
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPE 180
Query: 289 LLLGAT----DYGVGVDLWSAGCILAELLAGKP 317
+++ T Y D+WS G L E+ +P
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F + +G+G + V + TGK+ A K++ ++ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 176 NVIKLEGLVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
V+ L ++ + L L FH G F E + Y ++L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--------FEEERALFYAAEIL 112
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
GLE H ++RD+K N+L+DD G ++I+D GLA + RV T+ Y P
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAP 170
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
E +L Y + D W GC++ E++ G+ GR E + ++ + E Y K
Sbjct: 171 E-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 18/231 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + I K+G G + V+ K VA+K ++ + PES E I++
Sbjct: 3 IPR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLS 228
+L H +++L +V+ +Y+V YM L L P + Q+ +
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPP 287
G+ + +HRD++ +N+L+ D V KIADFGLA + N + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
L G + + D+WS G +L EL+ G+ P M R +EQ+ + Y++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLE- 181
+G+GT+ V ++ TGK A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
T C V Y S E F+E + + Y +++S L + H+ V++R
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVD 301
D+K NL++D DG +KI DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 302 LWSAGCILAELLAGK 316
W G ++ E++ G+
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 74/258 (28%), Positives = 104/258 (40%), Gaps = 48/258 (18%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPN 176
F KI IG G + V + + T + A+K +R D L + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
V+KL + + +LY V Y+ D+ L + F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH------------------------ 271
G +HRDIK N+LID DG +K+ DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 272 --KHPMT----------------SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313
+ + S V T Y PE+LL T Y D WS G IL E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 314 AGKPIMPGRTEVEQLHKI 331
G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 118 FEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+KI +G+G + V Y + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEH 232
H N++K +G + + L L+ Y+ L L P+ K Q+ + Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYRPPEL 289
H+ +HRD+ N+L+D+D ++KI DFGLA H++ WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE-- 180
Query: 290 LLGATDYGVGVDLWSAGCILAELL 313
L + D+WS G L ELL
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 42/228 (18%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMARE--ILILRRLDHPNVIKL 180
+G+G++ V A+ T ++ A+K ++ D L+ + V+ E +L L HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHP----- 56
Query: 181 EGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
+T SC L+ V Y M H +F EP+ + Y +++ G
Sbjct: 57 --FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR------SGRFDEPRARFYAAEIVLG 108
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW------ 283
L+ H G+++RD+K N+L+D +G +KIADFG+ K + V T
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPD 161
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
Y PE+L YG VD W+ G +L E+LAG+ G E E I
Sbjct: 162 YIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ F+ I IG+G + V + + ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
+ +++L + LY+V YM DL L ++ ++ E + Y +
Sbjct: 101 NSEWIVQLH--------YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAE 150
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
++ L+ H+ G +HRD+K N+L+D G LK+ADFG D N + V T Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 286 PPELLL---GATDYGVGVDLWSAGCILAELLAGKP 317
PE+L G YG D WS G L E+L G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 1/104 (0%)
Query: 213 KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272
FTE +V+ Y+ +++ L+H H G+++RDIK N+L+D +G + + DFGL+ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 273 HPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAG 315
S T+ Y PE++ G + + VD WS G + ELL G
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 76/251 (30%), Positives = 120/251 (47%), Gaps = 27/251 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V+ A+ T + A+K ++ D L + V+ + + +L L +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
T + +L+ V Y+ DL S KF P+ Y +++ GL+ H+ G++
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW------YRPPELLLGA 293
+RD+K N+L+D DG +KIADFG+ K M T Y PE+LLG
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMC-------KENMLGDAKTCTFCGTPDYIAPEILLG- 170
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW--KKSKLPNA 351
Y VD WS G +L E+L G+ G E E I +P W +++K
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILV 228
Query: 352 TLFKPREPYKR 362
LF REP +R
Sbjct: 229 KLFV-REPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L D P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+T SC LY V Y+ KF EPQ Y ++ GL H G
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATD 295
+++RD+K N+++D +G +KIADFG+ + +T+R T Y PE ++
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE-IIAYQP 177
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
YG VD W+ G +L E+LAG+P G E E I
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 27/220 (12%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A FE ++ +G GTY VYK + + TG++ A+K + E E +K +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 175 -PNVIKLEGLVTSR----MSCSLYLVFHYMEHDLAGLAASPEVKFT------EPQVKCYM 223
N+ G + M L+LV ME AG + + +K T E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLV---MEFCGAG-SVTDLIKNTKGNTLKEEWIAYIC 117
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
++L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D T + T +
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 176
Query: 284 YRPPELLLGATD------YGVGVDLWSAGCILAELLAGKP 317
+ PE++ A D Y DLWS G E+ G P
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRRLDHPNVIKLEG 182
IG+G++ V + + T +I ALK +R ++ S V E +L +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRD 242
S LYLV ++ E +F + + Y +LL LE+ H V++RD
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 243 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGV 300
+K N+L+D G + + DFGL N K + T Y PELLLG Y V
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAV 174
Query: 301 DLWSAGCILAELLAGKP 317
D W+ G +L E+L G P
Sbjct: 175 DWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
KI+K IG G + V + L GK VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N+I LEG+VT S + +V YME+ L + +FT Q+ + + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPELLLG 292
+ G +HRD+ N+L++ + V K++DFGL+ DP + + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 293 ATDYGVGVDLWSAGCILAELLA 314
+ D+WS G ++ E+++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPN 176
FE + +G G++ V AK TG+ A+K ++ L+ + V+ +A+E IL L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 177 VIKLEGLVTSRMSCS------LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
++ M CS +Y + ++ +F K Y +L+
Sbjct: 80 IVN--------MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW----YRP 286
E+ H+ +++RD+K NLL+D+ G +K+ DFG A + R TL Y
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLA 183
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
PE ++ + +G VD W+ G +L E +AG P T KI L G +
Sbjct: 184 PE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAG--------RL 232
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
K PN + R+ L++ LL D +RL
Sbjct: 233 KFPNWFDGRARD-------------------LVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 19/237 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + E K+GQG + V+ T + VA+K ++ + PE+ +E +++
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLS 228
+L H +++L +V+ +Y+V YM L L PQ+ Q+ S
Sbjct: 57 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPP 287
G+ + +HRD++ +N+L+ ++ V K+ADFGLA + N + ++ W P
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG---RTEVEQLHKIYKLCGSPSE 340
L G + + D+WS G +L EL G+ PG R ++Q+ + Y++ P E
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 41/275 (14%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A +GK+VA+KK+ D + + + + E++I+R H NV+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLEHCHNNGVL 239
+ + L++V ++E G A + V T E Q+ +L L H GV+
Sbjct: 85 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGV 298
HRDIK ++L+ DG +K++DFG + + + P +V T ++ PE L+ YG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE-LISRLPYGP 195
Query: 299 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358
VD+WS G ++ E++ G+P Y+ + L + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEP-----------------------PYFNEPPLKAMKMIRDNL 232
Query: 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
P K + PS ++ LL DPA+R TA
Sbjct: 233 PPK---LKNLHKVSPSLKGFLDRLLVRDPAQRATA 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 46/270 (17%)
Query: 163 AREILILRRLDHPNVIKLEGLVT-SRMSCSLYLVFHYMEHDL-AGLAASPEVKFTEPQVK 220
A E ILR ++HP++I+L+G T ++ +C L+ + DL LAA + + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAICD--IL 185
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF---FDPNHKHPMTS 277
+L +++ H N ++HRDIK N+ I+ G + + DFG A F + N +
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 278 RVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAG------KPIMPGRTEVE-QLH 329
+ T PELL A D YG VD+WSAG +L E+ K + G + + Q+
Sbjct: 246 TIAT---NAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300
Query: 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP------------ 377
I + G+ E+ A L E Y +++ + P S P
Sbjct: 301 LIIRRSGTHPNEFPID---AQANL---DEIYIGLAKKSSRK--PGSRPLWTNLYELPIDL 352
Query: 378 --LIETLLAIDPAERLTATVALNSEVIFQD 405
LI +LA D R +A L+ FQD
Sbjct: 353 EYLICKMLAFDAHHRPSAEALLDFAA-FQD 381
|
Length = 391 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 7/195 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLE- 181
+G+GT+ V ++ TG+ A+K +R + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
T C V Y S E FTE + + Y +++S LE+ H+ V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVD 301
DIK NL++D DG +KI DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 302 LWSAGCILAELLAGK 316
W G ++ E++ G+
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 117 SFEKIDKIGQGTYSNVY---KAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRR 171
+FE + +G G Y V+ K TGK+ A+K ++ L + ++V+ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 172 L-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ P ++ L + L+L+ Y+ F+E +V+ Y +++ L
Sbjct: 61 VRQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
EH H G+++RDIK N+L+D +G + + DFGL+ F K S T+ Y PE++
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 291 LGATDYGVGVDLWSAGCILAELLAG 315
G +G VD WS G ++ ELL G
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLV 184
++ K K T +VA+KK+ D+ E +K + +EI+ R+L HPN++ V
Sbjct: 11 EDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YV 65
Query: 185 TSRMSCS-LYLVFHYMEH----DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
TS + S LY+V M + DL L E + + +L+ L++ H+ G +
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLA-SFFD------PNHKHPMTSRVVTLWYRPPEL--- 289
HR +K S++L+ DG + ++ + S H P +S W P L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183
Query: 290 LLGATDYGVGVDLWSAGCILAELLAG 315
L G Y D++S G EL G
Sbjct: 184 LQG---YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
I+K IG G + V + + L GK VA+K ++ + + + + F+ E I+ + DHP
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N+I+LEG+VT + ++ YME+ L + KFT Q+ + + SG+++
Sbjct: 66 NIIRLEGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRPPELLLG 292
+HRD+ N+L++ + V K++DFGL+ + + T ++ W P +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 293 ATDYGVGVDLWSAGCILAELLA 314
+ D+WS G ++ E+++
Sbjct: 184 K--FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 117 SFEKIDKIGQGTYSNVY---KAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRR 171
+FE + +G G Y V+ K +GK+ A+K ++ + + ++ + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 172 LDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ P ++ L + L+L+ Y+ S +F E +V+ Y +++ L
Sbjct: 61 IRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
EH H G+++RDIK N+L+D +G + + DFGL+ F + S T+ Y P+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 291 LGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
G + VD WS G ++ ELL G SP +K+
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG--------------------ASPFTVDGEKNSQA 218
Query: 350 NAT--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ + K PY ++ + +I+ LL DP +RL
Sbjct: 219 EISRRILKSEPPYP-------QEMSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 41/280 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+PR ++ + + K+G G + V+ K VA+K ++ ++ PE+ F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLS 228
+L HP +++L +VT +Y++ YME+ L +PE +K T ++ Q+
Sbjct: 57 QLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ +HRD++ +N+L+ + KIADFGLA + N + + PE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 289 LLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRTE---VEQLHKIYKLC---GSP 338
A +YG + D+WS G +L E++ G+ PG T ++ L + Y++ P
Sbjct: 174 ----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
Query: 339 SEEY------WKKSKLPNATLFKPRE-PYKRCIQETFKDF 371
E Y WK+ KP E P ++ +DF
Sbjct: 230 EELYELMRLCWKE---------KPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+EKI +G+G + V+ + K+V +K++ + + + E +L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK-----FTEPQVKCYMHQLLSGLEH 232
I E +L +V Y G A K E + + Q+L L H
Sbjct: 62 I--EYYENFLEDKALMIVMEYAP---GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 233 CHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H +LHRD+K N+L+D V+KI DFG++ + K + V T Y PEL
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCE 174
Query: 292 GATDYGVGVDLWSAGCILAELLAGK 316
G Y D+W+ GC+L EL + K
Sbjct: 175 GKP-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
F+KI +G+G V+ + TGK+ ALK + + + ++ VK + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHY-MEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
P + L + + L LV Y +L L P +E + Y ++L LE+
Sbjct: 61 PFLPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA----------------SFFDPNHKHPMT 276
H G+++RD+K N+L+ + G + ++DF L+ + +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 277 SRVV------------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
T Y PE++ G +G VD W+ G +L E+L G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
W R D K K+G G Y VY+ VA+K ++ D +E V+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVM 56
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYM-HQLL 227
+ + HPN+++L G+ T Y++ +M + +L + V YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRP 286
S +E+ +HRD+ N L+ ++ ++K+ADFGL+ + ++ W P
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 287 PELLLGATDYGVGVDLWSAGCILAEL 312
L + + D+W+ G +L E+
Sbjct: 175 ES--LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ ++ + IG+G + V + + K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ P V++L + LY+V YM DL L ++ +V E K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALD 156
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H+ G++HRD+K N+L+D G LK+ADFG D + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 292 ---GATDYGVGVDLWSAGCILAELLAG 315
G YG D WS G L E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 121 IDKIGQGTYSNVYKAK-DML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
I ++G+G + +V + D L TG++VA+KK++ E ++ REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
++K +G+ S +L LV Y+ + L + ++ Y Q+ G+E+ +
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLWYRPPELL 290
+HRD+ N+L++ + +KI DFGL + + P S + WY P
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPES-- 182
Query: 291 LGATDYGVGVDLWSAGCILAEL 312
L + + V D+WS G +L EL
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ +E + IG+G + V + T K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ P V++L + LY+V YM DL L ++ +V E + Y +++ L+
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFYTAEVVLALD 156
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H+ G +HRD+K N+L+D G LK+ADFG + + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 292 ---GATDYGVGVDLWSAGCILAELLAG 315
G YG D WS G L E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A FE ++ +G GTY VYK + + TG++ A+K + E E +K EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 175 -PNVIKLEGLVTSRMSC----SLYLVFHYMEHDLAGLAASPEVK------FTEPQVKCYM 223
N+ G + L+LV ME AG + + VK E +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLV---MEFCGAG-SVTDLVKNTKGNALKEDWIAYIC 127
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
++L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D T + T +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 186
Query: 284 YRPPELLLGATD------YGVGVDLWSAGCILAELLAGKP 317
+ PE++ A D Y D+WS G E+ G P
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 58/292 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
+ FE + IG+G + V + TG + A+K +R D LE E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
V+K+ +++ LYL+ ++ D+ L + TE + + Y+ + + ++
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSI 117
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS----------FFDPNHKHPM-------- 275
H G +HRDIK NLL+D G +K++DFGL + + + NH P
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 276 TSRVVTLWYR----------------PPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 319
+ R W R PE+ + T Y D WS G I+ E+L G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 320 PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDF 371
T P E Y K +F P P I E KD
Sbjct: 237 CSET--------------PQETYKKVMNWKETLIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+T SC LY V Y+ KF EP Y ++ GL H+ G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATD 295
+++RD+K N+++D +G +KIADFG+ N T+R T Y PE++
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEIIA-YQP 177
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
YG VD W+ G +L E+LAG+P G E E I
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 13/220 (5%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+KIG+G + +VYK + VA+K R KF+ +E IL++ DHPN++KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 182 GLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
G+ + +Y+V + L + + T ++ +G+E+ + +H
Sbjct: 59 GVCVQKQP--IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPELLLGATDYGV 298
RD+ N L+ ++ VLKI+DFG++ + ++ W P L G Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YTS 174
Query: 299 GVDLWSAGCILAELLAGK----PIMPGRTEVEQLHKIYKL 334
D+WS G +L E + P M + E++ Y++
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM 214
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 6/210 (2%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V AK GK A+K ++ + + E MA ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ + + LY V Y+ E F EP+ + Y ++ S L + H+ +++R
Sbjct: 63 --YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVD 301
D+K N+L+D G + + DFGL H ++ T Y PE+L Y VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTVD 178
Query: 302 LWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
W G +L E+L G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 75/264 (28%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDHPN 176
F KI +G G + V A+ + T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
V++L + + +LY V Y+ D+ L + F E + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK----------------------- 272
G +HRDIK N+LID DG +K+ DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 273 ----------HPMTSR-------------VVTLWYRPPELLLGATDYGVGVDLWSAGCIL 309
P+ R V T Y PE+LL T Y D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 310 AELLAGKPIMPGRTEVEQLHKIYK 333
E+L G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 79/292 (27%), Positives = 115/292 (39%), Gaps = 58/292 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE + IG+G + V + TG I A+K +R D LE E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
V+K+ + + +LYL+ ++ D+ L + +E + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAI 117
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGL------------------------------ 263
H G +HRDIK NLL+D G +K++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 264 ----ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 319
A + N + S V T Y PE+ + T Y D WS G I+ E+L G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 320 PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDF 371
T P E Y K +F P P I E KD
Sbjct: 237 CSET--------------PQETYRKVMNWKETLVFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF--MAREILILRRLD 173
D E +D++G+G Y +VYK TG +A+K++R LE + KF + E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAV 57
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH---DLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
P ++ G + ++Y+ YM+ D E ++ + ++ GL
Sbjct: 58 SPYIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 231 EHC---HNNGVLHRDIKGSNLLIDDDGVLKIADFGL-----ASFFDPNHKHPMTSRVVTL 282
+ HN ++HRD+K +N+L++ +G +K+ DFG+ AS N +
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGCQ 165
Query: 283 WYRPPELL--LGATD---YGVGVDLWSAGCILAELLAGKPIMPGRT 323
Y PE + G Y V D+WS G + E+ G+ P T
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +IG G + V+ L + VA+K +R + E E ++ +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+++L G+ T R + LVF +MEH L+ + KF++ + + G+ +
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPELLLGA 293
++ V+HRD+ N L+ ++ V+K++DFG+ F D + ++ W P
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS- 176
Query: 294 TDYGVGVDLWSAGCILAELLA-GKPIMPGRTE---VEQL---HKIYK 333
Y D+WS G ++ E+ + GK R+ VE + ++YK
Sbjct: 177 -KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 118 FEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPES----VKFMAREILIL 169
++I +G+G + V Y + TG+ VA+K +L+PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLS 228
R L H N++K +G+ T + L+ ++ L + K Q Y Q+
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLW 283
G+++ + +HRD+ N+L++ + +KI DFGL + + K + S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELL 313
Y PE L+ + Y + D+WS G L ELL
Sbjct: 179 Y-APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEG 182
+G+GT+ V ++ +GK A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRD 242
+ + L V Y+ S E F+E + + Y +++S L++ H+ +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 243 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDL 302
+K NL++D DG +KI DFGL M + T Y PE +L DYG VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 303 WSAGCILAELLAGK 316
W G ++ E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 57/182 (31%), Positives = 86/182 (47%), Gaps = 35/182 (19%)
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHK 272
F EP+ Y Q++SGLEH H +++RD+K N+L+D+DG ++I+D GLA D K
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
T + PELL G +Y VD ++ G L E++A + P R E++
Sbjct: 154 --TKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARG--PFRARGEKVEN-- 206
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQE--TFKD-FPPSSLPLIETLLAIDPAE 389
+E +R + + T+ D F P+S E LLA DP +
Sbjct: 207 ------------------------KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEK 242
Query: 390 RL 391
RL
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 31/205 (15%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+ +G G VYKA +LT +I+A+K + D + E K + E+ IL + D P +I
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 182 G--LVTSRMS-CSLYL------VFHYM-EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
G V +R+S C+ ++ V+ + EH L +A + ++ GL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------------VVKGLT 109
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
+ + +LHRD+K SN+L++ G +K+ DFG+++ + V T Y PE +
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERIS 166
Query: 292 GATDYGVGVDLWSAGCILAELLAGK 316
G YG+ D+WS G EL G+
Sbjct: 167 G-EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 10/217 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+G G + V++ VA+K ++ D+L + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHL 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMH-QLLSGLEHCHN 235
I L + + +Y++ ME L SPE + M Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+HRD+ N+L+ +D V K+ADFGLA + ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 296 YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
+ D+WS G +L E+ G+ PG E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + + K+GQG + V+ T K VA+K ++ + PE+ +E I++
Sbjct: 3 IPRESLRLDV--KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVKFTE-PQVKCYMHQLLS 228
+L H ++ L +V+ +Y+V +M + L + K+ + PQ+ Q+
Sbjct: 57 KLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPP 287
G+ + +HRD++ +N+L+ D+ V KIADFGLA + N + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG---RTEVEQLHKIYKL 334
L G + + D+WS G +L EL+ G+ PG R +EQ+ + Y++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
+ ++G G + V+ K GKI VA+K +R + + F+ E ++ +L HPN+++
Sbjct: 9 LKELGSGQFGVVHLGK--WRGKIDVAIKMIREGAMSEDD--FI-EEAKVMMKLSHPNLVQ 63
Query: 180 LEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
L G+ T + +++V YM + L L TE + + +E+ +NG
Sbjct: 64 LYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTE-WLLDMCSDVCEAMEYLESNG 120
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
+HRD+ N L+ +D V+K++DFGLA + D + ++ W PPE+ + +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW-APPEVFD-YSRF 178
Query: 297 GVGVDLWSAGCILAELLA-GKPIMPGRTE---VEQLHKIYKL 334
D+WS G ++ E+ + GK + VE + Y+L
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 58/232 (25%), Positives = 110/232 (47%), Gaps = 16/232 (6%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W I R S + + K+G G + V++ T VA+K ++ ++P+ F+ E I
Sbjct: 1 WEIDRT--SIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQI 54
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQL 226
+++L HP +I+L + T + +Y+V M++ L L PQ+ Q+
Sbjct: 55 MKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
SG+ + +HRD+ N+L+ ++ + K+ADFGLA + + +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
PE L + + D+WS G +L E++ G+ P M ++Q+ + Y++
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 70/231 (30%), Positives = 105/231 (45%), Gaps = 28/231 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
+ FE I I G Y VY + T + A+KK+ NL + + V F+ R+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 172 LDHPNVIKLEG-LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSG 229
++P V+ + T R C +V Y+E D A L + + + Y + +
Sbjct: 59 -ENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLA 113
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-------------FFDPNHKHPMT 276
LE+ HN G++HRD+K NLLI G +K+ DFGL+ + + + +
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 277 SRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 326
+V T Y PE++L YG VD W+ G IL E L G G T E
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 123 KIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
++G+G++ VY KD ++ LK++ L P +E +L +LDHP ++K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 180 LEGLVTSRMSCSLYLVFHYME-HDL---AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
R + ++ Y E DL +E QV + QLL G+ + H
Sbjct: 67 FHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+LHRD+K N+ + ++ +LKI DFG++ T+ T +Y PE L
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKHQG 181
Query: 296 YGVGVDLWSAGCILAEL 312
Y D+WS GCIL E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V A+ T ++ A+K ++ D L+ + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 181 EGLVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+T+ C L+ V Y+ KF EP+ + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW------YRPPEL 289
+GV++RD+K N+L+D +G K+ADFG+ K + + V T Y PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDYIAPE- 166
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKP 317
+L +YG VD W+ G ++ E++AG+P
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 8/211 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V A+ T + A+K ++ D LE + V+ + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
T + L+ V Y+ +F E + + Y +++ GL+ H G+++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
RD+K N+L+D DG +KIADFG+ + N + ++ T Y PE+L G Y V
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQK-YNESV 177
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
D WS G +L E+L G+ G E E I
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKK-VRFDNLEPESVKFMAREILILRRLDH 174
+ E + +IG GT VYK + TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 175 PNVIKLEGLVTSR---------MS-CS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
P ++K G + MS C L + + D+ G K T VK
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIVKA 126
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
L L+ H GV+HRD+K SN+L+D G +K+ DFG++ + ++
Sbjct: 127 -----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 282 LWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKI 331
Y PE + Y + D+WS G L EL G+ P +TE E L KI
Sbjct: 180 --YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 124 IGQGTYSNVYKAKDML---TGKIVA---LKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+G+G Y V++ + + TGKI A LKK + ++ A E IL + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+ L + + LYL+ Y+ + E F E Y+ ++ LEH H G
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+++RD+K N+L+D G +K+ DFGL S + H T+ Y PE+L+ +
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG---TIEYMAPEILM-RSG 176
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
+G VD WS G ++ ++L G P + + KI K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 30/235 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH- 174
D E I+++G+G Y V K + + TG I+A+K++R + + K + ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 175 PNVIKLEGLVTSR---------MSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQVKCYMH 224
P + G + M SL + + L E +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGL---------TIPEDILGKIAV 110
Query: 225 QLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTL 282
++ LE+ H+ V+HRD+K SN+LI+ +G +K+ DFG++ + D K T
Sbjct: 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TIDAGCK 167
Query: 283 WYRPPELLLGATD---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYK 333
Y PE + + Y V D+WS G + EL G+ P +T +QL ++ +
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 12/190 (6%)
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP--- 217
+ EIL L RL+H N++K+E ++ R + Y++ + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 218 -QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276
Q + M QLL +E+ H+ ++HRDIK N+ ++ DG + + DFG A F+ +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP----GRTEVEQLHKIY 332
V T+ PE+L G Y D+WS G IL ++L+ P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 333 KLCGSPSEEY 342
EE+
Sbjct: 385 DSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
+ F + IG+G + V + TGKI A+K + + + + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P V+ L + + + LYL+ ++ DL + + F+E + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH--------------KHPMTSR- 278
H G +HRDIK N+LID G +K++DFGL++ F H K+ + +R
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 279 ---VVTLW----------------------------YRPPELLLGATDYGVGVDLWSAGC 307
V ++ Y PE+ L YG D WS G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236
Query: 308 ILAELLAGKPIMPGRTEVEQLHKI 331
I+ E L G P E KI
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 35/234 (14%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
R + +E I KIG G + V+ K T + K + + L+ + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV------KFTEPQVKCYMHQLL 227
H N+++ ++ + LY++ + D L+ + + K E + QLL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 228 SGLEHCHN-----NG--VLHRDIKGSNLL-----------------IDDDGVLKIADFGL 263
L +CHN NG VLHRD+K N+ ++ + KI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGK 316
+ + + S V T +Y PELLL T Y D+W+ GCI+ EL +GK
Sbjct: 189 SK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+ IG+G + V + + TG+ VA+K ++ D + F+ E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD---VTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
G++ + LY+V ME G L + Q+ + + G+E+ +
Sbjct: 66 GVI---LHNGLYIV---MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
++HRD+ N+L+ +DGV K++DFGLA S++ W P L +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKHK--KF 174
Query: 297 GVGVDLWSAGCILAELL----AGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
D+WS G +L E+ A P M + E + K Y++ P E
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 14/228 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK----KVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G++ V AK L GK A+K K+ + E + + MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
L + + + LY V ++ E F EP+ + Y ++ S L + H+ ++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 299
+RD+K N+L+D G + + DFGL T+ T Y PE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQ----LHKIYKLCGSPSEEYW 343
VD W G +L E+L G P R E LHK L S W
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 140 TGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKL--EGLVTSRMSCSLYLVF 196
TG VA+K +R D E E RE + RL HPN++ L G + L+ VF
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVF 58
Query: 197 HYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255
Y+ L + A+ + M Q+L L HN G++HRD+K N+++ GV
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 256 ---LKIADFGLASFFDPNHKH-----PMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAG 306
K+ DFG+ + T+ V+ T Y PE L G DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWG 176
Query: 307 CILAELLAGKPIMPGRTEVEQLHK 330
I E L G+ ++ G + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 75/259 (28%), Positives = 104/259 (40%), Gaps = 54/259 (20%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDHPN 176
F KI +G G + V A + T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
V+KL + + LY V Y+ D+ L EV F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF----------DPNHKHPMTSRVVTLW-- 283
G +HRDIK N+LID DG +K+ DFGL + F +H + LW
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 284 ----------------------------------YRPPELLLGATDYGVGVDLWSAGCIL 309
Y PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 310 AELLAGKP--IMPGRTEVE 326
E+L G+P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+G+Y V + GK +KK+ N K +E +L +L HPN+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 184 VTSRMS-----CSLYLVFHYMEH-DLAGLAASPEVKF-TEPQVKCYMHQLLSGLEHCHNN 236
V R S LY+V + E DL + K E QV + Q+ L++ H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 296
+LHRD+K N+ + ++K+ D G+A + N ++ + T +Y PE L Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 297 GVGVDLWSAGCILAEL 312
D+W+ GC + E+
Sbjct: 180 NYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 165 EILILRRLDHPNVIKLEGL-VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYM 223
E +LRRL HP V+ L + V ++C LV DL + QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TL 282
QLLS +++ H G++HRDIK N+L++ + + DFG A F + P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAE 311
PE+L G Y VD+WSAG ++ E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREILI 168
+ D+ ++G+G + V+ + + +VA+K ++ + ++ K RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAEL 61
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKF----------- 214
L H N++K G+ T +VF YMEH DL + P+ F
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKH 273
T Q+ Q+ SG+ + + +HRD+ N L+ D V+KI DFG++ + ++
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 312
++ + + PPE ++ + D+WS G +L E+
Sbjct: 180 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 14/224 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V AK G A+K ++ + + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ + + LY V Y+ E F EP+ + Y ++ S + + H+ +++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGV 300
D+K N+L+D G + + DFGL + TS T Y PE +L Y V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTV 177
Query: 301 DLWSAGCILAELLAGKPIMPGRTEVEQ-----LHKIYKLCGSPS 339
D W G +L E+L G P R +V Q LHK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR-EILILRRLDHPNVIKLE- 181
+G+G + V + TGK+ A KK+ L+ +S + MA E IL +++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 182 --------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
LV S M+ L +H GL +V Y Q+ G+ H
Sbjct: 61 AFESKTHLCLVMSLMNGG-DLKYHIYNVGERGLEME--------RVIHYSAQITCGILHL 111
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ +++RD+K N+L+DD G +++D GLA + +T R T Y PE+L
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330
Y VD ++ GC + E++AG+ P + E++ K
Sbjct: 170 P-YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLE 181
IG+G+Y+ V + T +I A+K V+ + + + E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ L+ V Y+ + K E + Y ++ L + H G+++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGV 300
D+K N+L+D +G +K+ D+G+ + TS T Y PE+L G DYG V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV 177
Query: 301 DLWSAGCILAELLAGK 316
D W+ G ++ E++AG+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + +V G+ VA+K ++ D+ ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 179 KLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHN 235
+L G+V LY+V YM L S V Q+ + + G+E+
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLEE 120
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+HRD+ N+L+ +D V K++DFGLA + ++ W P L
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--K 175
Query: 296 YGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
+ D+WS G +L E+ + G+ P +P + V + K Y++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + EK K+G G + V+ A K VA+K ++ ++ SV+ E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLS 228
L H ++KL +VT +Y++ +M L L + K P++ + Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ +HRD++ +N+L+ V KIADFGLA + N + + PE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 289 LLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRTEVE 326
A ++G + D+WS G +L E++ G+ PG + E
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 11/145 (7%)
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRV 279
Y +++ GL+ H+ G+++RD+K N+++D DG +KIADFG+ + F N ++
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFC 157
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
T Y PE+L G Y VD WS G +L E+L G+ G E E I +P
Sbjct: 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPH 214
Query: 340 EEYW--KKSKLPNATLFKPREPYKR 362
W K+SK LF+ R+P +R
Sbjct: 215 YPRWITKESKDILEKLFE-RDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 40/280 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + + K+G G + V+ + K VA+K ++ + SV+ E +++
Sbjct: 3 IPR--ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLS 228
L H +++L +VT +Y++ YM L L + K P++ + Q+
Sbjct: 57 TLQHDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ + +HRD++ +N+L+ + + KIADFGLA + N + + PE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 289 LLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRTE------VEQLHKIYKLCGSP 338
A ++G + D+WS G +L E++ GK PG + +++ +++ ++ P
Sbjct: 175 ----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP 230
Query: 339 SEEY------WKKSKLPNATLFKPRE-PYKRCIQETFKDF 371
E Y WK+ K E P +Q DF
Sbjct: 231 DELYDIMKTCWKE---------KAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 14/218 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G + V+K L K VA+K + D + +KF++ E IL++ DHPN++KL G
Sbjct: 3 LGKGNFGEVFKGT--LKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 183 LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ T R +Y+V + D + + Q+ + +G+ + + +HR
Sbjct: 60 VCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
D+ N L+ ++ VLKI+DFG++ D + ++ W P L G Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--YSSES 175
Query: 301 DLWSAGCILAELLA----GKPIMPGRTEVEQLHKIYKL 334
D+WS G +L E + P M + EQ+ K Y++
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 10/214 (4%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMARE--ILILRRLDHPNVIKL 180
+G+G++ V A+ +G++ A+K ++ D L+ + V+ E IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
+ L+ V ++ +F E + + Y ++ S L H+ G+++
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVG 299
RD+K N+L+D +G K+ADFG+ + TS T Y PE +L YG
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
VD W+ G +L E+L G E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 38/220 (17%)
Query: 121 IDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++++G+G + VYK + + L+ VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 176 NVIKLEGLVT-SRMSCSLYLVFHYMEH-DL----------AGLAASPEVKFTEPQVKC-- 221
N++ L G+ T + +C L F Y+ H DL + + A + + + C
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 222 YMH---QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL------ASFFDPNHK 272
++H Q+ +G+E+ ++ +HRD+ N L+ + +KI+DFGL A ++ K
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 312
+ R W P +L G + D+WS G +L E+
Sbjct: 186 SLLPVR----WMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 10/212 (4%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V A+ K A+K ++ + + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ + + LY V Y+ E F EP+ + Y ++ S L + H+ +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVG 299
D+K N+L+D G + + DFGL N +H T+ T Y PE +L Y
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRT 176
Query: 300 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
VD W G +L E+L G P R E I
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREI 166
PR ++ E + IGQG + V++A+ +L + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 167 LILRRLDHPNVIKLEGL-VTSRMSCSLYLVFHYMEH-DL--------------------- 203
++ DHPN++KL G+ + C L+F YM + DL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 204 AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263
A + + + C Q+ +G+ + +HRD+ N L+ ++ V+KIADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 264 A-SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 314
+ + + ++ + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 18/284 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P ++ G S S+ + +M+ + E + ++ GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 234 -HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
+ ++HRD+K SN+L++ G +K+ DFG++ + + S V T Y PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 293 ATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
T Y V D+WS G L E+ G+ PI P + ++L ++ G P E +S+
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMF---GCPVEGDPAESETSP- 229
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395
+PR P + PP ++ + + +P +L + V
Sbjct: 230 ---RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGV 270
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 46/197 (23%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IG G + V++ + G+ VA+K ++ E + F++ E I+ + H N+I+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 181 EGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
EG+VT ++ YME+ L + +F+ Q+ + + +G+++ + +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
HRD+ N+L++ + K++DFGL+ DP + + + + + PE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFT 188
Query: 298 VGVDLWSAGCILAELLA 314
D+WS G ++ E+++
Sbjct: 189 SASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEG 182
+G+GT+ V K+ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHR 241
+ + L V Y S E F+E + + Y +++S L++ H+ V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVD 301
D+K NL++D DG +KI DFGL M + T Y PE +L DYG VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 178
Query: 302 LWSAGCILAELLAGK 316
W G ++ E++ G+
Sbjct: 179 WWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 20/238 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
V+ L ++ + L L FH G F E + Y +L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--------FDEQRAIFYAAELC 112
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
GLE +++RD+K N+L+DD G ++I+D GLA + RV T+ Y P
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAP 170
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
E++ Y D W GC++ E++ G+ R E + ++ + EEY +K
Sbjct: 171 EVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+T SC LY V Y+ +F EP Y ++ GL H+ G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATD 295
+++RD+K N+++D +G +KIADFG+ N +T++ T Y PE ++
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPE-IIAYQP 177
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
YG VD W+ G +L E+LAG+ G E E I
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 12/224 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V K T +I A+K + +++ L+ E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
+ L + LYLV +Y+ DL L + E + E + Y+ +++ +
Sbjct: 61 QWITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLL 291
H +HRDIK N+L+D +G +++ADFG S N + S V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 292 GATD----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
D YG D WS G + E+L G+ + VE KI
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 123 KIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+IG+G ++VY A+ TG +V ++ +N E +K + E+++ HPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAAS------PEVKFTEPQVKCYMHQLLSGLEHCH 234
+ T+ L+++ +M + G A S PE +E + + L GL + H
Sbjct: 65 WTVFTT--GSWLWVISPFMAY---GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLH 118
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFG-LASFFDPNHKH------PMTSRVVTLWYRPP 287
NG +HR+IK S++LI DG++ ++ L S K P S V W P
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGK 316
L Y V D++S G EL G+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLE 181
IG+G+Y+ V + +I A+K V+ + + + E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241
+ + L+LV Y+ + K E + Y ++ L H G+++R
Sbjct: 63 SCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 242 DIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGV 300
D+K N+L+D DG +K+ D+G+ P ++ T Y PE+L G +YG V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRG-EEYGFSV 177
Query: 301 DLWSAGCILAELLAGK 316
D W+ G ++ E++AG+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 81/316 (25%), Positives = 133/316 (42%), Gaps = 64/316 (20%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK--FMAREILILRRLDHP 175
++ I IG+G VY A D + + VALKK+R D E +K F+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQ-------VKCYM---H 224
++ + + + +Y Y+E + L L S K + + V ++ H
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA----------SFFDPNHKHP 274
++ + +E+ H+ GVLHRD+K N+L+ G + I D+G A D + ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 275 MTSR-------VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 327
S V T Y PE LLG D+++ G IL ++L
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT------------- 226
Query: 328 LHKIYKLCGSPSEEYWKKSKLPNATLFKPRE--PYKRCIQETFKDFPPSSLPLIETLLAI 385
L Y+ + +K + + P E PY ++ PP + LA+
Sbjct: 227 LSFPYR------RKKGRKISYRD-VILSPIEVAPY--------REIPPFLSQIAMKALAV 271
Query: 386 DPAERLTATVALNSEV 401
DPAER ++ L ++
Sbjct: 272 DPAERYSSVQELKQDL 287
|
Length = 932 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLE 181
IG+G+Y+ V + T +I A+K ++ + + + E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 182 GL--VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
SR L+ V ++ + K E + Y ++ L H G++
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGV 298
+RD+K N+L+D +G +K+ D+G+ + TS T Y PE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 299 GVDLWSAGCILAELLAGK 316
VD W+ G ++ E++AG+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+ ++G G + V+ K K VA+K + + E F+ E ++ +L HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 181 EGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
G+ T + LY+V +ME+ L + K ++ + + G+E+ N +
Sbjct: 65 YGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
HRD+ N L+ GV+K++DFG+ + D + ++ W PPE+ + Y
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPEVFN-FSKYSS 180
Query: 299 GVDLWSAGCILAELLA-GKPIMPGR--------TEVEQLHKIYK 333
D+WS G ++ E+ GK MP + + ++Y+
Sbjct: 181 KSDVWSFGVLMWEVFTEGK--MPFEKKSNYEVVEMISRGFRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 8/222 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
+ FE + IG+G + V K K+ A+K + +++ L+ E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
+ L + +LYLV +Y+ DL L + E + E + Y+ +++ ++
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H +HRDIK N+L+D +G +++ADFG + + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 294 TD----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
D YG D WS G + E+L G+ + VE KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKL 180
++IG+G + V+ + VA+K R + L P+ KF+ +E IL++ HPN+++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRL 58
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
G+ T + +Y+V ++ D + + ++ + +G+E+ + +
Sbjct: 59 IGVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS---RVVTLWYRPPELLLGATDY 296
HRD+ N L+ + VLKI+DFG+ S + + + T ++ W P L G Y
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGM-SREEEDGVYASTGGMKQIPVKWTAPEALNYGR--Y 173
Query: 297 GVGVDLWSAGCILAE 311
D+WS G +L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 8/222 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
D FE + IG+G + V K TG++ A+K + +++ L+ E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
+ L + LYLV +Y+ DL L + E + E + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H G +HRDIK N+L+D +G +++ADFG + V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 294 TD----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
D YG D WS G + E+L G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 11/221 (4%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FE+I ++G G V K + +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P ++ G S S+ + +M+ + E + +L GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 234 -HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
+ ++HRD+K SN+L++ G +K+ DFG++ + + S V T Y PE L G
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 293 ATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIY 332
T Y V D+WS G L EL G+ PI P + ++L I+
Sbjct: 177 -THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 36/231 (15%)
Query: 112 PRRADSFEKIDKIGQGTYSNVY--KAKDMLTGK--------------IVALKKVRFDNLE 155
PR+ +F+ +K+G+G + V+ +A+ M +VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 156 PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME----------HDLAG 205
F+ +EI I+ RL PN+I+L L S L ++ YME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 206 LAASPEVKFTEPQVKCYMH-QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
A +V +M Q+ SG+++ + +HRD+ N L+ + +KIADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 265 SFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313
+ + R V W +LLG + D+W+ G L E+L
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 122 DKIGQGTYSNVYKAK-DMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
K+G G++ V + + GK+ VA+K ++ D L F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
+L G+V ++ L +V L L F + Y Q+ +G+ + +
Sbjct: 60 RLYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRPPELLLGAT 294
+HRD+ N+L+ D +KI DFGL N H + V + PE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 295 DYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYK 333
+ D+W G L E+ G+ G + + L KI K
Sbjct: 177 -FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 19/185 (10%)
Query: 143 IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH- 201
+VA+K +R D + F+ +EI I+ RL +PN+I+L G+ S L ++ YME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 202 DLAGLAASPEV--KFTE----PQVK----CYMH-QLLSGLEHCHNNGVLHRDIKGSNLLI 250
DL + E+ FT P V YM Q+ SG+++ + +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 251 DDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCI 308
+ +KIADFG++ + + R V W +LLG + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 309 LAELL 313
L E+
Sbjct: 221 LWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHK 272
F E +V +Q++ L+ H+ ++HRD+K +N+ + G++K+ DFG + + D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
+S T +Y PE L Y D+WS G IL ELL LH+ +
Sbjct: 226 DVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------LHRPF 271
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
K PS+ ++ L+ +P+ + K L++ LL+ +PA R T
Sbjct: 272 K---GPSQR-----EIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALRPT 316
Query: 393 ATVALNSEV------IFQD 405
L++E +FQD
Sbjct: 317 TQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G + +VY+ KI VA+K + KF+ E I+R+ DHP+++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 180 LEGLVTSRMS------CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
L G++T L + Y++ + L + + + Y QL + L +
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTALAYL 123
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268
+ +HRDI N+L+ +K+ DFGL+ + +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 124 IGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
+G+G + +V + + D K VA+K ++ D ++ E ++ DHPNV+K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 180 LEGLVTSRMSC-----SLYLVFHYMEH-DL------AGLAASPEVKFTEPQVKCYMHQLL 227
L G V S ++ +M+H DL + L PE K + +M +
Sbjct: 66 LIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKFMVDIA 123
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
G+E+ N +HRD+ N ++ +D + +ADFGL+
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 118 FEKIDKIGQGTYSNVYKA---KDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLD 173
EKI +G G + VYK + KI VA+K +R + P++ K + E ++ +D
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
HP+V++L G+ +S + L+ M L + + + + Q+ G+ +
Sbjct: 68 HPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRPPELL 290
++HRD+ N+L+ +KI DFGLA D + K +V W +L
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 291 LGATDYGVGVDLWSAGCILAELL 313
Y D+WS G + EL+
Sbjct: 185 HR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYM 223
E ++ +L H +++L G+ T + +Y+V YM + L +F Q+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTL 282
+ G+ + + +HRD+ N L+DD G +K++DFGL+ + D + + S+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAEL 312
W PPE+LL + + D+W+ G ++ E+
Sbjct: 167 W-SPPEVLL-YSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 16/220 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D FEK+ ++G G V K +G I+A K + + ++P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG---LAASPEVKFTEPQVKCYMHQLLSGLEH 232
++ G S S+ MEH G + E + +L GL +
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114
Query: 233 CHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
++HRD+K SN+L++ G +K+ DFG++ S V T Y PE L
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 171
Query: 292 GATDYGVGVDLWSAGCILAELLAGK-PI-MPGRTEVEQLH 329
G T Y V D+WS G L E+ G+ PI P E+E +
Sbjct: 172 G-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 114 RADSFEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
+ + F I +G G++ V YK +D I +K + ++ + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKIL 85
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC-YMHQLLS 228
++HP + L G + + LYLV ++ +F V C Y Q++
Sbjct: 86 NYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVL 142
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP-- 286
E+ + +++RD+K NLL+D DG +K+ DFG A D +R TL P
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TRTYTLCGTPEY 194
Query: 287 --PELLLGATDYGVGVDLWSAGCILAELLAGKP 317
PE+LL +G D W+ G + E+L G P
Sbjct: 195 IAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKI---VALKKV-RFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G + VY + + A+K + R +LE V+ +E +I++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 180 LEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMH---QLLSGLEHCHN 235
L G+ L +V YM+H DL S P VK + Q+ G+E+ +
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLA------SFFDP-NHKHPMTSRVVTLWYRPPE 288
+HRD+ N ++D+ +K+ADFGLA ++ NH +++ W
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG---AKLPVKWMALES 173
Query: 289 LLLGATDYGVGVDLWSAGCILAELLA-GKPIMP 320
L + D+WS G +L EL+ G P P
Sbjct: 174 --LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 71/238 (29%), Positives = 111/238 (46%), Gaps = 37/238 (15%)
Query: 124 IGQGTYSNVYKAK----DMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
+G+G + V KA+ D VA+K ++ D E + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DL---------AGLAAS------PEVKFTEPQVKC 221
I L G+ T LY+V Y H +L G AS PE T+ +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH----KHPMTS 277
+ +Q+ G+E + +HRD+ N+L+ +D V+KIADFGLA D +H +
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194
Query: 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYK 333
R+ W P L Y D+WS G +L E+ L G P PG VE+L K+ K
Sbjct: 195 RLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
R + E I +G G +V K K + TG ++A KKV + K + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 174 HPNVIKLEG---------LVTSRMSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQVK 220
P ++ G + M C +Y + ++ G A V+
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVE------- 114
Query: 221 CYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLA-----SFFDPNHKHP 274
GL + +N + ++HRDIK SN+L++ G +K+ DFG++ S D
Sbjct: 115 --------GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD------ 160
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 316
+ V T Y PE + G Y V D+WS G + EL GK
Sbjct: 161 --TFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 120 KIDKI-GQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
KI++I G G + + + L K VA+ +R + + F+A E L L + DH
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHS 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N+++LEG++T ++ +V YM + L E + Q+ + L SG+++
Sbjct: 67 NIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-----HPMTSRVVTLWYRPPEL 289
G +H+ + +L++ D V KI+ F K M+ + LW P +
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 290 LLGATDYGVGVDLWSAGCILAELLA 314
+ D+WS G ++ E+++
Sbjct: 181 QYH--HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 64/237 (27%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 124 IGQGTYSNVYKAK-DMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G G + +V K M +GK VA+K ++ K RE ++ +LDHP +++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-------TEPQVKCYMHQLLSG---L 230
G+ LV ME LA L P +K+ +K HQ+ G L
Sbjct: 62 IGVCKGEPLM---LV---ME--LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAYL 111
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLWYRPP 287
E H +HRD+ N+L+ + KI+DFG++ ++ R WY P
Sbjct: 112 ESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA--GKPI--MPGRTEVEQLHKIYKLCGSPSE 340
+ G D+WS G L E + KP M G + L +L P E
Sbjct: 169 CINYGKFSS--KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-PRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 124 IGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRL-DHP 175
+G+G + V A+ + K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHY-----------------MEHDLAGLAASPEVKFTEPQ 218
N+I L G T LY++ Y ME+ +A P+ + T
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSY-DIARVPDEQMTFKD 138
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN----HKHP 274
+ +Q+ G+E+ + +HRD+ N+L+ ++ V+KIADFGLA D N +K
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKT 196
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIY 332
R+ W P L Y D+WS G ++ E+ L G P PG VE+L K+
Sbjct: 197 TNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLL 252
Query: 333 K 333
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K K + K VA+K ++ DN +P + RE ++++LD+P ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-------TEPQVKCYMHQLLSGLEHC 233
G+ + S LV ME LA L P KF TE + +HQ+ G+++
Sbjct: 62 IGICEAE---SWMLV---ME--LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPN-HKHPMTSRVVTLWYRPPELL 290
+HRD+ N+L+ KI+DFGL+ D N +K + WY P
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 291 LGATDYGVGVDLWSAGCILAE 311
+ + D+WS G ++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 124 IGQGTYSNVYKAK---DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G + +V +A+ + + + VA+K ++ D ++ RE ++ DHPNVIKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 181 EGL-VTSRMSCSL---YLVFHYMEH-DL-AGLAASP--EVKFTEPQVKC--YMHQLLSGL 230
G+ + SR L ++ +M+H DL L S E FT P +M + SG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRVVTLWYRPPE 288
E+ + +HRD+ N +++++ + +ADFGL+ + ++ S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 289 LLLGATDYGVGVDLWSAGCILAELL 313
L Y D+W+ G + E++
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQVKCYMHQLLSGLE 231
PN++ L + S S VF ++H G S KF E VK + +++ L+
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H G++ RD+ +N+L+DD G +++ F S + + + Y PE +
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VG 154
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
G ++ D WS G IL ELL GK ++ H + SEE
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEE---------- 204
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396
+ L++ LL +P ERL A VA
Sbjct: 205 -----------------------ARSLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAR 164
W R + I ++GQG++ VY+ AK ++ G+ VA+K V + E ++F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAAS--PEVKFTEPQVKC 221
E +++ + +V++L G+V+ +V M DL S PE +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 222 YMHQLL-------SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKH 273
+ + + G+ + +HRD+ N ++ +D +KI DFG+ ++ ++
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
++ + + PE L + D+WS G +L E+ LA +P
Sbjct: 177 KGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 121 IDKIGQGTYSNVYKAKDMLTG-----KIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++++G+ + VYK T + VA+K ++ D E + E ++ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH--------------DLAGLAASPEVKFT-EPQVK 220
N++ L G+VT S+ +F Y H D+ VK T EP
Sbjct: 69 NIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD- 125
Query: 221 CYMH---QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKHPMT 276
++H Q+ +G+E ++ V+H+D+ N+L+ D +KI+D GL + ++ M
Sbjct: 126 -FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 277 SRVVTL-WYRPPELLLGATDYGVGVDLWSAGCILAELLA 314
+ ++ + W P ++ G + + D+WS G +L E+ +
Sbjct: 185 NSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----ESVKFMAREI 166
PR SF K +G G + V +A K A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 167 LILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYM 223
I+ L +H N++ L G T + + ++ Y + DL L E T + +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRVVT 281
+Q+ G+ + +HRD+ N+L+ ++KI DFGLA D N+ +R+
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 321
W P + Y D+WS G +L E+ L P PG
Sbjct: 208 KWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
IG+G + +V G VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 184 VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVK------CYMH---QLLSGLEHCH 234
+ LY+V YM A V + + + C + + +E+
Sbjct: 68 IVEEKG-GLYIVTEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
N +HRD+ N+L+ +D V K++DFGL T ++ W P L
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EK 174
Query: 295 DYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
+ D+WS G +L E+ + G+ P +P + V ++ K YK+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP----QV 219
REI IL+ + H +I L + R ++ +V + DL V + P Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTY-----VDRSGPLPLEQA 187
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR- 278
+LL L + H G++HRD+K N+ +D+ + DFG A D HP T +
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQC 244
Query: 279 ---VVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAGK 316
TL PELL A D Y D+WSAG +L E+
Sbjct: 245 YGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 66/240 (27%), Positives = 102/240 (42%), Gaps = 39/240 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+G+G + V A+ + K VA+K ++ D E + ++ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 177 VIKLEGLVTSRMSCSLYLVFHY-----------------MEHDLAGLAASPEVKFTEPQV 219
+I L G T LY++ Y ME+ E + V
Sbjct: 86 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH----KHPM 275
C +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA D +H K
Sbjct: 144 SC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTT 200
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYK 333
R+ W P L Y D+WS G +L E+ L G P PG VE+L K+ K
Sbjct: 201 NGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A+ + + +IG+G + V K +G I+A+K++R E E + + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 175 PNVIKLEGLVTSR---------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
P ++K G + M SL + Y+ ++ + E +
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYV-YE------VLKSVIPEEILGKIAVA 115
Query: 226 LLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
+ L + ++HRD+K SN+L+D +G +K+ DFG++ ++
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKTRDAGC 170
Query: 285 RP---PELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQL 328
RP PE + Y V D+WS G L E+ GK P V +QL
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 122 DKIGQGTYSNVYKA---KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
D IG+G + V KA KD L A+K+++ + + + A E+ +L +L HPN+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMD-AAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEP---------------QVKC 221
I L G R LYL Y H +L V T+P Q+
Sbjct: 71 INLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
+ + G+++ +HRD+ N+L+ ++ V KIADFGL+ + K M R+
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPV 187
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
W L + Y D+WS G +L E+ L G P
Sbjct: 188 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 65/239 (27%), Positives = 107/239 (44%), Gaps = 37/239 (15%)
Query: 124 IGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRLD-HP 175
+G+G + V +A+ K VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYM------EHDLAGLAASPEVKFTEPQ----------- 218
N+I L G+ T LY++ Y E A P+ F +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS- 277
V C +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA + TS
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 278 -RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYK 333
R+ W P L Y D+WS G ++ E+ L G P PG VE+L K+ +
Sbjct: 196 GRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG-IPVEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 50/213 (23%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 123 KIGQGTYSNVYKA--------KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++G+G + V+ A +D + +VA+K ++ + + K RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLK--DASDNARKDFHREAELLTNLQH 66
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DL----------AGLAA--SPEVKFTEPQVKC 221
+++K G+ L +VF YM+H DL A L A + + T+ Q+
Sbjct: 67 EHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVV 280
Q+ +G+ + + +HRD+ N L+ ++ ++KI DFG++ + ++ ++
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313
+ + PPE ++ + D+WS G +L E+
Sbjct: 185 PIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 124 IGQGTYSNVYK--AKDML---TGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+G G + VY+ A D+L +G I VA+K +R + E +F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEP--------QVKCYMHQLL 227
+KL G+ ++ Y++ ME L+ L + +F P + + +
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI-----DDDGVLKIADFGLA-SFFDPNHKHPMTSRVVT 281
LE H +HRD+ N L+ D D V+KI DFGLA + ++ ++
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
+ + PE LL + D+WS G ++ E+L G+ P E L +
Sbjct: 177 VRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 210 PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD- 268
PE + T + +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 269 -PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEV 325
+K R+ W P L Y D+WS G +L E+ L G P PG V
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPV 242
Query: 326 EQLHKIYK 333
E+L K+ K
Sbjct: 243 EELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 50/216 (23%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 121 IDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
++++G+ + +YK L G ++VA+K ++ D P+ +E ++ L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAG--LAASPEVKF-----TEPQVKC------Y 222
++ L G+VT + ++F Y+ DL + SP + VK +
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 223 MH---QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSR 278
+H Q+ +G+E+ ++ +H+D+ N+LI + +KI+D GL+ + ++
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 314
++ + + PPE ++ + D+WS G +L E+ +
Sbjct: 187 LLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 278
CY Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 321
+ W P + Y + D+WS G +L E+ + G PG
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 39/231 (16%)
Query: 124 IGQGTYSNVYKAKDM-LTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+G+G + V KA L G+ VA+K ++ +N ++ + E +L++++HP+VI
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 179 KLEGLVTSRMSCSLYLVFHYMEH------------------------DLAGLAASPEVKF 214
KL G + L L+ Y ++ + + L E
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHK 272
T + + Q+ G+++ ++HRD+ N+L+ + +KI+DFGL+ + + ++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 321
R+ W L Y D+WS G +L E+ L G P PG
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
+ ++I +G+G + V+ AK + +V +K ++ E +F RE+ + R+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF-RRELDMFRK 64
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDL-----AGLAASPEVK---FTEPQVKCY 222
L H NV++L GL R + Y++ Y + DL A + ++K + Q
Sbjct: 65 LSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
Q+ G++H N +HRD+ N L+ +K++ L+ + + + + ++ L
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAEL 312
+ PE + D+ D+WS G ++ E+
Sbjct: 183 RWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 123 KIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++G+G + V+ A+ ++L + +VA+K ++ + E F RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTVLQHQHI 69
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHD---------------LAGLAASPEVKFTEPQVKCY 222
++ G+ T L +VF YM H LAG + T Q+
Sbjct: 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVT 281
Q+ SG+ + + +HRD+ N L+ V+KI DFG++ + ++ ++
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELL 313
+ + PPE +L + D+WS G +L E+
Sbjct: 188 IRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 278
CY Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 321
+ W P + Y D+WS G +L E+ + G PG
Sbjct: 238 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG-------- 182
NV K + +L VA+K +R D + F+ +E+ IL RL PN+I+L G
Sbjct: 40 NVRKGRPLL----VAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVDEDPL 94
Query: 183 -LVTSRMSC---SLYLVFHYMEHDLA--GLAASPEVKFTEPQVKCYMH---QLLSGLEHC 233
++T M + +L H+++ A P +H Q+ SG+++
Sbjct: 95 CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLL 291
+ +HRD+ N L+ ++ +KIADFG++ + + R V W +L+
Sbjct: 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214
Query: 292 GATDYGVGVDLWSAGCILAELL 313
G + D+W+ G L E+L
Sbjct: 215 G--KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA----KDMLTGKI-VALKKVRFDNLEPESVKFMARE 165
+PR DS + +G G + VY+ +D ++ VA+K + E + F+ E
Sbjct: 3 VPR--DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-ME 59
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMH 224
LI+ + +H N+++L G+ R+ +++ M DL + P M
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSS-LTMK 116
Query: 225 QLL-------SGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA------SFFD 268
LL G ++ N +HRDI N L+ G V KIADFG+A S++
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQ 327
+ + + + PPE L + D+WS G +L E+ + G PGRT E
Sbjct: 177 KGGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
Query: 328 L 328
+
Sbjct: 231 M 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 54/272 (19%)
Query: 122 DKIGQGTYSNVYKA---KD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHP 175
D IG+G + V +A KD + I LK+ +N + A E+ +L +L HP
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD----FAGELEVLCKLGHHP 63
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEP---------------QV 219
N+I L G +R LY+ Y + +L V T+P Q+
Sbjct: 64 NIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279
+ + +G+++ +HRD+ N+L+ ++ KIADFGL+ + K M R+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRL 180
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYKLCGS 337
W L + Y D+WS G +L E+ L G P CG
Sbjct: 181 PVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------------YCGM 222
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFK 369
E ++ KLP ++ +P + C E ++
Sbjct: 223 TCAELYE--KLPQG--YRMEKP-RNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 14/130 (10%)
Query: 144 VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-D 202
VA+K +R D + F+ +E+ IL RL PN+ +L G+ T L ++ YME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGD 105
Query: 203 L---------AGLAASPEVKFTEPQVKCYMH-QLLSGLEHCHNNGVLHRDIKGSNLLIDD 252
L + K YM Q+ SG+ + + +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 253 DGVLKIADFG 262
+ +KIADFG
Sbjct: 166 NYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 17/236 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPES-VKFMAREILIL 169
+ +++ +G G + VYK + G+ V + K+ + P++ V+FM E LI+
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLS 228
+DHP++++L G+ +S ++ LV M H L + + + Q+
Sbjct: 64 ASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLWYRP 286
G+ + ++HRD+ N+L+ +KI DFGLA + + K + ++ W
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 287 PELLLGATDYGVGVDLWSAGCILAELL--AGKPI--MPGRTEVEQLHKIYKLCGSP 338
+ + D+WS G + EL+ GKP +P R + L K +L P
Sbjct: 181 E--CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 122 DKIGQGTYSNVY--KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
D+IG G + V +A ++ V +K++R E + F+ +E+ R L+HPNV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 180 LEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEV---KFTEPQVKCYM-HQLLSGLEHCH 234
G S LV + DL S + + V M ++ SGL H
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA------SFFDPNHKHPMTSRVVTLWYRPPE 288
+H D+ N + D +KI D+GLA ++ H V L + PE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH-----AVPLRWLAPE 172
Query: 289 LL------LGATDYGVGVDLWSAGCILAEL--LAGKP 317
L+ L D ++WS G + EL A +P
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 11/207 (5%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILR 170
+ K+ +G G + V+K + G KI K D ++ + + +L +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC-YMHQLLSG 229
LDH +++L G+ SL LV +PQ + Q+ G
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT--LWYRPP 287
+ + + ++HR++ N+L+ D +++IADFG+A P+ K S T W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA 314
+L G Y D+WS G + E+++
Sbjct: 182 SILFGR--YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 24/212 (11%)
Query: 126 QGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+GT+ ++ + V +K V+ D+ V + +E +L L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 182 GLVTSR----MSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSGLEHCH 234
+ Y+ + ++ L + Q+ Q+ G+ + H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP-----PEL 289
GV+H+DI N +ID++ +KI D L+ P H + RP E
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----NRPVKWMALES 190
Query: 290 LLGATDYGVGVDLWSAGCILAEL--LAGKPIM 319
L+ +Y D+WS G +L EL L P +
Sbjct: 191 LVN-KEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 278
Y Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 321
+ W P + Y D+WS G +L E+ L P PG
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASP-YPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 123 KIGQGTYSNVYKA--------KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++G+G + V+ A KD + +VA+K ++ L K RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKM---LVAVKALKDPTLAAR--KDFQREAELLTNLQH 66
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKFT----------EPQVKC 221
+++K G+ L +VF YM+H DL A P+ E +
Sbjct: 67 EHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 222 YMH---QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTS 277
+H Q+ SG+ + + +HRD+ N L+ + ++KI DFG++ + ++
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313
++ + + PPE ++ + D+WS G IL E+
Sbjct: 185 TMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG---KI-VALKKVRFDNLEPESVKFMAREILILRRLD 173
F+KI +G G + VYK + G KI VA+K++R + P++ K + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
+P+V +L G+ ++ ++ L+ M L + + + Q+ G+ +
Sbjct: 68 NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLWYRPPELL 290
++HRD+ N+L+ +KI DFGLA + K H +V W +L
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 291 LGATDYGVGVDLWSAGCILAELL 313
Y D+WS G + EL+
Sbjct: 185 --HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 24/46 (52%), Positives = 31/46 (67%)
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+K M Q+L+GL H G++HRDIK NLL+ DG +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI---------- 168
KIDK IG G + VY+ + I + +NLE E+ + E L+
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKI 71
Query: 169 -----LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA--SPEVKFTEPQVKC 221
+ +DH + K G S C +Y F +E + + +K
Sbjct: 72 ALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
M +L+ LE+ H +G+ H DIK N+++D + I D+G+AS F + KH S+
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCI 308
+R T Y G+D + C+
Sbjct: 191 DLHR-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K + K VA+K ++ +N E M RE I+ +LD+P ++++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAG----LAASPEVKFTEPQVKCYMHQLLSGLEHCHNN 236
G+ + +L LV ME G + + + T V MHQ+ G+++
Sbjct: 61 IGVCEAE---ALMLV---MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF---DPNHKHPMTSRVVTLWYRPPELLLGA 293
+HRD+ N+L+ + KI+DFGL+ D +K + WY P +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-- 172
Query: 294 TDYGVGVDLWSAGCILAELLA--GKP 317
+ D+WS G + E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 122 DKIGQGTYSNVYKA---KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
D IG+G + V KA KD L ++ A K + + + A E+ +L +L HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEP---------------QVKC 221
I L G R LYL Y H +L V T+P Q+
Sbjct: 59 INLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
+ + G+++ +HRD+ N+L+ ++ V KIADFGL+ + K M R+
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPV 175
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
W L + Y D+WS G +L E+ L G P
Sbjct: 176 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFM--AREILILRRLDH 174
F + I +G + VY + K+ A+K V+ D + V + R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--S 63
Query: 175 PNVIKLEGLVTSRMSCS-LYLVFHYM-EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
P ++ L S S + +YLV Y+ D+ L F E Y+ ++ L++
Sbjct: 64 PFIVHL---YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDY 119
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
H +G++HRD+K N+LI ++G +K+ DFGL+
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 16/125 (12%)
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF------ 267
F E + Q+L + H H+ ++HRDIK +N+L+ +G++K+ DFG + +
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 268 DPNHKHPMTSRVVT--LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 325
D T V +W R P Y D++S G +L ELL K G
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKP--------YSKKADMFSLGVLLYELLTLKRPFDGENME 251
Query: 326 EQLHK 330
E +HK
Sbjct: 252 EVMHK 256
|
Length = 496 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 22/120 (18%)
Query: 238 VLHRDIKGSNLLID----------------DDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
++H D+K N+L++ D ++I D G + +H T+ V T
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIVST 308
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK-LCGSPSE 340
YR PE++LG + D+WS GCI+ EL GK + +E LH + K L PSE
Sbjct: 309 RHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 49/214 (22%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+G+G + +V + + I VA+K ++ ++ E + ++ DHPNV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 182 GLVTSRMSCSLY----LVFHYMEH-DL------AGLAASPEVKFTEPQVKCYMHQLLSGL 230
G+ + Y ++ +M+H DL + L P+ T+ VK +M + SG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRVVTLWYRPPE 288
E+ + +HRD+ N +++++ + +ADFGL+ + ++ +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 289 LLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 321
L Y D+WS G + E+ G+ PG
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 127 GTYSNVY--KAKD---MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
G + V K K + KI+ K F+ +EP + M D+PN IKL
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKN--FNAIEPMVHQLMK---------DNPNFIKLY 75
Query: 182 GLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240
VT+ L+ Y+ + DL L E K +E +VK + QL+ L H + ++H
Sbjct: 76 YSVTT--LKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 241 RDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 299
DIK N+L D + + D+GL + TL Y PE + G +Y V
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGH-NYDVS 186
Query: 300 VDLWSAGCILAELLAGK-PIMPGRTE---VEQLHKIYK 333
D W+ G + ELL GK P E +E L K +
Sbjct: 187 FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224
|
Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 35/197 (17%)
Query: 140 TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG---------LVTSRM-- 188
TG+ V ++++ + E V F+ E+ + + +HPN++ +VTS M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 189 -SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSN 247
S + H+M+ G+ +E + + +L L++ H+ G +HR +K S+
Sbjct: 84 GSAKDLICTHFMD----GM--------SELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131
Query: 248 LLIDDDGVLKIADFGLASFFD---------PNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
+LI DG K+ GL S H P S V W P L Y
Sbjct: 132 ILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189
Query: 299 GVDLWSAGCILAELLAG 315
D++S G EL G
Sbjct: 190 KSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 15/231 (6%)
Query: 118 FEKIDKIGQGTYSNVYK---AKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+K+ +G G + VYK D KI KV +N P++ K + E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P V +L G+ ++ ++ LV M + L + + + + Q+ G+ +
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLWYRPPELLL 291
++HRD+ N+L+ +KI DFGLA D + H +V W +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL- 184
Query: 292 GATDYGVGVDLWSAGCILAELL--AGKPI--MPGRTEVEQLHKIYKLCGSP 338
+ D+WS G + EL+ KP +P R + L K +L P
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRV 279
+ Q+ G++ + +HRD+ N+L+ D V KI DFGLA D N+ +R+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 321
W P + Y V D+WS G +L E+ + GK PG
Sbjct: 277 PVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRV 279
+ +Q+ +G+E + +HRD+ N+LI + ++KI DFGLA D N+ ++ +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIYKLCGS 337
W P + Y D+WS G +L E+ L G P P EQ + +
Sbjct: 304 PLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------N 353
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSS 375
+ ++ +K +A+ + E ++C +E F+ P S
Sbjct: 354 AIKRGYRMAKPAHAS-DEIYEIMQKCWEEKFEIRPDFS 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 119 EKID---KIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAREILILR 170
EKI ++GQG++ VY+ A+D++ G+ VA+K V E ++F+ E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMK 64
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAAS--PEVKFTE----PQVKCYM 223
+V++L G+V S+ +L +V M H DL S PE + P ++ +
Sbjct: 65 GFTCHHVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 224 H---QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRV 279
++ G+ + + +HRD+ N ++ D +KI DFG+ ++ ++ +
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
+ + + PE L + D+WS G +L E+ LA +P
Sbjct: 183 LPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 5/103 (4%)
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRV 279
+ +Q+ G+E + +HRD+ N+L+ ++KI DFGLA D N+ ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 321
W P + Y D+WS G +L E+ + G PG
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 50/212 (23%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 123 KIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++GQG++ VY+ AK ++ + VA+K V E ++F+ E +++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLS------- 228
++L G+V S+ +L ++ DL S PE++ Q + +++
Sbjct: 72 VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPP 287
G+ + + N +HRD+ N ++ +D +KI DFG+ ++ ++ ++ + + P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 288 ELLLGATDYGVGVDLWSAGCILAEL--LAGKP 317
E L + D+WS G +L E+ LA +P
Sbjct: 191 ESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 22/180 (12%)
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMH---Q 225
R L HPN+++ G + LVF Y E DL + + Q+ +
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWY 284
+ +G+ H H + LH D+ N + D +K+ D+G+ S + ++ + V L +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 285 RPPEL-------LLGA--TDYGVGVDLWSAGCILAELL--AGKPIMPGRTEVEQLHKIYK 333
PEL L+ A T ++W+ G L EL A +P ++ E L+ + K
Sbjct: 168 LAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 13/154 (8%)
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRV 279
+ +Q+ G+ + +HRD+ N+L+ + KI DFGLA D N+ +R+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI----YKL 334
W P + Y D+WS G +L E+ + G PG + +K+ Y++
Sbjct: 279 PVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336
Query: 335 CG---SPSEEYWKKSKLPNATLFKPREPYKRCIQ 365
+PSE Y +A K R +K+ +Q
Sbjct: 337 LSPECAPSEMYDIMKSCWDADPLK-RPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 48/184 (26%), Positives = 73/184 (39%), Gaps = 41/184 (22%)
Query: 114 RADSFEKIDKIGQGTYSNVYKA----KDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
+ D F K+G+G + VYKA K LKK ++ A EI +
Sbjct: 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---------EYGAVEIWMN 180
Query: 170 RRLDH--PNVIK-----LEGLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVK-------F 214
R+ PN V+S+ +LV+ Y E LA L S E
Sbjct: 181 ERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL 240
Query: 215 TEPQ------------VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADF 261
+ Q ++ M Q+L L+ H+ G++HRD+K N++ + G KI D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 262 GLAS 265
G A+
Sbjct: 301 GAAA 304
|
Length = 566 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 33/213 (15%)
Query: 123 KIGQGTYSNVY--KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+IG G + V + T V +K++R E +KF+ E R L H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQC 60
Query: 181 EGLVTSRMS-------CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
G T C L + Y+ +P+ T ++ C ++ GL H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT-TLQRMAC---EIALGLLHL 116
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-------FFDPNHKHPMTSRVVTLWYRP 286
H N +H D+ N L+ D +KI D+GL+ + P+ V L +
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW------VPLRWIA 170
Query: 287 PELL------LGATDYGVGVDLWSAGCILAELL 313
PEL+ L D ++WS G + EL
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 4/108 (3%)
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
RE+ IL+ L + + L + YL+ ++E G + + +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE----GETLDEVSEEEKEDIAE 93
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269
+ +LL+ L + H D+ N+L+DD +L I D+ A + P
Sbjct: 94 QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 45/233 (19%), Positives = 87/233 (37%), Gaps = 43/233 (18%)
Query: 124 IGQGTYSNVYK------AKDMLTGKIVALKKVRFDNLEPESVKFMA--REILILRRLDHP 175
+GQGT++N+YK + + G + V L + +A ++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 176 NVIKLEGLVTSRMSCSLY-LVFHYMEHDLAGLAASPEVKFTEPQVKC--------YMHQL 226
+++KL G+ +V Y++ P F + QL
Sbjct: 62 HLVKLYGV----CVRDENIMVEEYVKF-------GPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------LKIADFGLASFFDPNHKHPMTSRV 279
S L + + ++H ++ G N+L+ G+ +K++D G+ P RV
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-----PITVLSREERV 165
Query: 280 VTLWYRPPELL-LGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHK 330
+ + PE + G + D WS G L E+ + + + E+
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 15/104 (14%)
Query: 214 FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273
E ++ Q L L H N+L+ DG+LK+ G +F P
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQAKSG------NILLTWDGLLKL--DGSVAFKTPE--- 62
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317
SR + PE++ G Y D++S G L E L +
Sbjct: 63 --QSRPDPYF-MAPEVIQG-QSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 410 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.4 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.25 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.2 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.01 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.91 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.89 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.8 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.55 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.69 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.66 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-73 Score=531.89 Aligned_cols=332 Identities=69% Similarity=1.165 Sum_probs=318.6
Q ss_pred CCCCCCCCccccccccCCCchhhhhhcccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH
Q 015247 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE 157 (410)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~ 157 (410)
+..+.+.....++...+||.|+..+.||.+.+|.+...+.|+.+++||+|.||.||+|++..+|+.||+|+++.+...+.
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 34445555666889999999999999999999999999999999999999999999999999999999999999887777
Q ss_pred HHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015247 158 SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237 (410)
Q Consensus 158 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 237 (410)
......+|+.||++|+||||++|.+.+.+...+.+|||+|||+++|..++......|++.+++.++.||+.||.|+|++|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 78888999999999999999999999999878899999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCC
Q 015247 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317 (410)
Q Consensus 238 ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 317 (410)
|+|||||.+|||||.+|.+||+|||||+++........++.+.|.||+|||+++|...|+.++|+||.||||.||++|++
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99999999999999999999999999999988887778899999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 318 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
.|+|.++.+++.+|+++||.|.+++|...++|....+.+..+|++.+.+..+.+++...+|+..||..||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCC
Q 015247 398 NSEVIFQDRTLC 409 (410)
Q Consensus 398 ~hp~~~~~~~~~ 409 (410)
.|+||+.++.+|
T Consensus 399 ~seyF~t~p~~~ 410 (560)
T KOG0600|consen 399 QSEYFTTEPLPC 410 (560)
T ss_pred cCcccccCCCCC
Confidence 999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-60 Score=425.09 Aligned_cols=293 Identities=42% Similarity=0.720 Sum_probs=257.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+.|+.++.|++|+||.||+|+++.+++.||+|+++.+.-....--.-++|+++|.+++|||||.+.+++....-..+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 37899999999999999999999999999999999866422222223567999999999999999999998777777999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||||++++...+.....+|...+++.++.|++.|++|||.+.|+||||||+|+|+++.|.+||+|||||+.+++.. ..
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KP 233 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc-cc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999999997653 34
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC-ccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN-ATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~ 353 (410)
.+..+.|.||+|||+++|...|+.+.|+||+|||+.||+++++.|+|..+.+++.+|++.+|.|....|....... ...
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 6778889999999999999999999999999999999999999999999999999999999999999998765433 322
Q ss_pred C-CCCCchhhhhhhhhCC--CCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 354 F-KPREPYKRCIQETFKD--FPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 354 ~-~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
. .+..++.+ +...+.. +++...+|++.+|.+||.+|.||+|+|.|+||.+.|+||
T Consensus 314 ~~f~~~pyn~-lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 314 MTFSEHPYNN-LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cccCCCCchh-hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 2 23333333 3333333 569999999999999999999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-59 Score=409.58 Aligned_cols=287 Identities=41% Similarity=0.754 Sum_probs=257.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|..+++||+|.||+||+|++..+|+.||||+++..+..+.......+|+..|+.++|+||+.+.++|.+... +.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~--l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN--LSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc--eEEE
Confidence 57999999999999999999999999999999999877655545567789999999999999999999988544 9999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+|||+.+|...+.+....++..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+.....
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997655443
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC-CCCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KLPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~ 354 (410)
+..+.|.||+|||.+.|...|+..+|+||.||++.||+-|.+.|+|.++.+++..|...+|+|..+.|.+. .+|+-..+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 33478999999999999999999999999999999999999999999999999999999999999999874 46654433
Q ss_pred C--CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 355 K--PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 355 ~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
. |..+ ....+...++++.||+.+||.+||.+|+|+.|+|+|+||++-|.||
T Consensus 239 ~~~P~~~----~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 239 QQFPKPP----LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred hcCCCCc----cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 3 2111 2225667899999999999999999999999999999999988876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=445.09 Aligned_cols=289 Identities=38% Similarity=0.648 Sum_probs=254.0
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 192 (410)
.+++|.++++||.|.||.||+|+.+.+|..||||.++.....-+... -+||+..|++++ |||||+|.+++.+... .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 45899999999999999999999999999999999976654433333 346999999998 9999999999988754 79
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+|||||+++|.+++..++..|++..++.|+.||++||+|+|++|+.|||+||+|||+.....+||+|||||+.+.+.
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999988543
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC-CCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~ 351 (410)
.+.+.++.|.||+|||+++....|+.+.|+||+|||++|+.+-++.|+|.++.+++-+|.+.+|+|..+.|.+. .+...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 45678899999999999998888999999999999999999999999999999999999999999999888773 22222
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
--+.....-...+.......++++.+||..||.+||.+||||.|+|+||||+...
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 2222222333455666778999999999999999999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=413.56 Aligned_cols=284 Identities=35% Similarity=0.592 Sum_probs=246.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++.|+.+.++|+|+||+||+|+++.+|+.||||++.-+.-++...+-..+|+.+|++++|+|+|.++++|.... .+++
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr--klhL 78 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR--KLHL 78 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--eeEE
Confidence 36799999999999999999999999999999999766656666777889999999999999999999998744 4999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|+|||+...+..+......++...++.++.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+... ...
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-cch
Confidence 9999999999988877778999999999999999999999999999999999999999999999999999998742 233
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC---C-CCC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS---K-LPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---~-~~~ 350 (410)
.+.++-|.||+|||.+.|...|+.++||||+||++.||++|.+.|+|.++.+++-.|.+.+|....+...-. . +.+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 567788999999999999888999999999999999999999999999999999999999998775443221 1 111
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
..+..+ .-...+....+.++.-+.||+.+||..||.+|++++|+|.||||.
T Consensus 238 v~lP~~--~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEP--EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCC--CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111111 122335556678888999999999999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-59 Score=429.62 Aligned_cols=263 Identities=29% Similarity=0.404 Sum_probs=223.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... .....+.+|+++|++|+|||||+++++|+...
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 467888999999999999999999999999999998765422 12334679999999999999999999999854
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeeccccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASF 266 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~ 266 (410)
+.||||||++|+.+....-.++.+.+...+.++.||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 250 -s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 -SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred -ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 489999999998777666667789999999999999999999999999999999999999866 6899999999999
Q ss_pred cCCCCCCCCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHh
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 343 (410)
.+.. ..+.+.||||.|+|||++.+. ..+..++|+||+||+||-+++|.+||....... ..++|.+.-.....
T Consensus 329 ~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p--- 403 (475)
T KOG0615|consen 329 SGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP--- 403 (475)
T ss_pred cccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC---
Confidence 8643 346889999999999999753 334558999999999999999999999876665 55666554322222
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..|..+++++++||..||..||++|||+.|+|+||||+..+
T Consensus 404 ----------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 ----------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ----------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 23357999999999999999999999999999999998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-58 Score=439.42 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=234.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+|...+.||+|||+.||.+++..+|..||+|++.+..+ .....+.+.+|++|.++|+|||||+++++|++ ..++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 579999999999999999999999999999999987654 55667789999999999999999999999998 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|+|+|..+.+..+.++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||||..+.... +.
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 99999998888777788899999999999999999999999999999999999999999999999999999987442 23
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
-.+.||||.|.|||++... .++..+||||+||++|.|++|+|||...+-.+++.+|...-...|
T Consensus 175 k~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P--------------- 238 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP--------------- 238 (592)
T ss_pred cceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc---------------
Confidence 4678999999999998864 499999999999999999999999999999999999976322221
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..++.++++||.+||++||.+|||++++|.|+||++.-.|
T Consensus 239 --------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 239 --------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred --------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 2789999999999999999999999999999999776554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-58 Score=419.60 Aligned_cols=258 Identities=29% Similarity=0.452 Sum_probs=230.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|+++++||+|+||+||+++.+.+++.||+|++++..+ .....+....|..+|..++||+||+++..|++ ...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEE
Confidence 4799999999999999999999999999999999988765 33456788899999999999999999877777 55699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|++|+.|+.+..++++.+.|++..++.++.+|+.||.|||++|||||||||+|||+|.+|+++|+||||++..-.. ..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999865433 23
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.+.+.|||+.|||||++.+. .|+.++||||||+++|||++|.+||.+.+.....++|.+.-...+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-------------- 245 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-------------- 245 (357)
T ss_pred ccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC--------------
Confidence 35668999999999999886 499999999999999999999999999999999999977421111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~elL~hp~~~~ 404 (410)
...++.++++||+++|..||++|. ++.++-+||||..
T Consensus 246 --------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 246 --------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred --------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 124789999999999999999996 6999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=414.14 Aligned_cols=259 Identities=30% Similarity=0.439 Sum_probs=226.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++.+.++.||+|..|+||+++++.+++.+|+|++. .+.+....+.+.+|++++++.+||+||.+||.|..+.. .+++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 367888999999999999999999999999999994 34567778889999999999999999999999998654 6999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+++.++......+.++|.....++.++++||.|||+ ++||||||||+|||++..|.|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999998888777777899999999999999999999996 89999999999999999999999999999988544
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR-----TEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
...+.+||..|||||.+.+.. |+.++||||||+.++|+++|+.||... ...+.+..|+. .++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP-------- 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP-------- 300 (364)
T ss_pred hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC--------
Confidence 467899999999999999865 999999999999999999999999875 34444444443 2221
Q ss_pred CCcccCCCCCchhhhhhhhhC-CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFK-DFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.... .+|+++++||..||++||.+|||+.|+|+|||+++-..
T Consensus 301 -----------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 301 -----------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1112 38999999999999999999999999999999986543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=396.37 Aligned_cols=293 Identities=40% Similarity=0.715 Sum_probs=251.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeEeeeEeecC----C
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRM----S 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----~ 189 (410)
+..|+.+++||+|+||+||+|+++.+|+.||+|+++.....+-.-....+|+.+|++++|+| ||.+++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 46799999999999999999999999999999999876543222334678999999999999 999999987743 2
Q ss_pred ceEEEEEeeccCCHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPE---VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
..+++||||++.++..++.... ..++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4699999999999998886655 4688899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
+.-.. ...++.++|.+|+|||++.|...|+...||||+|||+.||+++++.|++..+.+++..|.+.+|+|....|...
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 65332 22567789999999999999888999999999999999999999999999999999999999999999988875
Q ss_pred C-CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 347 K-LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 347 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
. +|+.....+...-...+....+..+++..+++.+||++||.+|.||+.+|.||||.+.+..
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 4 4444432222222344555556677899999999999999999999999999999988654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=389.03 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=231.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|+.++.||.|+||.|.+++++.+|..||+|++++... ...+.+...+|..+|+.+.||+++++++.|.+ ..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEE
Confidence 4789999999999999999999999999999999988764 45567788999999999999999999887777 56699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++|+.+..+..+.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999988888888889999999999999999999999999999999999999999999999999999987432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
+.+.||||.|+|||++... +|+.++|||||||++|||+.|.+||...+...++++|++..-..|
T Consensus 198 -T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-------------- 261 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-------------- 261 (355)
T ss_pred -EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------------
Confidence 5788999999999998875 499999999999999999999999999999999999988533222
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
..++++++|||.++|+.|-++|. ...++..||||+..
T Consensus 262 ---------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 262 ---------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ---------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 27899999999999999999993 57899999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=416.01 Aligned_cols=260 Identities=34% Similarity=0.496 Sum_probs=228.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
...+|.+.+.||.|+|++||+|+++.+++.||||++.+..+ .+...+-+.+|.++|.+| .||.|++|+..|++ ...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccc
Confidence 45799999999999999999999999999999999987665 334455677899999999 89999999777776 455
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+|+||+++|.+-.++.+.+.|++..++.++.||+.||+|||++|||||||||+|||||.||+++|+|||.|+.+.+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999986666666666899999999999999999999999999999999999999999999999999999886432
Q ss_pred CC------------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 015247 272 KH------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339 (410)
Q Consensus 272 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 339 (410)
.. ...+++||..|++||++... ..++.+|+|+|||+||+|+.|.+||.+.++..++++|+++-...+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 21 11458999999999988764 489999999999999999999999999999999999998643333
Q ss_pred HHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
+++++.+.|||+++|..||.+|+|+.|+-+||||...
T Consensus 308 -----------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 -----------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred -----------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 3889999999999999999999999999999999753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-55 Score=412.97 Aligned_cols=263 Identities=33% Similarity=0.458 Sum_probs=229.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|+++++||+|+||.||+|+.+.+|..||+|+++++.. ...+++.+..|..+|...++|+||+|+..|++ ..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCee
Confidence 45899999999999999999999999999999999998765 55678889999999999999999999877777 5679
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC---
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP--- 269 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~--- 269 (410)
||||||++||....++.+.+.+++..++.++.+++.|+..||+.|+|||||||+|+|||..|++||+||||++-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999988888888888999999999999999999999999999999999999999999999999999953321
Q ss_pred -------------------CCC------------------------CCCccccccccccccccccCCcCCCCccchHHHH
Q 015247 270 -------------------NHK------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAG 306 (410)
Q Consensus 270 -------------------~~~------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 306 (410)
... ....+.+|||.|+|||++++.. |+..+||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHH
Confidence 000 0113468999999999999865 99999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCC
Q 015247 307 CILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAID 386 (410)
Q Consensus 307 v~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 386 (410)
||+|||+.|.+||.+.+..++.++|+..-. ..++|. ...++++++|||.+||+ |
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------~l~fP~-----------------~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRE--------TLKFPE-----------------EVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------hccCCC-----------------cCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999987321 112221 12567999999999999 9
Q ss_pred CCCCCC---HHHHhcCCCCCCC
Q 015247 387 PAERLT---ATVALNSEVIFQD 405 (410)
Q Consensus 387 P~~Rpt---~~elL~hp~~~~~ 405 (410)
|.+|.. ++|+-+||||+..
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHhcCcccHHHHhcCCccccC
Confidence 999985 9999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-55 Score=396.32 Aligned_cols=289 Identities=39% Similarity=0.607 Sum_probs=244.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee---cCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS---RMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~ 192 (410)
..|..++.||+|+||.|..+.+..+|+.||||++.......-..++..+|+.+|++++|+||+.+.+++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 46777899999999999999999999999999987444455567788899999999999999999998865 234468
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC-C
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-H 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~ 271 (410)
|+|+|+|+.+|...+... ..++...+..++.||+.||.|+|+.+|+||||||+|+|++.+..+||+|||+|+...+. .
T Consensus 102 YiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 999999988888866544 36999999999999999999999999999999999999999999999999999988643 1
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....+.++.|.||+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|...+|+|+.+.+........
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 22346778899999999999888899999999999999999999999999999999999999999999877655442211
Q ss_pred c--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 352 T--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 352 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
. +..-...-+......+++.++.++||+.+||..||.+|+|++|+|+||||..-
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0 00001111223345566999999999999999999999999999999999753
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=398.26 Aligned_cols=285 Identities=38% Similarity=0.616 Sum_probs=239.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc---eE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC---SL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~ 192 (410)
-.|...+++|+|+||+||.|....+++.||||++-.+.. .--+|+++|+.++|||||+|..+|...... ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 468889999999999999999999999999999864432 122599999999999999999888654433 67
Q ss_pred EEEEeeccCCHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeeccccccC
Q 015247 193 YLVFHYMEHDLAGLAAS---PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFD 268 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 268 (410)
.+|||||+..+...+.. .+..++.-.++-+..||+.||+|||+.||+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 79999999998886653 46689999999999999999999999999999999999999965 999999999999997
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.+.. ..++..|..|+|||.+.|...|+.+.||||.||++.||+-|++.|+|.+..+++..|.+.+|.|..+.....+-
T Consensus 178 ~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 6544 46778899999999999999999999999999999999999999999999999999999999999877665443
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.......+.-.-.....-..+..++++.+|+.++|.++|.+|.++.|+|.||||++-+.+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 322222221111111112445789999999999999999999999999999999875543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=394.98 Aligned_cols=265 Identities=29% Similarity=0.465 Sum_probs=232.5
Q ss_pred CCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
......+|.+.+.||+|+||+||+|+++.++..||||.+.+..+.....+.+..|+.+|+.++|||||++++++..+ .
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~ 82 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--D 82 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--C
Confidence 34455789999999999999999999999999999999998887888888899999999999999999999998884 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC------CcEEEEeeccc
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD------GVLKIADFGLA 264 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~------~~vkl~DFGla 264 (410)
++|+|||||.++.+..+....+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 799999999988777777777799999999999999999999999999999999999999865 46899999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
+.+.+.. ...+.||+|.|||||+++.. .|+.|+|+||+|+++|+|++|++||...+..+.+..+.+....
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~------- 232 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI------- 232 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-------
Confidence 9996443 35788999999999998764 4999999999999999999999999999999988866543211
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
++.....+++...+|+...|..||.+|.+..+-+.|+++..++
T Consensus 233 -------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 -------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1112235677788999999999999999999999999998765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=412.25 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=230.7
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
....++|.++++||+|+||+|++++.+.+++.||||+++++.+ ..+.++....|.+|+... +||.+++++..|+. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 3456899999999999999999999999999999999999875 667788899999999887 59999999998888 4
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.++|+||||+.|+. ..+......|++..++.|+.+|+.||.|||++||||||||.+|||+|.+|++||+|||+++..-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 56999999999988 44455556999999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
....+++.||||.|+|||++.+.. |+.++|||||||+||||+.|..||+|.++.+.+..|+.- +..+|
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------~~~yP 588 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------EVRYP 588 (694)
T ss_pred -CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------CCCCC
Confidence 223578899999999999998865 999999999999999999999999999999999999862 22222
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
..+|.++.++++++|.+||++|.. ++++..||||++
T Consensus 589 -------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 589 -------------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -------------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 378999999999999999999985 689999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=397.91 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=225.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCC
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS 189 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 189 (410)
..+.|.+.+.||+|+||+|++|++..+|..||+|++...... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999999999999999987664221 133456778999999999 9999999999988544
Q ss_pred ceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeecccccc
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFF 267 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~ 267 (410)
+|+||||+.+ ++++.+.. .+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 95 --~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 --IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred --EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999998 56666655 7799999999999999999999999999999999999999999 99999999999987
Q ss_pred CCCCCCCCccccccccccccccccCCc-CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
. .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+...++.+|.+....
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~--------- 241 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK--------- 241 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc---------
Confidence 4 2334467889999999999998866 3468999999999999999999999998888888887653211
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCC-CCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC-CCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDF-PPSSLPLIETLLAIDPAERLTATVALNSEVIFQ-DRTL 408 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~-~~~~ 408 (410)
+| ..+ ++++.+||.+||..||.+|+|+.+++.||||+. +..+
T Consensus 242 -~p-------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~ 285 (370)
T KOG0583|consen 242 -IP-------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLP 285 (370)
T ss_pred -CC-------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCC
Confidence 11 245 899999999999999999999999999999998 5443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=386.23 Aligned_cols=283 Identities=37% Similarity=0.685 Sum_probs=234.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||.|+||.||+|++..++..||+|+++..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEE
Confidence 47899999999999999999999999999999999754322 2234567899999999999999999998764 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 999999988887766666789999999999999999999999999999999999999999999999999976543221 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc-
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL- 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 353 (410)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++.+.|..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3445779999999998776668999999999999999999999999999999999999999999988876543222110
Q ss_pred -CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 -FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
..+.. ...........+++++++||.+||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00100 0011122334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-54 Score=376.89 Aligned_cols=249 Identities=30% Similarity=0.502 Sum_probs=217.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|+++++||+|+||.||++++..+|..+|.|.+.....+.........|+.+|++|+|||||++++.-..+....+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 67999999999999999999999999999999999888888888899999999999999999999884333334458999
Q ss_pred EeeccCCHHHHh----cCCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 196 FHYMEHDLAGLA----ASPEVKFTEPQVKCYMHQLLSGLEHCHN--NG--VLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 196 ~e~~~~~l~~~~----~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
||||+++.+..+ .+....+++..++.++.|++.||.++|+ .+ |+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999998655533 3455689999999999999999999999 45 999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.... ..+.+.+|||.||+||.+.+.. |+.+|||||+||++|||+.-++||.|.+-.+..++|.+.-.+|...
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------ 250 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------ 250 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence 7544 3467889999999999998855 9999999999999999999999999998888888887653222211
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 393 (410)
...|.++..||..|+..||.+||+.
T Consensus 251 ---------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ---------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2578899999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=372.04 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=229.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+.|++.++||+|.|++||++.+..+|+.+|+|++..........+.+.+|+.|-+.|+|||||+|++.+.. ..+.|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 478999999999999999999999999999999998776666678889999999999999999999988776 567999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 271 (410)
|+|+|.|+.+..-.-....+++..+-.+++||+.+|.|+|.+||||||+||+|+|+-.. .-+||+|||+|..+. .
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 99999997655433333578999999999999999999999999999999999999643 369999999999987 3
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|||.|||||++... +|+..+|||+.||+||-|+.|++||.+.+....++.|.+.....+..+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~--------- 235 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE--------- 235 (355)
T ss_pred ccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc---------
Confidence 3346778999999999988764 499999999999999999999999999999999999987644443333
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
++++++++++||++||..||.+|+|+.|+|+|||+.+.-
T Consensus 236 ----------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 236 ----------------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ----------------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 368999999999999999999999999999999998753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=391.25 Aligned_cols=266 Identities=32% Similarity=0.486 Sum_probs=226.6
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC------------hHHHHHHHHHHHHHHhCCCCceeeEe
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE------------PESVKFMAREILILRRLDHPNVIKLE 181 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~l~ 181 (410)
..++|++.+.||+|.||+|-+|++..+++.||||++.+.... ....+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 358999999999999999999999999999999999764321 11245788999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
++..+.....+|||+|||..+-....-....-+++.+++.|+++++.||.|||.+|||||||||+|+||+++|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99999989999999999998776644333333999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC----CCCCccccccccccccccccC---CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 015247 262 GLASFFDPNH----KHPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 262 Gla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~ 334 (410)
|.+.....+. .......+|||.|+|||...+ ....+.+.||||+||+||.|+.|+.||.+....+++.+|.+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998763321 122345789999999999876 233567999999999999999999999999999999999873
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
-- .+|. .+.+.++++|||.+||++||.+|++..++-.|||.+.+.
T Consensus 335 pL----------~fP~-----------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 335 PL----------EFPE-----------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cc----------cCCC-----------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 11 1111 125788899999999999999999999999999998873
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=380.67 Aligned_cols=284 Identities=35% Similarity=0.589 Sum_probs=232.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 46999999999999999999999999999999998665444455677889999999999999999998877 4469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999998887766666899999999999999999999999999999999999999999999999999987754333333
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC-CCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL-PNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~ 354 (410)
....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+....+..+...+..... +.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 4567899999999987754 89999999999999999999999999988888888888877776554432111 100000
Q ss_pred -CC-CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 -KP-REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 -~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.+ ..............+|.++.+||.+||++||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0000111122334578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=375.73 Aligned_cols=264 Identities=27% Similarity=0.356 Sum_probs=226.8
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
...++|++++.||.|.-|+||+++...++..+|+|++.+..+. .....+...|.+||..++||.++.||+.|+. ..+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~ 151 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKY 151 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cce
Confidence 3458899999999999999999999999999999999887653 4556677789999999999999999999988 567
Q ss_pred EEEEEeeccCCHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 192 LYLVFHYMEHDLAGLAA--SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+++||||+|+.+..+. +.++.|++..++.|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999997766553 4557899999999999999999999999999999999999999999999999998743210
Q ss_pred ---------------------------------C-C---------------------CCCCccccccccccccccccCCc
Q 015247 270 ---------------------------------N-H---------------------KHPMTSRVVTLWYRPPELLLGAT 294 (410)
Q Consensus 270 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 294 (410)
. . .....+.+||..|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01124568999999999998854
Q ss_pred CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCC
Q 015247 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPS 374 (410)
Q Consensus 295 ~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (410)
.+.++|||+|||++|||+.|..||.|.++.+++.+|+.. ..++|+. ..++..
T Consensus 312 -HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----------~l~Fp~~-----------------~~vs~~ 363 (459)
T KOG0610|consen 312 -HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----------PLKFPEE-----------------PEVSSA 363 (459)
T ss_pred -CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------CCcCCCC-----------------CcchhH
Confidence 899999999999999999999999999999999999762 2223221 257788
Q ss_pred cHHHHHhccCCCCCCCCC----HHHHhcCCCCCCCC
Q 015247 375 SLPLIETLLAIDPAERLT----ATVALNSEVIFQDR 406 (410)
Q Consensus 375 ~~~li~~~L~~dP~~Rpt----~~elL~hp~~~~~~ 406 (410)
++|||+++|.+||++|.. |.|+-+||||+...
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 999999999999999998 99999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=381.11 Aligned_cols=288 Identities=36% Similarity=0.634 Sum_probs=229.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEE
Confidence 37899999999999999999999889999999998754322 2233466799999999999999999998874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999999988887766789999999999999999999999999999999999999999999999999987653222 22
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCHHHhhhCCC-CCcc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIYKLCGSPSEEYWKKSKL-PNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~ 352 (410)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+.+..+....+.+....|..... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 3456789999999998776668999999999999999999999998854 4566777877777777665543221 1100
Q ss_pred cCCCCCchhhhhhhhhC--CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFK--DFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...........+...+. ..++++.+||.+||++||++|||+.|+|+||||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000000111111111 3567899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=396.09 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=229.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecC-CCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.-|++.+.||.|+.|.|-+|++..+|+.+|||++.+. ...+.....+.+|+-+|+.+.|||+++++++++.. .++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEEE
Confidence 4578899999999999999999999999999999876 44555566788999999999999999999999984 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|.||+++|-+..+.-..+++++.+++.+++||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|..-.++..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl-- 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL-- 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc--
Confidence 999999877776666677999999999999999999999999999999999999999999999999999987655443
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
..+.||+|.|.|||++.|..+-+.++||||.|||||.|++|+.||.+.+-...+.++.+.....+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--------------- 232 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--------------- 232 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC---------------
Confidence 56779999999999999988778999999999999999999999998888888888876543332
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+|+++++||.+||..||++|+|.+|+++|||+..-
T Consensus 233 --------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 233 --------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred --------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 3789999999999999999999999999999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=379.74 Aligned_cols=262 Identities=30% Similarity=0.460 Sum_probs=213.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.++...+.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|.+++|||||+++|.........+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4678889999999999999999888999999999866322 26678899999999999999999997544332468999
Q ss_pred EeeccCCHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccccCC--CC
Q 015247 196 FHYMEHDLAGLAASPEV-KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDP--NH 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~--~~ 271 (410)
|||+.++.+..+....+ .+++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999866665554443 8999999999999999999999999999999999999999 79999999999988763 22
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........||+.|||||++........++|||||||++.||+||.+||... ...+.+-.+.....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~-------------- 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS-------------- 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC--------------
Confidence 233456789999999999985322345999999999999999999999873 33333333322110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+.....+|+++++||.+||..||.+||||+++|.|||.+++.
T Consensus 241 -------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 241 -------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1122347899999999999999999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=374.09 Aligned_cols=271 Identities=24% Similarity=0.381 Sum_probs=223.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++..+||.|..++||+|+...++..||||++..+..+.+ .+.+.+|+..|+.++||||++++..|..+. .+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeE
Confidence 34789999999999999999999999999999999998876655 788999999999999999999999998854 499
Q ss_pred EEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 194 LVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+||.||.++....+.. -...++|..+..+++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999754443322 22359999999999999999999999999999999999999999999999999887664332
Q ss_pred CC---CCcccccccccccccc-ccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 272 KH---PMTSRVVTLWYRPPEL-LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 272 ~~---~~~~~~gt~~y~aPE~-~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.. .....+||++|||||+ ......|+.|+||||||++..||++|..||........+..-+ .+.|+.-.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~----- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLL----- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcc-----
Confidence 11 1145689999999999 4455679999999999999999999999999887766654333 33333110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
....-.+..+.++..++++|..||.+||++||||+++|+|+||++.+
T Consensus 254 ------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 254 ------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 01112234456788999999999999999999999999999999765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=391.15 Aligned_cols=257 Identities=33% Similarity=0.504 Sum_probs=229.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+........+.+.+|+++++.++|||||.+++.|+.. ..+++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~v 78 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWV 78 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEE
Confidence 3689999999999999999999999999999999998887777788999999999999999999999999884 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|.||+.|++...+ ..++.++|+.++.++.+++.||.|||+.+|.|||+||.|||++..|++|+||||+|+....+ ...
T Consensus 79 Vte~a~g~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 79 VTEYAVGDLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred EehhhhhhHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9999999666644 55568999999999999999999999999999999999999999999999999999988654 344
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.++..|||.|||||++.+. +|+..+|+||+||++|||++|++||....-.+..+.|.+---.+ |
T Consensus 157 ltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------p----- 220 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------P----- 220 (808)
T ss_pred eeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----------c-----
Confidence 6778899999999998875 59999999999999999999999999988888888876521111 1
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..++..+.+|++.+|.+||.+|.|=.++|.|||.+..
T Consensus 221 --------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 221 --------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred --------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 2678899999999999999999999999999998764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=391.31 Aligned_cols=280 Identities=31% Similarity=0.548 Sum_probs=229.7
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-C-----CceeeEeeeEeecCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-H-----PNVIKLEGLVTSRMSC 190 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 190 (410)
+|++++.||+|+||+|.+|.+..+++.||||+++.. .........|+.+|..|+ | -|+|+++++|..+ .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence 689999999999999999999999999999999743 344455666999999986 3 6999999999995 4
Q ss_pred eEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC--CcEEEEeecccccc
Q 015247 191 SLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--GVLKIADFGLASFF 267 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DFGla~~~ 267 (410)
+++||+|.++.+|..++... ...++...++.++.||+.||.+||+.||||+|||||||||.+- ..|||+|||+|+..
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 59999999999999988654 4579999999999999999999999999999999999999854 47999999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ..+++.+..|+|||+++|.. |+.+.||||||||+.||++|.++|+|.++.+++..|++.+|.|+..+++.++
T Consensus 342 ~q~----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 23677789999999999966 9999999999999999999999999999999999999999999988776554
Q ss_pred CCCcccCC----CC-----C-----------------------c-hhhhhhhhhC-CCCCCcHHHHHhccCCCCCCCCCH
Q 015247 348 LPNATLFK----PR-----E-----------------------P-YKRCIQETFK-DFPPSSLPLIETLLAIDPAERLTA 393 (410)
Q Consensus 348 ~~~~~~~~----~~-----~-----------------------~-~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~ 393 (410)
........ +. . + ....+..... .-...++|||.+||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 32111100 00 0 0 0000111111 122346999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 015247 394 TVALNSEVIFQDR 406 (410)
Q Consensus 394 ~elL~hp~~~~~~ 406 (410)
.++|+||||+.-.
T Consensus 497 ~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 497 AQALNHPFLTGTS 509 (586)
T ss_pred HHHhcCccccccc
Confidence 9999999999443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=397.43 Aligned_cols=285 Identities=32% Similarity=0.494 Sum_probs=228.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec------C
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------M 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 188 (410)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 367999999999999999999998999999999886432 1234699999999999999998877432 2
Q ss_pred CceEEEEEeeccCCHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLA 264 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla 264 (410)
..++++||||+++++...+. .....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 33578999999998766543 3456899999999999999999999999999999999999999665 7999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
+.+..... .....||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..+.+.++.+..+.+.
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 87654332 3456789999999998776669999999999999999999999999999999999999999988876554
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
...-.......+......+........|+++++||.+||.+||.+|||+.|+|+||||.+-+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 321110111111111111122223457889999999999999999999999999999976543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=333.69 Aligned_cols=286 Identities=40% Similarity=0.710 Sum_probs=248.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|...++||+|.||+||+|++..+++.||+|.++.+.-++..-....+|+-+|+.++|.|||+++++...+ ..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd--kkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEe
Confidence 468888999999999999999999999999999998765554455677899999999999999999988764 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+|||..++..+....++.+..+.++.++.|++.||.++|++++.|||+||.|.||+.+|.+|++|||+++.++-.-.. .
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc-y 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence 999999999999998999999999999999999999999999999999999999999999999999999988644322 3
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC-CCCCccc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KLPNATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~ 353 (410)
+..+.|.+|++|.++.|..-|+...|+||.||++.|+.. |++.|+|.+..+++.+|...+|.+..+.|... ++|+-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 445679999999999998889999999999999999975 89999999999999999999999999998764 4554322
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.|.-+-.-.+....+.++..-+||++++|.-+|.+|++++++|+||||..-
T Consensus 239 -yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 -YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 222222223344556788899999999999999999999999999999853
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=358.28 Aligned_cols=259 Identities=31% Similarity=0.453 Sum_probs=230.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
+.|.-.+.||+|..++|.++.++.+|+.+|+|++..... ..+..+...+|+.||+++ .||+|+++.++|+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 568888999999999999999999999999999975432 223455677899999998 79999999999988
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...+++|+|.|+.+.+..+......+++...+.+++|++.|+.|||.++||||||||+|||++++.++||+|||+|+.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 56799999999988877777777899999999999999999999999999999999999999999999999999999997
Q ss_pred CCCCCCCcccccccccccccccc-----CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
++.. ....||||+|+|||.+. +.+.|+..+|+||+||++|.|+.|.+||......-+++.|++.........|
T Consensus 175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 7655 57789999999999874 3456899999999999999999999999999999999999887655554444
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
.++++..+|||.+||+.||++|.|++|+|+||||.
T Consensus 253 -------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 253 -------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred -------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 58999999999999999999999999999999993
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=370.55 Aligned_cols=281 Identities=38% Similarity=0.674 Sum_probs=224.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeEeeeEee---cC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTS---RM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---~~ 188 (410)
++|++.+.||+|+||.||+|++.. +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999754 468899999876544333334455677777665 69999999998853 23
Q ss_pred CceEEEEEeeccCCHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
...++++|||+++++...+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 456899999999988777654 3346899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC-
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS- 346 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 346 (410)
... .......||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+....+.+....|...
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 223456789999999998764 4899999999999999999999999999999999999998887766554332
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.++.... .+.. ...+....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAF-HSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhc-cCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 2221111 0000 112233345688899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=351.60 Aligned_cols=258 Identities=32% Similarity=0.450 Sum_probs=227.0
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|.||.||+|+.+.++..||+|++.++.+... .-..+.+|++|-.+|+||||++++++|.+.. ..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc--ee
Confidence 34899999999999999999999999999999999988765333 3346889999999999999999999999854 59
Q ss_pred EEEEeeccCCHHH-Hhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 193 YLVFHYMEHDLAG-LAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 193 ~lv~e~~~~~l~~-~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
|+++||...+.+. .+. .+..++++..+..++.|++.||.|+|..+++||||||+|+|++.++.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999875444 332 366789999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+.|||..|.|||...+.. ++..+|+|++|++.||++.|.+||...+..+++++|.+.-...+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----------- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----------- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-----------
Confidence 33356789999999999888754 99999999999999999999999999999999999987532222
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..++..+.|||.+||.++|.+|.+..|++.|||+....
T Consensus 243 ------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 243 ------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred ------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 27899999999999999999999999999999998654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=380.10 Aligned_cols=290 Identities=34% Similarity=0.521 Sum_probs=229.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~ 193 (410)
+|++.+.||+|+||.||+|++..+|+.||||.+............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333334456788999999999999999999875432 23589
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK- 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 272 (410)
+||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999999887776543 44799999999999999999999999999999999999999999999999999976532211
Q ss_pred -CCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 -HPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122346789999999987652 358899999999999999999999999999888888888888888765543322111
Q ss_pred ccc-C-CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 ATL-F-KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
... . ..............+.+++.+.+||.+||+.||++|||++++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 0 00000001122333567888999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=384.90 Aligned_cols=257 Identities=27% Similarity=0.492 Sum_probs=222.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
...|....+||+|+.|.||.++...+++.||||.+.+... ...+.+.+|+.+|+..+|+|||.+++.|... ..+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEE
Confidence 3568899999999999999999999999999999987653 3355688999999999999999999888775 44999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||||+++.+....... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999997766655443 599999999999999999999999999999999999999999999999999998875543 3
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
..+.+|||.|||||++... .|+++.||||||++++||+-|.+||...+....+..|.. .|.|...
T Consensus 426 R~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------------- 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------------- 490 (550)
T ss_pred cccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------------
Confidence 5677999999999998764 499999999999999999999999998877766666643 3333211
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
....+|+.++||+.+||+.||.+|++|.+||+||||+.
T Consensus 491 ------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 11378999999999999999999999999999999953
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=373.22 Aligned_cols=288 Identities=34% Similarity=0.642 Sum_probs=236.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+++|++.+.||+|+||.||+|++..+++.||+|.++..... .....+.+|+++++.++||||+++++++... ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 37899999999999999999999999999999999765432 2233466799999999999999999998874 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+++++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ .
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 999999998887776666789999999999999999999999999999999999999999999999999976543222 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc-
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL- 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 353 (410)
.....+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....|..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2345679999999998766668999999999999999999999999999999999999999988887775432211100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...............+.+++++.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000000111223346888999999999999999999999999999999755
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=383.97 Aligned_cols=289 Identities=33% Similarity=0.496 Sum_probs=233.1
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~ 193 (410)
+|++.+.||+|+||.||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++.... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999899999999998654333444567888999999999999999999987643 12589
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||+.+++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999888776644 347999999999999999999999999999999999999999999999999999876544333
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc-c
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA-T 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~ 352 (410)
......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..+.+.++.++...+........ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 344557899999999988766689999999999999999999999999999999999999999887654322110000 0
Q ss_pred --cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 --LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
......+............++++.+||.+||+.||.+|||+.++|+||||.+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 000000001111122345688899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=378.99 Aligned_cols=262 Identities=34% Similarity=0.486 Sum_probs=227.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
..|++.+.||+|.||.||+++++.+|+.+|+|++.+... .....+.+.+|+.+|+++. |||||.++++|+... .++
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~ 112 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVY 112 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEE
Confidence 679999999999999999999999999999999987665 2334667889999999998 999999999999854 699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEeeccccccCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGLASFFDP 269 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~~~ 269 (410)
+|||++.|+.+....... .+++..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999986554443322 49999999999999999999999999999999999999743 5799999999999876
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.......+||+.|+|||++... .|+..+||||+|+++|.|++|.+||.+.+..+...+|.........
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~--------- 259 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS--------- 259 (382)
T ss_pred --CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC---------
Confidence 3346788999999999988764 4999999999999999999999999999999999888765443333
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..|+.+++.+++||+.||..||.+|+|+.++|+|||++.....
T Consensus 260 ----------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 260 ----------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ----------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 3345889999999999999999999999999999999986443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=370.36 Aligned_cols=293 Identities=47% Similarity=0.783 Sum_probs=241.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++.............+|+.++++++|+|++++++++.......+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 37899999999999999999999999999999999765443333334567999999999999999999988765567899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+++++...+......+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999998877776655689999999999999999999999999999999999999999999999999998765432 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC-CCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL-PNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~ 353 (410)
.....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|..... +....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23344588899999987766688999999999999999999999999999999999999988887766644321 11111
Q ss_pred CC-CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 354 FK-PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 354 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
.. +...+ ..+.......++.+.+||.+||++||++|||+.++|+||||++.+.||
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 245 FTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred ccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 11 11111 122233345788999999999999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=366.88 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=230.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+|++.+.||+|.||+|-+|.....|+.||||.|+++.+ +......+.+|++||..|+||||+++|++|+..+ .+.+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEE
Confidence 579999999999999999999889999999999998877 4556778999999999999999999999999854 4999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||..++.+..+....+.+++.+++.+++||..|+.|+|+++++|||||.+|||+|.++++||+||||+-.+... ..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999888888888889999999999999999999999999999999999999999999999999999887543 44
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
..++||+|-|.+||++.|.++-++.+|.|||||+||.|+.|..||.|.+.....++|.......
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---------------- 272 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---------------- 272 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----------------
Confidence 6889999999999999998877899999999999999999999999999988888886542221
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
+.-|.++.-||+.||..||++|.|++++-+|-|++
T Consensus 273 --------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 --------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 25678889999999999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.26 Aligned_cols=287 Identities=31% Similarity=0.510 Sum_probs=228.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----c
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 190 (410)
.++|++.+.||+|+||.||++++..+|+.||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 378999999999999999999999999999999997654444555677789999999999999999998865432 3
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+|++|||+++++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5799999999988776532 5889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC-
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP- 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 349 (410)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+..+.+...++......
T Consensus 177 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 F--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred c--cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2 23456789999999998775 4899999999999999999999999999988888888888888776543321100
Q ss_pred ----CcccCCCCCchhhh--------hhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 350 ----NATLFKPREPYKRC--------IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 350 ----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
......+...+... ........++.+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00000000000000 00111235678999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=377.02 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=216.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++... ..+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEE
Confidence 4789999999999999999999999999999999976432 223456688899999999999999999998874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999988665555555568999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+..... .+|
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----------~~p---- 235 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL----------KFP---- 235 (329)
T ss_pred -cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc----------CCC----
Confidence 23457899999999987654 89999999999999999999999998887776666643210 001
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~ 405 (410)
..+++.+.+||.+||+.||.+|++ +.++++||||.+.
T Consensus 236 ---------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 236 ---------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ---------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 246778999999999999999997 7999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=370.68 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=214.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 469999999999999999999999999999999976433 22345567889999999999999999988776 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||+.++.+..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999987655545445568999999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----------~------- 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL----------E------- 216 (291)
T ss_pred cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----------C-------
Confidence 23457899999999887644 89999999999999999999999999888777776654210 0
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
....+++.+.+||.+||+.||.+||+ ++++++||||+.
T Consensus 217 ------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 217 ------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 11256778999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.29 Aligned_cols=282 Identities=24% Similarity=0.313 Sum_probs=219.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++... ...++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEE
Confidence 468999999999999999999999999999999643 22356799999999999999999998874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
++|++.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 161 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 9999998877766543 478999999999999999999999999999999999999999999999999997643332233
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR-------TEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||... +...++..+....+.++.++.....
T Consensus 240 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3456799999999998764 4899999999999999999999887643 2345677777777765543211000
Q ss_pred CC--Ccc----cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 348 LP--NAT----LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 348 ~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.. ... ......+...........++.++.+||.+||++||.+|||+.|+|+||||++.+.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 00 000 00000000000011122467789999999999999999999999999999886544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=362.93 Aligned_cols=280 Identities=38% Similarity=0.675 Sum_probs=224.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeEeeeEeec---CCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTSR---MSC 190 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~---~~~ 190 (410)
+|++.+.||+|+||.||+|++..+++.||+|.++.............+|+++++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999876543322223345577766655 799999999987642 234
Q ss_pred eEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.++++|||+.+++...+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999999887766443 34589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC-CC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS-KL 348 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~ 348 (410)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+....+.+.++....+.+....|... ..
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 234456899999999987654 899999999999999999999999999999999999988887766555431 11
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+... +.+ ..........+.+++.+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~-~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGA-FSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc-cCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111 111 11122334445788889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=374.88 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=210.3
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+.||+|+||.||+|++..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 33445567789999999999999999998877 446999999999
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
++.+.........+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccceec
Confidence 87666555556689999999999999999999999999999999999999999999999999987542221 22345679
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.... ..+
T Consensus 158 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~----------~~~------------ 214 (323)
T cd05571 158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------IRF------------ 214 (323)
T ss_pred CccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------CCC------------
Confidence 9999999998764 48999999999999999999999999887766665554311 011
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
...+++++.+||.+||++||++|| ++.++|+||||..
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 125788899999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=352.12 Aligned_cols=292 Identities=39% Similarity=0.637 Sum_probs=237.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
..|+.+..||+|.||.||+|....++ +.||||.++.............+|+.+++.++|||++.|..+|... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 57999999999999999999644332 3799999976532222233456799999999999999999988775 556
Q ss_pred EEEEEeeccCCHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEeecc
Q 015247 192 LYLVFHYMEHDLAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGL 263 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGl 263 (410)
+++++||.+++|+..+. .....++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999988653 233579999999999999999999999999999999999999877 8999999999
Q ss_pred ccccCCCCCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHHH
Q 015247 264 ASFFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT---------EVEQLHKIY 332 (410)
Q Consensus 264 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---------~~~~~~~i~ 332 (410)
++.+...-.. .....+.|.||+|||.++|...|+.+.||||+|||+.||+|-.+.|.+.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988543222 23456789999999999999999999999999999999999999998753 357899999
Q ss_pred HHhCCCCHHHhhhCC-CCCcccC--CCC-Cchhh----hhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 333 KLCGSPSEEYWKKSK-LPNATLF--KPR-EPYKR----CIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~-~~~~~~~--~~~-~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+.+|.|..+.|...+ .|+-... ..+ ..+.+ ......+.-++...+|+.+||.+||.+|+|++++|+|+||++
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 999999998887643 4543110 000 11111 123444556777999999999999999999999999999999
Q ss_pred CCCC
Q 015247 405 DRTL 408 (410)
Q Consensus 405 ~~~~ 408 (410)
++.|
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 9776
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=364.08 Aligned_cols=287 Identities=37% Similarity=0.672 Sum_probs=234.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEE
Confidence 47899999999999999999999899999999998754422 2233566799999999999999999998874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 999999988887776666899999999999999999999999999999999999999999999999999976543221 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc-c
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT-L 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~ 353 (410)
.....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+....|......... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 234466899999999877666889999999999999999999999999998999999998888877666543111100 0
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.................+++.+.+||.+||+.||.+|||+.++|+||||+.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0111111122333445788899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=361.31 Aligned_cols=283 Identities=40% Similarity=0.694 Sum_probs=229.1
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|++|.||+|++..+++.||+|.++...........+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4889999999999999999998899999999987654444445567789999999999999999999887 44689999
Q ss_pred eeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||+++++...+.. .+..+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999887776543 23579999999999999999999999999999999999999999999999999997664332 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23446789999999887666688999999999999999999999999988888888888777776665543221110000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
................+++++.+||.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000111122333445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=375.97 Aligned_cols=285 Identities=29% Similarity=0.502 Sum_probs=228.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999999999999999999765444445566778999999999999999998876432 23
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+|+||||+++++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 5899999999988876643 5889999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC--
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL-- 348 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 348 (410)
. ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++....+.+..+.+.....
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 F--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C--cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 23456789999999998775 489999999999999999999999999999999999998888877655433211
Q ss_pred -------CCcccCCCCC----chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 349 -------PNATLFKPRE----PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 349 -------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
+......... .............++.+++||.+||+.||.+|||+.++|+||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1000000000 00000011112345678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=362.54 Aligned_cols=282 Identities=40% Similarity=0.706 Sum_probs=229.6
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||+|++..+|+.||+|.++...........+.+|+.+++.++|||++++++++.+. ...++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 48899999999999999999999999999999976544433345677899999999999999999998774 4699999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||+++++...+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcC
Confidence 9999998887766667899999999999999999999999999999999999999999999999999987643322 223
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcccC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNATLF 354 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 354 (410)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....|.... .+.....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987766678999999999999999998877 56667777888888888877765554321 1221111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+............+.+++++.+||.+||+.||.+|||++++|.||||
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 -PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred -CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111112233445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=373.99 Aligned_cols=285 Identities=31% Similarity=0.508 Sum_probs=227.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999999899999999999765544555667778999999999999999999886532 23
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..|++|||+++++...... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999988776543 5889999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC--
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL-- 348 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 348 (410)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+.+....-
T Consensus 173 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 F--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred c--ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 2 23456789999999998765 489999999999999999999999999998888888888888776654432210
Q ss_pred -------CCcccCCCCC----chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 349 -------PNATLFKPRE----PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 349 -------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
+......... .............+..+.+||.+||+.||++|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000000000 00000011112345678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=362.61 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=211.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|+..+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++..++|+|++++++++... ...+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 378899999999999999999999999999998765432 22334577899999999999999999988774 469999
Q ss_pred EeeccCCHHHHh-c-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGLA-A-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~~-~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++.+... . .....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 999997655433 2 2334689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 158 -~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred -ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2455789999999998865 489999999999999999999999988765444333333221111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~ 405 (410)
......+++++.+||.+||+.||.+||| ++++++||||.+.
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 0112367889999999999999999997 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=364.49 Aligned_cols=278 Identities=36% Similarity=0.638 Sum_probs=216.2
Q ss_pred eeeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 121 IDKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
.++||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+|++++||||+++++++.......++++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999865 4678999999865432 2335679999999999999999999877666779999999
Q ss_pred ccCCHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEeeccccc
Q 015247 199 MEHDLAGLAAS--------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASF 266 (410)
Q Consensus 199 ~~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~ 266 (410)
+++++...... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99987765432 12358999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHHHh
Q 015247 267 FDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLC 335 (410)
Q Consensus 267 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---------~~~~~~i~~~~ 335 (410)
...... .......||+.|+|||++.+...++.++||||+||++|+|++|++||.+... ..++..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 653322 1234567899999999988766689999999999999999999999976543 46678888888
Q ss_pred CCCCHHHhhhCC-CCCcccCC--------CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 336 GSPSEEYWKKSK-LPNATLFK--------PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 336 ~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+.+....|.... .+...... ........+.......++.+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 888876665432 11110000 00001111111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=367.61 Aligned_cols=252 Identities=31% Similarity=0.430 Sum_probs=212.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCce-EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.+.+.+.||+|+||+||+|. ..|+. ||+|++.....+....+.+.+|+.+|.+++|||||+++|++..... .+.+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 556677779999999999996 66777 9999998776655557789999999999999999999999988642 5899
Q ss_pred EEeeccCCHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEEcCCC-cEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAGLAASP--EVKFTEPQVKCYMHQLLSGLEHCHNNG-VLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~ 270 (410)
||||++++.+..+... ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999998777766544 679999999999999999999999999 99999999999999998 9999999999877543
Q ss_pred CCCCCccccccccccccccccC-CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
. ...+...||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+....+....+......+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---------- 266 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---------- 266 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----------
Confidence 2 22345789999999999985 34599999999999999999999999999998555555543222221
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+..||..||+.||.+||+..+++.
T Consensus 267 -----------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -----------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11247889999999999999999999988763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=373.45 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=215.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCC-ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++.+.||+|+||.||+|.+..++ ..||+|++..... .....+.+.+|+.++..++||||+++++++... ..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEE
Confidence 378999999999999999999866554 6899999875432 233456678899999999999999999999874 569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999988666555555668999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+......
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 246 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--------------- 246 (340)
T ss_pred --cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 23567899999999987644 889999999999999999999999998887777766542111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
....+++.+.+||++||+.||.+|+ |++++++||||..
T Consensus 247 --------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 247 --------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 0125678899999999999999995 8999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=374.50 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=213.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||+||+|++..+++.||+|+++.... .......+.+|+.++..++||||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999976432 23345567889999999999999999998887 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 272 (410)
||||++++.+..+....+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999866665555566899999999999999999999999999999999999999999999999999976532110
Q ss_pred --------------------------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCC
Q 015247 273 --------------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 320 (410)
Q Consensus 273 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 320 (410)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 011245799999999998765 48999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCC---CCCCHHHHh
Q 015247 321 GRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA---ERLTATVAL 397 (410)
Q Consensus 321 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~Rpt~~elL 397 (410)
+.+..+.+.++....... .+|. ...+++++++||.+|+. +|. .||+++|++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~~p~-----------------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETL--------IFPP-----------------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcc--------cCCC-----------------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 988888777775421110 0000 01467889999999876 444 468999999
Q ss_pred cCCCCCCC
Q 015247 398 NSEVIFQD 405 (410)
Q Consensus 398 ~hp~~~~~ 405 (410)
+||||+..
T Consensus 292 ~hp~f~~~ 299 (363)
T cd05628 292 TNPFFEGV 299 (363)
T ss_pred CCCCCCCC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=370.93 Aligned_cols=285 Identities=34% Similarity=0.564 Sum_probs=229.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 191 (410)
++|++++.||+|+||+||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... ...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 7899999999999999999999999999999998754433334456778999999999999999998875421 234
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.|++++++++++...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 95 VYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred EEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 799999998877665532 46999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+........
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 34567899999999988755689999999999999999999999999998888999988888777655433211110
Q ss_pred ccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... .................++.+.+||.+||+.||.+|||+.++|+||||.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 0000001112233345677889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=366.94 Aligned_cols=249 Identities=29% Similarity=0.405 Sum_probs=209.5
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||+|+||.||+|++..+++.||+|++..... .......+.+|+.++.+++||||+++++++... ...|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 334456678899999999999999999988764 5699999999987
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccc
Q 015247 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282 (410)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 282 (410)
.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 665555556689999999999999999999999999999999999999999999999999997643222 2234567899
Q ss_pred cccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhh
Q 015247 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKR 362 (410)
Q Consensus 283 ~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (410)
.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.... .
T Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~----------~---------------- 210 (312)
T cd05585 158 EYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP----------L---------------- 210 (312)
T ss_pred ccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC----------C----------------
Confidence 99999998775 48999999999999999999999999888777666654311 0
Q ss_pred hhhhhhCCCCCCcHHHHHhccCCCCCCCC---CHHHHhcCCCCCCC
Q 015247 363 CIQETFKDFPPSSLPLIETLLAIDPAERL---TATVALNSEVIFQD 405 (410)
Q Consensus 363 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~elL~hp~~~~~ 405 (410)
.....+++.+.+||.+||++||.+|| ++.++|.||||.+.
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 01125788899999999999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=348.21 Aligned_cols=293 Identities=45% Similarity=0.742 Sum_probs=244.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee------cCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS------RMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 189 (410)
+.|+.+.+||+|.||.||+|+...+|+.||+|++-..+-....-....+|+.+|..++|+|++.+++.|.. +..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 67899999999999999999999999999999875544322223345679999999999999999887743 334
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
..+|+||.+|++++...+.+...+++..++..++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 56999999999999999999989999999999999999999999999999999999999999999999999999976643
Q ss_pred CCC---CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 270 NHK---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 270 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
... ...+..+.|.+|++||.++|...|+++.|||+.||++.||+|+.+.|.+.++..++..|..++|+...+.|...
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 222 22455677999999999999999999999999999999999999999999999999999999999998888664
Q ss_pred C-CCCcccC--C-CCCchhhhhhhhhC--CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 347 K-LPNATLF--K-PREPYKRCIQETFK--DFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 347 ~-~~~~~~~--~-~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
. +|--... . -...-.+.+....+ .-++++.||+..||..||.+|++++++|+|.||..++.|
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 2 2211111 1 01111122222222 236789999999999999999999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=370.26 Aligned_cols=262 Identities=27% Similarity=0.369 Sum_probs=218.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.++..++||||+++++++.. ....|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 3699999999999999999999999999999999765332 2345567889999999999999999998877 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999998866666655566899999999999999999999999999999999999999999999999999986543 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+........ .+. ..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------~~~--~~ 223 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------RPV--YD 223 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------CCC--CC
Confidence 3456789999999998875 589999999999999999999999999888777766654211100 000 00
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.....+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 224 -----------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 224 -----------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -----------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0002578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=375.02 Aligned_cols=261 Identities=30% Similarity=0.443 Sum_probs=215.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999976432 23445567889999999999999999999887 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH- 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 273 (410)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999988766655555568999999999999999999999999999999999999999999999999998765321110
Q ss_pred ------------------------------------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCC
Q 015247 274 ------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317 (410)
Q Consensus 274 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 317 (410)
...+.+||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCC
Confidence 11234689999999988764 48999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC---HH
Q 015247 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT---AT 394 (410)
Q Consensus 318 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ 394 (410)
||.+.+..+.+..+....... .++. ...+++++.+||.+||. ||.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~--------~~~~-----------------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL--------QFPD-----------------EVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc--------CCCC-----------------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999988877766665321100 0000 01467889999999997 9999998 99
Q ss_pred HHhcCCCCCCC
Q 015247 395 VALNSEVIFQD 405 (410)
Q Consensus 395 elL~hp~~~~~ 405 (410)
++|+||||+..
T Consensus 292 ~ll~h~~~~~~ 302 (364)
T cd05599 292 EIKSHPFFKGV 302 (364)
T ss_pred HHhcCCCcCCC
Confidence 99999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=352.51 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=230.6
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
..+++|..+++||+|.||+|-+++.+.+|+.||+|++++..+ ..+.+.....|-++|+..+||.+..|...|+. ...
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--Cce
Confidence 357899999999999999999999999999999999988765 55667778889999999999999999777776 445
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++||||..|+.+..++++...|++..++.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+||||++.--. .
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~ 321 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-Y 321 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-c
Confidence 999999999999988888888999999999999999999999999999999999999999999999999999986422 2
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
...+.+.||||.|+|||++.. ..|+.++|||.+||++|||++|+.||...+....+..|.-. +.++|
T Consensus 322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d~kFP-- 388 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------DLKFP-- 388 (516)
T ss_pred cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------hccCC--
Confidence 233678899999999999876 45999999999999999999999999999988888877652 23333
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
+.++++++.|+..+|.+||.+|. .+.|+.+|+||...
T Consensus 389 -----------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 389 -----------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred -----------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 38899999999999999999997 49999999999753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=371.09 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=222.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|..++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+|.+++++||.++|+.+.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 4688889999999999999999999999999999876543 446789999999999999999999999988 4459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||||.++....+...+..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+...... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 999999888878887777899999999999999999999999999999999999999999999999999888655443 3
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
.+++|||.|||||++.+ ..|+.++||||||++++||++|.+|+...+....+-.|-+
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------------- 225 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------------- 225 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------------
Confidence 78899999999999985 4599999999999999999999999988776332222211
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+.+...+++.+++||..||++||+.||+|.++|+|+|++.
T Consensus 226 ------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 ------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 0111222378889999999999999999999999999999997
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=373.96 Aligned_cols=260 Identities=30% Similarity=0.385 Sum_probs=211.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58999999999999999999999999999999976543 34455678899999999999999999999887 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC----
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH---- 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~---- 271 (410)
|||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999886655555555679999999999999999999999999999999999999999999999999986432100
Q ss_pred ------------------------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHH
Q 015247 272 ------------------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 309 (410)
Q Consensus 272 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l 309 (410)
.....+.+||+.|+|||++.+. .++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHH
Confidence 0011245799999999998764 489999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccC--CCC
Q 015247 310 AELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLA--IDP 387 (410)
Q Consensus 310 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dP 387 (410)
|||++|..||...+..+....+....... ..+ ....+++++.+||.+||. .+|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~~-----------------~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTL--------HIP-----------------PQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcccccc--------CCC-----------------CCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999887766665554311100 000 012578899999999654 455
Q ss_pred CCCCCHHHHhcCCCCCC
Q 015247 388 AERLTATVALNSEVIFQ 404 (410)
Q Consensus 388 ~~Rpt~~elL~hp~~~~ 404 (410)
..|+|+.++++||||++
T Consensus 294 ~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 294 LGRNGADDIKAHPFFSE 310 (381)
T ss_pred cCCCCHHHHhcCcccCC
Confidence 66999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.78 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=210.7
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+.||+|+||.||++++..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++... ..+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 469999999999999999999999999976432 233455677899999999999999999988774 46999999999
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 87666565556689999999999999999999999999999999999999999999999999987542221 22334678
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..... .+
T Consensus 158 t~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----------~~------------ 214 (323)
T cd05595 158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------RF------------ 214 (323)
T ss_pred CcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------CC------------
Confidence 9999999998765 489999999999999999999999998877766665543110 11
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
...+++++.+||.+||++||.+|+ ++.++++||||.+.
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 125788899999999999999998 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=367.40 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=209.7
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++... ..+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence 469999999999999999999999999976432 334456778899999999999999999888774 46999999999
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 8766655555668999999999999999999999999999999999999999999999999998754322 122345678
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... ..+
T Consensus 158 t~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~----------~~~------------ 214 (328)
T cd05593 158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED----------IKF------------ 214 (328)
T ss_pred CcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC----------ccC------------
Confidence 9999999998764 48999999999999999999999998877766555443210 011
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
...+++++.+||.+||++||.+|+ ++.++++||||...
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 215 -------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 125788899999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.64 Aligned_cols=285 Identities=42% Similarity=0.688 Sum_probs=234.8
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|||++++++++.. ....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4889999999999999999998899999999998765544555678889999999999999999999887 45699999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||+++++...+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966777766555568999999999999999999999999999999999999999999999999999877544322234
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC-CcccCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP-NATLFK 355 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~ 355 (410)
...++..|+|||.+.+...++.++||||+|+++|+|++|.++|.+.+....+..+....+.+....|...... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 4578999999999876666789999999999999999999999999988889999888888776655543211 110110
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
........+....+..+..+.+||.+||++||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 011111112344457788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=370.97 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=217.4
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 34789999999999999999999999999999999975432 22334557789999999999999999988877 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999987655544433 3689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCCccccccccccccccccCC---cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+....+.++....... .++
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~~ 269 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL--------TFP 269 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--------CCC
Confidence 333456799999999988653 237889999999999999999999999988877777665421100 000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQD 405 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~ 405 (410)
....+|.++.+||.+||+.+|.+ |+|++++++||||+..
T Consensus 270 -----------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 270 -----------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -----------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 01257889999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=373.57 Aligned_cols=260 Identities=30% Similarity=0.411 Sum_probs=212.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+. ..+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence 58999999999999999999999999999999975432 234456788899999999999999999998874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC----
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH---- 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~---- 271 (410)
|||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999886555454445679999999999999999999999999999999999999999999999999975331000
Q ss_pred ------------------------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHH
Q 015247 272 ------------------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 309 (410)
Q Consensus 272 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l 309 (410)
.......+||+.|+|||++.+. .++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHH
Confidence 0011235789999999998765 489999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC
Q 015247 310 AELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE 389 (410)
Q Consensus 310 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 389 (410)
|||++|++||.+.+..+....+........ .| ....+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~p-----------------~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH--------IP-----------------PQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------CC-----------------CcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999887776666553211100 00 01257889999999976 59999
Q ss_pred CCC---HHHHhcCCCCCCC
Q 015247 390 RLT---ATVALNSEVIFQD 405 (410)
Q Consensus 390 Rpt---~~elL~hp~~~~~ 405 (410)
|++ +.++++||||+..
T Consensus 293 R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred cCCCCCHHHHhcCCCcCCc
Confidence 997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=379.51 Aligned_cols=286 Identities=23% Similarity=0.322 Sum_probs=220.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC------CCceeeEeeeEeec
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD------HPNVIKLEGLVTSR 187 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 187 (410)
..++|+++++||+|+||+||+|.+..+++.||||+++... ........|+.+++.++ |++++++++++...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3478999999999999999999999999999999996432 22233455777777664 45688998888764
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCC------------
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG------------ 254 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~------------ 254 (410)
...+++||++++++++..+... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 -~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 204 -TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred -CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4568999999988888766543 479999999999999999999998 5999999999999998765
Q ss_pred ----cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 015247 255 ----VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330 (410)
Q Consensus 255 ----~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 330 (410)
.+||+|||++.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999886432 2234568999999999998754 99999999999999999999999999999999999
Q ss_pred HHHHhCCCCHHHhhhCCCCCc-------ccCCCC---Cchhhhhh-hhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 331 IYKLCGSPSEEYWKKSKLPNA-------TLFKPR---EPYKRCIQ-ETF--KDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 331 i~~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~-~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
+.+.++.++..+.......+. ....+. ..+..... ... ...++.+.|||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 999998887655432111100 000000 00000000 000 01245678999999999999999999999
Q ss_pred cCCCCCCCCCCC
Q 015247 398 NSEVIFQDRTLC 409 (410)
Q Consensus 398 ~hp~~~~~~~~~ 409 (410)
+||||.+....|
T Consensus 437 ~Hp~~~~~~~~~ 448 (467)
T PTZ00284 437 THPYVLKYYPEC 448 (467)
T ss_pred cCccccccCCcc
Confidence 999999865544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=363.11 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=212.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCC-ceeeEeeeEeecCCceEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHP-NVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~l 194 (410)
+|++++.||+|+||.||+|++..+++.||+|++..... .....+.+..|++++..++|+ +|+++++++... ..+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 58999999999999999999999999999999986432 233456677899999999765 588888888764 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999986665555555679999999999999999999999999999999999999999999999999987542221 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----------------- 219 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----------------- 219 (324)
T ss_pred eeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 34567899999999987754 899999999999999999999999998888777776542111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH-----HHHhcCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA-----TVALNSEVIFQ 404 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~elL~hp~~~~ 404 (410)
....+++++.+||.+||++||.+|++. .++++||||..
T Consensus 220 ------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 220 ------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 112577889999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=363.97 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|++..... .....+.+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 469999999999999999999999999976432 233455667788888876 699999999998774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 987666565556689999999999999999999999999999999999999999999999999987643222 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...... .
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------~----------- 215 (320)
T cd05590 158 GTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV----------Y----------- 215 (320)
T ss_pred cCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----------C-----------
Confidence 89999999998764 4899999999999999999999999998888777766542110 0
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH------HHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA------TVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~elL~hp~~~~ 404 (410)
...+++++.+||.+||+.||.+||++ +++++||||+.
T Consensus 216 --------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 216 --------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred --------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 12467889999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=370.76 Aligned_cols=261 Identities=33% Similarity=0.473 Sum_probs=216.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.++..++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 469999999999999999999999999999999986543 22445678889999999999999999988876 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC---
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH--- 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--- 271 (410)
||||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999875544444444689999999999999999999999999999999999999999999999999998765433
Q ss_pred -------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH
Q 015247 272 -------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 326 (410)
Q Consensus 272 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 326 (410)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 1123445789999999998875 48999999999999999999999999988777
Q ss_pred HHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-HHHHhcCCCCCCC
Q 015247 327 QLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-ATVALNSEVIFQD 405 (410)
Q Consensus 327 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~elL~hp~~~~~ 405 (410)
...++....... .+|. ...+++++.+||.+||. ||.+||+ ++++|+||||+..
T Consensus 238 ~~~~i~~~~~~~--------~~p~-----------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESL--------RFPP-----------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcc--------cCCC-----------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 766665421100 0000 01368899999999997 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=373.00 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=211.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++++.||+|+||.||++++..+++.||||++..... .......+.+|+++++.++||||+++++++.+ ..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999875432 33445678889999999999999999999887 446999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 272 (410)
||||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999998765555555556899999999999999999999999999999999999999999999999999964321000
Q ss_pred ----------C----------------------------------CCccccccccccccccccCCcCCCCccchHHHHHH
Q 015247 273 ----------H----------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 308 (410)
Q Consensus 273 ----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~ 308 (410)
. .....+||+.|+|||++.+. .++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchh
Confidence 0 00134689999999998764 48999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCC
Q 015247 309 LAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA 388 (410)
Q Consensus 309 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 388 (410)
+|||++|..||.+.+..+.+..+...... ..+|+ ...++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~p~-----------------~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRET--------LYFPD-----------------DIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCc--------cCCCC-----------------CCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999988887777766542110 00110 01467889999999998 777
Q ss_pred CC---CCHHHHhcCCCCCC
Q 015247 389 ER---LTATVALNSEVIFQ 404 (410)
Q Consensus 389 ~R---pt~~elL~hp~~~~ 404 (410)
+| +|+.++|.||||+.
T Consensus 292 ~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hcCCCCCHHHHhcCCCcCC
Confidence 65 59999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=366.19 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=208.8
Q ss_pred CcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
+|++.+.||+|+||.||++++. .+++.||+|++..... .....+.+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999999864 4789999999975432 223345677899999999 59999999988876 44
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.++++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 69999999998655555444567999999999999999999999999999999999999999999999999999876444
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........+||+.|+|||++.+...++.++|||||||++|||++|..||...........+........
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 227 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----------- 227 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 433344567999999999988755588999999999999999999999975432221111111100000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
......+++.+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 228 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 228 --------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 001125678899999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=373.36 Aligned_cols=261 Identities=29% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++||||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999865432 22334567789999999999999999999887 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC---
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH--- 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--- 271 (410)
||||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999886655555555689999999999999999999999999999999999999999999999999985331000
Q ss_pred ---------------------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHH
Q 015247 272 ---------------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 312 (410)
Q Consensus 272 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 312 (410)
.......+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeeh
Confidence 0011235799999999998764 489999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-
Q 015247 313 LAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL- 391 (410)
Q Consensus 313 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 391 (410)
++|+.||.+.+..+....+........ . .....+++.+.+||.+|+ .||.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~-----------------~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLH--------I-----------------PSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcccc--------C-----------------CCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999998887766555532110000 0 001257888999999976 5999999
Q ss_pred --CHHHHhcCCCCCCC
Q 015247 392 --TATVALNSEVIFQD 405 (410)
Q Consensus 392 --t~~elL~hp~~~~~ 405 (410)
|+.++++||||+.-
T Consensus 292 ~~t~~ell~h~~~~~~ 307 (376)
T cd05598 292 KNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCHHHHhCCCCcCCC
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=361.58 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=210.5
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHH---HhCCCCceeeEeeeEeecCCceEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILIL---RRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.++ ..++||||+++++++... ...|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 6789999999999999999999999999999975432 223345566676655 466899999999998874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+...... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999998766555443 479999999999999999999999999999999999999999999999999987543221 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~---------------- 219 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR---------------- 219 (324)
T ss_pred cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 23456789999999998764 4899999999999999999999999998887777766542111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
....+++.+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 220 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 220 -------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 1125788899999999999999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=365.37 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=209.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.+++++.||+|-||.|++|.. .....||+|.++...... +.+.+|+++|++|+|+|||++++++..+. .+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEE
Confidence 5688899999999999999974 333489999998654433 35778999999999999999999999855 49999
Q ss_pred EeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||..+ |++++.. .+..+...+...++.|||+||+||+++++|||||.+.||||+++..+||+|||||+....+...
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999965 6666654 5678999999999999999999999999999999999999999999999999999965544333
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
..........|.|||.+.-.. ++.+||||||||+||||+| |+.|+++.++.+.++.+.+...-|..
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------------ 426 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------------ 426 (468)
T ss_pred ecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------------
Confidence 233333467799999987654 9999999999999999998 99999999999999999775443322
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
..+|+++.+++..||+.+|++|||++.+.
T Consensus 427 ----------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 ----------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 37999999999999999999999988654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=355.65 Aligned_cols=277 Identities=36% Similarity=0.614 Sum_probs=214.1
Q ss_pred eeeccCCCeeEEEEEEcC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDML--TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++........+++|||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998653 567899999865432 23466799999999999999999998766667799999999
Q ss_pred cCCHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEeecccccc
Q 015247 200 EHDLAGLAAS--------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFF 267 (410)
Q Consensus 200 ~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~ 267 (410)
++++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9987775531 22358999999999999999999999999999999999999 56679999999999876
Q ss_pred CCCCC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHHHhC
Q 015247 268 DPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLCG 336 (410)
Q Consensus 268 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---------~~~~~~i~~~~~ 336 (410)
..... .......+|+.|+|||++.+...++.++|||||||++|||+||++||..... ..++..+...++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 54322 1233457899999999987766689999999999999999999999976442 356777888888
Q ss_pred CCCHHHhhhCCCCC-c---cc-----CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 337 SPSEEYWKKSKLPN-A---TL-----FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 337 ~~~~~~~~~~~~~~-~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.+....|....... . .. ..................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 77776665432111 0 00 0001111111122222345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=366.60 Aligned_cols=261 Identities=30% Similarity=0.414 Sum_probs=216.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 469999999999999999999999999999999986543 33445667889999999999999999988877 446999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||++++ +...+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999775 44444444468999999999999999999999999999999999999999999999999999877544333
Q ss_pred CCccccccccccccccccC-----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 274 PMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+....+.++....... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------~~ 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--------KF 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--------CC
Confidence 3334578999999998863 3347889999999999999999999999888877777665421100 00
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+ ....+++++.+||..||. ||.+|||+.++++||||.+
T Consensus 231 ~-----------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 231 P-----------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred C-----------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 0 012578889999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=351.66 Aligned_cols=286 Identities=44% Similarity=0.769 Sum_probs=234.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||.|+||.||+|.+..+++.+|+|.++...........+.+|+.+++.++||||+++++++........|++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 67999999999999999999998899999999998655444334456789999999999999999999887655779999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||+.+++...+......+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++........ ..
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 163 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PY 163 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-cc
Confidence 99999888777666555799999999999999999999999999999999999999999999999999987654321 22
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 354 (410)
....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+.+.++....+.+....|.... ++.....
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 344578899999998765557889999999999999999999999999999999999988888877665432 2221111
Q ss_pred CCCCchhhhhhhhhCC--CCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKD--FPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.........+....+. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111112222333 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=367.87 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=215.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999975332 23334567789999999999999999998887 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999987555444433 36899999999999999999999999999999999999999999999999999877543332
Q ss_pred CCccccccccccccccccCCc---CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+....+..+........ +|.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~p~ 270 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--------FPE 270 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--------CCC
Confidence 334567999999999986532 378899999999999999999999999888777777654221110 000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~ 405 (410)
...++..+++||..||..+|.+ |+|+.++++||||+..
T Consensus 271 -----------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 271 -----------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0246888999999999865544 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=364.69 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=209.4
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|++++..++||||+++++++... ..+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCC
Confidence 469999999999999999999999999976432 233445677899999999999999999888774 46999999999
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
++.+.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccccc
Confidence 87766666666689999999999999999999997 799999999999999999999999999987543222 2234457
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.... ..+
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------~~~----------- 215 (325)
T cd05594 158 GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------IRF----------- 215 (325)
T ss_pred CCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC----------CCC-----------
Confidence 89999999998765 48999999999999999999999999887766655553211 011
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
...+++++.+||.+||++||.+|+ ++.++|+||||...
T Consensus 216 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 216 --------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 125788899999999999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=364.50 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=231.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+++|..++++|+|+||.+++++++.+++.|++|.+..........+...+|+.++++++|||||.+.+.|..+ +++++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 4789999999999999999999999999999999998887666667788999999999999999999999874 567999
Q ss_pred EEeeccCCHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHDLAGLAA--SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||+||+|+.+.... +++..|+++.+..|+.||+.|+.|||+++|+|||||+.|||++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999987665443 334689999999999999999999999999999999999999999999999999999997654
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+.+||+.|++||++.+.+ |+.++|||||||++|||++-+++|.+.+......+|.+....|..
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 3467889999999999888755 999999999999999999999999999999999999886644332
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
...+.++..+|..||.++|..||++.++|.+|.+.
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 26788999999999999999999999999998775
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=347.61 Aligned_cols=281 Identities=37% Similarity=0.593 Sum_probs=227.5
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
|++.+.||+|+||.||+|.+..+++.||+|.++......... ...+|+.++.++. |+|++++++++.+.....++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678899999999999999998999999999987543333322 3346888999885 99999999999876446799999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||++++++..+......+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++........ ..
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--cC
Confidence 99999888877766668999999999999999999999999999999999999999 9999999999987643322 23
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
...++..|+|||.+.+...++.++|||||||++|||++|.+||.+.+..+.+..+....+.+..................
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987654557889999999999999999999999999999999998888887765433222111111111
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.......+......++..+.+||.+||++||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111122333345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=352.64 Aligned_cols=290 Identities=48% Similarity=0.859 Sum_probs=236.6
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---- 188 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 188 (410)
...++|++.+.||+|+||.||+|.+..+|+.||+|.++...........+.+|+++++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999999889999999999765433333456778999999999999999999886643
Q ss_pred ----CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 189 ----SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 189 ----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
...+++++||+++++...+......+++..++.++.||+.||+|||+.||+|+||||+||++++++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 2368999999999888877766668999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
...............++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+....|.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 87654432223334568889999988765557889999999999999999999999999889999999988877765554
Q ss_pred hCC-CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 345 KSK-LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 345 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
... .+..............+......+|..+.++|..||+.||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 321 1111111112222223334445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=359.57 Aligned_cols=284 Identities=25% Similarity=0.339 Sum_probs=215.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||.||++++..+|..||+|.+.... .......+.+|+++|+.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 78999999999999999999999999999999987543 344556788999999999999999999998874 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 99999866665555556799999999999999999999986 69999999999999999999999999997664322
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh-hCCCCC---
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK-KSKLPN--- 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~--- 350 (410)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+...........+. ....+.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 24557899999999987654 8999999999999999999999998776654433221111000000000 000000
Q ss_pred ------cccCCCCCchhhhhh----h-----hhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ------ATLFKPREPYKRCIQ----E-----TFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ------~~~~~~~~~~~~~~~----~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+......... . ....+++++++||.+||++||++|||++++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000000000000000 0 0123577899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=352.03 Aligned_cols=282 Identities=40% Similarity=0.752 Sum_probs=227.1
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++++.||.|++|.||+|++..+|+.||||.+............+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4889999999999999999998999999999987654444444568889999999999999999999876 44699999
Q ss_pred eeccCCHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 197 HYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 197 e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||+.+++...... ....+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 9998877765543 345789999999999999999999999999999999999999999999999999986643322 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 354 (410)
....+++.|+|||.+.+...++.++||||||+++|+|+||+.||.+.+....+.++.+..+.+....|.... .+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 334568899999988765557889999999999999999999999999888888888888877765543211 1100000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.+ ...........+.+++++.++|.+||+.||.+|||+.++|.||||
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FP-KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cc-cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 000111222334678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=361.37 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=209.2
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|++..... .....+.+..|.+++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 369999999999999989999999999976432 234455667788888866 799999999998874 4599999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 986665555555689999999999999999999999999999999999999999999999999987643222 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...... .|
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~----------~p---------- 216 (321)
T cd05591 158 GTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL----------YP---------- 216 (321)
T ss_pred cCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------CC----------
Confidence 89999999988764 4899999999999999999999999999888877776542100 00
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-------CHHHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERL-------TATVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------t~~elL~hp~~~~ 404 (410)
..+++++.+||.+||++||.+|| ++.++++||||..
T Consensus 217 ---------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 217 ---------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 14678899999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.34 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=212.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
+|++.+.||+|+||.||+|++..+++.||+|++.+... ..........|..++..+ +|++|+++++++... ..+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 58899999999999999999999999999999986532 223344566788888877 589999999888774 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999876555555555679999999999999999999999999999999999999999999999999997543222 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------------- 220 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---------------- 220 (323)
T ss_pred cccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 3456789999999998764 48999999999999999999999999988887777765421111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
...++.++.+||.+||++||.+|++ ..++++||||..
T Consensus 221 -------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 221 -------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred -------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1257888999999999999999998 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.92 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=209.0
Q ss_pred eeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 121 IDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++.||+|+||.||++++. .+++.||+|+++.... .......+.+|+.+|+.++||||+++++++... ..+|++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEE
Confidence 367999999999999863 4788999999976432 222344567899999999999999999988874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||+.++.+.......+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999876666666666889999999999999999999999999999999999999999999999999875432222 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------------- 217 (323)
T ss_pred cccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 4457899999999987644 88999999999999999999999998887776666644210
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
.....+++++.+||.+||++||++|| ++.++++||||...
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 01125678899999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=345.21 Aligned_cols=283 Identities=34% Similarity=0.617 Sum_probs=225.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++|||++++++++... ...+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEE
Confidence 469999999999999999999988999999999875543333345577899999999999999999998874 468999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++++.........+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887776666899999999999999999999999999999999999999999999999999987754332 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH---hhhCCCCCcc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY---WKKSKLPNAT 352 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~ 352 (410)
....++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..+.+..+...... +....+....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3345788999999987655588999999999999999999999999888887777766555433211 1111100000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
..+..............++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 -SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred -cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=358.50 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=205.8
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|+++.... .....+....|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 223344455677777654 89999999998876 44699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 887666555555689999999999999999999999999999999999999999999999999997653322 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP----------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999987654 89999999999999999999999999888777666543110
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH-HHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA-TVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~elL~hp~~~~ 404 (410)
.....++.++.+||.+||+.||.+||++ .+++.||||..
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 0112567889999999999999999986 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=349.72 Aligned_cols=287 Identities=44% Similarity=0.739 Sum_probs=232.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+..|+++++.++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488899999999999999999889999999999865543 3334456779999999999999999999887 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 9999996666666554444799999999999999999999999999999999999999999999999999987754322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 352 (410)
......+++.|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+.++....+.+....|.... .+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334568889999988765568899999999999999999999999988888888888877777665554321 11111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.... .............+..+.+||.+||++||.+|||+.++|.||||++++.+
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 238 EFKP--FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cccc--cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 1111 01111223345678889999999999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=351.71 Aligned_cols=288 Identities=46% Similarity=0.829 Sum_probs=232.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC------
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 188 (410)
.++|++.+.||+|+||.||+|++..+++.||+|.+..............+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999999999999999998765433333345668999999999999999998875432
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...++++++|+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 33689999999999888777766789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC----------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Q 015247 269 PNHKH----------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 269 ~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
..... ..+...+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 32211 11234668889999988765568899999999999999999999999999999899999888877
Q ss_pred CHHHhhhCC-CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 339 SEEYWKKSK-LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 339 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....|.... .+..............+......+++.+.+||.+||+.||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 665443322 1111110111111222333445677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.69 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=205.8
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+|+.||+|+++.... ..........|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 469999999999999999999999999976432 122344566688888754 899999999998874 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 986665555555689999999999999999999999999999999999999999999999999987542221 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~----------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP----------------------- 213 (316)
T ss_pred CCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------------
Confidence 89999999998765 489999999999999999999999998887766665533110
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH-HHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA-TVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~elL~hp~~~~~ 405 (410)
.....++.++.+||.+||+.||.+||++ +++++||||...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0112467789999999999999999997 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.44 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=213.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++++.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.++..++||||+++++.+.. ...+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975432 33445677889999999999999999998877 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 272 (410)
||||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.+++++|+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999866655555556899999999999999999999999999999999999999999999999999875532110
Q ss_pred --------------------------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCC
Q 015247 273 --------------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 320 (410)
Q Consensus 273 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 320 (410)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCC
Confidence 011245799999999998775 48999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC---CHHHHh
Q 015247 321 GRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL---TATVAL 397 (410)
Q Consensus 321 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~elL 397 (410)
+.+..+....+....... .+|. ...+++++.+||.+|+ .||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~~p~-----------------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETL--------VFPP-----------------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCce--------ecCC-----------------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 988877777665321000 0000 0146788999999987 4999998 489999
Q ss_pred cCCCCCCC
Q 015247 398 NSEVIFQD 405 (410)
Q Consensus 398 ~hp~~~~~ 405 (410)
+||||+..
T Consensus 292 ~hp~f~~~ 299 (360)
T cd05627 292 SHPFFEGV 299 (360)
T ss_pred cCCCCCCC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.12 Aligned_cols=288 Identities=40% Similarity=0.730 Sum_probs=232.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|++|.||+|.+..+|+.||+|.+..........+.+.+|+++++.++||||+++++++... ...|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 679999999999999999999988999999999876544434445677899999999999999999998874 469999
Q ss_pred EeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+++++........ ..+++..+..++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++........
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9999988877664433 34789999999999999999999999999999999999985 56799999999976543221
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 352 (410)
......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+.++....+.+....|.... +++..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 12344678999999988765558899999999999999999999999998888888888888888777665321 22211
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
...+. ..........+.+++.+.++|.+||+.||++||++.++|.||||.+.+.
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 239 SAFPK-WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhccc-CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 11010 0011222334578899999999999999999999999999999997654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=363.75 Aligned_cols=264 Identities=26% Similarity=0.337 Sum_probs=215.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999875332 23334567789999999999999999998876 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999987655544433 36899999999999999999999999999999999999999999999999999877543333
Q ss_pred CCccccccccccccccccCCc---CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+....+.++........ ++
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~~- 269 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------FP- 269 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--------CC-
Confidence 334567999999999986532 378899999999999999999999999888777777654211100 00
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~~ 406 (410)
....++..+.+||..||..+|.+ |++++++++||||++..
T Consensus 270 ----------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 270 ----------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ----------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 01257888999999999844433 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=357.85 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=209.3
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||+||+|++..+++.||+|+++.... .......+.+|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 469999999999999999999999999986532 233455667889999887 799999999998874 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 987666555556689999999999999999999999999999999999999999999999999987532222 2234457
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+.....
T Consensus 158 g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------------- 213 (318)
T ss_pred cCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999987754 89999999999999999999999998887766665543110
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH-----HHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA-----TVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~elL~hp~~~~~ 405 (410)
.....+++.+.+||.+||++||.+|||+ .+++.||||+..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0012567889999999999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=357.35 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=213.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++... ..+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 479999999999999999999999999999999975322 233455678899999999999999999988874 56999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+.++ +...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999775 44444444567999999999999999999999999999999999999999999999999999776543333
Q ss_pred CCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2334578999999999863 23478899999999999999999999998887777666643211000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQD 405 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~ 405 (410)
++.....+++.+.+||++||+.++.+ |+++.++|+||||...
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 01111247888999999999765444 7899999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.92 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=208.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|+.++.||+|+||.||+|++..+++.||||++.... .......+.+|+++++.++|+||+++++++.. ...++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEE
Confidence 3478999999999999999999999999999999986543 33445678899999999999999999999877 44699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||+.++.+.. .....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus 149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 9999999865532 2245788889999999999999999999999999999999999999999999998764322 2
Q ss_pred CCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
......||..|+|||++.. ....+.++|||||||++|||++|+.||......+....+........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 293 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---------- 293 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC----------
Confidence 2345678999999998743 12245689999999999999999999985433222222211110000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
......++.++.+||.+||+.||++|||+.|+|+||||......
T Consensus 294 ---------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 294 ---------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred ---------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 01113577889999999999999999999999999999987544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.57 Aligned_cols=285 Identities=56% Similarity=0.979 Sum_probs=236.8
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+++++.++|+|++++++++........++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67899999999999999999889999999999876433344556778999999999999999999988753467999999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
|+++++...+......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99998888777665689999999999999999999999999999999999999999999999999998775443322344
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC-CCcccCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL-PNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~ 356 (410)
..++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....+.+....|..... .......+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56788999999887655588999999999999999999999999999889999998888877666543321 11222223
Q ss_pred CCchhhhhhhhhCCC-CCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 357 REPYKRCIQETFKDF-PPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.......+.+..... ++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333333444444554 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=355.19 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=223.6
Q ss_pred CCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.+...+.|...++||+||||.||-++...+|+.||+|.+.+..+... ......+|..+|+.++.+.||.+-..|+..+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd- 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD- 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-
Confidence 35567899999999999999999999999999999999876654322 2334667999999999999999977777754
Q ss_pred ceEEEEEeeccCCHHHHhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEV--KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
.+++|+..|+|+.+.+++...+ .|++..++.++.+|+.||.+||+.+||+|||||+|||+|+.|+++|+|+|||..+
T Consensus 259 -~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 259 -ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred -ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 4999999999988887765544 7999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..+.. ....+||.+|||||++.+.. |+...|||||||++|||+.|+.||........-+.+-+.....+.+
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e------ 408 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE------ 408 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh------
Confidence 65544 45669999999999998866 9999999999999999999999998776555444444333222222
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
....+|+++++|.+.+|.+||.+|.. +.++-+||||+.
T Consensus 409 -------------------y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 409 -------------------YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred -------------------cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 12378999999999999999999974 779999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=348.74 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=203.7
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||+|+||+||++.+..+++.||+|.+...... ....+.+..|+++++.++|+||+++.+++... ...+++|||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCCC
Confidence 79999999999999999999999998764432 22345667899999999999999999888774 4599999999876
Q ss_pred HHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccc
Q 015247 203 LAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278 (410)
Q Consensus 203 l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 278 (410)
.+.... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 554332 2345799999999999999999999999999999999999999999999999999987654332 23345
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
.||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.......+.
T Consensus 158 ~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 218 (280)
T cd05608 158 AGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------------------ 218 (280)
T ss_pred CCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC------------------
Confidence 789999999998875 4899999999999999999999999876543322222221111000
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
.....+++.+.+|+.+||+.||++|| |++++++||||+..
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 219 -------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 11135788899999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=345.47 Aligned_cols=284 Identities=36% Similarity=0.666 Sum_probs=225.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+++++.++|+||+++++++.. ....++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 378999999999999999999998899999999987543221 22345679999999999999999999886 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+++...+......+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 999999988877766556889999999999999999999999999999999999999999999999999875432211 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||++.+...++.++||||+|+++|+|++|+.||.+.. ..+.+..+.+.++.+....|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 1233468889999998765558899999999999999999999998766 667778888888887776654432111100
Q ss_pred CCC-CCchhhhhhhhhCCCC--CCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 FKP-REPYKRCIQETFKDFP--PSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 ~~~-~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
... .......+......++ .++.++|.+||+.||++|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0000111222233445 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=343.75 Aligned_cols=282 Identities=37% Similarity=0.697 Sum_probs=229.6
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||.|++|.||+|++..+|..||+|.++..... .....+.+|+++++.++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 489999999999999999999899999999999765432 2244566799999999999999999999874 4589999
Q ss_pred eeccCCHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHDLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||+++++........ ..+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++........ .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 999998877665433 5689999999999999999999999999999999999999999999999999976543222 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23446788999999987755678999999999999999999999999999999999988888887766654331111111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
..............+.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111112233344678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=357.51 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=202.1
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|+++.... .......+.+|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999986543 233455677899999988 799999999998874 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 98665555555568999999999999999999999999999999999999999999999999998753211 12234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--------HH-HHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE--------VE-QLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--------~~-~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... .+ ..+.+... ..
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~---- 222 (329)
T cd05588 158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QI---- 222 (329)
T ss_pred CCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CC----
Confidence 89999999998774 489999999999999999999999963211 11 11111110 00
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC------HHHHhcCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT------ATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~elL~hp~~~~ 404 (410)
.....++..+.+||.+||++||.+|+| +.++++||||..
T Consensus 223 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 223 ---------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 011256788999999999999999987 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.44 Aligned_cols=258 Identities=27% Similarity=0.473 Sum_probs=234.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.-|.+.+.||+|-|++|-+|++..+|..||||++.+..++......+.+|++.|+.++|||||+||++...+ ..+|++
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ--TKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ--TKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--ceEEEE
Confidence 569999999999999999999999999999999999888777777888999999999999999999988774 459999
Q ss_pred EeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|.-++ ++.+++.+....+++..+++|++||+.|+.|+|+..+|||||||+||.+- .-|-|||.|||++-.+.++..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 999987 77888888888999999999999999999999999999999999999875 568999999999988877655
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.++.||+..|-|||+++|..+-.+++||||||||||-|++|++||...++.+.+..|+....+-+
T Consensus 175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-------------- 239 (864)
T KOG4717|consen 175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-------------- 239 (864)
T ss_pred -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--------------
Confidence 57889999999999999977556899999999999999999999999999999999987643332
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..++.+++|||..||..||.+|.+.+++..|+|++..-
T Consensus 240 ---------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 240 ---------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred ---------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 27889999999999999999999999999999998643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=357.42 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=205.6
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||+||+|++..+|+.||+|++..... .......+..|.. +++.++||||+++++.+... ...|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCC
Confidence 469999999999999999999999999976432 1222334445554 45779999999999988774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 98766655555668999999999999999999999999999999999999999999999999998754222 22234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (323)
T cd05575 158 GTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----------------------- 213 (323)
T ss_pred CChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 89999999998764 489999999999999999999999998887777666653210
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~~~ 404 (410)
.....+++.+.+||.+||++||.+||++ .++++||||..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 214 ------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 0112568889999999999999999997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=354.63 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=212.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l 194 (410)
+|+..+.||+|+||.||+|++..+|+.||+|++..... .....+.+..|+.++..+. |++|+++++++... ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 47889999999999999999999999999999976432 2334456777889988885 57788898888774 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999986666565556689999999999999999999999999999999999999999999999999987643222 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----------------- 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----------------- 219 (323)
T ss_pred ccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 3345789999999988764 4899999999999999999999999998887777766542111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQD 405 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~ 405 (410)
....++.++.+|+.+||++||.+|++ ..++++||||..-
T Consensus 220 ------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 220 ------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 11256788999999999999999997 5799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=358.86 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=208.3
Q ss_pred eeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
+.||+|+||.||++++. .+|+.||+|++............+.+|++++++++||||+++++++... ..+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcC
Confidence 67999999999999863 5789999999986544333445567899999999999999999998874 469999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccc
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 278 (410)
++++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9876555555555679999999999999999999999999999999999999999999999999997654322 223456
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
.||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+.+....
T Consensus 159 ~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--------------------- 216 (318)
T cd05582 159 CGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--------------------- 216 (318)
T ss_pred cCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence 789999999988764 4889999999999999999999999988877777666432110
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
....+++.+.+||.+||++||.+||| +.+++.||||..
T Consensus 217 --------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 217 --------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 11256788999999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=357.30 Aligned_cols=284 Identities=30% Similarity=0.529 Sum_probs=226.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 37899999999999999999999999999999998654444444566778999999999999999999886432 23
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..|+||||+.+++...+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999988776643 2899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.. .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+......++....+.++.++........
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CC--CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22 3345678999999998774 48999999999999999999999999999989999999988888765543321110
Q ss_pred cccC-----CCCCchhhh---------hhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 351 ATLF-----KPREPYKRC---------IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.... .....+... ........++.+.+||.+||+.||++|||+.|+|.||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 000000000 00111234667899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=345.80 Aligned_cols=286 Identities=41% Similarity=0.705 Sum_probs=226.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecC---Cce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRM---SCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~~ 191 (410)
++|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++ ||||+++++++.... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765433333456778999999995 699999999886532 234
Q ss_pred EEEEEeeccCCHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccc
Q 015247 192 LYLVFHYMEHDLAGLAASP----EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASF 266 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 266 (410)
.|++|||+++++...+... ...+++..++.++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999999877765432 346899999999999999999999999999999999999998 89999999999986
Q ss_pred cCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
+..... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+.++....+.+....|...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543221 1233456889999998876556889999999999999999999999999999888888888777766554322
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
.........+. .....+....+.+++.+.+||.+||++||.+|||+.++|.||||+
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQ-WKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCc-ccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 11110000000 001112333456889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=353.91 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=205.3
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHh-CCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR-LDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|+++.... ..........|..++.. ++||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999976432 12234455668888876 4899999999998874 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 876655555555679999999999999999999999999999999999999999999999999987543222 1234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+.... + .+
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~--------~~----------- 215 (316)
T cd05619 158 GTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P--------CY----------- 215 (316)
T ss_pred CCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C--------CC-----------
Confidence 89999999998765 48999999999999999999999999888776666553210 0 00
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH-HHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT-VALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-elL~hp~~~~~ 405 (410)
...++.++.+||.+||+.||.+||++. ++++||||...
T Consensus 216 --------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 216 --------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred --------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 024677889999999999999999996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=355.97 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=201.6
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++.++ +||||+++++++... ...|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999986533 334455677898888876 899999999998874 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 987666555555689999999999999999999999999999999999999999999999999987542221 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--------HH-HHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE--------VE-QLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--------~~-~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .. ....+... ..
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~---- 222 (329)
T cd05618 158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QI---- 222 (329)
T ss_pred CCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CC----
Confidence 89999999998765 489999999999999999999999953211 11 11111110 00
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC------HHHHhcCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT------ATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~elL~hp~~~~ 404 (410)
.....++..+.+||.+||++||.+||| ..++++||||.+
T Consensus 223 ---------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 223 ---------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 111356778899999999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=359.01 Aligned_cols=276 Identities=25% Similarity=0.306 Sum_probs=209.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|++++.||+|+||.||+|++..++..||+|+..... ...|+.+++.++||||+++++++... ...++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 57999999999999999999998899999999754321 24589999999999999999998874 458999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||++.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cc
Confidence 9999999988887777789999999999999999999999999999999999999999999999999997543221 22
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCC-CCCC---------hHHHHHHHHHHhCCCCHHHhhh
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM-PGRT---------EVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~---------~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
....||+.|+|||++.+.. ++.++|||||||++|||+++..++ .... ....+..+....+..+..+...
T Consensus 214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 3457899999999987754 899999999999999999865444 3321 1233444444444433222100
Q ss_pred CC--CCCcc---cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 346 SK--LPNAT---LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 346 ~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.. ..... ......++..........++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 00000 0000000111011112367888999999999999999999999999999985
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.90 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=210.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|++.+.||+|+||.||++.+..+++.||+|++....... .....+.+|+.+++.++||||+++++.+..+ ..++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 4889999999999999999998899999999997644322 2234567899999999999999999988774 469999
Q ss_pred EeeccCCHHHHh-cC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGLA-AS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~~-~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++.+... .. ....+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 999987655433 22 334699999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....|++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+........
T Consensus 158 -~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred -cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2345789999999998764 489999999999999999999999998766554444433211110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
......+++.+.+||.+||+.||.+|| +++++++||||.+
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 011135788899999999999999999 9999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.65 Aligned_cols=284 Identities=33% Similarity=0.597 Sum_probs=226.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++.. ....|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46899999999999999999998889999999986554333345567789999999999999999999876 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+||+.++.+..+......+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-cc
Confidence 99999988887766666799999999999999999999999999999999999999999999999999987644332 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC--ccc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN--ATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~ 353 (410)
....++..|+|||++.+...++.++||||||+++|+|++|++||.+....+....+....+.............. ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345678999999998765557889999999999999999999999888888777777665554322110000000 000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
..+............+.++..+.+|+.+||++||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0111111112233445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.75 Aligned_cols=288 Identities=45% Similarity=0.726 Sum_probs=227.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC------
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 188 (410)
.++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 47899999999999999999999999999999998755433333345567999999999999999999876532
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
....++||||+.+++...+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24579999999998888777766689999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCC---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 269 PNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 269 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
..... ......++..|+|||.+.+...++.++||||||+++|+|++|++||.+.+.......+....+..+...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 32221 123346788999999887655578899999999999999999999999988888888888887766554433
Q ss_pred CCCCCc-c-cCCCCCchhhhhhhhh-CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 346 SKLPNA-T-LFKPREPYKRCIQETF-KDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 346 ~~~~~~-~-~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
...... . ...+............ ...++.+.+||.+||+.||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 211100 0 0001111111111111 1235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.05 Aligned_cols=292 Identities=35% Similarity=0.567 Sum_probs=234.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~ 193 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++... ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999976544334456677899999999999999999887643 345689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||+.+++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999999877665543 456999999999999999999999999999999999999999999999999999766432221
Q ss_pred ---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 274 ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 274 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++...+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 12345789999999998765568999999999999999999999999999888999999988888765543321111
Q ss_pred ccc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 351 ATL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 351 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
... ...............+..++++.++|.+||+.||.+|||+.++|.||||.+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000 0000000011223345678999999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=341.07 Aligned_cols=285 Identities=34% Similarity=0.626 Sum_probs=232.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.+|+++++.++|+||+++++++.. ....+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999998899999999987655445556678899999999999999999999987 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++++..+......+++..+..++.||+.||.|||+.+++|+||+|+||++++++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999998887766666799999999999999999999999999999999999999999999999999988765543334
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC-CcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP-NATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~ 354 (410)
....++..|+|||++.+...++.++|+||||+++|+|++|++||.+....+.+..+....+..+...+...... .....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678899999999887646899999999999999999999999998888888888777776665433221110 00000
Q ss_pred C-CCCchhhhhhhhh-CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 K-PREPYKRCIQETF-KDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~-~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
. +............ ..++.++.+||.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 0000011112222 2358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.42 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=212.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.++||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++.+... ..+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 479999999999999999999999999999999865322 223344577899999999999999999988774 46999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+.++ +...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999865 55555444567999999999999999999999999999999999999999999999999999766433333
Q ss_pred CCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+....... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------~-- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------Q-- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc--------c--
Confidence 3344679999999998862 3348899999999999999999999999988877777665321100 0
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQ 404 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~ 404 (410)
.+.....+++++.+||.+||..+|.+ |+++.++++||||..
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 01112357889999999999765544 789999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=386.45 Aligned_cols=263 Identities=27% Similarity=0.347 Sum_probs=227.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|.++++||+|+||.|.+++++.+++.||+|++.+-. +.......|..|..+|..-+.+.|++++..|.+ ..++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceE
Confidence 479999999999999999999999999999999987633 234556678999999999999999999877777 56799
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||+||+||.+-.+.....++|+..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.++.+..-
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999998554444444449999999999999999999999999999999999999999999999999999988877666
Q ss_pred CCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.....+|||.|++||++.. ...|++..||||+||++|||+.|..||+..+-.+++.+|+.-. ....||
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--------~~l~FP 303 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--------ESLSFP 303 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh--------hhcCCC
Confidence 6777899999999999852 2458999999999999999999999999999999999998741 111222
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC---HHHHhcCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT---ATVALNSEVIFQD 405 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~ 405 (410)
+ ...+|+++++||++++. +|..|.. ++++-.||||...
T Consensus 304 ~-----------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 304 D-----------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred c-----------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 1 02589999999999998 6999998 9999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=342.57 Aligned_cols=281 Identities=42% Similarity=0.785 Sum_probs=226.6
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|++.+.||.|++|.||+|.+..+|+.||+|++............+.+|+++++.++|||++++++++... ...|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 6788999999999999999989999999999986654444445677899999999999999999998764 56999999
Q ss_pred eccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 198 YMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 198 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
|+++++...+.... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......... ..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cC
Confidence 99887776654432 47899999999999999999999999999999999999999999999999999766433221 23
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcccCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNATLFK 355 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~ 355 (410)
...+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+....+.++.+..+.+....|.... .++.....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988765557889999999999999999999999998888888888887777765553321 11110000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+ .............++..+.++|.+||+.||.+|||+++++.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 P-KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred c-cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 000111223345788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=358.19 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=205.0
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC---CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL---DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
||+|+||+||+|++..+++.||+|++..... ..........|..++... +||||+++++.+... ..+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 7999999999999999999999999975432 222334455677777665 699999999988774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 886665555556689999999999999999999999999999999999999999999999999987643222 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+..... .++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~~--------- 218 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV----------RFPK--------- 218 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC----------CCCC---------
Confidence 899999999987655689999999999999999999999998887776665543110 0000
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC----CHHHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERL----TATVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~elL~hp~~~~~ 405 (410)
..+++++.+||.+||++||.+|| ++.++++||||...
T Consensus 219 ---------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 219 ---------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ---------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 14678899999999999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=369.41 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=217.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC-----
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----- 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 189 (410)
.++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+.++..++|+|++++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 378999999999999999999999999999999998776666667778899999999999999999887654221
Q ss_pred -ceEEEEEeeccCCHH-HHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 190 -CSLYLVFHYMEHDLA-GLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 190 -~~~~lv~e~~~~~l~-~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
..+++||||+.++.+ ..+. .....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 247899999987544 4332 23457999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 265 SFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 265 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
+.+..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~------ 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD------ 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC------
Confidence 87643222 2234567999999999987744 899999999999999999999999988877766655432110
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....+++++.+||.+||+.||.+|||+.++|+|||++.
T Consensus 264 ----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 ----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 011367888999999999999999999999999999764
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.82 Aligned_cols=284 Identities=38% Similarity=0.625 Sum_probs=221.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+++++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 36899999999999999999999899999999998754322 222346679999999999999999999876 446899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||+.++++..+......+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988888776655678899999999999999999999999999999999999999999999999997653322 12
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCHHHhhhCC-CCCcc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIYKLCGSPSEEYWKKSK-LPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 352 (410)
.....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+ ..+.+.++....+.+....+.... .+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2344578999999998765557889999999999999999999997655 346667777777766655443221 11110
Q ss_pred cCCCCCchhhhhhhhhC--CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 353 LFKPREPYKRCIQETFK--DFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
...........+...+. ..+..+.+|+.+||+.||++|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000111112122 236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=350.37 Aligned_cols=289 Identities=34% Similarity=0.561 Sum_probs=229.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~ 192 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 68999999999999999999999999999999986432 2233455778999999999999999998875432 2458
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+++||+++++...... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99999999988776543 3799999999999999999999999999999999999999999999999999987643222
Q ss_pred C--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 H--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
. ......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+...++.+..+.+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 1 12335679999999987665558899999999999999999999999998888888888888877765544322111
Q ss_pred cc--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 AT--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. ..................+++++.+||.+||+.||.+|||+.++|+||||.+..-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 0000000011112233467899999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=355.13 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=205.3
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||+||+|++..+|+.||+|++..... .......+..|.. +++.++||||+++++.+... ..+|++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCC
Confidence 469999999999999999999999999975432 2223344555554 46778999999999888774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 98766655556668999999999999999999999999999999999999999999999999998754222 12234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----------------------- 213 (325)
T cd05604 158 GTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----------------------- 213 (325)
T ss_pred CChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-----------------------
Confidence 899999999987654 89999999999999999999999998887777666543100
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~~~~ 405 (410)
...+..+..+.++|.+||+.||.+||++ .++++||||...
T Consensus 214 ------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 214 ------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0112567789999999999999999976 599999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=356.10 Aligned_cols=278 Identities=23% Similarity=0.288 Sum_probs=215.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.+|++++.||+|+||.||++... .++..||+|.+.... ...+|+++|+.++||||+++++++... ..++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~ 162 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWK--STVC 162 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence 57999999999999999999753 356789999875421 245699999999999999999988764 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++||++.+++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 163 lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 99999998888766 44568999999999999999999999999999999999999999999999999999876543322
Q ss_pred -CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 -PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.. ....+..+.+.++..+.++.......
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22345789999999988764 48999999999999999999999997754 45667777776665543321110000
Q ss_pred ------C-cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 350 ------N-ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 350 ------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. .....+.......+ ....++.++.+||.+||..||.+|||+.++|.||||++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVI--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHhhcccccCCccccchh--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 00000000000000 0124677899999999999999999999999999999765
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=353.39 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=213.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.++..++|+||+++++++.. ..+.|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999875322 23334557789999999999999999998877 456999
Q ss_pred EEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+.++.+. .+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999875444 44444568999999999999999999999999999999999999999999999999999876544332
Q ss_pred CCccccccccccccccccCC----cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------~-- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--------Q-- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--------c--
Confidence 23345789999999988642 347889999999999999999999999888777766665321100 0
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQ 404 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~ 404 (410)
.+.....+++++.+||.+||+.++.+ |++++++++||||+.
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 01112357889999999999976654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=364.00 Aligned_cols=279 Identities=23% Similarity=0.283 Sum_probs=209.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++|+|||++++++... ...++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 3579999999999999999999999999999996431 2345799999999999999999988774 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH- 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 273 (410)
+|+++.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999999888877766668999999999999999999999999999999999999999999999999999876433222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHhhhC
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-------EVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
......||+.|+|||++.+.. ++.++|||||||++|||++|..++.... ...++.++++..+.....+....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 123457899999999988754 8999999999999999999886553321 12334444443322111100000
Q ss_pred --CCC----CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 347 --KLP----NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 347 --~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+. .....................++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 0000000000000000111246778999999999999999999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.61 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=204.6
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHH-HHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREI-LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|++...... ......+..|. .+++.++||||+++++++... ..+|++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 3699999999999999999999999999754321 12222334444 456788999999999988774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 98766656555668899999999999999999999999999999999999999999999999999754322 22234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05602 158 GTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------------- 213 (325)
T ss_pred CCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------
Confidence 99999999998774 489999999999999999999999999888777766654210
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH----HHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT----VALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----elL~hp~~~~ 404 (410)
.....+++.+.++|.+||++||.+|+++. ++++|+||..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 01136788899999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=350.31 Aligned_cols=284 Identities=24% Similarity=0.335 Sum_probs=212.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEE
Confidence 78999999999999999999999999999999987643 344456788999999999999999999999874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||+.++.+..+....+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 99998765555544555789999999999999999999985 79999999999999999999999999997653221
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH-hCCCCHHHhhhCCCCC---
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL-CGSPSEEYWKKSKLPN--- 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~--- 350 (410)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... .+.+..........+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 2345689999999998764 4889999999999999999999999876654332211100 0011000000000000
Q ss_pred ----cccCCCCCchhhhhh----hh-----hCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ----ATLFKPREPYKRCIQ----ET-----FKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ----~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+......... .. ...+++++.+||.+||++||.+|||+.++|.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000000000000000 00 012566789999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=350.38 Aligned_cols=290 Identities=37% Similarity=0.570 Sum_probs=231.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~ 192 (410)
++|++.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++|+||+++++++.... ....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999999999999999998764433334456678999999999999999999876532 2458
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+++||+++++...+.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 99999999888776554 4579999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+....+.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22344567899999998876445889999999999999999999999999888888888888887776544221111100
Q ss_pred cC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 353 LF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 353 ~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. .....-........+.+++.+.+||.+||+.||.+|||+.++|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00 00000001112234578899999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.74 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=211.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 5689999999999999999999899999999998765432 22345688899999999999999999998874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++++||++++.+.........+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998765554544455789999999999999999999999999999999999999999999999999986643322
Q ss_pred CCC--ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 HPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 211 3456788999999988754 889999999999999999999999877655544433221000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......++..+.+||..||..||.+|||+.++|+||||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01113578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=342.19 Aligned_cols=259 Identities=31% Similarity=0.475 Sum_probs=211.4
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|++.+.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++.. ....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 788999999999999999999999999999998776544444445669999999999999999999988 556899999
Q ss_pred eccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 198 YMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 198 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
|+.+ ++...+. ....+++..+..++.||+.||.+||+.||+|+||||+|||++.++.++|+|||.+.... .......
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999 5555444 55588999999999999999999999999999999999999999999999999997642 2223345
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
...+|..|+|||++.....++.++||||||+++|+|++|..||...........+.+.........+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------------- 223 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------------
Confidence 6678999999999873345899999999999999999999999988544544444443222111110
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......+..+.++|..||+.||++|||+.++++||||
T Consensus 224 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 ---------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001223689999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.57 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=203.0
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999986543 234456678899999888 699999999988774 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 887665555555689999999999999999999999999999999999999999999999999987532211 2234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh------HHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE------VEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+...... .+
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--------------- 219 (327)
T ss_pred CCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC---------------
Confidence 89999999998764 489999999999999999999999964321 1122111110 00
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC------HHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT------ATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~elL~hp~~~~~ 405 (410)
......++..+.++|.+||++||.+|++ ..++++||||..-
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 0111256788999999999999999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=350.80 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=203.0
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|.. +++.++||||+++++++... ...|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 469999999999999999999999999975432 2222334444554 57889999999999888764 4699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 98766555555668999999999999999999999999999999999999999999999999998754222 12234567
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.... .
T Consensus 158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~-------------------- 213 (321)
T cd05603 158 GTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---L-------------------- 213 (321)
T ss_pred CCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---C--------------------
Confidence 89999999998764 48999999999999999999999999988776666554310 0
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~~~ 404 (410)
......+..+.++|.+||++||.+|+++ .++++|+||..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 214 ------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 0112567789999999999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.57 Aligned_cols=286 Identities=39% Similarity=0.627 Sum_probs=222.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcC--CCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDML--TGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
+|++.+.||+|+||.||+|.+.. +++.||+|.+..... .......+.+|+.++..++||||+++++++.......++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999887 899999999976431 122335567899999999999999999999886557799
Q ss_pred EEEeeccCCHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC----CCcEEEEeecccc
Q 015247 194 LVFHYMEHDLAGLAAS----PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD----DGVLKIADFGLAS 265 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~----~~~vkl~DFGla~ 265 (410)
+||||+++++...+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999887765532 2237899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH---------HHHHHHHHH
Q 015247 266 FFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV---------EQLHKIYKL 334 (410)
Q Consensus 266 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---------~~~~~i~~~ 334 (410)
....... .......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.... ..+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 11234567899999998877666889999999999999999999999876543 356677777
Q ss_pred hCCCCHHHhhhC-CCCCccc---CCCCCchh----hhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 335 CGSPSEEYWKKS-KLPNATL---FKPREPYK----RCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 335 ~~~~~~~~~~~~-~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
++.+....|... ..++... ......+. ....+.....+..+.++|.+||+.||++|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 776665444321 1111100 00000000 11112223678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=330.79 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=211.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
.|++.+.||+|++|.||++.+..+++.||+|.+..........+.+.+|+++++.++|+|++++++.+... ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999988999999999976655555566788899999999999999998877543 44689999
Q ss_pred eeccCCHH-HHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHDLA-GLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~l~-~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||++++.+ ..+.. ....+++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 99987544 44433 34568999999999999999999999999999999999999999999999999998764332 22
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+.......+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP----------------- 220 (257)
T ss_pred cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------------
Confidence 34456789999999887654 889999999999999999999999887766555444331100
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=339.48 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=207.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|+|++.+++.+... ...+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 378889999999999999999999999999998765432 22334567899999999999999999888774 469999
Q ss_pred EeeccCCHHH-Hhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAG-LAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~-~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++.+. .+. .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999875444 332 2334689999999999999999999999999999999999999999999999999876543222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||..|+|||++.+.. ++.++|||||||++|+|++|+.||....................
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred -ccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 23457899999999987654 89999999999999999999999987543222111111100000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~ 405 (410)
......+++++.+||..||+.||.+||| +.++++||||++.
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0111357788999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.14 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=212.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..|.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++... ..+|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 4599999999999999999998777 788999977543 233445677899999999999999999999874 56999
Q ss_pred EEeeccCCHHH-Hh---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAG-LA---ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~-~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
||||+.++.+. .+ ......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999875443 32 233457899999999999999999999999999999999999999999999999999876533
Q ss_pred CC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP----------- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 22 123456799999999988764 48999999999999999999999999888777766664421110
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
....+++++.+||.+||.+||.+|||+.++|.|+|++.
T Consensus 291 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 -----------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 01256788999999999999999999999999999863
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=347.86 Aligned_cols=290 Identities=38% Similarity=0.621 Sum_probs=231.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|.+..+|+.+|+|.+............+.+|+.++.++ +||||+++++++........|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3789999999999999999999888999999999865433334445677899999999 999999999998766566789
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.+++....... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999998777665443 7889999999999999999999999999999999999999999999999999876433221
Q ss_pred ----CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 ----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
......+|+.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.+....+....-+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 2234568999999998876566889999999999999999999999999888888888888777665443322111
Q ss_pred Ccc--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 350 NAT--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 350 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... .......-........+.++.++.+||.+||+.||.+|||+.++|+||||++-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000 000000001112233445788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.87 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=215.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++++.||+|+||+||+|++..++..||+|++............+..|+.+|..++|||||+++++|.......+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44789999999999999999999999999999999987666666667788999999999999999999998776667899
Q ss_pred EEEeeccCC-HHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCEEEcC----------
Q 015247 194 LVFHYMEHD-LAGLAAS---PEVKFTEPQVKCYMHQLLSGLEHCHNN-------GVLHRDIKGSNLLIDD---------- 252 (410)
Q Consensus 194 lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-------~ivHrDlkp~NILl~~---------- 252 (410)
+||||+.++ |...+.. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999875 4444332 235799999999999999999999985 4999999999999964
Q ss_pred -------CCcEEEEeeccccccCCCCCCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCCh
Q 015247 253 -------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTE 324 (410)
Q Consensus 253 -------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 324 (410)
.+.+||+|||++..+.... ......||+.|+|||++.+. ..++.++|||||||+||+|++|..||...+.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999998764332 23455789999999988642 3488999999999999999999999987766
Q ss_pred HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 325 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+....... +. + .....+.++.+||..||+.||.+|||+.|+|.||||..
T Consensus 249 ~~qli~~lk~~--p~--------l------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRG--PD--------L------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcC--CC--------C------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 55443333211 00 0 01246788999999999999999999999999999975
Q ss_pred CC
Q 015247 405 DR 406 (410)
Q Consensus 405 ~~ 406 (410)
..
T Consensus 301 i~ 302 (1021)
T PTZ00266 301 VG 302 (1021)
T ss_pred cC
Confidence 43
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=344.64 Aligned_cols=289 Identities=40% Similarity=0.709 Sum_probs=231.1
Q ss_pred CCcce-eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHH------------HHHHHHHHHHHHhCCCCceeeEee
Q 015247 116 DSFEK-IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES------------VKFMAREILILRRLDHPNVIKLEG 182 (410)
Q Consensus 116 ~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~ 182 (410)
++|.. .+.||+|+||+||+|.+..+++.||+|.+......... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56765 46799999999999999899999999998754322100 124668999999999999999999
Q ss_pred eEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
++... ...+++|||+.+++...+.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~--~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEG--DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecC--CcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 98764 46999999999887776643 4579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 015247 263 LASFFDPNH-------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH 329 (410)
Q Consensus 263 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 329 (410)
++....... ........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 997664111 1112234568899999998776557899999999999999999999999999999999
Q ss_pred HHHHHhCCCCHHHhhhCC-CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 330 KIYKLCGSPSEEYWKKSK-LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.+....+.+....|.... .+....... .............+.++.++|.+||+.||.+|||++++|.||||+.++.+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCc--CCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 999988888765544321 111111111 01112233345678889999999999999999999999999999999887
Q ss_pred C
Q 015247 409 C 409 (410)
Q Consensus 409 ~ 409 (410)
|
T Consensus 323 ~ 323 (335)
T PTZ00024 323 C 323 (335)
T ss_pred C
Confidence 6
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.78 Aligned_cols=290 Identities=37% Similarity=0.580 Sum_probs=234.9
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~ 193 (410)
+|++.+.||+|++|.||+|++..+++.||+|.+..........+.+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999999888999999998764433444567888999999999999999999887643 23589
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK- 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 272 (410)
++|+|+++++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999877665544 34899999999999999999999999999999999999999999999999999987754331
Q ss_pred -CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 -HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+.+..+.+........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234456799999999988764689999999999999999999999999999999999999888887665542211111
Q ss_pred cc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. ...............+.++..+.+||.+||++||.+|||+.++|.||||.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00 000111112233344568899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=336.95 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=199.5
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||+|+||.||++++..+|+.||+|.+....... ........|+++++.++||||+++++.+.. ...++++|||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999987543321 223345569999999999999999998876 45699999999875
Q ss_pred HHH-Hhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 203 LAG-LAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 203 l~~-~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
.+. ... .....+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........ .....|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccCC
Confidence 544 332 2334689999999999999999999999999999999999999999999999999987643322 234568
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+........
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------------------- 214 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------------------
Confidence 99999999987755 99999999999999999999999976543222222221110000
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVIFQD 405 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~~~~ 405 (410)
.......+++++.+||.+||++||.+|||+ .+++.||||+..
T Consensus 215 ---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 215 ---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred ---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 000112578889999999999999999999 778899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=328.95 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=220.9
Q ss_pred ccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEE
Q 015247 118 FEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 118 y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv 195 (410)
|++. +.||+|+|+.|--+....+|..||||++.+.. .....++.+|++++.+. .|+||++|+++|+++. .+|+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEE
Confidence 4443 46999999999999999999999999998763 34456788899999998 5999999999999854 59999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeeccccccCCC--
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFDPN-- 270 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~~~-- 270 (410)
||-|.|+.+-.+......|++.++..++.+|+.||.|||.+||.|||+||+|||-.... -+||+||.|..-+...
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999876665666667999999999999999999999999999999999999987655 4899999988654322
Q ss_pred ----CCCCCcccccccccccccccc----CCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---------------hHHH
Q 015247 271 ----HKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRT---------------EVEQ 327 (410)
Q Consensus 271 ----~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---------------~~~~ 327 (410)
......+.+|+..|||||+.. ....|+.+.|.||||||||-|++|.+||.|.. ....
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 122345678999999999864 23458999999999999999999999997753 3446
Q ss_pred HHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 328 LHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 328 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
+..|.+....+++..| ..+|.+.+|||..+|..||.+|.++.++|+|||++.-..
T Consensus 315 FesIQEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 7888877777766555 479999999999999999999999999999999987655
Q ss_pred CC
Q 015247 408 LC 409 (410)
Q Consensus 408 ~~ 409 (410)
.|
T Consensus 370 ek 371 (463)
T KOG0607|consen 370 EK 371 (463)
T ss_pred hc
Confidence 44
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=336.39 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=212.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.|+..+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|+++++.++|+|++.+.+.+... ...+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 3778899999999999999999999999999987654322 2334567899999999999999999888774 469999
Q ss_pred EeeccCCHHHHhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGLAA-S-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~~~-~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++.+.... . ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999986554332 2 23469999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 12345789999999998764 4899999999999999999999999987766555554432211110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQDR 406 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~~ 406 (410)
.....+++.+.+|+..||+.||.+||| +.+++.|+||.+-+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 011357788999999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.57 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=226.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
+..+|..+.+||+|+||+|.++..+.+.+.||||+++++.+ +.+.++....|.++|... +-|.+++++..|+.-+ .
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--R 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--R 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh--h
Confidence 34689999999999999999999999999999999988765 556667677788888766 5788999999888744 4
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||+.|+.+.+..+.-+.|.+..+..++.+|+.||-+||++||++||||.+|||+|.+|++||+|||+++.---.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 9999999999999988888889999999999999999999999999999999999999999999999999999864222
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
...+.+.||||.|+|||++.- .+|+.++||||+||+||||+.|.+||.|.++.+.++.|..-.-..+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP------------ 570 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP------------ 570 (683)
T ss_pred CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc------------
Confidence 233567899999999998764 4599999999999999999999999999999999999987433222
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
+.+|.++.+++...|.+.|.+|.. -.++-.||||+.
T Consensus 571 -----------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 571 -----------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred -----------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 478999999999999999999975 468899999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=334.72 Aligned_cols=282 Identities=42% Similarity=0.742 Sum_probs=231.6
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|+..+.||+|+||.||+|++..+++.||+|.+..........+.+.+|+.+++.++|+|++++++++... ...++++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 5678899999999999999988999999999987643344455677899999999999999999998874 56999999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
|+++++...+......+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999888777766546799999999999999999999999999999999999999999999999999987653322 2233
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPR 357 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (410)
..++..|+|||.+.+...++.++|+|||||++|||++|++||.+.+..+.+.++....+.+....|.....-........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45678899999987664689999999999999999999999999999999999999999888877654322111011111
Q ss_pred CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 358 EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
...........+.++..+.++|..||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111112233345668889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=335.48 Aligned_cols=281 Identities=44% Similarity=0.779 Sum_probs=231.0
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+||+++++++... ...++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 6778899999999999999988999999999876654444456778899999999999999999988774 56999999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
|+++++...+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998888777766789999999999999999999999999999999999999999999999999998775443 12234
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC--CCcccCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL--PNATLFK 355 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~ 355 (410)
..++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+....+.+....|....- .......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 56788999999987764689999999999999999999999999999888888888877776655443221 0000000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+ ...........+.++.++.+||.+||++||.+||++.++|.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 P-KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred c-cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 000111123345678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=328.17 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=213.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++++... ...|++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 48889999999999999999999999999999987665666677888999999999999999999988874 5699999
Q ss_pred eeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||+.++ +...+.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 999874 4444433 245789999999999999999999999999999999999999999999999999987654322 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---------------- 220 (256)
T ss_pred hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 23456789999999887654 8899999999999999999999998888666555553311100
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....++..+.++|.+||+.||++||++.++++|||+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 ------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 011467789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=345.84 Aligned_cols=288 Identities=36% Similarity=0.613 Sum_probs=232.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----c
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 190 (410)
.++|++.+.||+|++|.||+|++..+++.||+|++............+.+|+.+++.++|||++++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 378999999999999999999998999999999987544344445667789999999999999999887755322 3
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..++|+||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998887776654 47999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 2345678899999988664458899999999999999999999999999988999998888877776654433221
Q ss_pred cccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 351 ATLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 351 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
...+ .....-..........+++.+.+||.+||+.||.+|||+.++|+||||.+...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1000 000000011222334578899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=343.38 Aligned_cols=285 Identities=36% Similarity=0.586 Sum_probs=226.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 191 (410)
++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 68999999999999999999998899999999987644333334567789999999999999999998865322 34
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++++++|+...+.... ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 6999999987665543 236899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+++.|+|||.+.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+....++.......
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 23456788999999987655588999999999999999999999999988888888888877776555443221110
Q ss_pred ccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
... .........+....+..+..+.+||.+||+.||.+|||+.++|.||||...+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 00000011122233467888999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=343.45 Aligned_cols=284 Identities=22% Similarity=0.302 Sum_probs=207.4
Q ss_pred eeeeeccC--CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 120 KIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 120 ~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
++++||+| +|++||++++..+|+.||+|.+..........+.+.+|+++++.++||||+++++++..+ ...++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 56789999 778999999999999999999977655555566788899999999999999999999874 45899999
Q ss_pred eccCCHHHHhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---
Q 015247 198 YMEHDLAGLAA-S-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--- 272 (410)
Q Consensus 198 ~~~~~l~~~~~-~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 272 (410)
|++++.+..+. . ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99976554443 2 234689999999999999999999999999999999999999999999999987544321110
Q ss_pred ---CCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC--------CCH
Q 015247 273 ---HPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS--------PSE 340 (410)
Q Consensus 273 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~--------~~~ 340 (410)
.......++..|+|||++.+. ..++.++|||||||++|||++|+.||.................. ++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 011223567789999998753 34889999999999999999999999876655444333221110 000
Q ss_pred HHhhhC-------CCCCcccCC-CC-CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 341 EYWKKS-------KLPNATLFK-PR-EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 341 ~~~~~~-------~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
+..... ......... .. .............+++.+.+||.+||++||++|||+.++|+||||++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000000 000000000 00 000011111223567789999999999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.55 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=212.0
Q ss_pred cCCCccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee--cCC
Q 015247 114 RADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS--RMS 189 (410)
Q Consensus 114 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~ 189 (410)
.+++|++- ++||-|-.|+|..+.++.+|+.+|+|++... ...++|++.--.. .|||||.++++|.+ +..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 35778776 5799999999999999999999999998632 2244577765554 69999999999865 345
Q ss_pred ceEEEEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccc
Q 015247 190 CSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLA 264 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla 264 (410)
..+.+|||.|+|+.+....+ ....|+|.++..+++||..|+.|||+.+|.||||||+|+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 57899999999976655543 3346999999999999999999999999999999999999975 457999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCH
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIYKLCGSPSE 340 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 340 (410)
+.-... ....+.+.||.|+|||++. ...|+...|+||+||++|-|++|.+||+.... ..+-.+|......++.
T Consensus 212 K~t~~~--~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQEP--GDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCCC--ccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 876543 3356788999999999764 45699999999999999999999999988764 3344555544444444
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..| ..+|++++|+|+.+|..+|++|.|+.++++|||+++.+
T Consensus 289 pEW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PEW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 433 57899999999999999999999999999999998754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=335.38 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=214.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 469999999999999999999988999999999875433 23445678889999999999999999999877 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||++++.+.........+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999966544444444468999999999999999999999999999999999999999999999999999876433
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.....+.+.... +
T Consensus 155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK--V---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--c----------------
Confidence 2345689999999988764 48889999999999999999999998887655555554211 0
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~ 406 (410)
.....+++.+.++|.+||..||.+|+ +++++++||||....
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 01124678899999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=340.75 Aligned_cols=265 Identities=27% Similarity=0.432 Sum_probs=214.3
Q ss_pred CCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
+......|+++++||+||.+.||++.. .+.+.||+|++.....+.....-+.+|+..|.+| .|.+||+|++|-.. +
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d 432 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--D 432 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--C
Confidence 334456899999999999999999984 6667888888877667778888999999999999 59999999998766 6
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.++||||||-+.+|...+.+....++.-.++.+..||+.|+.+.|++||||.||||.|+|+ -.|.+||+|||+|..+.+
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 7899999999999999888877777766899999999999999999999999999999998 568999999999998876
Q ss_pred CCCCC-CccccccccccccccccCCc----------CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Q 015247 270 NHKHP-MTSRVVTLWYRPPELLLGAT----------DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 270 ~~~~~-~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
+.... ..+.+||+.||+||.+.... ..++++||||||||||+|+.|++||..-.+ ...++.... .|
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~-~P 588 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAIT-DP 588 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhc-CC
Confidence 65443 23578999999999986321 256899999999999999999999975431 222332222 12
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCC--CCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFP--PSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.. .+.. +.+| .+++++++.||..||.+|||+.++|+|||++--+
T Consensus 589 ~~-----------~Ief-------------p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 589 NH-----------EIEF-------------PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred Cc-----------cccc-------------cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 11 1111 1222 2289999999999999999999999999998533
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.37 Aligned_cols=283 Identities=23% Similarity=0.327 Sum_probs=212.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||++++..++..||+|.+.... .......+.+|++++++++||||+++++++... ..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEE
Confidence 46999999999999999999999999999999986542 344456688899999999999999999999874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+......+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999986665555555689999999999999999999997 599999999999999999999999999987653221
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.... ..+.......... ......+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEA-KESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccc-cCCcccccCCCC
Confidence 2345789999999988764 488999999999999999999999987664332 2222211100000 000000000000
Q ss_pred -CCC-Cc----hhhhhhhhh-----CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 355 -KPR-EP----YKRCIQETF-----KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 355 -~~~-~~----~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.+. .. ......... ..++.++.+||.+||..||++|||+.++|+||||.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 000 00 000000000 125667999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=341.14 Aligned_cols=285 Identities=36% Similarity=0.577 Sum_probs=228.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----c
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 190 (410)
.++|++.+.||+|+||.||++.+..+|..||+|.+............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 478999999999999999999999999999999986544334444567789999999999999999998865432 2
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++||+|+++++...... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4689999997777665543 47899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....+.++.+..+.++..++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2344678899999998764458899999999999999999999999998888888888877776655443322111
Q ss_pred ccc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 ATL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
... ..........+......+++.+.++|.+||+.||.+|||+.++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000 0000000111233345788889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.33 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=208.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999989999999999875432 22345568889999999999999999998877656678
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++++||++++.+.........+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999998755544444445789999999999999999999999999999999999999999999999999976543211
Q ss_pred --CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 --HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~---------- 227 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN---------- 227 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC----------
Confidence 112234578899999998764 488999999999999999999999987655444433321 1100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
+.....+++.+.+|| .||..||.+|||++++|+||||+
T Consensus 228 --------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 --------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 001124567788898 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=344.60 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=197.6
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.++..+ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 7899999999999999999974 2446789999986433 334456688899999999 899999999988754 3
Q ss_pred ceEEEEEeeccCCHHH-HhcCC----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAG-LAASP---------------------------------------------------------- 210 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~~---------------------------------------------------------- 210 (410)
..++++|||++++.+. .+...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999875443 33211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccc
Q 015247 211 ---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRP 286 (410)
Q Consensus 211 ---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~a 286 (410)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 124788899999999999999999999999999999999999999999999999865432221 1223345778999
Q ss_pred cccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhh
Q 015247 287 PELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQ 365 (410)
Q Consensus 287 PE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (410)
||++.+.. ++.++|||||||++|||++ |..||.+....+.+.........+
T Consensus 245 PE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------- 296 (338)
T cd05102 245 PESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--------------------------- 296 (338)
T ss_pred cHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC---------------------------
Confidence 99987644 8999999999999999997 999998866544333322210000
Q ss_pred hhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 366 ETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 366 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 297 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001256778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=331.35 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=206.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|++++.+++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence 36889999999999999999999999999999987653 334455688899999999999999999999874 458999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++....... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 999998766543 257899999999999999999999999999999999999999999999999998664322 2
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ---LHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+|..|+|||++.+.. ++.++|+||||+++|+|++|..||......+. .....+....... +.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~-- 219 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------PV-- 219 (279)
T ss_pred cCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------CC--
Confidence 3457899999999987654 89999999999999999999999975332111 0111111100000 00
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
......++++.+||.+||+.||.+||+++++|+||||.+-
T Consensus 220 -------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 220 -------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0012466789999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.49 Aligned_cols=290 Identities=36% Similarity=0.547 Sum_probs=228.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee--cCCce
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLT--GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS--RMSCS 191 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~ 191 (410)
+|++.+.||+|+||.||++++..+ ++.||+|.+............+.+|+.+++++ +||||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999998877 89999999875433333445677899999999 59999999886543 22345
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|++++|+++++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 889999999887776643 4579999999999999999999999999999999999999999999999999998764332
Q ss_pred CC---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.. ......||+.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+...++.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 21 123457899999999887655689999999999999999999999999999999999999998887655443322
Q ss_pred CCcccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 349 PNATLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 349 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
+..... .....-...........+..+.+||.+||+.||.+|||+.++|.||||.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 211000 00000001112233456788999999999999999999999999999985543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.58 Aligned_cols=260 Identities=26% Similarity=0.378 Sum_probs=212.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+-|++.+.||+|+||.||+|++..++..+++|.+.... ....+.+.+|+++++.++|||++++++++... ...+++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence 34788999999999999999998999999999986432 34456788899999999999999999998774 468999
Q ss_pred EeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+||++++.+... ......+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999998766544 3445679999999999999999999999999999999999999999999999999987653221 22
Q ss_pred CccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+++.|+|||++.. ...++.++|+|||||++|+|++|++||...+..+....+........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL----------- 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-----------
Confidence 234568999999998742 23477899999999999999999999988776666555543211000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++.++.+||.+||++||.+|||+.++++||||....
T Consensus 229 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 229 ---------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ---------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 00124677899999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.41 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=205.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHH-HHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI-LRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||+|.++......... .+..|+.+ ++.++|||++++++++... ...|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEE
Confidence 47999999999999999999999999999999997654433333 34446554 6667999999999998764 45999
Q ss_pred EEeeccCCHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+|||+++++...+. .....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999987755442 3445799999999999999999999997 9999999999999999999999999999876432
Q ss_pred CCCCCccccccccccccccccCC---cCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+.... .+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~------- 226 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SP------- 226 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CC-------
Confidence 2 12335678899999987642 33688999999999999999999999653 2233333332210 00
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..+ ...+|.++.+||.+||..||.+|||+.+++.||||.+...
T Consensus 227 ~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 227 QLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 000 0246788999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=329.83 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=213.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||.|+||.||+|++..+++.||+|.+..... ......+.+|+++++.++|+|++++++++... ...|++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 468999999999999999999999999999999876542 33345678899999999999999999988874 569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+||+.++.+..+.... .+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999886555444433 88999999999999999999999999999999999999999999999999998875432 223
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......
T Consensus 156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------------ 216 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP------------------ 216 (274)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC------------------
Confidence 4456788999999987755 899999999999999999999999877655544443321100
Q ss_pred CCCchhhhhhhhhC-CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 PREPYKRCIQETFK-DFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 ~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.... .++..+.++|.+||..||.+|||++++++||||++..
T Consensus 217 ----------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 217 ----------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ----------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 0001 2678899999999999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=340.82 Aligned_cols=287 Identities=36% Similarity=0.567 Sum_probs=225.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 37899999999999999999999899999999998764433334556778999999999999999999876432 23
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..|++++++++++...... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 4789999988777665443 36899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+....+.......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 2345678999999988765558899999999999999999999999988888888888887776655443221110
Q ss_pred cccC-C-CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 ATLF-K-PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.... . ................++++.+||.+||++||.+|||+.++|.||||.+-..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 0 0000000011122346788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=349.92 Aligned_cols=258 Identities=29% Similarity=0.493 Sum_probs=222.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..|+-++.||.|+||-||-+++..+.+.||||++..+.. ..+.+..+..|+..|++++|||++.+.|+|... ...|+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHH
Confidence 358889999999999999999999999999999987654 456677899999999999999999999998873 44899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||||-|+-.+.+.-..+++-+.++..|..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|....+
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 999999987777766667899999999999999999999999999999999999999999999999999977644
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
..+++|||.|||||+++. -..|+-++||||||++..||.-.++|..+.+....+--|.+.- +|. ++
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPt--------Lq--- 246 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPT--------LQ--- 246 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCC--------CC---
Confidence 467899999999999863 2359999999999999999999999998888776666554421 110 00
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
-...++.+.+|+..||++-|.+|||.+++|.|+|+...+-
T Consensus 247 ---------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 247 ---------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred ---------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 0245778999999999999999999999999999987653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.85 Aligned_cols=286 Identities=37% Similarity=0.602 Sum_probs=220.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS------ 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 189 (410)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 689999999999999999999999999999999876543 335567789999999999999999887655322
Q ss_pred ------ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeec
Q 015247 190 ------CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFG 262 (410)
Q Consensus 190 ------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFG 262 (410)
...|++|||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35799999999877665543 36899999999999999999999999999999999999984 5678999999
Q ss_pred cccccCCCCCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 263 LASFFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 263 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
++..+...... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99766432211 1123457889999998766556889999999999999999999999998888877777665444332
Q ss_pred HHhhhC--CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 341 EYWKKS--KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 341 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...... ..+.. ..................++.++.+||.+||+.||.+|||+.++|.||||+...
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 221110 00000 000001111112333456888999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.97 Aligned_cols=286 Identities=36% Similarity=0.597 Sum_probs=229.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||.|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++... ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 4789999999999999999999999999999999875444444456677899999999999999999988653 335889
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
++||+++++...+.. ..+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 88 VTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred EeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 999998877665543 36889999999999999999999999999999999999999999999999998755322
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+...++.++||||||+++|+|++|++||.+.+.......+.+.++.++.+.+...........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23446788999999887655689999999999999999999999999988888888888888887665543211110000
Q ss_pred --CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 355 --KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 355 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
...........+..+.+++.+.++|.+||+.||++|||+.++|.||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 00000001112333567889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.46 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=212.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||.|+||.||+|.+..++..||+|.+... .....+.+.+|++++++++|||++++++.+..+ ...|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEE
Confidence 6799999999999999999998889999999998754 334456788899999999999999999998874 469999
Q ss_pred EeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+ ......+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 999998655544 44456799999999999999999999999999999999999999999999999999876543222 1
Q ss_pred CccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+++.|+|||.+.. ...++.++|+||||+++|+|++|+.||...+....+.++.... ++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---------- 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PPT---------- 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CCC----------
Confidence 234568999999998752 2347789999999999999999999998877665555443211 000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
. .....++.++.++|..||+.||.+|||+.++|+||||.+.
T Consensus 228 --~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 --L------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --c------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0 0012567789999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.68 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=214.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||.|+||.||++.+..+++.||+|.+..........+.+.+|+++++.++|||++++++++........+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999999987666666677788999999999999999999988766667789999
Q ss_pred eeccCC-HHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 197 HYMEHD-LAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 197 e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH-----~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
||++++ +...+. .....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999875 443332 22467999999999999999999999 889999999999999999999999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+..+.+.....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----------- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----------
Confidence 54332 123456899999999987654 88999999999999999999999998875554444432110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......++..+.+++.+||+.||.+|||+.++|+|||+
T Consensus 228 -----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 -----------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01112567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=331.57 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=210.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|+++++||.|+||.||+|++..+++.|++|.+... .....+.+.+|+.+++.++|||++++++.+... ...++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEE
Confidence 6799999999999999999999999999999998654 344566788899999999999999999988764 469999
Q ss_pred EeeccCCHHHH-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGL-AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+.. .......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 99999876554 34445579999999999999999999999999999999999999999999999999987643221 12
Q ss_pred CccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+......++.... ++ .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----------~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP----------T 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc----------c
Confidence 234567889999998852 2347889999999999999999999998776555444442210 00 0
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
......++.++.+||.+||+.||.+||+++++|+||||..
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 235 --------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred --------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0001256678999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=359.70 Aligned_cols=286 Identities=24% Similarity=0.325 Sum_probs=207.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCC-ceEEEEEEe--------------c-CCCChHHHHHHHHHHHHHHhCCCCcee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVR--------------F-DNLEPESVKFMAREILILRRLDHPNVI 178 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~--------------~-~~~~~~~~~~~~~E~~~l~~l~h~niv 178 (410)
.++|++++.||+|+||+||+|...... ..++.|.+. + ..........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754322 222222110 0 011223345678899999999999999
Q ss_pred eEeeeEeecCCceEEEEEeeccCCHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP----EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 179 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
++++++... ...|++++++.+++...+... ........++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 227 ~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999874 458999999998887765432 22345677889999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC---CChHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG---RTEVEQLHKI 331 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~---~~~~~~~~~i 331 (410)
.+||+|||++..+...........+||+.|+|||++.+. .++.++|||||||++|||++|..++.+ .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999988754443334456899999999998775 489999999999999999998865432 2344555666
Q ss_pred HHHhCCCCHHH-------hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 332 YKLCGSPSEEY-------WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 332 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...++....++ +.... ..............+.. ..++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~--~~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYID--SAEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhh--hhhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 55544332211 10000 00001111111112211 246788999999999999999999999999999987
Q ss_pred CCC
Q 015247 405 DRT 407 (410)
Q Consensus 405 ~~~ 407 (410)
...
T Consensus 460 ~~~ 462 (501)
T PHA03210 460 EEE 462 (501)
T ss_pred CCc
Confidence 544
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.10 Aligned_cols=261 Identities=21% Similarity=0.383 Sum_probs=211.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||.||++++..+|+.||+|.+... ........+.+|+.++++++||||+++++.+.. ....|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4689999999999999999999889999999998754 234445678889999999999999999998877 4569999
Q ss_pred EeeccCCHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 196 FHYMEHDLAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|||++++.+..+... ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999998655544333 3478999999999999999999997 599999999999999999999999999997653222
Q ss_pred CCCCccccccccccccccccCCc-----CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
.....+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+.........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 228 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------ 228 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC------
Confidence 23446788999999875432 3578999999999999999999999876555444433332211110
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.....+++++.+||.+||+.||.+||++.+++.||||...+.
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 229 -------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred -------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 111257888999999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=327.25 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=208.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-------hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-------PESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
+|.+...||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 367788999999999999998889999999998754332 12345678899999999999999999998774
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+.+++|||++++.+..+....+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 46899999998865555555556789999999999999999999999999999999999999999999999999987753
Q ss_pred CCCC-----CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 270 NHKH-----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 270 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
.... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+......++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 229 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-------- 229 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC--------
Confidence 2111 112245788999999887644 88899999999999999999999988766554443322100
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+.....++..+.++|.+||++||.+||++.++++||||
T Consensus 230 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 --------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 01113577889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=327.01 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=212.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||.|+||.||+|....++..+|+|++....... ....+.+|+.+++.++|+|++++++.+.. ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999988899999999987654433 56678899999999999999999998877 4569999
Q ss_pred EeeccCCHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||++.++.+...... ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999987655444322 24689999999999999999999999999999999999999999999999999987754332
Q ss_pred C---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 273 H---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 273 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
. ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.+..... +.. ++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~------~~ 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPS------LE 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---CCC------cC
Confidence 2 22344689999999998765458899999999999999999999998877665555443320 000 00
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
. ......+++.+.+|+.+||+.||.+|||+.++|.||||
T Consensus 229 ~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 229 T--------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred C--------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00023677889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=323.11 Aligned_cols=254 Identities=27% Similarity=0.461 Sum_probs=215.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|+.++.||.|+||.||.+++..+++.+++|.+.....+......+.+|++++++++|+||+++++++.+ ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999998766666666778899999999999999999999987 45699999
Q ss_pred eeccCC-HHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHD-LAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||+.++ +...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999874 44444332 45789999999999999999999999999999999999999999999999999987644332 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+......+
T Consensus 158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---------------- 220 (256)
T ss_pred ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 34557899999999887654 8889999999999999999999998887777666664311000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....++.++.++|.+||++||.+|||+.++|+|||+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.22 Aligned_cols=261 Identities=30% Similarity=0.390 Sum_probs=214.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|++++..++||||+++++.+.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999998899999999998765432 345678889999999999999999998876 456999
Q ss_pred EEeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||+.++ +...+.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999875 4444332 335799999999999999999999999999999999999999999999999999876532211
Q ss_pred C----------------------------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh
Q 015247 273 H----------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 324 (410)
Q Consensus 273 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 324 (410)
. ......||..|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 112346788999999987654 88999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC----HHHHhcCC
Q 015247 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT----ATVALNSE 400 (410)
Q Consensus 325 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~elL~hp 400 (410)
...+..+...... ++. ...+++.+.++|.+||+.||.+||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~----------~~~-----------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVT----------FPG-----------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCcc----------CCC-----------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 7766655431100 000 0136788999999999999999999 99999999
Q ss_pred CCCCCC
Q 015247 401 VIFQDR 406 (410)
Q Consensus 401 ~~~~~~ 406 (410)
||++-+
T Consensus 291 ~~~~~~ 296 (316)
T cd05574 291 FFRGVN 296 (316)
T ss_pred hhhcCC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=327.33 Aligned_cols=280 Identities=38% Similarity=0.663 Sum_probs=220.2
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeEeeeEeecCC---ce
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTSRMS---CS 191 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---~~ 191 (410)
|++.+.||+|+||.||+|++..+++.||+|.++...........+.+|+.+++++ +|+|++++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999988899999999976543333344566788777666 69999999999876432 34
Q ss_pred EEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
++++|||+.+++...+... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998877655443 236899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.. .....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.++......+....|.......
T Consensus 161 ~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 MA--LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cc--cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22 23445788999999987754 8899999999999999999999999999999888888876665543332221100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
...+. ...........+.+++.+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000 000111233334667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.75 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=207.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 589999999999999999999989999999999876532 234457789999999999999999998877 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+....+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999986665555555689999999999999999999999999999999999999999999999999987664322 223
Q ss_pred cccccccccccccccc--CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 276 TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....|++.|+|||++. ....++.++|+|||||++|+|++|..||...........+......++. .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK------------L 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc------------c
Confidence 3457899999999874 2234788999999999999999999999766544433322211000000 0
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
.....++..+.+||.+||..||.+|||++++|.|||
T Consensus 232 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 ------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000145677899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=332.96 Aligned_cols=262 Identities=28% Similarity=0.344 Sum_probs=212.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++||||+++++.+.. ...+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 469999999999999999999999999999999876543 22345567789999999999999999998876 446999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 272 (410)
+|||++++.+..+......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999866655555556799999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 273 ------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 273 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
.......++..|+|||.+.+. .++.++|+|||||++|||++|..||.+.+..+.+..+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011123568889999988764 4899999999999999999999999988776666655432111100
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC---HHHHhcCCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT---ATVALNSEVIFQDR 406 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~~ 406 (410)
....++..+.++|.+||++||.+||| +.++|+||||...+
T Consensus 238 --------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 238 --------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred --------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 00246788999999999999999998 89999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=323.84 Aligned_cols=254 Identities=25% Similarity=0.469 Sum_probs=211.8
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||++++..+|+.||+|.+............+.+|+.+++.++||||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4899999999999999999999999999999998655555556678889999999999999999998876 44699999
Q ss_pred eeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||+.+ .+...... ....+++..+..++.|++.||.|||+.+++|+||+|+|||++.++.++|+|||++........ .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 99987 45444433 334689999999999999999999999999999999999999999999999999987643321 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP----------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----------------
Confidence 22345788999999887654 888999999999999999999999888777666655432110
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....++.++.++|.+||+.||.+||++.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0112567789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=330.23 Aligned_cols=244 Identities=19% Similarity=0.199 Sum_probs=203.0
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEee--cCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTS--RMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv~e~ 198 (410)
..||+|++|.||+|.. +|+.||||.++..... ....+.+.+|+.+|.+++||||+++++++.+ ....+++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999974 7899999999765432 2335678899999999999999999999876 445678999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
+.++.+.........+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99876666655566899999999999999999999985 9999999999999999999999999999865432 234
Q ss_pred ccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 278 RVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
..+|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 5678999999998652 3589999999999999999999999998887777666544221111
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+.+||.+||+.||.+|||+.++|.
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00156788999999999999999999999985
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.71 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=205.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++... ...++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEE
Confidence 689999999999999999999989999999999875432 2344677899999999999999999998774 468999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999866655544456789999999999999999999999999999999999999999999999999987643221 12
Q ss_pred ccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 276 TSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....+++.|+|||.+.+ ...++.++|+|||||++|||++|..||......+....+......++
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 229 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP-------------- 229 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC--------------
Confidence 34567899999998742 23477899999999999999999999976554333222211000000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
. ......++..+.+||++||+.||++|||++++|+|+|
T Consensus 230 ---~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 ---K-------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---C-------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 0001246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=327.95 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=204.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC----Cc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~ 190 (410)
+.|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.++..+ +|+|++++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 679999999999999999999989999999999875432 234577899999998 7999999999987532 24
Q ss_pred eEEEEEeeccCCHHH-HhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 191 SLYLVFHYMEHDLAG-LAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
..|++|||+.++.+. .+.. ....+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 689999999875444 3433 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
... .......|++.|+|||++.+ ...++.++|||||||++|||++|..||...........+... +.
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 233 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA----- 233 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC-----
Confidence 322 22345678999999998853 224788999999999999999999999765544333222110 00
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+ ......++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 234 ----~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 ----P---------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----C---------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 00012467789999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=331.21 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=213.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|||++++++++... ...|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 569999999999999999999888999999999875433 344456788899999999999999999999874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+++..........+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999999888877655567999999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+++.|+|||++.+ ...++.++||||||+++|||++|..||.+.+.......+... .++. .
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~-------~---- 234 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT-------L---- 234 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC-------C----
Confidence 23467889999998752 244888999999999999999999999887765544433211 0000 0
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+..+.++|.+||+.||.+|||+.+++.||||....
T Consensus 235 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 235 --------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 0013567789999999999999999999999999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.96 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=214.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+-|.++.+||+|+||.||++.++.+|+.+|||.+..+ .....+..|+.+|++++.|++|++||.+.... .+|+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEee
Confidence 4589999999999999999999999999999988643 34667888999999999999999999877643 49999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+ ..+.+..+++++++.++..+++..++||+|||...-+|||||..|||++.+|+.||+|||.|-.+.. ....
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK 185 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence 9999964 5555667788999999999999999999999999999999999999999999999999999977642 2233
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
..+..|||.|||||++.... |+.++||||||++..||..|++||........ |+-.-..|+. ..+.|
T Consensus 186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPP----TF~KP----- 252 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPP----TFKKP----- 252 (502)
T ss_pred hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCC----CCCCh-----
Confidence 46788999999999998644 99999999999999999999999987655322 1111111111 00111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
...|+++.|||+.||.++|++|.||.++++|||+++.+-
T Consensus 253 --------------E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 253 --------------EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred --------------HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 145788999999999999999999999999999987653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=351.06 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=220.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.++++..||.|+||+||+|.++.++-..|.|+|... ..+..+.+.-|++||..++||+||+|++.|... ..+++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEE
Confidence 5678999999999999999999988888999998643 456678888899999999999999999988774 449999
Q ss_pred EeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
.|||+|+-.+.. ..-+..+++.++..++.|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 999999876643 45566899999999999999999999999999999999999999999999999999865432 2233
Q ss_pred CccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
..++.|||+|||||+.+. ..+|+.++||||||++|.||..+.+|-...+....+-+|.+.- +.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---PP---------- 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP---------- 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---CC----------
Confidence 467899999999998752 3469999999999999999999999999888888877776531 11
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+..| ...+..+.||+.+||.+||..||++.++|+||||+..+
T Consensus 254 -TLlqP------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 254 -TLLQP------------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -cccCc------------chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 01111 14577899999999999999999999999999998643
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=330.39 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=210.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++.+.. ....++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEe
Confidence 6899999999999999999999899999999998765433 24567789999999999999999999887 4469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||+.++.+..+... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........ ..
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 999987554444332 3689999999999999999999999999999999999999999999999999886543322 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+... +.+..
T Consensus 174 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~--------------- 236 (296)
T cd06654 174 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL--------------- 236 (296)
T ss_pred CcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC---------------
Confidence 345688999999988764 4789999999999999999999999887664443322210 00000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.....++..+.+||.+||.+||.+|||+.++|+||||...+-
T Consensus 237 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred ----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 001256778999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=323.80 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=209.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.+|++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999989999999999865432 23345678889999999999999999998877655678
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+++|||++++.+.........+++..+..++.|++.||.|||+.+++|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999998765554544445789999999999999999999999999999999999999999999999999976542211
Q ss_pred --CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 --HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 112334678899999998764 488999999999999999999999987655544433321 1100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
......++..+.++|.+||. +|.+|||++++++|||+.
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00112456778999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=330.37 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=213.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++|||++++++++.. ...+|++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 679999999999999999999999999999999875433 234567889999999999999999999877 4469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+||+.++.+..+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999998766655443 3689999999999999999999999999999999999999999999999999887654332 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.......+... ..+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~--------------- 235 (296)
T cd06655 173 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL--------------- 235 (296)
T ss_pred CCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc---------------
Confidence 345678999999988764 4889999999999999999999999988776555444321 11000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.....+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 236 ----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 236 ----------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ----------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0112567889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.39 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=208.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+++++.++|+||+++++++... ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 478889999999999999985 6889999999875432 223345688899999999999999999998874 579
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH- 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 271 (410)
++++||+.++.+..+......+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999987666555555678999999999999999999999999999999999999999999999999987653211
Q ss_pred ----CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 272 ----KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 272 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
........++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM--------- 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC---------
Confidence 11123456799999999887644 8899999999999999999999998776555443333211110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+.....++.++.+||.+||++||.+|||+.++|.||||
T Consensus 228 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 -----------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01113577889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=326.05 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=208.5
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC----
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---- 188 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 188 (410)
..++|++.+.||+|++|.||+|.+..+++.|++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34899999999999999999999988899999999875542 345678899999999 7999999999987643
Q ss_pred CceEEEEEeeccCCHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAAS----PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
...++++|||++++.+..+.. .+..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 456899999999854443322 2467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCccccccccccccccccCC----cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
........ ......+++.|+|||++... ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~ 236 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP 236 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC
Confidence 76643222 22345689999999987532 346789999999999999999999998766555444443210 00
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.. .....+++.+.+||.+||..||.+|||+.++++|||+
T Consensus 237 -----------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -----------TL------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----------CC------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00 0011367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=332.18 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=209.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++.. ....|+|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEe
Confidence 6899999999999999999999899999999999765432 24567889999999999999999999887 4469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 999988655544432 3689999999999999999999999999999999999999999999999999987643322 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+.. .+.+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~--------------- 235 (297)
T cd06656 173 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL--------------- 235 (297)
T ss_pred CcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC---------------
Confidence 345678999999988764 488999999999999999999999987655433222211 011100
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.+||.+||..||.+|||+.++|.||||...+
T Consensus 236 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 236 ----------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 00124677789999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=326.15 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=207.5
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC---C
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---S 189 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---~ 189 (410)
..++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++.... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 3578999999999999999999998999999999986532 2234566799999998 8999999999987532 2
Q ss_pred ceEEEEEeeccCCHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 190 CSLYLVFHYMEHDLAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
...++||||++++.+..+. .....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999875544332 244578999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccccccccCCc----CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGAT----DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
........ .....++..|+|||.+.... .++.++|||||||++|+|++|+.||...+....+..+.+.. ..
T Consensus 177 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~- 251 (291)
T cd06639 177 QLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PP- 251 (291)
T ss_pred hccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CC-
Confidence 76433221 23456789999999875432 26789999999999999999999998877655554443210 00
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
. ... ....+..+.+||.+||+.||.+||++.++|+||||+
T Consensus 252 --------~--~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 --------T--LLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------C--CCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 000 013456789999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=343.24 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=227.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
....|.+.+.||+|.|++|.++++..++..||||.+++...+......+.+|+++|..++|||||+++.+...+ ..+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeE
Confidence 34679999999999999999999999999999999999888777777789999999999999999999998874 4599
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.++....+....+...+..++.++.|+..|++|||+++|||||||++||||+.+.++||+|||++..+..+ .
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--c
Confidence 99999998877777777778888999999999999999999999999999999999999999999999999998744 3
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
...+.||++.|.|||++.+....++.+|+||+|+++|-|+.|..||.+.+-.+.-...+....
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~----------------- 272 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY----------------- 272 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-----------------
Confidence 467889999999999999988778999999999999999999999998876554433322110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
....-++-++.+||+++|..+|.+|++++++..|.|....
T Consensus 273 ------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 273 ------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 0112468889999999999999999999999999998753
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.14 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=210.8
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+++++.++|||++++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4889999999999999999999999999999998766555567788899999999999999999998876 45699999
Q ss_pred eeccCC-HHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCCCC
Q 015247 197 HYMEHD-LAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 197 e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 273 (410)
||++++ +.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999875 44444332 34689999999999999999999999999999999999998654 689999999987643322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+......
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred -ccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 23456789999999887644 888999999999999999999999887776665555331110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....++.++.++|..||+.||.+|||+.++|+||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0112578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.93 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=209.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||.|+||.||+|.+..+++.+++|++...... ..+.+.+|+++++.++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 6899999999999999999999888999999999765432 45678889999999999999999998877 4469999
Q ss_pred EeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+. .....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999986665544 3336899999999999999999999999999999999999999999999999999987643221 1
Q ss_pred CccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...+.......+......+..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------------ 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc------------
Confidence 2345678899999988654 24788999999999999999999999887765554443321000000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
. .....++.++.+||.+||..||.+|||+.++|.|+|
T Consensus 226 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 L------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred c------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 001235667899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.92 Aligned_cols=261 Identities=30% Similarity=0.522 Sum_probs=207.7
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--------hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------PESVKFMAREILILRRLDHPNVIKLEGLVTSRM 188 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 188 (410)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... ....+.+.+|+.+++.++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 477889999999999999998889999999998643211 12245677899999999999999999988764
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...++||||+.++.+.........+++..++.++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++....
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 4689999999886655555555689999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-CCccccccccccccccccCCc-CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 269 PNHKH-PMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 269 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
..... ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||......+....+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 22211 123446788999999887543 47889999999999999999999997665544433322110000
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.+ ..+....++..+.+||.+||.+||.+|||++++|+||||
T Consensus 232 ~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 PI---------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cC---------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 011223678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.95 Aligned_cols=280 Identities=36% Similarity=0.637 Sum_probs=224.9
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
|++.+.||+|++|.||+|....+++.|++|.+........ .....+|+..+.+++ |+|++++++++.. ....++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 6788999999999999999888899999999865433222 223456899999998 9999999999877 45699999
Q ss_pred eeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 197 HYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 197 e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||+++++...+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 999888877665543 5789999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||++.+...++.++|+||||+++|+|++|++||+.....+.+.++....+.+....|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34567889999998866555889999999999999999999999999999999999998888876655443211111110
Q ss_pred C-CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 356 P-REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 356 ~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
. .......+.......+..+.+||++||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0000111223333457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.68 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=204.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec----CCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR----MSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 190 (410)
+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +|+|++++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 67999999999999999999999999999999986532 3345577899999998 799999999988542 245
Q ss_pred eEEEEEeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 191 SLYLVFHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
..|++|||++++ +...+.. ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 789999999875 4444432 33468899999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
.... ......|++.|+|||.+.. ...++.++|+|||||++|+|++|..||...........+.... ..
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~---- 244 (282)
T cd06636 173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PP---- 244 (282)
T ss_pred cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---CC----
Confidence 3221 2234568999999998752 2347889999999999999999999997765544333222110 00
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......++.++.+||.+||+.||.+|||+.++|.||||
T Consensus 245 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 --------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00012567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=319.27 Aligned_cols=259 Identities=29% Similarity=0.505 Sum_probs=210.9
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.+|+++++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5889999999999999999988899999999998776555567789999999999999999999998776 45699999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC-
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM- 275 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 275 (410)
||+.++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999876666655556789999999999999999999999999999999999999999999999999987754332211
Q ss_pred --ccccccccccccccccCCc--CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 276 --TSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 276 --~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....+++.|+|||++.+.. .++.++||||||+++|+|++|+.||............... +..+ .+|
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------~~~-- 228 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP-------PIP-- 228 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC-------CCC--
Confidence 1346788999999987543 3788999999999999999999999766433322221111 1100 000
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 229 ---------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 229 ---------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 012457888999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=311.34 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=218.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
..++.+.+..||+|+.|+|++++.+.+|...|||.+.... +.+..++++..+.++... ++|+||+.+|+|..+.. +
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--V 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--H
Confidence 3567888899999999999999999999999999998765 445566777788877766 49999999999998655 8
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++.||.|..-+..++..-.++++|..+-.+...++.||.||-++ +|+|||+||+|||+|+.|++||||||++-.+-...
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 89999998777666666667899999999999999999999965 99999999999999999999999999998775444
Q ss_pred CCCCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
. .+...|-+.|||||.+.- ...|+.++||||||++++||+||..||.+. .+.+.+.++.+.. |+. +
T Consensus 247 A--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP~-------L 315 (391)
T KOG0983|consen 247 A--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PPL-------L 315 (391)
T ss_pred c--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CCC-------C
Confidence 3 355678889999999863 356899999999999999999999999985 4567777776621 110 1
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+ ....+|+++++|+..||.+|+.+||.-.++|+|||+..
T Consensus 316 ~-----------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 316 P-----------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred C-----------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 1 11258999999999999999999999999999999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=335.21 Aligned_cols=266 Identities=25% Similarity=0.318 Sum_probs=195.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.+++|...+.||+|+||.||+|. ..+|..||||++....... ...|.+|+.++.+++|||+|+|+|||.+... ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEE
Confidence 45889999999999999999998 4667999999876554332 3449999999999999999999999998543 589
Q ss_pred EEEeeccCCHHHHh-cCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 194 LVFHYMEHDLAGLA-ASPEV-KFTEPQVKCYMHQLLSGLEHCHNNG---VLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 194 lv~e~~~~~l~~~~-~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
||+|||..+.+..+ ..... .++|..+.+|+.++|.||+|||+.. |+||||||+|||+|+++++||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 99999997555444 44444 8999999999999999999999864 9999999999999999999999999996654
Q ss_pred CCCCCCCccc-cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC--hHH-HHHHHHHHhCCCCHHHhh
Q 015247 269 PNHKHPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT--EVE-QLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 269 ~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~--~~~-~~~~i~~~~~~~~~~~~~ 344 (410)
....+ .... .||.+|+|||++... ..+.++|||||||+|+||+||+.+..... ... ...-............+-
T Consensus 229 ~~~~~-~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 229 EGDTS-VSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred ccccc-eeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 31111 1222 899999999998763 48999999999999999999998877542 111 111111111111111110
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+..+.. ..+... ..-..+..+...|++.+|.+||++.|++.
T Consensus 307 D~~l~~-------~~~~~~------~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKE-------GEYPDE------KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccC-------CCCChH------HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 101000 000000 00012677889999999999999999754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.93 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=207.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+++.|++|.+.... ..+.+.+|+++++.++||||+++++.+... ...|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 68999999999999999999988889999999986432 156788899999999999999999998874 569999
Q ss_pred EeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+||++++.+. .+......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999985554 4444456789999999999999999999999999999999999999999999999999987654321 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+... .. +.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~---------~~---- 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP---------PT---- 218 (256)
T ss_pred cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC---------CC----
Confidence 2344578899999998765 4889999999999999999999999876554433222110 00 00
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 219 ----------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 ----------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00012467789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.64 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=208.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
+|+..+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+. ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeE
Confidence 47888999999999999999999999999999875432 122456788999999999999999999998774 458
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 271 (410)
++++||+.++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999876665555556899999999999999999999999999999999999998776 59999999997764331
Q ss_pred C---CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 K---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
. .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------- 228 (268)
T ss_pred ccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---------
Confidence 1 112234678899999988764 488999999999999999999999976554333333322110000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
.......+++++.+++.+||..||.+|||+.++|+||||+
T Consensus 229 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ---------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0011125678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=323.96 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=210.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999988999999999976543 22456778899999999999999999988876 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+||+.++.+.........+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999886665555545689999999999999999999999999999999999999999999999999998764432 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 3456788999999887644 89999999999999999999999987764 2222221110 0
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH--HHHhcCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA--TVALNSEVI 402 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~elL~hp~~ 402 (410)
.......++..+.++|.+||+.||.+||++ .++++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001112567889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.55 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=206.5
Q ss_pred CCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee---
Q 015247 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS--- 186 (410)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 186 (410)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3445589999999999999999999999999999999876432 1234567799999999 79999999998753
Q ss_pred cCCceEEEEEeeccCCHHHHh----cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 187 RMSCSLYLVFHYMEHDLAGLA----ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
......+++|||++++.+... ......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 234579999999987544432 2344578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Q 015247 263 LASFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 263 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
++....... .......|++.|+|||++.. ...++.++|||||||++|+|++|+.||...+....+..+.... +
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~ 246 (286)
T cd06638 170 VSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--P 246 (286)
T ss_pred ceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--C
Confidence 998764322 12234568999999998753 1337889999999999999999999998766544433221110 0
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+ ... ....++..+.+||.+||+.||.+|||+.++|+|+||
T Consensus 247 ~------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 P------------TLH------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred C------------ccc------------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 000 001356679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=304.86 Aligned_cols=282 Identities=31% Similarity=0.561 Sum_probs=234.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+++|+|.|+.||.|.+..+++.++||+++. -..+.+.+|+.||+.|. ||||++|++++.++.+....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3799999999999999999999999999999999874 34667889999999996 99999999999998888899
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~~~ 272 (410)
+++||++......+-. .++..+++.++.|++.||.|+|+.||+|||+||.|++||.. -.++|+|+|||.++.++..
T Consensus 112 LiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 9999999854443332 67889999999999999999999999999999999999965 4699999999999876554
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCH-HHhhhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM-PGRTEVEQLHKIYKLCGSPSE-EYWKKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~ 350 (410)
.+-.+.+..|--||.+.....|+..-|+|||||++..|++.+.|| .|.++.+++-+|.+.+|+..- .++......-
T Consensus 189 --YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred --eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 344556778899999998888999999999999999999988776 678899999999999997653 3443333221
Q ss_pred c------ccCCCCCchhhhhhhhhCCC-CCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 A------TLFKPREPYKRCIQETFKDF-PPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~------~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. -....+.++.+++......+ +++++||+.++|.+|..+|+||.|++.||||....
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 1 11223445555666655554 59999999999999999999999999999997543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.95 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=202.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.+|++.+.||+|+||.||+|... ..+..||+|.++... .......+.+|+.++..++||||+++++++... ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 57999999999999999999764 346789999987543 334456688899999999999999999998864 459
Q ss_pred EEEEeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||++++.+..+. .....+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999987666443 444579999999999999999999999999999999999999999999999999876543222
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........++..|+|||.+.+. .++.++|||||||++||+++ |..||...+..+.+..+.+....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 228 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------------ 228 (266)
T ss_pred hhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC------------
Confidence 1111223346789999988764 48999999999999999775 999999888777666553321100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....++..+.+++..||+.||.+|||++++++
T Consensus 229 ----------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ----------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=330.29 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=211.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+|++++++.+.. ..+.+++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666778999999999999998899999999986533 3345568889999999999999999998876 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998766655433 368999999999999999999999999999999999999999999999999987654322 222
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...+....+..+.........
T Consensus 176 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 239 (292)
T cd06658 176 KSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK--------------- 239 (292)
T ss_pred ceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc---------------
Confidence 345689999999988664 4889999999999999999999999887766655544332111000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
....++..+.++|.+||..||.+|||++++|+||||...+-
T Consensus 240 -----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 240 -----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred -----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 01246778999999999999999999999999999996554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=325.91 Aligned_cols=281 Identities=25% Similarity=0.406 Sum_probs=222.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC------CceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH------PNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~ 188 (410)
..+|.++..+|+|.||.|-.+.+..++..||||+++.. ....+...-|+++|+++.+ --+|++.++|..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 57899999999999999999999999999999998642 2334445559999999832 246778788877
Q ss_pred CceEEEEEeeccCCHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---------------
Q 015247 189 SCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--------------- 252 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------------- 252 (410)
.++.++|+|.++.++.+.+.. ...+++..+++.++.|++.+++|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 455999999999888887765 5568999999999999999999999999999999999999842
Q ss_pred -----CCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH
Q 015247 253 -----DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 327 (410)
Q Consensus 253 -----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 327 (410)
+..|+|+|||.|+.-.... +..+.|..|+|||++++.. ++.++||||+||||+|+.+|..+|.+.++.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2368999999998764433 5667799999999999865 99999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCHHHhhhC---------CCC--CcccC-------CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC
Q 015247 328 LHKIYKLCGSPSEEYWKKS---------KLP--NATLF-------KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE 389 (410)
Q Consensus 328 ~~~i~~~~~~~~~~~~~~~---------~~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 389 (410)
+..|...+|+.|..+.... ++. +.... .+..+....+. ..+.-...+.|||++||.+||++
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~-~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYML-QDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhc-cCcHHHhHHHHHHHHHHccCccc
Confidence 9999999998887665443 111 11111 11111111100 00111233799999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 015247 390 RLTATVALNSEVIFQDR 406 (410)
Q Consensus 390 Rpt~~elL~hp~~~~~~ 406 (410)
|+|+.|+|.||||+.-+
T Consensus 397 RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 397 RITLREALSHPFFARLT 413 (415)
T ss_pred cccHHHHhcCHHhhcCC
Confidence 99999999999998654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.04 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=207.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l 194 (410)
++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEE
Confidence 5788889999999999999999999999999998765433 34556788999999996 99999999988764 45889
Q ss_pred EEeeccCCHHHHh----cCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLA----ASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~----~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
+|||+..++.... ......+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999987654432 22346799999999999999999999975 999999999999999999999999999976643
Q ss_pred CCCCCCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+.+........
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 230 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------ 230 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc------
Confidence 221 2344678899999998765 3588999999999999999999999976542 222222221111000
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
+ .......++.++.+||.+||++||.+|||+++++.||||...
T Consensus 231 ~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 231 L---------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred C---------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0 001112578889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=318.15 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=209.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++... ..++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 47778999999999999999888999999999876432 234556788999999999999999999988764 4689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+++||+++..+..+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999886555555555578999999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......+++.|+|||.+.....++.++|+||||+++|+|++|+.||...........+......
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 220 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------------- 220 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC----------------
Confidence 2345568899999998865444789999999999999999999999877654444333221000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......+++.+.+|+.+||+.||.+|||+.++|.|||+
T Consensus 221 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 -----------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01112567889999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.37 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=210.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||+||++++..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++... ..+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEE
Confidence 68999999999999999999998899999999987543 234456788899999999999999999998874 569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+....+.+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999987666665555689999999999999999999997 599999999999999999999999999987553221
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-------HHHHHHHhCCCCHHHhhhCC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-------LHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~~~~~~~ 347 (410)
.....++..|+|||++.+. .++.++|+|||||++|+|++|+.||......+. +............ ..
T Consensus 159 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-----PR 232 (284)
T ss_pred cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----CC
Confidence 2345789999999988765 488999999999999999999999987554211 1111110000000 00
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
++ ...++..+.+||.+||++||.+|||+.++++|+||.+...
T Consensus 233 ~~------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 233 LP------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CC------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00 0136678999999999999999999999999999977643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.85 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=195.8
Q ss_pred eeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHH---HhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILIL---RRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
.||+|+||.||++.+..+++.||+|.+........ ......+|..++ ...+|||++.+++.+... ...++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 48999999999999989999999999976543221 122233444333 344799999999888774 458999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccc
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 278 (410)
+.++.+.......+.+++..+..++.|++.||.|||+.+|+||||||+|||+++++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9987666555555689999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
.||+.|+|||.+.+...++.++|+|||||++|+|++|..||...... ..+..... ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~------------------ 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV------------------ 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC------------------
Confidence 68999999998865455889999999999999999999999765322 11111110 00
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
.......+++++.++|.+||+.||.+|| |+.++++||||+.
T Consensus 215 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 215 -------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 0011235788899999999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=319.19 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=205.9
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||.|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+... ..+++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 6999999999999988899999999976543 234456788999999999999999999988764 4599999999876
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccc
Q 015247 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282 (410)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 282 (410)
.+.........+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 665555555579999999999999999999999999999999999999999999999999998775432 123456789
Q ss_pred cccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT--EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 283 ~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
.|+|||.+.+. .++.++|+||||+++|+|++|..||.... ..+...++......+
T Consensus 157 ~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 99999987764 48899999999999999999999998776 444444443211000
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQD 405 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~~ 405 (410)
......++++.++|.+||+.||.+||| ++|+++||||++.
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 001144788999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=338.02 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=219.1
Q ss_pred ccee--eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 118 FEKI--DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 118 y~~~--~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
|++. ++||+|.||+||-|+++.+|+.||||+|.+-.........+++|+.||++++||.||.+...|+..+ .+++|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 5554 6899999999999999999999999999987765555678999999999999999999988888754 49999
Q ss_pred EeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 015247 196 FHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 271 (410)
||-+.|+.+..++ ...+++++...+.++.||+.||.|||-++|+|+||||+|||+... ..+||||||+|+.+++..
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 9999999888765 455789999999999999999999999999999999999999754 379999999999996544
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
...+.+|||.|+|||++.+.. |+..-|+||.|||+|--++|..||.... ++-.+|.+...-.+.
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp----------- 785 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPP----------- 785 (888)
T ss_pred --hhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCC-----------
Confidence 357789999999999998754 9999999999999999999999996543 233344332221221
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.-|+.+++.++|||+.+|+..-++|.|.+..|.|||+++-.
T Consensus 786 --------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 786 --------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred --------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 23458999999999999999999999999999999998643
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.58 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=207.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 368889999999999999999988999999999876543 34456678899999999999999999988774 569999
Q ss_pred EeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||+++ ++...+......+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999996 4554444443689999999999999999999999 9999999999999999999999999999876643222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-----EVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||.... ..+.++.+.. ....
T Consensus 157 --~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-------- 222 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP-------- 222 (265)
T ss_pred --hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC--------
Confidence 126678899999998775 48999999999999999999999997652 2222222211 0000
Q ss_pred CCcccCCCCCchhhhhhhhhC-CCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFK-DFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.... .+++.+.++|.+||..||.+|||+.+++.||||++
T Consensus 223 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 223 -----------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred -----------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0001 26778999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.36 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=213.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.|...+.||+|+||.||+|++..+|+.|++|.+..... .......+.+|+++++.++|||++++++++.+. ...|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEE
Confidence 457778899999999999999989999999999976543 334445678899999999999999999998874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||+.+++...+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 999999988887766666899999999999999999999999999999999999999999999999999864321
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....++..|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.... .+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~------------- 239 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPT------------- 239 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC-------------
Confidence 234568899999998742 2347889999999999999999999998887666655543311 000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.+||.+||++||.+|||+.++|.||||...+
T Consensus 240 -------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 240 -------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00124566789999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=322.35 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=209.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~ 193 (410)
.|++.+.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.++ |||++++++++.. ....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4888999999999999999998999999999987543 2334556778999999986 9999999998876 45689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||+.++.+..+... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 99999988655544433 3789999999999999999999999999999999999999999999999999987754432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......|+..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+... .++ .++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-------~~~---- 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-------RLE---- 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC-------CCC----
Confidence 2334568899999998876555789999999999999999999999876544332221110 000 000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...++.++.++|.+||+.||.+|||+.+++.|+||++..
T Consensus 224 --------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 224 --------------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred --------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 013677899999999999999999999999999998765
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.15 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=211.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|+....||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.++..++|||++++++++.. ....|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEE
Confidence 446667789999999999999988999999999875432 224557789999999999999999998877 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
+||++++.+..+... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999998665544433 468999999999999999999999999999999999999999999999999997654332 222
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||++.+.. ++.++|+|||||++|||++|+.||...+..+.+..+... +..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~--------------- 235 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP--------------- 235 (297)
T ss_pred cceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------------
Confidence 3457899999999987644 889999999999999999999999887766655544221 000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.......+++.+.++|..||+.||.+|||+.++++||||.+...
T Consensus 236 --------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 --------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00111256778999999999999999999999999999997754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=320.67 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=210.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|||++++++++.. ....++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 5666789999999999999988899999999986433 2334567889999999999999999998876 44589999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||+.++.+...... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99987555544433 4789999999999999999999999999999999999999999999999998876543221 223
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
...|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.... .+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~---------------- 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKL---------------- 235 (285)
T ss_pred cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCC----------------
Confidence 456899999999887644 8899999999999999999999998877666655544321 0000
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.....++..+.+||.+||++||.+|||+.++|+||||.+.+.
T Consensus 236 ---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 236 ---------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ---------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 001246788999999999999999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=323.12 Aligned_cols=255 Identities=36% Similarity=0.522 Sum_probs=211.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 469999999999999999999988999999999876433 3344566788999999998 99999999988764 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK- 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 272 (410)
++||++.++.+.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999996654444444445899999999999999999999999999999999999999999999999999987654332
Q ss_pred ------------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 015247 273 ------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 273 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~ 334 (410)
.......++..|+|||.+.+.. ++.++|+||||++++++++|+.||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 1122345689999999887644 888999999999999999999999988866666555431
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCC
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVI 402 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~ 402 (410)
... ....+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 238 ~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYS-----------------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCC-----------------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 111 112567889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.88 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=206.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.......++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468999999999999999999988999999999875432 2445668889999999999999999999877666679999
Q ss_pred EeeccCCHHH-H---hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 196 FHYMEHDLAG-L---AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~l~~-~---~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|||++++.+. . .......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999875443 2 22344578999999999999999999999999999999999999999999999999987653222
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHhhhC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE-----VEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
. ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||..... .+....+.. .... .
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-~---- 227 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNP-E---- 227 (287)
T ss_pred c---ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCch-h----
Confidence 1 2345688899999887644 88999999999999999999999986632 222222111 0000 0
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+.. .......++.+.+||.+||.+||.+|||+.|++.||||++.
T Consensus 228 -~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 228 -LKDE-------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -hccC-------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0000 00001245678999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.04 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=217.4
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
...+||+|+|-+||+|.|..+|..||.-.++.... .+...+++..|+.+|+.|+|||||+++..+.+.....+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35679999999999999999999998776655443 4556688999999999999999999999998877788999999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCCC
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~ 274 (410)
.+..|.+..+..+.+.++...++.|++||++||.|||++ .|+|||||.+||||+. .|.|||+|+|||+......
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--- 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence 999988888888888999999999999999999999999 5999999999999985 5899999999999875443
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
..+..|||.|||||++. ..|+..+||||||++++||+|+..||....+..+ ++++.... .|.
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi--KP~------------- 263 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI--KPA------------- 263 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC--CHH-------------
Confidence 34589999999999987 3599999999999999999999999988766554 45554322 111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.+.+--.+++++||.+||.. .+.|+|+.|+|.||||..+..
T Consensus 264 ------------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 264 ------------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred ------------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 11123368899999999999 999999999999999999744
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=320.62 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=211.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|+.++.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 468899999999999999999988999999999875432 3445678889999999999999999999887 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... .++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999988655544433 4689999999999999999999999999999999999999999999999999977653322 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||++.+.. ++.++|+|||||++|||++|..||...+.......+.... +
T Consensus 159 ~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--P----------------- 218 (277)
T ss_pred ccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--C-----------------
Confidence 3456788999999887644 8899999999999999999999998776554443321100 0
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
+.....++..+.++|.+||+.||.+|||+.++|.||||.+.+.
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 219 ---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 0111245677899999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=317.13 Aligned_cols=254 Identities=26% Similarity=0.478 Sum_probs=207.9
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||+|.+..+|..||+|.+..........+.+.+|+++++.++|+|++++++.+.. ....++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4889999999999999999999999999999997755444445677889999999999999999998876 45699999
Q ss_pred eeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-EEEEeeccccccCCCCCC
Q 015247 197 HYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-LKIADFGLASFFDPNHKH 273 (410)
Q Consensus 197 e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~~~~~~~ 273 (410)
||+.+. +...+.. ....+++..+..++.|++.||.|||+.+++|+||||+||++++++. ++|+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 999874 4444433 2335899999999999999999999999999999999999998864 6999999998765332 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----------------- 219 (257)
T ss_pred cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----------------
Confidence 223346889999999887644 88999999999999999999999987766555544332100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....+.++..+.++|.+||..||++|||+.++++||||
T Consensus 220 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 -----------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00112567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=320.37 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=197.5
Q ss_pred eeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHH-HHHHHHHH---HHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREI---LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
.||+|+||.||++++..+++.||+|.+......... ......|. ..+....||+|+.+++++... ...++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 489999999999999899999999999765432211 11223333 344556899999999888874 469999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccc
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 278 (410)
+.++.+..+......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9987666665566689999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
.|+..|+|||.+.+...++.++||||+||++|+|++|+.||...................
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------- 215 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------------------- 215 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC--------------------
Confidence 789999999998765458899999999999999999999998763322111110000000
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
......++.++.++|.+||..||.+|| ++.++++||||...
T Consensus 216 ------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 216 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 011125688899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=316.38 Aligned_cols=256 Identities=32% Similarity=0.462 Sum_probs=211.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|++|.||+|++..+++.|++|.+...... .....+.+|+.++..++|+|++++++++... ...+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 3689999999999999999999889999999998765432 4456788899999999999999999998874 569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999976555554444689999999999999999999999 99999999999999999999999999999877543322
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... ..+....+... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~------------ 220 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP------------ 220 (264)
T ss_pred ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC------------
Confidence 2345678999999988765 48899999999999999999999998774 23333333211 00
Q ss_pred ccCCCCCchhhhhhhhhCC-CCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKD-FPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...... ++..+.++|..||.++|++|||+.++|+||||++
T Consensus 221 -------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 221 -------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 001123 7788999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=321.98 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=200.8
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+++++.++|||++++++.+... ...|++|||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCC
Confidence 68999999999999999999999998764332 22344566799999999999999999988774 4689999999975
Q ss_pred HHHHhc-CC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 203 LAGLAA-SP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 203 l~~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
.+.... .. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 544333 22 237999999999999999999999999999999999999999999999999998766432 12234567
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
+..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+.......
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------------------- 213 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------------------
Confidence 88999999987655 8899999999999999999999998765432222222211000
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
.......+++.+.++|.+||+.||.+|| ++.++++||||.+-
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 214 ---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 0011135688899999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=322.17 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=203.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 57999999999999999999875554 689999986443 344456788999999999999999999998764 4
Q ss_pred eEEEEEeeccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 191 SLYLVFHYMEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
..+++|||++++ +...+... ...+++..+..++.|++.||.|||+.|++|+||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 589999999875 44433221 14688999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
.++|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976543322 1233445688999999887644 8999999999999999998 999999887776665554
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..... .....+|+++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 31110 0113678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=323.35 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=214.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..|+..+.||+|+||.||++++..++..||+|.+..... ..+....+.+|+++++.++|||++++++++... ...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 458999999999999999999988999999999876533 334455788899999999999999999998874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
+|||+.+++..........+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999999988877766666799999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+......+.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 244 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL------------- 244 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-------------
Confidence 234567889999998742 23478899999999999999999999988776666555544211110
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
....+++.+.+||.+||+.||.+|||+.++++|+|+....
T Consensus 245 --------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 --------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0024567789999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.77 Aligned_cols=254 Identities=32% Similarity=0.514 Sum_probs=213.8
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|++|.||++++..+++.|++|.+..........+.+.+|++++++++|+|++++++++... ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 48889999999999999999988999999999987765556677889999999999999999999988773 5699999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||+++..+.........+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......... ..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99998665555555568999999999999999999999999999999999999999999999999999877544332 23
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
...++..|+|||...+.. ++.++|+||||+++|+|++|..||...+......++.... .
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 216 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--H------------------ 216 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--C------------------
Confidence 456789999999887654 8899999999999999999999998776544444332100 0
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
......+++.+.++|.+||..||++|||+.++|.||||
T Consensus 217 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 --------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00112567889999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.49 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=209.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ........+.+|++++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999886432 123445678889999999999999999999877656678
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++++||+.++.+.......+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999998765544444445689999999999999999999999999999999999999999999999999986542211
Q ss_pred --CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 --HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..........++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC----------
Confidence 1123356789999999887644 88999999999999999999999987665554443321 1110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
+.....+++.+.++|.+||. +|.+|||+.++|.|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01123678889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.32 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=213.4
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||++.+..+++.||+|++............+.+|+++++.++|||++++.+.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 58899999999999999999988999999999987665556677788999999999999999999988774 5699999
Q ss_pred eeccCC-HHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 197 HYMEHD-LAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 197 e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||++++ +...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999874 54444333 3689999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP--------------- 221 (258)
T ss_pred ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC---------------
Confidence 2233457889999999877644 889999999999999999999999887765555544321100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....++..+.++|..||+.||++|||+.++|+||||
T Consensus 222 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0112567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=323.68 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=198.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC----------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML----------------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 179 (410)
++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 689999999999999999997532 34579999987543 3444567889999999999999999
Q ss_pred EeeeEeecCCceEEEEEeeccCCHH-HHhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHDLA-GLAASP------------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLH 240 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 240 (410)
+++++... ...+++|||+.++.+ ..+... ...+++..+..++.||+.||.|||+.||+|
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99998874 358999999987544 333211 124788899999999999999999999999
Q ss_pred ccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc--CCC
Q 015247 241 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKP 317 (410)
Q Consensus 241 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~ 317 (410)
|||||+|||++.++.+||+|||++......... ......++..|+|||++.+. .++.++||||||+++|||++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999866433221 12234457889999988764 48999999999999999986 567
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 318 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
||.+.+..+.+..+........... . ......++..+.+||.+||+.||.+|||+.++.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~---------~------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQV---------Y------------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccc---------c------------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887776666555433211110000 0 001125678899999999999999999999984
Q ss_pred c
Q 015247 398 N 398 (410)
Q Consensus 398 ~ 398 (410)
+
T Consensus 300 ~ 300 (304)
T cd05096 300 A 300 (304)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.53 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=200.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++... ...+++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEE
Confidence 45556678999999999999998899999999886543 33456788999999999999999999998774 569999
Q ss_pred EeeccCCHHH-HhcCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccccCCCC
Q 015247 196 FHYMEHDLAG-LAASPEVKF--TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~l~~-~~~~~~~~~--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~ 271 (410)
+||+.++.+. .+......+ ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999875444 444333445 88999999999999999999999999999999999986 6799999999997664322
Q ss_pred CCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
. ......+++.|+|||++.+. ..++.++|+||||+++|+|++|+.||.................
T Consensus 164 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 228 (268)
T cd06624 164 P-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-------------- 228 (268)
T ss_pred C-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--------------
Confidence 2 12334578999999987543 3478899999999999999999999976443221111000000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
..+.....+++++.+|+.+||+.||.+|||+.+++.||||
T Consensus 229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0001113567789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=334.93 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=197.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+++++.+ +|+|||++++++...
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 689999999999999999998543 34579999997543 233456788899999999 899999999998874
Q ss_pred ceEEEEEeeccCCHHH-HhcC-----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAG-LAAS----------------------------------------------------------- 209 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~----------------------------------------------------------- 209 (410)
..++++|||+.++.+. .+..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 4589999999875433 2211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC-Cccc
Q 015247 210 ----------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP-MTSR 278 (410)
Q Consensus 210 ----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~ 278 (410)
....+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++......... ....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11357889999999999999999999999999999999999999999999999998664332211 1122
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPR 357 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (410)
.++..|+|||++.+. .++.++|||||||++|||++ |+.||........+..+......+.
T Consensus 275 ~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~------------------ 335 (374)
T cd05106 275 RLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS------------------ 335 (374)
T ss_pred CCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc------------------
Confidence 346679999998764 48999999999999999997 9999987665444444333110000
Q ss_pred CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 358 EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++++.++|.+||+.||.+|||+.++++
T Consensus 336 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 ---------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.12 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=200.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+++. .++..+|+|.+...... .+.+.+|+++++.++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEE
Confidence 5799999999999999999985 45668999988654333 34577899999999999999999988774 458999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++ +...+......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999865 554444444578999999999999999999999999999999999999999999999999998654332222
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 2233446689999988764 48899999999999999999 999999888777777664421100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+..+.+|+.+||+.||.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00134667899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.79 Aligned_cols=254 Identities=21% Similarity=0.345 Sum_probs=207.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+++.+...||+|.||+||+|++. | .||||++.....+++..+.|.+|+.++++-+|.||+-+.|++..+. +.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAI 464 (678)
T ss_pred HHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eee
Confidence 367888999999999999999753 3 5999999988888899999999999999999999999999998753 499
Q ss_pred EEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC-CCC
Q 015247 195 VFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP-NHK 272 (410)
Q Consensus 195 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~-~~~ 272 (410)
|+.+|+|+.+. .+......|.....+.|++||++|+.|||.++|||||||..|||+.+++.|||+||||+..-.- ...
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999996555 4445567899999999999999999999999999999999999999999999999999965321 112
Q ss_pred CCCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.......|...|||||++.. ..+|++.+|||||||++|||+||..||...+..+++-.+-+....+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd----------- 613 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD----------- 613 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-----------
Confidence 22344567888999999863 35699999999999999999999999995544444333322211111
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+-....+.+.++++|+..||.++|++||++.++|.
T Consensus 614 -------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 01111367789999999999999999999999886
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.04 Aligned_cols=249 Identities=21% Similarity=0.369 Sum_probs=202.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+++++.++|+||+++++++... ..++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 56899999999999999999998899999999986432 2345678899999999999999999988764 458999
Q ss_pred EeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||++++ +...+.. ....+++..++.++.|++.||+|||+.|++||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999865 4444433 3346899999999999999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------- 223 (263)
T ss_pred ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence 22223346689999988764 48899999999999999998 9999998877665555432110
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+|.++.++|.+||+.||++|||+.++++
T Consensus 224 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0111367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=356.73 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=206.4
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec------
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------ 187 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 187 (410)
-..+|+.+..||+||||.||+++++-+|+.||||+|.... .......+.+|+..|.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4678999999999999999999999999999999998765 566677888999999999999999986422110
Q ss_pred --------------------------------------------------------------------------------
Q 015247 188 -------------------------------------------------------------------------------- 187 (410)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (410)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -------------------------------CCceEEEEEeeccCCHHHHhcCCCCCC-CHHHHHHHHHHHHHHHHHHHH
Q 015247 188 -------------------------------MSCSLYLVFHYMEHDLAGLAASPEVKF-TEPQVKCYMHQLLSGLEHCHN 235 (410)
Q Consensus 188 -------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~qi~~~L~~LH~ 235 (410)
...++||-||||+..++..+...+... ....++++++||+.||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 002378999999999999887776544 578899999999999999999
Q ss_pred CCceeccCCCCCEEEcCCCcEEEEeeccccccC-----------------CCCCCCCccccccccccccccccCCc--CC
Q 015247 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-----------------PNHKHPMTSRVVTLWYRPPELLLGAT--DY 296 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~~ 296 (410)
+|||||||||.||++++++.|||+|||+|+... .......++.+||.-|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998721 11122356779999999999987665 69
Q ss_pred CCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCc
Q 015247 297 GVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSS 375 (410)
Q Consensus 297 ~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (410)
+.|+|+|||||+++||+. ||... .....+.++. ...+|... ..+..--+.-
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR------------~g~iP~~~-------------~f~~~~~~~e 847 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR------------KGSIPEPA-------------DFFDPEHPEE 847 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc------------cCCCCCCc-------------ccccccchHH
Confidence 999999999999999996 45432 2222333332 12222210 0011222445
Q ss_pred HHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 376 LPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 376 ~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
..+|+.||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999997
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.43 Aligned_cols=251 Identities=30% Similarity=0.390 Sum_probs=201.6
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHH-hCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILR-RLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|.+..+|+.||+|.+...... ......+..|..++. ..+|+|++++++++.. ....|+++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999889999999998754432 222333445555444 4589999999999876 44699999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 279 (410)
+++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9876665655556899999999999999999999999999999999999999999999999999876432 22345
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.......+
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 213 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------- 213 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------------------
Confidence 788999999987755 88999999999999999999999988877666555533211000
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC---HHHHhcCCCCCCC
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLT---ATVALNSEVIFQD 405 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~ 405 (410)
......+++.+.++|.+||+.||.+||| +.|+|.||||.+-
T Consensus 214 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 214 -----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 0111257889999999999999999995 5799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=333.90 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|+. ..++..||+|+++.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 6899999999999999999963 34567899999865432 23355688899999999 899999999998774
Q ss_pred ceEEEEEeeccCCH-HHHhcCC----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDL-AGLAASP---------------------------------------------------------- 210 (410)
Q Consensus 190 ~~~~lv~e~~~~~l-~~~~~~~---------------------------------------------------------- 210 (410)
...++||||++++. ...+...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 45899999998753 3333211
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 211 ----------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 211 ----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1257889999999999999999999999999999999999999999999999998764332211
Q ss_pred -CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 -MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....++..|+|||++.+.. ++.++|||||||++|||++ |..||........+.+.......+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-------------- 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------------
Confidence 12233466799999987654 8999999999999999998 899998766544433333210000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......+.++.+||..||+.||.+|||+.++++.
T Consensus 337 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 -------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0012356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=322.59 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=208.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+... ...|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEE
Confidence 468889999999999999999888999999999875432 33456788999999999999999999988774 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+...... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 999998655544433 4789999999999999999999999999999999999999999999999999987643321 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||++.+. .++.++|+|||||++|||++|+.||...........+.... +
T Consensus 159 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--P----------------- 218 (277)
T ss_pred hcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--C-----------------
Confidence 334678899999998765 48899999999999999999999997665544333221100 0
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+.....++..+.++|.+||+.||.+|||+.++|+||||..
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 219 ---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 0011246677999999999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.97 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=210.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+-|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++..++||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 358889999999999999999888999999999865432 2345678889999999999999999999887 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+..... ..
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999998655544433 3689999999999999999999999999999999999999999999999999877643321 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.... +
T Consensus 159 ~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--P----------------- 218 (277)
T ss_pred ccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--C-----------------
Confidence 345678899999988764 47889999999999999999999998766555444432210 0
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+.....++.++.++|.+||+.||.+||++.++++||||.+..
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 219 ---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 001125677899999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=315.07 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=201.8
Q ss_pred cceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----c
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 190 (410)
|++.+.||+|+||.||.|....+ +..||+|.++...........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57789999999999999986543 4789999998765555556778899999999999999999998765322 3
Q ss_pred eEEEEEeeccCCHHHHhc------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 191 SLYLVFHYMEHDLAGLAA------SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
..+++|||+.++.+.... .....+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999875443332 12346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 265 SFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 265 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
+......... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL----- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 8764333221 1223346789999987654 48999999999999999999 89999888776666555331100
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=312.29 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=206.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||.|+||.||++++..+++.||+|.++.... ....+.+.+|+.+++.++|+|++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 58899999999999999999999999999999875432 3345677889999999999999999999877 45699999
Q ss_pred eeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 197 HYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 197 e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||++++ +...... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999874 5444432 345689999999999999999999999999999999999999999999999999976643221 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---------------- 219 (255)
T ss_pred cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 23456889999999887644 8899999999999999999999998877666555443311100
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
....++..+.+||.+||+.||.+|||+.++|+--
T Consensus 220 ------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 220 ------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred ------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 0124567789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=328.90 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=199.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|++++.++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 68999999999999999999743 345789999987543 334455677899999999 899999999987654 3
Q ss_pred ceEEEEEeeccCCHHHHhcCC-----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAGLAASP----------------------------------------------------------- 210 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~----------------------------------------------------------- 210 (410)
..++++|||+.++.+......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 468899999987544433211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC-Ccccccccccccc
Q 015247 211 --EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPP 287 (410)
Q Consensus 211 --~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~y~aP 287 (410)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 1268999999999999999999999999999999999999999999999999998764333221 2233456789999
Q ss_pred ccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhh
Q 015247 288 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQE 366 (410)
Q Consensus 288 E~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (410)
|++.+.. ++.++|||||||++|||++ |..||.+....+.+.........+ .
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~ 296 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------------R 296 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC---------------------------C
Confidence 9887754 8999999999999999998 999998765544443332210000 0
Q ss_pred hhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 367 TFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 367 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....++++.+++.+||+.+|++|||+.++++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=329.01 Aligned_cols=279 Identities=24% Similarity=0.337 Sum_probs=203.4
Q ss_pred eeeccC--CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
..||+| +||+||++++..+|+.||+|++..........+.+.+|+.+++.++||||++++++|... ...+++|||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecc
Confidence 456666 999999999999999999999987655556667888999999999999999999999874 4589999999
Q ss_pred cCCHHH-HhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC---
Q 015247 200 EHDLAG-LAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--- 274 (410)
Q Consensus 200 ~~~l~~-~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--- 274 (410)
.++.+. .+... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 975444 33322 2358999999999999999999999999999999999999999999999998654332111100
Q ss_pred ---CccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 ---MTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+.......+. .....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL---DITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc---cccccch
Confidence 0112345679999998653 34789999999999999999999999887766555444332111110 0000000
Q ss_pred c--c-----------cCCC--------CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 A--T-----------LFKP--------REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~--~-----------~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
. . .... ..............+++.+.+||.+||+.||.+|||++++|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0 0 0000 0000000111123456779999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.28 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=212.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..|+..+.||+|+||.||+|++..+++.+|+|.+..... .......+.+|+++++.++|+|++++++++... ...++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 568889999999999999999988999999999875432 334455677899999999999999999998874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+++..........+++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 9999998887776655667899999999999999999999999999999999999999999999999998766432
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+..... +.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------------- 233 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------------- 233 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC-------------
Confidence 23467889999998752 23478899999999999999999999987665554443332110 00
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.+||.+||+++|.+|||+.+++.|||+....
T Consensus 234 -------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 234 -------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred -------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 00125677899999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.03 Aligned_cols=253 Identities=18% Similarity=0.266 Sum_probs=199.1
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
|.+.+.||+|+||.||+|++..++. .||+|.++.........+.+.+|+.+++.++|+||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999876665 689999876555556667788899999999999999999876432 1235
Q ss_pred EEEEEeeccCCHH-HHhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 192 LYLVFHYMEHDLA-GLAA-----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 192 ~~lv~e~~~~~l~-~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.+++|||+.++.+ ..+. .....+++..+..++.||+.||+|||+++|+||||||+|||+++++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999986543 3321 223458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 266 FFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 266 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
......... .....+++.|+|||.+.+. .++.++||||||+++|||++ |..||.+....+....+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL------ 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 764332211 1223457789999988764 48999999999999999999 89999887766555544321000
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0012567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.19 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=194.3
Q ss_pred CCcceeeee--ccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKI--GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
+.|++.+.+ |+|+||.||++++..++..+|+|.+........ |+.....+ +|||++++++.+... ...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~--~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTL--KGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecC--Cee
Confidence 456676666 999999999999999999999999875432211 22222222 799999999998874 369
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 271 (410)
++||||++++.+..+......+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998754444444445899999999999999999999999999999999999999998 9999999999766432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
....++..|+|||++.+.. ++.++||||||+++|+|++|..||........ ...+.... ...
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------- 226 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK----------- 226 (267)
T ss_pred ----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-----------
Confidence 2345788999999987644 88999999999999999999999986544332 11121111 000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-HHHHhcCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-ATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~elL~hp~~~~ 404 (410)
....+.+++.+.+||.+||++||.+||+ .+++|+||||..
T Consensus 227 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 --------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred --------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0111367889999999999999999996 599999999974
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.90 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=201.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+... ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEE
Confidence 37899999999999999999985 566789999876433 2345688899999999999999999888764 45899
Q ss_pred EEeeccC-CHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||+.+ ++...+. .....+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999976 4544443 2345789999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2223334577899999887644 8889999999999999998 99999988776666655432110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++.++.+++.+||+.||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011256788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.17 Aligned_cols=274 Identities=23% Similarity=0.286 Sum_probs=199.8
Q ss_pred CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHh
Q 015247 128 TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA 207 (410)
Q Consensus 128 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~ 207 (410)
++|.||++++..+++.||+|++..........+.+.+|+++++.++|+||+++++++... ...+++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHHHH
Confidence 445666666677999999999987655556677899999999999999999999988774 458999999997655444
Q ss_pred cC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC------CCCcccc
Q 015247 208 AS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK------HPMTSRV 279 (410)
Q Consensus 208 ~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~------~~~~~~~ 279 (410)
.. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||.+........ .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 32 234689999999999999999999999999999999999999999999999998875532211 1122345
Q ss_pred ccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC---
Q 015247 280 VTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK--- 355 (410)
Q Consensus 280 gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--- 355 (410)
++..|+|||++.+. ..++.++|+|||||++|||++|..||........+..... +..+. .+.....+......
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcc
Confidence 67889999988653 3488899999999999999999999987765544322222 11110 00001111000000
Q ss_pred -----CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 -----PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 -----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...............++.++.+||..||+.||.+|||++++|+||||++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000011111224566789999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=333.97 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=206.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
..+.|.+...+|.|+|+.|-.+.+..+++.+++|++.....+ ..+|+.++... +|||++++++.+.+ ....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecC--Ccee
Confidence 467899999999999999999999999999999999765211 22366666555 79999999999888 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE-cCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI-DDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl-~~~~~vkl~DFGla~~~~~~~ 271 (410)
|+|||.+.++.+.........+. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999976655544443444 7888899999999999999999999999999999 69999999999999887544
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
..+.+.|..|.|||++.. ..|+.++||||||++||+|++|+.||....... .|+..++.+...
T Consensus 470 ---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s---------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFS---------- 532 (612)
T ss_pred ---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCccc----------
Confidence 345577999999998875 559999999999999999999999998876662 233322222210
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..+|+.++|||+.||+.||.+|+++.+++.||||.+.++
T Consensus 533 -----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 533 -----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred -----------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 378999999999999999999999999999999955543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.12 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=209.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++... ...|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEE
Confidence 378999999999999999999988899999999986443 22345678899999999999999999998874 45899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|+||+.++.+..+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999988655544433 2588999999999999999999999999999999999999999999999999876654332 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+... +.+. .
T Consensus 172 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~--------------~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------L 235 (293)
T ss_pred cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC--------------C
Confidence 2344688899999988764 4889999999999999999999999877655443322110 0000 0
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.++|..||+.||.+||++.+++.|+||+..+
T Consensus 236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 236 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 00124567799999999999999999999999999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.13 Aligned_cols=251 Identities=32% Similarity=0.437 Sum_probs=205.5
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||+|+||.||++++..+|+.|++|.+..... .....+.+.+|+++++.++||||+++++.+.. ....|+++||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999988899999999876543 23445678889999999999999999988876 45699999999875
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-------CCC
Q 015247 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-------HPM 275 (410)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-------~~~ 275 (410)
.+..+......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 5554444444899999999999999999999999999999999999999999999999999876543211 122
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+......++.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--------------- 222 (265)
T ss_pred cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc---------------
Confidence 3456788999999887654 888999999999999999999999888877666555431100000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH---HHHhcCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA---TVALNSEVIFQ 404 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~elL~hp~~~~ 404 (410)
...+++.+.+||.+||+.||.+|||+ .++|+||||+.
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 223 ------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 01257889999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=313.00 Aligned_cols=253 Identities=31% Similarity=0.467 Sum_probs=202.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ........+.+|+++++.++|||++++++++... ...++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 57999999999999999999998999999999887543 2445556788899999999999999999998874 46899
Q ss_pred EEeeccCCHHHH-h---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAGL-A---ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~~-~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
++||++++.+.. . ......+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999754432 2 223456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ......+ ...+.++.
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-------- 228 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL-------- 228 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC--------
Confidence 21 123346788999999887644 88999999999999999999999976542 2222222 11111110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+..+.++|.+||+.||.+|||+.++|+.
T Consensus 229 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 ------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.96 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=210.1
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|+...+||+|+||.||++....+++.||+|.+.... ......+.+|+.+++.++|+|++++++.+.. ....+++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444578999999999999998999999999885432 2345568889999999999999999999887 456999999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
|++++.+..+... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9998766655433 368999999999999999999999999999999999999999999999999987654322 12234
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPR 357 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (410)
..+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+........
T Consensus 176 ~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------------ 236 (292)
T cd06657 176 LVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL------------------ 236 (292)
T ss_pred cccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc------------------
Confidence 5678999999987654 478999999999999999999999988776655554432111000
Q ss_pred CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 358 EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.....++..+.++|.+||+.||.+||++.++|.||||.....+
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 237 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred --------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence 0112467788999999999999999999999999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=308.28 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=211.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999988999999999987655456677888999999999999999999988875336799999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CC
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PM 275 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 275 (410)
||+++..+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99976555544444448999999999999999999999999999999999999999999999999999887544321 12
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ..+.......
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~----------------- 220 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSSG----------------- 220 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccccC-----------------
Confidence 3456788999999887644 8899999999999999999999998776221 1111111000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.........+..+.+||.+||+.||.+|||+.++|.||||
T Consensus 221 -------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 -------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0001112558889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.21 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=199.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.+|++.+.||+|+||.||+|++..++.. ||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 6799999999999999999987666654 8999986432 334456688899999999999999999988763 3
Q ss_pred EEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++++|+.++ +.+.+......+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 67899998864 55555555567899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+.. .+.......
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---------- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL---------- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC----------
Confidence 3221 1223346789999988764 48999999999999999997 99999877655433 332211000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+ ....++.++.+++.+||..||.+|||+.+++.+
T Consensus 231 ~-----------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 P-----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred C-----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 012456778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=310.89 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=209.9
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|++.+.||+|+||.||++++..+++.+|+|.+............+.+|+.+++.++|+||+++++++... ...++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 48899999999999999999989999999999987665555566778899999999999999999988774 5699999
Q ss_pred eeccCCHHH-HhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 197 HYMEHDLAG-LAAS---PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 197 e~~~~~l~~-~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||+++..+. .+.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999875443 3322 2357899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+..... +
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~--- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------------P--- 219 (256)
T ss_pred -CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------C---
Confidence 22345678999999998764 488899999999999999999999988876655444432110 0
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....++.++.++|.+||+.||.+|||+.++|+||++
T Consensus 220 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0112467789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=311.44 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=200.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|+.. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEE
Confidence 57999999999999999999753 4556999988754432 34578899999999999999999998764 458999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||+.++ +...+......+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999875 444444444478999999999999999999999999999999999999999999999999988664332221
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.+....+.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-------------- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC--------------
Confidence 22234567799999887644 8899999999999999998 9999988777666665543211100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.+.+++.+||+.||.+|||+.+++.+
T Consensus 223 --------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 --------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 01356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.12 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=229.9
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
....+++++..||-||||.|-+++.......+|+|++++..+ +..+.+.+..|.++|...+.|.||++|..|.+ ..+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chh
Confidence 345788899999999999999998655555699999987654 55667788899999999999999999887776 678
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+.||.|-|+.+.......+.|.+..++.++..+++|++|||++|||+|||||+|.|++.+|-+||.|||+|+.++.+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999887777777777899999999999999999999999999999999999999999999999999999997665
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
. +.++||||.|+|||++++.. .+.++|.||||+++|||++|.+||.+.+...++..|++.+.
T Consensus 575 K--TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------------- 636 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------------- 636 (732)
T ss_pred c--eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------
Confidence 5 67899999999999998754 89999999999999999999999999999999999988642
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
..+.++.++....+||+++...+|.+|.. +.++-.|-||..
T Consensus 637 ------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 637 ------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 11223478899999999999999999986 899999999964
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=316.53 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=203.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|.+.+.||+|+||.||+|.+. .++..||+|.++... ..+....+.+|+++++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence 67999999999999999999864 345789999986543 333456788999999999999999999998874 5
Q ss_pred eEEEEEeeccCCHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcE
Q 015247 191 SLYLVFHYMEHDLAGLAAS--------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 256 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 256 (410)
..+++|||+.++.+..+.. ....+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 6999999998755443322 12458899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 015247 257 KIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 257 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~ 334 (410)
+|+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976533221 1123344578899999987754 8999999999999999998 99999888777666555421
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
... .....++..+.++|.+||+.||.+|||+.|+++
T Consensus 241 ~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLL----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 110 011256788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.59 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=207.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|.+..+++.||+|.++...... ....+.+|+.++... +||||+++++++... ...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC--CeE
Confidence 3478999999999999999999988889999999997654332 234455677766666 599999999998874 459
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|++|||+++.+..........+++..+..++.||+.||+|||+ .||+||||+|+||++++++.++|+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999987777666655689999999999999999999997 599999999999999999999999999997664322
Q ss_pred CCCCccccccccccccccccCC---cCCCCccchHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHHHhhhCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGRTE-VEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
. .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+..+.... .. .
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~------~ 238 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---PP------S 238 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC---CC------C
Confidence 2 2334578899999998653 2378899999999999999999999976433 23333332210 00 0
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+ ....++.++.+||.+||+.||.+|||+++++.||||+...
T Consensus 239 ~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 239 LP-----------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CC-----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00 0014677899999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.06 Aligned_cols=252 Identities=33% Similarity=0.543 Sum_probs=207.7
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
+|+..+.||+|++|.||++.+..+++.+++|++..... .....+.+|+++++.++|+|++++++.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 47889999999999999999888999999999876543 3456788899999999999999999998774 4589999
Q ss_pred eeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 197 HYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||+++. +...+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999964 4444444446899999999999999999999999999999999999999999999999999987754432 3
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.... .+. .+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--------~~~----- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPG--------LRN----- 219 (253)
T ss_pred cceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCC--------cCc-----
Confidence 4557789999999887654 8899999999999999999999998876554444332210 000 000
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
...++..+.++|.+||+.||++|||+.++|.|||
T Consensus 220 ------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 ------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0124778999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=309.45 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=194.6
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+++++.++||||+++++++... ...++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence 3699999999999999889999999987643 3344556788899999999999999999998774 458999999987
Q ss_pred CHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC-cccc
Q 015247 202 DLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRV 279 (410)
Q Consensus 202 ~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 279 (410)
+.+. .+......+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 5444 4444455789999999999999999999999999999999999999999999999999876543211111 1112
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
.+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+......
T Consensus 158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 245799999887654 8899999999999999997 88899776665544433321100
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.+|+.+||++||.+|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=311.27 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=199.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+++++.++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 46899999999999999999864 5678999998654432 23467799999999999999999988764 468999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++ +.+.+......+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999775 555554445578999999999999999999999999999999999999999999999999997654322211
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 12222345799999887644 8899999999999999999 89999887776665554321100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......+..+.+++.+||+.+|++|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0112567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=311.08 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=202.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||.||+|++..+ ...||+|.++... .......+.+|+.++..++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cce
Confidence 6799999999999999999987544 4579999886543 334455678899999999999999999988764 458
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++|||+.++ +...+....+.+++..+..++.|++.||.|||+.+|+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999875 444444445589999999999999999999999999999999999999999999999999998875222
Q ss_pred CC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 KH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.+....+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 229 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---------- 229 (266)
T ss_pred cceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 11 11122346789999988764 48999999999999999998 9999987776666555543211110
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.+.+|+..||+.||++||++.+++++
T Consensus 230 ------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 ------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=316.51 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=200.4
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|.+.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|++++.+++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 6799999999999999999975 234567999988643 23445678889999999999999999999876 45
Q ss_pred eEEEEEeeccCCHHH-HhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 015247 191 SLYLVFHYMEHDLAG-LAASP------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 257 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vk 257 (410)
..+++|||+.++.+. .+... ...+++..+..++.|++.||+|||++|++||||||+|||+++++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 699999999875444 33211 13589999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Q 015247 258 IADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLC 335 (410)
Q Consensus 258 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~ 335 (410)
|+|||++......... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999866432211 12233457789999988764 48999999999999999998 999998888777666654321
Q ss_pred CCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.. .....++.++.+|+.+||++||.+|||+.++++
T Consensus 240 ~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 011256778999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=309.52 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=199.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+ .+++.||+|.++..... .+.+.+|+.++++++||||+++++++... ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence 6799999999999999999985 45678999998754432 34577899999999999999999988774 458999
Q ss_pred EeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.+ ++...+... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999965 555554333 347899999999999999999999999999999999999999999999999999877533222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.......+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+....+..+.+....+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-------------- 224 (261)
T ss_pred ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 12222234579999988764 48999999999999999999 999999887776666554321100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+..+.+++.+||+.||.+||++.++++
T Consensus 225 --------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 --------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=316.35 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=207.0
Q ss_pred CcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
+|++.+.||.|+||.||+|++. .+|..||+|++..... .....+.+.+|+.++..+ +|+||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4889999999999999999864 4789999999875432 122345677899999999 599999999888764 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..|++|||++++.+.........+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 68999999998655544444567899999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.........|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 228 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------- 228 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC----------
Confidence 33333455689999999988643 2367899999999999999999999975433322222222110000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQDR 406 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~ 406 (410)
....+.+++.+.+|+.+||+.||.+|| ++++++.||||++..
T Consensus 229 ---------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 229 ---------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ---------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 001124677889999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=314.45 Aligned_cols=252 Identities=20% Similarity=0.349 Sum_probs=200.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+++++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 67999999999999999999853 456789999986433 334456788899999999999999999988774 45
Q ss_pred EEEEEeeccCCHH-HHhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 192 LYLVFHYMEHDLA-GLAASP----------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 192 ~~lv~e~~~~~l~-~~~~~~----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
.|++|||+.++.+ ..+... ...+++..+..++.||+.||.|||++|++||||||+|||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 8999999987544 333211 23478999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987643321 1123344577899999887644 8999999999999999998 999998877655544443
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
... .+ .....+++.+.+++..||++||.+||++.+++++
T Consensus 241 ~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 211 00 0112567889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.58 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=196.9
Q ss_pred eeccCCCeeEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 123 KIGQGTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+||+|+||.||+|.. ..++..+|+|+++.........+.+.+|+.+++.++||||+++++++.. ...+++|||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4567899999987655555566778899999999999999999998754 24789999999
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC--Cccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSR 278 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~~~ 278 (410)
++.+..+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 76555454455679999999999999999999999999999999999999999999999999998764333211 1122
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPR 357 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (410)
.++..|+|||.+.+. .++.++|+|||||++|||++ |..||...+..+....+.+... +
T Consensus 159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 345789999987654 48889999999999999998 9999988777666555533110 0
Q ss_pred CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 358 EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++++.+||..||++||.+||++.++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011257888999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.35 Aligned_cols=257 Identities=31% Similarity=0.533 Sum_probs=210.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.+.|+..+.||+|+||.||+|.+..++..|++|++..... ....+.+|+++++.++|+|++++++.+... ...|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 3679999999999999999999888899999999976543 355677899999999999999999998874 56999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++||+++ ++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999996 45444444334899999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.... .+..
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------------- 236 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPPL------------- 236 (286)
T ss_pred hhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCC-------------
Confidence 12334578899999988764 48999999999999999999999998776655544433210 0000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....++..+.+||..||+.||.+|||+.++|.|+||++
T Consensus 237 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 ------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001236778999999999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=313.16 Aligned_cols=253 Identities=17% Similarity=0.246 Sum_probs=198.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 378999999999999999999754 345689999886433 223345678899999999999999999988764
Q ss_pred ceEEEEEeeccCCHHH-HhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 190 CSLYLVFHYMEHDLAG-LAASP---------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
...++||||++++.+. .+... ...+++..+..++.|++.||.|||+.|++||||||+|||+++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 4589999999875444 33221 1246788899999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||++......... ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765432211 112234577899999987644 8999999999999999999 78999887776655544331100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......++.+.++|.+||+.||.+|||+.+++++
T Consensus 241 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=315.60 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=202.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.+|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 578999999999999999998653 35789999987543 3344566888999999999999999999988754
Q ss_pred eEEEEEeeccCCHHHHhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 191 SLYLVFHYMEHDLAGLAAS----------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
..++++||+.++.+..+.. ....+++..+..++.|++.||.|||+.||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 4899999998754433321 123588999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
.+||+|||+++....... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999886543221 1123344578899999987644 8899999999999999998 888998887776666654
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+ ....+++.+.+|+..||+.||.+||++.++++.
T Consensus 241 ~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLP----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCC----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 421110 113678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.65 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=201.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|.... .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 3789999999999999999997542 35589999876443 223344577899999999999999999988764
Q ss_pred ceEEEEEeeccCC-HHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 190 CSLYLVFHYMEHD-LAGLAASP---------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
...+++|||+.++ +...+... ...++...+..++.|++.||.|||+++|+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 4589999999864 44443221 1245678889999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||+++........ ......++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+....+....+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99998765332221 112234567899999887644 8999999999999999998 7889988776665554432100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc------CCCCCC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN------SEVIFQ 404 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~------hp~~~~ 404 (410)
. ......++.+.+++.+||+.||.+|||+.++++ ||||..
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 L---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 001245778999999999999999999999987 999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.39 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=205.9
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
-+||+|.||+||-|++..+...+|||-+... +.....-+..|+..-++|+|.|||+++|.+.. .+++-+.||-++|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCC
Confidence 3799999999999999999999999988533 23445568889999999999999999999776 4578899999998
Q ss_pred CHHHHh-cCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeeccccccCCCCCCCCcc
Q 015247 202 DLAGLA-ASPEVKF--TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTS 277 (410)
Q Consensus 202 ~l~~~~-~~~~~~~--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~ 277 (410)
+.+..+ ...=+++ .+..+-.+.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+.. -...+.+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 666554 4444566 8999999999999999999999999999999999997 578999999999998753 2334567
Q ss_pred cccccccccccccc-CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 278 RVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
+.||..|||||++. |...|+.++|||||||++.||.||++||......+.. |.+.. ....-|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVG---------------myKvHP 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVG---------------MYKVHP 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhc---------------ceecCC
Confidence 88999999999996 4456999999999999999999999999765444321 11110 000000
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.....++.++++||.+|+.+||.+||+|.++|..||++.+
T Consensus 799 ---------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 799 ---------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1112567788999999999999999999999999999877
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.23 Aligned_cols=266 Identities=27% Similarity=0.451 Sum_probs=223.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.-+++....||.|.||.||-|.+..+|...|+|-+............+.+|..++..++|||+|+++|+-.++.. ++|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--VYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH--HHH
Confidence 345677889999999999999999999999999998776666667778899999999999999999999888655 899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH- 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 273 (410)
.||||.++.+..+...+...++...+.+..|++.|++|||++|||||||||+|||++.+|.+|++|||.|..+..+...
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999999888888888899999999999999999999999999999999999999999999999999988654311
Q ss_pred --CCccccccccccccccccCCc--CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 274 --PMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 274 --~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.....+||+.|||||++.+.. ....+.|||||||++.||+||+.||...++.=++.--+.....|. +|
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq--------~P 1463 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ--------IP 1463 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC--------Cc
Confidence 234578999999999998653 356799999999999999999999987655433322222221121 11
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
..++++..|||..||..||++|.++.|+|+|-|=+.....|
T Consensus 1464 -------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1464 -------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred -------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 25889999999999999999999999999999877655443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=347.63 Aligned_cols=254 Identities=28% Similarity=0.361 Sum_probs=198.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.++||+|+||.||+|++..+|+.||+|+++.... .....+.+.+|++++..++||||+++++++.+. ...|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 689999999999999999999999999999999975433 233455788899999999999999999988774 46899
Q ss_pred EEeeccCCHHHHhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 195 VFHYMEHDLAGLAAS-----------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 195 v~e~~~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
+|||++++.+..+.. ....++...+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 999998854443321 123456778899999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH
Q 015247 264 ASFFDPNH-----------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 326 (410)
Q Consensus 264 a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 326 (410)
+....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 98762111 01112356899999999987754 8999999999999999999999998754433
Q ss_pred HHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 327 QLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 327 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.... .....+.. ......+|+.+.+++.+||+.||.+|++..+.|.
T Consensus 239 i~~~--~~i~~P~~------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 239 ISYR--DVILSPIE------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhh--hhccChhh------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2211 10000000 0011367888999999999999999988666554
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.06 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 679999999999999999999876 67889999876433 233345678899999999999999999988764 3
Q ss_pred eEEEEEeeccCC-HHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEe
Q 015247 191 SLYLVFHYMEHD-LAGLAASPE------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIAD 260 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~D 260 (410)
..+++|||+.++ +...+.... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 478999999764 444432221 2589999999999999999999999999999999999998765 599999
Q ss_pred eccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCC
Q 015247 261 FGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 261 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
||+++........ .......+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~ 240 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-RL 240 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC
Confidence 9999876322111 111223356799999987654 8999999999999999997 999999877766554433210 00
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....++..+.+++.+||+.||.+|||+.++|+|
T Consensus 241 ---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 ---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0112567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.32 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=198.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+ .++..+|+|.+...... .+.+.+|+.+++.++|+|++++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 6899999999999999999985 46677999998765433 2457889999999999999999988743 347899
Q ss_pred EeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++ +...... ....+++..++.++.|++.||.|||+.+++||||||+||++++++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999874 4444433 2346899999999999999999999999999999999999999999999999999876443322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--------------- 222 (260)
T ss_pred cccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 22233456689999987664 48899999999999999999 89999888776666655331100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+..+.+|+.+||.+||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011256778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=295.26 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=200.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee---cCCc
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS---RMSC 190 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~ 190 (410)
..++|.+.+.||.|||+.||++++..++..||+|++.... .+..+...+|++.-++++|||+++++++... +...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3478999999999999999999999999999999998766 4556778889999999999999999876533 2344
Q ss_pred eEEEEEeeccCC-HHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 191 SLYLVFHYMEHD-LAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
..|++++|...+ +++.+. ..+..+++.++..|+.+|+.||.+||+.. +.||||||.|||+++.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 689999998865 666442 34457999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCC--------CCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 015247 265 SFFDPNHKH--------PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 265 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~ 334 (410)
+...-.-.. .......|..|+|||.+.- ....+.++|||||||+||+|+.|..||... ++.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhc
Confidence 765321111 1122345889999998752 233788999999999999999999999522 111
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.|+-.-.. ....+..|+. ..+|+.+.+||+.||+.||.+||++.++|.+
T Consensus 248 GgSlaLAv------~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAV------QNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEee------eccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11000000 0001111111 1488999999999999999999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.70 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=197.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.++||+|+||.||+|++..+ ..||+|.++..... .+.+.+|+++++.++||||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 6799999999999999999987544 56999998754332 3457789999999999999999987643 347999
Q ss_pred EeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++ +...+.. ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999874 4444433 2346899999999999999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||+..+.. ++.++||||||+++|+|++ |..||.+....+....+......+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------- 223 (262)
T ss_pred cccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC--------------
Confidence 222344577899999876544 8999999999999999999 888998887766655543211000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....++..+.+||.+||++||.+|||+.++++
T Consensus 224 --------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 --------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01256788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=316.84 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=197.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|++..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CC
Confidence 37899999999999999999998777764 477666432 2344456788899999999 899999999998774 45
Q ss_pred EEEEEeeccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 015247 192 LYLVFHYMEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 255 (410)
.|++|||+.++ +...+... ...+++..++.++.||+.||+|||+.|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 99999999864 44433221 235889999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 015247 256 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 256 vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~ 334 (410)
+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999864321111 1122346679999988664 48899999999999999998 99999887766555443211
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
... .....+++++.+||.+||+.||.+|||+.++|.+
T Consensus 240 ~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=309.68 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=204.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
..+|++.++||.|+||.||+|.+.. +..+|+|++.... ......+.+|+++++.++|+||+++++++... ...++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEE
Confidence 3689999999999999999999766 8899999987543 22345678899999999999999999988774 45899
Q ss_pred EEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||+++ ++...+.. ....+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999987 45554433 345689999999999999999999999999999999999999999999999999987643322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
. .....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+.+..+......+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------------- 224 (261)
T ss_pred c-ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------------
Confidence 1 2233457789999988764 48899999999999999998 899998888777776665321111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++.+.++|.+||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ---------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01366788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=342.44 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=202.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeee-Eeec---C
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGL-VTSR---M 188 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~---~ 188 (410)
...++++.+.|.+|||+.||+|++...|..||+|++-.. +....+.+.+|+++|+.|. |+|||.+++. .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 346789999999999999999998777799999998654 6777889999999999996 9999999983 3221 2
Q ss_pred -CceEEEEEeecc-CCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 189 -SCSLYLVFHYME-HDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 189 -~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
...++|.||||. +++.+++..+ ...|++.++.+|+.|+++|+++||..+ |||||||-|||||+.+|+.||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 345789999999 5888877532 235999999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCCC-CCC-------cccccccccccccccc--CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 015247 264 ASFFDPNHK-HPM-------TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 264 a~~~~~~~~-~~~-------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~ 333 (410)
|+..-.... ... ....-|+.|+|||++. ++...+.|+|||+|||+||-|+....||.......++..-+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y- 271 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY- 271 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc-
Confidence 975422211 000 1123499999999985 33458999999999999999999999998764433322111
Q ss_pred HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
.+|. .+.++..+.+||..||+.||.+||++-|++.+-
T Consensus 272 -------------~~P~-----------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 272 -------------SFPP-----------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -------------cCCC-----------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 1111 136788899999999999999999999998753
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.39 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=199.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++++.||+|+||.||+|++..+|. .||+|++.... .......+.+|+.++..++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 689999999999999999999777776 48999986543 334456788899999999999999999988653 3
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++++|+++ ++...+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 6789999986 555555555567999999999999999999999999999999999999999999999999999876533
Q ss_pred CCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||...........+.. ...++
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~--------- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLP--------- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC---------
Confidence 221 11223346789999998764 48999999999999999998 8999987665554433322 11100
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+.++.++|.+||+.||.+|||+.+++.
T Consensus 232 ------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 ------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.97 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=216.1
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
...++|.++++||+|+|++|.+++...+.+.||+|++++... +.+..+....|..+..+. +||.+|-++.+|+.. .
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte--s 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--S 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--c
Confidence 346899999999999999999999999999999999988765 445566677788888776 799999999999884 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|.||++++.+.+..++..+++++.++.+..+|..||.|||++||++||||.+|+|+|..|++||+|+|+++.--.
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 5999999999999888888888999999999999999999999999999999999999999999999999999986422
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC--CCh-----HH-HHHHHHHHhCCCCHHH
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG--RTE-----VE-QLHKIYKLCGSPSEEY 342 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~--~~~-----~~-~~~~i~~~~~~~~~~~ 342 (410)
.-..+++.||||.|.|||++.|. .|+..+|||+|||+++||+.|+.||.- .++ .+ .++-|++..
T Consensus 404 ~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------- 475 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------- 475 (593)
T ss_pred CCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-------
Confidence 22336789999999999988874 599999999999999999999999952 111 11 233333211
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC------HHHHhcCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT------ATVALNSEVIFQ 404 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~elL~hp~~~~ 404 (410)
. ...+.+|-.+..+++..|++||.+|.. ..++-.|+||+.
T Consensus 476 ---i-------------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 476 ---I-------------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ---c-------------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 1 111355666778899999999999964 789999999974
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.35 Aligned_cols=247 Identities=23% Similarity=0.425 Sum_probs=200.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++|+|++++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 7899999999999999999985 56788999998754433 3457789999999999999999988643 348999
Q ss_pred EeeccCC-HHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD-LAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~-l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.++ +..... .....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999764 554443 23457899999999999999999999999999999999999999999999999999876533222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-------------- 223 (260)
T ss_pred cccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--------------
Confidence 223344577899999887644 8899999999999999999 999999887766655553321110
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+.++.++|.+||+.||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 --------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=310.27 Aligned_cols=266 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred CCc-ceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSF-EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y-~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++| ++++.||+|+||+||++. ...+++.||+|.++... .......+.+|+++++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 445 899999999999998864 34578899999987543 233455677899999999999999999988776566
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.++++|||+.++.+..+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 78999999998655544433 36999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC-CCCHHHhhhCC
Q 015247 271 HKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG-SPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 347 (410)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... +..+..... ......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhh
Confidence 2211 1222346679999988764 4889999999999999999999998654321 111111000 00000000000
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
... ........++..+.+++..||+.||++|||+.++++
T Consensus 238 ~~~------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERG------------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcC------------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 000111356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=305.86 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=202.9
Q ss_pred eeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
+.||+|+||.||+|.+... +..|++|.+....... ..+.+.+|+.++..++|+|++++++++.. ...++++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999998765 8899999987654333 46678899999999999999999998887 4569999999
Q ss_pred ccC-CHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 199 MEH-DLAGLAASP--------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 199 ~~~-~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
+.+ ++...+... ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 965 455544443 47899999999999999999999999999999999999999999999999999987754
Q ss_pred CCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~--------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--R--------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence 321 122344568899999988765 48999999999999999999 699999887766666554310 0
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......+|+++.+++.+||+.||.+|||+.+++++
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 -----------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01112568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.36 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|++++..+ +|+||+++++++...
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 7899999999999999999986533 3689999987543 333455688899999999 899999999988774
Q ss_pred ceEEEEEeeccCCHHHHhc----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 190 CSLYLVFHYMEHDLAGLAA----------------SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~----------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
..++++|||+.++.+..+. .....+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 4599999999875444332 224578999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 015247 254 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331 (410)
Q Consensus 254 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i 331 (410)
+.+||+|||++..+...... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999999876433211 11222346779999987664 48899999999999999997 99999988776666554
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...... ......+..+.+|+.+||..||.+|||+.++|++
T Consensus 248 ~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRM----------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 321100 0012467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.99 Aligned_cols=252 Identities=32% Similarity=0.468 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..++..||||.+..... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 579999999999999999999989999999998865432 334456788899999999999999999998874 46899
Q ss_pred EEeeccCCHHH-Hhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAG-LAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+|||+.++.+. .+. .....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999875443 332 23457899999999999999999999999999999999999999999999999998876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... .....+.... .++
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--------- 227 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPP--------- 227 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CCC---------
Confidence 22 123456889999999887644 888999999999999999999999765432 2222221100 000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.++|.+||+.||.+|||+.+++.
T Consensus 228 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 -----------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 001246778999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.49 Aligned_cols=149 Identities=26% Similarity=0.415 Sum_probs=130.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|+++++||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 3789999999999999999999988999999999976443 34445678889999999999999999988776 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
+||||+.++.+..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999875555454445578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=305.31 Aligned_cols=252 Identities=32% Similarity=0.496 Sum_probs=201.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .....+.+.+|++++++++|+|++++++++... ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 679999999999999999999988999999999875433 334466788999999999999999999998874 46899
Q ss_pred EEeeccCC-HHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHD-LAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+|||++++ +...+. .....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999874 444332 23456899999999999999999999999999999999999999999999999998876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...... +....+.... .
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------~ 225 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------------Y 225 (267)
T ss_pred Cc-ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC------------C
Confidence 22 12345678899999988764 4889999999999999999999999655421 2222221100 0
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+. .....++..+.++|.+||.+||++|||+.++++
T Consensus 226 ~~---------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 226 PP---------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CC---------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 001256778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.95 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=196.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||.||+|....++. .+++|.++.. ......+.+.+|++++.++ +||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence 689999999999999999998777665 4688877532 2334456688899999999 799999999988764 458
Q ss_pred EEEEeeccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcE
Q 015247 193 YLVFHYMEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 256 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 256 (410)
++++||++++ +...+... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999864 44443221 1358899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Q 015247 257 KIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLC 335 (410)
Q Consensus 257 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~ 335 (410)
||+|||++........ ......+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864321111 11122355799999887644 8999999999999999997 999998887766655543211
Q ss_pred CCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.. .....++..+.+||.+||+.||.+|||++++++.
T Consensus 236 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0112577889999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=329.25 Aligned_cols=260 Identities=28% Similarity=0.375 Sum_probs=213.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.-|..++.||-|+||.|.+++...+...||+|.+++... ...++..+..|..||...+.+.||+||..|.++ ..+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEE
Confidence 458899999999999999999889999999999987543 556677888999999999999999998777775 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC------
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD------ 268 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~------ 268 (410)
||+|++|+....++-+.+-|.|..++.++.+++.|+++.|+.|+|||||||+|||||.+|+|||+||||++-+.
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999997777666666799999999999999999999999999999999999999999999999999996331
Q ss_pred ---CCC--------------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHH
Q 015247 269 ---PNH--------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313 (410)
Q Consensus 269 ---~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 313 (410)
.++ .......+||+.|+|||++.... |+...||||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHh
Confidence 100 00123468999999999998754 999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-
Q 015247 314 AGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT- 392 (410)
Q Consensus 314 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt- 392 (410)
.|++||...+..++-.++.+.-. ...+ ....+++.++.++|.++.+ ++.+|..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~--------~l~~-----------------~~~~~ls~e~~~li~kLc~-sad~RLGk 919 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRN--------FLHI-----------------PYQGNLSKEALDLIQKLCC-SADSRLGK 919 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhh--------cccc-----------------ccccccCHHHHHHHHHHhc-Chhhhhcc
Confidence 99999998877666554433100 0000 0113789999999998765 7889984
Q ss_pred --HHHHhcCCCCCC
Q 015247 393 --ATVALNSEVIFQ 404 (410)
Q Consensus 393 --~~elL~hp~~~~ 404 (410)
++++-.||||+.
T Consensus 920 ng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 920 NGADQVKAHPFFKG 933 (1034)
T ss_pred cchhhhhcCccccc
Confidence 888999999974
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.99 Aligned_cols=258 Identities=20% Similarity=0.277 Sum_probs=202.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC----------------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----------------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 179 (410)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 68999999999999999999865433 568999987543 3345667888999999999999999
Q ss_pred EeeeEeecCCceEEEEEeeccCCHHHHhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE-----------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 248 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 248 (410)
+++++... ...+++|||+.++.+..+.... ..+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99998774 4689999999875444333222 2689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc--CCCCCCCCChH
Q 015247 249 LIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 325 (410)
Q Consensus 249 Ll~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~pf~~~~~~ 325 (410)
+++.++.++|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999976543322 1223445678899999887644 8999999999999999998 77888877766
Q ss_pred HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 326 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+.+..+......... ... ......+|.++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGR-----------QIY----------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccc-----------ccc----------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666555432111100 000 0011246778999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=307.76 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=200.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 37899999999999999999987543 4789999986443 333345677899999999999999999998874
Q ss_pred ceEEEEEeeccCC-HHHHhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 190 CSLYLVFHYMEHD-LAGLAAS---------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
...+++|||+.++ +...+.. ....+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 5589999999864 4443322 12347889999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 9999976543321 1223345678899999887644 8899999999999999998 99999887766655544321 00
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+ .....++..+.++|.+||+.||.+|||+.++++.
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 L---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0012457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=304.60 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=194.1
Q ss_pred eeeccCCCeeEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999765544 78999998765443 345568889999999999999999998754 247999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc-
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS- 277 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~- 277 (410)
+.++.+.........+++..+..++.|++.||.|||+.+++|+||||+|||++.++.+||+|||++.............
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9875444444444489999999999999999999999999999999999999999999999999998775443221111
Q ss_pred -ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 278 -RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 278 -~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
..++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+..... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~----------------- 217 (257)
T cd05060 157 AGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-L----------------- 217 (257)
T ss_pred CccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-C-----------------
Confidence 12346799999887654 8999999999999999998 9999988776655544432100 0
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.++|.+||.+||.+|||+.++++
T Consensus 218 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.57 Aligned_cols=246 Identities=32% Similarity=0.476 Sum_probs=203.5
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
||.|+||.||++.+..+++.||+|.+..... .......+..|+.+++.++|||++++++.+.. ....+++|||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6999999999999888899999999876544 23355678889999999999999999988876 45699999999654
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccc
Q 015247 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282 (410)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 282 (410)
.+.........+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 444444444578999999999999999999999999999999999999999999999999998764432 1234556788
Q ss_pred cccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhh
Q 015247 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKR 362 (410)
Q Consensus 283 ~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (410)
.|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.... .
T Consensus 158 ~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--L------------------------ 210 (250)
T ss_pred cccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--C------------------------
Confidence 999999887644 7889999999999999999999998877655555543310 0
Q ss_pred hhhhhhCCCCCCcHHHHHhccCCCCCCCCCH---HHHhcCCCC
Q 015247 363 CIQETFKDFPPSSLPLIETLLAIDPAERLTA---TVALNSEVI 402 (410)
Q Consensus 363 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~elL~hp~~ 402 (410)
.....++..+.++|.+||..||.+|||+ +++++||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0112457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.55 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=198.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+.+.+|+++++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--D 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--C
Confidence 57999999999999999999853 345678999875432 33345688899999999999999999998764 4
Q ss_pred eEEEEEeeccCCHHHHhc-C---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 191 SLYLVFHYMEHDLAGLAA-S---------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~-~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
..++||||++++.+..+. . ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 589999999875444332 2 123589999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
.++|+|||++........ .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976543321 1123345678899999887644 8899999999999999998 999998877766555442
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.... + .....+|..+.+++.+||++||.+|||+.++++
T Consensus 240 ~~~~------------~----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRV------------L----------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCC------------C----------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2100 0 011246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=306.25 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=201.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||.||+|++..++. .+|+|.++... .....+.+.+|+.++..++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ccc
Confidence 579999999999999999998764443 79999886543 334456788899999999999999999998764 468
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++|||++++ +...+......+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999875 544544445678999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCC--ccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... ....++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+.+....+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP---------- 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC----------
Confidence 2211 122235689999998764 48999999999999999886 999998877666555554321100
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+.+++.+||+++|.+|||+.++++
T Consensus 230 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 ------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.57 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=203.4
Q ss_pred CcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
+|++.+.||+|+||.||++++. .+++.||+|+++.... .....+.+.+|+.++.++ +||||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4889999999999999999854 4678999999875432 123345677899999999 699999999888764 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..++||||+.++.+.........+++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 68999999987655544444457999999999999999999999999999999999999999999999999998876544
Q ss_pred CCCCCccccccccccccccccCCc-CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.........++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----------
Confidence 332233456789999999876532 36789999999999999999999996543222222221110000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC---HHHHhcCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT---ATVALNSEVIFQD 405 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~elL~hp~~~~~ 405 (410)
.......++..+.++|.+||+.||++||| +.++|+||||+..
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 00011256788999999999999999998 5678999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.91 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=202.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|+..+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|++++..++|||++++.+++... ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 679999999999999999999876554 79999886543 333456688899999999999999999998774 458
Q ss_pred EEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++|||++++.+. .+......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999985554 444445679999999999999999999999999999999999999999999999999998664332
Q ss_pred CCCCc--cccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KHPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
..... ....++.|+|||++.+. .++.++|||||||++|||++ |+.||...+..+....+......+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 231 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA--------- 231 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---------
Confidence 21111 12234579999988764 48899999999999999997 9999988877666666543211110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+..+.+++.+||..||.+||++.++++
T Consensus 232 -------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 -------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=304.24 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=201.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|+.+++.++|+|++++++++... ...++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEE
Confidence 47899999999999999999986 45678999998754433 34577899999999999999999988763 45899
Q ss_pred EEeeccCC-HHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHD-LAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||++++ +...+... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999875 54444333 34789999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+....+..+......+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 225 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR------------ 225 (261)
T ss_pred hhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 111222345689999988764 48899999999999999998 9999998887777766644211110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+..+.+++.+||+.||.+|||++++++
T Consensus 226 ----------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 ----------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.25 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=196.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+|.+++ ||||+++++++...
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 689999999999999999998643 23479999986543 3344567888999999996 99999999998764
Q ss_pred ceEEEEEeeccCCHHH-HhcC-----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAG-LAAS----------------------------------------------------------- 209 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~----------------------------------------------------------- 209 (410)
...|+||||++++.+. .+..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 4599999999875433 2211
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 210 ------------------------------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 210 ------------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
....+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 01247888999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 015247 254 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331 (410)
Q Consensus 254 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i 331 (410)
+.+||+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||........+...
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999876432221 122345678899999887644 8999999999999999997 99999876544433322
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+ .....++..+.++|.+||+.||.+|||+.++.+
T Consensus 353 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2210000 001256788999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=306.89 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=196.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||+||+|....++. .+++|.+... ........+..|+.++.+++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 689999999999999999999877776 4677776432 223344567778889999999999999998753 34
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.++++||+.+ ++.+.+......+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7789999885 555555555668999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+.+ ...+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~--------- 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERLA--------- 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC---------
Confidence 3221 22344677899999887644 8999999999999999998 9999988766554333321 10000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+.++.+++..||..||.+|||+.++++
T Consensus 232 ------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 ------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00134567889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=324.98 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+...-++-||+|+.|-||+|+ ..++.||||+++. .-..++..|++|+||||+.+.|+|.. ...++|+
T Consensus 124 e~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIi 190 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGR--LHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCII 190 (904)
T ss_pred HHhhhhhhhccCcccceeeee--ccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC--CceeEEe
Confidence 344556779999999999997 5678999998742 11237888999999999999999987 5569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||||..+-+...++.+..++......|..+||.|+.|||.++|||||||.-||||+.+..|||+|||.++..... ...
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 999999888878777889999999999999999999999999999999999999999999999999999887533 335
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
.+++||..|||||++.+. +.+.|+|||||||+||||+||..||...+...++.-+ |.+.. .+
T Consensus 269 MSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----GsNsL-----------~L-- 330 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GSNSL-----------HL-- 330 (904)
T ss_pred hhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEec----cCCcc-----------cc--
Confidence 678999999999999874 4999999999999999999999999876654433211 11110 00
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
.....+|+-++=||+.||+..|..||++.++|.|-
T Consensus 331 ----------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 331 ----------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ----------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 01126788899999999999999999999999984
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.49 Aligned_cols=291 Identities=31% Similarity=0.518 Sum_probs=237.7
Q ss_pred hhhhhhcccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC----
Q 015247 98 WLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---- 173 (410)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---- 173 (410)
++.-..||.++ .+|.+....|+|-|++|..|.+..-|..||||+|+.+.+ -.+.-+.|+++|++|+
T Consensus 421 YYrv~igE~LD-------~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 421 YYRVRIGELLD-------SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADP 490 (752)
T ss_pred eEEEehhhhhc-------ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCc
Confidence 34445566655 689999999999999999999999999999999986543 2334567999999994
Q ss_pred --CCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 015247 174 --HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLL 249 (410)
Q Consensus 174 --h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIL 249 (410)
.-|+++|+..|.+ ..+++||||.+.-+|...+.. .+..+....++.|+.|+..||..|-..||+|.||||+|||
T Consensus 491 Edk~Hclrl~r~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNIL 568 (752)
T ss_pred hhhhHHHHHHHHhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceE
Confidence 4688888877777 446999999999998887754 3456888999999999999999999999999999999999
Q ss_pred EcCC-CcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHH
Q 015247 250 IDDD-GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328 (410)
Q Consensus 250 l~~~-~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 328 (410)
+++. ..+||||||.|.....+. .+.+..+..|.|||+++|.. |+...|+||+||+||||.||+..|+|.++.+++
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9965 568999999998875443 46777788999999999965 999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCC----------------------CCCchhhhhhhhhC--CCCC-------CcHH
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFK----------------------PREPYKRCIQETFK--DFPP-------SSLP 377 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~--~~~~-------~~~~ 377 (410)
...+.+.|..+..++..+.|-+.++-. ...+.+.+..++.. .+++ .+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 999999999999988887765442211 11111122112111 1333 3789
Q ss_pred HHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 378 LIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 378 li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
|+.+||..||++|.|+.|+|.||||+.
T Consensus 725 LLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcCCcccC
Confidence 999999999999999999999999985
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.88 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=199.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.+|+..++||+|+||.||+++.. .++..+|+|.+... .......+.+|++++..++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 57889999999999999999742 35678999987643 344456788999999999999999999988774 4
Q ss_pred eEEEEEeeccCCHHH-HhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 015247 191 SLYLVFHYMEHDLAG-LAASPE--------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 255 (410)
..+++|||+.++.+. .+.... ..+++..+..++.||+.||+|||+.|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 589999999875444 332211 35899999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 015247 256 LKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 256 vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~ 333 (410)
++|+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||......+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999765332211 112334578899999887654 8999999999999999998 9999988777666655543
Q ss_pred HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.... .....+++.+.+||.+||+.||.+||++.+++.
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2100 011256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=304.17 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=197.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++...||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+++++.++|+|++++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 5799999999999999999986444 4699998765432 23457789999999999999999988753 347899
Q ss_pred EeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.+ ++...+.. ....+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999987 56555543 2345899999999999999999999999999999999999999999999999999876433322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+....+....+......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 222334577899999887644 8899999999999999999 99999988777666554331100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.+++.+||++||.+||+++++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=311.89 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=199.8
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||++.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 6899999999999999999975 2345689999886543 234456788899999999 799999999988774
Q ss_pred ceEEEEEeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 190 CSLYLVFHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
...+++|||+.++ +...+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 4589999999865 4444433 2234899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 268 DPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 268 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
...... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+.+.......+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------- 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------- 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-------
Confidence 433211 112234577899999887654 8899999999999999998 999998877665554443211000
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......++.+.+|+.+||++||.+|||+.++++
T Consensus 264 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 --------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001245778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.63 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=208.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.+.+..+.||+|.||+||+|+.. .....||||.++... +.....+|.+|+++|..++|||||+|+|+|...+.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P- 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP- 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe-
Confidence 56677899999999999999843 334689999997543 44456789999999999999999999999998544
Q ss_pred eEEEEEeeccCCHHH-HhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcE
Q 015247 191 SLYLVFHYMEHDLAG-LAASP-------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 256 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 256 (410)
+++|+|||..+.+. ++... ..+++..+...++.|||.||.||-++.+|||||...|+||.++..|
T Consensus 564 -~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 564 -LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred -eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999975544 33211 1238899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCc-cccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 015247 257 KIADFGLASFFDPNHKHPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 257 kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~ 334 (410)
||+||||++.+-..+.+... ...-..+|||||.++-. +|+.+||||||||+|||+++ |..|+.+..+.+.++.|.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999876544433333 34557889999999864 49999999999999999997 99999999999999988763
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 396 (410)
.- -+...++|.++.+|+..||+.+|++||++.|+
T Consensus 722 ~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 QL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred Cc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 21 12224899999999999999999999999886
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.96 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=195.1
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
+.||+|+||.||+|.. .+++.||+|.++... .......+.+|+++++.++||||+++++++... ...+++|||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCC
Confidence 3689999999999985 578899999886543 334445688899999999999999999998774 458999999987
Q ss_pred C-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 202 D-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 202 ~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
+ +..........+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 5 444444445578999999999999999999999999999999999999999999999999997654332221222344
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.........+......
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 213 (250)
T cd05085 157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---------------------- 213 (250)
T ss_pred cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 6779999988764 48899999999999999998 99999888766655544321100
Q ss_pred hhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 360 YKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.+|+.+||+.||++|||+.++++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=307.25 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.+|++.+.||+|+||.||++. +..++..||+|.+... .....+.+.+|+++++.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 579999999999999999997 3457889999998643 3344567889999999999999999999876655567
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
++++|||+++ ++...+......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 8999999986 455555444557899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCC--ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC-CCCHHHhhhCC
Q 015247 271 HKHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG-SPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 347 (410)
..... ....++..|+|||++.+.. ++.++|||||||++|||++|..++...... ....+..... ..........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~- 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIEL- 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHH-
Confidence 22111 1122345699999887644 889999999999999999998776443221 1111100000 0000000000
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.... ........++.++.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNN-----------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcC-----------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000 000011356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=309.74 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=195.2
Q ss_pred ceeeeeccCCCeeEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 119 EKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++.+.||.|.||.||+|... ..+..|+||.+.. ....+..+.+.+|++.+++++||||++++|++.... ..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccc--cccc
Confidence 46788999999999999876 3467899999954 334455778889999999999999999999999533 4999
Q ss_pred EEeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||+.+ .+...+... ...+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999986 555555544 56899999999999999999999999999999999999999999999999999987632211
Q ss_pred -CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 -HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
...........|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~------------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL------------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-------------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-------------
Confidence 1122344677899999987654 8999999999999999999 78999988887777766432110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.++|..||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 225 ---------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111257888999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=317.55 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=195.8
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 6899999999999999999974 3567899999997543 233455678899999999 689999999987654 3
Q ss_pred ceEEEEEeeccCCHHHHhc-CC----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAGLAA-SP---------------------------------------------------------- 210 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~-~~---------------------------------------------------------- 210 (410)
..++++|||++++.+..+. ..
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4688999999875444322 11
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CCcccccc
Q 015247 211 --------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVT 281 (410)
Q Consensus 211 --------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt 281 (410)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 124688889999999999999999999999999999999999999999999999765322211 11223346
Q ss_pred ccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 282 ~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
+.|+|||.+.+. .++.++||||||+++|+|++ |..||........+..........
T Consensus 245 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 301 (343)
T cd05103 245 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 301 (343)
T ss_pred cceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC----------------------
Confidence 779999988764 48999999999999999997 999998765443332222110000
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......++++.+++..||+.||.+|||+.++++|
T Consensus 302 -----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001356678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=311.71 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=197.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
++|.+.+.||+|+||.||++++.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 689999999999999999998643 23579999987543 233455677899999999 799999999998774
Q ss_pred CCceEEEEEeeccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 188 MSCSLYLVFHYMEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
...|++|||+.++ +...+... ...+++..+..++.||+.||+|||+.|++||||||+|||++
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4589999999874 44444322 13588999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999998766432211 111223456899999887644 8899999999999999998 889998776655554
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.+..... .+....++.++.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4432100 01112567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.43 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=192.9
Q ss_pred eeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeecc
Q 015247 123 KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
.||+|+||.||+|... ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999764 345679999986543 34445678899999999999999999998754 35899999998
Q ss_pred CCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc--c
Q 015247 201 HDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT--S 277 (410)
Q Consensus 201 ~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~--~ 277 (410)
++.+. .+......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............ .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 75444 44445568999999999999999999999999999999999999999999999999999866443322111 1
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
..+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.+... +
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------------------ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-L------------------ 217 (257)
T ss_pred CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C------------------
Confidence 22357899999887644 8899999999999999996 9999988877665554433110 0
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......++++.++|.+||..||.+||++.++++
T Consensus 218 ---------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 ---------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011256788999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.01 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=200.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++|||++++++++... ...+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEE
Confidence 57999999999999999999864 5778999988654433 23577899999999999999999988764 458999
Q ss_pred EeeccCCHHHH-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGL-AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||+.++.+.. +......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99998765544 44444578999999999999999999999999999999999999999999999999997664332211
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+. .++.++||||||+++|||++ |..||......+....+.+.....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY--------------- 221 (256)
T ss_pred cCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC---------------
Confidence 2223346789999988764 48899999999999999998 999998877766665553211000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....++.+.+|+.+||+.||.+|||+.++++.
T Consensus 222 -------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 -------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 002357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.02 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=197.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+|++++++++.. ....+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEE
Confidence 6899999999999999999974 588999999875432 45678889999999999999999999877 4558999
Q ss_pred EeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+++ .+...+.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999996 4444443322 368999999999999999999999999999999999999999999999999998763222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.... .+
T Consensus 157 --~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM-------------- 218 (256)
T ss_pred --ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC--------------
Confidence 123346679999988764 48889999999999999997 999998776655544332210 00
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.++|.+||..||++|||+.+++.
T Consensus 219 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 -------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011256888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.05 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=201.2
Q ss_pred cceeeeeccCCCeeEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
|++.+.||.|+||.||++++...+ ..||+|++..... ......+.+|+.++..++|+||+++++++... ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 457789999999999999987766 8999999865432 22456788899999999999999999988874 4699
Q ss_pred EEEeeccCCH-HHHhcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 194 LVFHYMEHDL-AGLAASPEVK-FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 194 lv~e~~~~~l-~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++|||+.++. ...+...... +++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999998754 4444333323 9999999999999999999999999999999999999999999999999998765442
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+.......+......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 222212336789999998855 348999999999999999998 88999887776666655432110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+.++.+++.+||..||++|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ---------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 001246788999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.97 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=200.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---Cc
Confidence 5799999999999999999986543 3468999875433 344556788899999999999999999988653 36
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++|||+.++ +...+......+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 8999999875 444444444468999999999999999999999999999999999999999999999999998764433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........++..|+|||.+.+. .++.++||||||+++|||++ |..||.+.+..+....+.+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-------------
Confidence 2222233345689999987654 48899999999999999986 99999988877666554321100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+|..+.++|.+||..||.+|||+.+++..
T Consensus 228 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 ---------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.54 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+... ........+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 568999999999999999999876665 6999998653 2344566788999999999999999999988763 458
Q ss_pred EEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++|||++++.+. .+....+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999875444 444445678999999999999999999999999999999999999999999999999987664332
Q ss_pred CCCC-cccc---ccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 272 KHPM-TSRV---VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 272 ~~~~-~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
.... .... .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP-------- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC--------
Confidence 2111 1111 24579999988764 48999999999999999886 999998887766655553211100
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++..+.+++..||..||.+||++.+++..
T Consensus 232 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 232 --------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred --------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.33 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=195.7
Q ss_pred CcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.++..++||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 47889999999999999998643 23578888876443 334456788899999999999999999988764 45
Q ss_pred EEEEEeeccCCHHHHhcC------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 015247 192 LYLVFHYMEHDLAGLAAS------------------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSN 247 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 247 (410)
.++++||+.++.+..+.. ....+++..+..++.|++.||.|||+.+++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999999754443321 12358899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChH
Q 015247 248 LLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 325 (410)
Q Consensus 248 ILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 325 (410)
||+++++.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765332221 11223456789999988764 48999999999999999998 99999887665
Q ss_pred HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 326 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+....+...... .....++.++.+|+..||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRM----------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 544433211000 011256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=305.48 Aligned_cols=253 Identities=20% Similarity=0.340 Sum_probs=200.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++++.||+|+||.||+|+... +.+.|++|.+.... .......+.+|++++++++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 679999999999999999998643 35679999875432 233456788899999999999999999988763 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 191 SLYLVFHYMEHDLAGLAASPEV---------KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
..++||||++++.+..+..... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 5899999999755544433222 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
|++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--- 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE--- 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC---
Confidence 998755333222233445678899999887644 7889999999999999998 88899876665554443221000
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
. .....++..+.++|.+||+.||.+|||+.+++..
T Consensus 238 -------~-----------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 -------L-----------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------C-----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0012567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.50 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=198.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
++|.+.+.||+|+||.||+|++. .....+|+|.++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 68999999999999999999753 234579999886543 334456688899999999 699999999988764
Q ss_pred CCceEEEEEeeccCCHHH-HhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 188 MSCSLYLVFHYMEHDLAG-LAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~-~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
..++++|||+.++.+. ++... ...+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 4589999999875443 33221 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||+++........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999866432211 11222335679999988764 48999999999999999999 899998877766665
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+..... ......++.++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5432100 0011256778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.23 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCc---e-EEEEEEecC-CCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK---I-VALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++-.+.++||+|+||.||+|+....+. . ||+|..+.. ....+....+.+|+++|++++|||||+++|+...+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4566677999999999999998665422 3 899998753 3567778889999999999999999999999988554
Q ss_pred ceEEEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 190 CSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
+++|||+|.|+.+. ++......++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+||||++...
T Consensus 236 --l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 236 --LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred --cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999986555 444444579999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.-... .....-...|+|||.+... .|+.++|||||||++||+.+ |..||++....+...+|.....+.+
T Consensus 314 ~~~~~-~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-------- 383 (474)
T KOG0194|consen 314 QYVMK-KFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-------- 383 (474)
T ss_pred ceeec-cccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC--------
Confidence 11110 1111246789999999876 59999999999999999998 8899999999998888854211111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....|..+..++.+|+..||++|||+.++.+
T Consensus 384 -------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 -------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 01256778899999999999999999988753
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=310.47 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=200.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|+.. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 378999999999999999999742 234579999886432 334456788899999999 89999999999887
Q ss_pred cCCceEEEEEeeccCCHHH-HhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 015247 187 RMSCSLYLVFHYMEHDLAG-LAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~-~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl 250 (410)
. ...|++|||+.++.+. .+... ...+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4 4589999999875443 33321 2357889999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||+++......... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999998764332221 2223456789999988764 48999999999999999998 88999888776666
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+...... .....++..+.+||.+||+.+|.+|||+.++|+.
T Consensus 250 ~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 554321100 0012567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=302.14 Aligned_cols=244 Identities=22% Similarity=0.378 Sum_probs=196.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.+++.++|+|++++++++... ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 36899999999999999999974 58889999886432 244677899999999999999999876543 345899
Q ss_pred EEeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||+++ .+...+.... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999986 4555444333 358999999999999999999999999999999999999999999999999987653222
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------------
Confidence 233446689999988764 48899999999999999997 99999877666555544321000
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.++|.+||+.||.+|||+.++++
T Consensus 219 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 --------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111356888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=306.75 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=198.2
Q ss_pred CCcceeeeeccCCCeeEEEEEE----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
..|++++.||+|+||.||+++. ..++..||+|.++... .......+.+|+++++.++|||++++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3589999999999999999973 4578899999986443 3344567889999999999999999999988765567
Q ss_pred EEEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|||++++.+. .+......+++..+..++.||+.||+|||+.|++||||||+|||++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999875444 44343446899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH-----Hh
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE-----YW 343 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~ 343 (410)
... ......++..|+|||.+.+. .++.++|||||||++|+|++++.|+..... .. .+..+..... ..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHHHH
Confidence 221 11234567789999988764 488999999999999999998876533211 00 1111100000 00
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..... . ........++..+.+||.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~-~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEE-G------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHc-C------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000 0 0001123578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=304.11 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=201.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
+|.+.+.||+|+||.||++.+...+..+++|+++... ........+..|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 5889999999999999999988777777777765422 2223334566799999999999999999988764 3589
Q ss_pred EEEeeccCCHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 194 LVFHYMEHDLAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 194 lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
+++||+.++.+.... .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999875444322 34457999999999999999999999999999999999999975 6799999999977643
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... ..+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~---------- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP---------- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC----------
Confidence 322 22345678899999988654 4788999999999999999999999876665555444321 000
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....++.++.++|.+||..||.+||++.++|+||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0112567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.63 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=200.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|+|++++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 3789999999999999999999765 3678999988633 3455567788899999999999999999987654 34
Q ss_pred eEEEEEeeccCC-HHHHhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 191 SLYLVFHYMEHD-LAGLAASP-------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
..+++++|+.++ +...+... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 588999999864 44433221 1468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 263 LASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 263 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
+++.+....... .....++..|+|||++.+.. ++.++|||||||++||+++ |+.||...+..+....+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC--
Confidence 998664332221 12234567899999887644 8999999999999999999 999998876655443332210 00
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++++.+++.+||..||++|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 -------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001245778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=308.88 Aligned_cols=258 Identities=20% Similarity=0.272 Sum_probs=198.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC--------------CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEe
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT--------------GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 181 (410)
++|++.+.||+|+||.||+|++..+ ...||+|.++... .......+.+|++++.+++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 6899999999999999999986432 2358999987543 344456788999999999999999999
Q ss_pred eeEeecCCceEEEEEeeccCCHHHHhc-CCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 015247 182 GLVTSRMSCSLYLVFHYMEHDLAGLAA-SPE-----------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLL 249 (410)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIL 249 (410)
+++... ...+++|||+.++.+.... ... ..+++..+..++.|++.||.|||+.|++||||||+|||
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 998764 4589999999875444332 211 24788999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc--CCCCCCCCChHH
Q 015247 250 IDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEVE 326 (410)
Q Consensus 250 l~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~pf~~~~~~~ 326 (410)
++.++.+||+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999976533221 1122334577899999887644 8999999999999999988 668888877766
Q ss_pred HHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 327 QLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 327 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+.+........ ........+|+.+.+||.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQ---------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhcccc---------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 665554321110000 000111246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.94 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=198.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||++.+ ..+..+|+|.+.... ...+.+.+|+++++.++|+|++++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 7899999999999999999985 456679999876432 234567889999999999999999988776 348999
Q ss_pred EeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+++ ++.+.+.. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999986 55555443 3456889999999999999999999999999999999999999999999999999876433322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......++..|+|||++.+. .++.++|+|||||++|+|++ |+.||.+.+.......+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------------- 222 (260)
T ss_pred cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---------------
Confidence 22233456779999988764 48889999999999999998 99999987766655544321100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+.++.+++.+||++||.+||++.++++
T Consensus 223 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 -------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011356788999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.95 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=197.9
Q ss_pred eeeccCCCeeEEEEEEcC-CCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDML-TGK--IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998754 333 6999998766544 556778899999999999999999998876 568999999
Q ss_pred ccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--C
Q 015247 199 MEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH--P 274 (410)
Q Consensus 199 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~ 274 (410)
+++ .+...+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 976 4555444433 57899999999999999999999999999999999999999999999999999877543221 1
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 12345678899999887644 8999999999999999998 999998887777666654311000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+|..+.+++.+||+.+|++|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 001246778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=301.06 Aligned_cols=292 Identities=35% Similarity=0.541 Sum_probs=236.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc---e
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC---S 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~ 191 (410)
..+.+-.+.||.|+||+||.+.+..+|+.||+|++......-...+.+.+|+.+|...+|.|++..+++....... .
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3456677889999999999999999999999999864332333456778899999999999999987765543221 2
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+++|.|..++...+.... .++.+.++-++.||+.||.|||+.+|.||||||.|+|++.+..+||||||+++..+...
T Consensus 132 iYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 68899999988888776654 89999999999999999999999999999999999999999999999999999887777
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC-
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN- 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 350 (410)
....+..+.|..|+|||+++|...|+.+.||||.|||+.|++..+..|...+..++++.|..++|+|..+..+...-..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 6667777889999999999999999999999999999999999999999999999999999999999976543221100
Q ss_pred cccC--CCCCchhhhhhhh--hCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 ATLF--KPREPYKRCIQET--FKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~~~--~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..+. ....+.-..+... ..+-..+..+++..||..||.+|.+..+++.|+++.+.++
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 0000 0011100111111 1133445789999999999999999999999999998875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=298.40 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=195.0
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
++||.|+||.||++.+.. ++.||+|.+...... .....+.+|++++++++|+||+++++++... ...+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 469999999999999766 999999998765433 3456788899999999999999999988774 458999999976
Q ss_pred C-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC-cccc
Q 015247 202 D-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRV 279 (410)
Q Consensus 202 ~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 279 (410)
+ +...+......+++..+..++.|++.||.|||+++++||||+|+|||++.++.++|+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 5 5444444455789999999999999999999999999999999999999999999999999976542221111 1223
Q ss_pred ccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 280 gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+......
T Consensus 157 ~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 36679999988764 48999999999999999999 88999877765544443221000
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....++..+.++|.+||+.+|.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001256778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.55 Aligned_cols=279 Identities=22% Similarity=0.287 Sum_probs=185.6
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCC----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEe----
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLT----GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT---- 185 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---- 185 (410)
..++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+....+ .+....+.+++.+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 458999999999999999999999888 89999998753221 1111111 122222222322221111
Q ss_pred ecCCceEEEEEeeccCCHHH-HhcCCCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 015247 186 SRMSCSLYLVFHYMEHDLAG-LAASPEV-------------------KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKG 245 (410)
Q Consensus 186 ~~~~~~~~lv~e~~~~~l~~-~~~~~~~-------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 245 (410)
......+++|+||++++.+. .+..... ......+..++.||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 12345689999999876443 3322211 122445678999999999999999999999999
Q ss_pred CCEEEcC-CCcEEEEeeccccccCCCCCCCCccccccccccccccccCCc---------------------CCCCccchH
Q 015247 246 SNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT---------------------DYGVGVDLW 303 (410)
Q Consensus 246 ~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diw 303 (410)
+|||++. ++.+||+|||+|+.+...........++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 689999999999876554444455678899999999764221 134567999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhcc
Q 015247 304 SAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLL 383 (410)
Q Consensus 304 SlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 383 (410)
||||++|||+++.. ...+....+..+....+..... |.....+. ....... ..+..+..+...++||.+||
T Consensus 364 SlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~-----~~~~~~~-~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVA-WRKLVEPR-----ASPDLRR-GFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHH-HHHhhccc-----cchhhhh-hhhhccccchHHHHHHHHHc
Confidence 99999999998654 4445555555555544433222 21111000 0000000 01112233455679999999
Q ss_pred CCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 384 AIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 384 ~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
++||.+|||+.++|+||||+....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999999987543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=302.31 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.+|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.++..++|||++++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 679999999999999999999776665 58999876543 34445678889999999999999999998876 35
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|||+.+ ++.+.+......+++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 8999999986 455555555567999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCC-ccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHPM-TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
..... ....++..|+|||.+... .++.++|+||||+++||+++ |+.||.+....+....+......+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 231 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP---------- 231 (279)
T ss_pred ccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC----------
Confidence 22111 112235679999988654 48899999999999999998 999998887666555443211000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+..+.+++.+||..||.+|||+.++++
T Consensus 232 ------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 ------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00235667899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.17 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=198.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 68999999999999999999864 267899999986543 334456688899999999999999999988764 4
Q ss_pred eEEEEEeeccCC-HHHHhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 015247 191 SLYLVFHYMEHD-LAGLAASP---------------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 248 (410)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 248 (410)
..+++|||+.++ +...+... ...+++..+..++.||+.||.|||+.+++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 589999999874 44433211 12478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHH
Q 015247 249 LIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVE 326 (410)
Q Consensus 249 Ll~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 326 (410)
|++.++.++|+|||++........ ........+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876533221 111223346679999988764 48999999999999999997 888998877766
Q ss_pred HHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 327 QLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 327 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+...... .....++.++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVL----------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55544321000 001256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.33 Aligned_cols=239 Identities=18% Similarity=0.253 Sum_probs=185.0
Q ss_pred eeeccCCCeeEEEEEEcC------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 122 DKIGQGTYSNVYKAKDML------------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
+.||+|+||.||+|.... ....+++|++.... ......+.+|+.++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999997432 22358888865432 33345677899999999999999999998764
Q ss_pred ceEEEEEeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-------EEEEee
Q 015247 190 CSLYLVFHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------LKIADF 261 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-------vkl~DF 261 (410)
...+++|||++++.+.... .....+++..+..++.||+.||+|||+.+|+||||||+|||++.++. ++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 3478999999987665544 34557999999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
|++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+.. .+....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~----- 225 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ----- 225 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC-----
Confidence 998755322 23457888999998875556899999999999999998 588888765443322 111100
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
. ......++++.+||.+||+.||.+||++.++|++
T Consensus 226 -------~-----------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -------C-----------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------c-----------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0001235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.89 Aligned_cols=238 Identities=20% Similarity=0.281 Sum_probs=185.4
Q ss_pred eeccCCCeeEEEEEEcCC------------------------CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee
Q 015247 123 KIGQGTYSNVYKAKDMLT------------------------GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 178 (410)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 2358888875432 23345677899999999999999
Q ss_pred eEeeeEeecCCceEEEEEeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---
Q 015247 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG--- 254 (410)
Q Consensus 179 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--- 254 (410)
++++++... ...++||||++++.+..+. .....+++..+..++.||+.||+|||+.+|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999998874 4589999999987666554 4456789999999999999999999999999999999999998654
Q ss_pred ----cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHH-cCCCCCCCCChHHHHH
Q 015247 255 ----VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLH 329 (410)
Q Consensus 255 ----~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell-~g~~pf~~~~~~~~~~ 329 (410)
.++++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999988644221 22356788999998876556899999999999999995 7999998766544322
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.. ... ...+ ...++.+.++|.+||+.||.+|||+.++|++
T Consensus 233 ~~-~~~----------~~~~-------------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKK----------HRLP-------------------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-Hhc----------cCCC-------------------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 110 0000 1345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=310.90 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=198.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-------CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-------GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
.+|++.+.||+|+||.||+|++... +..||+|.+... ......+.+.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 5799999999999999999986432 236899987643 3344466788899999999 899999999998874
Q ss_pred CCceEEEEEeeccCCHHH-HhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 188 MSCSLYLVFHYMEHDLAG-LAAS---------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~-~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
...++++||++++.+. .+.. ....+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 91 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 --GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4589999999875444 3322 123578899999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||+++........ ......++..|+|||++.+.. ++.++||||||+++|||++ |..||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999876432211 112223356799999987644 8899999999999999998 889998887766655
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.+...... .....++..+.+||.+||+.+|.+|||+.++|.+
T Consensus 248 ~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRM----------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55321100 0112567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=301.03 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=189.1
Q ss_pred eeeccCCCeeEEEEEEcCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
+.||+|+||.||+|++..++. .+++|.+... ........+.+|++++.++ +||||+++++++... ...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEe
Confidence 358999999999999877775 4688877532 2344456788899999999 899999999998774 458999999
Q ss_pred ccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 199 MEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 199 ~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
+.++ +...+... ...+++..++.++.|++.||+|||+.|++||||||+|||+++++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 9864 44443221 1358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 263 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 263 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
++........ ......+..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----- 229 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----- 229 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-----
Confidence 9864321111 1112235679999988654 48999999999999999997 9999988776655554422100
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+....++.++.+|+.+||+.||.+|||+.+++.
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 -----------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0011246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.65 Aligned_cols=253 Identities=20% Similarity=0.253 Sum_probs=198.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 189 (410)
++|.+.+.||+|+||.||+|++. .++..||+|+++.... ....+.+.+|+.+|..+. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 67889999999999999999853 3456899999975432 333456788999999997 99999999998874
Q ss_pred ceEEEEEeeccCCHHHHhcCC-----------------------------------------------------------
Q 015247 190 CSLYLVFHYMEHDLAGLAASP----------------------------------------------------------- 210 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~----------------------------------------------------------- 210 (410)
...++||||+.++.+..+...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 459999999987544322211
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 211 ---------------------------------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 211 ---------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
...+++..+..++.||+.||.|||+.+++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 12467788899999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
+++.+||+|||+++.+..... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||......+.+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999986533221 1122345678899999887644 8899999999999999998 899998766555544
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
........+ .....++..+.+||.+||+.||.+||++.+++..
T Consensus 353 ~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333210000 0112567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=297.80 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=189.4
Q ss_pred eeeccCCCeeEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
+.||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++|||++++++++... ....+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 3457999987532 2334456778899999999999999999977543 3357899999
Q ss_pred ccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---CC
Q 015247 199 MEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK---HP 274 (410)
Q Consensus 199 ~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---~~ 274 (410)
+.++ +...+......+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9864 4444444445678888899999999999999999999999999999999999999999999976532211 11
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+++.|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+.... +.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~~-------------- 221 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--RL-------------- 221 (262)
T ss_pred cccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CC--------------
Confidence 1233457789999988764 48999999999999999999 567777766555444432210 00
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.+++..||..||++||++.+++..
T Consensus 222 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 222 ------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0012457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=304.59 Aligned_cols=258 Identities=20% Similarity=0.287 Sum_probs=196.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEc----------------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM----------------LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 179 (410)
++|++.+.||+|+||.||++++. .++..||+|.+.... .......+.+|+++++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 57999999999999999998643 234579999986543 3344567888999999999999999
Q ss_pred EeeeEeecCCceEEEEEeeccCC-HHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHD-LAGLAASP----------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 248 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 248 (410)
+++++... ...+++|||+.++ +...+... ...+++..+..++.||+.||+|||+.|++||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99998774 4589999999864 44433321 12477889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc--CCCCCCCCChH
Q 015247 249 LIDDDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 325 (410)
Q Consensus 249 Ll~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~pf~~~~~~ 325 (410)
|++.++.++|+|||++..+....... .....+++.|+|||...+. .++.++|+|||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998664332211 2223446789999987764 48999999999999999998 77889877666
Q ss_pred HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 326 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+.......... .... . ... .....+++.+.+|+..||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~--------~~~~-~--~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFR--------DQGR-Q--VYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHh--------hccc-c--ccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55543322110 0000 0 000 001246678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.94 Aligned_cols=251 Identities=23% Similarity=0.394 Sum_probs=207.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-C----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-G----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
..-+..+.||+|.||.||.|.-... | ..||+|.+.... +.+....|.+|..+|+.++|||||+++|++.+. .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--G 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--C
Confidence 5677889999999999999985432 2 248999886543 556677889999999999999999999999884 4
Q ss_pred eEEEEEeeccC-CHHHHhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 191 SLYLVFHYMEH-DLAGLAASP------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
..++++|||++ +|+.++... ...++..+...++.|||+|+.||+++++|||||...|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 58999999997 566666655 45799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCccc-cccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 264 ASFFDPNHKHPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 264 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
|+.+-.......... .-...|||||.+.... ++.++|||||||++||++| |..||++.++.+.+.-..+.-..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~--- 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD--- 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC---
Confidence 995432322222222 3356799999998744 9999999999999999998 889999999998887665532111
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+|+.+.++|..||+.+|++||++..+++
T Consensus 925 -------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 -------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11378999999999999999999999999887
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.73 Aligned_cols=239 Identities=18% Similarity=0.246 Sum_probs=186.2
Q ss_pred eeeccCCCeeEEEEEEcCCCc-------eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.||+|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.++|||++++++++... ...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEE
Confidence 368999999999998755443 48888875432 33345677899999999999999999998874 34899
Q ss_pred EEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--------EEEEeecccc
Q 015247 195 VFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--------LKIADFGLAS 265 (410)
Q Consensus 195 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vkl~DFGla~ 265 (410)
||||+.++.+. .+......+++..+..++.||+.||+|||+.||+||||||+|||++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999886554 44444557899999999999999999999999999999999999987765 6999999986
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
.... .....++..|+|||++.+...++.++||||||+++|+|++|. .||...+...... .....
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~--------- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDR--------- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcc---------
Confidence 5532 223467888999999876555889999999999999999995 6665554443322 11100
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+ ....+.++.+||.+||+.||.+|||++++++.
T Consensus 222 -~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 -HQL-------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -ccC-------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 11345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.52 Aligned_cols=281 Identities=31% Similarity=0.553 Sum_probs=227.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 191 (410)
.+|.-++.+|.|.- .|-.+.+...+++||+|.+..........++..+|...+..+.|+|+++++.+|..+.. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888999999988 77788888999999999886654344445667789999999999999999999875321 24
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+|||+|..++-.... -.+....+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|..-+..
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 79999999998877665 25678899999999999999999999999999999999999999999999999876544
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
...+.++.|..|+|||++.+.. |...+||||+||++.||++|+..|+|.+..++..++.+.+|+|...+.+...-...
T Consensus 172 -~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3467788999999999999876 99999999999999999999999999999999999999999999876543211111
Q ss_pred ccCCCCCc-----hhhhhhhh-h-------CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 352 TLFKPREP-----YKRCIQET-F-------KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 352 ~~~~~~~~-----~~~~~~~~-~-------~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
........ +....++. + +--+..+.||+.+||..||++|.+++++|+||||+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11111100 01111100 0 11234579999999999999999999999999997
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.14 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=197.7
Q ss_pred cceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----c
Q 015247 118 FEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 190 (410)
|.+.+.||+|+||.||+|... .+++.||||++..........+.+.+|+++++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999854 357899999997665555566778899999999999999999998765322 2
Q ss_pred eEEEEEeeccCCHHH-Hhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 191 SLYLVFHYMEHDLAG-LAA-----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
..+++++|+.++.+. .+. .....+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347888999865443 321 11235789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 265 SFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 265 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
......... ......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-L---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-C----
Confidence 876433211 112234567899999887644 8889999999999999999 8999988776655554432100 0
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0002567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=303.74 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=197.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence 679999999999999999999877776 46888876433 233344677899999999999999999988653 3
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++++|+++ ++..........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6789999986 455555555557899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+ .....++
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~--------- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP--------- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC---------
Confidence 221 122334577899999887644 8999999999999999997 89999876544433322 2110000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+..+.+++..||..||.+||++.++++.
T Consensus 232 ------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 ------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 002356678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=298.28 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=187.4
Q ss_pred eeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|... .....+|+|.+.... .......+.+|+.+++.++|+||+++++.+... ...+++|||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeC
Confidence 36899999999999643 234578888775433 333445677899999999999999999988774 4589999999
Q ss_pred cCCHHH-HhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-C
Q 015247 200 EHDLAG-LAASPE----VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-H 273 (410)
Q Consensus 200 ~~~l~~-~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 273 (410)
+++.+. .+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 875444 333221 2356888899999999999999999999999999999999999999999999865432211 1
Q ss_pred CCccccccccccccccccC------CcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 274 PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
......+++.|+|||++.. ...++.++|||||||++|||++ |..||......+.+..+........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL------- 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC-------
Confidence 1123345778999998742 2346889999999999999999 7889988777666655543221110
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+. +.....+++.+.+++..|+ .||.+|||++++++
T Consensus 231 --~~--------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 --PK--------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred --CC--------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 0011256777888999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.82 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=201.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcC-CCceEEEEEEecCC--------CChHHHHHHHHHHHHHHh-CCCCceeeEeeeEee
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDN--------LEPESVKFMAREILILRR-LDHPNVIKLEGLVTS 186 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 186 (410)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 67899999886432 122344567778888875 799999999999877
Q ss_pred cCCceEEEEEeeccCC-HHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEee
Q 015247 187 RMSCSLYLVFHYMEHD-LAGLA---ASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~-l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
....+++|||++++ +...+ ......+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 45699999999874 43332 2345579999999999999999999996 68999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
|++....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998765432 234556889999999987644 89999999999999999999999987776665555543211110
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+++.+.++|.+||+.||.+|||+.|+.++
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 002467789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.98 Aligned_cols=260 Identities=20% Similarity=0.188 Sum_probs=188.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCCh--HH-------HHHHHHHHHHHHhCCCCceeeEeee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEP--ES-------VKFMAREILILRRLDHPNVIKLEGL 183 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~--~~-------~~~~~~E~~~l~~l~h~niv~l~~~ 183 (410)
++|++.+.||+|+||.||+|++..+ +..+|+|+........ +. ......+...+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999998776 6677887654332110 00 0112223445566789999999886
Q ss_pred EeecCC--ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 184 VTSRMS--CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 184 ~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
...... .+.+++++++..++...... ....++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 554322 24578888887766654433 234688999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Q 015247 262 GLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335 (410)
Q Consensus 262 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~ 335 (410)
|+|+.+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+...........+.
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~- 248 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC- 248 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-
Confidence 999876432211 122346899999999887654 899999999999999999999999877432222111110
Q ss_pred CCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+++.....+ .......++.+.++++.|+..||.+||+..++++
T Consensus 249 -----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 -----DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000000 0011356788999999999999999999999875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.85 Aligned_cols=250 Identities=21% Similarity=0.237 Sum_probs=187.1
Q ss_pred eeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECC
Confidence 36899999999999754 3456799998865543 23344677899999999999999999988764 4589999999
Q ss_pred cCCHHH-HhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 015247 200 EHDLAG-LAAS----PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH- 273 (410)
Q Consensus 200 ~~~l~~-~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 273 (410)
+++.+. .+.. .....++..+..++.|++.||.|||+.+++||||||+||+++.+++++|+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 975444 3322 1235677888899999999999999999999999999999999999999999998754322211
Q ss_pred CCccccccccccccccccCC------cCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 274 PMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
......++..|+|||++.+. ..++.++|+||||+++|||++ |+.||......+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL--------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------
Confidence 11234567889999988542 135789999999999999996 99999877665544332221000
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
..+. +......++.+.+++..|+ .||.+|||+++++.
T Consensus 229 ~~~~--------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLPK--------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCC--------------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0000 0011245677899999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.93 Aligned_cols=257 Identities=22% Similarity=0.360 Sum_probs=199.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEc----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|+.. .++..||+|++...... .....+.+|+++++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57889999999999999999854 34789999998765433 34567889999999999999999999988766667
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|||+++ ++...+......+++..+..++.|++.||+|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 9999999976 555555444447999999999999999999999999999999999999999999999999999877532
Q ss_pred CCCC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-----------HHHHHHHhCC
Q 015247 271 HKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-----------LHKIYKLCGS 337 (410)
Q Consensus 271 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-----------~~~i~~~~~~ 337 (410)
.... .....++..|+|||.+.+. .++.++||||||+++|||++|..||........ ...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2211 1122345679999988765 488999999999999999999999865432210 1111111100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.. .. .....++.++.+|+.+||++||.+|||+.++++
T Consensus 242 ~~-------~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GE-------RL-----------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CC-------cC-----------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00 001245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.94 Aligned_cols=282 Identities=26% Similarity=0.402 Sum_probs=219.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--------CCceeeEeeeEee-
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--------HPNVIKLEGLVTS- 186 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~- 186 (410)
.+|.+.++||.|-|++||+|.+..+.+.||+|+.+.. +...+....|+.+|++++ ..+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6899999999999999999999999999999998742 344556777999999883 3579999999975
Q ss_pred -cCCceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCC----------
Q 015247 187 -RMSCSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDD---------- 253 (410)
Q Consensus 187 -~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~---------- 253 (410)
..+.+++||+|+++.+|+..+...+ ..++...++.|++||+.||.|||.. ||||.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 3456899999999999999886544 5699999999999999999999976 99999999999998110
Q ss_pred --------------------------------------------------------------------------------
Q 015247 254 -------------------------------------------------------------------------------- 253 (410)
Q Consensus 254 -------------------------------------------------------------------------------- 253 (410)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------------------------------------------------------------CcEE
Q 015247 254 ----------------------------------------------------------------------------GVLK 257 (410)
Q Consensus 254 ----------------------------------------------------------------------------~~vk 257 (410)
-++|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0145
Q ss_pred EEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC------ChHHHHHHH
Q 015247 258 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR------TEVEQLHKI 331 (410)
Q Consensus 258 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~------~~~~~~~~i 331 (410)
|+|||-|+..... .+....|..|+|||++.|.. |+..+||||++|+++||+||..+|... .+.+.+..|
T Consensus 395 IaDlGNACW~~kh----FT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhhhh----hchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 5555555543211 23334588899999999976 999999999999999999999999542 367889999
Q ss_pred HHHhCCCCHHHhhhCCCCCccc-----------CCCCCchhhhhhhhhCCC----CCCcHHHHHhccCCCCCCCCCHHHH
Q 015247 332 YKLCGSPSEEYWKKSKLPNATL-----------FKPREPYKRCIQETFKDF----PPSSLPLIETLLAIDPAERLTATVA 396 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~el 396 (410)
++++|..|..+...++.....+ ..+=..+ ..+.+.. .+ ..++.||+.-||+.+|++||||.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~-~VL~eKY-~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLY-EVLIEKY-EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHH-HHHHHHh-CCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 9999999877665554432211 1111111 1111111 23 3457899999999999999999999
Q ss_pred hcCCCCCCCCC
Q 015247 397 LNSEVIFQDRT 407 (410)
Q Consensus 397 L~hp~~~~~~~ 407 (410)
|+|||++..+.
T Consensus 548 l~hPwLn~~~~ 558 (590)
T KOG1290|consen 548 LKHPWLNPVAG 558 (590)
T ss_pred hcCccccCCCC
Confidence 99999997654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.29 Aligned_cols=241 Identities=23% Similarity=0.413 Sum_probs=195.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||++. .+++.||+|.++... ....+.+|+.++..++|||++++++++... ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEE
Confidence 679999999999999999986 578899999986432 234677899999999999999999988653 37899
Q ss_pred EeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||+.+ ++...+... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999986 555554433 346899999999999999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------------- 216 (254)
T ss_pred -CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---------------
Confidence 1222345679999988764 48899999999999999997 99999888766555444321000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+++.+||+.+|.+|||+.+++.
T Consensus 217 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 -------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.87 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=192.1
Q ss_pred eeeccCCCeeEEEEEEcCCC------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTG------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.||+|+||.||+|++.... +.+|+|.+.... .......+.+|+++++.++||||+++++++... ...+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEE
Confidence 36899999999999875433 689999886432 223455678899999999999999999998764 458999
Q ss_pred EeeccCC-HHHHhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-----cEEEEeecc
Q 015247 196 FHYMEHD-LAGLAAS------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGL 263 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-----~vkl~DFGl 263 (410)
|||++++ +...+.. ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999864 4444322 223578999999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 264 ASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 264 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
+........ .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----- 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR----- 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-----
Confidence 976533221 1112334578899999887654 8999999999999999998 9999988777665554422100
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+|..+.+||.+||.++|.+||++.++++
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 -----------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0111256788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.59 Aligned_cols=236 Identities=21% Similarity=0.290 Sum_probs=184.9
Q ss_pred eeeccCCCeeEEEEEEcCCC----------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 122 DKIGQGTYSNVYKAKDMLTG----------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36899999999999987666 35778876543211 4567889999999999999999998876 23
Q ss_pred EEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-------cEEEEeecc
Q 015247 192 LYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-------VLKIADFGL 263 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-------~vkl~DFGl 263 (410)
.+++|||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 7899999998766555443 33789999999999999999999999999999999999999888 799999999
Q ss_pred ccccCCCCCCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 264 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
+..... .....++..|+|||++.+. ..++.++||||||+++|+|++ |..||...+..+....... .
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~------ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q------ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C------
Confidence 986543 1234566789999998765 358899999999999999999 5777766653332221110 0
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...+ ......+.++|.+||..||.+|||+.++++
T Consensus 223 ----~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----HRLP-------------------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----CCCC-------------------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 012267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=294.38 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=208.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-CCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR-LDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++.+-+..||.|+||+|++..++.+|+..|||.++..+...+ ..+++.|.+...+ -+.||||+++|....+.. -|+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eee
Confidence 567778899999999999999999999999999998776444 4456667776555 479999999998877544 899
Q ss_pred EEeeccCCHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.||.|+-++..++. -.+..++|..+-.+...++.||.||-.. +|+|||+||+|||++..|.+||||||.+-.+..
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999987665442 3445799999999999999999999975 899999999999999999999999999977643
Q ss_pred CCCCCCccccccccccccccccCCcC-CCCccchHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAGKPIMPGRTE-VEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGv~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
+. ..+..+|-..|||||.+..... |+.+|||||||++|||++||+.|+.+=+. .+++..++. |.|+.-.
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~----- 291 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL----- 291 (361)
T ss_pred HH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec-----
Confidence 22 2344567778999999975443 99999999999999999999999876443 344444432 3332110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
......+++..+..||..||.+|-+.||.-.+++.+||++-
T Consensus 292 ----------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 292 ----------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ----------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 00111357888999999999999999999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=294.45 Aligned_cols=229 Identities=26% Similarity=0.325 Sum_probs=182.0
Q ss_pred CCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHH
Q 015247 127 GTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206 (410)
Q Consensus 127 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 206 (410)
|.||.||++++..+++.||+|.++... ...+|...+....|||++++++++... ...+++|||++++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHH
Confidence 899999999999999999999997543 122355555566799999999988774 46999999999755444
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccc
Q 015247 207 AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286 (410)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~a 286 (410)
.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||++...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4334446999999999999999999999999999999999999999999999999988765432 223455778999
Q ss_pred cccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhh
Q 015247 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQE 366 (410)
Q Consensus 287 PE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (410)
||.+.+. .++.++|+||+|+++|||++|+.||...... +. . ... ..
T Consensus 151 PE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------~----~~~------------~~ 196 (237)
T cd05576 151 PEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------T----HTT------------LN 196 (237)
T ss_pred CcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------c----ccc------------cC
Confidence 9987654 4889999999999999999999877432110 00 0 000 01
Q ss_pred hhCCCCCCcHHHHHhccCCCCCCCCCH-----HHHhcCCCC
Q 015247 367 TFKDFPPSSLPLIETLLAIDPAERLTA-----TVALNSEVI 402 (410)
Q Consensus 367 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~elL~hp~~ 402 (410)
....+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 113567889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=316.07 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=218.2
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee---c
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS---R 187 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---~ 187 (410)
+...+.|++..+||.|.||.||++++..+++..|+|++...... .+.+..|.++|+.+ .|||++.++|+|.. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34457899999999999999999999999999999998765433 33466689999987 69999999999864 3
Q ss_pred CCceEEEEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.+..+|||||||+++....+.+ .+..+.|..+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 4567999999999976665532 25689999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccCC----cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
.++.. .....+..|||.|||||++... ..|+..+|+||||++..||.-|.+|+........+-.| ...|+..
T Consensus 172 QldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk 247 (953)
T KOG0587|consen 172 QLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK 247 (953)
T ss_pred eeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc
Confidence 88643 4456778999999999998642 23777999999999999999999999887765444333 2223221
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. ..+..-+.++.+||..||.+|-.+||+..++|.|||+++.+
T Consensus 248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 1 00124577899999999999999999999999999999654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.50 Aligned_cols=250 Identities=18% Similarity=0.249 Sum_probs=186.1
Q ss_pred eeeccCCCeeEEEEEEcCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLT--GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+++...+ ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+... ...|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecC
Confidence 3699999999999975333 2346677665433 233456788899999999999999999998874 4589999999
Q ss_pred cCCHHH-HhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CCC
Q 015247 200 EHDLAG-LAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-KHP 274 (410)
Q Consensus 200 ~~~l~~-~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~ 274 (410)
.++.+. .+... ...+++..++.++.||+.||.|||+.+++||||||+|||++.++.++|+|||++....... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 975444 33322 2356778888999999999999999999999999999999999999999999986432111 112
Q ss_pred CccccccccccccccccCC------cCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 275 MTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.....++..|+|||++... ..++.++|||||||++|||++ |..||...+..+.+..+.+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK--------- 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---------
Confidence 2345678899999987431 235789999999999999997 577888777766666554321100
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+. +.....+++.+.+++..|+ .||.+|||+.++++
T Consensus 229 ~~~--------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 LFK--------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCC--------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 0111246778899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.54 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=210.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-CCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-TGK--IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++..+.++||+|.||+|++|.+.. +|+ .||||.++.+.... ....|++|+.+|.+|+|+|+++|||++.++. +
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp---~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP---A 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch---h
Confidence 567788999999999999998653 344 68999998776554 5778999999999999999999999998732 7
Q ss_pred EEEEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 193 YLVFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+|||.+.. +|++.+.+ ....|.......|+.||+.||.||.++++|||||...|+|+-..-.|||+||||++.++.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999986 45555544 5678999999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCCc--cccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKHPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
...... .....+.|+|||.+.-. .++.++|||+|||++|||++ |..||.|....+++++|-+.-..
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL---------- 334 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL---------- 334 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC----------
Confidence 554321 22346779999988764 49999999999999999998 78999999999999888542111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+.+|+++.+++..||..+|.+|||+..+.+.
T Consensus 335 ------------------pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 ------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1124789999999999999999999999887543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=300.32 Aligned_cols=268 Identities=23% Similarity=0.379 Sum_probs=216.5
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-----ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-----EPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 187 (410)
...++|-++..||+|||+.||++.+....+.||+|+-..+.. .....+...+|.+|-+.|+||.||++|++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 346789999999999999999999999999999998655432 222345667899999999999999999999765
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcC---CCcEEEEeec
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDD---DGVLKIADFG 262 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~---~~~vkl~DFG 262 (410)
...++.|+|||+|+.++++++....+++.+++.|+.||+.||.||.+. .|||-||||.|||+.. -|.+||+|||
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 345899999999999999998888999999999999999999999987 5999999999999954 4789999999
Q ss_pred cccccCCCCCC------CCccccccccccccccccC---CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 015247 263 LASFFDPNHKH------PMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 263 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~ 333 (410)
|++..+..... .++...||.||++||.+.- .+..+.++||||+|||+|..+.|+.||........ |++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---ILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---ILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---HHh
Confidence 99988643322 2445688999999999863 24578899999999999999999999987644332 222
Q ss_pred HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
....... .+..+|. . +.+++++++||++||++--++|....++-.||+|.-
T Consensus 696 eNTIlkA---tEVqFP~-------K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKA---TEVQFPP-------K----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcc---eeccCCC-------C----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1100000 1112221 1 368899999999999999999999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=306.76 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred cceeeeeccCCCeeEEEEEEcC--CCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDML--TGK--IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
....+.||.|.||.||.|.-.. .|. -||||..+.+. +.+..+.|..|..+|++++|||||+|+|++.+.. .|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---MW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---ee
Confidence 3444689999999999997432 233 58999886543 4555788999999999999999999999998753 89
Q ss_pred EEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||.+.-+.+. ++......++......++.||+.||+|||+.++|||||...|||+....-|||+||||++.+.....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999865554 5556667899999999999999999999999999999999999999999999999999999876555
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
...+...-...|||||.+.-. .++.++|||.|||++||++. |..||.+..+.+.+-.|.+.-..|.
T Consensus 547 YkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~------------ 613 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC------------ 613 (974)
T ss_pred hhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC------------
Confidence 444444457789999988654 49999999999999999865 9999999988887766654322221
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
.+++|+.+..|+.+||++||.+||++.++.
T Consensus 614 ----------------P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 614 ----------------PPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ----------------CCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 248999999999999999999999987764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.09 Aligned_cols=201 Identities=33% Similarity=0.529 Sum_probs=171.1
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----CceEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCSLY 193 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~ 193 (410)
+...+.||+|+||.||+++++.+|..||||.++... .....+...+|+++|++++|+|||++.++-+... ...-.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455677999999999999999999999999987644 3344666778999999999999999988766554 44568
Q ss_pred EEEeeccCCHHHHhc-CC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCC--cEEEEeeccccc
Q 015247 194 LVFHYMEHDLAGLAA-SP--EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDG--VLKIADFGLASF 266 (410)
Q Consensus 194 lv~e~~~~~l~~~~~-~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~--~vkl~DFGla~~ 266 (410)
++||||.++.+.... .+ ...+++.+...++.++..||.|||++||+||||||.||++- .+| .-||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999986655443 32 24699999999999999999999999999999999999984 445 369999999999
Q ss_pred cCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 321 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 321 (410)
++.+. ...+.+||..|++||++.....|+..+|.|||||++|+.+||..||-.
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 87554 578899999999999998555699999999999999999999999954
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=314.80 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=217.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
....+.++||.|.||.|+.|+.+..|+ .||||.++... .+.+...|+.|+.||.+.+||||++|.|++... ..+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--KPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--cee
Confidence 456788999999999999999876664 79999997544 555677888999999999999999999999874 448
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.|+.|||+.+ |..++..+++.|+..+...+++.|+.||.||-+.|+|||||.+.|||++.+..+|++||||++.+..+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999975 445667777899999999999999999999999999999999999999999999999999999886555
Q ss_pred CCCCccccc--cccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
....++.-| ...|-|||.+.- .+++.++||||+||++||.++ |..|+...++.+.+..|.+..+.|+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------- 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------- 856 (996)
T ss_pred CccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--------
Confidence 333333333 678999998875 459999999999999999765 99999999999999999987776654
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.++|..+..|+..||++|-.+||++.|++++
T Consensus 857 --------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3899999999999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.29 Aligned_cols=275 Identities=24% Similarity=0.310 Sum_probs=186.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEc----------------CCCceEEEEEEecCCCCh------------HHHHHHHHH
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDM----------------LTGKIVALKKVRFDNLEP------------ESVKFMARE 165 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E 165 (410)
..++|++.++||+|+||+||+|... ..++.||||.+....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3579999999999999999999642 345689999986532110 011223347
Q ss_pred HHHHHhCCCCce-----eeEeeeEeec------CCceEEEEEeeccCCHHHHhcCC------------------------
Q 015247 166 ILILRRLDHPNV-----IKLEGLVTSR------MSCSLYLVFHYMEHDLAGLAASP------------------------ 210 (410)
Q Consensus 166 ~~~l~~l~h~ni-----v~l~~~~~~~------~~~~~~lv~e~~~~~l~~~~~~~------------------------ 210 (410)
+.++.+++|.++ ++++++|... .....++||||++++.+..+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 5666766532 12357999999997544433211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccc
Q 015247 211 EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290 (410)
Q Consensus 211 ~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 290 (410)
...+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12346778999999999999999999999999999999999999999999999976543322222223458999999987
Q ss_pred cCCcC-------------------CC--CccchHHHHHHHHHHHcCCC-CCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 291 LGATD-------------------YG--VGVDLWSAGCILAELLAGKP-IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 291 ~~~~~-------------------~~--~~~DiwSlGv~l~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
..... |+ .+.|+||+||++|+|++|.. ||.+...... ..+.. ......|...+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc-cchHHHHHhhcc
Confidence 53210 12 24799999999999999985 6654322111 11100 000111211110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCC---CCCCCHHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDP---AERLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~elL~hp~~~~ 404 (410)
... -...++..++..+||+.+||.++| .+|+|+.|+|+||||..
T Consensus 459 ~~~------------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKY------------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCC------------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 001234678999999999999876 68999999999999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=296.81 Aligned_cols=254 Identities=21% Similarity=0.376 Sum_probs=208.8
Q ss_pred cCCCCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec
Q 015247 108 NGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (410)
Q Consensus 108 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 187 (410)
+.|.-.+ .+....++||-|.||.||.|.++.-...||||.++-+. -.++.|+.|+.+|+.++|||+|+|+|+|..+
T Consensus 260 DkWEmeR-tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMER-TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccc-hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4553333 35667789999999999999998888999999987543 3467789999999999999999999999985
Q ss_pred CCceEEEEEeecc-CCHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 188 MSCSLYLVFHYME-HDLAGLAASPEV-KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 188 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.. +||++|||. |+|++++...+. -++......++.||..||.||..+++|||||...|.|+.++..||++||||++
T Consensus 336 pP--FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 336 PP--FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CC--eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 44 999999997 578887766553 46777778889999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
++..+.............|-|||.+.- +.++.++|||+|||+|||+.| |-.||+|.+-.+.+..+.+...
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR-------- 484 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR-------- 484 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------
Confidence 986554322223334677999998754 458999999999999999987 8899999988777665544211
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 396 (410)
.+...++|+.+.+|++.||++.|++||++.++
T Consensus 485 --------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 485 --------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 11224899999999999999999999998775
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.62 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=207.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+...+.++||+|-||.|.+|+ ...+..||+|.++.... ......|.+|+.+|.+++|||||.++|+|..++. ++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHH
Confidence 457788999999999999998 35579999999976553 3446779999999999999999999999988554 9999
Q ss_pred EeeccCCHHHH-hcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGL-AASPEVK-FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~-~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|||+.+.+.. +.....+ +.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-++..+
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999765554 4433222 355566679999999999999999999999999999999999999999999977555544
Q ss_pred CCc-cccccccccccccccCCcCCCCccchHHHHHHHHHHH--cCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 274 PMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL--AGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 274 ~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
... ..+-...|||||.+.... ++.++|+|+||+++||++ +...||...++.+..++.......+....
T Consensus 694 ~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~-------- 764 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV-------- 764 (807)
T ss_pred eeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--------
Confidence 333 345578999999998754 999999999999999975 57789998888888877766544333210
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......-+|..+.+||..|+..|-++|||++++-.
T Consensus 765 -------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 -------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11122468889999999999999999999999843
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=274.71 Aligned_cols=243 Identities=39% Similarity=0.617 Sum_probs=195.3
Q ss_pred CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHh
Q 015247 128 TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA 207 (410)
Q Consensus 128 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~ 207 (410)
+||.||+|....+|+.+|+|++........ .+.+.+|++.+++++|+|++++++.+... ...++++||++++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999888899999999876543322 56788899999999999999999988874 468999999998444434
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccccccccccc
Q 015247 208 ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287 (410)
Q Consensus 208 ~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 287 (410)
......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 3333348999999999999999999999999999999999999999999999999998775432 23455678899999
Q ss_pred ccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhh
Q 015247 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQE 366 (410)
Q Consensus 288 E~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (410)
|.+.+. .++.++|+||||+++|+|++|..||......+. ...+.........
T Consensus 156 E~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------- 208 (244)
T smart00220 156 EVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-------------------------- 208 (244)
T ss_pred HHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--------------------------
Confidence 988754 478899999999999999999999987433333 3322211100000
Q ss_pred hhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 367 TFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 367 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
....++.++.+++.+||..||.+||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 001277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=305.93 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=194.0
Q ss_pred CCcceeeeeccCCCee-EEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSN-VYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
.-|.--+++|.|+.|+ ||+|. ..|+.||||.+- .+..+...+|+..|+.- .|||||++ ||.++...+.|
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~Y 579 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGV--YEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLY 579 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEe--eCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceEE
Confidence 3456667899999885 89996 789999999874 34456678899999988 69999999 55566678899
Q ss_pred EEEeeccCCHHHHhcCC--CCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---C--CcEEEEeecccc
Q 015247 194 LVFHYMEHDLAGLAASP--EVK-FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---D--GVLKIADFGLAS 265 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~--~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~--~~vkl~DFGla~ 265 (410)
|..|.|..+|.++.... ... ......+.++.|++.||++||+.+||||||||.||||+. + .+++|+|||+++
T Consensus 580 IalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 580 IALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99999999999888763 111 112456788899999999999999999999999999986 3 478999999999
Q ss_pred ccCCCCCCC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 266 FFDPNHKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 266 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
.+..+.... .....||-+|+|||++.... -+.++|||||||++|+.++| ..||...-. .-.+|.... ...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~--~~L-- 732 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGN--YTL-- 732 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCc--cce--
Confidence 987655432 34567899999999998755 56799999999999999987 788865432 223333211 000
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
......-..++.|||.+||++||..||+|.++|.||||=.
T Consensus 733 ----------------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 733 ----------------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ----------------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0000011127899999999999999999999999999943
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=252.40 Aligned_cols=217 Identities=25% Similarity=0.399 Sum_probs=180.9
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
....++...+..||+|+||.|-+.++..+|+..|+|.+...... ...+.+++|+++..+. .+|.+|.++|..... .
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--g 118 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--G 118 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--c
Confidence 34457777888999999999999999999999999999765433 4455677799887765 799999999977664 4
Q ss_pred eEEEEEeeccCCHHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 191 SLYLVFHYMEHDLAGLA---ASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
.+++.||.|..++..+. ...++.++|..+-+++..++.||.|||++ .++|||+||+||||+.+|++|+||||.+-.
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 49999999998876544 56788999999999999999999999987 899999999999999999999999999987
Q ss_pred cCCCCCCCCccccccccccccccccC---CcCCCCccchHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHH
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEVEQLHKIYK 333 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGv~l~ell~g~~pf~~-~~~~~~~~~i~~ 333 (410)
+..+-. .+-..|-..|+|||.+.. ...|+.++||||||+++.||.+++.|+.. .+..+++.++++
T Consensus 199 L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 743222 122456677999999853 23589999999999999999999999965 677788888776
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=277.98 Aligned_cols=281 Identities=30% Similarity=0.481 Sum_probs=208.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
..+.|..+++||.|.|++||++.+.. .+..||+|.+..... ...+.+|+++|..+ .+.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd- 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNND- 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCC-
Confidence 34679999999999999999999877 788999999875432 33478899999999 5999999999888744
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeeccccccC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFD 268 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~ 268 (410)
.+.+|+||+++.....+.. .++...++.+++.++.||.++|.+|||||||||+|+|.+ ..++-.|+|||||...+
T Consensus 109 -~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 109 -QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred -eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 4999999999865544433 467899999999999999999999999999999999998 56789999999996211
Q ss_pred CC-------------------------------------------CCCCCccccccccccccccccCCcCCCCccchHHH
Q 015247 269 PN-------------------------------------------HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSA 305 (410)
Q Consensus 269 ~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 305 (410)
.. .........||++|+|||++.....-++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 00001235789999999999988878899999999
Q ss_pred HHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHH----------HhhhCCCCCc------------ccCCCCCchhh
Q 015247 306 GCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEE----------YWKKSKLPNA------------TLFKPREPYKR 362 (410)
Q Consensus 306 Gv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~----------~~~~~~~~~~------------~~~~~~~~~~~ 362 (410)
|||++-+++++.||... ++.+.+..|....|...-. .|.....+.. ..+.+.... +
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~-n 343 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP-N 343 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc-c
Confidence 99999999999998654 4444445554444432211 1221111100 000000000 0
Q ss_pred hhhhhh-CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 363 CIQETF-KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 363 ~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+..+.. ..++..+.||+.+||..||.+|.||+++|.||||++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 111111 234557899999999999999999999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.93 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=183.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..|...+.||+|+||.||+|++..++..||+|.+...... ...|++++++++|||||++++++... ...|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEE
Confidence 3466778999999999999998899999999988643211 12368889999999999999999874 358999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH---NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||++++.+..+.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999766655543 4889999999999999999999 6699999999999999999888875 666544321
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCC-CCHHHhhhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGS-PSEEYWKKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~-~~~~~~~~~~~~~ 350 (410)
.....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... .......+.... .....|......
T Consensus 835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 910 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR- 910 (968)
T ss_pred --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc-
Confidence 1234678999999988764 4999999999999999999999998542211 111111111000 000000000000
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.... .......++.+++.+||+.||++|||+.|+++.
T Consensus 911 -----~~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 911 -----GDVS-------VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -----CCCC-------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 000112346789999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.70 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=221.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+.+..+|+|.||.||+++++.+++..|+|+++.... +...-+.+|+-+++..+|||||.+++.+..+.. +++.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwic 90 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWIC 90 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcC--cEEE
Confidence 789999999999999999999999999999999987653 335567789999999999999999998877544 9999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||||+++.++..-.-.+++++.++....++.+.||+|||+.|-+|||||-.|||+++.|.+|+.|||.+..+... ....
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Kr 169 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKR 169 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhhh
Confidence 999999888888777789999999999999999999999999999999999999999999999999999877532 2234
Q ss_pred cccccccccccccccc--CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 276 TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.++.||+.|||||+.. ....|+..+|||++|+...|+-.-++|.........+..+-+....|+. .
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------------l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------------L 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------------c
Confidence 5678999999999863 2334999999999999999999999888777777666666554333331 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.++ ..-++.+.+|++.+|.++|.+|||++.+|.|||..+.
T Consensus 238 kDk------------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 238 KDK------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cCC------------ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 111 1346778999999999999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.09 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEc---C----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM---L----TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
++.++.+.||+|.||.|++|.-. . ....||||.++..... ...+.+..|+++|+.+ +|+||+.+.|++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 44567779999999999999732 1 1457999998765544 6677899999999998 59999999999988
Q ss_pred CCceEEEEEeeccC-CHHHHhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 188 MSCSLYLVFHYMEH-DLAGLAASPE---------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
.+.+++|+||+.. +++.++.... ..++..+...++.||+.|++||++.++|||||...|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 5569999999986 4555554443 2489999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCCCCcccc--ccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCC-hHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKHPMTSRV--VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT-EVEQ 327 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~-~~~~ 327 (410)
++..+||+|||+|+.............. -...|||||.+.. ..|+.++|||||||+||||++ |..|+++.. ..+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999999865433332212222 2345999999987 459999999999999999998 788998855 4444
Q ss_pred HHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 328 LHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 328 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
++.+.++.. .+....+++++.+++..||+.+|++||++.++..
T Consensus 532 ~~~l~~G~r----------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKEGNR----------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 443322111 0112367899999999999999999999988753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=268.89 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=187.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeEeeeEeecC--Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSRM--SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--~~ 190 (410)
....++++.||+|.||.||+|+ -+++.||||++.. +....+.+|.+|... ++|+||++++++-.... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 4567888999999999999996 5679999999863 445667778887775 58999999977643321 34
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEcCCCcEEEEee
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN---------GVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
.++||++|.+.+.+..++..+ .++|....+++..|+.||+|||+. .|+|||||..||||..|++..|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 589999999876665555444 789999999999999999999963 5999999999999999999999999
Q ss_pred ccccccCCCCCC-CCccccccccccccccccCCcCCC-----CccchHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHH
Q 015247 262 GLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYG-----VGVDLWSAGCILAELLAGKPIMP-GRTEVEQLHKIYKL 334 (410)
Q Consensus 262 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlGv~l~ell~g~~pf~-~~~~~~~~~~i~~~ 334 (410)
|||..+.++... .+...+||..|||||++.|...+. .+.||||+|.+||||++....+. +....=++. ....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp-fe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP-FEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc-hhHH
Confidence 999988755432 234579999999999998865554 36899999999999999765443 211110000 0001
Q ss_pred hC-CCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCC--CCCCcHHHHHhccCCCCCCCCCHH
Q 015247 335 CG-SPSEEYWKKSKLPNATLFKPREPYKRCIQETFKD--FPPSSLPLIETLLAIDPAERLTAT 394 (410)
Q Consensus 335 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~ 394 (410)
+| .|..+..+..-. .... +..+++.|.. ....+++.+..||+.||+-|.||.
T Consensus 440 vG~hPt~e~mq~~VV----~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVV----RKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hcCCCCHHHHHHHHH----hhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 11 111111000000 0000 0112222222 234579999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.05 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=177.2
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh------HHHHHHHHHHHHHHhCC---CCceeeEee
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------ESVKFMAREILILRRLD---HPNVIKLEG 182 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~ 182 (410)
.....+|..++.||.|+||.|++|.++.+...|+||.|.+.++-. ...-.+-.|++||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344567999999999999999999999999999999998765411 11223456999999997 999999999
Q ss_pred eEeecCCceEEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 183 LVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
+|++ ..++|++||--+.+ .+..+......++|.+++.+++|++.|+++||++||||||||-+|+.++.+|-+||+||
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9998 56799999987653 34445566678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 321 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 321 (410)
|.|.....+. ...++||..|.|||++.|..+.+..-|||++|++||.++....||++
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998876544 46789999999999998877778899999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=280.03 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=203.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.....++||+|+||+||+|.....|+ +||+|++.... .......+..|+.+|.+++|||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence 45667899999999999998877665 78999886544 3344567888999999999999999999988643 7
Q ss_pred EEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.||++||+. .|+++....+..+-......|..||++||.|||.+++|||||...|||+..-.++||.|||+++.+.+..
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 899999996 5677777777889999999999999999999999999999999999999999999999999999987665
Q ss_pred CCCCcc-ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 KHPMTS-RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
...... -...+.|||-|.+... .|+.++|||||||++||++| |..|+.+....++-..+.+... +
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-----------L- 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-----------L- 919 (1177)
T ss_pred ccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-----------C-
Confidence 543222 2336779999988764 49999999999999999988 8899988877665444432111 0
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
...+..+-++.-++.+||..|+..||+++++-
T Consensus 920 ----------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 920 ----------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred ----------------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 11136788899999999999999999998874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=253.68 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=182.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeEeeeEee--cCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTS--RMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--~~~~~ 191 (410)
.+..+.+.||+|.||.||+|+ ..|..||||++.... + ....+|.+|.+. |+|+||+.+++.-.. .....
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd--E---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD--E---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecc--ccCCceEEEEecccc--h---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 578899999999999999996 789999999986322 2 234456666664 699999999775432 22346
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
+|||.+|-+.+.+..++.+ ..++...+.+++..++.||++||.. .|.|||||..|||+..+|.+.|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999998766666665 4899999999999999999999963 499999999999999999999999999
Q ss_pred ccccCCCCCC---CCccccccccccccccccCCcCCC-----CccchHHHHHHHHHHHcC----------CCCCCCCC--
Q 015247 264 ASFFDPNHKH---PMTSRVVTLWYRPPELLLGATDYG-----VGVDLWSAGCILAELLAG----------KPIMPGRT-- 323 (410)
Q Consensus 264 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlGv~l~ell~g----------~~pf~~~~-- 323 (410)
|....+.... ..+..+||..|||||++....... ..+||||||.++||++.. .+||....
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9877654322 345679999999999986532211 368999999999999863 25665422
Q ss_pred --hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCC--CCcHHHHHhccCCCCCCCCCHHHH
Q 015247 324 --EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFP--PSSLPLIETLLAIDPAERLTATVA 396 (410)
Q Consensus 324 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~el 396 (410)
..+.+.+++-.-. ++..++..|...+ ..+-.+|+.||..||.-|.||-.+
T Consensus 443 DPs~eeMrkVVCv~~-----------------------~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQK-----------------------LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCHHHHhcceeecc-----------------------cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 2223332221100 0111111111111 235778999999999999997544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=231.53 Aligned_cols=213 Identities=39% Similarity=0.645 Sum_probs=179.4
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccC-C
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-D 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~ 202 (410)
||+|++|.||++....+++.+++|++....... ....+.+|++.++.++|++++++++++... ...++++|++.+ .
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999987779999999987654322 346788899999999999999999988874 569999999995 5
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCCCCcccccc
Q 015247 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVT 281 (410)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt 281 (410)
+..........+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 55544443357899999999999999999999999999999999999999 89999999999987654321 12345568
Q ss_pred ccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchh
Q 015247 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYK 361 (410)
Q Consensus 282 ~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (410)
..|++||.+.....++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999887643578899999999999999
Q ss_pred hhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 362 RCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 362 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
..+.+++..||+.||.+||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1255689999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=288.88 Aligned_cols=203 Identities=17% Similarity=0.194 Sum_probs=145.4
Q ss_pred CCC-CceeeEeeeEeec-----CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 015247 172 LDH-PNVIKLEGLVTSR-----MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKG 245 (410)
Q Consensus 172 l~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 245 (410)
++| +||+++++.|... ....+++++|+++++|...+......+++..++.++.||+.||.|||++||+||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 344 4677777766211 1235788899999988888766666799999999999999999999999999999999
Q ss_pred CCEEEcCCCc-------------------EEEEeeccccccCCCC---------------CCCCcccccccccccccccc
Q 015247 246 SNLLIDDDGV-------------------LKIADFGLASFFDPNH---------------KHPMTSRVVTLWYRPPELLL 291 (410)
Q Consensus 246 ~NILl~~~~~-------------------vkl~DFGla~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~ 291 (410)
+||||+..+. +|++|||+++...... .......+||++|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999965444 5555556554321100 00011246799999999988
Q ss_pred CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCC
Q 015247 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDF 371 (410)
Q Consensus 292 ~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (410)
+.. |+.++|||||||+||||++|.+|+.... ..+..+.... .++. ....
T Consensus 189 ~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~---------------------------~~~~ 237 (793)
T PLN00181 189 GSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ---------------------------ILLN 237 (793)
T ss_pred cCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh---------------------------hhhc
Confidence 754 8999999999999999999988865322 1222221110 0000 0011
Q ss_pred CCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 372 PPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 372 ~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+...+++..||++||.+|||+.|+|+||||.+.
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 2345789999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=231.56 Aligned_cols=213 Identities=38% Similarity=0.603 Sum_probs=174.1
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e 197 (410)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|++.+..++|+|++++++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEe
Confidence 56788999999999999998888999999998765433 2466788899999999999999999988764 45899999
Q ss_pred eccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 198 YMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 198 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
++.+ .+..........+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998 454444333222899999999999999999999999999999999999999999999999999877544211224
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC-CChH-HHHHHHHH
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEV-EQLHKIYK 333 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~-~~~~-~~~~~i~~ 333 (410)
...++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+.. ...+.+..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 456788899999874334578899999999999999999999987 4444 44555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=230.61 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=200.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++++....+-+|.||.||.|..+. +.+.|-+|.++ +...+-+...+..|...+..+.|||+..+.++..+. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-c
Confidence 4678888899999999999995432 23456677764 333555677888999999999999999999988764 4
Q ss_pred ceEEEEEeeccCCHHH-Hhc-----C--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 190 CSLYLVFHYMEHDLAG-LAA-----S--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~-----~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
...++.+.+++-+.+. ++. + .-..++..+...++.|++.|++|||++|+||.||...|.+||+..++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 4577888888854443 333 1 1235778888999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCcc-ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCC
Q 015247 262 GLASFFDPNHKHPMTS-RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPS 339 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 339 (410)
.+++.+-+.+.+-... .--...||+||.+.... |+.++|+|||||++|||+| |+.|+...+..+....+.+...
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR--- 516 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR--- 516 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce---
Confidence 9999886665443221 11256799999998754 9999999999999999998 8899999998888776654321
Q ss_pred HHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
+.+| -++|+++..++.-||..+|++||+..|+.
T Consensus 517 -------------laQP------------~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 517 -------------LAQP------------FNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred -------------ecCC------------CCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 1111 28999999999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=223.99 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=184.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
.+.|.+.+.||+|-||.+-+++++.+.+.+++|.+..... ..+.|.+|..---.| .|.||+.-|++.... ..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 4789999999999999999999999999999999876543 345677787766666 589999887654332 44788
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCCcEEEEeeccccccCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~~ 271 (410)
+++||++-+.+..-... ..+-|...+.++.|++.|+.|||++++||||||.+||||- +..+|||||||+....+..-
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999997666544443 3578999999999999999999999999999999999995 34589999999987654221
Q ss_pred CCCCccccccccccccccccCC----cCCCCccchHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHhhhC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 346 (410)
...-.+..|.|||..... ....+.+|+|.||+++|.++||..||......+ -+.+..+. ...
T Consensus 178 ----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w---------~~r 244 (378)
T KOG1345|consen 178 ----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW---------LKR 244 (378)
T ss_pred ----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH---------hcc
Confidence 122236669999976432 225678999999999999999999997432211 12222221 111
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 390 (410)
+-+ .++..++.+++.+..+.++-|..+|.+|
T Consensus 245 k~~-------------~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 245 KNP-------------ALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cCc-------------cCchhhcccCHHHHHHHHHhcCCccccc
Confidence 111 2344556788999999999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=216.88 Aligned_cols=167 Identities=21% Similarity=0.255 Sum_probs=127.7
Q ss_pred CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 201 HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
|+|.+.+...+..+++..++.++.||+.||.|||+.+ ||+|||++.++.+++ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCC
Confidence 3455555555667999999999999999999999998 999999999999999 99998764322 257
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCc
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP 359 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (410)
|+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..+......... . ..
T Consensus 67 ~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~---~~---- 129 (176)
T smart00750 67 DPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------R---DR---- 129 (176)
T ss_pred cccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---------c---cc----
Confidence 89999999987754 899999999999999999999999765443 233333322111000 0 00
Q ss_pred hhhhhhhhhCCCCC--CcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 360 YKRCIQETFKDFPP--SSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 360 ~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....+++ .+.++|.+||+.||.+|||+.+++.|+|+..
T Consensus 130 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 ------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00012333 6999999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=252.81 Aligned_cols=265 Identities=26% Similarity=0.323 Sum_probs=199.3
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEec----CCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF----DNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.....+|.|++|.|+.+......+.++.|..+. ..........+..|+-+-..+.|||++.....+.+... .+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chh
Confidence 456789999999999888777666666665542 11122222236667777788899999887766665433 344
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 272 (410)
+||||+. .+..+....+.+...++..++.|++.|+.|||+.||.|||+|++|+++..+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 4999999 4444444446889999999999999999999999999999999999999999999999999988754443
Q ss_pred -CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCCHHHhhhCCCCC
Q 015247 273 -HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH-KIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......+|+..|+|||++.+...-....||||.|++++.|++|+.||......+... .+... .+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~--------------~~ 543 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS--------------DQ 543 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc--------------cc
Confidence 456678899999999999886633457999999999999999999997654433221 11000 00
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. ........+..++.+.+.+|.+||+.||.+|.|++++++.+||++-..
T Consensus 544 ~~-------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 544 RN-------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cc-------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00 011122334568889999999999999999999999999999997643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=223.20 Aligned_cols=166 Identities=22% Similarity=0.231 Sum_probs=129.4
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcC-CCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceee-EeeeEeec
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIK-LEGLVTSR 187 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 187 (410)
...+.|++.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+++|++++|+|++. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345789999999999999999998775 678889998753311 2334567889999999999999985 4331
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEcCCCcEEEEeeccccc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDI-KGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DFGla~~ 266 (410)
...|+||||+++..+..... . . ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~~~~-~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLARP-H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHhCc-c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 23799999999876653321 1 1 1467889999999999999999999 99999999999999999999987
Q ss_pred cCCCCCC-------CCcccccccccccccccc
Q 015247 267 FDPNHKH-------PMTSRVVTLWYRPPELLL 291 (410)
Q Consensus 267 ~~~~~~~-------~~~~~~gt~~y~aPE~~~ 291 (410)
+...... ......+++.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 7533211 113456788999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=240.96 Aligned_cols=239 Identities=27% Similarity=0.399 Sum_probs=200.1
Q ss_pred eeccCCCeeEEEEEE---cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEEEEee
Q 015247 123 KIGQGTYSNVYKAKD---MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
.+|.|.||.|++++. ...|+.||+|+.++.............|..++...+ ||.+|+++..++.+. .+++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc--chhHhhhh
Confidence 379999999998762 356788999998776543222225556888999987 999999988888754 49999999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccc
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 278 (410)
..++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99988887777777899999999999999999999999999999999999999999999999999987644332 2
Q ss_pred cccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCC
Q 015247 279 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358 (410)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (410)
|||..|||||++.+ ...+.|+||||++++||++|..||.+ +....|.+.....+
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------- 207 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------- 207 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------
Confidence 99999999999873 67899999999999999999999988 66677766332222
Q ss_pred chhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
+.++..+.+++..|+..+|..|.- +.++++|+||..
T Consensus 208 ----------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 208 ----------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred ----------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 256778999999999999999975 589999999974
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-25 Score=208.71 Aligned_cols=263 Identities=34% Similarity=0.516 Sum_probs=203.9
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH-HHHHHHHHHHHHHhCCCC-ceeeEeeeEeecCCceEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHP-NVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~lv 195 (410)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +++++.+.+.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 678899999999999999876 7899999976654332 566788899999999988 79999998855 3348999
Q ss_pred EeeccCCHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 015247 196 FHYMEHDLAGLAASPEV---KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 271 (410)
++++.+..+........ .++...+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999866654444433 799999999999999999999999999999999999999988 79999999998665443
Q ss_pred CC-----CCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCC-CH
Q 015247 272 KH-----PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSP-SE 340 (410)
Q Consensus 272 ~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~-~~ 340 (410)
.. ......||..|+|||.+.+. ..++...|+||+|++++++++|..||..... .............+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22 24667899999999998874 4588899999999999999999999887764 23333333322211 00
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
........ ......+.+++..++..+|..|.+..+...++|....
T Consensus 237 --------------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 --------------SPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred --------------cccCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 00000000 1223468899999999999999999999988766544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-25 Score=211.13 Aligned_cols=207 Identities=27% Similarity=0.304 Sum_probs=165.7
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhCC----CCceeeEeeeEeecCCce
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLD----HPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~ 191 (410)
+|.+.+.||+|+||.||+|.+..++ ..+|+|........... .+..|..++..+. .+++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999987664 67899987654322211 3556888888876 257778876664 23567
Q ss_pred EEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-----CcEEEEeecccc
Q 015247 192 LYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-----GVLKIADFGLAS 265 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-----~~vkl~DFGla~ 265 (410)
-|+||+.++.+|.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999999999999987544 4789999999999999999999999999999999999999865 369999999998
Q ss_pred ccC---CCC---CCC---CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH
Q 015247 266 FFD---PNH---KHP---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 327 (410)
Q Consensus 266 ~~~---~~~---~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 327 (410)
... ... ... .....||..|.++.++.+.. .+++.|+||++.++.+++.|..||.+......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 322 111 111 12345999999999998865 89999999999999999999999977665433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=195.93 Aligned_cols=213 Identities=24% Similarity=0.281 Sum_probs=172.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC-CceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~ 193 (410)
...|.++++||+|+||.+|+|....+|..||||+-+.....+ .+..|..+...|++ ..|..+..+..+ ..+-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--cccce
Confidence 368999999999999999999999999999999876443322 35568888887754 556666555555 55688
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccccccCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASFFDPN 270 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~ 270 (410)
+||+.++.++-+++.-....|+...+..++-|++.-++|+|.++++||||||+|+|..- -..+.|+|||||+.+...
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999999999988888889999999999999999999999999999999999999974 346899999999987433
Q ss_pred CCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHH
Q 015247 271 HKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV---EQLHKIYKL 334 (410)
Q Consensus 271 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~~~~~i~~~ 334 (410)
... ......||..|.+-..+.+.. -+...|+-|+|.+|+..--|..||.+.... +..++|.+.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 221 123457899999988887754 688999999999999999999999986544 445555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=230.98 Aligned_cols=221 Identities=31% Similarity=0.388 Sum_probs=169.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+.++.|..|+||-||+++++.+.+.+|+| +.++++ +.+ +++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhh--ccccccCCccee-----------------
Confidence 78999999999999999999999999999994 433321 111 133333444444
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC----
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH---- 271 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~---- 271 (410)
++....+ +.-++++.. ++.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++..-...
T Consensus 136 -----gDc~tll-k~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 -----GDCATLL-KNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred -----chhhhhc-ccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 2222222 222344433 3889999999999999999999999999999999999987542111
Q ss_pred --------CC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 272 --------KH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 272 --------~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
.+ .....+|||.|.|||++.... |+..+|||++|+|+||.+-|..||.+.+..+.+...+.-....++
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE- 279 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE- 279 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc-
Confidence 00 123458999999999998744 999999999999999999999999999999999888764322222
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC---CHHHHhcCCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL---TATVALNSEVIFQ 404 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~elL~hp~~~~ 404 (410)
.....+++++++|..+|+.+|..|. .+-++-+|+||+.
T Consensus 280 -------------------------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 -------------------------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred -------------------------cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 2236789999999999999999995 5889999999973
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=195.77 Aligned_cols=213 Identities=22% Similarity=0.259 Sum_probs=174.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
-.|.+.++||+|+||+.|.|.+..++++||||.-..... .-.+..|.+..+.| ..+.|...+. ..+.+.+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceee--eccccchhhh
Confidence 479999999999999999999999999999997543322 22355677777777 5788888843 3444667789
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-----cEEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-----~vkl~DFGla~~~~~ 269 (410)
|+|.++.+|-+++.-.+..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .|-|+|||+|+.+..
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999999999998888888999999999999999999999999999999999999998544 589999999998743
Q ss_pred CCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHh
Q 015247 270 NHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIYKLC 335 (410)
Q Consensus 270 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---~~~~~~~i~~~~ 335 (410)
.... ...+..||..||+-..++|.. -+...|+-|||-+++..+-|..||.|.. ..+.+++|-...
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 3221 123567999999999999865 7899999999999999999999998854 455566654443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=188.11 Aligned_cols=141 Identities=22% Similarity=0.256 Sum_probs=108.4
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHH------------------------HHHHHHHHHHHHhCCCCc
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES------------------------VKFMAREILILRRLDHPN 176 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~n 176 (410)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999975 8999999999865321111 122345999999998777
Q ss_pred eeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEEcCCCc
Q 015247 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC-HNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlkp~NILl~~~~~ 255 (410)
+.....+... . .++||||++++.+.........+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6433222111 2 389999999865433322345789999999999999999999 799999999999999998 588
Q ss_pred EEEEeecccccc
Q 015247 256 LKIADFGLASFF 267 (410)
Q Consensus 256 vkl~DFGla~~~ 267 (410)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=194.59 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=180.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCC-----------------------------------ceEEEEEEecCCC---Ch
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-----------------------------------KIVALKKVRFDNL---EP 156 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----------------------------------~~vavK~~~~~~~---~~ 156 (410)
.++|++...||+|....||.++...+| -+.|||.+-.-.. +.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 477999999999999999988643211 1446665532111 12
Q ss_pred HHHHHHHHHHH------HH-----------H----h-CCCCceeeEeeeEeec-------------------------CC
Q 015247 157 ESVKFMAREIL------IL-----------R----R-LDHPNVIKLEGLVTSR-------------------------MS 189 (410)
Q Consensus 157 ~~~~~~~~E~~------~l-----------~----~-l~h~niv~l~~~~~~~-------------------------~~ 189 (410)
...+.+.+|.- .+ . + -+|||||++.++|.+. ..
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 22223333321 11 1 1 2699999998877541 23
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCC--cEEEEeecccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDG--VLKIADFGLAS 265 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~--~vkl~DFGla~ 265 (410)
..+|+||....+.+..++..+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 458999999999998877655 457777888999999999999999999999999999985 333 57999999774
Q ss_pred ccCCCC-----CCCCccccccccccccccccCCcCC-----CCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Q 015247 266 FFDPNH-----KHPMTSRVVTLWYRPPELLLGATDY-----GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335 (410)
Q Consensus 266 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~ 335 (410)
.-+... .......-|....||||+....+.. -.++|.|+.|.+.||++....||++..+...-..-
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---- 469 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---- 469 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----
Confidence 332211 1112234567778999987543221 13889999999999999999999984332211100
Q ss_pred CCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH---HHhc------CCCCCCCC
Q 015247 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT---VALN------SEVIFQDR 406 (410)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---elL~------hp~~~~~~ 406 (410)
+++.++| .....+|+.+++|+..+|+.||++|+++. .+|+ |.|++.-+
T Consensus 470 -------Yqe~qLP----------------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~ 526 (598)
T KOG4158|consen 470 -------YQESQLP----------------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMM 526 (598)
T ss_pred -------hhhhhCC----------------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhc
Confidence 1222222 23347889999999999999999999853 4443 55666555
Q ss_pred CCC
Q 015247 407 TLC 409 (410)
Q Consensus 407 ~~~ 409 (410)
++|
T Consensus 527 ~~~ 529 (598)
T KOG4158|consen 527 EKC 529 (598)
T ss_pred ccc
Confidence 555
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=196.42 Aligned_cols=238 Identities=21% Similarity=0.290 Sum_probs=151.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCC----------CceeeEeeeE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH----------PNVIKLEGLV 184 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 184 (410)
..+.....||.|+++.||.+++..+|+.+|+|++..... .....+.+.+|......+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778899999999999999999999999999876553 23346667666655544322 1222222221
Q ss_pred e---------ecC-Cc-----eEEEEEeeccCCHHHHhc-----CCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 015247 185 T---------SRM-SC-----SLYLVFHYMEHDLAGLAA-----SPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDI 243 (410)
Q Consensus 185 ~---------~~~-~~-----~~~lv~e~~~~~l~~~~~-----~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 243 (410)
. ... .. ..+++|+-+.+++..... ... ..+.......+..|++..+++||+.|++|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 111 11 246788888887765432 111 12233334455589999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCC-------cCCCCccchHHHHHHHHHHHcCC
Q 015247 244 KGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAGK 316 (410)
Q Consensus 244 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGv~l~ell~g~ 316 (410)
+|+|+|++.+|.++|+||+.....+.... ....+..|.|||..... ..++.+.|.|+||+++|.|+||+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999998876543211 13345779999976321 23788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCC
Q 015247 317 PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390 (410)
Q Consensus 317 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 390 (410)
.||........... .-..+.++|+.+++||..||+.||.+|
T Consensus 248 lPf~~~~~~~~~~~---------------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99976533211000 011224788999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=180.52 Aligned_cols=141 Identities=23% Similarity=0.303 Sum_probs=110.9
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH------------------------HHHHHHHHHHHHHhCCCCc
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------------------------SVKFMAREILILRRLDHPN 176 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~n 176 (410)
...||+|++|.||+|.+. +|+.||||+++....... ....+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999976 899999999986532100 0123457899999999988
Q ss_pred eeeEeeeEeecCCceEEEEEeeccCCH-HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCC
Q 015247 177 VIKLEGLVTSRMSCSLYLVFHYMEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~ 254 (410)
+.....+... . .|+||||++++. ..... ....++...+..++.|++.++.+||+ .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--C--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 7554433322 1 489999999863 22222 23467889999999999999999999 9999999999999998 89
Q ss_pred cEEEEeeccccccC
Q 015247 255 VLKIADFGLASFFD 268 (410)
Q Consensus 255 ~vkl~DFGla~~~~ 268 (410)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=184.72 Aligned_cols=173 Identities=14% Similarity=0.161 Sum_probs=130.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-HHHHH------HHHHHHHHHhCCCCceeeEeeeEeecC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKF------MAREILILRRLDHPNVIKLEGLVTSRM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~ 188 (410)
++|+.++.||.|+||.||++.. ++..+|+|+++...... ..... +.+|++.+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 7899999999999999999754 57789999997554322 22222 578999999999999999988866432
Q ss_pred ------CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 189 ------SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 189 ------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
....+++|||++|..+.... .+++ ....+++.+|..||+.|++|||++|+||+++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 23579999999986544432 2333 2456999999999999999999999999999988 9999999
Q ss_pred cccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHH
Q 015247 263 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 313 (410)
Q Consensus 263 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 313 (410)
........... . .+++. ..|+.++|+||||+++....
T Consensus 180 ~~~~~~e~~a~---d----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK---D----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH---H----------HHHHH-hHhcccccccceeEeehHHH
Confidence 88765322111 0 01222 33778999999999887554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=178.04 Aligned_cols=192 Identities=17% Similarity=0.141 Sum_probs=141.5
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l 194 (410)
+.+...|++|+||+||++. ..+.+++.+.+...... .-....+.+|+++|+++. |+++++++++ ...++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 3456789999999999886 47788887777654331 111235778999999995 5889998775 12699
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDI-KGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|+|+.|..+...... . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 76 vmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred EEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9999998766432211 1 1357789999999999999999999 799999999999999999999865432210
Q ss_pred ----C--------CccccccccccccccccCCcCCC-CccchHHHHHHHHHHHcCCCCCCCCCh
Q 015247 274 ----P--------MTSRVVTLWYRPPELLLGATDYG-VGVDLWSAGCILAELLAGKPIMPGRTE 324 (410)
Q Consensus 274 ----~--------~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwSlGv~l~ell~g~~pf~~~~~ 324 (410)
. ..-...++.|++|+........+ ...++++-|.-+|.++|++.++.+..+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00123478888888654332233 567999999999999999988876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=214.75 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=176.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC--CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN--LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+|...+.||++.|=+|.+|++ ..|. |+||++-+.. ..-........|+. ...+++||++.+.-+... ....|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 678889999999999999985 5555 8899986544 22233334444555 556799999998655444 445789
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc--CCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHK 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~--~~~~~ 272 (410)
|-+|..++|.+.+..+ ..+...+.+-++.|++.||..+|..||+|||||.+||||+.=+-+.|+||..-+.. .+++.
T Consensus 99 vRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999999998866544 36778888889999999999999999999999999999999999999999876432 11111
Q ss_pred CCC----ccccccccccccccccCCc---------C-CCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 273 HPM----TSRVVTLWYRPPELLLGAT---------D-YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 273 ~~~----~~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
... .+..--.+|+|||.+.... . .+++.||||+||++.||++ |++||.- .++...-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhcc
Confidence 111 1111134699999986421 1 5679999999999999987 7888841 111111000
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCC-CCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKD-FPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.. ......+.. -+..+++||..|++.||++|.+|++.|+-
T Consensus 251 ~~----------------------~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NA----------------------DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Cc----------------------cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 000001111 23478999999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=181.99 Aligned_cols=257 Identities=17% Similarity=0.216 Sum_probs=195.1
Q ss_pred cccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeee
Q 015247 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183 (410)
Q Consensus 104 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 183 (410)
...++.+......+..++.+|.....|..|+|+ ..|..+++|++..........+.|..|.-.|+-..||||+.+++.
T Consensus 178 datlsr~~gid~~~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 178 DATLSRYTGIDVSSLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred ccccccccCcchhhhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhh
Confidence 344444555556778888999999999999997 566677889887776666666778889999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-c-eeccCCCCCEEEcCCCcEEEE
Q 015247 184 VTSRMSCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNG-V-LHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i-vHrDlkp~NILl~~~~~vkl~ 259 (410)
|..+. .+.++..||+.+.+..... ...-....++.+++.+|+.|++|||+.. + .---|....++||++.+.+|+
T Consensus 256 cnspp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 256 CNSPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred ccCCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence 98864 4899999999766554433 3345778899999999999999999984 3 334688999999999887764
Q ss_pred eeccccccCCCCCCCCccccccccccccccccCCcC--CCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
- +-+++ +.........|.||+||.+...+. .-.+.|+|||++++||+.|...||......+.-.+|.-
T Consensus 334 m-ad~kf-----sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---- 403 (448)
T KOG0195|consen 334 M-ADTKF-----SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---- 403 (448)
T ss_pred c-cccee-----eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----
Confidence 1 11111 111123445889999999876442 22479999999999999999999998887776554421
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
+.+.....++++..+..|++-|++.||.+||.++.++
T Consensus 404 -----------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 -----------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1222334468999999999999999999999887653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-23 Score=195.49 Aligned_cols=177 Identities=29% Similarity=0.420 Sum_probs=125.4
Q ss_pred EEEEEeeccCCHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 192 LYLVFHYMEHDLAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
+|+.|++|....+..++.+ ....+......++.|++.|+.| ++.+|||+||.||+...+..+||+|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 3445555554444444322 2245677888899999999999 999999999999999999999999999998775
Q ss_pred CCC-----CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 269 PNH-----KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 269 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
... ....+..+||.+||+||.+.+.. |+.++||||||++|+|++. -...|. ....+..+
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~----------- 472 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI----------- 472 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh-----------
Confidence 444 22345678999999999998854 9999999999999999997 221111 11111111
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
+...+|... + .-.+.-.+|+..||.+.|.+||++.+.-.|+|.+
T Consensus 473 -r~g~ip~~~---------------~-~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 -RDGIIPPEF---------------L-QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred -hcCCCChHH---------------h-hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 111111100 0 1124456899999999999999998888888753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=170.10 Aligned_cols=146 Identities=25% Similarity=0.214 Sum_probs=113.5
Q ss_pred CCcceeeeeccCCCeeEEEEE-EcCCCceEEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAK-DMLTGKIVALKKVRFDNLEP----------------------ESVKFMAREILILRRL 172 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 172 (410)
.-|++.+.||+|+||.||+|. +..+|+.||+|+++...... .....+.+|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 66899999999997643210 0112356799999999
Q ss_pred CCCc--eeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEE
Q 015247 173 DHPN--VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG-VLHRDIKGSNLL 249 (410)
Q Consensus 173 ~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NIL 249 (410)
.+.. +.++++. . ..++||||+++..+.........+....+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 7533 3444332 1 24799999999655443333345677778899999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccC
Q 015247 250 IDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 250 l~~~~~vkl~DFGla~~~~ 268 (410)
++ ++.++|+|||.+...+
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-20 Score=163.71 Aligned_cols=137 Identities=18% Similarity=0.223 Sum_probs=104.0
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-----CCCceeeEeeeEeecCC-ceE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-----DHPNVIKLEGLVTSRMS-CSL 192 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~-~~~ 192 (410)
.-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ +||||+++++++.+..+ ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3457899999999995 6666666 69998764322 345688999999999 67999999999988643 343
Q ss_pred E-EEEeecc--C-CHHHHhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCEEEcCC----CcEEEEeecc
Q 015247 193 Y-LVFHYME--H-DLAGLAASPEVKFTEPQVKCYMHQLLSGL-EHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGL 263 (410)
Q Consensus 193 ~-lv~e~~~--~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L-~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGl 263 (410)
+ +|+||.+ + +|.+.+.+ . .+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-C-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-c-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 4 7899954 4 45555533 2 46666 35678888888 89999999999999999999743 3799999554
Q ss_pred c
Q 015247 264 A 264 (410)
Q Consensus 264 a 264 (410)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.7e-20 Score=189.38 Aligned_cols=195 Identities=24% Similarity=0.286 Sum_probs=148.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCc
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 190 (410)
..+.|.|.+.||+|+||+||+|... +|+.||+|+-+..+..+-.+ -.+++.+|+ -+.|..+...+....
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~-- 767 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQN-- 767 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCC--
Confidence 4577999999999999999999964 49999999877654322111 234444554 223333333333322
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-------CCcEEEEeecc
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-------DGVLKIADFGL 263 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~DFGl 263 (410)
.-++|++|.+.+.+-.+.+..+.+++..++.++.||+..+.+||..+|||+||||+|+||.. .--++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 36899999997655556667789999999999999999999999999999999999999952 23589999998
Q ss_pred ccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCC
Q 015247 264 ASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317 (410)
Q Consensus 264 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 317 (410)
+..+.--.. ......++|-.+-.+|+..|.. ++...|.|.|+.+++-|++|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 865432111 2345667899999999888755 9999999999999999999973
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-21 Score=193.50 Aligned_cols=263 Identities=27% Similarity=0.391 Sum_probs=202.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
..|.+.+.||+|+|+.|-+.... .+...+|+|.+............+..|..+-..+. |+|++.+++..... ...+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--cccc
Confidence 57888999999999999888753 33445677766544333444555666777777776 99999998877664 4588
Q ss_pred EEEeeccCCHHHHhc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEcCCC-cEEEEeeccccccCC
Q 015247 194 LVFHYMEHDLAGLAA-SPEV-KFTEPQVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDP 269 (410)
Q Consensus 194 lv~e~~~~~l~~~~~-~~~~-~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~ 269 (410)
+.++|..++.+.... .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998776555554 4444 6788888999999999999999 99999999999999999999 999999999988765
Q ss_pred --CCCCCCccccc-cccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 270 --NHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 270 --~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
+........+| ++.|+|||...+.....+..|+||.|+++.-+++|..|+...........- |...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-----------~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-----------WKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-----------eccc
Confidence 22333445678 999999999887555788999999999999999999998765443311000 0000
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+ ...-...+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00011233578889999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=154.11 Aligned_cols=140 Identities=24% Similarity=0.226 Sum_probs=107.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh--------------------HHHHHHHHHHHHHHhCCCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP--------------------ESVKFMAREILILRRLDHPN 176 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~n 176 (410)
.|.+.+.||+|+||.||++.. .+|+.||||+++...... .......+|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 478889999999999999986 589999999987543110 01123567888898887774
Q ss_pred --eeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 177 --VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 177 --iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
++..++ ....+++|||+++..+...... .....++.+++.++.++|+.||+||||||+||++++++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444432 1235899999998665443221 34567889999999999999999999999999999999
Q ss_pred cEEEEeeccccccCC
Q 015247 255 VLKIADFGLASFFDP 269 (410)
Q Consensus 255 ~vkl~DFGla~~~~~ 269 (410)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=153.58 Aligned_cols=137 Identities=19% Similarity=0.232 Sum_probs=107.1
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.||+|++|.||+|.. +|..+++|+......... ....+.+|+.++..+.|++++....++... ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999975 778899998654332111 123577899999999999887666565543 347899
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
|||+++..+........ . ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++...
T Consensus 78 ~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99998855544433221 2 7788999999999999999999999999999999 889999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=169.28 Aligned_cols=205 Identities=27% Similarity=0.415 Sum_probs=151.8
Q ss_pred HHhCCCCceeeEeeeEeecCCceEEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 015247 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV-LHRDIKGS 246 (410)
Q Consensus 169 l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i-vHrDlkp~ 246 (410)
|+.+.|.|+.+++|.+.+. ...+++.+||..+ +.+.+......+++-....++++|+.||.|||+..| +|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999886 5599999999865 555555667788999999999999999999999866 99999999
Q ss_pred CEEEcCCCcEEEEeeccccccCCCC-CCCCccccccccccccccccCCc--C----CCCccchHHHHHHHHHHHcCCCCC
Q 015247 247 NLLIDDDGVLKIADFGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGAT--D----YGVGVDLWSAGCILAELLAGKPIM 319 (410)
Q Consensus 247 NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~DiwSlGv~l~ell~g~~pf 319 (410)
|.+++..+.+||+|||+........ ........-..-|.|||.+.+.. . .+.+.|+||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987764210 01111122355589999886531 1 366799999999999999999999
Q ss_pred CCCChH----HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHH
Q 015247 320 PGRTEV----EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395 (410)
Q Consensus 320 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 395 (410)
...... +....+.+ .+.+ +++..+.... .+++++..++..||..+|.+||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~--------------------~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSN--------------------PFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCC--------------------CcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHH
Confidence 874332 23332222 1110 1111111111 55668999999999999999999887
Q ss_pred Hh
Q 015247 396 AL 397 (410)
Q Consensus 396 lL 397 (410)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 63
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.2e-18 Score=149.15 Aligned_cols=133 Identities=18% Similarity=0.224 Sum_probs=100.9
Q ss_pred eeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh------HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
.||+|+||.||+|. .+|..+++|......... .....+.+|++++..++|+++.....++... ...+++|
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 38999999999997 577899999865432211 1235567899999999887654443343332 2368999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
||+++..+......... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99988655544332211 7889999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=146.02 Aligned_cols=138 Identities=27% Similarity=0.279 Sum_probs=97.3
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHH----------------------HHHHHHHHHhCCCCc--
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF----------------------MAREILILRRLDHPN-- 176 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n-- 176 (410)
.+.||+|+||.||+|.+. +|+.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999875 8999999998764322111111 134555666654332
Q ss_pred eeeEeeeEeecCCceEEEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCC
Q 015247 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~ 254 (410)
+.+.+++ ...+++|||++++... ...... ... ..+..++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444332 1258999999983211 101100 011 6778899999999999999 9999999999999999 99
Q ss_pred cEEEEeeccccccC
Q 015247 255 VLKIADFGLASFFD 268 (410)
Q Consensus 255 ~vkl~DFGla~~~~ 268 (410)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=167.09 Aligned_cols=139 Identities=17% Similarity=0.177 Sum_probs=105.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-C-----hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-E-----PESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
..|...+.||+|+||+||+|... +..+++|+...... . ....+.+.+|++++..++|++++....++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34567889999999999999753 33445554322111 1 11235678899999999999998876665553
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
...++||||+++..+..... ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 33689999998865554332 356789999999999999999999999999999 6789999999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=168.36 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=202.7
Q ss_pred CCcceeeeecc--CCCeeEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQ--GTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+...........-.+|....+.+ .|+|.++.+..+.. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 56788899999 99999999988 78899999998443322222222333466666666 49999997777776 45
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeecccc
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLS----GLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLAS 265 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~----~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~ 265 (410)
.+|+-+|+++..+..+.......++...++..+.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 69999999999999988888888999999999999999 9999999999999999999999999 889999999999
Q ss_pred ccCCCCCCCC----ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHHhCCCC
Q 015247 266 FFDPNHKHPM----TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR--TEVEQLHKIYKLCGSPS 339 (410)
Q Consensus 266 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~ 339 (410)
.+..+..... ....|..-|++||...+. ++.+.|+|++|.+..+..+|-.++... +.+.+++.++.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i------ 343 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI------ 343 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC------
Confidence 8876553211 122567789999988763 788999999999999999998777665 45544443321
Q ss_pred HHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..+...+.+.++...+..|++.||..|+++..+++|+++.+
T Consensus 344 ------------------------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 ------------------------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ------------------------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11233456666777999999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-16 Score=142.08 Aligned_cols=138 Identities=20% Similarity=0.254 Sum_probs=102.0
Q ss_pred eeec-cCCCeeEEEEEEcCCCceEEEEEEecCCC-----------ChHHHHHHHHHHHHHHhCCCCce--eeEeeeEeec
Q 015247 122 DKIG-QGTYSNVYKAKDMLTGKIVALKKVRFDNL-----------EPESVKFMAREILILRRLDHPNV--IKLEGLVTSR 187 (410)
Q Consensus 122 ~~LG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 187 (410)
..|| .||.|+||.+.. .+..++||.+..... +......+.+|++++..+.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 889999999974 477899998854321 11223457789999999988775 6666664443
Q ss_pred CCc--eEEEEEeeccC--CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 188 MSC--SLYLVFHYMEH--DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 188 ~~~--~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
... ..++|||++++ ++...+.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 222 23599999996 44444332 2455543 56899999999999999999999999999999999999998
Q ss_pred cccc
Q 015247 264 ASFF 267 (410)
Q Consensus 264 a~~~ 267 (410)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=127.55 Aligned_cols=133 Identities=24% Similarity=0.233 Sum_probs=107.8
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeEeeeEeecCCceEEEEEe
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e 197 (410)
+++.||+|.++.||++.. ++..+++|....... ...+.+|+.++..+++ .++++++++.... ...+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEE
Confidence 457899999999999985 347899998765432 3457789999999976 5888887776653 46899999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN---GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
|+.+..+... +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||++...
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9987644422 5567778899999999999985 6999999999999999999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-17 Score=166.64 Aligned_cols=265 Identities=23% Similarity=0.244 Sum_probs=200.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..+.|.+.+-+-+|+++.++.+.-..+|...++|+..... +.....+....+-.++-..++|.++....-+.. ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCc
Confidence 3478889999999999999999877778777777655432 122233444455555555567777766433333 3458
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC---
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP--- 269 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~--- 269 (410)
+++++|.+++.+...+..-+..+.+-++.++..+..++++||...+.|+|++|.|+|+..+++.++.|||+....+-
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999998755554555555678888899999999999999999999999999999999999999999985432210
Q ss_pred ---------------------------CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 015247 270 ---------------------------NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 322 (410)
Q Consensus 270 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 322 (410)
+.........+|+.|.+||...+.. .+..+|+|++|++++|.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0000123356799999999988765 788999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH---HHhcC
Q 015247 323 TEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT---VALNS 399 (410)
Q Consensus 323 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---elL~h 399 (410)
.....+++|.+.-...+ .-....+.++++++..+|..+|.+|..+. ++-.|
T Consensus 1039 tpq~~f~ni~~~~~~~p--------------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWP--------------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred chhhhhhccccCCCCCC--------------------------CCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 99888887765321111 11125688899999999999999999987 99999
Q ss_pred CCCCCCCC
Q 015247 400 EVIFQDRT 407 (410)
Q Consensus 400 p~~~~~~~ 407 (410)
+||+....
T Consensus 1093 ~~~~~~~~ 1100 (1205)
T KOG0606|consen 1093 PFFQDVDW 1100 (1205)
T ss_pred CccCCCCc
Confidence 99987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-13 Score=119.20 Aligned_cols=140 Identities=19% Similarity=0.204 Sum_probs=99.6
Q ss_pred eeeccCCCeeEEEEEEcC------CCceEEEEEEecCCC-----------C---------hHHHHHHH----HHHHHHHh
Q 015247 122 DKIGQGTYSNVYKAKDML------TGKIVALKKVRFDNL-----------E---------PESVKFMA----REILILRR 171 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~-----------~---------~~~~~~~~----~E~~~l~~ 171 (410)
..||.|.-+.||.|.... .+..+|||+.+.+.. + ......+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357999998764211 0 11122233 79999998
Q ss_pred CCC--CceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCE
Q 015247 172 LDH--PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC-HNNGVLHRDIKGSNL 248 (410)
Q Consensus 172 l~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlkp~NI 248 (410)
+.. -++.+++++ . .-++||||++++.+....-.+..++...+..+..+++.+|..| |+.|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 843 455666543 1 2579999998742211111222456667778889999999998 899999999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 015247 249 LIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 249 Ll~~~~~vkl~DFGla~~~~ 268 (410)
|++ ++.+.|+|||.+...+
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 996 5789999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-14 Score=140.69 Aligned_cols=258 Identities=19% Similarity=0.223 Sum_probs=186.2
Q ss_pred CCCCCcCCCcceeeeeccCCCeeEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 015247 109 GWIPRRADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS 186 (410)
Q Consensus 109 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 186 (410)
.|......+|..+..||.|.|+.|+.+... .++..|++|.+............-..|+.+...+ -|.+++..+..+..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 344455678999999999999999987754 7788999998866544433333344577666666 48888887666655
Q ss_pred cCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeecccc
Q 015247 187 RMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLAS 265 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~ 265 (410)
... .|+-.|||++............+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||..+
T Consensus 338 ~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 333 56899999886666554444467888899999999999999999999999999999999886 788999999986
Q ss_pred ccCCCCCCCCcccccccccc-ccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYR-PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
.+.-. ......+-+++ ..|.+.....+..+.|++|||..+.+.++|.+.-...+....+. .
T Consensus 416 ~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~---~----------- 477 (524)
T KOG0601|consen 416 RLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR---S----------- 477 (524)
T ss_pred cccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee---c-----------
Confidence 43211 11222334455 35556555568889999999999999999986544333222111 1
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+ ..++...++..+.+.|..+|+..||.+.++..|.=|..
T Consensus 478 -~~~p-----------------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 478 -GDTP-----------------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -cccc-----------------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 01234467888999999999999999999998876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-12 Score=128.89 Aligned_cols=169 Identities=21% Similarity=0.325 Sum_probs=125.2
Q ss_pred EEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCC
Q 015247 134 KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK 213 (410)
Q Consensus 134 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~ 213 (410)
.|..+.++.+|.|.+.+.... .......+-+..|+.++||||+++++.+... ..+|+|+|.+..-....- .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~Pl~~~lk-----~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVRPLETVLK-----E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccccHHHHHH-----H
Confidence 455578889999998876553 4445566788899999999999999888774 469999998875321111 1
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccC
Q 015247 214 FTEPQVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292 (410)
Q Consensus 214 ~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 292 (410)
+....+..-+.||+.||.||| +.+++|++|.-+.|+++..|+.||++|.++........ +.....--..|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 225666777889999999998 56899999999999999999999999998865532221 1112222334667775432
Q ss_pred CcCCCCccchHHHHHHHHHHHcC
Q 015247 293 ATDYGVGVDLWSAGCILAELLAG 315 (410)
Q Consensus 293 ~~~~~~~~DiwSlGv~l~ell~g 315 (410)
-+-..|.|.|||++++++.|
T Consensus 180 ---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 ---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhhHHHHHHHHhCc
Confidence 12357999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.9e-13 Score=133.04 Aligned_cols=143 Identities=20% Similarity=0.236 Sum_probs=93.7
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH--------------------------------HHH------HHH
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE--------------------------------SVK------FMA 163 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--------------------------------~~~------~~~ 163 (410)
+.||+|++|.||+|+. .+|+.||||+.+......- ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999984 6899999999865421000 000 233
Q ss_pred HHHHHHHhC----CCCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcC-CCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 015247 164 REILILRRL----DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLS-GLEHCHNNG 237 (410)
Q Consensus 164 ~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~-~L~~LH~~~ 237 (410)
+|+..+.++ ++.+-+.+-.++.+. ....++||||++|..+..... ...... ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555544 232223333333221 223689999999854433221 111122 2345555555 467899999
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 238 ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
++|+|++|.||+++.++.++++|||++..++.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.1e-14 Score=126.35 Aligned_cols=205 Identities=17% Similarity=0.177 Sum_probs=141.5
Q ss_pred HHHhCCCCceeeEeeeEeecC---CceEEEEEeeccCCHHHH----hcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 015247 168 ILRRLDHPNVIKLEGLVTSRM---SCSLYLVFHYMEHDLAGL----AASPEVKFTEPQVKCYMHQLLSGLEHCHNN--GV 238 (410)
Q Consensus 168 ~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~l~~~----~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i 238 (410)
-|-++-|-|||+++.|+.+.. .....++.|||+.+.+.. .......+.....++|+.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345667999999999987642 345789999999754443 334556799999999999999999999998 49
Q ss_pred eeccCCCCCEEEcCCCcEEEEeeccccccC---CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC
Q 015247 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315 (410)
Q Consensus 239 vHrDlkp~NILl~~~~~vkl~DFGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 315 (410)
+|+++..+-|++..+|-+|++--.-...-. ...........+.++|.|||.-... ..+.++|||+||....+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHh
Confidence 999999999999999999875322111100 0000111223457889999975433 367799999999999999988
Q ss_pred CCCC-CCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH
Q 015247 316 KPIM-PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394 (410)
Q Consensus 316 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 394 (410)
..-- .+....+.-..|.+.+.. --.+.-.++|.+||+..|..||++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~--------------------------------len~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIG--------------------------------LENGLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred eeccCCCcceeehhhhhhhheee--------------------------------ccCccccCcCcccccCCCCCCcchh
Confidence 7432 222222222222221100 0112234679999999999999999
Q ss_pred HHhcCCCCCCC
Q 015247 395 VALNSEVIFQD 405 (410)
Q Consensus 395 elL~hp~~~~~ 405 (410)
++|.||-+-+.
T Consensus 327 ~llfHpllfeV 337 (458)
T KOG1266|consen 327 LLLFHPLLFEV 337 (458)
T ss_pred hhhcCceeeec
Confidence 99999987654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=138.86 Aligned_cols=146 Identities=18% Similarity=0.228 Sum_probs=94.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--------------------------------hHHHHHH
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------------------------------PESVKFM 162 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~~~ 162 (410)
..+|+. +.||+|++|+||+|+...+|+.||||+++..... .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 356776 7899999999999998777999999999754210 0111222
Q ss_pred HH------HHHHHHhCC----CCceeeEeeeEeecCCceEEEEEeeccCCHHHHh--cCCCC----CCCHHHHHHHHHHH
Q 015247 163 AR------EILILRRLD----HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA--ASPEV----KFTEPQVKCYMHQL 226 (410)
Q Consensus 163 ~~------E~~~l~~l~----h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~----~~~~~~~~~~~~qi 226 (410)
.+ |+..+.+++ +.+.+.+-.++.+- ....++||||+.|.-.... ....+ .+.+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 23 333333331 33333333333221 2236899999998554332 11111 24444444455554
Q ss_pred HHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeeccccccCC
Q 015247 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFFDP 269 (410)
Q Consensus 227 ~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~~~ 269 (410)
...|++|+|++|.||+++.+| .++++|||++..++.
T Consensus 277 -------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 458999999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=112.45 Aligned_cols=128 Identities=16% Similarity=0.155 Sum_probs=92.4
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeEeeeEeecCCceEEEEEeec
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~ 199 (410)
++.|+.|.++.||+++. .+..|++|....... ....+.+|+.++..+.+.++ .+++.+... ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEEEEec
Confidence 46789999999999974 478899998754321 11235678888888865443 345443221 247999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV-----LHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i-----vHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
++..+... ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98644321 01123456799999999999985 9999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.1e-13 Score=132.77 Aligned_cols=159 Identities=21% Similarity=0.314 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcc--------ccccccccccccccCCcC
Q 015247 225 QLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--------RVVTLWYRPPELLLGATD 295 (410)
Q Consensus 225 qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~--------~~gt~~y~aPE~~~~~~~ 295 (410)
+++.||.|+|.. ++||++|.|++|.++.++..||+.|+.+....++...+... ..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 445999999976 89999999999999999999999999987654422211110 122667999999887 44
Q ss_pred CCCccchHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCC
Q 015247 296 YGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPS 374 (410)
Q Consensus 296 ~~~~~DiwSlGv~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (410)
.+.++|+||+|+++|.+. .|+..+.+.........-....+... + ..-..+|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--------------~-----------~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--------------F-----------GYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--------------c-----------cccccCcHH
Confidence 788999999999999998 66666665544433322222111100 0 001378999
Q ss_pred cHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 375 SLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 375 ~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
+++=+.++|..|+..||++..++..|||...+..+
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA 275 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence 99999999999999999999999999999876554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-10 Score=112.46 Aligned_cols=215 Identities=20% Similarity=0.253 Sum_probs=153.3
Q ss_pred CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCceEEEEEeeccC--CH
Q 015247 128 TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLYLVFHYMEH--DL 203 (410)
Q Consensus 128 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~--~l 203 (410)
.-.+.|++....+|..|++|+++......- .....-+++++++.|+|+|++.++|... ....+++|++|.++ .|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 345789999999999999999954332111 1122357889999999999999988632 34568999999986 45
Q ss_pred HHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 204 AGLAAS--------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 204 ~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+.+.. .+...++..+|.++.|++.||.++|+.|+..+-|.|.+||++.+.+++|+.-|....+.+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 554422 223578999999999999999999999999999999999999999999998888776654
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
+.. |.+.+ -.+-|.=.||.+++.|.||..--...+.....+
T Consensus 446 d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~-------------------- 486 (655)
T KOG3741|consen 446 DPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH-------------------- 486 (655)
T ss_pred CCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------------------
Confidence 431 11322 236799999999999999975433333222210
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+.......+.++.++|.-+...++.+ -++.++|.
T Consensus 487 --------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 487 --------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred --------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 11111356777777888777777775 45555543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=99.03 Aligned_cols=134 Identities=22% Similarity=0.265 Sum_probs=91.5
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEE-ecCC----CChH-HHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDN----LEPE-SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~-~~~~----~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
..+++|+-+.+|.+. .-|..+++|.= .+.- +++. ..+...+|+.++..++--.|....=++.+... ..++
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLIV 77 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEEE
Confidence 357889999999985 34555666642 2211 1221 23456679999988854333222213333222 6799
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
|||++|.++....... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+..-
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998877554433 145667777778889999999999999999997655 999999999753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-10 Score=96.50 Aligned_cols=144 Identities=18% Similarity=0.256 Sum_probs=99.2
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEe-c----CCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-F----DNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~----~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.+..|-+|+-+.|+++. ..|+.+.||.=. + ..++ +-...+..+|+.+|.++.--.|.-..=+|.+... -.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQ 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--Ce
Confidence 56788899999999995 788888888522 1 1122 2234567789999998753232221113333222 46
Q ss_pred EEEeeccC--CHHHHhcCCCCCCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeecccccc
Q 015247 194 LVFHYMEH--DLAGLAASPEVKFTE-PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFF 267 (410)
Q Consensus 194 lv~e~~~~--~l~~~~~~~~~~~~~-~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~ 267 (410)
++|||+++ ...+++......-.+ .....++++|-..+.-||..+|+|+||..+||++..++ .+.++|||++...
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 89999998 444444333222223 33378899999999999999999999999999997665 4689999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-10 Score=102.42 Aligned_cols=142 Identities=20% Similarity=0.244 Sum_probs=102.9
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeEeeeEeecC-CceEEEEEee
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRM-SCSLYLVFHY 198 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~lv~e~ 198 (410)
+.|+.|..+.||+++. .+|..+++|........ .....+.+|+.++..+.+ .++.+++.+..... ....+++|||
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5689999999999985 44689999987543321 123457789999999865 34566665544321 1246899999
Q ss_pred ccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 015247 199 MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN------------------------------------------- 235 (410)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------- 235 (410)
+++..+...... ..+++.....++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998654433221 356777777888888888888873
Q ss_pred -------------CCceeccCCCCCEEEcC--CCcEEEEeeccccc
Q 015247 236 -------------NGVLHRDIKGSNLLIDD--DGVLKIADFGLASF 266 (410)
Q Consensus 236 -------------~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~ 266 (410)
..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.1e-10 Score=98.23 Aligned_cols=128 Identities=26% Similarity=0.304 Sum_probs=82.2
Q ss_pred eEEEEEEcCCCceEEEEEEecCCC-----------------------C-hHHHHHHHHHHHHHHhCCCC--ceeeEeeeE
Q 015247 131 NVYKAKDMLTGKIVALKKVRFDNL-----------------------E-PESVKFMAREILILRRLDHP--NVIKLEGLV 184 (410)
Q Consensus 131 ~Vy~~~~~~~~~~vavK~~~~~~~-----------------------~-~~~~~~~~~E~~~l~~l~h~--niv~l~~~~ 184 (410)
.||.|.. .+|..+|+|+.+.... . ........+|.+.|..+... ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899984 7888999999865211 0 11234566899999999765 45666543
Q ss_pred eecCCceEEEEEeecc--CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 185 TSRMSCSLYLVFHYME--HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH-CHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 185 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~-LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
.+ -++||||++ |..+..+... .++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+||
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred -eC----CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 21 369999999 5433333222 11134456677788885555 679999999999999999887 9999999
Q ss_pred ccccccC
Q 015247 262 GLASFFD 268 (410)
Q Consensus 262 Gla~~~~ 268 (410)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.9e-09 Score=95.48 Aligned_cols=133 Identities=19% Similarity=0.175 Sum_probs=89.9
Q ss_pred eEEEEEEcCCCceEEEEEEecCCCChHHHH----------HHHHHHHHHHhCCCCce--eeEeeeEeecC---CceEEEE
Q 015247 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVK----------FMAREILILRRLDHPNV--IKLEGLVTSRM---SCSLYLV 195 (410)
Q Consensus 131 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~~~---~~~~~lv 195 (410)
.|+.+. ..|+.|.||........ +..+ ...+|...+..+...+| +.++++..... ...-++|
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 355553 56788999976332211 1111 25678888877743222 33344443221 2246899
Q ss_pred EeeccCC--HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-------CCcEEEEeecccc
Q 015247 196 FHYMEHD--LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-------DGVLKIADFGLAS 265 (410)
Q Consensus 196 ~e~~~~~--l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~DFGla~ 265 (410)
+|++++. +.+.... .....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999984 4444322 1235567788899999999999999999999999999999975 4689999999885
Q ss_pred c
Q 015247 266 F 266 (410)
Q Consensus 266 ~ 266 (410)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.8e-08 Score=95.42 Aligned_cols=252 Identities=16% Similarity=0.135 Sum_probs=152.0
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEee-----eEeecCCceEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEG-----LVTSRMSCSLY 193 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-----~~~~~~~~~~~ 193 (410)
..+.||+|+-+.+|-.- .-+.. +.|+......... . +-+..|... .||-+-.=+. .+-.+.+...-
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~-VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQ-VAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecc--hhhch-hheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 45679999999999763 22223 4587765432111 1 123334443 4554332010 01112233356
Q ss_pred EEEeeccCC--HHHHh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 194 LVFHYMEHD--LAGLA-----ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 194 lv~e~~~~~--l~~~~-----~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
+.|..+.+- ....+ .+....+.|..+.+.++.++.+.+.||..|.+-+|+.++|+|+++++.+.|+|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 777777652 22222 23334578999999999999999999999999999999999999999999998654443
Q ss_pred cCCCCCCCCcccccccccccccccc-C---CcCCCCccchHHHHHHHHHHHcC-CCCCCCCChH----HHH-HHHHHHhC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLL-G---ATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEV----EQL-HKIYKLCG 336 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~----~~~-~~i~~~~~ 336 (410)
...+.. ....+|...|.+||.-. + ...-+..+|.|.||+++++++.| +.||.|.... .-+ ..|-...
T Consensus 167 ~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~- 243 (637)
T COG4248 167 NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR- 243 (637)
T ss_pred ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce-
Confidence 322222 24467899999999643 1 11245679999999999999887 8999874210 000 0111111
Q ss_pred CCCHHHhhhCCCCCcccCCCCCchhhh-hhhhhCCCCCCcHHHHHhccCC--CCCCCCCHHH
Q 015247 337 SPSEEYWKKSKLPNATLFKPREPYKRC-IQETFKDFPPSSLPLIETLLAI--DPAERLTATV 395 (410)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~--dP~~Rpt~~e 395 (410)
+..... ....++.. ...-+.-+++++..|..+|+.. +|.-|||++.
T Consensus 244 -----------f~ya~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 244 -----------FAYASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred -----------eeechh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111000 00000000 0011224688899999999876 4678999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=90.93 Aligned_cols=138 Identities=25% Similarity=0.256 Sum_probs=99.6
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--------------------hHHHHHHHHHHHHHHhCCCC--
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------------------PESVKFMAREILILRRLDHP-- 175 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~-- 175 (410)
..+.+.||-|.-|.||.|.+ .+|.++|||.=+..... ........+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678999999999999985 68999999975432110 11233456799999998644
Q ss_pred ceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 015247 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 176 niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 255 (410)
.+.+.++. ..-.+|||++++-.+.... +.......++..|+.-+.-+-..||||+|+.+-|||++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666443 2357999999985544222 134444555666666666666899999999999999999999
Q ss_pred EEEEeecccccc
Q 015247 256 LKIADFGLASFF 267 (410)
Q Consensus 256 vkl~DFGla~~~ 267 (410)
+.++||--+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.7e-08 Score=87.87 Aligned_cols=106 Identities=23% Similarity=0.279 Sum_probs=77.8
Q ss_pred HHHHHHHHHHhCCCC--ceeeEeeeEeecCC--ceEEEEEeeccC--CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015247 161 FMAREILILRRLDHP--NVIKLEGLVTSRMS--CSLYLVFHYMEH--DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234 (410)
Q Consensus 161 ~~~~E~~~l~~l~h~--niv~l~~~~~~~~~--~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 234 (410)
...+|...+..+... .++..+++...... ...++++|++++ ++...... ....+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~-~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ-WEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh-hcccchhhHHHHHHHHHHHHHHHH
Confidence 456677777776422 23444444444222 345899999987 34444433 223677788899999999999999
Q ss_pred HCCceeccCCCCCEEEcCCC---cEEEEeecccccc
Q 015247 235 NNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFF 267 (410)
Q Consensus 235 ~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~ 267 (410)
..||+|+|+++.|||++.++ .+.++||+-+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=84.10 Aligned_cols=139 Identities=22% Similarity=0.264 Sum_probs=95.8
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--------------------hHH--HHHHHHHHHHHHhCC--CCce
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------------------PES--VKFMAREILILRRLD--HPNV 177 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------~~~--~~~~~~E~~~l~~l~--h~ni 177 (410)
-.|..|.-++||+|. ..++..+|+|+.+..... ... .....+|..-|.++. +=.+
T Consensus 54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 367788888999997 477899999998653211 111 122335666677663 3333
Q ss_pred eeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcE
Q 015247 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVL 256 (410)
Q Consensus 178 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~v 256 (410)
.+.+++.. -.++|||++..-.-.-.-....+...++..+..+++..+.-|-. .++||+||..-|||+. ++.+
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 44443322 36999999875211111122234444788888899999988777 8999999999999998 8999
Q ss_pred EEEeeccccccC
Q 015247 257 KIADFGLASFFD 268 (410)
Q Consensus 257 kl~DFGla~~~~ 268 (410)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-09 Score=106.55 Aligned_cols=247 Identities=16% Similarity=0.076 Sum_probs=165.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeEeeeEeecCCceEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv 195 (410)
-+...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++ ..+.+.+.+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~--d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE--DYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc--cCCcccccchh
Confidence 3667788999999999999854444333 5655432 22334889999999999 343333 33446678999
Q ss_pred EeeccCC--HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHD--LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+++++++ .........-.+-+.+.....+.-+.++++||+.-=+|+| ||+..+ +..+..||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999876 2222222223455556666777788899999998778998 777654 789999999998775443
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
...+..+|+.++|||+..... +..+.|.|++|+-..+|.-|-+|-... +........-++...
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P----------------~~~~~~~g~~p~s~~ 448 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP----------------PAVLPMIGNGPNSPM 448 (829)
T ss_pred ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC----------------ccccCCCCCCCCccc
Confidence 345677899999999887654 888999999999888888888776541 100000000000000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.... +. .-+..-.++...|+..-|..|+++-.++.|.+|+.=++
T Consensus 449 L~~~--------~a--w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 449 LTDK--------SA--WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cchh--------hh--cCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 0000 00 01111125788999999999999999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.8e-07 Score=80.27 Aligned_cols=139 Identities=14% Similarity=0.154 Sum_probs=97.8
Q ss_pred ccCCCeeEEEEEEcCCCceEEEEEEecCC---C-ChHHHHHHHHHHHHHHhCCC--CceeeEeeeEe---ecCCceEEEE
Q 015247 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDN---L-EPESVKFMAREILILRRLDH--PNVIKLEGLVT---SRMSCSLYLV 195 (410)
Q Consensus 125 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~-~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~---~~~~~~~~lv 195 (410)
|+||-+.|+... ..|+.|-+|.-.... . -+.-...+.+|...|..+.. -.+.++. ++. ......-+||
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 568888898875 455578888754111 0 02234568889999988843 2244443 222 1223346899
Q ss_pred EeeccC--CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEeeccccc
Q 015247 196 FHYMEH--DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASF 266 (410)
Q Consensus 196 ~e~~~~--~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~ 266 (410)
+|-+++ ++...+... -.+.+......++.+++..+.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999984 565554332 235677878899999999999999999999999999999987777 99999986643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.1e-07 Score=78.89 Aligned_cols=140 Identities=18% Similarity=0.239 Sum_probs=88.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHH------HHHHHHHHHhC---CCCceeeEeeeEe
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKF------MAREILILRRL---DHPNVIKLEGLVT 185 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~------~~~E~~~l~~l---~h~niv~l~~~~~ 185 (410)
.+|...+++-......|.+.. .+|+.+++|..+....- +..... ..+++..+..+ .......++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 678888998888877777775 77899999987643321 111111 12233333333 3333333322222
Q ss_pred ec---CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 186 SR---MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 186 ~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
-. .....+++|||++|--+..... +++ .+...+..++.-||+.|++|+|..|.|++++.++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 11 1234568999999854432221 222 2445677889999999999999999999998554 9999998
Q ss_pred cccc
Q 015247 263 LASF 266 (410)
Q Consensus 263 la~~ 266 (410)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.8e-07 Score=96.29 Aligned_cols=205 Identities=20% Similarity=0.173 Sum_probs=139.4
Q ss_pred HHHHHHHHHHHhCCCCceeeEeeeEeecCCce--EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015247 160 KFMAREILILRRLDHPNVIKLEGLVTSRMSCS--LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237 (410)
Q Consensus 160 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 237 (410)
.....|...+....|+|++.++.+-..+.... +.+..+++.........+.-..++....+.+..++.+||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 33445777788889999999987765433222 2234466666555555666668999999999999999999999996
Q ss_pred ceeccCCCC---CEEEcCCCcEEEE--eeccccccCCCCCCCCccccccccccccccccCCc-CCCCccchHHHHHHHHH
Q 015247 238 VLHRDIKGS---NLLIDDDGVLKIA--DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAE 311 (410)
Q Consensus 238 ivHrDlkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~e 311 (410)
..|.-+..+ +.-.+.++.+.++ ||+.++.+..... ......+..+.|||...... ......|+|++|.++..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 666655555 4444566677777 9988877643322 22333455678888665322 12345799999999999
Q ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCC-CCCcHHHHHhccCCCCCCC
Q 015247 312 LLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDF-PPSSLPLIETLLAIDPAER 390 (410)
Q Consensus 312 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R 390 (410)
+..|..+-... ..+.. ..+.. .....+++.+|+.-|+++|
T Consensus 385 ~~~~~~i~~~~------~~~~~---------------------------------~l~~~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 385 LSQGEDISEKS------AVPVS---------------------------------LLDVLSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred hhhcCcccccc------cchhh---------------------------------hhccccchhhhhhhhhhcchhhhhc
Confidence 99887432111 11111 11111 2267889999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 015247 391 LTATVALNSEVIFQD 405 (410)
Q Consensus 391 pt~~elL~hp~~~~~ 405 (410)
+.+.++|.|+|.+..
T Consensus 426 l~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 426 LSALELLTHPFLRFP 440 (1351)
T ss_pred cchhhhhhchhcccc
Confidence 999999999998754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.3e-06 Score=75.56 Aligned_cols=139 Identities=24% Similarity=0.316 Sum_probs=78.1
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC--ceeeEeeeEee-cCCceEEEEEe
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP--NVIKLEGLVTS-RMSCSLYLVFH 197 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-~~~~~~~lv~e 197 (410)
++.|+.|..+.||++.. .+ ..+++|..... .....+.+|..+++.+... .+.+++..... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~-~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT-DD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEE-TT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEE-CC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 46799999999999984 33 58999986532 3455677888888887422 35566554332 22334799999
Q ss_pred eccCCHHHH---------------------hcC--CCCCCCHHH------HHHH---------------HHHHHH-HHHH
Q 015247 198 YMEHDLAGL---------------------AAS--PEVKFTEPQ------VKCY---------------MHQLLS-GLEH 232 (410)
Q Consensus 198 ~~~~~l~~~---------------------~~~--~~~~~~~~~------~~~~---------------~~qi~~-~L~~ 232 (410)
++++..+.. ... ....+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998742222 000 111111000 0000 011222 2333
Q ss_pred HHH-------CCceeccCCCCCEEEc-CCCcEEEEeecccc
Q 015247 233 CHN-------NGVLHRDIKGSNLLID-DDGVLKIADFGLAS 265 (410)
Q Consensus 233 LH~-------~~ivHrDlkp~NILl~-~~~~vkl~DFGla~ 265 (410)
+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 3599999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3e-06 Score=85.00 Aligned_cols=143 Identities=22% Similarity=0.260 Sum_probs=85.1
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--------------------------------hHHHH------HHH
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------------------------------PESVK------FMA 163 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------------~~~~~------~~~ 163 (410)
+-|+.++-|+||.|+. .+|+.||||+.+.+-.. .+..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5699999999999994 67999999998753110 00001 123
Q ss_pred HHHHHHHhCC-----CCceeeEeeeEeecCCceEEEEEeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015247 164 REILILRRLD-----HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237 (410)
Q Consensus 164 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 237 (410)
+|...+.+++ .+++. +=.++.+- ...-.++|||++|--.... ......++...+.....++ -+..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 3444444431 23332 11222221 2236899999998322211 1111234433322222111 122333479
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 238 ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
++|.|..|.||+++.+|++.+.|||+...+++
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=72.97 Aligned_cols=134 Identities=16% Similarity=0.105 Sum_probs=77.4
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
..||+|..+.||+. .|..+++|...... ....+.+|.+++..+..-. +.+.+++... .....++|+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 56899999999984 24467788775422 1234677999998875333 3445555444 33467899999
Q ss_pred cCCH-HH-Hh--------------------cCCC--CCCCHHHH-HHHHHH----------HHH-HHHHHHH----CCce
Q 015247 200 EHDL-AG-LA--------------------ASPE--VKFTEPQV-KCYMHQ----------LLS-GLEHCHN----NGVL 239 (410)
Q Consensus 200 ~~~l-~~-~~--------------------~~~~--~~~~~~~~-~~~~~q----------i~~-~L~~LH~----~~iv 239 (410)
+|.. .. .. ...- ........ ..+..+ +.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8841 10 00 0000 01111110 011000 111 1222221 1478
Q ss_pred eccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 240 HRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 240 HrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.7e-05 Score=68.15 Aligned_cols=129 Identities=25% Similarity=0.344 Sum_probs=91.0
Q ss_pred CCcceeeeeccCCC-eeEEEEEEcCCCceEEEEEEec---CC-------CCh---------HHHHHHHHHHHHHHhC---
Q 015247 116 DSFEKIDKIGQGTY-SNVYKAKDMLTGKIVALKKVRF---DN-------LEP---------ESVKFMAREILILRRL--- 172 (410)
Q Consensus 116 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~-------~~~---------~~~~~~~~E~~~l~~l--- 172 (410)
.+++.++.||.|.- |.||+++ .+|+.||+|+++. .. ... ....-+..|.++..+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999996 6788999999432 11 000 1233566677776666
Q ss_pred CCCce--eeEeeeEeec----------------CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015247 173 DHPNV--IKLEGLVTSR----------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234 (410)
Q Consensus 173 ~h~ni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 234 (410)
.+.++ |+++|+..-. ......||.||+.... .+.. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 45566 8999987321 1123467888766533 2222 23457888888999
Q ss_pred HCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 235 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3588999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.7e-06 Score=69.35 Aligned_cols=131 Identities=21% Similarity=0.240 Sum_probs=91.0
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee-eEeeeEeecCCceEEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI-KLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~ 196 (410)
-+..+.|++|.+|.||+|. ..|..+|+|+-+.+ .....+..|+++|..+.-.++- +++.+ .. .++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y-g~-----~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY-GE-----DFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe-ch-----hhhhh
Confidence 4556789999999999996 67779999986643 3345678899999988765553 34322 11 34569
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCEEEcCCCcEEEEeecccccc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIK-GSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk-p~NILl~~~~~vkl~DFGla~~~ 267 (410)
||+.|-.+....... . +.-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|+.-
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999984443332211 1 2334456666555777899999987 77777777779999999998743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.7e-05 Score=69.68 Aligned_cols=70 Identities=17% Similarity=0.119 Sum_probs=44.7
Q ss_pred eccCCC-eeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 124 IGQGTY-SNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 124 LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
|-.|.+ ..||+... .+..+.+|...... ...+.+|+++++.+. +-.+.+++++.... ...++||++++|
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCC
Confidence 444555 78999963 34678888764322 224566888888773 33455666655443 347899999987
Q ss_pred C
Q 015247 202 D 202 (410)
Q Consensus 202 ~ 202 (410)
.
T Consensus 77 ~ 77 (244)
T cd05150 77 V 77 (244)
T ss_pred c
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-05 Score=78.79 Aligned_cols=140 Identities=18% Similarity=0.201 Sum_probs=85.3
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-----------------------------hHHHHHHHH------HH
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-----------------------------PESVKFMAR------EI 166 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~~------E~ 166 (410)
+.||.-+.|.||+|+. .+|+.||||+-+.+-.. ++..+.+.. |+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5699999999999995 66999999987653111 111122222 33
Q ss_pred HHHHh----CCCCc------eeeEeeeEeecCCceEEEEEeeccC---CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015247 167 LILRR----LDHPN------VIKLEGLVTSRMSCSLYLVFHYMEH---DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233 (410)
Q Consensus 167 ~~l~~----l~h~n------iv~l~~~~~~~~~~~~~lv~e~~~~---~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L 233 (410)
+-..+ +.|-+ |.+++ .+ ....-.|+||||+| +.++.+... .++...+...+.++..- -+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy---~~-~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~--qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY---WD-LSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLE--QI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh---hh-cCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHH--HH
Confidence 22222 23444 33332 21 12236899999998 333434333 34444443333332221 23
Q ss_pred HHCCceeccCCCCCEEEcC----CCcEEEEeeccccccCCC
Q 015247 234 HNNGVLHRDIKGSNLLIDD----DGVLKIADFGLASFFDPN 270 (410)
Q Consensus 234 H~~~ivHrDlkp~NILl~~----~~~vkl~DFGla~~~~~~ 270 (410)
=..|++|+|=.|-||+++. ++.+.+.|||+...+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3468999999999999984 678999999999877543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.3e-05 Score=80.95 Aligned_cols=81 Identities=25% Similarity=0.343 Sum_probs=54.6
Q ss_pred eeeeccCCCeeEEEEEEcCCC--ceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCce--eeEeeeEeec-CCceEEE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTG--KIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNV--IKLEGLVTSR-MSCSLYL 194 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~-~~~~~~l 194 (410)
++.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.+. |.++ .+++.++.+. .....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 577899999999998753322 467888754332211 2345778999999985 6654 6676666543 1235789
Q ss_pred EEeeccCC
Q 015247 195 VFHYMEHD 202 (410)
Q Consensus 195 v~e~~~~~ 202 (410)
||||+++.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=9.9e-05 Score=67.18 Aligned_cols=30 Identities=30% Similarity=0.493 Sum_probs=25.5
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00045 Score=60.87 Aligned_cols=133 Identities=20% Similarity=0.268 Sum_probs=86.9
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCC--------------CChHHHHHHHHHHHHHHhCC------CCceeeE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN--------------LEPESVKFMAREILILRRLD------HPNVIKL 180 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~niv~l 180 (410)
...||+|+.=.||.- .......||++.... ......+...+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456999999999975 445566789987665 00112334455555555444 8899999
Q ss_pred eeeEeecCCceEEEEEeeccC-------CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 181 EGLVTSRMSCSLYLVFHYMEH-------DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~~-------~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
+|+.+...+ .-+|+|.+.. .+..++.. +.+++ . +...+-.-..||-+.+|+.+|++|.||++...
T Consensus 83 ~G~veT~~G--~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLG--LGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCc--eEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 999988655 7788887642 23333322 24554 2 22334445568889999999999999999743
Q ss_pred C----cEEEEe-eccc
Q 015247 254 G----VLKIAD-FGLA 264 (410)
Q Consensus 254 ~----~vkl~D-FGla 264 (410)
. .+.|+| ||-.
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 2 577887 4533
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.83 E-value=7.9e-05 Score=65.26 Aligned_cols=99 Identities=27% Similarity=0.254 Sum_probs=77.3
Q ss_pred HHHHHHHhCCC-CceeeEeeeEeecCCceEEEEEeeccCC-HHHHh--cCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 015247 164 REILILRRLDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLA--ASPEVKFTEPQVKCYMHQLLSGLEHCHNN--- 236 (410)
Q Consensus 164 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~~--~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--- 236 (410)
.|.-+|+.+.+ +++++++|+|-. +++.||.+.+ +.... ...-...+|..+.+++.+++..+.+|+..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888865 699999998743 6788998853 32111 11112468999999999999999999983
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
.+.-.|++|+|+-++++|++|++|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 57779999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00021 Score=67.49 Aligned_cols=142 Identities=22% Similarity=0.281 Sum_probs=97.9
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC----------------------ChHHHH--HHHHHHHHHHhCCCCc
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----------------------EPESVK--FMAREILILRRLDHPN 176 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~--~~~~E~~~l~~l~h~n 176 (410)
-.+|..|.-+.||.|. ..+|..+|||+.+.+-+ ++...- ....|++-|.+++...
T Consensus 149 nGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3467788899999998 58899999998754211 111111 2234666777775444
Q ss_pred eeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCc
Q 015247 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~ 255 (410)
|.-.--+.. ..-.|||++++.+-+-.-.-.+..++...+..+-.|++..+.-|-+ .++||.||.--|+|+ .+|.
T Consensus 228 IP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 228 IPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 322111111 1147999999865444334445578888899999999988887654 599999999999998 6789
Q ss_pred EEEEeeccccccC
Q 015247 256 LKIADFGLASFFD 268 (410)
Q Consensus 256 vkl~DFGla~~~~ 268 (410)
+.|+|.+-+...+
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999999886543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.8e-06 Score=90.14 Aligned_cols=166 Identities=12% Similarity=-0.009 Sum_probs=116.0
Q ss_pred CCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHh-cCCC---CCCCHHHHHHHHHHHH
Q 015247 152 DNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA-ASPE---VKFTEPQVKCYMHQLL 227 (410)
Q Consensus 152 ~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~-~~~~---~~~~~~~~~~~~~qi~ 227 (410)
++..+...+....|+.-++...|++++....-.........|.+++|+.++.+... .+.- ..+...-+.....+.+
T Consensus 1266 e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsv 1345 (2724)
T KOG1826|consen 1266 ENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSV 1345 (2724)
T ss_pred HHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHH
Confidence 33444445566667777777899998877655555555567889999987655433 3221 2233333333333436
Q ss_pred HHHHHHHHC-C----ceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccch
Q 015247 228 SGLEHCHNN-G----VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDL 302 (410)
Q Consensus 228 ~~L~~LH~~-~----ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 302 (410)
.+..-.|+. + .+|+++|+.|.+|..+.+++++++|+.+... .........++++.|++|++... ..++.++|+
T Consensus 1346 l~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdi 1423 (2724)
T KOG1826|consen 1346 LNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDI 1423 (2724)
T ss_pred hccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHH
Confidence 666666654 2 6899999999999999999999999998432 23333455677889999997654 347878999
Q ss_pred HHHHHHHHHHHcCCCCC
Q 015247 303 WSAGCILAELLAGKPIM 319 (410)
Q Consensus 303 wSlGv~l~ell~g~~pf 319 (410)
|..|+.+|+...|.++|
T Consensus 1424 lr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHhcccHHH
Confidence 99999999999998776
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=3.6e-05 Score=71.41 Aligned_cols=138 Identities=19% Similarity=0.200 Sum_probs=92.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH--------------------HHHHHHHHHHHHHhCCC-
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE--------------------SVKFMAREILILRRLDH- 174 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~h- 174 (410)
.-+.+.+.||-|.-+.||.+-+ ..|++.++|.-+.....-. ..-...+|...|+.|..
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3577889999999999999984 7799999996443221100 01123457777777732
Q ss_pred -CceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 175 -PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 175 -~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
-.+.+.+++ +.-++|||++.+.-+.....- ..+..+...+..-+.-|-.+|+||+|+.-=||+++++
T Consensus 171 gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 171 GFPVPKPIDH------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCCcccc------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 233333332 235789998887544433221 1122344455555667889999999999999999999
Q ss_pred CcEEEEeeccccc
Q 015247 254 GVLKIADFGLASF 266 (410)
Q Consensus 254 ~~vkl~DFGla~~ 266 (410)
+.++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999976543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0006 Score=61.92 Aligned_cols=72 Identities=14% Similarity=0.153 Sum_probs=43.7
Q ss_pred eeeeccCCCeeEEEEEEcC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeEeeeEeecCCceEEEEEee
Q 015247 121 IDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv~e~ 198 (410)
++.|..|-...+|++.... +++.|++|+...... . .-...+|+.++..+.... .+++++.+. . .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--L-IIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--c-eecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4567778888999997422 357888997653221 1 112346888888874333 344443322 1 379999
Q ss_pred ccC
Q 015247 199 MEH 201 (410)
Q Consensus 199 ~~~ 201 (410)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0007 Score=62.43 Aligned_cols=133 Identities=20% Similarity=0.216 Sum_probs=73.4
Q ss_pred eccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeEeeeEeecCCceEEEEEeeccCC
Q 015247 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 124 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
+..|-.+.+|+.. .++..+++|........- .. ...+|..+++.+....+ .+++... . -++||+|++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCc
Confidence 4567778899886 567788888754321110 01 24568888888853322 3333322 1 25899998873
Q ss_pred HHH-------------------HhcC--CCCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeccC
Q 015247 203 LAG-------------------LAAS--PEVKFTE-PQVKCYMHQL---------LSGLEHCHN--------NGVLHRDI 243 (410)
Q Consensus 203 l~~-------------------~~~~--~~~~~~~-~~~~~~~~qi---------~~~L~~LH~--------~~ivHrDl 243 (410)
... .+.. ...+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 221 0100 1111221 1112222111 111222221 24899999
Q ss_pred CCCCEEEcCCCcEEEEeecccccc
Q 015247 244 KGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 244 kp~NILl~~~~~vkl~DFGla~~~ 267 (410)
.|.||++++++ +.|+||..+..-
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcC
Confidence 99999999877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00037 Score=68.53 Aligned_cols=172 Identities=22% Similarity=0.292 Sum_probs=113.2
Q ss_pred HHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015247 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241 (410)
Q Consensus 162 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHr 241 (410)
+.--.++++.+.|+|+.+.+.+-... .....+|||+++.++.+....+. +-.. +++ -+++.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~- 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH- 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce-
Confidence 44467889999999999987765543 34589999999998887665442 1000 111 112222
Q ss_pred cCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCC
Q 015247 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 321 (410)
Q Consensus 242 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 321 (410)
-|| ++.+| -++. . | |- ..++++||||+|.++.++.-|...+..
T Consensus 91 ----~~~-------~~~td-~~~t-----------~------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 ----LNI-------IYITD-HFLT-----------K------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ----ehh-------hhccc-cccc-----------c------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 122 22333 0000 0 0 11 123599999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 322 RTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 322 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
....+.+..+.+....+..... ..+-......++....++...|+-..|..||...++.+++-
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 8888888888776544432110 00111222357788899999999999999999999999998
Q ss_pred CCCC
Q 015247 402 IFQD 405 (410)
Q Consensus 402 ~~~~ 405 (410)
|.+.
T Consensus 197 ~~ev 200 (725)
T KOG1093|consen 197 FTEV 200 (725)
T ss_pred HHHH
Confidence 8653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0043 Score=60.63 Aligned_cols=77 Identities=19% Similarity=0.113 Sum_probs=50.7
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecC-----CCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCceE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-----NLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~ 192 (410)
.+.||.|.+..||++.....++.++||.-... ...+...++...|.+.|..+. -.++++++.+-. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCC
Confidence 46799999999999986433358999975311 000123455667888888763 345677765522 236
Q ss_pred EEEEeeccC
Q 015247 193 YLVFHYMEH 201 (410)
Q Consensus 193 ~lv~e~~~~ 201 (410)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 799999875
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0036 Score=59.67 Aligned_cols=30 Identities=33% Similarity=0.522 Sum_probs=26.0
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
++||+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 799999999999998665568999998853
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0015 Score=61.55 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=79.4
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC--ceeeEeeeE----eecCCceEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP--NVIKLEGLV----TSRMSCSLY 193 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~----~~~~~~~~~ 193 (410)
-++.|..|....+|+... ++..+++|+... .. ...+..|+.++..+.+. .+.+++... ........+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356778888889999863 445788998753 11 23455677777777432 244443211 001123468
Q ss_pred EEEeeccCCHHH----------------Hhc---CCCCC------CCHHHH----------HHHHHHHHHHHHHHHH---
Q 015247 194 LVFHYMEHDLAG----------------LAA---SPEVK------FTEPQV----------KCYMHQLLSGLEHCHN--- 235 (410)
Q Consensus 194 lv~e~~~~~l~~----------------~~~---~~~~~------~~~~~~----------~~~~~qi~~~L~~LH~--- 235 (410)
+++++++|.... .+. .-... ..+... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 999999863211 010 00000 010000 0011112334444443
Q ss_pred ----CCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 236 ----NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 236 ----~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887788999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0042 Score=58.69 Aligned_cols=149 Identities=20% Similarity=0.220 Sum_probs=83.6
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeEeeeEeecCCceEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv 195 (410)
..+++.+-.|..-.+|... .+++.++++ ...............+|..+|+.+.- -.+...++++.+......|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEe--cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 4455555444333455554 338888888 32212223345566778888887743 233444556655433457999
Q ss_pred EeeccCCHHHH-----------hc-----------C---C-----C--CCCCHHHHHHHHHHH--------------HHH
Q 015247 196 FHYMEHDLAGL-----------AA-----------S---P-----E--VKFTEPQVKCYMHQL--------------LSG 229 (410)
Q Consensus 196 ~e~~~~~l~~~-----------~~-----------~---~-----~--~~~~~~~~~~~~~qi--------------~~~ 229 (410)
|+|+.|..... .. + . . ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998721100 00 0 0 0 001112222222222 122
Q ss_pred HHHHHHC--------CceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 230 LEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 230 L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
..+|+.+ .++|+|+.+.||+++.++.+=|.||+++..-++
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 3444433 489999999999999998899999999976543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0068 Score=57.23 Aligned_cols=78 Identities=14% Similarity=0.135 Sum_probs=52.6
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC---CceeeEeeeEeec-CCceEEE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH---PNVIKLEGLVTSR-MSCSLYL 194 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-~~~~~~l 194 (410)
.-.+.||.|..+.||.... .++ .+.+|..+ .... ...+..|...|+.+.. -.+.++++++... .....++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMAR-SFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEec-cccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3457799999999999863 334 56777743 2111 2357789999988843 3577777766542 2344899
Q ss_pred EEeeccCC
Q 015247 195 VFHYMEHD 202 (410)
Q Consensus 195 v~e~~~~~ 202 (410)
|||++++.
T Consensus 91 VmE~i~G~ 98 (297)
T PRK10593 91 LLERLRGV 98 (297)
T ss_pred EEeccCCE
Confidence 99998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.005 Score=58.38 Aligned_cols=143 Identities=16% Similarity=0.131 Sum_probs=79.2
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeEeeeE----eecCCce
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLV----TSRMSCS 191 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~----~~~~~~~ 191 (410)
...++.++.|....+|++.. .+| .+++|+.+... .. +.+..|.+++..|.... +.+++... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 33466778888889999863 344 68889765422 12 23445667776663222 33333211 1112345
Q ss_pred EEEEEeeccCCHH----------------HHhcC-CCC--C----CC---HHHHH------------HHHHHHHHHHHHH
Q 015247 192 LYLVFHYMEHDLA----------------GLAAS-PEV--K----FT---EPQVK------------CYMHQLLSGLEHC 233 (410)
Q Consensus 192 ~~lv~e~~~~~l~----------------~~~~~-~~~--~----~~---~~~~~------------~~~~qi~~~L~~L 233 (410)
.+++++|++|... ..+.. .+. . .. +.... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 7899999876210 01100 000 0 00 00000 0011233345555
Q ss_pred HH-------CCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 234 HN-------NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 234 H~-------~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0032 Score=59.52 Aligned_cols=30 Identities=30% Similarity=0.481 Sum_probs=26.6
Q ss_pred CceeccCCCCCEEEcCC----CcEEEEeeccccc
Q 015247 237 GVLHRDIKGSNLLIDDD----GVLKIADFGLASF 266 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~----~~vkl~DFGla~~ 266 (410)
.++|+|+.+.|||++.+ +.+.++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0065 Score=58.27 Aligned_cols=29 Identities=31% Similarity=0.668 Sum_probs=25.6
Q ss_pred ceeccCCCCCEEEcC-CCcEEEEeeccccc
Q 015247 238 VLHRDIKGSNLLIDD-DGVLKIADFGLASF 266 (410)
Q Consensus 238 ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 266 (410)
++|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 57899999998854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0086 Score=55.87 Aligned_cols=31 Identities=26% Similarity=0.391 Sum_probs=26.0
Q ss_pred CceeccCCCCCEEEcCCCc-EEEEeecccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGV-LKIADFGLASFF 267 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~ 267 (410)
.++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.015 Score=55.75 Aligned_cols=75 Identities=17% Similarity=0.158 Sum_probs=46.0
Q ss_pred eeccCCCeeEEEEEEcCCCceEEEEEEec-----CCCChHHHHHHHHHHHHHHhCC--CC-ceeeEeeeEeecCCceEEE
Q 015247 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRF-----DNLEPESVKFMAREILILRRLD--HP-NVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~~~l 194 (410)
.||.|....||++.+...++.|+||.-.. ....+-..++...|.++|+... -| .+++++.+ ++ ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc--cccee
Confidence 57999999999999643336799997431 1111223344556888887763 34 45556443 22 22568
Q ss_pred EEeeccC
Q 015247 195 VFHYMEH 201 (410)
Q Consensus 195 v~e~~~~ 201 (410)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.023 Score=54.78 Aligned_cols=153 Identities=14% Similarity=0.190 Sum_probs=81.5
Q ss_pred ccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcC----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-ee
Q 015247 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDML----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IK 179 (410)
Q Consensus 105 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~ 179 (410)
+....|......+..-+..|-.|-...+|++.... .++.|++|+..... ....+ ..+|..+++.+...++ .+
T Consensus 25 ~~~~~w~~~~~~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~ 101 (344)
T PLN02236 25 SLASKWGDVVDDEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPR 101 (344)
T ss_pred HhcchhcCCCCcCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCc
Confidence 34445643211223334456558888899986322 24689999775432 12222 3558888888753333 34
Q ss_pred EeeeEeecCCceEEEEEeeccCCHHH-------------------HhcC--CCC--CCCHHHHHHHHHHHH---------
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHDLAG-------------------LAAS--PEV--KFTEPQVKCYMHQLL--------- 227 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~-------------------~~~~--~~~--~~~~~~~~~~~~qi~--------- 227 (410)
+++.+.. + .+.+|+++..+. .+.. ... ......+..+..++.
T Consensus 102 ~~~~~~~--g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~ 175 (344)
T PLN02236 102 LLGRFPN--G----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAK 175 (344)
T ss_pred eEEEECC--c----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhh
Confidence 4454432 2 467777652111 0000 000 112333334432221
Q ss_pred --------HHHHHH----H----HCCceeccCCCCCEEEcC-CCcEEEEeeccccc
Q 015247 228 --------SGLEHC----H----NNGVLHRDIKGSNLLIDD-DGVLKIADFGLASF 266 (410)
Q Consensus 228 --------~~L~~L----H----~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 266 (410)
..+..| . ...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 176 ~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 176 EFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111122 1 125899999999999986 47899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.039 Score=53.98 Aligned_cols=76 Identities=18% Similarity=0.184 Sum_probs=49.6
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC--C---hHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCce
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--E---PESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 191 (410)
..+.||.|....||+..+ .+..|+||.-..... . +....+...|.+.|+.+. ..++.+++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~-- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M-- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C--
Confidence 367789999999999985 345688997542111 1 112344445677777663 2477778776553 2
Q ss_pred EEEEEeeccC
Q 015247 192 LYLVFHYMEH 201 (410)
Q Consensus 192 ~~lv~e~~~~ 201 (410)
-+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5788999965
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.041 Score=52.25 Aligned_cols=30 Identities=27% Similarity=0.309 Sum_probs=27.7
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
+++|+|+.+.|||++.++.+-++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.045 Score=53.49 Aligned_cols=92 Identities=20% Similarity=0.233 Sum_probs=49.5
Q ss_pred hhhcccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcCC-Cce-----EEEEEEecCCCChHHHHHHHHHHHHHHhCCC
Q 015247 101 AVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLT-GKI-----VALKKVRFDNLEPESVKFMAREILILRRLDH 174 (410)
Q Consensus 101 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 174 (410)
..|.+....|.....+..++. .|..|-...+|++..... +.. |.++.. ...... .-...+|+++++.+..
T Consensus 36 ~~~~~~~p~w~~~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~--g~~~~l-~IdR~~E~~i~~~Ls~ 111 (383)
T PTZ00384 36 SLCIRHVPFWNNVNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS--STYNSL-VIDNDLQYNIAKLLGD 111 (383)
T ss_pred HHHHHHCCccccCCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEec--cCCCce-EeccHHHHHHHHHHHh
Confidence 344555556644433445444 555588889999974322 222 333332 111111 1123458889988864
Q ss_pred Cce-eeEeeeEeecCCceEEEEEeeccCC
Q 015247 175 PNV-IKLEGLVTSRMSCSLYLVFHYMEHD 202 (410)
Q Consensus 175 ~ni-v~l~~~~~~~~~~~~~lv~e~~~~~ 202 (410)
.++ .++++.+.. +++.||++|.
T Consensus 112 ~glgP~l~~~f~~------g~l~efIeGr 134 (383)
T PTZ00384 112 NNFGPKIIGRFGD------FTIQEWVEGN 134 (383)
T ss_pred CCCCCeEEEecCC------EEEEEEeccc
Confidence 444 455555432 4888888763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.021 Score=54.38 Aligned_cols=75 Identities=21% Similarity=0.305 Sum_probs=59.9
Q ss_pred cCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 187 RMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
....|.|++|++-++.+...- .-...++..++++.+..++-|... .+=|||+...||||+ +|+|-|+||-+++
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 346678899998776554322 235778888899988888877765 789999999999999 9999999999998
Q ss_pred cc
Q 015247 266 FF 267 (410)
Q Consensus 266 ~~ 267 (410)
.-
T Consensus 370 l~ 371 (488)
T COG5072 370 LS 371 (488)
T ss_pred cc
Confidence 43
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.22 Score=55.10 Aligned_cols=31 Identities=35% Similarity=0.597 Sum_probs=26.4
Q ss_pred CCceeccCCCCCEEEcCCC--cEE-EEeeccccc
Q 015247 236 NGVLHRDIKGSNLLIDDDG--VLK-IADFGLASF 266 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~--~vk-l~DFGla~~ 266 (410)
.++||+|+.+.|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.086 Score=52.56 Aligned_cols=93 Identities=12% Similarity=0.169 Sum_probs=52.9
Q ss_pred hhhhhcccccCCCCCcCCCcceeeeeccCCCeeEEEEEEcCC--------CceEEEEEEecCCCChHHHHHHHHHHHHHH
Q 015247 99 LTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLT--------GKIVALKKVRFDNLEPESVKFMAREILILR 170 (410)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~ 170 (410)
....|.+...+|.....++. -++.|..|-.-.+|++..... ++.|.+++..... .... ...+|..+++
T Consensus 89 ~~~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~ 164 (442)
T PTZ00296 89 IKKICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYK 164 (442)
T ss_pred HHHHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHH
Confidence 33455555667764444555 566777788888999874321 4678888764322 1111 2345777777
Q ss_pred hCCCCce-eeEeeeEeecCCceEEEEEeeccC
Q 015247 171 RLDHPNV-IKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 171 ~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
.+....| .++++.+.. +.+.+|+++
T Consensus 165 ~ls~~gi~P~l~~~f~g------g~I~efi~g 190 (442)
T PTZ00296 165 TMSKYRIAPQLLNTFSG------GRIEEWLYG 190 (442)
T ss_pred HHHHCCCCCceEEEeCC------CEEEEeeCC
Confidence 7643333 234444431 246777765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.054 Score=52.72 Aligned_cols=77 Identities=18% Similarity=0.125 Sum_probs=48.6
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEec----CCCChHHHHHHHHHHHHHHhCC--CC-ceeeEeeeEeecCCceEE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRF----DNLEPESVKFMAREILILRRLD--HP-NVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~~~ 193 (410)
.+.||.|.-.-||++.+...++.|+||.-.. ....+-..++...|.++|+... .| .+++++.+ ++ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc--HHhh
Confidence 6779999999999998733356789986421 1111233455566888888763 34 45666443 21 2256
Q ss_pred EEEeeccC
Q 015247 194 LVFHYMEH 201 (410)
Q Consensus 194 lv~e~~~~ 201 (410)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88888753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.36 Score=46.16 Aligned_cols=137 Identities=19% Similarity=0.240 Sum_probs=77.4
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc------eeeEeeeEeecCC--ceEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN------VIKLEGLVTSRMS--CSLY 193 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~--~~~~ 193 (410)
..|.+ .-..||+... .+|. +++|+.+.. ... ..+..|...|..|.-.. +..+-|-....-. .+.+
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGR-YILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEe-cCCC-eEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 33444 5567898873 4444 488988765 333 34555777777773211 3333332222222 3788
Q ss_pred EEEeeccCCHHHH-----------------hc-CCCC---------CCCHH----H---------HHHHHHHHHHHHHHH
Q 015247 194 LVFHYMEHDLAGL-----------------AA-SPEV---------KFTEP----Q---------VKCYMHQLLSGLEHC 233 (410)
Q Consensus 194 lv~e~~~~~l~~~-----------------~~-~~~~---------~~~~~----~---------~~~~~~qi~~~L~~L 233 (410)
-+++|++|..... +. .++. ...|. . -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999998743321 00 0000 11111 0 011223444445544
Q ss_pred HH--------CC--ceeccCCCCCEEEcCCCc-EEEEeecccc
Q 015247 234 HN--------NG--VLHRDIKGSNLLIDDDGV-LKIADFGLAS 265 (410)
Q Consensus 234 H~--------~~--ivHrDlkp~NILl~~~~~-vkl~DFGla~ 265 (410)
.+ .+ +||+|+.|.||+++.+.. +-++|||-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 43 24 999999999999998885 8999999774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.35 Score=45.31 Aligned_cols=76 Identities=16% Similarity=0.194 Sum_probs=43.9
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCceEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~l 194 (410)
.+-.+.++.|....+|... .+++.+.||+-... ....+..|.+-|+.|. --.+++++++-..... -|+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceE
Confidence 3445678989999999986 78889999987622 2234666777777773 3446667666554333 489
Q ss_pred EEeeccCC
Q 015247 195 VFHYMEHD 202 (410)
Q Consensus 195 v~e~~~~~ 202 (410)
+|||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.82 Score=43.70 Aligned_cols=28 Identities=29% Similarity=0.203 Sum_probs=23.8
Q ss_pred CCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999774
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.18 Score=44.88 Aligned_cols=116 Identities=17% Similarity=0.183 Sum_probs=69.0
Q ss_pred CCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHH
Q 015247 127 GTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206 (410)
Q Consensus 127 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 206 (410)
|+.++.-.+.... | +..+|+++.....- ....+..+.+++.++. .|+++.. +....+-++.|+|..--
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~--- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK--- 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc---
Confidence 4444544444222 3 44567665433221 1334567888887764 5666642 22334567888775311
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 207 AASPEVKFTEPQVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
... ..++.-=+.+|.-.|+. +.+|+|..|+||+-|..|.+||.|=+..
T Consensus 141 ---------i~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ---------INF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ---------cch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 001 11222224567778843 7999999999999999999999997743
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.077 Score=50.22 Aligned_cols=29 Identities=28% Similarity=0.521 Sum_probs=25.7
Q ss_pred CCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.053 Score=47.14 Aligned_cols=30 Identities=30% Similarity=0.449 Sum_probs=26.0
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
-.+|+|+.|.||++++++ ++|+||+.+..-
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 369999999999998877 999999988654
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.057 Score=51.02 Aligned_cols=53 Identities=25% Similarity=0.224 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHHHH----HCCceeccCCCCCEEEcCCC------------------cEEEEeeccccccC
Q 015247 216 EPQVKCYMHQLLSGLEHCH----NNGVLHRDIKGSNLLIDDDG------------------VLKIADFGLASFFD 268 (410)
Q Consensus 216 ~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NILl~~~~------------------~vkl~DFGla~~~~ 268 (410)
..-++.++.||+.-.-..- ..+++|-||||+|||+-+.. .++|.||.+|...+
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 4455667777766542222 23689999999999984321 46888998887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 410 | ||||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-63 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-63 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-63 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-63 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-58 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-58 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-58 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-58 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-58 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-58 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-58 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-58 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-58 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-58 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-57 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-57 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-57 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-57 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-57 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-57 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-57 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-57 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-57 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-57 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-57 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-57 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-57 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-57 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-57 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-57 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-57 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-57 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-57 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-57 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-57 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-57 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-57 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-57 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-57 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-56 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-56 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-56 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-52 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-52 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-51 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-51 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-50 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-49 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-47 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-47 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-47 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-47 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-46 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-46 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-46 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-45 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-43 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-43 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-43 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-43 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-43 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-43 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-43 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-43 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-43 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-43 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-43 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-43 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-43 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-43 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-43 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-43 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-43 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-43 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-43 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-42 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-42 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-41 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-41 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-41 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-41 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-41 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-41 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-41 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-41 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-41 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-41 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-41 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-41 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-41 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-41 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-41 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-41 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-41 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-41 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-41 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-41 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-41 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-41 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-41 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-41 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-41 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-41 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-41 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-41 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-41 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-40 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-40 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-40 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-40 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-40 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-40 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-40 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-40 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-40 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-40 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-40 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-40 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-40 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-40 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-40 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-40 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-40 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-40 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-40 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-40 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-40 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-40 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-40 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-40 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-40 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-40 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-40 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-40 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-40 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-40 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-40 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-40 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-40 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-40 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-40 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-40 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-39 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-39 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-39 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-39 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-39 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-39 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-38 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-38 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-37 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-37 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-36 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-35 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-34 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-34 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-34 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-34 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-34 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-34 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-34 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-34 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-34 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-34 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-34 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-34 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-34 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-34 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-34 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-33 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-33 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-32 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-30 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-30 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-27 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-27 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-27 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-26 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-26 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-26 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-26 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-26 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-26 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-26 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-26 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-26 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-26 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-25 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-24 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-24 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-24 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-24 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-17 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-17 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 |
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-175
Identities = 136/309 (44%), Positives = 182/309 (58%), Gaps = 14/309 (4%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA- 163
+++ +EK+ KIGQGT+ V+KA+ TG+ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 164 REILILRRLDHPNVIKLEGLVTSRMS------CSLYLVFHYMEHDLAGLAASPEVKFTEP 217
REI IL+ L H NV+ L + ++ S S+YLVF + EHDLAGL ++ VKFT
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 218 QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---P 274
++K M LL+GL + H N +LHRD+K +N+LI DGVLK+ADFGLA F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
T+RVVTLWYRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 335 CGSPSEEYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSS--LPLIETLLAIDPAERL 391
CGS + E W + + KR +++ K + L LI+ LL +DPA+R+
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 392 TATVALNSE 400
+ ALN +
Sbjct: 305 DSDDALNHD 313
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 447 bits (1151), Expect = e-157
Identities = 123/295 (41%), Positives = 176/295 (59%), Gaps = 11/295 (3%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMA-REIL 167
+ RA +EK+D +G+G ++ VYKA+D T +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
+L+ L HPN+I L + + + LVF +ME DL + + T +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRP 286
GLE+ H + +LHRD+K +NLL+D++GVLK+ADFGLA SF PN T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRA 180
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK- 345
PELL GA YGVGVD+W+ GCILAELL P +PG ++++QL +I++ G+P+EE W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
LP+ FK + F L LI+ L +P R+TAT AL +
Sbjct: 241 CSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-136
Identities = 119/296 (40%), Positives = 175/296 (59%), Gaps = 9/296 (3%)
Query: 108 NGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REI 166
N + + ++K++K+G+GTY VYKAKD G+IVALK++R D E E + A REI
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA-EDEGIPSTAIREI 70
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
+L+ L HPN++ L ++ S L LVF +ME DL + + + Q+K Y++QL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYR 285
L G+ HCH + +LHRD+K NLLI+ DG LK+ADFGLA F P T VVTLWYR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYR 186
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
P++L+G+ Y VD+WS GCI AE++ GKP+ PG T+ +QL KI+ + G+P+ W +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 346 -SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+LP + K+ F + L+ +L DP +R++A A+N
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-135
Identities = 106/299 (35%), Positives = 152/299 (50%), Gaps = 17/299 (5%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF---MAREILIL 169
+E + +IG G Y VYKA+D +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 170 RRL---DHPNVIKLEGLVTSR---MSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCY 222
RRL +HPNV++L + + + LVF +++ DL L +P +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
M Q L GL+ H N ++HRD+K N+L+ G +K+ADFGLA + +T VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTL 183
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342
WYR PE+LL +T Y VD+WS GCI AE+ KP+ G +E +QL KI+ L G P E+
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 343 WKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
W + LP R +Q + S L+ +L +P +R++A AL
Sbjct: 243 WPRDVSLPRGAFPPRG---PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-134
Identities = 105/287 (36%), Positives = 157/287 (54%), Gaps = 7/287 (2%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+++ K+DK+G+GTY+ VYK K LT +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N++ L ++ + S L LVF Y++ DL VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGAT 294
VLHRD+K NLLI++ G LK+ADFGLA P + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGST 176
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATL 353
DY +D+W GCI E+ G+P+ PG T EQLH I+++ G+P+EE W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ + + L+ LL + R++A A+
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-133
Identities = 119/289 (41%), Positives = 171/289 (59%), Gaps = 10/289 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N+++L ++ S L LVF + + DL S VK ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGA 293
+ VLHRD+K NLLI+ +G LK+A+FGLA F P ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 176
Query: 294 TDYGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNA 351
Y +D+WSAGCI AEL AG+P+ PG +QL +I++L G+P+EE W +KLP+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ P P + + L++ LL +P +R++A AL
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-132
Identities = 108/288 (37%), Positives = 166/288 (57%), Gaps = 10/288 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ + ++KIG+GTY VYKA++ G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++KL ++ ++ L LVF +++ DL L E K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGA 293
+ VLHRD+K NLLI+ +G LKIADFGLA F P T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGS 175
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNAT 352
Y +D+WS GCI AE++ G P+ PG +E +QL +I+++ G+P+ + W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ K S + L+ +L +DP +R+TA AL
Sbjct: 236 PNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-131
Identities = 107/299 (35%), Positives = 165/299 (55%), Gaps = 14/299 (4%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
D + +I K+G+GTY VYKA D +T + VA+K++R ++ E E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLS 228
L+ L H N+I+L+ ++ L+L+F Y E+DL + +K +++QL++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLIN 143
Query: 229 GLEHCHNNGVLHRDIKGSNLLID-----DDGVLKIADFGLASFF-DPNHKHPMTSRVVTL 282
G+ CH+ LHRD+K NLL+ + VLKI DFGLA F P T ++TL
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITL 201
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342
WYRPPE+LLG+ Y VD+WS CI AE+L P+ PG +E++QL KI+++ G P +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 343 WKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
W + LP+ P+ K + L L+ +L +DP +R++A AL
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-131
Identities = 112/329 (34%), Positives = 165/329 (50%), Gaps = 39/329 (11%)
Query: 107 LNGWIPRRADSFEKID-KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMA 163
L+ R D FE K+G+GTY +VYKA KD K ALK++ + +
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC---- 66
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL--------AASPEVKFT 215
REI +LR L HPNVI L+ + S ++L+F Y EHDL + A V+
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGLASFF-DPN 270
VK ++Q+L G+ + H N VLHRD+K +N+L+ + G +KIAD G A F P
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 271 HKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV---- 325
+ VVT WYR PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246
Query: 326 -----EQLHKIYKLCGSPSEEYWKK-SKLPNATLFKP---REPYKRC-----IQETFKDF 371
+QL +I+ + G P+++ W+ K+P + R Y C +++
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 372 PPSSLPLIETLLAIDPAERLTATVALNSE 400
+ L++ LL +DP +R+T+ A+
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDP 335
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-130
Identities = 112/300 (37%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ F++++K+G GTY+ VYK + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK-----FTEPQVKCYMHQLL 227
H N+++L ++ + L LVF +M++DL S V VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRP 286
GL CH N +LHRD+K NLLI+ G LK+ DFGLA F P + +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRA 176
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK- 345
P++L+G+ Y +D+WS GCILAE++ GKP+ PG + EQL I+ + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLP-----LIETLLAIDPAERLTATVALNSE 400
+KLP + P + +++ + L + LL ++P RL+A AL+
Sbjct: 237 TKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-130
Identities = 110/301 (36%), Positives = 162/301 (53%), Gaps = 17/301 (5%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMA-REIL 167
+ R +E + +IG+G Y V+KA+D+ G+ VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 168 ILRRL---DHPNVIKLEGLVTSRMS---CSLYLVFHYMEHDLAG-LAASPEVKFTEPQVK 220
+LR L +HPNV++L + T + L LVF +++ DL L PE +K
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
M QLL GL+ H++ V+HRD+K N+L+ G +K+ADFGLA + +TS VV
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVV 181
Query: 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340
TLWYR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P E
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 341 EYWKK-SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
E W + LP + I++ D L+ L +PA+R++A AL+
Sbjct: 241 EDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 400 E 400
Sbjct: 298 P 298
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-127
Identities = 86/290 (29%), Positives = 153/290 (52%), Gaps = 9/290 (3%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRR 171
+ + +E + +G+G+Y V K ++ TG+IVA+KK + + + VK +A REI +L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQ 80
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
L H N++ L + + YLVF +++H + V+ Y+ Q+++G+
Sbjct: 81 LRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELL 290
CH++ ++HRDIK N+L+ GV+K+ DFG A + P V T WYR PELL
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELL 196
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLP 349
+G YG VD+W+ GC++ E+ G+P+ PG ++++QL+ I G+ + + +K P
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 350 NATLFK-PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ P + ++ + + L + L IDP +R L+
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-127
Identities = 102/287 (35%), Positives = 155/287 (54%), Gaps = 9/287 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ +EKI KIG+G+Y V+K ++ TG+IVA+KK + +K +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
PN++ L + R L+LVF Y +H + + E VK Q L + CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
+ +HRD+K N+LI V+K+ DFG A P+ V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGD 177
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNAT 352
T YG VD+W+ GC+ AELL+G P+ PG+++V+QL+ I K G + + S +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 353 LFKPREPYKRC-IQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
K +P ++ F + +L L++ L +DP ERLT L+
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-108
Identities = 115/341 (33%), Positives = 166/341 (48%), Gaps = 19/341 (5%)
Query: 67 RGERKRSKSNPRLSNLPKHLRGEQVAAGWPP-WLTAVCGEALNGWIPRRADSFEKIDKIG 125
R + + P +V+ +T V G + S+ IG
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 126 QGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT 185
G++ VY+AK +G++VA+KKV D +F RE+ I+R+LDH N+++L
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 186 S----RMSCSLYLVFHYMEHDLAGLAASPEV---KFTEPQVKCYMHQLLSGLEHCHNNGV 238
S + L LV Y+ + +A VK YM+QL L + H+ G+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 239 LHRDIKGSNLLIDDD-GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 297
HRDIK NLL+D D VLK+ DFG A P S + + +YR PEL+ GATDY
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYT 235
Query: 298 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPR 357
+D+WSAGC+LAELL G+PI PG + V+QL +I K+ G+P+ E ++ PN T FK
Sbjct: 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKFP 294
Query: 358 EPYKRCIQETF-KDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ + F PP ++ L LL P RLT A
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 103/297 (34%), Positives = 156/297 (52%), Gaps = 25/297 (8%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+R ++ IG G++ V++AK + + + VA+KKV D +F RE+ I+R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIV 89
Query: 173 DHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAAS---PEVKFTEPQVKCYMHQ 225
HPNV+ L+ S L LV Y+ + + + +K YM+Q
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
LL L + H+ G+ HRDIK NLL+D GVLK+ DFG A P S + + +Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYY 207
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PEL+ GAT+Y +D+WS GC++AEL+ G+P+ PG + ++QL +I K+ G+PS E
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI- 266
Query: 345 KSKLPNATLFK----PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
K+ PN K P+ + + PP ++ LI LL P+ RLTA AL
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFR---PRTPPDAIDLISRLLEYTPSARLTAIEAL 320
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 5e-95
Identities = 92/316 (29%), Positives = 141/316 (44%), Gaps = 27/316 (8%)
Query: 100 TAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV 159
+ A + + D F+ GQGT+ V K+ TG VA+KKV D
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------P 60
Query: 160 KFMAREILILRRL---DHPNVIKLEGLVTSRMSCS-----LYLVFHYMEHDLAGLAASPE 211
+F RE+ I++ L HPN+++L+ + L +V Y+ L +
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY 120
Query: 212 VK---FTEPQVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLID-DDGVLKIADFGLAS 265
+ +K ++ QL+ + H V HRDIK N+L++ DG LK+ DFG A
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 325
P+ P + + + +YR PEL+ G Y VD+WS GCI AE++ G+PI G
Sbjct: 181 KLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFK----PREPYKRCIQETFKDFPPSSLPLIET 381
QLH+I ++ G PS E +K P+ T P+ + + L+
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLN-PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 382 LLAIDPAERLTATVAL 397
LL P ER+ AL
Sbjct: 298 LLQYLPEERMKPYEAL 313
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-93
Identities = 89/295 (30%), Positives = 150/295 (50%), Gaps = 23/295 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D ++ + K+G+G YS V++A ++ + V +K ++ P K + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHY-MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
PN+I L +V +S + LVF + D L T+ ++ YM+++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 234 HNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+ G++HRD+K N++ID + L++ D+GLA F+ P RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVD 204
Query: 293 ATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEE-YWKKSKLPN 350
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ Y K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 351 ATLFK------PREPYKRCI-QETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
F R+ ++R + E P +L ++ LL D RLTA A+
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-92
Identities = 86/330 (26%), Positives = 149/330 (45%), Gaps = 56/330 (16%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
+ + +G G++ V + D+ +GK ALKKV D ++ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 172 LDHPNVIKLEGLVTSRMSCS------------------------------------LYLV 195
LDH N+IKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 196 FHYMEHDLAGLAASPEV---KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID- 251
Y+ L + S + Y++QL + H+ G+ HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 252 DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 311
D LK+ DFG A P+ P + + + +YR PEL+LGAT+Y +DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 312 LLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK----PREPYKRCIQET 367
L+ GKP+ G T ++QL +I ++ G+P++E + P+ T + + +++ +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLKAKDWRKILP-- 291
Query: 368 FKDFPPSSLPLIETLLAIDPAERLTATVAL 397
+ P ++ L+E +L +P R+ A+
Sbjct: 292 -EGTPSLAIDLLEQILRYEPDLRINPYEAM 320
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 4e-89
Identities = 103/296 (34%), Positives = 158/296 (53%), Gaps = 20/296 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P+ + +G G Y +V A D +G+ VA+KK+ F + K RE+L+
Sbjct: 22 LPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLL 76
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
L+ + H NVI L + T S YLV +M+ DL + F+E +++ ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVY 133
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
Q+L GL++ H+ GV+HRD+K NL +++D LKI DFGLA D MT VVT WY
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 189
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++L Y VD+WS GCI+AE+L GK + G+ ++QL +I K+ G P E+ +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 345 KSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
K A + P ++ + F P + L+E +L +D +RLTA AL
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 5e-89
Identities = 106/305 (34%), Positives = 160/305 (52%), Gaps = 25/305 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ R + + +G G V+ A D K VA+KK+ + P+SVK REI I+R
Sbjct: 9 LGSR---YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIR 63
Query: 171 RLDHPNVIKLEGLVTSRMSCS------------LYLVFHYMEHDLAGLAASPEVKFTEPQ 218
RLDH N++K+ ++ S +Y+V YME DLA + E
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEH 121
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHP--M 275
+ +M+QLL GL++ H+ VLHRD+K +NL I+ +D VLKI DFGLA DP++ H +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335
+ +VT WYR P LLL +Y +D+W+AGCI AE+L GK + G E+EQ+ I +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 336 GSPSEEYWKK--SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
EE ++ S +P EP + + + ++ +E +L P +RLTA
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 394 TVALN 398
AL+
Sbjct: 301 EEALS 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 6e-89
Identities = 100/296 (33%), Positives = 155/296 (52%), Gaps = 15/296 (5%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILIL 169
+ R + + IG+G Y V A D L VA+KK+ F++ + REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKIL 79
Query: 170 RRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
R H N+I + ++ + +Y+V ME DL L + + + +++Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQI 137
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWY 284
L GL++ H+ VLHRD+K SNLL++ LKI DFGLA DP+H H +T V T WY
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++L + Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 345 KSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
A + P+ K F + +L L++ +L +P +R+ AL
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 2e-87
Identities = 104/352 (29%), Positives = 162/352 (46%), Gaps = 70/352 (19%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
IP R +E IG G+Y +V +A D L ++VA+KK+ F++ K + REI I
Sbjct: 51 IPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAI 105
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
L RL+H +V+K+ +V + LY+V + D L +P V TE +K ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYN 164
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--------------------- 264
LL G+++ H+ G+LHRD+K +N L++ D +K+ DFGLA
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 265 -----SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL------ 313
N K +T VVT WYR PEL+L +Y +D+WS GCI AELL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 314 -----AGKPIMPG--------------------RTEVEQLHKIYKLCGSPSEEYWKKSKL 348
P+ PG R +QL+ I+ + G+PSEE + +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 349 PNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+A + P + E F ++ L++ +L +P +R+T L
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-87
Identities = 98/296 (33%), Positives = 151/296 (51%), Gaps = 19/296 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ + + +G G Y V A D TG VA+KK+ F + K RE+ +
Sbjct: 23 VRAV---YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRL 77
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
L+ + H NVI L + T + YLV +M DL L K E +++ ++
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVY 135
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
Q+L GL + H G++HRD+K NL +++D LKI DFGLA D MT VVT WY
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 191
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++L Y VD+WS GCI+AE++ GK + G ++QL +I K+ G+P E+ +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 345 KSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ + A + P K+ + P ++ L+E +L +D +R+TA AL
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 6e-87
Identities = 85/306 (27%), Positives = 131/306 (42%), Gaps = 27/306 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-----------FDNLEPESV 159
+ + I G+Y V D G VA+K+V +
Sbjct: 20 MQSP---YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSD--SFLC 73
Query: 160 KFMAREILILRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTE 216
K + REI +L HPN++ L + + LYLV M DLA + + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276
++ +M+ +L GL H GV+HRD+ N+L+ D+ + I DF LA + T
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKT 191
Query: 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG 336
V WYR PEL++ + VD+WSAGC++AE+ K + G T QL+KI ++ G
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 337 SPSEEYWKKSKLPNATLF----KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+P E P+A + P R P +L LI +L +P R++
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 393 ATVALN 398
AL
Sbjct: 311 TEQALR 316
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 1e-86
Identities = 104/296 (35%), Positives = 153/296 (51%), Gaps = 19/296 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P R ++ + +G G Y +V A D TG VA+KK+ F + K RE+ +
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRL 81
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
L+ + H NVI L + T S +YLV H M DL + K T+ V+ ++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIY 139
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
Q+L GL++ H+ ++HRD+K SNL +++D LKI DFGLA MT V T WY
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWY 195
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++L Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P E K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 345 KSKLPNATLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
K +A + K F P ++ L+E +L +D +R+TA AL
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 3e-85
Identities = 97/308 (31%), Positives = 153/308 (49%), Gaps = 31/308 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILIL 169
I F+ +G+G Y V A TG+IVA+KK+ FD P REI IL
Sbjct: 9 ISSD---FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKIL 63
Query: 170 RRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
+ H N+I + + + +Y++ M+ DL + ++ ++ ++ +++Q
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQT 121
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---------HKHPMTS 277
L ++ H + V+HRD+K SNLLI+ + LK+ DFGLA D + + M
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337
V T WYR PE++L + Y +D+WS GCILAEL +PI PGR QL I+ + G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 338 P-SEEYWKKSKLPNATLF------KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390
P S+ + + P A + P P + + F P + L++ +L DPA+R
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLE----KMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 391 LTATVALN 398
+TA AL
Sbjct: 298 ITAKEALE 305
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-81
Identities = 87/311 (27%), Positives = 151/311 (48%), Gaps = 38/311 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D + + VA+KK+ F N K RE+++
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVL 77
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
++ ++H N+I L + T + S +Y+V M+ +L + ++ ++
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLY 134
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA + MT VVT +Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 192
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++LG Y VD+WS GCI+ E++ G + PG ++Q +K+ + G+P E+ K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 345 K---------SKLPNATLFKPREPYKR--------CIQETFKDFPPSSLPLIETLLAIDP 387
K P +++ E K + L+ +L ID
Sbjct: 252 KLQPTVRTYVENRP----KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 388 AERLTATVALN 398
++R++ AL
Sbjct: 308 SKRISVDEALQ 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 6e-81
Identities = 100/328 (30%), Positives = 166/328 (50%), Gaps = 48/328 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ R+ +E + K+G+G Y V+K+ D TG++VA+KK+ F N + REI+I
Sbjct: 7 VLRK---YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMI 61
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
L L H N++ L ++ + +YLVF YME DL + + + ++QL+
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLI 119
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--------------------SFF 267
+++ H+ G+LHRD+K SN+L++ + +K+ADFGL+ +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 327
+ + +T V T WYR PE+LLG+T Y G+D+WS GCIL E+L GKPI PG + + Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 328 LHKIYKLCGSPSEEYW----------------KKSKLPNATLFKPREPYKRCIQETF--K 369
L +I + PS E +K ++ + +K + +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 370 DFPPSSLPLIETLLAIDPAERLTATVAL 397
D +L L++ LL +P +R++A AL
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDAL 327
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 7e-81
Identities = 90/311 (28%), Positives = 152/311 (48%), Gaps = 38/311 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D + + VA+KK+ F N K RE+++
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVL 114
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
++ ++H N+I L + T + + +YLV M+ +L + ++ ++
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 171
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA + MT VVT +Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 229
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE++LG Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ K
Sbjct: 230 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 345 K---------SKLPNATLFKPREPYKR--------CIQETFKDFPPSSLPLIETLLAIDP 387
K P + + E K + L+ +L IDP
Sbjct: 289 KLQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 388 AERLTATVALN 398
A+R++ AL
Sbjct: 345 AKRISVDDALQ 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-80
Identities = 100/344 (29%), Positives = 158/344 (45%), Gaps = 62/344 (18%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P + IG+G+Y VY A D T K VA+KKV F++ K + REI I
Sbjct: 24 VPDN---YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITI 78
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
L RL +I+L L+ LY+V + DL L +P + TE +K ++
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYN 137
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP----------- 274
LL G H +G++HRD+K +N L++ D +K+ DFGLA +
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 275 ----------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG--------- 315
+TS VVT WYR PEL+L +Y +D+WS GCI AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 316 --KPIMPG-----------------RTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356
P+ PG ++ +QL+ I+ + G+P+E+ K P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 357 REPYKRCI--QETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P+++ I ++ + + L+E++L +P +R+T AL+
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 74/313 (23%), Positives = 125/313 (39%), Gaps = 55/313 (17%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R A FE+I +GQG + V KA++ L + A+KK+R + ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 173 DHPNVIKL-----------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVK 220
+H V++ + + + +L++ Y E L L S + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP------ 274
Q+L L + H+ G++HRD+K N+ ID+ +KI DFGLA +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 275 -------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 327
+TS + T Y E+L G Y +D++S G I E++ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 328 LHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDP 387
L K+ + ++ + K +I L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFDDN------------------KMKVEKK-------IIRLLIDHDP 272
Query: 388 AERLTATVALNSE 400
+R A LNS
Sbjct: 273 NKRPGARTLLNSG 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-63
Identities = 68/305 (22%), Positives = 113/305 (37%), Gaps = 33/305 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ D +GQG +NV++ + TG + A+K + V RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHK 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPE--VKFTEPQVKCYMHQLLSG 229
N++KL + + L+ ME L + P E + + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 230 LEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
+ H NG++HR+IK N++ D V K+ DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYL 182
Query: 286 PPELLLGATD-------YGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIYKL 334
P++ A YG VDLWS G G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT- 241
Query: 335 CGSPSEEYWKKSKLPNATL-FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
G PS K N + + P + + P++ +L D +
Sbjct: 242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGF 297
Query: 394 TVALN 398
Sbjct: 298 DQFFA 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+I+L + +Y+V DL + + K Y +L + H
Sbjct: 89 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPELLLGA- 293
+G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 294 ---------TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
+ D+WS GCIL + GK P + + Q+ K++ + P+ E
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPNHEI-- 259
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ ++ +D ++ L DP +R++ L
Sbjct: 260 --------------EFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLA 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-62
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 33/300 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ D +GQG +NV++ + TG + A+K + V RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHK 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPE--VKFTEPQVKCYMHQLLSG 229
N++KL + + L+ ME L + P E + + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 230 LEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
+ H NG++HR+IK N++ D V K+ DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYL 182
Query: 286 PPELLLGATD-------YGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIYKL 334
P++ A YG VDLWS G G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT- 241
Query: 335 CGSPSEEYWKKSKLPNATL-FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
G PS K N + + P + + P++ +L D +
Sbjct: 242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGF 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-61
Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+I+L + +Y+V DL + + K Y +L + H
Sbjct: 70 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPELLLG-- 292
+G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 293 --------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
+ D+WS GCIL + GK P + + Q+ K++ + P+ E
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPNHEI-- 240
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ ++ +D ++ L DP +R++ L
Sbjct: 241 --------------EFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLA 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-60
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
P RA+ +E + IG G+Y K + GKI+ K++ + ++ + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGL---AASPEVKFTEPQVKCYMH 224
L HPN+++ + R + +LY+V ME+ DLA + E V M
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIV---MEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 225 QLLSGLEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279
QL L+ CH + VLHRD+K +N+ +D +K+ DFGLA + + + V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFV 177
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
T +Y PE + Y D+WS GC+L EL A P ++ E KI +
Sbjct: 178 GTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 230
Query: 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
+ + +I +L + R + L +
Sbjct: 231 ---------------GKFRRIPYRYSDELNE-------IITRMLNLKDYHRPSVEEILEN 268
Query: 400 EVI 402
+I
Sbjct: 269 PLI 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 67/307 (21%), Positives = 121/307 (39%), Gaps = 58/307 (18%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
R F++I+ IG G + V+KAK + GK +K+V+++N + RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 172 LDHPNVIKL--------------EGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFT 215
LDH N++ + + L++ + + L + K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275
+ Q+ G+++ H+ +++RD+K SN+ + D +KI DFGL + + K
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335
T TL Y PE + DYG VDL++ G ILAELL + +
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD--TAFETSKFFTDL---- 231
Query: 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395
+ + + + K L++ LL+ P +R +
Sbjct: 232 --------RDGIISD------------IFDKKEKT-------LLQKLLSKKPEDRPNTSE 264
Query: 396 ALNSEVI 402
L + +
Sbjct: 265 ILRTLTV 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-59
Identities = 63/292 (21%), Positives = 106/292 (36%), Gaps = 37/292 (12%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
SF+++ ++G G+Y V+K + G++ A+K+ P+ E+ +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 172 L-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ HP ++LE LYL L + E QV Y+ L L
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
H H+ G++H D+K +N+ + G K+ DFGL + Y PELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELL 228
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
G YG D++S G + E+ +P E ++ + LP
Sbjct: 229 QG--SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLR------------QGYLP- 270
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
+ + + + +L DP R TA L V+
Sbjct: 271 -------PEFTAGLSSELRSV-------LVMMLEPDPKLRATAEALLALPVL 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+I+L + +Y+V DL + + K Y +L + H
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPELLLGAT 294
+G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V + Y PPE + +
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 295 D----------YGVGVDLWSAGCILAELLAGKPIMP---GRTEVEQLHKIYKLCGSPSEE 341
D+WS GCIL + GK P ++ +LH I P+ E
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAI----IDPNHE 286
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ ++ +D ++ L DP +R++ L
Sbjct: 287 I----------------EFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLA 320
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-58
Identities = 83/294 (28%), Positives = 139/294 (47%), Gaps = 50/294 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G++ V K KD +T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLSG 229
N++KL ++ S Y+V E G + +F+E + Q+ SG
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GEL-YTGGELFDEIIK--RKRFSEHDAARIIKQVFSG 133
Query: 230 LEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
+ + H + ++HRD+K N+L+ + D +KI DFGL++ F N K M R+ T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIA 191
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWK 344
PE+L G Y D+WSAG IL LL+G P G+ E + L ++ G + W+
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWR 247
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
I + KD LI +L P+ R+TAT L
Sbjct: 248 T------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 87/294 (29%), Positives = 136/294 (46%), Gaps = 50/294 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++++ K+G G Y V +D +T A+K +R ++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLL 227
N++KL + + YLV ME E+ KF E + Q+L
Sbjct: 97 NIMKLYDFFEDKR--NYYLV---ME-----CYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
SG+ + H + ++HRD+K NLL+ + D ++KI DFGL++ F+ K M R+ T +Y
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYY 204
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE+L Y D+WS G IL LLAG P G+T+ E L K+ K + WK
Sbjct: 205 IAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ E KD I+ +L D R++A AL
Sbjct: 263 N------------------VSEGAKDL-------IKQMLQFDSQRRISAQQALE 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-58
Identities = 84/296 (28%), Positives = 139/296 (46%), Gaps = 54/296 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G++ V K KD +T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQVKCYMHQLL 227
N++KL ++ S Y+V E L E +F+E + Q+
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GE-----LYTGGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
SG+ + H + ++HRD+K N+L+ + D +KI DFGL++ F N K M R+ T +Y
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYY 189
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEY 342
PE+L G Y D+WSAG IL LL+G P G+ E + L ++ G +
Sbjct: 190 IAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQ 245
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W+ I + KD LI +L P+ R+TAT L
Sbjct: 246 WRT------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-57
Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 55/297 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
D ++ +G+G++ V KD +TG+ A+K + ++ + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQL 226
PN++KL + YLV E + E+ +F+E + Q+
Sbjct: 86 PNIMKLYEFFEDKGY--FYLV---GE-----VYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
LSG+ + H N ++HRD+K NLL+ D ++I DFGL++ F+ + K M ++ T +
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAY 193
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EE 341
Y PE+L G Y D+WS G IL LL+G P G E + L K+ K G +
Sbjct: 194 YIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELP 249
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
WKK + E+ KD I +L P+ R++A AL+
Sbjct: 250 QWKK------------------VSESAKDL-------IRKMLTYVPSMRISARDALD 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 67/291 (23%), Positives = 116/291 (39%), Gaps = 38/291 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + ++ KIG+G++ K G+ +K++ + + + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 176 NVIK-LEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLSGLEH 232
N+++ E + SLY+V Y E DL + A V F E Q+ + Q+ L+H
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLL 291
H+ +LHRDIK N+ + DG +++ DFG+A N + + T +Y PE+
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICE 198
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y D+W+ GC+L EL K + + KI
Sbjct: 199 N-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS------------------ 239
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
P + L+ L +P +R + L I
Sbjct: 240 ---GSFPPVSLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 19/308 (6%)
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
G + +E +++G G + V + TG+ VA+K+ R + L P++ +
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 164 REILILRRLDHPNVIKL----EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE--VKFTE 216
EI I+++L+HPNV+ +GL + L Y E DL E E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFDPNHKH 273
++ + + S L + H N ++HRD+K N+++ + KI D G A D
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
T V TL Y PELL Y V VD WS G + E + G + Q H +
Sbjct: 180 -CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
+ + P ++ +L +R T
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTD 292
Query: 394 TVALNSEV 401
N
Sbjct: 293 PQNPNVGC 300
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-56
Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 53/296 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQVKCYMHQLL 227
N+++L + YLV + L E ++E + Q+L
Sbjct: 66 NIVRLHDSIQEES--FHYLV---FD-----LVTGGELFEDIVAREFYSEADASHCIQQIL 115
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
+ +CH+NG++HR++K NLL+ +K+ADFGLA + + T Y
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGY 173
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEY 342
PE+L Y VD+W+ G IL LL G P + +I G+
Sbjct: 174 LSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE 230
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W + K LI+++L ++P +R+TA AL
Sbjct: 231 WDT------------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-55
Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 50/290 (17%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILR 170
PR + + +G+G ++ ++ D T ++ A K V L + M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCY 222
L H +V+ G +++V +E L + TEP+ + Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVV---LE-----LCRRRSLLELHKRRKALTEPEARYY 120
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
+ Q++ G ++ H N V+HRD+K NL +++D +KI DFGLA+ + + + T
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTP 179
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342
Y PE+L + VD+WS GCI+ LL GKP E +I K EY
Sbjct: 180 NYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY 232
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+P K P + LI+ +L DP R T
Sbjct: 233 ----SIP-------------------KHINPVAASLIQKMLQTDPTARPT 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-55
Identities = 74/294 (25%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLSG 229
N+++L + YLVF + G + A ++E + Q+L
Sbjct: 89 NIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVA--REFYSEADASHCIQQILES 140
Query: 230 LEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
+ +CH+NG++HR++K NLL+ +K+ADFGLA + + T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 198
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWK 344
PE+L Y VD+W+ G IL LL G P + +I G+ W
Sbjct: 199 PEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWD 255
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ K LI+++L ++P +R+TA AL
Sbjct: 256 T------------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-55
Identities = 77/317 (24%), Positives = 125/317 (39%), Gaps = 62/317 (19%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R FE I +G+G + V++AK+ + A+K++R N E K M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 173 DHPNVIK----------LEGLVTSRMSCSLYLVFHYMEH----DLAGL--AASPEVKFTE 216
+HP +++ E L S LY+ M+ +L +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ---MQLCRKENLKDWMNGRCTIEERER 117
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-------- 268
Q+ +E H+ G++HRD+K SN+ D V+K+ DFGL + D
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 269 ---PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 325
T +V T Y PE + G Y VD++S G IL ELL P T++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL-----YPFSTQM 231
Query: 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAI 385
E++ + + + K P F P +++ +L+
Sbjct: 232 ERVRTLTDV---------RNLKFP----------------PLFTQKYPCEYVMVQDMLSP 266
Query: 386 DPAERLTATVALNSEVI 402
P ER A + + V
Sbjct: 267 SPMERPEAINIIENAVF 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-55
Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 61/305 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-----------FDNLEPESVKFMAR 164
+S+ K+ K+G G Y V K+ A+K ++ + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTE 216
EI +L+ LDHPN+IKL + + YLV E E+ KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLV---TE-----FYEGGELFEQIINRHKFDE 145
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKH 273
M Q+LSG+ + H + ++HRDIK N+L+ + +KI DFGL+SFF ++K
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK- 204
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
+ R+ T +Y PE+L Y D+WS G I+ LL G P G+ + + + K+ K
Sbjct: 205 -LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
WK I + K+ I+ +L D +R TA
Sbjct: 262 GKYYFDFNDWKN------------------ISDEAKEL-------IKLMLTYDYNKRCTA 296
Query: 394 TVALN 398
ALN
Sbjct: 297 EEALN 301
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 7e-55
Identities = 75/289 (25%), Positives = 139/289 (48%), Gaps = 35/289 (12%)
Query: 106 ALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAR 164
+L I + + F+ + +G+G+++ VY+A+ + TG VA+K + + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYM 223
E+ I +L HP++++L +YLV + ++ + F+E + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
HQ+++G+ + H++G+LHRD+ SNLL+ + +KIADFGLA+ H+ T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
Y PE+ + +G+ D+WS GC+ LL G+P T L+K+ +Y
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
++P+ + LI LL +PA+RL+
Sbjct: 230 ---EMPS-------------------FLSIEAKDLIHQLLRRNPADRLS 256
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-55
Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 66/314 (21%)
Query: 112 PRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVK---- 160
F + + +G+G S V + T K A+K + E V+
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 161 FMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE-------- 211
+E+ ILR++ HPN+I+L+ + +LV + L E
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTF--FFLV---FD-----LMKKGELFDYLTEK 118
Query: 212 VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271
V +E + + M LL + H ++HRD+K N+L+DDD +K+ DFG + DP
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 272 KHPMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAGKPIMPGRTEVE 326
K + T Y PE++ + + YG VD+WS G I+ LLAG P R ++
Sbjct: 179 K--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 327 QLHKIYKLCGSPS--EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLA 384
L I + G+ W +T KD L+ L
Sbjct: 237 MLRMI--MSGNYQFGSPEWDD------------------YSDTVKD-------LVSRFLV 269
Query: 385 IDPAERLTATVALN 398
+ P +R TA AL
Sbjct: 270 VQPQKRYTAEEALA 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 86/296 (29%), Positives = 123/296 (41%), Gaps = 56/296 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + IG+G++ V A T A KK+ +E V +EI I++ LDHP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHP 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLL 227
N+I+L +YLV ME L E+ F E M +L
Sbjct: 67 NIIRLYETFEDNTD--IYLV---ME-----LCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
S + +CH V HRD+K N L D LK+ DFGLA+ F P M ++V T +Y
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYY 174
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEY 342
P++L G YG D WSAG ++ LL G P T+ E + KI G+ + E+
Sbjct: 175 VSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKD 230
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W + + LI LL P +R+T+ AL
Sbjct: 231 WLN------------------VSPQAES-------LIRRLLTKSPKQRITSLQALE 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-54
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ +++G+G +S V + +L G+ A + L + + RE I R L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-----HDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
N+++L ++ YL+F + D+ ++E + Q+L +
Sbjct: 71 NIVRLHDSISEEG--HHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAV 123
Query: 231 EHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
HCH GV+HR++K NLL+ +K+ADFGLA + + T Y P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSP 182
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWKK 345
E+L YG VDLW+ G IL LL G P + +I G+ W
Sbjct: 183 EVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDT 239
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ KD LI +L I+P++R+TA AL
Sbjct: 240 ------------------VTPEAKD-------LINKMLTINPSKRITAAEALK 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 50/290 (17%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILR 170
PR + + +G+G ++ ++ D T ++ A K V L + M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCY 222
L H +V+ G +++V +E L + TEP+ + Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVV---LE-----LCRRRSLLELHKRRKALTEPEARYY 146
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
+ Q++ G ++ H N V+HRD+K NL +++D +KI DFGLA+ + + + T
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTP 205
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342
Y PE+L + VD+WS GCI+ LL GKP E +I K EY
Sbjct: 206 NYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY 258
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+P K P + LI+ +L DP R T
Sbjct: 259 ----SIP-------------------KHINPVAASLIQKMLQTDPTARPT 285
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+F KIG+G +S VY+A +L G VALKKV+ +L + +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQVKCYMHQLLSGL 230
PNVIK L +V + DL+ + + E V Y QL S L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
EH H+ V+HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKP 317
Y D+WS GC+L E+ A +
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQS 234
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-54
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 54/302 (17%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ I K+G+G +S V + + G ALK++ + + RE + R +HPN+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNI 88
Query: 178 IKLEG--LVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQVKCYMHQLLSGLE 231
++L L +L+ + + L TE Q+ + + GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--------TLW 283
H G HRD+K +N+L+ D+G + D G + + + + + T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 284 YRPPELLLGATDYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
YR PEL + + D+WS GC+L ++ G+ P +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--------------------PYDM 248
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP-----LIETLLAIDPAERLTATVA 396
++K + +Q L+ +++ +DP +R +
Sbjct: 249 VFQKG-----------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
Query: 397 LN 398
L+
Sbjct: 298 LS 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 63/293 (21%), Positives = 103/293 (35%), Gaps = 45/293 (15%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HP 175
SF D +G G + + M + VA+K++ PE F RE+ +LR D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
NVI+ R Y+ L + + + Q SGL H H+
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 236 NGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFFDPNHK--HPMTSRVVTLWYRPPE 288
++HRD+K N+LI I+DFGL + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 289 LLLGATD--YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
+L VD++SAGC+ +++ G + + + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++ LIE ++A+DP +R +A L
Sbjct: 257 D-------------------VIARE-------LIEKMIAMDPQKRPSAKHVLK 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-54
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D F K+G G + +V+ ++ +G +K + D + ++ + EI +L+ LDHP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
N+IK+ + + +Y+V E + A + +E V M Q+++ L
Sbjct: 81 NIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 232 HCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
+ H+ V+H+D+K N+L +KI DFGLA F + T+ T Y PE
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE 196
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS-EEYWKKSK 347
+ D D+WSAG ++ LL G G + E K P+ +
Sbjct: 197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP-- 250
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ D ++ +L DP R +A L+
Sbjct: 251 ----------------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 45/327 (13%), Positives = 81/327 (24%), Gaps = 56/327 (17%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRR 171
+ + ++ + G S V+ +D+ + ALK S ++ + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 172 LDHPN------------------------VIKLEGLVTSRMSCSLYLVFHYMEHDLAGL- 206
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 207 -----AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261
+ QL+ + + G++H NL I DG L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMP 320
+ V + Y P E L + ++ W G + +
Sbjct: 239 SALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 321 GRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIE 380
T + P + + C P LI
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSL---------------AFGSC-----TPLPDFVKTLIG 334
Query: 381 TLLAIDPAERLTATVALNSEVIFQDRT 407
L D RL A+ + Q +
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFLQLQN 361
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-53
Identities = 93/376 (24%), Positives = 134/376 (35%), Gaps = 69/376 (18%)
Query: 51 ESRKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGW 110
E R + + + S + G G
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELP 84
Query: 111 IPRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVALK------KVRFDNLEPESVK 160
A F + D IG+G S V + TG A+K + E +
Sbjct: 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 161 FMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE-------- 211
RE ILR++ HP++I L S ++LV + L E
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSF--MFLV---FD-----LMRKGELFDYLTEK 194
Query: 212 VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271
V +E + + M LL + H N ++HRD+K N+L+DD+ ++++DFG + +P
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 272 KHPMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAGKPIMP--GRTE 324
K + T Y PE+L + D YG VDLW+ G IL LLAG P P R +
Sbjct: 255 K--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQ 310
Query: 325 VEQLHKIYKLCGSPS--EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETL 382
+ L I + G W T KD LI L
Sbjct: 311 ILMLRMI--MEGQYQFSSPEWDD------------------RSSTVKD-------LISRL 343
Query: 383 LAIDPAERLTATVALN 398
L +DP RLTA AL
Sbjct: 344 LQVDPEARLTAEQALQ 359
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 56/296 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+F ++ +G G +S V+ K LTGK+ ALK ++ + + EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHE 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLL 227
N++ LE + S YLV M+ L + E+ +TE + Q+L
Sbjct: 67 NIVTLEDIYESTTH--YYLV---MQ-----LVSGGELFDRILERGVYTEKDASLVIQQVL 116
Query: 228 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
S +++ H NG++HRD+K NLL +++ + I DFGL+ M++ T Y
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGY 173
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEY 342
PE+L Y VD WS G I LL G P TE + KI G +
Sbjct: 174 VAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI--KEGYYEFESPF 230
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W I E+ KDF I LL DP ER T AL+
Sbjct: 231 WDD------------------ISESAKDF-------ICHLLEKDPNERYTCEKALS 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 81/309 (26%), Positives = 124/309 (40%), Gaps = 70/309 (22%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV------RFDNLEPESVKFMAREILIL 169
D + +G G V A + T K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQVKC 221
++L+HP +IK++ + Y+V +E L E + E K
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIV---LE-----LMEGGELFDKVVGNKRLKEATCKL 118
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSR 278
Y +Q+L +++ H NG++HRD+K N+L+ ++D ++KI DFG + M +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTL 176
Query: 279 VVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMP---GRTEVEQLHKI-- 331
T Y PE+L+ Y VD WS G IL L+G P P RT+V +I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQITS 234
Query: 332 --YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE 389
Y E W + + E D L++ LL +DP
Sbjct: 235 GKYNF----IPEVWAE------------------VSEKALD-------LVKKLLVVDPKA 265
Query: 390 RLTATVALN 398
R T AL
Sbjct: 266 RFTTEEALR 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-53
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 46/296 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL 172
D +E + IG+G +S V + + TG+ A+K +F + S + + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPEVKFTEPQVKCYMHQLLS 228
HP++++L +S LY+VF +M+ A ++E YM Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 229 GLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
L +CH+N ++HRD+K +L+ ++ +K+ FG+A + RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRVGTPHFM 200
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH-KIYKLCGSPS--EEY 342
PE++ YG VD+W G IL LL+G P E+L I + G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILFILLSGCL--PFYGTKERLFEGI--IKGKYKMNPRQ 255
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W I E+ KD L+ +L +DPAER+T ALN
Sbjct: 256 WSH------------------ISESAKD-------LVRRMLMLDPAERITVYEALN 286
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 64/306 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV------RFDNLEPESVKFMAREILIL 169
D + +G G V A + T K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQVKCY 222
++L+HP +IK++ + Y+V ME +L + E K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 244
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 279
+Q+L +++ H NG++HRD+K N+L+ ++D ++KI DFG + M +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 302
Query: 280 VTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMP---GRTEVEQLHKIYKL 334
T Y PE+L+ Y VD WS G IL L+G P P RT+V +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--T 358
Query: 335 CGSPS--EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
G + E W + + E D L++ LL +DP R T
Sbjct: 359 SGKYNFIPEVWAE------------------VSEKALD-------LVKKLLVVDPKARFT 393
Query: 393 ATVALN 398
AL
Sbjct: 394 TEEALR 399
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-52
Identities = 73/334 (21%), Positives = 120/334 (35%), Gaps = 80/334 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL 172
+ IGQG+Y V A + T I A+K K + + P+ V+ + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME-------------------------------- 200
HPN+ +L + + LV
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 201 --------HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI-- 250
+ G S + E + M Q+ S L + HN G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 251 DDDGVLKIADFGLASFFDPNHK---HPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAG 306
+ +K+ DFGL+ F + + MT++ T ++ PE+L + YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 307 CILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWKKSKLPNATLFKPREPYKRCI 364
+L LL G PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------L 303
Query: 365 QETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+D L+ LL + ER A AL
Sbjct: 304 SPLARD-------LLSNLLNRNVDERFDAMRALQ 330
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G + V++ + + K K V+ + VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++ L S L ++F ++ D+ + + E ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 235 NNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
++ + H DI+ N++ +KI +FG A P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
D+WS G ++ LL+G P T + + I + EE +K+
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE----- 229
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
I DF ++ LL + R+TA+ AL
Sbjct: 230 -------------ISIEAMDF-------VDRLLVKERKSRMTASEALQ 257
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
D ++ ++++G G + V++ + TG++ K + +VK EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P +I L + + L+ ++ +L A+ + K +E +V YM Q GL+H
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 234 HNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H + ++H DIK N++ +KI DFGLA+ +P+ + T + PE++
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVD 223
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
G D+W+ G + LL+G G ++E L + + E+ +
Sbjct: 224 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------ 276
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ KDF I+ LL +P +RLT AL
Sbjct: 277 ------------VSPEAKDF-------IKNLLQKEPRKRLTVHDALE 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-51
Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 54/299 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ S + + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA--------SPEVKFTEPQVKCYM 223
+ HPNVI L + ++ + L+ +E L A + + TE + ++
Sbjct: 71 IQHPNVITLHEVYENKTD--VILI---LE-----LVAGGELFDFLAEKESLTEEEATEFL 120
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRV 279
Q+L+G+ + H+ + H D+K N+++ +KI DFGLA D ++ +
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
T + PE++ G+ D+WS G I LL+G G T+ E L + +
Sbjct: 179 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+EY+ KDF I LL DP +R+T +L
Sbjct: 238 DEYFSN------------------TSALAKDF-------IRRLLVKDPKKRMTIQDSLQ 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-51
Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 46/283 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRRLDH 174
+ FE +G+G + NVY A++ + I+ALK + LE + RE+ I L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
PN+++L G +YL+ Y + KF E + Y+ +L + L +C
Sbjct: 69 PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 125
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL----WYRPPEL 289
H+ V+HRDIK NLL+ G LKIADFG + H +SR L Y PPE+
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM 178
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+ G + VDLWS G + E L GKP T E +I ++ E+ P
Sbjct: 179 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP 227
Query: 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ + LI LL +P++R
Sbjct: 228 D-------------------FVTEGARDLISRLLKHNPSQRPM 251
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 54/308 (17%)
Query: 109 GWIPRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVK 160
G P + E +++G G ++ V K ++ TG A K ++ S +
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKF 214
+ RE+ ILR++ H NVI L + +R + L+ + +G LA +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELV----SGGELFDFLAQ--KESL 112
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPN 270
+E + ++ Q+L G+ + H + H D+K N+++ +K+ DFGLA +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330
+ + T + PE++ G+ D+WS G I LL+G G T+ E L
Sbjct: 173 VE--FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
Query: 331 IYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390
I + EE++ E KDF I LL + +R
Sbjct: 230 ITSVSYDFDEEFFSH------------------TSELAKDF-------IRKLLVKETRKR 264
Query: 391 LTATVALN 398
LT AL
Sbjct: 265 LTIQEALR 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 59/304 (19%), Positives = 113/304 (37%), Gaps = 43/304 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMA--------- 163
+ + I + QG ++ + + K ALK K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 164 ---REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME--------HDLAGLAASPEV 212
E+ I+ + + + EG++T+ +Y+++ YME L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 213 KFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271
+KC + +L+ + HN + HRD+K SN+L+D +G +K++DFG + +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 272 KHPMTSRVVTLWYRPPELLLGATDY-GVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLH 329
+ T + PPE + Y G VD+WS G L + P + VE +
Sbjct: 207 ---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE 389
I + + P + + + ++ L +PAE
Sbjct: 264 NIRT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 390 RLTA 393
R+T+
Sbjct: 314 RITS 317
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 62/313 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-H 174
+ +G G+ V G+ VA+K+ + + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEIKLLTESDDH 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLA------GLAASPEVKFTEPQVKCYMHQLLS 228
PNVI+ T+ LY+ +L ++ E + Q+ S
Sbjct: 69 PNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 229 GLEHCHNNGVLHRDIKGSNLLID-------------DDGVLKIADFGLASFFDPNH---K 272
G+ H H+ ++HRD+K N+L+ ++ + I+DFGL D +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 273 HPMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELL-AGKPIMPGRTEV 325
+ + T +R PELL + + +D++S GC+ +L GK P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244
Query: 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAI 385
+ I + + +L + + + R + D LI ++
Sbjct: 245 SRESNIIR------GIF---------SLDEMKCLHDRSLIAEATD-------LISQMIDH 282
Query: 386 DPAERLTATVALN 398
DP +R TA L
Sbjct: 283 DPLKRPTAMKVLR 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-50
Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 52/298 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D +E +++G G ++ V K + TGK A K ++ L S + + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYME-----HDLAGLAASPEVKFTEPQVKCYMHQL 226
+ HPN+I L + ++ + L+ + LA + TE + ++ Q+
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQI 117
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
L G+ + H+ + H D+K N+++ + +K+ DFG+A + ++ + T
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTP 175
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIYKLCGSPSE 340
+ PE++ G+ D+WS G I LL+G P G T+ E L I + E
Sbjct: 176 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYDFDE 232
Query: 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
EY+ E KDF I LL DP R+T +L
Sbjct: 233 EYFSN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSLE 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-50
Identities = 64/303 (21%), Positives = 113/303 (37%), Gaps = 49/303 (16%)
Query: 111 IPRRADSFEKI-----DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMARE 165
+ ++F ++G+G ++ V + TG+ A K ++ + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 166 ILILRRLDH-PNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVK 220
I +L P VI L + + + L+ Y L +E V
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSE--IILILEYAAGGEIFSL--CLPELAEMVSENDVI 134
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTS 277
+ Q+L G+ + H N ++H D+K N+L+ G +KI DFG++ + +
Sbjct: 135 RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LRE 192
Query: 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIYKLC 335
+ T Y PE+L D+W+ G I LL P G E I ++
Sbjct: 193 IMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVN 249
Query: 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395
SEE + + + DF I++LL +P +R TA +
Sbjct: 250 VDYSEETFSS------------------VSQLATDF-------IQSLLVKNPEKRPTAEI 284
Query: 396 ALN 398
L+
Sbjct: 285 CLS 287
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-49
Identities = 96/337 (28%), Positives = 145/337 (43%), Gaps = 77/337 (22%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILR 170
A +E + IG+G++ V KA D + VALK VR + K R EI IL
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILE 148
Query: 171 RL------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT 215
L + NVI + + +S +LY +L + + F+
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY--------EL--IKKNKFQGFS 198
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG--VLKIADFGLASFFDPNHKH 273
P V+ + H +L L+ H N ++H D+K N+L+ G +K+ DFG + +
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-- 256
Query: 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
+ + + +YR PE++LGA YG+ +D+WS GCILAELL G P++PG E +QL + +
Sbjct: 257 --YTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQET-----------------FKDFPPSSL 376
L G PS++ SK A F + Y R T PP S
Sbjct: 314 LLGMPSQKLLDASK--RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371
Query: 377 P---------------LIETLLAIDPAERLTATVALN 398
++ L DPA R+T AL
Sbjct: 372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 71/352 (20%), Positives = 124/352 (35%), Gaps = 42/352 (11%)
Query: 50 DESRKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNG 109
++ E+ + + + + P + + +
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL- 156
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
D ++ +++G G + V++ + TG A K V + + + +EI +
Sbjct: 157 ------DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTM 208
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLS 228
L HP ++ L + +++ +M +L A K +E + YM Q+
Sbjct: 209 SVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 229 GLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
GL H H N +H D+K N++ LK+ DFGL + DP + T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAA 324
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
PE+ G G D+WS G + LL+G G + E L + + + +
Sbjct: 325 PEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG- 382
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
I E KDF I LL DP R+T AL
Sbjct: 383 -----------------ISEDGKDF-------IRKLLLADPNTRMTIHQALE 410
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 38/290 (13%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+IG+G++ VYK D T VA +++ L + E +L+ L HPN+++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 182 G--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE--HCHNN 236
T + + LV M L + ++ + Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 237 GVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
++HRD+K N+ I G +KI D GLA+ + + T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE--MYEEK 205
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
Y VD+++ G + E+ + P +E + +IY+ S K
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV---------------K 247
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405
P K I E K+ IE + + ER + LN ++
Sbjct: 248 PASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 72/285 (25%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+ K + +G G + V+K ++ TG +A K ++ ++ + + EI ++ +LDH N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHAN 147
Query: 177 VIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
+I+L S+ + LV Y++ +L TE +M Q+ G+ H H
Sbjct: 148 LIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 236 NGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
+LH D+K N+L D +KI DFGLA + P K + T + PE++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNY- 262
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
D+WS G I LL+G G + E L+ I +E ++
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-------- 314
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
I E K+F I LL + + R++A+ AL
Sbjct: 315 ----------ISEEAKEF-------ISKLLIKEKSWRISASEALK 342
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 62/286 (21%), Positives = 103/286 (36%), Gaps = 49/286 (17%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++G+G++ V++ KD TG A+KKVR + E E++ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 178 IKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
+ L G R + + +E L E + Y+ Q L GLE+
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 234 HNNGVLHRDIKGSNLLIDDDGVL-KIADFGLASFFDPNHKHPMTSRVVTL----WYRPPE 288
H +LH D+K N+L+ DG + DFG A P+ + + PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
+++G VD+WS+ C++ +L G P T+ + K+ P
Sbjct: 227 VVMG-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP---------- 272
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P I+ L +P R +A
Sbjct: 273 ------PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAM 305
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 68/293 (23%), Positives = 106/293 (36%), Gaps = 56/293 (19%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
+G G V + TG+ ALK + +E+ + P+++ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCI 87
Query: 181 EGLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLSGLEH 232
+ L ++ ME G + + FTE + M + + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 233 CHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
H++ + HRD+K NLL + D VLK+ DFG A N + + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE- 199
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK--LCGSPS--EEYWKK 345
+LG Y D+WS G I+ LL G P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ E K LI LL DP ERLT T +N
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 50/297 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ + + RE+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQ 225
+ HPN+I L + +R + L+ + +G LA + +E + ++ Q
Sbjct: 72 VLHPNIITLHDVYENRTD--VVLILELV----SGGELFDFLAQ--KESLSEEEATSFIKQ 123
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVVT 281
+L G+ + H + H D+K N+++ +K+ DFGLA + + + T
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGT 181
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
+ PE++ G+ D+WS G I LL+G G T+ E L I + EE
Sbjct: 182 PEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++ + E KDF I LL + +RLT AL
Sbjct: 241 FFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQEALR 272
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 84/283 (29%), Positives = 118/283 (41%), Gaps = 46/283 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV-KFMAREILILRRLDH 174
D F+ +G+G + NVY A++ I+ALK + LE E V + REI I L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQVKCYMHQLLSG 229
PN++++ R +YL+ +E G L +F E + +M +L
Sbjct: 74 PNILRMYNYFHDRKR--IYLM---LEFAPRGELYKELQKHG--RFDEQRSATFMEELADA 126
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
L +CH V+HRDIK NLL+ G LKIADFG + + M TL Y PPE+
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEM 183
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+ G + VDLW AG + E L G P + E +I + + K P
Sbjct: 184 IEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFP 232
Query: 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
S LI LL P +RL
Sbjct: 233 P-------------------FLSDGSKDLISKLLRYHPPQRLP 256
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 53/314 (16%), Positives = 105/314 (33%), Gaps = 62/314 (19%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R F +++KIG G + +V+K L G I A+K+ + + RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 173 -DHPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLL 227
H +V++ + + Y D F E ++K + Q+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVL-------------------KIADFGLASFFD 268
GL + H+ ++H DIK SN+ I + KI D G +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328
+ E+L + D+++ + +P+ +Q
Sbjct: 186 SPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQW 237
Query: 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA 388
H+I ++ +LP + + + F + ++ ++ DP
Sbjct: 238 HEI------------RQGRLP---------RIPQVLSQEFTEL-------LKVMIHPDPE 269
Query: 389 ERLTATVALNSEVI 402
R +A + V+
Sbjct: 270 RRPSAMALVKHSVL 283
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 83/310 (26%), Positives = 121/310 (39%), Gaps = 72/310 (23%)
Query: 112 PRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVAL----KKVRFDNLEPESVKFMA 163
D+ ++G+G S VY+ K T K AL K V +
Sbjct: 45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR-------- 96
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFT 215
EI +L RL HPN+IKL+ + + + LV +E L E+ ++
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTE--ISLV---LE-----LVTGGELFDRIVEKGYYS 146
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHK 272
E + Q+L + + H NG++HRD+K NLL D LKIADFGL+ +
Sbjct: 147 ERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
M + T Y PE+L G YG VD+WS G I LL G P E ++
Sbjct: 207 --MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMF 260
Query: 333 K--LCGSPS--EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA 388
+ L +W + + KD + L+ +DP
Sbjct: 261 RRILNCEYYFISPWWDE------------------VSLNAKDL-------VRKLIVLDPK 295
Query: 389 ERLTATVALN 398
+RLT AL
Sbjct: 296 KRLTTFQALQ 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 48/329 (14%), Positives = 94/329 (28%), Gaps = 80/329 (24%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRR 171
R + + +GQ +A D TG+ + F P ++K M E+L LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 172 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206
L +I++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 207 ------AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 260
+S Q++ L H+ G++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 261 FGLASFFDPNHKHPMTSRVVTLWYRPPELL----------LGATDYGVGVDLWSAGCILA 310
F V+ + PPEL T D W+ G ++
Sbjct: 250 FEHLVRDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 311 ELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKD 370
+ + + I++ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 371 FPPSSLPLIETLLAIDPAERLTATVALNS 399
P L+E L +RL A+ +
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-48
Identities = 79/299 (26%), Positives = 124/299 (41%), Gaps = 67/299 (22%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLD-HPNV 177
+G+G++S K + + A+K K N + +EI L+ + HPN+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 178 IKLEGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+KL + ++ +LV + + F+E + M +L+S +
Sbjct: 69 VKLHEVFHDQLH--TFLVMELLNGGELFERIKK------KKHFSETEASYIMRKLVSAVS 120
Query: 232 HCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
H H+ GV+HRD+K NLL +D+ +KI DFG A P+ P+ + TL Y PE
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPE 179
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKP-------IMPGRTEVEQLHKIYKLCGSPS-- 339
LL Y DLWS G IL +L+G+ + + VE + KI G S
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--KKGDFSFE 236
Query: 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
E WK + + KD LI+ LL +DP +RL +
Sbjct: 237 GEAWKN------------------VSQEAKD-------LIQGLLTVDPNKRLKMSGLRY 270
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 73/297 (24%), Positives = 115/297 (38%), Gaps = 40/297 (13%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
D +G+G ++ V +++T + A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 181 EGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
YLVF M H F E + + + S L+ H
Sbjct: 77 IEFFEEEDR--FYLVFEKMRGGSILSHIHK------RRHFNELEASVVVQDVASALDFLH 128
Query: 235 NNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKH------PMTSRVVTLWYR 285
N G+ HRD+K N+L + +KI DF L S N + + + Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 286 PPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
PE++ A+ Y DLWS G IL LL+G P GR + + C +
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++ + P + + I KD LI LL D +RL+A L
Sbjct: 249 LFESIQ--EGKYEFPDKDWAH-ISCAAKD-------LISKLLVRDAKQRLSAAQVLQ 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 72/300 (24%), Positives = 119/300 (39%), Gaps = 59/300 (19%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK------------------------KVRFDNLEP 156
D+IG+G+Y V A + A+K
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 157 ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFT 215
++ + +EI IL++LDHPNV+KL ++ LY+VF + + + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLS 135
Query: 216 EPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275
E Q + Y L+ G+E+ H ++HRDIK SNLL+ +DG +KIADFG+++ F +
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 276 TSRVVTLWYRPPELLLGAT-DY-GVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIY 332
+ V T + PE L + G +D+W+ G L + G+ P M + KI
Sbjct: 196 NT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCLHSKIK 253
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ + P+ D LI +L +P R+
Sbjct: 254 S------QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRIV 286
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 76/301 (25%), Positives = 119/301 (39%), Gaps = 63/301 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D +E + IG G+YS + T A+K + +P EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLS 228
PN+I L+ + +Y+V M+ G + + F+E + + +
Sbjct: 76 PNIITLKDVYDDGKY--VYVVTELMK----GGELLDKILR--QKFFSEREASAVLFTITK 127
Query: 229 GLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
+E+ H GV+HRD+K SN+L + ++I DFG A + + T +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANF 186
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP---IMPGRTEVEQLHKI----YKLCGS 337
PE+L Y D+WS G +L +L G P T E L +I + L
Sbjct: 187 VAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL--- 242
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397
S YW + +T KD L+ +L +DP +RLTA + L
Sbjct: 243 -SGGYWNS------------------VSDTAKD-------LVSKMLHVDPHQRLTAALVL 276
Query: 398 N 398
Sbjct: 277 R 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 59/295 (20%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
+G G V + + T + ALK + + RE+ + R P+++++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 181 EGLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLSGLEH 232
+ L +V ++ G + + FTE + M + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 233 CHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
H+ + HRD+K NLL + +LK+ DFG A + + +T+ T +Y PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE- 233
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIYKLCGSPS--EEYW 343
+LG Y D+WS G I+ LL G P +I G W
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFPNPEW 291
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ + E K LI LL +P +R+T T +N
Sbjct: 292 SE------------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 79/333 (23%), Positives = 129/333 (38%), Gaps = 78/333 (23%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILRRL---- 172
+ K+G G +S V+ AKDM+ VA+K VR K EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 173 -------DHPNVIKLEG-------------LVTSRMSCSLYLVFHYMEHDLAGLAASPEV 212
+++KL +V + +L L +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL--------AL--IKKYEHR 126
Query: 213 KFTEPQVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDD------DGVLKIADFGLAS 265
VK QLL GL++ H G++H DIK N+L++ +KIAD G A
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT-- 323
++D ++ T+ + T YR PE+LLGA +G G D+WS C++ EL+ G +
Sbjct: 187 WYDEHY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGH 241
Query: 324 ----EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP-- 377
+ + + +I +L G + K T F R + + F
Sbjct: 242 SYTKDDDHIAQIIELLGELPSYLLRNGKY-TRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 378 ------------LIETLLAIDPAERLTATVALN 398
+ +L +DP +R A +N
Sbjct: 301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 74/341 (21%), Positives = 126/341 (36%), Gaps = 82/341 (24%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILRRL- 172
F I K+G GT+ V + + K A+K VR ++K R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 173 ----DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQV 219
++ N++K G L+ + SLY ++ + + F +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY--------EI--ITRNNYNGFHIEDI 139
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV------------------------ 255
K Y ++L L + + H D+K N+L+DD
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 256 -LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 314
+K+ DFG A+F H S + T YR PE++L + V D+WS GC+LAEL
Sbjct: 200 GIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254
Query: 315 GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFP-- 372
G + +E L + + + ++ N + + ++ K E
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 373 ---PSSLP------------LIETLLAIDPAERLTATVALN 398
LP + ++L IDP R + L
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK-----KVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+G+G+Y V + D T A+K K+R +VK +EI +LRRL H NVI
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGL-AASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
+L ++ + +Y+V Y + + + PE +F Q Y QL+ GLE+ H+ G
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDY 296
++H+DIK NLL+ G LKI+ G+A P + + ++PPE+ G +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 297 -GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
G VD+WSAG L + G G + I K Y +P
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------GSY----AIP------ 233
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
D P L++ +L +PA+R +
Sbjct: 234 -------------GDCGPPLSDLLKGMLEYEPAKRFS 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-46
Identities = 78/349 (22%), Positives = 131/349 (37%), Gaps = 94/349 (26%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILR 170
D +E IG+G++ V KA D + + VA+K ++ + K E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 171 RL------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT 215
+ ++ L+ LV +S +LY DL L + +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY--------DL--LRNTNFRGVS 155
Query: 216 EPQVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDDDG--VLKIADFGLASFFDPNH 271
+ + Q+ + L ++H D+K N+L+ + +KI DFG +
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215
Query: 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
+ + +YR PE+LLG Y + +D+WS GCIL E+ G+P+ G EV+Q++KI
Sbjct: 216 ----YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 332 YKLCGSPSEEYWKKS---------------------------------KLPNATLFKPRE 358
++ G P ++ KL N +
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 359 PYKRCIQET---------FKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P R E+ FKD I +L DP R+ AL
Sbjct: 331 PGGRRAGESGHTVADYLKFKDL-------ILRMLDYDPKTRIQPYYALQ 372
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-46
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D +G+GTY VY +D+ +A+K++ + + + EI + + L H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHK 79
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKF--TEPQVKCYMHQLLSGLEH 232
N+++ G + + + + + L+ L S E + Y Q+L GL++
Sbjct: 80 NIVQYLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 233 CHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELL 290
H+N ++HRDIKG N+LI+ GVLKI+DFG + + T TL Y PE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 291 LGATD-YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYWKKSKL 348
YG D+WS GC + E+ GKP E + + K+ P ++
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------EI 247
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P + + K F I DP +R A
Sbjct: 248 PES------------MSAEAKAF-------ILKCFEPDPDKRACAN 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 7e-46
Identities = 54/392 (13%), Positives = 109/392 (27%), Gaps = 84/392 (21%)
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+ ++ + E +S ++ +S + W L
Sbjct: 30 EELFNRIPQANVRTTSEYMQSAADSLVS-----------TSLWNTGQPFRVESELGE--- 75
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRR 171
R + + +GQ +A D TG+ + F P + +K M E+L LR
Sbjct: 76 -RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 172 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206
L +I++ S + ++ M+ +L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 207 -----AASPEVKFTEPQVKCY-MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 260
+ S K + Q++ L H+ G++H ++ ++++D G + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 261 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGK 316
F + P+ +L T D W+ G + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 317 PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSL 376
+ I++ C K+ P
Sbjct: 315 LPNTDDAALGGSEWIFRSC---------------------------------KNIPQPVR 341
Query: 377 PLIETLLAIDPAERLTATVALNSEVIFQDRTL 408
L+E L +RL A+ + Q RT
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 9e-46
Identities = 61/317 (19%), Positives = 109/317 (34%), Gaps = 48/317 (15%)
Query: 115 ADSFEKIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+E + IG+G V A+ TG+ V ++++ + E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLS 228
+HPN++ + L++V +M DL + E + + +L
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLK 139
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG-LASFFDPNHKH-----PMTSRVVTL 282
L++ H+ G +HR +K S++LI DG + ++ S + V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 283 WYRPPELLL-GATDYGVGVDLWSAGCILAELLAGKP------------------------ 317
+ PE+L Y D++S G EL G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP 377
E + + S + S + P PY R F F
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF------ 313
Query: 378 LIETLLAIDPAERLTAT 394
+E L +P R +A+
Sbjct: 314 -VEQCLQRNPDARPSAS 329
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 58/284 (20%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G Y V A + +T + VA+K R + PE++K +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 181 -EGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ YL F +E D + EP + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPEL 289
+ H G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
L + VD+WS G +L +LAG+ P ++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ +K + L L+ +L +P+ R+T
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 51/278 (18%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL-EG 182
IG+G ++ V A+ +LTG+ VA+K + L P S++ + RE+ I++ L+HPN++KL E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLLSGLEHCH 234
+ T + LYL+ ME+ A+ EV + E + + Q++S +++CH
Sbjct: 83 IETEKT---LYLI---MEY-----ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
++HRD+K NLL+D D +KIADFG ++ F K + + Y PEL G
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQGKK 189
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
G VD+WS G IL L++G G+ E ++ + +Y
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------GKY------------ 231
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
R P+ L++ L ++P +R T
Sbjct: 232 --RIPFY---------MSTDCENLLKRFLVLNPIKRGT 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 58/284 (20%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G Y V A + +T + VA+K R + PE++K +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 181 -EGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ YL F +E D + EP + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPEL 289
+ H G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
L + VD+WS G +L +LAG+ P ++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ +K + L L+ +L +P+ R+T
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 42/299 (14%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
D +E + IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 172 LDHPNVIKLEG--LVTSRMSCSLYLVFHYME----HDL----AGLAASPEVKFTEPQVKC 221
HPN++ +V L+LV + D+ E +
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKHPMTSR-- 278
+ ++L GLE+ H NG +HRD+K N+L+ +DG ++IADFG+ A R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 279 -VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337
V T + PE++ Y D+WS G EL G P HK
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-------YHKY-----P 231
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQ--ETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P + + +L + + + ++F+ I L DP +R TA
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM-------ISLCLQKDPEKRPTAA 283
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 69/337 (20%), Positives = 122/337 (36%), Gaps = 80/337 (23%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAR----EILILRRL 172
+E +D +G+G + V + D G + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 173 ------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP 217
+++ +V + S Y D + + + F
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY--------DF--IKENGFLPFRLD 118
Query: 218 QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------------------LKI 258
++ +Q+ + H+N + H D+K N+L +K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 259 ADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI 318
DFG A++ D +H ++ V T YR PE++L + D+WS GCIL E G +
Sbjct: 179 VDFGSATYDDEHH----STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 319 MPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPL 378
P E L + ++ G + +K++ F + + PL
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTR--KRKYFHHDRLDWDEHSSAGRYVSRACKPL 291
Query: 379 -----------------IETLLAIDPAERLTATVALN 398
I+ +L DPA+R+T AL
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 69/338 (20%), Positives = 125/338 (36%), Gaps = 76/338 (22%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK-IVALKKVRFDNLEPESVKFMAR----EILIL 169
+ +E + +G+GT+ V + D GK VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 170 RRL------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF 214
+++ + + + + + + + + L + +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF--------EF--LKENNFQPY 120
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV------------------- 255
P V+ +QL L H N + H D+K N+L +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 256 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
+++ADFG A+F +H T+ V T YRPPE++L + D+WS GCIL E G
Sbjct: 181 IRVADFGSATFDHEHH----TTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRG 235
Query: 316 KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK------------LPNATLFKPREPYKRC 363
+ E L + K+ G +++ N++ + + +
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295
Query: 364 IQETFKD---FPPSSLPLIETLLAIDPAERLTATVALN 398
++ L+ +L DPA+R+T AL
Sbjct: 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-44
Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 26/224 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPN 176
+ +G ++ VY+A+D+ +G+ ALK++ + E + + +E+ +++L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 177 VIKLEG---LVTSRMSCSLYLVFHYMEHDLAGL-----AASPEVKFTEPQVKCYMHQLLS 228
+++ + E L + V +Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 229 GLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--------- 277
++H H ++HRD+K NLL+ + G +K+ DFG A+ + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 278 --RVVTLWYRPPEL--LLGATDYGVGVDLWSAGCILAELLAGKP 317
R T YR PE+ L G D+W+ GCIL L +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 56/292 (19%), Positives = 96/292 (32%), Gaps = 76/292 (26%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLE 181
+G G V + + T + ALK + + RE+ + R P+++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 182 GLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQVKCYMHQLLSGLEHC 233
+ L +V ++ G + + FTE + M + +++
Sbjct: 78 DVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 234 HNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
H+ + HRD+K NLL + +LK+ DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK--LCGSPS--EEYWKKS 346
Y D+WS G I+ LL G P + + G W +
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 228
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ E K LI LL +P +R+T T +N
Sbjct: 229 -----------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 256
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK-----KVRFDNL-EPES 158
E L + + + +G G + V+ A D K V +K KV D E
Sbjct: 13 EGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK 72
Query: 159 VKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEV 212
+ + EI IL R++H N+IK+ + ++ LV ME +G + P
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGF--FQLV---MEKHGSGLDLFAFIDRHP-- 125
Query: 213 KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272
+ EP QL+S + + ++HRDIK N++I +D +K+ DFG A++ +
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
+ T+ Y PE+L+G G +++WS G L L+
Sbjct: 186 --FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-42
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLD 173
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 174 HPNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
HPN I+ G L +LV Y + L + E ++ H L GL
Sbjct: 113 HPNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYRPPE 288
+ H++ ++HRD+K N+L+ + G++K+ DFG AS M V T ++ PE
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANSFVGTPYWMAPE 220
Query: 289 LLLGATD--YGVGVDLWSAGCILAELLAGKP 317
++L + Y VD+WS G EL KP
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 27/216 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
I +D ++ + IG G + +D LT ++VA+K + E+V+ REI+ R
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHR 71
Query: 171 RLDHPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKC 221
L HPN+++ E ++T L ++ ME+ A+ E+ +F+E + +
Sbjct: 72 SLRHPNIVRFKEVILTPTH---LAII---MEY-----ASGGELYERICNAGRFSEDEARF 120
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASFFDPNHKHPMTSRV 279
+ QLLSG+ +CH+ + HRD+K N L+D LKI DFG + + + P ++ V
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST-V 178
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
T Y PE+LL G D+WS G L +L G
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-41
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 52/279 (18%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIKL-E 181
+G GT+ V + LTG VA+K + + V + REI L+ HP++IKL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLLSGLEHC 233
+ T ++V ME+ + E+ + E + + Q+LS +++C
Sbjct: 79 VISTPTD---FFMV---MEY-----VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H + V+HRD+K N+L+D KIADFGL++ + + + Y PE++ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGR 185
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
G VD+WS G IL LL G KI + +P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------GVF----YIP---- 231
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ S L+ +L +DP +R T
Sbjct: 232 ---------------EYLNRSVATLLMHMLQVDPLKRAT 255
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 52/291 (17%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRL 172
R + F+ +G+G++S V A+++ T + A+K + + ++ V ++ RE ++ RL
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 173 DHPNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQVKCYM 223
DHP +KL T + LY Y+ F E + Y
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYT 136
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TL 282
+++S LE+ H G++HRD+K N+L+++D ++I DFG A P K + V T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342
Y PELL DLW+ GCI+ +L+AG P E KI K
Sbjct: 197 QYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--------- 246
Query: 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
+ P + F P + L+E LL +D +RL
Sbjct: 247 -LEYDFP-------------------EKFFPKARDLVEKLLVLDATKRLGC 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 82/300 (27%), Positives = 140/300 (46%), Gaps = 54/300 (18%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ F K++KIG+G++ V+K D T K+VA+K + + E E ++ + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQVKCYMHQLLSG 229
P V K G L ++ L+++ ME+ L G +A ++ E Q+ + ++L G
Sbjct: 80 PYVTKYYGSYLKDTK----LWII---MEY-LGGGSALDLLEPGPLDETQIATILREILKG 131
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
L++ H+ +HRDIK +N+L+ + G +K+ADFG+A T V T ++ PE+
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEV 190
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIYKLCGSPS-EEYWK 344
+ + Y D+WS G EL G+P + P + L I K P+ E +
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK-NNPPTLEGNYS 244
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
K K+F +E L +P+ R TA L + I +
Sbjct: 245 KP---------------------LKEF-------VEACLNKEPSFRPTAKELLKHKFILR 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 71/288 (24%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLE-PESVKFMAREILILRRLDHPNVIK 179
+G+G++ V A T + VALK + + V+ REI L+ L HP++IK
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIK 73
Query: 180 L-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLLSGL 230
L + + T + +V +E+ A E+ + TE + + + Q++ +
Sbjct: 74 LYDVITTPTD---IVMV---IEY------AGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK------HPMTSRVVTLWY 284
E+CH + ++HRD+K NLL+DD+ +KIADFGL++ + P Y
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------Y 173
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE++ G G VD+WS G +L +L G+ K+ Y
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY-- 225
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+P P + LI ++ DP +R+T
Sbjct: 226 --VMP-------------------DFLSPGAQSLIRRMIVADPMQRIT 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREIL 167
+ +G+G + V+ + VA+K + + + E+
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 168 ILRRLD----HPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTE 216
+L ++ HP VI+L + T LV +E L + E
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEG---FMLV---LERPLPAQDLFDYITEKG--PLGE 138
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPM 275
+C+ Q+++ ++HCH+ GV+HRDIK N+LID G K+ DFG +
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-- 196
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 315
T Y PPE + + + +WS G +L +++ G
Sbjct: 197 DF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 63/293 (21%), Positives = 103/293 (35%), Gaps = 68/293 (23%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILRRLD 173
++ +G G + +VY + VA+K V D + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 174 H--PNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV----------KFTEPQVK 220
VI+L + L+ +E P E +
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLI---LER------PEPVQDLFDFITERGALQEELAR 152
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRV 279
+ Q+L + HCHN GVLHRDIK N+LID + G LK+ DFG +
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF-D 209
Query: 280 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
T Y PPE + +G +WS G +L +++ G +P + +I + G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHD----EEIIR--GQVF 261
Query: 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
LI LA+ P++R T
Sbjct: 262 FRQR---------------------------VSSECQHLIRWCLALRPSDRPT 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 48/295 (16%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ +E + ++G G + VYKAK+ TG + A K + + E ++ EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
P ++KL G + L+++ + + + + TEPQ++ Q+L L
Sbjct: 76 PYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H+ ++HRD+K N+L+ +G +++ADFG+++ S + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVVM 190
Query: 292 GAT----DYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIYKLCGSPSEEYW 343
T Y D+WS G L E+ +P + P R L KI K P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKS-DPP----- 240
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
L + + F+DF ++ L +P R +A L
Sbjct: 241 ---TLLTPSKWSV----------EFRDF-------LKIALDKNPETRPSAAQLLE 275
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-40
Identities = 52/226 (23%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
I R +D + +G+G + K TG+++ +K+ + E+ + +E+ ++
Sbjct: 5 RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVM 61
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLS 228
R L+HPNV+K G++ L + Y++ L G+ S + ++ Q + + S
Sbjct: 62 RCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP-------------M 275
G+ + H+ ++HRD+ N L+ ++ + +ADFGLA P
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 321
+ V ++ PE++ G Y VD++S G +L E++ P
Sbjct: 180 YTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
A FE ++ +G GTY VYK + + TG++ A+K + ++ + + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 174 HPNVIKLEG----LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQ 225
H N+ G M L+LV + DL + + E + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
+L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWM 196
Query: 286 PPELLLGATD----YGVGVDLWSAGCILAELLAGKP 317
PE++ + Y DLWS G E+ G P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 73/362 (20%), Positives = 123/362 (33%), Gaps = 102/362 (28%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R FE I +G+G + V++AK+ + A+K++R N E K M RE+ L +L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 61
Query: 173 DHPNVIKLEG-----------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
+HP +++ + + A S +++ +P
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 222 YMHQLLSG----------LEHCHN------------------------------------ 235
L ++ C
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 236 -NGVLHRDIKGSNLLIDDDGVLKIADFGLA-----------SFFDPNHKHPMTSRVVTLW 283
G++HRD+K SN+ D V+K+ DFGL T +V T
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
Y PE + G +Y VD++S G IL ELL T++E++ I +
Sbjct: 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV--------- 286
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403
+ K P F P +++ +L+ P ER AT + + IF
Sbjct: 287 RNLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA-IF 329
Query: 404 QD 405
++
Sbjct: 330 EN 331
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-39
Identities = 44/283 (15%), Positives = 89/283 (31%), Gaps = 35/283 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+G+G ++ VY+A D + LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-----LAGLAASPEVKFTEPQVKCYMHQ 225
+K + LV + + +PE + V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLI-----------DDDGVLKIADFGLA---SFFDPNH 271
+L +E H+ ++H DIK N ++ D L + D G + F
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
T++ T ++ E+L + +D + + +L G M + E +
Sbjct: 241 I--FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTY-MKVKNEGGECKPE 296
Query: 332 YKLCGSPSEEYWKK--SKLPNATLFKPREPYKRCIQETFKDFP 372
P + W + + N P +++ K
Sbjct: 297 GLFRRLPHLDMWNEFFHVMLNIPDCH-HLPSLDLLRQKLKKVF 338
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +KIGQG VY A D+ TG+ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--NEILVMRENKNP 77
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAAS---PEVKFTEPQVKCYMHQLLSGL 230
N++ LV L++V Y+ G + + E E Q+ + L L
Sbjct: 78 NIVNYLDSYLVGDE----LWVVMEYLA----GGSLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
E H+N V+HRDIK N+L+ DG +K+ DFG + P T V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVV 188
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
YG VD+WS G + E++ G+P + L+ I G+P +L N
Sbjct: 189 TR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--------ELQN 238
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
F+DF + L +D +R +A
Sbjct: 239 PEKLSA----------IFRDF-------LNRCLEMDVEKRGSAK 265
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 56/281 (19%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIKL-E 181
+G GT+ V K LTG VA+K + + V + REI L+ HP++IKL +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQVKCYMHQLLSGLEHC 233
+ T +++V ME+ + E+ + E + + Q+LSG+++C
Sbjct: 84 VISTPSD---IFMV---MEY-----VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H + V+HRD+K N+L+D KIADFGL++ + + + Y PE++ G
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGR 190
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
G VD+WS+G IL LL G +P KI + P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF----YTP-- 236
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392
+ PS + L++ +L +DP +R T
Sbjct: 237 -----------------QYLNPSVISLLKHMLQVDPMKRAT 260
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 45/285 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F+ ++K+G+G+Y +VYKA TG+IVA+K+V +E ++ + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVE-SDLQEIIKEISIMQQCDSP 84
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
+V+K G + L++V Y D+ L TE ++ + L G
Sbjct: 85 HVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKG 137
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
LE+ H +HRDIK N+L++ +G K+ADFG+A + + T ++ PE+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEV 196
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+ Y D+WS G E+ GKP + + I P
Sbjct: 197 IQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFR 246
Query: 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
L+ F DF ++ L P +R TAT
Sbjct: 247 KPELWSD----------NFTDF-------VKQCLVKSPEQRATAT 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 47/286 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ KIG+G+ V A++ +G+ VA+K + D + + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
NV+++ LV L+++ +++ D+ +V+ E Q+ +L
Sbjct: 103 NVVEMYKSYLVGEE----LWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQA 153
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKHPMTSRVVTLWYRPPE 288
L + H GV+HRDIK ++L+ DG +K++DFG A K S V T ++ PE
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPE 211
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
++ + Y VD+WS G ++ E++ G+P + V+ + ++ P KL
Sbjct: 212 VISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP--------KL 261
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
N+ P +DF +E +L DP ER TA
Sbjct: 262 KNSHKVSP----------VLRDF-------LERMLVRDPQERATAQ 290
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 35/202 (17%), Positives = 73/202 (36%), Gaps = 18/202 (8%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
K+ + ++K + G + +K ++ + + E LR HPNV+ + G
Sbjct: 17 KLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 183 LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGLE--HCHNN 236
S + L+ H+M +++ L + Q + + G+ H
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG--AT 294
+ + +++ID+D +I+ + F R+ + PE L
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 295 DYGVGVDLWSAGCILAELLAGK 316
D+WS +L EL+ +
Sbjct: 187 TNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W IP +IG G++ VYK K G VA+K + P+ ++ E+ +
Sbjct: 19 WEIPD--GQITVGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLL 227
LR+ H N++ G T+ L +V + E L + E KF ++ Q
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP-NHKHPMTSRVVTLWYRP 286
G+++ H ++HRD+K +N+ + +D +KI DFGLA+ + H ++ +
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 287 PELLLGATD--YGVGVDLWSAGCILAELLAGK 316
PE++ Y D+++ G +L EL+ G+
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-----VKFMAREILILR 170
+ E +IG+G + V+K + + +VA+K + + E E+ + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSG 229
L+HPN++KL GL+ + +V ++ DL M + G
Sbjct: 79 NLNHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 230 LE--HCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFFDPNHKHPMTSRVVTL 282
+E N ++HRD++ N+ + K+ADFGL+ H ++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNF 190
Query: 283 WYRPPELLLGATD-YGVGVDLWSAGCILAELLAGK 316
+ PE + + Y D +S IL +L G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 118 FEKID---KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ ++ KIG G++ V++A+ G VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKFTEPQVKCYMHQLLSGLE 231
PN++ G VT + L +V Y+ L L + + E + + + G+
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 232 --HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
H N ++HR++K NLL+D +K+ DFGL+ + S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEV 210
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGK 316
L D++S G IL EL +
Sbjct: 211 LRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E + +G+G + V KAK K VA+K++ ++ F+ E+ L R++HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKA---FI-VELRQLSRVNHP 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKFTEPQVKCYMHQLLSGLEH 232
N++KL G + + LV Y E L + A P +T + Q G+ +
Sbjct: 62 NIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 233 CHN---NGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
H+ ++HRD+K NLL+ G VLKI DFG A + MT+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGK 316
+ G ++Y D++S G IL E++ +
Sbjct: 174 VFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 69/292 (23%), Positives = 107/292 (36%), Gaps = 47/292 (16%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRL 172
+ D FE + IG+G +S V K TG++ A+K + + L+ V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
D + +L + LYLV Y DL L + + + Y+ +
Sbjct: 119 DRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
++ ++ H G +HRDIK N+L+D G +++ADFG + V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 286 PPELLLG------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339
PE+L YG D W+ G E+ G+ + E KI
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH------ 284
Query: 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
K L P + P + I+ LL P RL
Sbjct: 285 ----YKEHLSL-----PLVD---------EGVPEEARDFIQRLL-CPPETRL 317
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 46/215 (21%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 118 FEKID---KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
FE+++ IG+G + VY + G+ VA++ + + + +K RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
NV+ G S L ++ + L + ++ + + +++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF----FDPNHKHPMTSRVVTLWYRPPEL 289
H G+LH+D+K N+ D+G + I DFGL S + + + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 290 LLGATD--------YGVGVDLWSAGCILAELLAGK 316
+ + + D+++ G I EL A +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 62/296 (20%), Positives = 113/296 (38%), Gaps = 39/296 (13%)
Query: 107 LNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMARE 165
+ G + E + ++G GT V+K + TG ++A+K++R E K + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
+ ++ + D P +++ G + + +++ M L + E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 225 QLLSGLEHCH-NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
++ L + +GV+HRD+K SN+L+D+ G +K+ DFG++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAA 189
Query: 284 YRPPE----LLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSP 338
Y PE DY + D+WS G L EL G+ P +T+ E L K+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV---LQEE 246
Query: 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
LP F F+ F ++ L D +R
Sbjct: 247 PP------LLPGHMGFSG----------DFQSF-------VKDCLTKDHRKRPKYN 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 25/302 (8%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G ++A K + + +P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
P ++ G S + + +M+ L + + E + ++ GL +
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 146
Query: 233 CHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
++HRD+K SN+L++ G +K+ DFG++ + + S V T Y PE L
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 203
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
G T Y V D+WS G L E+ G+ +P E + E + + P
Sbjct: 204 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 352 TLFKPREPYKRC------IQETFKDFPPSSLP---------LIETLLAIDPAERLTATVA 396
L K + + + PP + L +PAER
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 397 LN 398
+
Sbjct: 323 MV 324
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 20/230 (8%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRL 172
+ FE + IG+G + V K K+ A+K + ++ L+ E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
D + L + LYLV Y DL L + E + E + Y+ +
Sbjct: 132 DSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
++ ++ H +HRDIK N+L+D +G +++ADFG + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 286 PPELLLGATD----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
PE+L YG D WS G + E+L G+ + VE KI
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL- 172
A+ + + +IG+G Y +V K +G+I+A+K++R ++ + K + ++ ++ R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYM----EHDLAGLAASPEVKFTEPQVKCYMHQLLS 228
D P +++ G + ++ M + + + + E + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 229 GLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
L H N ++HRDIK SN+L+D G +K+ DFG++ T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194
Query: 288 ELLLGATD---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYW 343
E + + Y V D+WS G L EL G+ P + +QL ++ K G P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247
Query: 344 KKSKLPNATLFKPREPYKRCIQ--ETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P+ + +F +F + L D ++R
Sbjct: 248 ------------PQLSNSEEREFSPSFINF-------VNLCLTKDESKRPKYK 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 69/299 (23%), Positives = 106/299 (35%), Gaps = 33/299 (11%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A + + +IG+G Y V+ K G+ VA+K E+ F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 175 PNVIKLEGLVT--SRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
N++ + LYL+ Y E+ L S + + +SGL
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLC 148
Query: 232 HCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRVV 280
H H + HRD+K N+L+ +G IAD GLA F + P +RV
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 281 TLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLC 335
T Y PPE+L + + D++S G IL E+ E + +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
E+ + + P L+ A +PA RLTA
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK-------LMTECWAHNPASRLTAL 320
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 68/320 (21%), Positives = 120/320 (37%), Gaps = 75/320 (23%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
++ + ++ +G + V+KA L + VA+K F + +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 174 HPNVIKLEGLVT--SRMSCSLYLVFHYMEH----------------------DLA-GLAA 208
H N+++ G + + L+L+ + E +A GLA
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA- 135
Query: 209 SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268
Y+H+ + GL+ H + HRDIK N+L+ ++ IADFGLA F+
Sbjct: 136 -------------YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 269 PNHKHPMTSRVV-TLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRT 323
T V T Y PE+L GA D + +D+++ G +L EL + G
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLL 383
+ L ++ PS E ++ + K + P +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQE-----VVVHKKKRPV-----------LRDYWQKHAGMA 286
Query: 384 AI----------DPAERLTA 393
+ D RL+A
Sbjct: 287 MLCETIEECWDHDAEARLSA 306
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 63/294 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D FE + IG+G++ V + T K+ A+K + +E V+ + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYME------HDLAGLAASPEVKFTEPQVKCY 222
P ++ L S +++V + H V F E VK +
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH------LQQNVHFKEETVKLF 120
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 282
+ +L+ L++ N ++HRD+K N+L+D+ G + I DF +A+ + T+ T
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTK 178
Query: 283 WYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKP---IMPGRTEVEQLHKIYKLCGS 337
Y PE+ Y VD WS G ELL G+ I + E +H
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---- 234
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
P+A + + L++ LL +P +R
Sbjct: 235 ------TVVTYPSA-------------------WSQEMVSLLKKLLEPNPDQRF 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D F +G+G + V+ + TGK+ A KK+ + + + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHYMEH-DL---AGLAASPEVKFTEPQVKCYMHQ 225
++ L L LV M D+ F EP+ Y Q
Sbjct: 245 RFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
++SGLEH H +++RD+K N+L+DDDG ++I+D GLA + T +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFM 356
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
PELLLG +Y VD ++ G L E++A + R E + ++ +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------ 403
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
L + Y F P+S E LL DP +RL
Sbjct: 404 -----RVLEQA-VTYPD-------KFSPASKDFCEALLQKDPEKRL 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 25/218 (11%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
A +E I G +Y A D + G+ V LK + + E+ E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV 137
Query: 174 HPNVIKLEGLV---TSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQL 226
HP+++++ V Y+V ME L + Y+ ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIV---MEYVGGQSLKRSKGQK---LPVAEAIAYLLEI 191
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYR 285
L L + H+ G+++ D+K N+++ ++ + K+ D G S + + T ++
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN------SFGYLYGTPGFQ 244
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 323
PE++ V D+++ G LA L P GR
Sbjct: 245 APEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 41/290 (14%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI-LRRL 172
+AD E I ++G+G Y V K + + +G+I+A+K++R + + K + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME---HDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
D P + G + +++ M+ E + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 230 LEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
LEH H+ V+HRD+K SN+LI+ G +K+ DFG++ + Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE 179
Query: 289 LLLGATD---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
+ + Y V D+WS G + EL + P T +QL ++ PS
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV---VEEPS----- 231
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P+ P + E F DF L + ER T
Sbjct: 232 -----------PQLPADKFSAE-FVDF-------TSQCLKKNSKERPTYP 262
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 9/223 (4%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRL 172
+A+ +E + IG+G + V + T K+ A+K + F+ ++ F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ P V++L + LY+V YM DL L + E + Y +++ L+
Sbjct: 127 NSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALD 182
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H+ G +HRD+K N+L+D G LK+ADFG + + V T Y PE+L
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 292 ---GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331
G YG D WS G L E+L G + V KI
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 51/288 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
++F + +G+G + V + TGK+ A KK+ + + + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHYME------HDLAGLAASPEVKFTEPQVKCYM 223
V+ L +L LV M H + + F E + Y
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYA 292
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
++ GLE H +++RD+K N+L+DD G ++I+D GLA + RV T+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
Y PE++ Y D W+ GC+L E++AG+ R + + ++ +
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---------- 399
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
P E Y F P + L LL DPAERL
Sbjct: 400 -------LVKEVP-EEYSE-------RFSPQARSLCSQLLCKDPAERL 432
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP--ESVKFMAREILILRRLDHPNVIKL 180
IG G + VY+A G VA+K R D E ++++ + +E + L HPN+I L
Sbjct: 14 IIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG-- 237
G+ +L LV + L + + + + + Q+ G+ + H+
Sbjct: 72 RGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARGMNYLHDEAIV 127
Query: 238 -VLHRDIKGSNLLID--------DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
++HRD+K SN+LI + +LKI DFGLA + H+ S + PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMAPE 184
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGK 316
++ + + G D+WS G +L ELL G+
Sbjct: 185 VIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 26/220 (11%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A ++ +G+G Y V++ G+ VA+K + E F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRD---EKSWFRETELYNTVMLRH 61
Query: 175 PNVIKLEGLVTSRMSCS--LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
N++ + S L+L+ HY E L + + SGL
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLA 119
Query: 232 HCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRVV 280
H H + HRD+K N+L+ +G IAD GLA + RV
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 281 TLWYRPPELLLGATDYGVG-----VDLWSAGCILAELLAG 315
T Y PE+L VD+W+ G +L E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 75/389 (19%), Positives = 132/389 (33%), Gaps = 119/389 (30%)
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
G+ NG + I K+G G +S V+ + D+ K VA+K V+ E+
Sbjct: 32 GDLFNG-------RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL--- 81
Query: 164 REILILRRL-----DHPN---VIKL------EG-------LVTSRMSCSLYLVFHYMEHD 202
EI +L+ + + PN V++L G +V + L
Sbjct: 82 DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKW------- 134
Query: 203 LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLI----------- 250
+ S P VK + Q+L GL++ H ++H DIK N+L+
Sbjct: 135 ---IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 251 --------------------------------------DDDGVLKIADFGLASFFDPNHK 272
+ +KIAD G A + +
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT------EVE 326
+ +R YR E+L+G+ Y D+WS C+ EL G + + + +
Sbjct: 252 EDIQTRQ----YRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
Query: 327 QLHKIYKLCGSPSEEYWKKSK-----------LPNATLFKPREPYKRCIQETFKDFPP-- 373
+ I +L G + K L + T KP ++ +++ ++
Sbjct: 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEE 364
Query: 374 --SSLPLIETLLAIDPAERLTATVALNSE 400
+ +L + P +R TA L
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHP 393
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 68/310 (21%), Positives = 118/310 (38%), Gaps = 48/310 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D+ + ++ IG+G Y VYK L + VA+K F ++ F+ + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 175 PNVIKLEG---LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
N+ + VT+ LV Y + L + + H + GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW--VSSCRLAHSVTRGL 124
Query: 231 EHCH---------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-------KHP 274
+ H + HRD+ N+L+ +DG I+DFGL+ N +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 275 MTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328
S V T+ Y PE+L GA + VD+++ G I E+ + V +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 329 HKIY--KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLA-- 384
+ ++ P+ E + + + P E +K+ + L ET+
Sbjct: 245 QMAFQTEVGNHPTFEDMQV-----LVSREKQRPK---FPEAWKENSLAVRSLKETIEDCW 296
Query: 385 -IDPAERLTA 393
D RLTA
Sbjct: 297 DQDAEARLTA 306
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA---REIL-ILRR 171
+ F IG+G + VY + TGK+ A+K + ++ + + +A R +L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQVKCYMHQ 225
D P ++ + + L + M H S F+E ++ Y +
Sbjct: 249 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYH------LSQHGVFSEADMRFYAAE 300
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
++ GLEH HN V++RD+K +N+L+D+ G ++I+D GLA F + V T Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYM 357
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
PE+L Y D +S GC+L +LL G P R + K
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTK----------------DK 399
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
++ TL + L+E LL D RL
Sbjct: 400 HEIDRMTLTMA-VELPDSFSPELRS-------LLEGLLQRDVNRRL 437
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIK 179
+G+G +VY+A+D + +IVALK + + +P M RE RL P+V+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 180 L------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
+ +G LY+ + DLA + + P+ + Q+ S L+
Sbjct: 99 IHDFGEIDGQ--------LYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDA 149
Query: 233 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVV-TLWYRPPEL 289
H G HRD+K N+L+ D + DFG+AS +T V TL+Y PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK---LTQLGNTVGTLYYMAPER 206
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKP 317
+ D+++ C+L E L G P
Sbjct: 207 FSESH-ATYRADIYALTCVLYECLTGSP 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPN 176
++ +DK+G G S VY A+D + VA+K + + E++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 177 VIKL------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
++ + + YLV Y+E L+ S + + +Q+L G
Sbjct: 73 IVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDG 123
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPE 288
++H H+ ++HRDIK N+LID + LKI DFG+A T+ V+ T+ Y PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPE 182
Query: 289 LLLGATDYGVGVDLWSAGCILAELLAGKP 317
G D++S G +L E+L G+P
Sbjct: 183 QAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPN 176
+E + +G G S V+ A+D+ + VA+K +R D +P RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 177 VIKL--EGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
++ + G + Y+V ME L + + E T + + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIV---MEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT--SRVV-TLWYRPP 287
H NG++HRD+K +N++I +K+ DFG+A + + +T + V+ T Y P
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSP 188
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKP 317
E G + D++S GC+L E+L G+P
Sbjct: 189 EQARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 57/235 (24%), Positives = 85/235 (36%), Gaps = 33/235 (14%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + V++ K G+ VA+K E F EI L H N++
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENIL 99
Query: 179 KLEGLVTSRMSCS--LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH- 234
L+LV Y EH L T + SGL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHM 157
Query: 235 -------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRVVTLWY 284
+ HRD+K N+L+ +G IAD GLA D RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 285 RPPELLLGATDYGVG-----VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
PE+L + + D+++ G + E+ R + +H+ Y+L
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-------RCSIGGIHEDYQL 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 63/290 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D F++I +G G++ V K +G A+K + ++ + ++ E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 175 PNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
P ++KLE + + + +LY+V F ++ +F+EP + Y Q
Sbjct: 101 PFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQ 149
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
++ E+ H+ +++RD+K NLLID G +++ DFG A R TL
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------GRTWTLCGT 201
Query: 283 -WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
PE++L Y VD W+ G ++ E+ AG P ++ KI
Sbjct: 202 PEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------- 252
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
K + P F L+ LL +D +R
Sbjct: 253 --GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 44/278 (15%), Positives = 78/278 (28%), Gaps = 58/278 (20%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIK 179
+ G ++A D + VAL V + P+ V L L R+D P V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 180 LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGV 238
+ +V +R +V ++ L +A + + M L + + H GV
Sbjct: 96 VLDVVHTRAGG--LVVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGV 150
Query: 239 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 298
S + + DG + +A +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMP--------DANPQ-------------------- 182
Query: 299 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPRE 358
D+ G L LL + +P L + P E
Sbjct: 183 -DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ-----------------PIE 224
Query: 359 PYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA 396
P + +D P + + D R +T+
Sbjct: 225 P-----ADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 60/290 (20%), Positives = 115/290 (39%), Gaps = 63/290 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
F+ + +G G++ V+ + G+ A+K ++ + + + V+ E L+L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
P +I++ G T + + ++++ F + +F P K Y +
Sbjct: 66 PFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAE 114
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW-- 283
+ LE+ H+ +++RD+K N+L+D +G +KI DFG A + TL
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--------DVTYTLCGT 166
Query: 284 --YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
Y PE++ Y +D WS G ++ E+LAG ++ KI
Sbjct: 167 PDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------- 217
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ + P F L+ L+ D ++RL
Sbjct: 218 --AELRFP-------------------PFFNEDVKDLLSRLITRDLSQRL 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 68/294 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
+ F+ + +G+GT+ V ++ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVKCYM 223
P + L+ L V Y H S E FTE + + Y
Sbjct: 65 PFLTALK-------YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEERARFYG 111
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--- 280
+++S LE+ H+ V++RDIK NL++D DG +KI DFGL K ++
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKT 164
Query: 281 ---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337
T Y PE+L DYG VD W G ++ E++ G+ + I
Sbjct: 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---- 219
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
++ + P + P + L+ LL DP +RL
Sbjct: 220 ------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQRL 248
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 78/301 (25%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
+ FE + +G+G Y V++ + + TGKI A+K ++ + + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 171 RLDHPNVIKLEGLVTSRMSC-----SLYLV---------FHYMEHDLAGLAASPEVKFTE 216
+ HP ++ L + LYL+ F +E E F E
Sbjct: 77 EVKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLER---------EGIFME 120
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276
Y+ ++ L H H G+++RD+K N++++ G +K+ DFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIH 173
Query: 277 SRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330
V T+ Y PE+L+ + + VD WS G ++ ++L G P G + + K
Sbjct: 174 DGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
Query: 331 IYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390
I K K LP + L++ LL + A R
Sbjct: 233 ILK----------CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
Query: 391 L 391
L
Sbjct: 264 L 264
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 74/298 (24%)
Query: 116 DSFEKIDKIGQGTYSNVY---KAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR 171
FE + +GQG++ V+ K ++ A+K ++ L + V+ E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 172 LDHPNVIKLEGLVTSRMSCS------LYLVFHY------MEHDLAGLAASPEVKFTEPQV 219
++HP ++KL + LYL+ + S EV FTE V
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR------LSKEVMFTEEDV 128
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 279
K Y+ +L L+H H+ G+++RD+K N+L+D++G +K+ DFGL+ K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEK 181
Query: 280 V------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333
T+ Y PE++ + D WS G ++ E+L G G+ E + I K
Sbjct: 182 KAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
K +P + P + L+ L +PA RL
Sbjct: 241 ----------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANRL 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 69/295 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
+ FE + +G+GT+ V K+ TG+ A+K ++ + + + V E +L+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVKCYM 223
P + L+ L V Y H S E F+E + + Y
Sbjct: 208 PFLTALK-------YSFQTHDRLCFVMEYANGGELFFH------LSRERVFSEDRARFYG 254
Query: 224 HQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-- 280
+++S L++ H+ V++RD+K NL++D DG +KI DFGL K +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMK 307
Query: 281 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG 336
T Y PE+L DYG VD W G ++ E++ G+ + + I
Sbjct: 308 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--- 363
Query: 337 SPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
++ + P + P + L+ LL DP +RL
Sbjct: 364 -------EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQRL 392
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 47/341 (13%), Positives = 97/341 (28%), Gaps = 76/341 (22%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE------PESVKFMAREILIL 169
+ ++ +KIG+G + V++ VA+K + + + ++ + + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 170 RRL---------DHPNVIKLEGLVTSRMSCSLYLVFHY---------------------- 198
+ L I L + + S L+ +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 199 -----MEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDD 252
E L + K +HQL + L + HRD+ N+L+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 253 DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 312
+ K+ P V++ DY + + ++
Sbjct: 198 TSLKKLHYTLNGKSS----TIPSCGLQVSII-----------DYTLSRLERDGIVVFCDV 242
Query: 313 LAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN---------ATLFKPREPYKRC 363
+ + G + + IY+L + W + + + K +C
Sbjct: 243 SMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 364 IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
K T+L A L L +F+
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFSSATDL-----LCQHSLFK 336
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 73/297 (24%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
F + IG+G++ V A+ A+K ++ + E + + R +L L+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL-LKN 95
Query: 172 LDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVK 220
+ HP ++ L LY V Y H E F EP+ +
Sbjct: 96 VKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPRAR 142
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280
Y ++ S L + H+ +++RD+K N+L+D G + + DFGL K +
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNST 195
Query: 281 ------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKL 334
T Y PE+L Y VD W G +L E+L G P R E I
Sbjct: 196 TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN- 253
Query: 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
K +L + S+ L+E LL D +RL
Sbjct: 254 ---------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKRL 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 13/211 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREI 166
+R ++I +G+G + V + G VA+K ++ ++ +EI
Sbjct: 18 FEKR--FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEI 74
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
ILR L H N++K +G+ T + L+ ++ L + K Q Y Q
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ G+++ + +HRD+ N+L++ + +KI DFGL + + ++
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELL 313
WY PE L+ + + + D+WS G L ELL
Sbjct: 195 WY-APECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 73/299 (24%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
D+FE I +G+G++ V A+ TG + A+K ++ D + + E + IL L
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSL 79
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
R +HP + +L C L+ V + M H +F E +
Sbjct: 80 AR-NHPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEAR 125
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278
+ Y +++S L H+ G+++RD+K N+L+D +G K+ADFG+ K + +
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNG 178
Query: 279 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
V T Y PE+L YG VD W+ G +L E+L G E + I
Sbjct: 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ P + ++++ + +P RL
Sbjct: 238 N----------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMRL 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 73/299 (24%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ + F +G+G++ V+ A+ T + A+K ++ D + + E + + +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL-S 72
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
+HP + + +L+ V Y M H KF +
Sbjct: 73 LAWEHPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYH------IQSCHKFDLSR 119
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278
Y +++ GL+ H+ G+++RD+K N+L+D DG +KIADFG+ K M
Sbjct: 120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGD 172
Query: 279 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
T Y PE+LLG Y VD WS G +L E+L G+ G+ E E H I
Sbjct: 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
P + + L+ L +P +RL
Sbjct: 232 M----------DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKRL 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 63/294 (21%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ F + +G+G++ V ++ T ++ A+K ++ D + + E + + +L L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL 397
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYM 223
P + +L SC LY V Y+ DL +F EP Y
Sbjct: 398 PG-KPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYA 448
Query: 224 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--- 280
++ GL + G+++RD+K N+++D +G +KIADFG+ K + V
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKT 501
Query: 281 ---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337
T Y PE++ YG VD W+ G +L E+LAG+ G E E I +
Sbjct: 502 FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---- 556
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
P K ++ + + L+ P +RL
Sbjct: 557 ------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKRL 585
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 73/299 (24%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ F + +G+G++ V ++ T ++ A+K ++ D + + E + + +L L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL 76
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
P + +L SC LY V Y M H +F EP
Sbjct: 77 PG-KPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPH 122
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 278
Y ++ GL + G+++RD+K N+++D +G +KIADFG+ K +
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDG 175
Query: 279 VV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
V T Y PE++ YG VD W+ G +L E+LAG+ G E E I
Sbjct: 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ P K ++ + + L+ P +RL
Sbjct: 235 E----------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKRL 264
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 53/248 (21%), Positives = 104/248 (41%), Gaps = 17/248 (6%)
Query: 95 WPPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN 153
+ W + R K+G G Y VY+ VA+K ++ D
Sbjct: 200 RNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257
Query: 154 LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPE 211
+E E +F+ E +++ + HPN+++L G+ T Y++ +M + +L L
Sbjct: 258 MEVE--EFLK-EAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNR 312
Query: 212 VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPN 270
+ + + Q+ S +E+ +HR++ N L+ ++ ++K+ADFGL+
Sbjct: 313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVE 326
+ ++ W P L + + D+W+ G +L E+ G P + E
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
Query: 327 QLHKIYKL 334
L K Y++
Sbjct: 431 LLEKDYRM 438
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 67/306 (21%), Positives = 119/306 (38%), Gaps = 82/306 (26%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRR-LD 173
F+ + IG+G+Y+ V + T +I A+K V+ + + E + ++ E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 174 HPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVKCY 222
HP ++ L SC L+ V Y M H + K E + Y
Sbjct: 69 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 115
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-- 280
++ L + H G+++RD+K N+L+D +G +K+ D+G+ K +
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 168
Query: 281 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG 336
T Y PE+L G DYG VD W+ G ++ E++AG+
Sbjct: 169 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------------- 208
Query: 337 SPSEEYWKKSKLPNATLFKPREPYKRCIQETFK-------DFPPS----SLPLIETLLAI 385
P + P + F+ P S + ++++ L
Sbjct: 209 ------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 256
Query: 386 DPAERL 391
DP ERL
Sbjct: 257 DPKERL 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 36/155 (23%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ + ++IG+G + V+ + +VA+K R KF+ +E IL+
Sbjct: 111 LNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILK 167
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSG 229
+ HPN+++L G+ T + +Y+V ++ D + + + + +G
Sbjct: 168 QYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+E+ + +HRD+ N L+ + VLKI+DFG++
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + + ++G+G + +V + TG++VA+KK++ + E F REI
Sbjct: 7 FEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 62
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
IL+ L H N++K +G+ S +L L+ Y+ + L + + ++ Y Q
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ G+E+ +HRD+ N+L++++ +KI DFGL + +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELL 313
WY PE L + + V D+WS G +L EL
Sbjct: 183 WY-APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + + ++G+G + +V + TG++VA+KK++ + E F REI
Sbjct: 38 FEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 93
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
IL+ L H N++K +G+ S +L L+ Y+ + L + + ++ Y Q
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ G+E+ +HRD+ N+L++++ +KI DFGL + ++
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 283 WYRPPELLLGATDYGVGVDLWSAGCILAELL 313
WY PE L + + V D+WS G +L EL
Sbjct: 214 WY-APESLTESK-FSVASDVWSFGVVLYELF 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 67/299 (22%), Positives = 125/299 (41%), Gaps = 66/299 (22%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
++FE + +G G Y V+ + + TGK+ A+K ++ + + ++ + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 171 RLDH-PNVIKLEGLVTSRMSCS------LYLV---------FHYMEHDLAGLAASPEVKF 214
+ P ++ L + L+L+ F ++ +F
Sbjct: 114 HIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTHLSQ---------RERF 156
Query: 215 TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274
TE +V+ Y+ +++ LEH H G+++RDIK N+L+D +G + + DFGL+ F +
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 275 MTSRVVTLWYRPPELLLGATDYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY 332
T+ Y P+++ G D G VD WS G ++ ELL G E +I
Sbjct: 217 AYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL 391
+ ++ + P+ + + LI+ LL DP +RL
Sbjct: 276 R-------------RILKSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRL 309
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 64/306 (20%), Positives = 117/306 (38%), Gaps = 82/306 (26%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRR-LD 173
F+ + IG+G+Y+ V + T +I A++ V+ + + E + ++ E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 174 HPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQVKCY 222
HP ++ L SC L+ V Y M H + K E + Y
Sbjct: 112 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 158
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-- 280
++ L + H G+++RD+K N+L+D +G +K+ D+G+ K +
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 211
Query: 281 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG 336
T Y PE+L G DYG VD W+ G ++ E++AG+
Sbjct: 212 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------------- 251
Query: 337 SPSEEYWKKSKLPNATLFKPREPYKRCIQETF-----------KDFPPSSLPLIETLLAI 385
P + P + F + + ++++ L
Sbjct: 252 ------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 299
Query: 386 DPAERL 391
DP ERL
Sbjct: 300 DPKERL 305
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
I + + IG+G + VY D KI A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
+I++ HPNV+ L G+ R S +V YM+H DL + T + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ G+++ + +HRD+ N ++D+ +K+ADFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 21/232 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREIL 167
+ + +G G + V + L K VA+K ++ E + F+ E
Sbjct: 42 LDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEAS 98
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
I+ + DHPN+I+LEG+VT S + +V YME+ L + +FT Q+ + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL---W 283
SG+++ + G +HRD+ N+LI+ + V K++DFGL + + + T+R + W
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 284 YRPPELLLGATDYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
PE A Y D+WS G +L E+++ G+ + + + +
Sbjct: 217 T-SPE----AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREIL 167
I IG G V + + G+ VA+K ++ E + F+ E
Sbjct: 46 IEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEAS 102
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
I+ + DHPN+I+LEG+VT +V YME+ L + + +FT Q+ + +
Sbjct: 103 IMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL---W 283
+G+ + + G +HRD+ N+L+D + V K++DFGL+ + + T+ + W
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 284 YRPPELLLGATDYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
PE A + D+WS G ++ E+LA G+ T + + +
Sbjct: 221 T-APE----AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREI 166
+R +KI +G+G + V T +VA+K ++ D + +EI
Sbjct: 28 FHKR--YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEI 84
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
ILR L H ++IK +G + SL LV Y+ L P Q+ + Q
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQ 142
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ G+ + H +HRD+ N+L+D+D ++KI DFGLA
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 22/232 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
+ F+KI +G G + VYK + KI VA+K++R + + + E
Sbjct: 12 LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEA 68
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
++ +D+P+V +L G+ + ++ L+ M L + + + Q
Sbjct: 69 YVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLW 283
+ G+ + + ++HRD+ N+L+ +KI DFGLA K +V W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 284 YRPPELLLGATDYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
E +L + + D+WS G + EL+ G G E +
Sbjct: 186 M-ALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 19/247 (7%)
Query: 96 PPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL 154
P G A + W IPR +S K+GQG + V+ T + VA+K ++ +
Sbjct: 248 PTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM 304
Query: 155 EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEV 212
PE F+ +E ++++L H +++L +V+ +Y+V YM L L
Sbjct: 305 SPE--AFL-QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGK 358
Query: 213 KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNH 271
PQ+ Q+ SG+ + +HRD++ +N+L+ ++ V K+ADFGLA D +
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418
Query: 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQ 327
++ W P L G + + D+WS G +L EL G+ P M R ++Q
Sbjct: 419 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
Query: 328 LHKIYKL 334
+ + Y++
Sbjct: 477 VERGYRM 483
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
I + + IG+G + VY D KI A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
+I++ HPNV+ L G+ R S +V YM+H DL + T + + Q
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ G++ + +HRD+ N ++D+ +K+ADFGLA
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 18/231 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S K+GQG + V+ T + VA+K ++ + PE F+ +E +++
Sbjct: 181 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMK 234
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLS 228
+L H +++L +V+ +Y+V YM L L PQ+ Q+ S
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPP 287
G+ + +HRD++ +N+L+ ++ V K+ADFGLA D + ++ W P
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
L G + + D+WS G +L EL G+ P M R ++Q+ + Y++
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + I ++G+G + +V + TG +VA+K+++ P+ + REI
Sbjct: 20 FEER--HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREI 75
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
IL+ L ++K G+ SL LV Y+ L + ++ Y Q
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ G+E+ + +HRD+ N+L++ + +KIADFGLA + + +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 283 WYRPPELLLGATDYGV---GVDLWSAGCILAELL 313
WY PE L + D+WS G +L EL
Sbjct: 196 WY-APESLS----DNIFSRQSDVWSFGVVLYELF 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 53/234 (22%), Positives = 104/234 (44%), Gaps = 24/234 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREI 166
I + IG G + VYK + VA+K ++ E + V F+ E
Sbjct: 41 IHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEA 97
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
I+ + H N+I+LEG+++ + ++ YME+ L + +F+ Q+ +
Sbjct: 98 GIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ +G+++ N +HRD+ N+L++ + V K++DFGL+ + + + T+ +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 283 WYRPPELLLGATDYGV---GVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKI 331
W PE + Y D+WS G ++ E+ +P + E + I
Sbjct: 216 WT-APEAIS----YRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 12 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 68
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
+R+ DHP+++KL G++T ++++ +L + + Y +QL
Sbjct: 69 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ L + + +HRDI N+L+ + +K+ DFGL+
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 6/159 (3%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
IP IG+G + VY D +I A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
L++R L+HPNV+ L G++ +++ YM H DL SP+ T + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ G+E+ +HRD+ N ++D+ +K+ADFGLA
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILI 168
+ R I ++G G + +V + + K VA+K ++ + ++ + M RE I
Sbjct: 6 LKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQI 63
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLL 227
+ +LD+P +++L G+ + +L LV L + V +HQ+
Sbjct: 64 MHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
G+++ +HRD+ N+L+ + KI+DFGL+
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
I R + +G+G + VY+ + KI VA+K + D KFM E +
Sbjct: 9 IAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAV 65
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
I++ LDHP+++KL G++ +++ + +L + + Y Q+
Sbjct: 66 IMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ + + +HRDI N+L+ +K+ DFGL+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W I + +IG G + V+ K VA+K +R + E F+ E
Sbjct: 3 WVIDP--SELTFVQEIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMSEE--DFI-EEAE 55
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
++ +L HP +++L G+ + + LV +MEH L+ + F + +
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL---- 282
G+ + V+HRD+ N L+ ++ V+K++DFG+ F + TS T
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVK 170
Query: 283 WYRPPELLLGATDYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
W PE+ + D+WS G ++ E+ + GK R+ E + I
Sbjct: 171 WA-SPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W + R K+G G Y VY+ VA+K ++ D +E E +F+ +E +
Sbjct: 8 WEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAV 62
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQL 226
++ + HPN+++L G+ T Y++ +M + +L L + + + Q+
Sbjct: 63 MKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
S +E+ +HRD+ N L+ ++ ++K+ADFGL+
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 37/158 (23%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W I + ++G G + V K G+ VA+K ++ ++ + +F+ E
Sbjct: 19 WEIDP--KDLTFLKELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED--EFI-EEAK 71
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
++ L H +++L G+ T + ++++ YM + L +F Q+ +
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+E+ + LHRD+ N L++D GV+K++DFGL+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ ++ + F+ E
Sbjct: 15 GWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQ--AFL-AEAS 66
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQ 225
++ +L H N+++L G++ LY+V YM L L + + +
Sbjct: 67 VMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ +E+ N +HRD+ N+L+ +D V K++DFGL
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 42/186 (22%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 92 AAGWPPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALK 147
++G P + L I R + +G+G + +V + K + VA+K
Sbjct: 11 SSGLVPRGSEELQNKLEDVVIDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68
Query: 148 KVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT---SRMSCSLYLVFHYMEH-DL 203
++ DN ++ E ++ HPNVI+L G+ S+ ++ +M++ DL
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 204 -----AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKI 258
+ + +M + G+E+ N LHRD+ N ++ DD + +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188
Query: 259 ADFGLA 264
ADFGL+
Sbjct: 189 ADFGLS 194
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 22/232 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
K+ +G G + V+K + + KI V +K + + +
Sbjct: 10 FKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHM 66
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQ 225
L + LDH ++++L GL SL LV Y+ L + + Q
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLW 283
+ G+ + +G++HR++ N+L+ +++ADFG+A P+ K + S + W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 284 YRPPELLLGATDYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331
E + +G D+WS G + EL+ G G E +
Sbjct: 184 M-ALESIH----FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 33/240 (13%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W +PR ++ + ++++G G + V+ G VA+K ++ ++ P+ F+A E
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPD--AFLA-EAN 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQ 225
++++L H +++L +VT +Y++ YME+ L L +K T ++ Q
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL--- 282
+ G+ +HRD++ +N+L+ D KIADFGLA + N T+R
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPI 174
Query: 283 -WYRPPELLLGATDYGV---GVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL 334
W PE A +YG D+WS G +L E++ G+ P M ++ L + Y++
Sbjct: 175 KWT-APE----AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 34/158 (21%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
+ R + + ++G G + V K G+ VA+K ++ ++ + +F +E
Sbjct: 3 MELKR--EEITLLKELGSGQFGVVKLGK--WKGQYDVAVKMIKEGSMSED--EFF-QEAQ 55
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
+ +L HP ++K G+ + +Y+V Y+ + L S Q+ + +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
G+ ++ +HRD+ N L+D D +K++DFG+
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 58/252 (23%), Positives = 102/252 (40%), Gaps = 77/252 (30%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+F + +G+G + VYK + + G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYME--------HDLA------------------- 204
N+++L G C LV+ YM +
Sbjct: 88 NLLRLRGF------CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 205 -GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263
GLA Y+H +HC ++HRD+K +N+L+D++ + DFGL
Sbjct: 142 RGLA--------------YLH------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 264 ASFFDPNHKHPMTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELLAG- 315
A D H +T+ V T+ + PE TD +G GV +L EL+ G
Sbjct: 181 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV-------MLLELITGQ 232
Query: 316 KPIMPGRTEVEQ 327
+ R +
Sbjct: 233 RAFDLARLANDD 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVK 160
+AL + F+KI +G G + VYK + KI VA+K++R + +
Sbjct: 6 QALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQV 219
+ E ++ +D+P+V +L G+ + ++ L+ M L + +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 220 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS-- 277
+ Q+ G+ + + ++HRD+ N+L+ +KI DFGLA K
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 278 RVVTLWYRPPELLLGATDYGV---GVDLWSAGCILAELL 313
+V W E +L + + D+WS G + EL+
Sbjct: 180 KVPIKWM-ALESIL----HRIYTHQSDVWSYGVTVWELM 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 16/228 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 387 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEAL 443
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
+R+ DHP+++KL G++T ++++ +L + + Y +QL
Sbjct: 444 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYR 285
+ L + + +HRDI N+L+ + +K+ DFGL+ D + ++ W
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 286 PPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKI 331
P + + D+W G + E+ KP G + + +I
Sbjct: 561 PESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESV--KFMARE 165
I ++K+G G++ V + + VA+K ++ D L F+ RE
Sbjct: 15 IGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-RE 71
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMH 224
+ + LDH N+I+L G+V + + +V L + F + Y
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
Q+ G+ + + +HRD+ NLL+ ++KI DFGL
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 105 EALNGW-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVK 160
E L IP F +G+G + +V +A K + VA+K ++ D + ++
Sbjct: 13 EKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 161 FMAREILILRRLDHPNVIKLEGLVT----SRMSCSLYLVFHYMEH-DL-----AGLAASP 210
RE ++ DHP+V KL G+ ++ +M+H DL A
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 211 EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ +M + G+E+ + +HRD+ N ++ +D + +ADFGL+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 8e-22
Identities = 39/205 (19%), Positives = 82/205 (40%), Gaps = 8/205 (3%)
Query: 64 KKPRGERKRSKSNPRLSNLPKHLRGEQVA-AGWPPWLTAVCGEALNGWIPRRADSFEKID 122
+ P P R + + + + +R +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 123 KIGQGTYSNVYKAK-DMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + +V + M +I VA+K ++ + ++ + M RE I+ +LD+P +++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
G+ + +L LV L + V +HQ+ G+++ +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLA 264
HR++ N+L+ + KI+DFGL+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 35/169 (20%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+ R + ++GQG++ VY+ AK ++ + VA+K V E ++F+ E
Sbjct: 22 VAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 78
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG--LAASPEVKFTEPQVKCY 222
+++ + +V++L G+V+ ++ M DL + P +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 223 MHQLL-------SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ +++ G+ + + N +HRD+ N ++ +D +KI DFG+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I A F + ++G+ + VYK G+ VA+K ++ P +F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HE 62
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAAS 209
++ RL HPNV+ L G+VT L ++F Y H DL +
Sbjct: 63 AMLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 210 PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ P + Q+ +G+E+ ++ V+H+D+ N+L+ D +KI+D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ ++ + F+ E
Sbjct: 187 GWALNM--KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATAQ--AFL-AEAS 238
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQ 225
++ +L H N+++L G++ LY+V YM L L + + +
Sbjct: 239 VMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ +E+ N +HRD+ N+L+ +D V K++DFGL
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 53/286 (18%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + K+G G + V+ A K VA+K ++ ++ E F+ E +++
Sbjct: 185 IPR--ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEANVMK 238
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLS 228
L H ++KL +VT +Y++ +M L L + K P++ + Q+
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL----WY 284
G+ +HRD++ +N+L+ V KIADFGLA + N T+R W
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWT 352
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIYKL-----C 335
P + G+ + + D+WS G +L E++ G+ P M + L + Y++ C
Sbjct: 353 APEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 410
Query: 336 GSPSEEY------WKKSKLPNATLFKPREPYKR----CIQETFKDF 371
P E Y WK P +R IQ DF
Sbjct: 411 --PEELYNIMMRCWKN------------RPEERPTFEYIQSVLDDF 442
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK----FMAREILI 168
+K+G+G + VYK + VA+KK+ ++ + + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYM-----EHDLAGLAASPEVKFTEPQV 219
+ + H N+++L G S L LV+ YM L+ L +P
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP--------- 128
Query: 220 KCYMHQLLS-------------GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266
LS G+ H N +HRDIK +N+L+D+ KI+DFGLA
Sbjct: 129 ------PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 267 FDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTE 324
+ + MTSR+V T Y PE L G + D++S G +L E++ G + R
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 32/145 (22%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K + + VA+K ++ + +P + E ++++LD+P ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVL 239
G+ + S LV E L + + +HQ+ G+++ + +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 240 HRDIKGSNLLIDDDGVLKIADFGLA 264
HRD+ N+L+ KI+DFGL+
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
+ + + D IG+G + V KA K A+K+++ + + F E+ +
Sbjct: 22 LDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEV 78
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAASPE 211
L +L HPN+I L G R LYL Y H +L +A S
Sbjct: 79 LCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 212 VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ Q+ + + G+++ +HRD+ N+L+ ++ V KIADFGL+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 26/174 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I RR + ++G+G + V+ ++L + +VA+K ++ + E F RE
Sbjct: 38 IKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-RE 93
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL--------------AGLAASP 210
+L L H ++++ G+ T L +VF YM H DL AG
Sbjct: 94 AELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 211 EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
Q+ Q+ +G+ + +HRD+ N L+ V+KI DFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 27/178 (15%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMA 163
W PR D + +G+G + V +A T + VA+K ++ E M
Sbjct: 22 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 78
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGL 206
E+ IL + H NV+ L G T + L ++ + + +L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 207 AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ T + CY Q+ G+E + +HRD+ N+L+ + V+KI DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-20
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I RR ++ ++G+G + V+ ++ K +VA+K ++ D F RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-RE 67
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAAS 209
+L L H +++K G+ L +VF YM+H DL G
Sbjct: 68 AELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 210 PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ + Q+ Q+ SG+ + + +HRD+ N L+ + ++KI DFG++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 40/241 (16%), Positives = 82/241 (34%), Gaps = 34/241 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-------VALKKVRFDNLEPESVKFMA 163
I + + +GQGT++ ++K G V LK + + F
Sbjct: 5 IRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF- 60
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCY 222
++ +L H +++ G+ LV +++ L +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 223 MHQLLSGLEHCHNNGVLHRDIKGSNLLID--------DDGVLKIADFGLASFFDPN--HK 272
QL + + N ++H ++ N+L+ + +K++D G++ P +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHK 330
+ W PPE + + + D WS G L E+ KP + +L
Sbjct: 179 ERIP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQF 230
Query: 331 I 331
Sbjct: 231 Y 231
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 35/185 (18%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR + +G+G + V KA + VA+K ++ + E +
Sbjct: 18 WEFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL- 74
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------------------- 203
E +L++++HP+VIKL G + L L+ Y ++ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 204 ----AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259
+ L E T + + Q+ G+++ ++HRD+ N+L+ + +KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 260 DFGLA 264
DFGL+
Sbjct: 193 DFGLS 197
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 70/247 (28%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK----FMAREILILRR 171
++F+ IG G + VYK + G VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 172 LDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHD-----LAGLAASPEVKFTEPQVKCY 222
HP+++ L G C + L++ YME+ L G
Sbjct: 92 CRHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYGSDLPTMS---------- 135
Query: 223 MHQLLS-------------GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFD 268
+S GL + H ++HRD+K N+L+D++ V KI DFG++ +
Sbjct: 136 ----MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 269 PNHKHPMTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELLAGK-PIMP 320
+ H +++ V TL Y PE L +D Y GV +L E+L + I+
Sbjct: 192 LDQTH-LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV-------VLFEVLCARSAIVQ 243
Query: 321 GRTEVEQ 327
Sbjct: 244 SLPREMV 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
PR + + IG+G + V++ A +L + +VA+K ++ + F RE
Sbjct: 44 YPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 100
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL--------------------- 203
++ D+PN++KL G+ + + L+F YM + DL
Sbjct: 101 AALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 204 --AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261
A +++ + + C Q+ +G+ + +HRD+ N L+ ++ V+KIADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 262 GLA 264
GL+
Sbjct: 219 GLS 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 20/169 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+PR + I +G G + VY+ M VA+K + E + + F+ E
Sbjct: 27 VPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 83
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQ 218
LI+ + +H N+++ G+ + +++ M DL S
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA 264
+ + G ++ N +HRDI N L+ G V KI DFG+A
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 30/180 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK-----IVALKKVRFDNLEPESVKF 161
W PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 30 WEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 88 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 205 GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ PE + T + +QL G+E+ + +HRD+ N+L+ ++ V+KIADFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 30/180 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR + +G G + V +A ++ VA+K ++ E M
Sbjct: 18 WEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM- 74
Query: 164 REILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL-----------------A 204
E+ +L L +H N++ L G T ++ Y + DL
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 205 GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ E+ + + +Q+ G+ + +HRD+ N+L+ + KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 30/180 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK-----IVALKKVRFDNLEPESVKF 161
W PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 76 WEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 134 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 205 GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ PE + T + +QL G+E+ + +HRD+ N+L+ ++ V+KIADFGLA
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK-----IVALKKVRFDNLEPESVKF 161
W +PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 64 WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 122 I-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 205 GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ +PE + + + +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 20/169 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+PR+ + + +G G + VY+ M VA+K + E + + F+ E
Sbjct: 68 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 124
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQ 218
LI+ + +H N+++ G+ + +++ M DL S
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 219 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA 264
+ + G ++ N +HRDI N L+ G V KI DFG+A
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 66/272 (24%), Positives = 98/272 (36%), Gaps = 70/272 (25%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF--MAREILILRRLDH- 174
F KIG G + + K++ T + VA+K LEP + + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 175 ---PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
P V G +V + SL +F + F+ V Q
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR-----------TFSLKTVLMIAIQ 113
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFF-DP-NHKH-PMTS 277
L+S +E+ H+ +++RD+K N LI G V+ I DF LA + DP KH P
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP--- 170
Query: 278 RVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK-P--IMPGRT 323
YR + L G Y +G DL + G + L G P + T
Sbjct: 171 ------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224
Query: 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
E+ KI K P L +
Sbjct: 225 LKERYQKIGD----------TKRATPIEVLCE 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 48/224 (21%), Positives = 84/224 (37%), Gaps = 40/224 (17%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE- 181
KIG G + +Y A + A V+ +E + + E+ +R+ + IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 182 ----------------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
GL + ++V + DL ++ F + V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
+L LE+ H N +H DIK +NLL+ + + +AD+GL+ + PN H
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH------KQYQ 213
Query: 284 YRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK 316
P + G ++ GV + D+ G + L GK
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMA 163
W PR ++ + +G G + V +A GK VA+K ++ E M
Sbjct: 41 WEFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM- 97
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL-------------AGLAA 208
E+ I+ L H N++ L G T + ++ Y + DL A
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 209 SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264
+ + + Q+ G+ + +HRD+ N+L+ + V KI DFGLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 67/290 (23%), Positives = 105/290 (36%), Gaps = 63/290 (21%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF--MAREILILRRL 172
+ + KIG G++ ++Y D+ G+ VA+K E K + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMM 61
Query: 173 DH----PNVIKL--EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
P + EG +V + L L KF+ V Q+
Sbjct: 62 QGGVGIPTIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF-DP-NHKHPMTSRVVT 281
+S +E+ H+ +HRD+K N L+ ++ I DFGLA + D H+H
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP------ 168
Query: 282 LWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK---PIMPGRTEVEQ 327
YR + L G Y +G+ DL S G +L G + T+ ++
Sbjct: 169 --YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 328 LHKIYKLCGSPSEEYWKKSKLPNATLFK--PRE---PYKRCIQETFKDFP 372
+I + KK P L K P E C F D P
Sbjct: 227 YERISE----------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 44/185 (23%), Positives = 71/185 (38%), Gaps = 35/185 (18%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR ++ E +G G + V A + VA+K ++ E M
Sbjct: 40 WEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM- 96
Query: 164 REILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------------------ 203
E+ ++ +L H N++ L G T +YL+F Y + DL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 204 ----AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259
T + C+ +Q+ G+E +HRD+ N+L+ V+KI
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 260 DFGLA 264
DFGLA
Sbjct: 215 DFGLA 219
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 68/274 (24%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++ +IG+G++ +++ ++L + VA+K + P+ + E + L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 175 ----PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMH 224
PNV EG LV + SL + KF+ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----------KFSVKTVAMAAK 113
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFF-DP-NHKH-PMT 276
Q+L+ ++ H +++RDIK N LI ++ + DFG+ F+ DP +H P
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-- 171
Query: 277 SRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK---PIMPGR 322
YR + L G Y +G DL + G + L G +
Sbjct: 172 -------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 323 TEVEQLHKIYK---------LC-GSPSE--EYWK 344
T ++ +I + LC G P E +Y
Sbjct: 225 TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 76/296 (25%), Positives = 111/296 (37%), Gaps = 69/296 (23%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
PR + F KIG G++ +Y ++ T + VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 172 LDH----PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
L PNV EG LV + SL +F++ K + V
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-----------KLSLKTVLM 107
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF-DPN-HKH-PM 275
Q+++ +E H+ LHRDIK N L+ + I DFGLA + D + H+H P
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP- 166
Query: 276 TSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK---PIMPG 321
YR + L G Y +G+ DL S G +L L G +
Sbjct: 167 --------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
Query: 322 RTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK--PRE--PY-KRCIQETFKDFP 372
T+ ++ KI + KK L + P E Y C F D P
Sbjct: 219 GTKKQKYEKISE----------KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP 264
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 53/263 (20%), Positives = 91/263 (34%), Gaps = 42/263 (15%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE- 181
IGQG + +Y A DM + + V +EP + E+ +R P I+
Sbjct: 42 PIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 182 ----------------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQ 225
GL +++ DL + + +F+ V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 283
+L LE+ H + +H DIK SNLL++ + + + D+GLA + P H
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH------KAYA 214
Query: 284 YRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK-P--IMPGRTEVEQLH 329
P G ++ GV DL G + + L G P + +
Sbjct: 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274
Query: 330 KI-YKLCGSPSEEYWKKSK-LPN 350
KI Y+ + + + P
Sbjct: 275 KIRYRENIASLMDKCFPAANAPG 297
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 42/229 (18%), Positives = 74/229 (32%), Gaps = 47/229 (20%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--------VALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ +Y+A T +LK L+ + + + R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 175 PNVIKLEGLVTSRMSC--SLY-----------LVFHYMEHDLAGL-AASPEVKFTEPQVK 220
V K + L ++ + + LV + L SP+ +E V
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 221 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSR 278
+LL LE H N +H ++ N+ + +D + +A +G A + P+ KH
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH----- 217
Query: 279 VVTLWYRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK 316
V G ++ G G DL S G + + L G
Sbjct: 218 -VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 2e-10
Identities = 63/406 (15%), Positives = 123/406 (30%), Gaps = 90/406 (22%)
Query: 14 VSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKE--EKVVDGEKKPRGERK 71
V +K + F++ S + + + T V + + + + +
Sbjct: 253 VQNAKAWNAFNL--SCK----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 72 RSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYS 130
K + R +LP +V P ++ E++ D+++ ++
Sbjct: 307 LLKYLDCRPQDLP-----REVLTT-NPRRLSIIAESIRDG-LATWDNWKHVNC------- 352
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190
D LT I + + LEP + M + + P+ + + +
Sbjct: 353 ------DKLTTII----ESSLNVLEPAEYRKMFDRLSVFP----PSA-----HIPTILLS 393
Query: 191 SL--YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL-LSGLEHCHNNGVLHRDIKGS- 246
+ ++ + + L V+ + + + L N LHR I
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 247 NLL--IDDDGVLKIADFGLASFFDPNH--KHPMTSRVVTLWYRPPELLLGATDYGVGVDL 302
N+ D D ++ F+ +H H + L D+
Sbjct: 454 NIPKTFDSDDLIPPYLDQY--FY--SHIGHHLKNIEHPERMTLFRMVFL---DFR----- 501
Query: 303 WSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREP-YK 361
+ I + A ++QL K YK Y +P Y+
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQL-KFYK-------PY-----------ICDNDPKYE 542
Query: 362 RCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE--VIFQD 405
R + DF LP IE L L +AL +E IF++
Sbjct: 543 RLV-NAILDF----LPKIEENLICSKYTDLL-RIALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 49/388 (12%), Positives = 108/388 (27%), Gaps = 93/388 (23%)
Query: 46 EVQNDESRKKEEKVVDGEKKPRGERKRSKSN-PR---LSNLPKHLRGEQVAAG------- 94
Q S + ++ + +K N R L + L + A
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 95 ----WPPWLTA-VC-----GEALNG---WIP-RRADSFEKIDKIGQGTYSNVYKAKDMLT 140
W+ VC ++ W+ + +S E + ++ Q + +
Sbjct: 160 GSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 141 GKIVALKKVRFDNLEPESVKFMARE-----ILILRRLDHPNVIK-LEG----LVTSRMSC 190
+K +R +++ E + + + +L+L + + L+T+R
Sbjct: 218 DHSSNIK-LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 191 -----SLYLVFHY-MEHDLAG---------LAASPEVKFTE-PQVKCYMHQLLSGL---- 230
S H ++H L + + + P+ + +
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 231 ---EHCHNNGVLHRDIKGSNLLIDDD-GVLKIADF-----GLASFFDPNHKHPMTSRVVT 281
+ H + +I+ VL+ A++ L+ F P H T +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF--PPSAHIPTILLSL 394
Query: 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIY-KLCGSPSE 340
+W+ + V + L+ +P + + IY +L
Sbjct: 395 IWFDVIK---------SDVMVVVNKLHKYSLVEKQP----KESTISIPSIYLELKVKLEN 441
Query: 341 E----------YWKKSKLPNATLFKPRE 358
E Y + L P
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYL 469
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 7/138 (5%)
Query: 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 256
+ + T + CY Q+ G+E + +HRD+ N+L+ + V+
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 257 KIADFGLA--SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL-- 312
KI DFGLA + DP++ +R+ W PE + Y + D+WS G +L E+
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290
Query: 313 LAGKPIMPGRTEVEQLHK 330
L P PG E+ +
Sbjct: 291 LGASP-YPGVKIDEEFCR 307
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMA 163
W PR D + +G+G + V +A T + VA+K ++ + + +
Sbjct: 17 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH 201
E+ IL + H NV+ L G T + L ++ + +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 26/174 (14%), Positives = 55/174 (31%), Gaps = 41/174 (23%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK-------------------KVRFDNLEPESVKF 161
+G+G S V+ +K + F L S +
Sbjct: 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR- 152
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKC 221
E L++L V K+ + ++ ++ L V+ P
Sbjct: 153 --NEFRALQKLQGLAVPKVYAWEGN------AVLMELIDAK--EL---YRVRVENPD--E 197
Query: 222 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275
+ +L + ++ G++H D+ N+L+ ++G+ I DF +
Sbjct: 198 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQSV----EVGEEG 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 410 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.6 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.5 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=468.80 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=209.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||+||+|++..+|+.||||++++.... ......+.+|+++|+.++|||||++++++.+. ..+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEE
Confidence 37899999999999999999999999999999999876543 34456788999999999999999999999874 5699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+++++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 90 ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp EEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 99999988888876544 479999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
...+.+||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.++.+.+.... +
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~----------~----- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT----------L----- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------C-----
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------C-----
Confidence 2456789999999999988665578999999999999999999999999888888877653211 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
...+|+++++||.+||++||++|||++|+|+||||+.+
T Consensus 232 --------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 232 --------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 12678899999999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=482.86 Aligned_cols=259 Identities=24% Similarity=0.445 Sum_probs=221.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+++|++++.||+|+||+||+|++..+|+.||||++.+........+.+.+|+.+|++++|||||++++++.+. ..+|+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 5899999999999999999999999999999999998877777788899999999999999999999999884 56999
Q ss_pred EEeeccCC-HHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHD-LAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~-l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||||+++ |.+.+. .....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999875 555543 344578999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.+|.+....+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 123456899999999998875 49999999999999999999999999999999888887632111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
....+|+++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 245 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 --------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 113678899999999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-64 Score=476.16 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=224.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+++|+.++|||||+++++|.+. ..+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 3789999999999999999999999999999999986543 223456788999999999999999999999874 5699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-C
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-K 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 272 (410)
+|||||+++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.... .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999986555554455689999999999999999999999999999999999999999999999999999875433 2
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.+.... +|
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------~p--- 254 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----------FP--- 254 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------CC---
T ss_pred ccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------CC---
Confidence 3356779999999999998754 999999999999999999999999999999999888763211 11
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHH------HhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV------ALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------lL~hp~~~~ 404 (410)
..+|+++++||.+||++||++|||++| +++||||+.
T Consensus 255 ----------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 255 ----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ----------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 267889999999999999999999988 589999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-64 Score=477.67 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=224.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|+++++||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+. ..+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 57999999999999999999999999999999998654322 34577899999999999999999999884 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||||+++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999998655545433 479999999999999999999999999999999999999999999999999999875432 235
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
.+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|........
T Consensus 228 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------------- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------------- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------------
T ss_pred cccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------------
Confidence 678999999999988764 499999999999999999999999999999888887765321110
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..+..+|+++++||.+||++||++|||+.|+|+||||++...+
T Consensus 291 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 291 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 1123678999999999999999999999999999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-63 Score=483.57 Aligned_cols=291 Identities=33% Similarity=0.522 Sum_probs=242.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+++|+.++|||||++++++... ....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 689999999999999999999999999999999987665666667788999999999999999999988643 2357
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+|||||++++...+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 134 ~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 999999999887776654 4589999999999999999999999999999999999999999999999999998764321
Q ss_pred ---CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 ---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.....+.+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++..|.+..+.++...+.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 23345679999999999998877689999999999999999999999999999999999999999998766543221
Q ss_pred CCccc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 349 PNATL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 349 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..... ..........+....+.++++++|||.+||.+||.+|||+.|+|+||||++...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 11000 000000111234455678999999999999999999999999999999997543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=459.39 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=216.3
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee--cCCceEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS--RMSCSLYLV 195 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv 195 (410)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+++|++++|||||+++++|.. .....+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999999999999999998777777777889999999999999999999999865 234568999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcC-CCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+++.+..+......+++..++.++.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999998766656555668999999999999999999999998 999999999999984 79999999999986532
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....+....... ..+.
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~------------ 249 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA------------ 249 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG------------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCC------------
Confidence 23456789999999998865 49999999999999999999999998876655443332211 1110
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.....+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 250 -------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 250 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1123567889999999999999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=477.96 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=224.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|+++++||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+. ..+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 57999999999999999999999999999999998764332 34578899999999999999999999884 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
||||+++.+..+... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.... ...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999998665555433 369999999999999999999999999999999999999999999999999999875432 235
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
.+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|........
T Consensus 305 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------------- 367 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------------- 367 (423)
T ss_dssp CCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------------
T ss_pred cccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------------
Confidence 678999999999998765 499999999999999999999999999999888887765321110
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..+..+|+++++||.+||++||.+|||+.|+|+||||++...+
T Consensus 368 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 368 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp ----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 1123688999999999999999999999999999999986544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-63 Score=467.11 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=214.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++++.||+|+||+||+|++. .+++.||||++++..........+.+|+++|++++|||||++++++.+. ..+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 68999999999999999999874 4678999999986554333344577899999999999999999999884 569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+|||||+++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999986665555556689999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+.+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+.+|.+.....
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 245 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-------------- 245 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred ccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 234567899999999998875 49999999999999999999999999999999988887632111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
...+|+++.+||.+||++||++||| ++|+|+||||+.
T Consensus 246 ---------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 246 ---------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ---------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1267889999999999999999998 589999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=459.21 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=216.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+|+.++|||||++++++.+. ..+|+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~--~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG--PWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 6799999999999999999999999999999999865432 3599999999999999999999874 569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCCCC-
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKH- 273 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~- 273 (410)
||||+++.+..+....+.+++..++.++.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.+......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999866555555556899999999999999999999999999999999999999988 6999999999987543221
Q ss_pred ---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 274 ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 274 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.+|.... ++
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~----------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP----------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG-----------
T ss_pred ceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC-----------
Confidence 12346899999999999875 49999999999999999999999999988777777775521 10
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH-------------hcCCCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA-------------LNSEVIFQDRTL 408 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-------------L~hp~~~~~~~~ 408 (410)
..+..+.+|+.+.+||.+||++||.+|||+.|+ |+|||+.+-+.|
T Consensus 275 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 112234789999999999999999999999997 689999987665
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-59 Score=448.48 Aligned_cols=286 Identities=27% Similarity=0.395 Sum_probs=219.9
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
+...++|++.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+++|+.+ +|||||+++++|.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~- 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK- 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-
Confidence 334578999999999999999999875 457899999986543 234577899999998 69999999999987
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeeccccc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASF 266 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~ 266 (410)
..++|+||||++++.+..+.. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 92 -~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 92 -NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp -TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 456999999998754443442 58999999999999999999999999999999999999876 8999999999976
Q ss_pred cCCCC---------------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCC
Q 015247 267 FDPNH---------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 319 (410)
Q Consensus 267 ~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 319 (410)
..... ....++.+||++|+|||++.+...|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 112345689999999999988767999999999999999999999998
Q ss_pred -CCCChHHHHHHHHHHhCCCCHHHhhhCC---------CCCccc------------CCC----CCchhhhhhhhhCCCCC
Q 015247 320 -PGRTEVEQLHKIYKLCGSPSEEYWKKSK---------LPNATL------------FKP----REPYKRCIQETFKDFPP 373 (410)
Q Consensus 320 -~~~~~~~~~~~i~~~~~~~~~~~~~~~~---------~~~~~~------------~~~----~~~~~~~~~~~~~~~~~ 373 (410)
.+.++.+++..|.+.+|.+....+.... .+.... ..+ .........+.+..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 4567788999999988875543322110 000000 000 00000111233457889
Q ss_pred CcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 374 SSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 374 ~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+++|||.+||++||++|||++|+|+||||++-+
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=439.59 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=196.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC-------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------- 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 188 (410)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999999999999999998654 3444567889999999999999999999987543
Q ss_pred ---CceEEEEEeeccCCHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 189 ---SCSLYLVFHYMEHDLAGLAASPEV---KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 189 ---~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
..++|+|||||+++.+..+..... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 235899999998755544433332 34567789999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-----------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 015247 263 LASFFDPNHKH-----------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331 (410)
Q Consensus 263 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 331 (410)
+|+.+...... ..++.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+. .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 99887543221 12346899999999998875 49999999999999999996 77543 2333333
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
......... ..+...++.+.+||.+||++||.+|||+.|+|+||||++-
T Consensus 238 ~~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 322111110 0112345567899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-58 Score=430.84 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=210.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.++||+|+||+||+|+.. ..||||+++......+..+.+.+|+.+|++++|||||++++++... .+|+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEE
Confidence 378999999999999999999742 3599999987666777788899999999999999999999987642 3799
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-C
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-K 272 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 272 (410)
|||||+++ |.+.+......+++..+..++.||+.||+|||+++||||||||+||||++++++||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999975 445555666789999999999999999999999999999999999999999999999999998765322 2
Q ss_pred CCCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+......++.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---------- 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC----------
Confidence 334567899999999998643 34899999999999999999999999998877766655542211110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH------hcCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA------LNSEVIF 403 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------L~hp~~~ 403 (410)
+.....++|+.+.+||.+||+.||++|||+.|+ |+|++-+
T Consensus 259 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 259 -------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp -------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred -------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 112224678899999999999999999999876 5677654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=461.35 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=228.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+ ...+|+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997653 3445678899999999999999999999987 456999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC--CcEEEEeeccccccCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--GVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 271 (410)
|||||++ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999987 4556666666789999999999999999999999999999999999999854 899999999999886443
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..|......++.
T Consensus 312 --~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 377 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 377 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-----------
T ss_pred --ceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-----------
Confidence 24567899999999998875 4999999999999999999999999999999999888764333222
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..+..+|+++++||.+||++||.+|||+.|+|+||||+....+
T Consensus 378 --------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 378 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp --------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 2224789999999999999999999999999999999976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=462.35 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=215.4
Q ss_pred CCcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec
Q 015247 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (410)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 187 (410)
+...++|+++++||+|+||+||+|++..+|+.||||++.+... ..........++.++..++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4457899999999999999999999999999999999976432 122222333456677788999999999999884
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
..+|+|||||+|+.+..+....+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 265 --~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 --DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred --CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 569999999998766666555678999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHHHhh
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 344 (410)
.... ..+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+. .+....+....
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------- 410 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------- 410 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC---------
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC---------
Confidence 5433 45679999999999997655699999999999999999999999986433 23333333211
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
.. .+..+|+++++||.+||++||.+|++ ++|+++||||+.
T Consensus 411 -~~-------------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 411 -VE-------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp -CC-------------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred -CC-------------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 01 11368899999999999999999998 799999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=424.64 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=207.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++++|||||++++++.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--
Confidence 68999999999999999999864 35789999999753 3455678999999999999999999999998743
Q ss_pred eEEEEEeeccCCHHH-HhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 015247 191 SLYLVFHYMEHDLAG-LAAS------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 257 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vk 257 (410)
.+|+|||||+++.+. .+.. ....+++..+..++.||+.||.|||+++|+||||||+||||++++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 599999999975544 3322 235799999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Q 015247 258 IADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLC 335 (410)
Q Consensus 258 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~ 335 (410)
|+|||+|+........ .....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+.+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543322 223456899999999998754 9999999999999999998 899999999888888776532
Q ss_pred CCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
..+ ....+|+++.+||.+||+.||++|||+.+++
T Consensus 248 ~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 248 VLQ----------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCC----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 111 1136788999999999999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=426.02 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=203.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|.+.++||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 67999999999999999999854 46889999999643 355567899999999999999999999999874 4
Q ss_pred eEEEEEeeccCCHHHHh-cCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 015247 191 SLYLVFHYMEHDLAGLA-ASP--------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~-~~~--------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 255 (410)
.+|+|||||+++.+..+ ... ..++++.++..++.||+.||.|||+++|+||||||+||||++++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 59999999998655433 221 246999999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 015247 256 LKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 256 vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~ 333 (410)
+||+|||+|+........ .....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+.+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876543322 234567999999999988754 9999999999999999999 8999999998888877765
Q ss_pred HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+ ....+|+++.+||.+||+.||++|||+.|++++
T Consensus 276 g~~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELE----------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCC----------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCC----------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 32111 113678899999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=422.61 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=209.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
+++++.++||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++++|||||+++|++....
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-- 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-- 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence 57889999999999999999843 467899999986543 3344567899999999999999999999998743
Q ss_pred eEEEEEeeccCCHH-HHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 191 SLYLVFHYMEHDLA-GLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 191 ~~~lv~e~~~~~l~-~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
.+++|||||+++.+ +++... ...+++..+..++.||+.||.|||+++||||||||+||||++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 48999999997544 444322 24689999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCC-CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
++||+|||+|+...... .......+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+.+..+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998764333 22345678999999999988754 9999999999999999998 899999999888877765
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+....+ ....+|+.+.+||.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 421111 113678889999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=409.94 Aligned_cols=288 Identities=38% Similarity=0.640 Sum_probs=241.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||+||+|++..+|+.||+|++............+.+|+.++++++||||+++++++... ..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 689999999999999999999999999999999987766556667788999999999999999999999874 569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999998887777789999999999999999999999999999999999999999999999999998775332 223
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 4567899999999988766689999999999999999987766 677888889999999999888766544221111111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+..+.........+.+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 1111111222333456788899999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=409.51 Aligned_cols=288 Identities=39% Similarity=0.705 Sum_probs=235.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++++.||+|+||+||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++... ..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEE
Confidence 347899999999999999999997 4699999999976654444556788999999999999999999998874 4599
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9999999999998888777899999999999999999999999999999999999999999999999999987753322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc-c
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA-T 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~ 352 (410)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....|....-... .
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 234567899999999988766689999999999999999999999999999999999999998887655543221100 0
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
................+.+++++.+||.+||++||.+|||+.|+|+||||++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 00000000112334445788899999999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=404.95 Aligned_cols=285 Identities=37% Similarity=0.674 Sum_probs=231.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||.||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++... ...++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEE
Confidence 6899999999999999999997 7899999999976554333345677899999999999999999999874 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence 99999998888877777899999999999999999999999999999999999999999999999999987653322 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 354 (410)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....|.... .+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 455789999999998776668999999999999999999999999999999999999988887765443211 1110000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
. ..............+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 F-TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp C-CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred c-ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 0000011223345788899999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=417.64 Aligned_cols=289 Identities=35% Similarity=0.581 Sum_probs=229.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999765555666777889999999997 99999999999876666799
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC--
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-- 271 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 271 (410)
+||||+++++...+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999988776654 379999999999999999999999999999999999999999999999999998764211
Q ss_pred ------------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 015247 272 ------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 272 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~ 333 (410)
....+..+||++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11234568999999999998766699999999999999999999999999999999999999
Q ss_pred HhCCCCHHHhhhCCCCCcc-------------cCCCCCch---hhhhhh--hhCCCCCCcHHHHHhccCCCCCCCCCHHH
Q 015247 334 LCGSPSEEYWKKSKLPNAT-------------LFKPREPY---KRCIQE--TFKDFPPSSLPLIETLLAIDPAERLTATV 395 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~---~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 395 (410)
.++.|..+.+.....+... .......+ ...... ....+++++.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 9999988766543322110 00000000 011111 11267889999999999999999999999
Q ss_pred HhcCCCCCCC
Q 015247 396 ALNSEVIFQD 405 (410)
Q Consensus 396 lL~hp~~~~~ 405 (410)
+|+||||+.-
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-55 Score=417.92 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=207.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC-CceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||+||+|++... ++.||||.+.... .....+.+.+|+.+|.+++| ||||+++++|... .
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence 7899999999999999999986543 4689999997543 34456678899999999965 8999999998764 3
Q ss_pred ceEEEEEeeccCCHHH-HhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 190 CSLYLVFHYMEHDLAG-LAAS---------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
..+|+|||||+++.+. ++.. ....+++..+..++.||+.||.|||+++||||||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 4589999999975444 3322 13458999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 015247 254 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 331 (410)
Q Consensus 254 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i 331 (410)
+.+||+|||+|+.+...... .....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999877544332 234567899999999998754 9999999999999999998 99999987755554444
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+.....+. ....+++++.+||..||+.||++|||+.|+++|
T Consensus 301 i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 301 LKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33211110 112578889999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=407.83 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=225.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999998776666777788899999999999999999999887 446999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....... .
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--K 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--G
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--c
Confidence 99999875544444344579999999999999999999999999999999999999999999999999998775432 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--------------- 234 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--------------- 234 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 45678999999999998766456899999999999999999999999998888877765321111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 235 --------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 235 --------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp --------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred --------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 25678899999999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=424.29 Aligned_cols=291 Identities=34% Similarity=0.555 Sum_probs=225.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec---CCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR---MSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~ 192 (410)
++|++.+.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++|||||++++++... ....+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 789999999999999999999999999999999976655666677888999999999999999999998543 23569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||+++++...+... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.......
T Consensus 133 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 999999999888776543 5799999999999999999999999999999999999999999999999999987643221
Q ss_pred --------------------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-----------C
Q 015247 273 --------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------G 315 (410)
Q Consensus 273 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-----------g 315 (410)
...+..+||++|+|||++.....|+.++|||||||++|||++ |
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 123456789999999987665669999999999999999999 7
Q ss_pred CCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHhhhCCCCCccc--CCCCCchhhhhhhhhCCCCC
Q 015247 316 KPIMPGRT--------------------EVEQLHKIYKLCGSPSEEYWKKSKLPNATL--FKPREPYKRCIQETFKDFPP 373 (410)
Q Consensus 316 ~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 373 (410)
+++|++.+ ..+++..|.+.+|.++.+.+.......... ..........+.+.++.+++
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 88888765 367889999999999987665433211000 00000011123344567789
Q ss_pred CcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 374 SSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 374 ~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
++++||.+||.+||.+|||++|+|+||||++...
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 9999999999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=424.68 Aligned_cols=285 Identities=30% Similarity=0.515 Sum_probs=229.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 37899999999999999999999999999999999876555666778889999999999999999999986542 24
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+|+||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999998887754 4899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......+||++|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.+..+.+.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 234567899999999999875 49999999999999999999999999999999999999999999887764432000
Q ss_pred ccc-----CCCCCchhhhhhhhh--------CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 ATL-----FKPREPYKRCIQETF--------KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~-----~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
... ......+....+... +..++++++||.+||.+||.+|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000 000001111111000 0114568999999999999999999999999999854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=405.82 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=225.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 368999999999999999999999999999999998765422 134678899999999999999999999987 45
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeeccccc
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASF 266 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~ 266 (410)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 6999999998765555555566899999999999999999999999999999999999998877 799999999988
Q ss_pred cCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (361)
T 2yab_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF---- 241 (361)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCCCC--ccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh----
Confidence 75432 24566899999999998764 489999999999999999999999999999888888876543333322
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+..+++.+++||.+||.+||.+|||+.|+|+||||+.
T Consensus 242 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ---------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ---------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 3478889999999999999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=403.90 Aligned_cols=288 Identities=37% Similarity=0.687 Sum_probs=223.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEEEE
Confidence 689999999999999999999999999999999976542 22335577899999999999999999998874 469999
Q ss_pred EeeccCCHHHHhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 196 FHYMEHDLAGLAAS-----PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 196 ~e~~~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
|||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99999987776532 2246999999999999999999999999999999999999999999999999999877533
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~ 349 (410)
. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...|.... .+
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 V-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp C-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred c-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 223456789999999998875568999999999999999999999999999999999999999988876665432 11
Q ss_pred Ccc---cCCCCCchhhh-hhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 350 NAT---LFKPREPYKRC-IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 350 ~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
... ...+....... .......+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 110 01111111221 22223467889999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=405.62 Aligned_cols=293 Identities=45% Similarity=0.711 Sum_probs=240.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC------
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 188 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999999999999999998766544444456778999999999999999999987643
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 34689999999999999888877789999999999999999999999999999999999999999999999999998765
Q ss_pred CCC---CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 269 PNH---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 269 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
... ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 322 22234567899999999988766689999999999999999999999999999999999999998887665543
Q ss_pred CCCCCc-ccC----CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 346 SKLPNA-TLF----KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 346 ~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
...... ... .........+.. ...++.+.+||.+||+.||.+|||+.|+|+||||+.++.++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKA--YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHH--HHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhh--ccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 211100 000 000111111111 12467799999999999999999999999999999988775
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=395.65 Aligned_cols=287 Identities=37% Similarity=0.641 Sum_probs=230.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhC---CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRL---DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 47899999999999999999999999999999999754321 11123455677776666 5999999999987643
Q ss_pred C---ceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 189 S---CSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 189 ~---~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
. ..++++|||+++++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999998888776543 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++...|.
T Consensus 168 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTCC--CSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCCc--ccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 8765332 245678899999999988754 8999999999999999999999999999999999999999988876664
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.........+.+ ..........+.+++.+.+||.+||++||.+|||+.|+|+||||+++.
T Consensus 245 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 245 RDVSLPRGAFPP--RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SSCSSCGGGSCC--CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred chhhccccccCC--CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 332111111111 111233445567899999999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=415.25 Aligned_cols=291 Identities=33% Similarity=0.546 Sum_probs=235.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC---ce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS---CS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 191 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 378999999999999999999999999999999997665555667788899999999999999999999876432 46
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||+++++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999999999988776654 4579999999999999999999999999999999999999999999999999998775432
Q ss_pred C---------------------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-----------CCCCC
Q 015247 272 K---------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------GKPIM 319 (410)
Q Consensus 272 ~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-----------g~~pf 319 (410)
. ...+..+||++|+|||++.....|+.++|||||||++|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 123567899999999987666669999999999999999998 56666
Q ss_pred CCCC-----------------hHHHHHHHHHHhCCCCHHHhhhCCCCCccc--CCCCCchhhhhhhhhCCCCCCcHHHHH
Q 015247 320 PGRT-----------------EVEQLHKIYKLCGSPSEEYWKKSKLPNATL--FKPREPYKRCIQETFKDFPPSSLPLIE 380 (410)
Q Consensus 320 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~ 380 (410)
++.+ ..+++..|.+.+|.|+.+.+.....+.... ..............++.+++++.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 6654 467899999999999987765433221100 000000111233444678999999999
Q ss_pred hccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 381 TLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 381 ~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+||+.||.+|||++|+|+||||++..
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=401.08 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=220.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||+||+|++..+|+.||+|++++... .......+.+|+.+|+.++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 4789999999999999999999999999999999976432 223355678899999999999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...... .
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 999999986655555555689999999999999999999999999999999999999999999999999998643322 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+..... .+|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------~~p---- 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------RFP---- 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------CCC----
T ss_pred cccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------CCC----
Confidence 34567899999999998765 489999999999999999999999999988888777765211 111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+++++.+||.+||++||.+|| ++.++++||||..
T Consensus 226 ---------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 226 ---------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ---------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 26788899999999999999999 9999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=391.73 Aligned_cols=289 Identities=34% Similarity=0.563 Sum_probs=233.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEE
Confidence 689999999999999999999999999999999977665666667788999999999999999999999874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++++..+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-cc
Confidence 99999988887766667899999999999999999999999999999999999999999999999999987653322 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc--cc
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA--TL 353 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~ 353 (410)
....||+.|+|||++.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+............... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 4567899999999998766689999999999999999999999999999999999988888766543221111000 00
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..+............+.+++.+.+||.+||+.||.+|||++|+|+||||++-+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 000111111223334578889999999999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=405.02 Aligned_cols=288 Identities=36% Similarity=0.656 Sum_probs=230.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++... ...++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEE
Confidence 6899999999999999999999999999999999754321 1112344699999999999999999999874 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||+++++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999999988887777789999999999999999999999999999999999999999999999999998664332 223
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc-ccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA-TLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~ 354 (410)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....|........ ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4557899999999988766689999999999999999999999999999999999999999888766543211100 000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
................+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 00001111223344578889999999999999999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=400.58 Aligned_cols=289 Identities=36% Similarity=0.658 Sum_probs=226.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|++..+++.||||+++...........+.+|+.+++.++||||+++++++... ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--TEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CEEE
Confidence 34789999999999999999999999999999999976655555556677899999999999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-----CCCcEEEEeeccccccC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-----DDGVLKIADFGLASFFD 268 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-----~~~~vkl~DFGla~~~~ 268 (410)
+||||+++++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 lv~e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999999887766543 4699999999999999999999999999999999999994 45569999999998775
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK- 347 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 347 (410)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....|....
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 3322 23456789999999999876668999999999999999999999999999999999999998888765543321
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+......+..............+++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 11111011110111111222234788999999999999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=407.18 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=216.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+.+|+.++..+ +||||+++++++... ..+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CEE
Confidence 4789999999999999999999999999999999986432 233456677899999988 799999999999874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999986665555555689999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..|....... |
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------p--- 244 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----------P--- 244 (353)
T ss_dssp -------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------C---
T ss_pred ccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------C---
Confidence 234567899999999998764 48999999999999999999999999999999888887632111 1
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH------HHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA------TVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~elL~hp~~~~ 404 (410)
..+++++.+||.+||++||.+||++ .++++||||++
T Consensus 245 ----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 245 ----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 2578889999999999999999998 89999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=399.78 Aligned_cols=290 Identities=41% Similarity=0.703 Sum_probs=235.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh---HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP---ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
..++|++.+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--S 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--T
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--C
Confidence 4478999999999999999999998999999999987543221 1123577899999999999999999998874 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..++||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 58999999999988888777778999999999999999999999999999999999999999999999999999877533
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC-CC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK-LP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~ 349 (410)
. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|.... .+
T Consensus 166 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 N-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp C-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 223456789999999998776668999999999999999999999999999999999999999988876664432 22
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
+........ ...+......+++++.+||.+||+.||.+|||+.|+|+||||++.+.+
T Consensus 245 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 245 DYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred ccccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 211111110 111334446788999999999999999999999999999999987655
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=404.65 Aligned_cols=285 Identities=34% Similarity=0.550 Sum_probs=231.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 191 (410)
++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 68999999999999999999999999999999997655555566778899999999999999999999876422 35
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 799999997777776654 47999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....++|++|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..|.+..+.++.+.+........
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 34567899999999998756699999999999999999999999999999999999999999999877654321100
Q ss_pred ccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... ................+++.+.+||.+||..||.+|||+.++|+||||++-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 0000000112233457788999999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=404.06 Aligned_cols=282 Identities=30% Similarity=0.495 Sum_probs=231.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec-------
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------- 187 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 187 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+|+.+|+.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 37899999999999999999999999999999999754321 23599999999999999999988542
Q ss_pred -----------------------------CCceEEEEEeeccCCHHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015247 188 -----------------------------MSCSLYLVFHYMEHDLAGLA---ASPEVKFTEPQVKCYMHQLLSGLEHCHN 235 (410)
Q Consensus 188 -----------------------------~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~ 235 (410)
...++++||||+++++...+ ...+..+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23458999999998765544 3456689999999999999999999999
Q ss_pred CCceeccCCCCCEEEc-CCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc
Q 015247 236 NGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 314 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 314 (410)
+||+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+...++.++|||||||++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 689999999999987754332 3556789999999998876669999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH
Q 015247 315 GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394 (410)
Q Consensus 315 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 394 (410)
|++||.+.+..+++..+.+.++.+..+.+....-.......+..............+++++.+||.+||++||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999999999999999997766543221111111111111222223346788899999999999999999999
Q ss_pred HHhcCCCCCC
Q 015247 395 VALNSEVIFQ 404 (410)
Q Consensus 395 elL~hp~~~~ 404 (410)
|+|+||||++
T Consensus 318 e~l~hp~f~~ 327 (383)
T 3eb0_A 318 EAMAHPFFDH 327 (383)
T ss_dssp HHHTSGGGHH
T ss_pred HHhcCHHHHH
Confidence 9999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=409.95 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=223.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 368999999999999999999999999999999998876666667778899999999999999999999987 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~ 271 (410)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999998855544443445799999999999999999999999999999999999998 46789999999998775432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 235 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP---------- 235 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred -ceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc----------
Confidence 223457899999999998764 49999999999999999999999999999988888887643332221
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+..+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 236 ---------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 ---------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 12467889999999999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=400.49 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=224.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 67999999999999999999999999999999998877666677788999999999999999999999887 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~~~~~ 272 (410)
|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999865544444556899999999999999999999999999999999999998654 59999999998775332
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+..
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----------- 252 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----------- 252 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----------
T ss_pred -ccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence 23456899999999998764 48999999999999999999999999998888888776643322221
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+..+++++.+||.+||++||.+|||+.++|+||||..
T Consensus 253 --------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 --------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 12367889999999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=394.03 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=224.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEE
Confidence 37899999999999999999999999999999998643 23455688899999999999999999999874 46999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 271 (410)
||||+++ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999987 555555555568999999999999999999999999999999999999997 7899999999998875433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 225 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------- 225 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----------
T ss_pred --ccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh----------
Confidence 234567899999999987754 8999999999999999999999999999988888887754443332
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.++.+|+++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 226 ---------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 226 ---------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ---------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ---------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 2347889999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=390.79 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=224.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 67999999999999999999999999999999998754321 135678899999999999999999999887 446
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~ 267 (410)
.++||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999998765555555566899999999999999999999999999999999999999887 8999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 169 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 239 (326)
T 2y0a_A 169 DFGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE------ 239 (326)
T ss_dssp CTTSC--CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred CCCCc--cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc------
Confidence 54332 3456799999999988764 48999999999999999999999999999888888776643333322
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 -------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 240 -------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp -------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred -------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 2246788899999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=402.45 Aligned_cols=286 Identities=35% Similarity=0.561 Sum_probs=221.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 191 (410)
++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6899999999999999999999999999999999765555556677889999999999999999999986531 245
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+++|++++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 899999998776665543 47999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....+||++|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..|.+.++.+..+.+........
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 34568899999999988756699999999999999999999999999999999999999999998876654322110
Q ss_pred ccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
... .....-...........++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 000 00000011223344577889999999999999999999999999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=406.18 Aligned_cols=282 Identities=37% Similarity=0.559 Sum_probs=229.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
.+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++|+.++|||||++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 579999999999999999999999999999999975431 123699999999999999999988542 2345
Q ss_pred EEEEEeeccCCHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~ 267 (410)
+++||||+++++..... .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999997766443 345689999999999999999999999999999999999999965 57899999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... ....+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.++.+.++.+..+.+....
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 54332 3456789999999998876569999999999999999999999999999999999999999999887665432
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
-.......+..............+++++++||.+||.+||.+|||+.|+|+||||++-
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1111111111111111112224678899999999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=393.12 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=219.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++++... .....+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEE
Confidence 3789999999999999999999999999999999976432 11235567789999999999999999999887 44699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999998655555545568999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.++...... +|
T Consensus 160 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~p---- 223 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR----------FP---- 223 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------CC----
T ss_pred -cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------CC----
Confidence 3456899999999998764 4899999999999999999999999999988888887663111 11
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+++++.+||.+||+.||.+|| +++++++||||+.
T Consensus 224 ---------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 224 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ---------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 25788899999999999999999 9999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=402.75 Aligned_cols=257 Identities=22% Similarity=0.399 Sum_probs=212.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|+++++||+|+||+||+|++..+++.||+|++++.... ....+.+.+|+.++.++ +|||||++++++.. ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 47899999999999999999999999999999999875442 33345677899999887 89999999999887 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999998666555555568999999999999999999999999999999999999999999999999999864322 2
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHHHhCCCCHHHh
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~ 343 (410)
......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+... ......+....
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--------
T ss_pred CccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--------
Confidence 235667899999999998875 499999999999999999999999965321 22333333211
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH------HHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA------TVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~elL~hp~~~~ 404 (410)
..+ ...+++++.+||.+||++||.+||++ .|+++||||+.
T Consensus 279 --~~~-------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 279 --IRI-------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp --CCC-------------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred --cCC-------------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 011 13678889999999999999999985 79999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=399.02 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=219.3
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
..++|++.+.||+|+||.||+|++..+|+.||||++++... .....+.+.+|..++..+ +||||+++++++.+. ..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence 34789999999999999999999999999999999976432 122345677899999876 999999999999874 46
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999876555554444579999999999999999999999999999999999999999999999999998653322
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...... +|
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------~p-- 238 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----------YP-- 238 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------CC--
T ss_pred -CcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC----------CC--
Confidence 234567899999999998875 4899999999999999999999999999988888877652111 11
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH-HHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT-VALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-elL~hp~~~~~ 405 (410)
..+++++.+||.+||+.||.+||++. ++++||||+.-
T Consensus 239 -----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 239 -----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 25788899999999999999999998 99999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=385.23 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=219.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEE
Confidence 478999999999999999999999999999999997654322 45678899999999999999999999874 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999775554443322 689999999999999999999999999999999999999999999999999987754433 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------- 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred cCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 44568999999999988754 89999999999999999999999999888777766654321111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 237 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 237 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 00125778899999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=391.68 Aligned_cols=254 Identities=25% Similarity=0.283 Sum_probs=187.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC--ceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~ 193 (410)
.+|.+.++||+|+||+||+|+. +|+.||||+++... ........|+..+.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4688999999999999999975 78999999986432 212223346666678899999999999986533 3689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
+|||||+++.+..+... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999997655544433 3689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCCC---CCccccccccccccccccCCc-----CCCCccchHHHHHHHHHHHcCCCCCCCCCh-------------
Q 015247 266 FFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMPGRTE------------- 324 (410)
Q Consensus 266 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~------------- 324 (410)
........ .....+||+.|||||++.+.. .|+.++|||||||++|||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 77543321 223468999999999987532 367899999999999999999887653321
Q ss_pred -HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 325 -VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETF--KDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 325 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+.+.+.....+. .+. ++... ...++.+.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~-----------------rp~------~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL-----------------RPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSCC-----------------CCC------CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhcccC-----------------CCC------CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111111110000 000 00000 012345789999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=393.20 Aligned_cols=258 Identities=23% Similarity=0.408 Sum_probs=214.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
..++|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.++..+ +||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 34789999999999999999999999999999999987654 445566788899999988 89999999999887 456
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999886555454444579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHHHHHhCCCCHHH
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR---------TEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~ 342 (410)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||... ........+....
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred -CcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 234567899999999998875 4899999999999999999999999753 2222333333210
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH------HHHhcCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA------TVALNSEVIFQ 404 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~elL~hp~~~~ 404 (410)
..+ ...+++++.+||.+||++||.+||++ .++++||||+.
T Consensus 236 ---~~~-------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 236 ---IRI-------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp ---CCC-------------------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred ---CCC-------------------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 011 12578889999999999999999995 89999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=387.52 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=214.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh------------------------HHHHHHHHHHHHHH
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------------------------ESVKFMAREILILR 170 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 170 (410)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 378999999999999999999999999999999997654211 12356788999999
Q ss_pred hCCCCceeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 015247 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250 (410)
Q Consensus 171 ~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl 250 (410)
.++||||+++++++.......+|+||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998766678999999999866554433 3479999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcC--CCCccchHHHHHHHHHHHcCCCCCCCCChHHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||++........ ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+.....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 9999999999999987754322 2345678999999999876432 477899999999999999999999988776666
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..+....... + ....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 250 ~~~~~~~~~~----------~-----------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 250 SKIKSQALEF----------P-----------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHCCCCC----------C-----------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHhcccCCC----------C-----------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 5554421110 0 01367888999999999999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=392.68 Aligned_cols=288 Identities=29% Similarity=0.560 Sum_probs=235.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEE
Confidence 3478999999999999999999999999999999998776666666778899999999999999999999987 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++++..+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 9999999998887766666899999999999999999999999999999999999999999999999999987653322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhh---hCC-CC
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK---KSK-LP 349 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---~~~-~~ 349 (410)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+........ ... ..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 23456789999999998876568999999999999999999999999999999999999888877654321 110 00
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... .+............+.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 260 ~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 260 GVR--LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp TCC--CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccc--CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 000 0111111223344457899999999999999999999999999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=400.17 Aligned_cols=283 Identities=35% Similarity=0.542 Sum_probs=229.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
.+|++.+.||+|+||+||+|++..+++ ||+|++...... ..+|+++|+.++||||+++++++... ...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 679999999999999999999866655 888888644321 22599999999999999999998653 2345
Q ss_pred EEEEEeeccCCHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~ 267 (410)
+++||||++++++.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999998766443 3456899999999999999999999999999999999999999 7999999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.++.+..+.+....
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 54332 3456789999999998876669999999999999999999999999999999999999999999977655432
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
-.......+..............+++++.+||.+||++||.+|||+.|+|+||||++-+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 111111111111111122223458889999999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=394.30 Aligned_cols=289 Identities=34% Similarity=0.556 Sum_probs=237.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---Cce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~ 191 (410)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++..++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 368999999999999999999999999999999997533 3445567889999999999999999999986532 246
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999999988876654 369999999999999999999999999999999999999999999999999998765332
Q ss_pred CC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 KH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.+......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 21 2345689999999998876666899999999999999999999999999999999999999999987765432110
Q ss_pred Ccc--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 350 NAT--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 350 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... ..................+++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 000 000000001112334457888999999999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=395.10 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=219.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 34789999999999999999999999999999999976432 12335668889999999999999999999887 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999987555444444457999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...... +|
T Consensus 195 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------~p--- 258 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----------FP--- 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------CC---
T ss_pred --cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC----------CC---
Confidence 3456899999999998875 4899999999999999999999999999988888888663111 11
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
..+++++.+||.+||+.||.+||+ ++++++||||+.
T Consensus 259 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 267888999999999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=395.86 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=219.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+.+|..++..+ +||||+++++++... ..+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CEE
Confidence 4789999999999999999999999999999999976432 223355677899999988 899999999998874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999886555454444579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..|...... +|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------~p--- 241 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------YP--- 241 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------CC---
T ss_pred cccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----------CC---
Confidence 234567899999999998764 4899999999999999999999999999988888888763111 11
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+++++.+||.+||++||.+|| ++.++++||||+.
T Consensus 242 ----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 242 ----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 26788999999999999999999 4799999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=408.62 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=221.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.++||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++..++||||++++++|.+ ...+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 4789999999999999999999999999999999975321 11122347789999999999999999999987 45699
Q ss_pred EEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+||||+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999976 45555555567899999999999999999999999999999999999999999999999999987765544
Q ss_pred CCCcccccccccccccccc----CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 273 HPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
......+||+.|+|||++. +...|+.++|||||||++|||++|+.||.+.+..+.+.+|..... ...+
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------~~~~ 302 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------RFQF 302 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------HCCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--------cccC
Confidence 4445578999999999986 234589999999999999999999999999999998888865321 0111
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~ 404 (410)
| .....+++++++||.+||+.+|.+ |++++|+++||||+.
T Consensus 303 p----------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 303 P----------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp C----------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred C----------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 1 111357889999999999998888 999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=400.69 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=214.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++... ...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEE
Confidence 347899999999999999999999999999999999754221 12234678899999999999999999999874 459
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++||||+++++.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999999988888766543 479999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+..
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~------------------- 222 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------------------- 222 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS-------------------
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------------
Confidence 235668999999999998766457899999999999999999999976543222111100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
........+++.+.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus 223 ----------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 223 ----------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0001113578889999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=400.25 Aligned_cols=290 Identities=37% Similarity=0.627 Sum_probs=218.0
Q ss_pred CCccee-eeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKI-DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~-~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
+.|++. ++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.++||||+++++++.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 557774 57999999999999965 57889999998754433 246789999999999999999999977667789
Q ss_pred EEEEeeccCCHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEe
Q 015247 193 YLVFHYMEHDLAGLAAS--------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIAD 260 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~D 260 (410)
|+||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999988776531 22359999999999999999999999999999999999999 6788999999
Q ss_pred eccccccCCCCC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------HHHHH
Q 015247 261 FGLASFFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLH 329 (410)
Q Consensus 261 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---------~~~~~ 329 (410)
||+++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987753321 2234568899999999998766699999999999999999999999987655 47899
Q ss_pred HHHHHhCCCCHHHhhhCC-CCCccc--------CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 330 KIYKLCGSPSEEYWKKSK-LPNATL--------FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
.+...++.+....|.... .+.... ..........+.......++.+.+||.+||++||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999998876665432 111000 00001111122222234578899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 015247 401 VIFQDRTLC 409 (410)
Q Consensus 401 ~~~~~~~~~ 409 (410)
||++.+.++
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=393.78 Aligned_cols=285 Identities=35% Similarity=0.577 Sum_probs=233.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc----e
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC----S 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~ 191 (410)
++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++...... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 689999999999999999999999999999999987665666677888999999999999999999998764332 3
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+++||||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 122 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 49999999988777653 35999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+........
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 34567899999999988756699999999999999999999999999999999999999999988776544321100
Q ss_pred cc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. .................+++.+.+||.+||+.||.+|||+.|+|+||||+.-..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 00 000000011223344577899999999999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=395.53 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=215.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEE
Confidence 4789999999999999999999999999999999975432 223356788899999999999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 999999887666666666789999999999999999999999999999999999999999999999999998775432
Q ss_pred CCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.....+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+... .+....+......
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------- 238 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT----------- 238 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-----------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC-----------
Confidence 34667899999999998642 3489999999999999999999999975433 3333333221110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-HHHHhcCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-ATVALNSEVIFQ 404 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~elL~hp~~~~ 404 (410)
....+++.+.+||.+||++||.+||+ +.++++||||+.
T Consensus 239 ------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 239 ------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 11257888999999999999999998 999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=387.81 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=214.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 37899999999999999999999999999999999765432 223567789999999999999999999887 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-KH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 273 (410)
||||++++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999986666666666689999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.................
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------
Confidence 23456899999999999876645789999999999999999999998766543322222111000
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
...+..+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 01123578889999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=406.32 Aligned_cols=264 Identities=26% Similarity=0.337 Sum_probs=219.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.++..++|||||++++++.+ ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 34789999999999999999999999999999999975321 11112346789999999999999999999987 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999977544434332 3699999999999999999999999999999999999999999999999999988765443
Q ss_pred CCCccccccccccccccccCCc---CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
......+||+.|+|||++.+.. .|+.++|||||||++|||++|+.||.+.+..+.+.+|.+.... ..+|
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------~~~p 295 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--------LTFP 295 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------CCCC
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--------ccCC
Confidence 3345678999999999987543 2788999999999999999999999999999888888753210 0111
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCC--CCCHHHHhcCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAE--RLTATVALNSEVIFQD 405 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~elL~hp~~~~~ 405 (410)
....+++++++||.+||..+|.+ ||+++|+++||||+..
T Consensus 296 -----------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 296 -----------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp -----------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred -----------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 01267889999999999999988 9999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=397.79 Aligned_cols=281 Identities=32% Similarity=0.500 Sum_probs=228.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC------CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL------DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 188 (410)
..+|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 36899999999999999999999999999999999643 33445667788888776 578999999999874
Q ss_pred CceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEeecccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLAS 265 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~ 265 (410)
..+++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 172 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 -NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp -TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred -CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 5699999999998888765433 46999999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
..... ....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+++..+.+.++.++...+..
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCCc----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 65432 34568899999999998754 89999999999999999999999999999999999999999999876654
Q ss_pred CCCCCcccC------------------------------CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHH
Q 015247 346 SKLPNATLF------------------------------KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395 (410)
Q Consensus 346 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 395 (410)
......... .................++.+.+||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 321100000 00000111111222345677899999999999999999999
Q ss_pred HhcCCCCCCC
Q 015247 396 ALNSEVIFQD 405 (410)
Q Consensus 396 lL~hp~~~~~ 405 (410)
+|+||||++.
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=394.27 Aligned_cols=285 Identities=29% Similarity=0.500 Sum_probs=222.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 190 (410)
.++|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37899999999999999999999999999999999876556666777889999999999999999999987643 23
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
..|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 6899999999988887653 5899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
. .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+......-
T Consensus 181 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 F--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c--ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 23456889999999998875 48999999999999999999999999999999999999998888776654321000
Q ss_pred -----cccCCCCCchhhhhhhh--------hCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 -----ATLFKPREPYKRCIQET--------FKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 -----~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.........+....+.. ....++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00000000011111000 01124568999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=387.12 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=209.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.++||+|+||+||+|++..+|+.||||++...............|+..+..+ +||||+++++++.. ...+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 679999999999999999999999999999999876555544455555666666555 99999999999987 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+++++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 99999999888877666789999999999999999999999999999999999999999999999999998775433 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+...... +.. +..
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~---------------- 269 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYL---------------- 269 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCC----------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCC----------------
Confidence 345678999999998876 489999999999999999999877765433222 111 000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..+....+++++.+||.+||++||.+|||+.|+|+||||++
T Consensus 270 ---------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ---------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 11223478899999999999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=376.17 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=224.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 378999999999999999999999999999999998776666677788899999999999999999999876 455899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~~~~~ 271 (410)
+|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999988544433333457999999999999999999999999999999999999987665 9999999998765332
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.......+.
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 228 (284)
T 3kk8_A 163 --AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------- 228 (284)
T ss_dssp --BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred --cccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-----------
Confidence 234567899999999987754 899999999999999999999999999888888777654332221
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
..+..+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 229 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 229 --------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred --------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 112367888999999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=403.40 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=219.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+.+|+.++..++||||+++++++.+ ...+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 34789999999999999999999999999999999975322 12233457789999999999999999999887 4569
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|+||||+.++ +...+...+..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999764 555544444589999999999999999999999999999999999999999999999999998876544
Q ss_pred CCCCccccccccccccccccC------CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 272 KHPMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
.......+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+.+..+.+.+|......
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------- 288 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-------- 288 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence 333445689999999999872 234899999999999999999999999999998888888652100
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCC---CCHHHHhcCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER---LTATVALNSEVIFQ 404 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~elL~hp~~~~ 404 (410)
..+| .....+|+++++||.+||+ ||.+| |+++++++||||+.
T Consensus 289 ~~~p----------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 289 LSLP----------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCC--------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCC----------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 0011 1113688999999999999 99998 59999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=389.39 Aligned_cols=279 Identities=25% Similarity=0.375 Sum_probs=227.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----CCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----HPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~ 189 (410)
.++|++.++||+|+||.||+|++..+++.||||++... .........|+.+++.+. ||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 37899999999999999999999999999999998642 344556777999999986 99999999999874
Q ss_pred ceEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC----------------
Q 015247 190 CSLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---------------- 252 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---------------- 252 (410)
...++||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 469999999987887766543 346999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 015247 253 ---------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 323 (410)
Q Consensus 253 ---------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 323 (410)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999875432 24567899999999988754 9999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCHHHhhhCCCCCcccC---------CCCCc--------hhhhhhhhhCCCCCCcHHHHHhccCCC
Q 015247 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLF---------KPREP--------YKRCIQETFKDFPPSSLPLIETLLAID 386 (410)
Q Consensus 324 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~d 386 (410)
..+.+..+....+..+...+........... .+... .....+......++.+.+||.+||++|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 9999999999998888766544322111000 00000 000111111233567889999999999
Q ss_pred CCCCCCHHHHhcCCCCC
Q 015247 387 PAERLTATVALNSEVIF 403 (410)
Q Consensus 387 P~~Rpt~~elL~hp~~~ 403 (410)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=390.75 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=220.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.. ...+++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 368999999999999999999999999999999997543 3334568899999999999999999999987 456999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 271 (410)
||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999875 55555555568999999999999999999999999999999999999974 5789999999998875432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 23455789999999998764 4899999999999999999999999999888888777653211111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+..+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 272 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11236788999999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=394.31 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=211.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHH-HHhCCCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILI-LRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
..++|++++.||+|+||.||+|++..+++.||||++++... .......+.+|..+ ++.++||||+++++++.. ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 34789999999999999999999999999999999987654 22334456667776 467899999999999887 456
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999998665555555568999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..|..... .+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------~~--- 258 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------QL--- 258 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC----------CC---
T ss_pred CCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------CC---
Confidence 2234567899999999998775 499999999999999999999999999998888888865211 11
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH----HHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA----TVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~elL~hp~~~~ 404 (410)
...+++.+.+||.+||++||.+||++ .++++||||+.
T Consensus 259 ----------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 259 ----------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp ----------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred ----------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 13678889999999999999999986 69999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=385.17 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=207.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|++. .+|+.||+|+++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 378999999999999999999975 6899999999976543 223345677899999999999999999999874
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
..+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 45999999998755544444445799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..... +
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----------p 241 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL----------P 241 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------C
T ss_pred CC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------C
Confidence 22 2234567999999999987654 8999999999999999999999999999888888776632111 1
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+++++.+||.+||..||.+|| ++.++|+||||+.
T Consensus 242 -------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 242 -------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred -------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 25788899999999999999999 8999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=389.77 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=214.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 679999999999999999999999999999999975321 112356688999999999999999999999874 569
Q ss_pred EEEEeeccCC-HHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEeecccc
Q 015247 193 YLVFHYMEHD-LAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLAS 265 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~ 265 (410)
|+||||++++ +...+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999975 433332 23446899999999999999999999999999999999999987654 9999999998
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. .+.+..+.........
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~----- 253 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP----- 253 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH-----
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc-----
Confidence 875432 223456899999999998765 48999999999999999999999998853 4455555543222222
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..+..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus 254 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 254 --------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 223468899999999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=404.37 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=222.4
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|.+.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 347899999999999999999999999999999999754321 12345788999999999999999999999874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 9999999876555555566789999999999999999999999999999999999999999999999999998875432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+.++.......+
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------- 236 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP------------- 236 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC-------------
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC-------------
Confidence 245668999999999998765457899999999999999999999999888888777754321111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+++++.+||.+||+.||.+|||+.++++||||+++
T Consensus 237 ----------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 ----------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 2567889999999999999999999999999999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=387.52 Aligned_cols=289 Identities=30% Similarity=0.463 Sum_probs=226.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec-----CC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR-----MS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 189 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....++++.+..++||||+++++++... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999998754322 22355678888899999999999998652 23
Q ss_pred ceEEEEEeeccCCHHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEcC-CCcEEEEeecc
Q 015247 190 CSLYLVFHYMEHDLAGLA---ASPEVKFTEPQVKCYMHQLLSGLEHCH--NNGVLHRDIKGSNLLIDD-DGVLKIADFGL 263 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NILl~~-~~~vkl~DFGl 263 (410)
.++++||||+++++...+ ......+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 358899999999876644 346668999999999999999999999 999999999999999996 89999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 264 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
+........ .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...+
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 987754332 345678999999999877666899999999999999999999999999999999999999999988776
Q ss_pred hhCCCCCcc---cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 344 KKSKLPNAT---LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 344 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
......... .......+...........++++.+||.+||++||.+|||+.|+|+||||++...+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 554322111 11112222333333333466789999999999999999999999999999876544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=392.39 Aligned_cols=291 Identities=21% Similarity=0.283 Sum_probs=217.2
Q ss_pred cCCCcceeeeeccC--CCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
..++|++.+.||+| +||.||+|++..+|+.||||++..........+.+.+|+.+++.++|||||++++++... ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CE
Confidence 34789999999999 999999999999999999999988766667778888999999999999999999999874 46
Q ss_pred EEEEEeeccCCHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 192 LYLVFHYMEHDLAGLAA--SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
+|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999875544333 2335799999999999999999999999999999999999999999999999999865421
Q ss_pred CC------CCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC---
Q 015247 270 NH------KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--- 339 (410)
Q Consensus 270 ~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--- 339 (410)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 1112335789999999998763 4589999999999999999999999998776665554433211100
Q ss_pred -----HHHhhhC-------CCCCcccC-CCC-CchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 340 -----EEYWKKS-------KLPNATLF-KPR-EPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 340 -----~~~~~~~-------~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
....... ........ .+. .............+++.+.+||.+||++||.+|||+.|+|+||||++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000000 00000000 000 000001112334678889999999999999999999999999999875
Q ss_pred C
Q 015247 406 R 406 (410)
Q Consensus 406 ~ 406 (410)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=379.70 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=221.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--TD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CE
Confidence 67999999999999999999999999999999998754322 1356788999999999999999999998874 56
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~ 267 (410)
.++||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999998755444444456899999999999999999999999999999999999999888 8999999999877
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+.......+.
T Consensus 170 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 239 (321)
T 2a2a_A 170 EDGVE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------- 239 (321)
T ss_dssp CTTCC--CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred Ccccc--ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------
Confidence 54322 3456789999999998764 4899999999999999999999999999888888777654322222
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 240 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 ------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 2224678889999999999999999999999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=404.97 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=211.7
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 34789999999999999999999999999999999975432 233345677899999999999999999999874 459
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|+||||++++.+.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999986665555555689999999999999999999998 999999999999999999999999999998643322
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+...... +|
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------~p-- 369 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----------FP-- 369 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------CC--
T ss_pred -cccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----------CC--
Confidence 2245678999999999987754 999999999999999999999999999888887777652111 11
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
..+++++.+||.+||++||.+|| |+.|+|+||||+.-
T Consensus 370 -----------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 370 -----------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 25788899999999999999999 99999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=387.80 Aligned_cols=289 Identities=29% Similarity=0.442 Sum_probs=228.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---------ChHHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---------EPESVKFMAREILILRRLDHPNVIKLEGLVT 185 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 185 (410)
.++|++.+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEEC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEEC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 47899999999999999999997 4599999999865332 1223467889999999999999999999986
Q ss_pred e---cCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 186 S---RMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 186 ~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
. .....+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 5 2344789999999999999888877789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 263 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 263 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
++....... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....
T Consensus 180 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 998654332 234567899999999988756689999999999999999999999999999999999999999888654
Q ss_pred hhhCCCCCccc---CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 343 WKKSKLPNATL---FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 343 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+.....+.... ..................++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 43221110000 00000001122334456788899999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=385.58 Aligned_cols=285 Identities=36% Similarity=0.581 Sum_probs=231.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC----ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 191 (410)
++|.+.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 68999999999999999999999999999999997765556666778899999999999999999999876433 23
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|++|||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 69999999987666543 35999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...+........
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 34567899999999988755689999999999999999999999999999999999999999888766543221100
Q ss_pred cc--CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 352 TL--FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 352 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. .................+++++.+||.+||+.||.+|||+.++|+||||+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 00 000000001112233467888999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=377.80 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=218.2
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 47888899999999999999988999999999976543 2345678899999999999999999999874 4599999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||++++.+..+... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ...
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccc
Confidence 99988666655543 3799999999999999999999999999999999999999999999999999987754322 234
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
...||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+........
T Consensus 200 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 261 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------------- 261 (321)
T ss_dssp CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----------------
T ss_pred cccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-----------------
Confidence 56799999999998764 489999999999999999999999999888777666654211100
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||.+...+
T Consensus 262 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 262 ---------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 0012567889999999999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=385.67 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=222.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.|++++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 5699999999999999999999999999999999876443 34456788999999999999999999999874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||+.+++...+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999999988887765566899999999999999999999999999999999999999999999999999987643
Q ss_pred CccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+....+..+........
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 273 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 273 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 234678999999999853 34589999999999999999999999999888777766654211000
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
....+++.+.+||.+||+.||.+|||+.++|+||||...+.+
T Consensus 274 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 274 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred --------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 012567889999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=405.88 Aligned_cols=258 Identities=31% Similarity=0.503 Sum_probs=215.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998765444445678899999999999999999999987 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~~ 272 (410)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999885544343334579999999999999999999999999999999999999764 559999999998775432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 194 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 259 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----------- 259 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-----------
T ss_pred -cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-----------
Confidence 2455689999999998764 48999999999999999999999999999998888887654333221
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+..+|+.+.+||.+||++||.+|||+.++|+||||++
T Consensus 260 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 260 --------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 22468889999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=384.12 Aligned_cols=259 Identities=30% Similarity=0.403 Sum_probs=201.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++... ...++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEE
Confidence 478999999999999999999999999999999997542 234577899999999999999999999874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~ 271 (410)
||||+.++.+.........+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999987655545555567999999999999999999999999999999999999975 8899999999998764332
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+ .+..+........
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~----------- 271 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI----------- 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-----------
T ss_pred --ccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-----------
Confidence 234567899999999988754 8999999999999999999999998776655 4444443211111
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
...+..++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 272 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 272 --------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp --------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred --------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 0112367888999999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=388.73 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=200.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||++++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++... ..++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEE
Confidence 347899999999999999999999999999999999765432 23477899999999999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEeeccccccCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASFFDPNH 271 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~~~~~ 271 (410)
+||||+.++.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999987555444444457999999999999999999999999999999999999987765 9999999997543222
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+........ ..++
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~-- 242 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK------YSIP-- 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC------CCCC--
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC------CCCC--
Confidence 234567999999999998765334559999999999999999999987655333333322211000 0000
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
....+++.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus 243 ---------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 243 ---------------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 012578889999999999999999999999999999654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=405.47 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=219.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEE
Confidence 68999999999999999999999999999999997543323335678899999999999999999999887 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99998755443333345799999999999999999999999999999999999995 45689999999998775433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+..........
T Consensus 179 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 244 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----------- 244 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-----------
T ss_pred -ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-----------
Confidence 2455689999999999876 38999999999999999999999999999988888887643322211
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+..+|+++++||.+||++||.+|||+.++|+||||++..
T Consensus 245 --------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 245 --------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp --------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred --------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 1246788999999999999999999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=370.56 Aligned_cols=256 Identities=32% Similarity=0.468 Sum_probs=220.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 6799999999999999999999999999999999765432 24568889999999999999999999987 4559999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||++++.+.........+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999875554444344579999999999999999999999999999999999999 788999999999998775433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..+....+.......+...+
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 231 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--------- 231 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---------
T ss_pred -chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---------
Confidence 23456789999999988653 899999999999999999999999999988888888765444443222
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..+++.+.+||.+||++||.+|||+.++|+||||++
T Consensus 232 ----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 367889999999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=379.14 Aligned_cols=291 Identities=31% Similarity=0.525 Sum_probs=230.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec---CCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR---MSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~ 191 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 378999999999999999999999999999999996433 344456678899999999999999999987653 2356
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.+++|||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999988776654 379999999999999999999999999999999999999999999999999998765322
Q ss_pred CC---------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 272 KH---------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 272 ~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123457899999999887655689999999999999999999999999999999999998888776321
Q ss_pred h-hhCCCCCc--ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 343 W-KKSKLPNA--TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 343 ~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
. .....+.. ............+......+++++.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 1 00000000 000000000011233445788999999999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.07 Aligned_cols=261 Identities=31% Similarity=0.456 Sum_probs=219.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh-----------HHHHHHHHHHHHHHhCCCCceeeEeee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----------ESVKFMAREILILRRLDHPNVIKLEGL 183 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~ 183 (410)
.++|++++.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999999999999999998654321 235678899999999999999999999
Q ss_pred EeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEe
Q 015247 184 VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIAD 260 (410)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~D 260 (410)
+.. ...+|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 456999999998754443333345799999999999999999999999999999999999999776 699999
Q ss_pred eccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 261 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 261 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 193 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99998875432 2456679999999998864 4899999999999999999999999999999988888764433332
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.. +..+|+++++||.+||++||.+|||+.|+|+||||++..
T Consensus 269 ~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 269 ND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 22 347889999999999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=376.29 Aligned_cols=287 Identities=37% Similarity=0.633 Sum_probs=230.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEc-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeEeeeEee---
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTS--- 186 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 186 (410)
..++|++.+.||+|+||.||+|++. .+|+.||+|++............+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999985 6789999999976443322222355677766655 89999999998862
Q ss_pred cCCceEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 187 RMSCSLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
......++||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 235578999999999887766543 3469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....|..
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccCCC--CccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 764322 234567899999999987754 89999999999999999999999999999999999999988887765543
Q ss_pred CC-CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 346 SK-LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 346 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.. .+....... ....+......+++.+.+||.+||+.||.+|||+.++|+||||++-.
T Consensus 246 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 246 DVALPRQAFHSK---SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TCSSCGGGSCCC---CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhccc---CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 21 111111110 01123344467888999999999999999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=374.59 Aligned_cols=258 Identities=31% Similarity=0.453 Sum_probs=215.3
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 347899999999999999999999999999999999754321 12245678899999999999999999999874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++||||++++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 9999999975554444444579999999999999999999999999999999999999999999999999986654322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....||+.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+.......+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 227 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 227 (279)
T ss_dssp ------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred --ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-------------
Confidence 2456789999999998764 488999999999999999999999999988888777765322111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 228 ----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 228 ----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 25678899999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.53 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=212.9
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEee
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~ 198 (410)
...+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+|+.++||||+++++++... ..+++||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeC
Confidence 33678999999999999999999999999998643 24456788999999999999999999999874 469999999
Q ss_pred ccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE--cCCCcEEEEeeccccccCCCCCCCC
Q 015247 199 MEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 199 ~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
++++ +...+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+..... .
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9874 555555555679999999999999999999999999999999999999 5678999999999988754332 3
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
...+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+.
T Consensus 246 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS---------------
T ss_pred ccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh---------------
Confidence 455799999999988764 4899999999999999999999999999998888888764322211
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+..+++++.+||.+||++||.+|||+.|+|+||||++.+
T Consensus 310 ----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 310 ----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 12246789999999999999999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=403.23 Aligned_cols=258 Identities=31% Similarity=0.491 Sum_probs=222.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 103 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYL 103 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 6899999999999999999999999999999999876542 3345678899999999999999999999987 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 271 (410)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999876554444445589999999999999999999999999999999999999 567899999999998875433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+.+........
T Consensus 184 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 249 (484)
T 3nyv_A 184 --KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP---------- 249 (484)
T ss_dssp --SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG----------
T ss_pred --ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc----------
Confidence 2455679999999999876 38999999999999999999999999999998888887643322211
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+..+|+.+++||.+||++||.+|||+.|+|+||||+.
T Consensus 250 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 250 ---------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp ---------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ---------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 12367889999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=382.13 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=191.0
Q ss_pred CCccee---eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCce
Q 015247 116 DSFEKI---DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~---~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 191 (410)
++|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 346654 7899999999999999999999999999743 2455778999999997 9999999999987 456
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeeccccccC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFD 268 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~ 268 (410)
.|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999998855544444456899999999999999999999999999999999999998766 89999999998765
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHHHHHhCCCCHH
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE-------VEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~ 341 (410)
... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+.........
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 237 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG- 237 (325)
T ss_dssp C-----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-
T ss_pred CCC-CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-
Confidence 432 234556789999999998764 489999999999999999999999987543 2333333222111111
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 238 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 238 ------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp ------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 22246889999999999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=384.94 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=209.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+|++++.++ +||||+++++++.+ ...+|+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 93 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVYV 93 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEE
Confidence 6799999999999999999999999999999999865432 23588888887 79999999999887 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~~~~ 270 (410)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999875444444445579999999999999999999999999999999999998543 35999999999876543
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR---TEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
. ......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+. +..+.+..+.......+.
T Consensus 174 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------- 244 (342)
T 2qr7_A 174 N-GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG------- 244 (342)
T ss_dssp T-CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-------
T ss_pred C-CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-------
Confidence 2 234566889999999998764 3889999999999999999999999863 444555555442211111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+..+++++.+||.+||..||.+|||+.++|+||||.+.
T Consensus 245 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 245 ------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 1224688899999999999999999999999999999653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=375.70 Aligned_cols=282 Identities=30% Similarity=0.532 Sum_probs=222.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++........+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 378999999999999999999999999999999986432 456788999999997 99999999999886677799
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 272 (410)
+||||++++.+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999866555543 489999999999999999999999999999999999999777 899999999987754432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCCH-HHhhhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP-GRTEVEQLHKIYKLCGSPSE-EYWKKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~ 350 (410)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+.+.. ..+.......
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 3456789999999998875669999999999999999999999984 55666777777776664332 1111111110
Q ss_pred cc------cCCCCCchhhh-hhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 AT------LFKPREPYKRC-IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~------~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.. .......+... .......+++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 00 00000000000 0111224788999999999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=380.63 Aligned_cols=260 Identities=32% Similarity=0.471 Sum_probs=219.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC--Ch----HHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EP----ESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
++|++.+.||+|+||.||+|++..+|+.||||+++.... .. ...+.+.+|+.++..+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 579999999999999999999988999999999986542 11 2245677899999999 89999999999877
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
....|+||||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 45699999999985554444444579999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCccccccccccccccccC-----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
.... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....+..+..........
T Consensus 252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 327 (365)
T 2y7j_A 252 PGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP-- 327 (365)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH--
T ss_pred CCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence 4432 355789999999998863 2348889999999999999999999999988888877776643333222
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.+..+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 328 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 -----------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -----------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22467888999999999999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=414.83 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=220.8
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
..++|++++.||+|+||.||+|++..+++.||||++++... .....+.+..|..++..+ +||+|+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 45789999999999999999999999999999999986422 223345677899999987 79999999998877 446
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999986666555555689999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|...... +|
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------~p-- 562 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------YP-- 562 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC----------CC--
T ss_pred -cccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----------CC--
Confidence 234567899999999998765 4999999999999999999999999999999888888652211 11
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCH-----HHHhcCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA-----TVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~elL~hp~~~~ 404 (410)
..+++++.+||.+||++||.+||++ +++++||||+.
T Consensus 563 -----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 563 -----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred -----------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 2678899999999999999999997 99999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=403.01 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=213.8
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+|..++|||||++++++.+. ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CE
Confidence 345789999999999999999999999999999999976432 122345677899999999999999999998874 46
Q ss_pred EEEEEeeccCCHHH-HhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 192 LYLVFHYMEHDLAG-LAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 192 ~~lv~e~~~~~l~~-~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
+|+||||++++.+. .+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999875544 44332 34599999999999999999999999999999999999999999999999999988754
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCHHHhhh
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 345 (410)
.. .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+. .+....+....
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 405 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------- 405 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----------
T ss_pred Cc--cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----------
Confidence 33 234568999999999988754 89999999999999999999999987643 23333332210
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
. .....+++++.+||.+||++||.+|| ++.|+++||||+.
T Consensus 406 ~-------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 406 E-------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp C-------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred c-------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 0 01136788999999999999999999 8999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=374.43 Aligned_cols=263 Identities=26% Similarity=0.338 Sum_probs=205.0
Q ss_pred cCCCccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 114 RADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 114 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
..+.|++. +.||+|+||.||+|++..+++.||||++..... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~ 85 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DR 85 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CE
Confidence 34789986 789999999999999989999999999976542 2345678899999985 799999999999874 46
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEeeccccccC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLASFFD 268 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~~ 268 (410)
+|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999986544444433457999999999999999999999999999999999999998776 9999999997664
Q ss_pred CCCC------CCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--------------
Q 015247 269 PNHK------HPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTE-------------- 324 (410)
Q Consensus 269 ~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-------------- 324 (410)
.... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11234568999999999864 13378999999999999999999999987642
Q ss_pred -HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 325 -VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 325 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
......+.......+. ..+..+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 2233333332111111 12246788999999999999999999999999999998
Q ss_pred CC
Q 015247 404 QD 405 (410)
Q Consensus 404 ~~ 405 (410)
+.
T Consensus 301 ~~ 302 (316)
T 2ac3_A 301 GC 302 (316)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=374.28 Aligned_cols=285 Identities=36% Similarity=0.590 Sum_probs=224.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR-------- 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 187 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 7899999999999999999999999999999998754 345567788999999999999999999987432
Q ss_pred ----CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeec
Q 015247 188 ----MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFG 262 (410)
Q Consensus 188 ----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFG 262 (410)
.....|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 2356899999999887776643 4799999999999999999999999999999999999997 56799999999
Q ss_pred cccccCCCCC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 263 LASFFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 263 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
++........ .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9987653221 12334567999999999876556899999999999999999999999999999999988887766655
Q ss_pred HHhhhCCC--CC---cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 341 EYWKKSKL--PN---ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 341 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..+..... +. .....+. ..+....+.+++++.+||.+||+.||.+|||+.++|+||||+....|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPH----KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCC----CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhcCcccccccccCCC----CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 44322110 00 0000010 11233445789999999999999999999999999999999987665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=368.09 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=215.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~ 193 (410)
..|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++... ....++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 568999999999999999999999999999999987766777778899999999999999999999988653 345689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEc-CCCcEEEEeeccccccCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLID-DDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~ 270 (410)
+||||++++.+..+......+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999988555545444467999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..................+
T Consensus 186 ---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 248 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------ 248 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------------
T ss_pred ---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------------
Confidence 2345678999999998874 38999999999999999999999998866655443332211111
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.......++++.+||.+||+.||.+|||+.++|+||||+++
T Consensus 249 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 --------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp --------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred --------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01123567789999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=376.02 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=217.9
Q ss_pred CCccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
+.|.+. +.||+|+||.||+|++..+|+.||+|++............+.+|+.++..+ +||||+++++++.. ....+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEE
Confidence 568887 889999999999999999999999999987655555566788999999999 56999999999887 44599
Q ss_pred EEEeeccCCHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccccccC
Q 015247 194 LVFHYMEHDLAGLAA--SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASFFD 268 (410)
Q Consensus 194 lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~ 268 (410)
+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999885444443 23467999999999999999999999999999999999999997 7899999999998775
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.......+.
T Consensus 186 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 254 (327)
T 3lm5_A 186 HACE--LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-------- 254 (327)
T ss_dssp ----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--------
T ss_pred Cccc--cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--------
Confidence 3322 3456789999999998765 4899999999999999999999999999988888877765433322
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.....+++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 255 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 -----------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp -----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred -----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 112367888999999999999999999999999999987643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=371.83 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=201.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.++...++.++||||+++++++... ...++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEEE
Confidence 4789999999999999999999999999999999976544444445555566668888999999999999874 45999
Q ss_pred EEeeccCCHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 195 VFHYMEHDLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 195 v~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 99999997755443 3566899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCCccccccccccccccc---cCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 271 HKHPMTSRVVTLWYRPPELL---LGATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
.. .....||+.|+|||++ .....++.++||||||+++|+|++|+.||... .....+..+........
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 234 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL------- 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-------
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-------
Confidence 22 2345789999999997 23345889999999999999999999999873 44444444433211000
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 --------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 235 --------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp --------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 012577889999999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=382.71 Aligned_cols=280 Identities=25% Similarity=0.386 Sum_probs=226.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--------CCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--------HPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~ 187 (410)
++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 6899999999999999999999999999999999643 344567888999999885 78899999988732
Q ss_pred --CCceEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCC---------
Q 015247 188 --MSCSLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDG--------- 254 (410)
Q Consensus 188 --~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~--------- 254 (410)
....+++||||++++++..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 35579999999999988877544 35799999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------cEEEEeeccccccCCCCCCCCccccccccccccccccCCc
Q 015247 255 ----------------------------------------VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294 (410)
Q Consensus 255 ----------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 294 (410)
.+||+|||++...... ....+||+.|+|||++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCC
Confidence 7999999999876433 34567899999999998754
Q ss_pred CCCCccchHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC-----------CC
Q 015247 295 DYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK-----------PR 357 (410)
Q Consensus 295 ~~~~~~DiwSlGv~l~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 357 (410)
++.++|||||||++|||++|+.||.+.+ ....+..+.+..+.++...+............ +.
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 8999999999999999999999998765 56778889999999887766544432211110 00
Q ss_pred Cchhhhhhhh---hCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 358 EPYKRCIQET---FKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 358 ~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
... ..+... ....++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus 349 ~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLF-EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHH-HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chh-HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 001100 1123456889999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=370.35 Aligned_cols=261 Identities=28% Similarity=0.400 Sum_probs=221.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEE
Confidence 4789999999999999999999999999999999976543 44556778899999999999999999999887 44699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
++|||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999765554544455899999999999999999999999999999999999999999999999999987653322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+..... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~----- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------SI----- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------CC-----
T ss_pred ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------CC-----
Confidence 23456789999999998764 489999999999999999999999999887776665543110 01
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
...+++.+.+||.+||+.||.+|||+.++|+||||++...+
T Consensus 235 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 235 --------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 12567789999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=369.28 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=209.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..++..||+|++..... ....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 3689999999999999999999999999999999976543 2335678889999999999999999999987 446999
Q ss_pred EEeeccC-CHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeecccccc
Q 015247 195 VFHYMEH-DLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF 267 (410)
Q Consensus 195 v~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~ 267 (410)
||||+++ ++...+. .....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999987 4544442 234679999999999999999999999999999999999999 45688999999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+....+........
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 245 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-------- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred CCccc--CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc--------
Confidence 54322 345678999999998764 488999999999999999999999999887776655543211110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 246 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011246788999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=399.00 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=215.2
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+.... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CE
Confidence 3458899999999999999999999999999999999764321 12345678899999999999999999998874 56
Q ss_pred EEEEEeeccCCHHH-HhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAG-LAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~-~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
+|+||||++++.+. .+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999975554 33322 347999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCCHHHh
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT----EVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 343 (410)
..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ..+....+.....
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------- 410 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------- 410 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-------
T ss_pred cCCCc-ccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-------
Confidence 54432 23456899999999998874 49999999999999999999999998764 3444444443111
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
.+ ...+++.+.+||.+||++||.+||+ +.++++||||+.
T Consensus 411 ---~~-------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 411 ---TY-------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp ---CC-------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred ---CC-------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 11 1267889999999999999999996 589999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=390.18 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=205.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLDHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 188 (410)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4789999999999999999999999999999999976432 112223477899999999999999999987542
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeecccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLAS 265 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~ 265 (410)
..|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 213 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp --EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred --ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 3799999998866665656667899999999999999999999999999999999999997544 59999999998
Q ss_pred ccCCCCCCCCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-HhCCCCHHH
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYK-LCGSPSEEY 342 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 342 (410)
..... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..... .....
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 77533 22456789999999999853 34578899999999999999999999987654433332222 11111
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+..+..+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 223345788999999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=369.40 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=192.0
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 44789999999999999999999989999999999975322 11224568889999999999999999999887 4569
Q ss_pred EEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||+++ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999976 5555555655789999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
. ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.+..+.. ..
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~~- 228 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------AD- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------SC-
T ss_pred C-cceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------cc-
Confidence 2 22345789999999988764 488999999999999999999999987654433322210 00
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. .....++.++.+||.+||+.||.+|||+.++|+||||.+..
T Consensus 229 -~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 229 -Y------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -c------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 0 01125678899999999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=380.43 Aligned_cols=282 Identities=26% Similarity=0.447 Sum_probs=223.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CC-----ceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HP-----NVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.++ |+ +++++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 47899999999999999999999999999999999642 344556777888888874 44 499999998874
Q ss_pred CceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEc--CCCcEEEEeecc
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCH--NNGVLHRDIKGSNLLID--DDGVLKIADFGL 263 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NILl~--~~~~vkl~DFGl 263 (410)
...++||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+
T Consensus 129 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 -NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred -CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 4699999999998888775443 56999999999999999999999 46999999999999995 478899999999
Q ss_pred ccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 264 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+.+..+.++...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9877432 34567899999999988754 999999999999999999999999999999999999999998887665
Q ss_pred hhCC--------CCCcccC---------CCCCchhhhhhhhhC-----------CC-------CCCcHHHHHhccCCCCC
Q 015247 344 KKSK--------LPNATLF---------KPREPYKRCIQETFK-----------DF-------PPSSLPLIETLLAIDPA 388 (410)
Q Consensus 344 ~~~~--------~~~~~~~---------~~~~~~~~~~~~~~~-----------~~-------~~~~~~li~~~L~~dP~ 388 (410)
.... ++..... ....+....+..... +. ++++++||.+||++||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 4321 1110000 000000000111000 00 12578999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 015247 389 ERLTATVALNSEVIFQDR 406 (410)
Q Consensus 389 ~Rpt~~elL~hp~~~~~~ 406 (410)
+|||+.|+|+||||++..
T Consensus 363 ~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TSCCHHHHTTSGGGCC--
T ss_pred hCCCHHHHhcCcccccCC
Confidence 999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=376.71 Aligned_cols=261 Identities=29% Similarity=0.401 Sum_probs=222.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|.+.+.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 4789999999999999999999999999999999976543 44556778899999999999999999999987 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999755554444445899999999999999999999999999999999999999999999999999987653322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+...... +
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~----- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS----------I----- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------C-----
T ss_pred cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC----------C-----
Confidence 234567899999999987754 899999999999999999999999998877776666542110 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
...+++.+.+||.+||+.||.+|||+.++|+||||++...+
T Consensus 261 --------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 261 --------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 12567789999999999999999999999999999887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=382.29 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=209.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------SVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|++..+++.||||++........ ....+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 689999999999999999999999999999999987643221 23356679999999999999999999987 4
Q ss_pred ceEEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 190 CSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
..+++||||+..+ .+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 5699999998664 444444455679999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...... .. .
T Consensus 182 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----------~--- 239 (335)
T 3dls_A 182 RGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----------A--- 239 (335)
T ss_dssp TTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----------T---
T ss_pred CCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----------h---
Confidence 4432 345678999999999987664588999999999999999999999753210 00 0
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.. .....+++++.+||.+||++||.+|||+.++|+||||++.
T Consensus 240 ---~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 ---AI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---cc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 0012478889999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=382.04 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=215.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 368999999999999999999999999999999997542 133456678899999999999999999999987 456
Q ss_pred EEEEEeeccCCHHHHhcCC----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015247 192 LYLVFHYMEHDLAGLAASP----------------------------------------EVKFTEPQVKCYMHQLLSGLE 231 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~----------------------------------------~~~~~~~~~~~~~~qi~~~L~ 231 (410)
.++||||++++.+...... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999987554443320 123468889999999999999
Q ss_pred HHHHCCceeccCCCCCEEEcCCC--cEEEEeeccccccCCCC---CCCCccccccccccccccccCC-cCCCCccchHHH
Q 015247 232 HCHNNGVLHRDIKGSNLLIDDDG--VLKIADFGLASFFDPNH---KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSA 305 (410)
Q Consensus 232 ~LH~~~ivHrDlkp~NILl~~~~--~vkl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSl 305 (410)
|||+.||+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999998764322 1123456789999999998652 458999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCC
Q 015247 306 GCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAI 385 (410)
Q Consensus 306 Gv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 385 (410)
||++|+|++|+.||.+.+..+....+......... .....+++.+.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHHHcCC
Confidence 99999999999999999998888877663222211 11135788899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 015247 386 DPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 386 dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
||.+|||+.++|+||||++...
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=369.08 Aligned_cols=265 Identities=28% Similarity=0.463 Sum_probs=222.7
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
...++|++.+.||+|+||.||+|++..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++........
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34589999999999999999999999999999999998877677777889999999999999999999998876666789
Q ss_pred EEEEeeccC-CHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 193 YLVFHYMEH-DLAGLAAS---PEVKFTEPQVKCYMHQLLSGLEHCHNNG-----VLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
++||||+++ ++...+.. ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999987 55554432 3345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 264 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
+........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------ 234 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred heeeccccc-cccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc------
Confidence 987643321 123456899999999988754 899999999999999999999999998877776666542110
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.....+++++.+||.+||+.||.+|||+.++|+|+|++++..
T Consensus 235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 235 ----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred ----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 011257888999999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.74 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=201.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS------ 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 189 (410)
++|++.+.||+|+||.||+|++..+|+.||||+++... .....+.+.+|+.+|++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 67999999999999999999999999999999998654 33445678899999999999999999998865322
Q ss_pred -------------------------------------------------ceEEEEEeeccCCHHH-HhcCCC--CCCCHH
Q 015247 190 -------------------------------------------------CSLYLVFHYMEHDLAG-LAASPE--VKFTEP 217 (410)
Q Consensus 190 -------------------------------------------------~~~~lv~e~~~~~l~~-~~~~~~--~~~~~~ 217 (410)
.++++||||++++.+. .+.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2489999999985444 443322 235677
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-----------CCCccccccccccc
Q 015247 218 QVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-----------HPMTSRVVTLWYRP 286 (410)
Q Consensus 218 ~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~a 286 (410)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 7999999999999999999999999999999999999999999999988754421 12244578999999
Q ss_pred cccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhh
Q 015247 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQE 366 (410)
Q Consensus 287 PE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (410)
||++.+. .++.++|||||||++|+|++|..|+. +....+........ +.
T Consensus 245 PE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~-------------------------~~ 293 (332)
T 3qd2_B 245 PEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF-------------------------PL 293 (332)
T ss_dssp HHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC-------------------------CH
T ss_pred hHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC-------------------------Cc
Confidence 9998875 48999999999999999999876542 11111111111100 01
Q ss_pred hhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 367 TFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 367 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11234667899999999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=362.35 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=215.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 6799999999999999999999999999999999765432 345678899999999999999999999887 4568999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~ 274 (410)
|||++++.+.........+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99998855555555566899999999999999999999999999999999999999999999999999986643221 22
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||+.|+|||++.+...++.++||||||+++|+|++|+.||.+..... .+..+..... .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~--------------- 227 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-Y--------------- 227 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-T---------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-c---------------
Confidence 3456789999999998875545789999999999999999999998765432 2222211000 0
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
......+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -----------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 0011357888999999999999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=365.78 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=215.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--Ce
Confidence 57999999999999999999999999999999998754321 1356788999999999999999999998874 46
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~ 267 (410)
.++||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999998654444444445799999999999999999999999999999999999999877 8999999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+.......+.
T Consensus 163 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 232 (283)
T 3bhy_A 163 EAGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------- 232 (283)
T ss_dssp C----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCCCc--ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-------
Confidence 54322 3455789999999988764 4899999999999999999999999999888777776543222221
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 233 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 ------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 223467888999999999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=364.61 Aligned_cols=263 Identities=29% Similarity=0.420 Sum_probs=220.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC---C----hHHHHHHHHHHHHHHhCC-CCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---E----PESVKFMAREILILRRLD-HPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999986542 1 123456778999999995 9999999999877
Q ss_pred cCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 187 RMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
....++||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 456999999998754444444445799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCcccccccccccccccc-----CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
...... .....||+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+..+....+.......+.
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 1phk_A 174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 250 (298)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred cCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-
Confidence 754332 34567899999999875 2345889999999999999999999999998888777777653222111
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 251 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 11235788899999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=375.70 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=212.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC--ce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~ 191 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++..++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 3789999999999999999999999999999999987543 34556678899999999999999999998876433 35
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 69999999875554444444579999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 K--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 240 (311)
T ss_dssp -----------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---------
T ss_pred cccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---------
Confidence 2 123345789999999998875 4899999999999999999999999998887777666553222211
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
.....+++++.+||.+||+.||.+||++.++|.|+|++
T Consensus 241 ----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ----------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 22246889999999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=369.78 Aligned_cols=258 Identities=30% Similarity=0.425 Sum_probs=214.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.. ....++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 679999999999999999999999999999999986432 223457789999999999999999999887 4469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||++++.+.........+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999874443333334579999999999999999999999999999999999999 78899999999999765322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.+.......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 228 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES------------ 228 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT------------
T ss_pred -ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc------------
Confidence 23455789999999988764 4899999999999999999999999999888887777653222111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 229 -------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 11236788899999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=375.19 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~ 192 (410)
.++|++.+.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|..++| |||+++++++.. ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 46899999999999999999986 678999999998777677777888999999999976 999999999887 4569
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+|||+.++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999877777776654 45799999999999999999999999999999999999996 68899999999987754332
Q ss_pred C-CCccccccccccccccccC----------CcCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCH
Q 015247 273 H-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSE 340 (410)
Q Consensus 273 ~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 340 (410)
. .....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+... ...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~ 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHE 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---TSC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC---Ccc
Confidence 2 2345679999999999853 134888999999999999999999999875443 233322211 000
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. ......++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 240 -----~-------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 -----I-------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp -----C-------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -----c-------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 0 00123456789999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.89 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=219.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3789999999999999999999989999999999975432 12345678899999999999999999999866556679
Q ss_pred EEEEeeccCCHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||+++++...+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 9999999998766554 345679999999999999999999999999999999999999999999999999998765322
Q ss_pred C-CCCccccccccccccccccCCc-CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 K-HPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
. .......||+.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+..+....+.+....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------------ 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------------
Confidence 2 2223456899999999987532 2477999999999999999999999998887777766542110
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
....+++.+.+||.+||+.||.+|||+.++|+||||++...+
T Consensus 232 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 232 -----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp -----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred -----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 112577889999999999999999999999999999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=366.26 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=208.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeEE
Confidence 3789999999999999999999988999999999975422 122345688899999999999999999998874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999998744443433345799999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+|+.|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.......
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 230 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--------------- 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC---------------
Confidence 3455789999999998875544689999999999999999999999888777766665421110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 231 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 231 --------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred --------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 125677899999999999999999999999999998763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=383.42 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=200.4
Q ss_pred cCCCccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHH-hCCCCceeeEeeeEee--cCC
Q 015247 114 RADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR-RLDHPNVIKLEGLVTS--RMS 189 (410)
Q Consensus 114 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~--~~~ 189 (410)
..++|.+. +.||+|+||+||+|++..+|+.||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34678887 6899999999999999999999999999632 23567888874 4589999999998864 234
Q ss_pred ceEEEEEeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccc
Q 015247 190 CSLYLVFHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLA 264 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla 264 (410)
..+|+||||+.+ ++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 568999999987 555555443 346999999999999999999999999999999999999997 789999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHHhCCCCH
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE----QLHKIYKLCGSPSE 340 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~ 340 (410)
+...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+... ....+.......+.
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp EECC-------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 8765332 23567889999999988764 49999999999999999999999998765432 22333221111100
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+..+++++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 289 -------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 -------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1123678899999999999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=367.48 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=215.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+++++.++||||+++++++.. ....+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence 47899999999999999999999999999999999754321 1224568889999999999999999999887 45699
Q ss_pred EEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++|||+++ ++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp EEECCCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEEEeCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 99999987 444444 333479999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+..... .+
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~---- 231 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----------KF---- 231 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------CC----
T ss_pred --cccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----------CC----
Confidence 34567899999999987754 89999999999999999999999999888777666654211 01
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
...+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 232 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 ---------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 12577889999999999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=363.94 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=206.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.++..+ +||||+++++++... ...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEE
Confidence 3689999999999999999999999999999999987655555566788899999999 999999999999874 4699
Q ss_pred EEEeeccC-CHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----------------
Q 015247 194 LVFHYMEH-DLAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---------------- 253 (410)
Q Consensus 194 lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---------------- 253 (410)
+||||+++ ++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999987 555544322 2579999999999999999999999999999999999999844
Q ss_pred ---CcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 015247 254 ---GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330 (410)
Q Consensus 254 ---~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 330 (410)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++...... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HH
Confidence 47999999999876543 23458999999999987655778999999999999999999887654322 22
Q ss_pred HHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 331 IYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 331 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+... ..+ .....+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 240 ~~~~------------~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 240 IRQG------------RLP----------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHTT------------CCC----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHcC------------CCC----------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 2211 000 11136788899999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.75 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=208.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--CCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~ 193 (410)
++|++.+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+|..++ ||||+++++++... ..+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 57999999999999999999974 4999999999887666677788999999999996 59999999998874 4599
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|||+.++++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+......
T Consensus 133 lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 99997777777766543 4789999999999999999999999999999999999995 689999999999877543322
Q ss_pred -CCccccccccccccccccCC----------cCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHH
Q 015247 274 -PMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEE 341 (410)
Q Consensus 274 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 341 (410)
.....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.... ..+..+.......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~--- 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--- 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC---
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC---
Confidence 23456799999999998652 24889999999999999999999999876433 3333332210000
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.+ ....++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 288 -----~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 -----EF-------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -----CC-------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -----CC-------------------CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00 113466789999999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=367.24 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=208.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++..++||||+++++++.. ....|+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEEE
Confidence 689999999999999999999999999999999976544 44556788899999999999999999999877 456999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..........
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 99999885555454445589999999999999999999999999999999999999999999999999998776544444
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..............
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------- 230 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP----------------- 230 (294)
T ss_dssp ------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-----------------
T ss_pred cCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-----------------
Confidence 45567999999999988754 899999999999999999999999998877665444321110
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~ 401 (410)
.........+|+.+.++|.+||++||.+||+..+.|.+.|
T Consensus 231 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 231 -------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp -------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred -------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 0112233478899999999999999999996555555544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=368.38 Aligned_cols=281 Identities=23% Similarity=0.375 Sum_probs=225.1
Q ss_pred CCcceeeeeccCCCeeEEEEEE-cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC------ceeeEeeeEeecC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP------NVIKLEGLVTSRM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~ 188 (410)
++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 6899999999999999999998 568899999998643 34456678899999988655 599999998874
Q ss_pred CceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---------------
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--------------- 252 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------------- 252 (410)
...++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 -GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred -CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 4699999999888888765443 47899999999999999999999999999999999999987
Q ss_pred ----CCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHH
Q 015247 253 ----DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328 (410)
Q Consensus 253 ----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 328 (410)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999875432 24567899999999988754 899999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCccc-----CCCCCchhhhhhhh----------hCCCCCCcHHHHHhccCCCCCCCCCH
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATL-----FKPREPYKRCIQET----------FKDFPPSSLPLIETLLAIDPAERLTA 393 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~ 393 (410)
..+....+..+...+.......... .............. ....++.+.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 9999999888877665433211100 00000000000000 01124568899999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 015247 394 TVALNSEVIFQDR 406 (410)
Q Consensus 394 ~elL~hp~~~~~~ 406 (410)
.|+|+||||++-+
T Consensus 324 ~ell~hp~f~~~~ 336 (339)
T 1z57_A 324 REALKHPFFDLLK 336 (339)
T ss_dssp HHHTTSGGGGGGG
T ss_pred HHHhcCHHHHHHh
Confidence 9999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=369.46 Aligned_cols=260 Identities=29% Similarity=0.437 Sum_probs=207.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+++++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 689999999999999999999999999999999975432 1122345778999999999999999999987532
Q ss_pred ceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEeeccccc
Q 015247 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLASF 266 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~ 266 (410)
.|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp --EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred --eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999987544444445568999999999999999999999999999999999999987664 99999999987
Q ss_pred cCCCCCCCCcccccccccccccccc--CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCCHHHh
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL-HKIYKLCGSPSEEYW 343 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 343 (410)
..... ......||+.|+|||++. +...++.++|||||||++|+|++|..||........+ ..+.......
T Consensus 167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 239 (322)
T 2ycf_A 167 LGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----- 239 (322)
T ss_dssp CCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-----
T ss_pred ccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-----
Confidence 64321 123457899999999874 3345889999999999999999999999876543322 2232211111
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+..+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 240 --------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 240 --------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp --------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred --------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 123335788899999999999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=366.90 Aligned_cols=280 Identities=24% Similarity=0.390 Sum_probs=225.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc------eeeEeeeEeecC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLDHPN------VIKLEGLVTSRM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 188 (410)
++|++.+.||+|+||.||+|++..++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH- 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-
Confidence 78999999999999999999988776 68999998643 344566778999999887655 88998888774
Q ss_pred CceEEEEEeeccCCHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE-----------------
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----------------- 250 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----------------- 250 (410)
...++||||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 -GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred -CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 4699999999999888775443 579999999999999999999999999999999999999
Q ss_pred --cCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHH
Q 015247 251 --DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 328 (410)
Q Consensus 251 --~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999875432 24567899999999987654 899999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCccc-----CCCCCchhhhhhhhhC----------CCCCCcHHHHHhccCCCCCCCCCH
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATL-----FKPREPYKRCIQETFK----------DFPPSSLPLIETLLAIDPAERLTA 393 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~li~~~L~~dP~~Rpt~ 393 (410)
..+.+..+..+...+.......... ............+... ..+.++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 9999999988877665443221100 0000000111111110 113468899999999999999999
Q ss_pred HHHhcCCCCCCC
Q 015247 394 TVALNSEVIFQD 405 (410)
Q Consensus 394 ~elL~hp~~~~~ 405 (410)
.|+|+||||++-
T Consensus 329 ~e~l~hp~f~~~ 340 (355)
T 2eu9_A 329 AEALLHPFFAGL 340 (355)
T ss_dssp HHHTTSGGGGGC
T ss_pred HHHhcChhhcCC
Confidence 999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=380.78 Aligned_cols=265 Identities=17% Similarity=0.204 Sum_probs=194.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC--CCCceeeEe-------eeEe
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL--DHPNVIKLE-------GLVT 185 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 185 (410)
.+|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 569999999999999999999999999999999988665 334455677785544444 699988854 3333
Q ss_pred ecCC---------------ceEEEEEeeccCCHHHHhcCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceeccCC
Q 015247 186 SRMS---------------CSLYLVFHYMEHDLAGLAASPEVKFTEPQV------KCYMHQLLSGLEHCHNNGVLHRDIK 244 (410)
Q Consensus 186 ~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~------~~~~~qi~~~L~~LH~~~ivHrDlk 244 (410)
.... ..+|+||||++++|...+...+..+++..+ ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3221 448999999998888877654444555555 6777999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccC-CcCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 015247 245 GSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGRT 323 (410)
Q Consensus 245 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 323 (410)
|+|||++.++.+||+|||+++..+.. .....+|+.|+|||++.+ ...++.++|||||||++|||++|+.||.+..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999876422 224567799999999875 2358999999999999999999999998764
Q ss_pred hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 324 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
.... ..+........ ............+++.+.+||.+||++||.+|||+.++|+||||+
T Consensus 298 ~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 298 PGIK-------------GSWKRPSLRVP-------GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTCT-------------TCCCBCCTTSC-------CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred cccc-------------cchhhhhhhhc-------cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 3210 00000000000 000001111247889999999999999999999999999999997
Q ss_pred C
Q 015247 404 Q 404 (410)
Q Consensus 404 ~ 404 (410)
+
T Consensus 358 ~ 358 (371)
T 3q60_A 358 Q 358 (371)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=363.24 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=217.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+.++++++||||+++++++.. ....+++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 99 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEEE
Confidence 68999999999999999999998899999999998665544456678899999999999999999999887 4569999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 271 (410)
|||+.++ +...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 100 ~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 100 GELYTGGELFDEII-KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp ECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999875 444433 33479999999999999999999999999999999999999754 479999999998775433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
. .....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........
T Consensus 179 ~--~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 243 (287)
T 2wei_A 179 K--MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------- 243 (287)
T ss_dssp S--CSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred c--cccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2 3445689999999988753 889999999999999999999999998888777766553211111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 244 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 --------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1123678889999999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=377.37 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=208.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|++. .+++.||||+++.... .....+.+.+|++++..+ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 478999999999999999999974 5899999999865321 112233466799999999 699999999998874
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
..+++||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 4699999999885554444444579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCHHHh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 343 (410)
..........+||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-------
Confidence 4433334456899999999998753 3478899999999999999999999976433 222222222100
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQD 405 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~~ 405 (410)
.....+++.+.+||.+||+.||.+|| |+.++|+||||++-
T Consensus 284 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 284 ----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 01135778899999999999999999 99999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=366.88 Aligned_cols=270 Identities=24% Similarity=0.372 Sum_probs=192.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.++..++||||+++++++.... ..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS--CEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEE
Confidence 4789999999999999999999888999999998865432 233456778999999999999999999998754 5899
Q ss_pred EEeeccCC-HHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 195 VFHYMEHD-LAGLAAS-------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
||||++++ +...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999764 4443321 345699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 267 FDPNHK----HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 267 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
...... .......||+.|+|||++.+...++.++||||||+++|+|++|+.||......................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 249 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET- 249 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc-
Confidence 643321 112345789999999988654458999999999999999999999999877665544333211100000
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..........+++++.+||.+||+.||.+|||+.++|+||||++.+
T Consensus 250 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 250 ------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp -----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0001122346788899999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=374.92 Aligned_cols=283 Identities=23% Similarity=0.332 Sum_probs=212.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEE
Confidence 378999999999999999999999999999999997653 455567788999999999999999999999874 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||++++.+..+......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999998855544444445799999999999999999999996 99999999999999999999999999997653221
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC---
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN--- 350 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--- 350 (410)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+...................
T Consensus 187 -~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2455789999999998775 48999999999999999999999999887665533332111111100000000000
Q ss_pred --ccc-CCCCCchhhhh----hhh-----hCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 351 --ATL-FKPREPYKRCI----QET-----FKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 351 --~~~-~~~~~~~~~~~----~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
... ..+.......+ ... ...+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 000 00000000000 000 1235778999999999999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=361.34 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=204.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++ +|+.||+|++..........+.+.+|+.++++++||||+++++++.... .+++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceEE
Confidence 47899999999999999999974 6889999999877666777778899999999999999999999988743 4899
Q ss_pred EEeeccCC-HHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 195 VFHYMEHD-LAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
||||++++ +...+.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999875 444444332 13999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------- 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----------- 258 (309)
T ss_dssp -----------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred cc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 32 2234567899999999988754 8999999999999999999999999988877766654321111
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc--CCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN--SEVIF 403 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~--hp~~~ 403 (410)
.....+++.+.+||.+||+.||.+|||+.++++ .++++
T Consensus 259 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 259 ----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111367888999999999999999999999987 44443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=357.86 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=217.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 6799999999999999999999999999999999865433 3456788999999999999999999999874 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 176 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence 999998554444433 4799999999999999999999999999999999999999999999999999987654322 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......
T Consensus 177 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 237 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP------------------ 237 (303)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------------------
T ss_pred CccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC------------------
Confidence 456789999999998765 4899999999999999999999999988777666555431100
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 238 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 238 ----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 11136778899999999999999999999999999996543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=367.82 Aligned_cols=278 Identities=21% Similarity=0.310 Sum_probs=209.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+++++.++||||+++++++........++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 689999999999999999999999999999999975432 2224567789999999999999999999988766679999
Q ss_pred EeeccC-CHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEeeccccccC
Q 015247 196 FHYMEH-DLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFD 268 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~~ 268 (410)
|||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999986 4545444322 239999999999999999999999999999999999999 788889999999998875
Q ss_pred CCCCCCCccccccccccccccccC-------CcCCCCccchHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLG-------ATDYGVGVDLWSAGCILAELLAGKPIMPGRT----EVEQLHKIYKLCGS 337 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~ 337 (410)
.... .....||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+..+....
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 243 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK-- 243 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC--
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC--
Confidence 4432 345678999999998752 2458999999999999999999999997543 234444444432
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
+...+................+. ........+++.+.+||.+||+.||++|||+.|+|+||
T Consensus 244 -p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 -PSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp -CTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred -CcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11111100000000000000000 00011123455689999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.18 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=210.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++..++||||+++++++... ...++|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 94 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIM 94 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEEE
Confidence 78999999999999999999999999999999986543 23356788899999999999999999998874 459999
Q ss_pred EeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+. .+......+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 9999885544 444445579999999999999999999999999999999999999999999999999975432111 11
Q ss_pred Ccccccccccccccccc----CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
.....||+.|+|||++. ....++.++||||||+++|+|++|..||...+.......+........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 242 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL----------- 242 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-----------
Confidence 23457899999999884 334588999999999999999999999999888777666654211100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....++..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 243 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 ---------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00125677899999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.13 Aligned_cols=283 Identities=29% Similarity=0.454 Sum_probs=222.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCceeeEeeeE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----------HPNVIKLEGLV 184 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 184 (410)
++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 6899999999999999999999999999999998643 334556778999998876 89999999998
Q ss_pred eec--CCceEEEEEeeccCCHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEc------CCC
Q 015247 185 TSR--MSCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLID------DDG 254 (410)
Q Consensus 185 ~~~--~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~------~~~ 254 (410)
... ....++++|||+++++...+.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ ..+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 763 2347899999998788877654 345699999999999999999999998 999999999999995 344
Q ss_pred cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC------hHHHH
Q 015247 255 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQL 328 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------~~~~~ 328 (410)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+ ..+.+
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 8999999999876532 24457899999999998754 8999999999999999999999998754 56778
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcc-----cCC-----CCCchhhhhhh---hhCCCCCCcHHHHHhccCCCCCCCCCHHH
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNAT-----LFK-----PREPYKRCIQE---TFKDFPPSSLPLIETLLAIDPAERLTATV 395 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 395 (410)
..+...++..+...+...+..... ... ...+....+.. .....++++.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 888899998887666544322100 000 00001111111 11234567889999999999999999999
Q ss_pred HhcCCCCCCCC
Q 015247 396 ALNSEVIFQDR 406 (410)
Q Consensus 396 lL~hp~~~~~~ 406 (410)
+|+||||++..
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=386.71 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=198.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHH---HHHhCCCCceeeEe-------ee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL---ILRRLDHPNVIKLE-------GL 183 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 183 (410)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999888999999999986533 3445677889994 55556899999998 55
Q ss_pred EeecCC------------c---eEEEEEeeccCCHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 015247 184 VTSRMS------------C---SLYLVFHYMEHDLAGLAASPE------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRD 242 (410)
Q Consensus 184 ~~~~~~------------~---~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrD 242 (410)
+..... . ..|++|||+++++...+.... ..+++..+..++.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 443311 0 378999999887777654321 2234588889999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCC----------cCCCCccchHHHHHHHHHH
Q 015247 243 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAEL 312 (410)
Q Consensus 243 lkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGv~l~el 312 (410)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 2345567 999999998765 2489999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC
Q 015247 313 LAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392 (410)
Q Consensus 313 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 392 (410)
++|+.||.+.+.......+ ......+++++.+||.+||+.||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999765432221111 1112477889999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 015247 393 ATVALNSEVIFQ 404 (410)
Q Consensus 393 ~~elL~hp~~~~ 404 (410)
+.++|+||||++
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=369.22 Aligned_cols=275 Identities=22% Similarity=0.347 Sum_probs=215.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH---------------HHHHHHHHHHHHHhCCCCceee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE---------------SVKFMAREILILRRLDHPNVIK 179 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~ 179 (410)
.++|++.+.||+|+||.||+|++ +|+.||+|++........ ..+.+.+|+.++..++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999997 999999999975432111 1267889999999999999999
Q ss_pred EeeeEeecCCceEEEEEeeccCCHHHHh------cCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEE
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLA------ASP--EVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLI 250 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~------~~~--~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl 250 (410)
+++++... ...++||||++++.+..+ ... ...+++..++.++.||+.||.|||+ .||+||||||+|||+
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 99998874 469999999998544433 333 5689999999999999999999999 999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCC-ccchHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV-GVDLWSAGCILAELLAGKPIMPGRTE-VEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlGv~l~ell~g~~pf~~~~~-~~~~ 328 (410)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++||||||+++|+|++|..||.+.+. .+..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876433 2345678999999999887644665 99999999999999999999998877 5555
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
..+.......+ .....................+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 263 ~~i~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYP----------LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCC----------CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCc----------cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 55543211111 000000000000001122246888999999999999999999999999999999765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=358.60 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=210.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 102 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWIV 102 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEE
Confidence 789999999999999999999999999999999976432 34577899999999999999999998874 458999
Q ss_pred EeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||+++ ++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 999987 45554444456899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+........
T Consensus 182 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 245 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--------------- 245 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------
T ss_pred cCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc---------------
Confidence 3455789999999998765 489999999999999999999999998877665544433110000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+++.+.+||.+||+.||.+|||+.++|+||||++.+
T Consensus 246 -----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 246 -----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00124678899999999999999999999999999998765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=362.62 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=209.4
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC----
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---- 188 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 188 (410)
..++|++.+.||+|+||.||+|++..+|+.||+|++...... .+.+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 347899999999999999999999899999999999765432 34577899999998 8999999999987643
Q ss_pred CceEEEEEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 189 SCSLYLVFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
...+++||||+++ ++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 4579999999987 55554433 235799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 179 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 251 (326)
T 2x7f_A 179 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA------ 251 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred cCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------
Confidence 64322 12344578999999999862 23488999999999999999999999998887766655543110
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
+. .....+++.+.+||.+||..||.+|||+.++|+||||++.+
T Consensus 252 ------~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 252 ------PR---------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp ------CC---------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ------cc---------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 00 00135788899999999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=357.77 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=202.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR-------- 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 187 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 6799999999999999999999999999999999642 34566788999999999999999999988653
Q ss_pred ---CCceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecc
Q 015247 188 ---MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 263 (410)
Q Consensus 188 ---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGl 263 (410)
.....|+||||+++ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 24568999999986 56665555556789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-------------CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHH
Q 015247 264 ASFFDPNH-------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLH 329 (410)
Q Consensus 264 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~ 329 (410)
+....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||... +..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 98764321 1123455789999999998865568999999999999999998 55432 2223333
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+....... +. ......++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~----------~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 240 KLRSVSIEF----------PP---------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHSTTCCC----------CT---------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hcccccccc----------Cc---------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 332211100 00 1112455668999999999999999999999999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=362.02 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.++..+++.++||||+++++++... ...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Confidence 34789999999999999999999989999999999987654444444555566678888999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+||||+++.+..........+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++........
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 9999997665555554456899999999999999999999995 999999999999999999999999999977643322
Q ss_pred CCCccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 273 HPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||... ...+.+..+.......
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 249 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--------- 249 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---------
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---------
Confidence 345578999999999852 345889999999999999999999999874 4445555554421100
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
++ ....+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus 250 ~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 LP-----------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CC-----------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CC-----------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00 01257888999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=350.99 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=210.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++. +++.||+|++....... +.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEE
Confidence 78999999999999999999974 67889999997655433 4578899999999999999999998874 449999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++ +...+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999875 555555666689999999999999999999999999999999999999999999999999998765433333
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------- 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC--------------
T ss_pred ccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC--------------
Confidence 34456688999999987644 8999999999999999999 9999999888887776654211110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++.+.+||.+||+.||.+|||+.++++|
T Consensus 229 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 --------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12467889999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.18 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=208.7
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|++..+++ .||||+++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--Cc
Confidence 4789999999999999999999876554 59999997543 455567788999999999999999999998774 45
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.|+||||+++ ++...+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 8999999977 555555566678999999999999999999999999999999999999999999999999999887543
Q ss_pred CCCC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 275 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-------- 275 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--------
T ss_pred ccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC--------
Confidence 3221 22334578899999987644 8999999999999999999 9999999988887777654321111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...+++.+.+||..||+.||.+|||+.++++
T Consensus 276 --------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 --------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1267888999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=351.22 Aligned_cols=253 Identities=22% Similarity=0.388 Sum_probs=204.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++.. ......+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEE
Confidence 3789999999999999999999999999999999854 3456677888999999999999999999999874 45999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999987 555555555678999999999999999999999999999999999999999999999999999876433221
Q ss_pred C-------------CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 274 P-------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 274 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------- 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------- 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence 1 1256789999999998874 48999999999999999999999986532211000
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...............+|+.+.+||.+||+.||.+|||+.++++
T Consensus 233 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 ---------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000011112478999999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=362.66 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=193.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc-
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC- 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 190 (410)
.++|++.+.||+|+||.||+|++..++. .||+|++..........+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3789999999999999999999776665 899999987655556677889999999999999999999998764331
Q ss_pred ---eEEEEEeeccCCHHH-Hhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 191 ---SLYLVFHYMEHDLAG-LAA-----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 191 ---~~~lv~e~~~~~l~~-~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
..+++|||+.++.+. .+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 248999999985443 332 12236999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCC
Q 015247 262 GLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPS 339 (410)
Q Consensus 262 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 339 (410)
|++......... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 259 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK- 259 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC-
Confidence 999876543321 122345688999999987644 8999999999999999999 999999988877776665421110
Q ss_pred HHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-------HHHHhcCCCCCCC
Q 015247 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-------ATVALNSEVIFQD 405 (410)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~elL~hp~~~~~ 405 (410)
....+++.+.+||.+||+.||.+||| ++++++|||+...
T Consensus 260 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 260 ---------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ---------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 11367788999999999999999999 8999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.85 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=207.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 378999999999999999999864 345679999987543 445567788999999999 89999999999887
Q ss_pred cCCceEEEEEeeccCC-HHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 015247 187 RMSCSLYLVFHYMEHD-LAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl 250 (410)
. ..+|+||||++++ |...+... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 159 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred C--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 4 4589999999874 54444322 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 2233456788999999988754 9999999999999999999 99999988777666
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+...... .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 316 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555332100 0112577889999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=357.66 Aligned_cols=251 Identities=21% Similarity=0.220 Sum_probs=206.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEE
Confidence 6899999999999999999999999999999999755322 2367799999999 99999999999887 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-----EEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-----LKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~~~~~ 269 (410)
||||+++++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+++.+..
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 83 VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999977777777655668999999999999999999999999999999999999998887 99999999987643
Q ss_pred CCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 015247 270 NHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSE 340 (410)
Q Consensus 270 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 340 (410)
.... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+. .+.+..+.......+.
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 3221 124568999999999988754 89999999999999999999999988543 3444444332211111
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+| ++.+||..||+.||.+||++.++++
T Consensus 242 ------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 ------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11123455 8999999999999999999988876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.15 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=209.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|++ .++..||+|++....... +.+.+|+.++..++||||+++++++... ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEE
T ss_pred chhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccC--CceE
Confidence 347899999999999999999986 467789999997655433 4578899999999999999999998764 4599
Q ss_pred EEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+||||++++ +...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999875 5555554455699999999999999999999999999999999999999999999999999987755443
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 226 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------------ 226 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC------------
Confidence 3334455678899999987644 8999999999999999999 9999999888877766644211110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.+.+||..||+.||.+|||+.++|++
T Consensus 227 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 ----------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12457789999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=350.60 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=204.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|.....||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEE
Confidence 45666779999999999999999999999999997653 23356688899999999999999999999874 469999
Q ss_pred EeeccC-CHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeeccccccCCCC
Q 015247 196 FHYMEH-DLAGLAASP--EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~ 271 (410)
|||+++ ++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999976 454444332 235679999999999999999999999999999999999987 8999999999998765332
Q ss_pred CCCCccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
. ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...................
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 244 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH------------ 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC------------
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc------------
Confidence 1 23455789999999998653 237889999999999999999999997654433221111111100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 245 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 245 --------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 011136788899999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=347.91 Aligned_cols=252 Identities=18% Similarity=0.215 Sum_probs=209.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.++..+ +|+|++++++++.. ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 83 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 83 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEE
Confidence 6899999999999999999999999999999998754322 2366799999999 79999999998876 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-----EEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-----LKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~~~~~ 269 (410)
||||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 84 v~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999977788777666667999999999999999999999999999999999999987776 99999999987754
Q ss_pred CCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCH
Q 015247 270 NHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 270 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 340 (410)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+ ..+.+..+......++
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 241 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP- 241 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-
Confidence 3321 234567899999999987754 8999999999999999999999998843 4444444443221111
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+|+++.+||..||+.||.+|||+.++++
T Consensus 242 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 -----------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp -----------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22333478899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=349.18 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=207.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+ .++..||+|++....... +.+.+|+.++..++||||+++++++... ...++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeEE
Confidence 47899999999999999999986 477789999997654433 4577899999999999999999998774 45999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999976 555555554667999999999999999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+........
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred cccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------------
Confidence 233445688899999987644 8999999999999999998 9999999988887777654321111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.+.+||..||+.||.+|||+.++|+|
T Consensus 243 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 ---------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12467789999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=366.32 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=207.6
Q ss_pred CCCcceeeeeccCCCeeEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 3789999999999999999999 44678899999986432 444455688899999999999999999998774
Q ss_pred ceEEEEEeeccC-CHHHHhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEE
Q 015247 190 CSLYLVFHYMEH-DLAGLAASP------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~ 259 (410)
...++||||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 347999999976 555544322 24699999999999999999999999999999999999999555 59999
Q ss_pred eeccccccCCCC-CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||+++...... ........+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998653221 22234456799999999987644 8999999999999999998 99999999888877766542211
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
. ....+++.+.+||.+||+.||.+|||+.+++++.++
T Consensus 306 ~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 306 D----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 113577889999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=363.38 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=206.6
Q ss_pred CCCcceeeeeccCCCeeEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 3789999999999999999998 55677899999997543 444566788999999999 799999999998764
Q ss_pred CceEEEEEeeccC-CHHHHhcCCC--------------------------------------------------------
Q 015247 189 SCSLYLVFHYMEH-DLAGLAASPE-------------------------------------------------------- 211 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------- 211 (410)
...+++||||+.+ ++...+....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3458999999987 4444443322
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CCCcccccc
Q 015247 212 ---------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVT 281 (410)
Q Consensus 212 ---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt 281 (410)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 1289999999999999999999999999999999999999999999999999987643322 223445679
Q ss_pred ccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCch
Q 015247 282 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPY 360 (410)
Q Consensus 282 ~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (410)
+.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+.........+.
T Consensus 259 ~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 316 (359)
T 3vhe_A 259 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--------------------- 316 (359)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------
T ss_pred ceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---------------------
Confidence 999999998764 48999999999999999998 9999998776555544443211111
Q ss_pred hhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 361 KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 361 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+++++.+||..||+.||.+|||+.++++|
T Consensus 317 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 112567889999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=349.23 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=196.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 37899999999999999999997653 4579999876432 44556678899999999999999999998754 34
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.|+||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 7899999987 555555555567999999999999999999999999999999999999999999999999999887544
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.........+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+......+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~----------- 237 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------- 237 (281)
T ss_dssp ---------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred cccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-----------
Confidence 43333445668899999998764 48999999999999999996 999999888777766664321100
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 238 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 -----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113678889999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.46 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=205.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--CCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++.+.||+|+||.||+|++ .+++.||+|++..........+.+.+|+.++..++ ||||+++++++... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEE
T ss_pred cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEE
Confidence 36899999999999999999996 56899999999877666677788899999999997 59999999998874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+++||+.++++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 104 ~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 999997777777766543 4789999999999999999999999999999999999996 58999999999987654332
Q ss_pred C-CCccccccccccccccccCC----------cCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCH
Q 015247 273 H-PMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSE 340 (410)
Q Consensus 273 ~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 340 (410)
. ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...... ..+..+......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc---
Confidence 1 22345789999999998652 34788999999999999999999999876443 223322211000
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
. ......++.+.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 259 -----~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 259 -----I-------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp -----C-------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred -----c-------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 0 00124467799999999999999999999999999999876553
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=351.63 Aligned_cols=259 Identities=21% Similarity=0.367 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.......
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 789999999999999999998 5678999999998743 3455677889999999999999999999987655556
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+++||||+++ ++...+......+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||++......
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 8999999976 565555555556999999999999999999999999999999999999999999999999999877543
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH-H------
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE-E------ 341 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~------ 341 (410)
... ......+|..|+|||++.+.. ++.++||||||+++|+|++|..||...... .. ...+.... .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQGQMIVFHL 241 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCCTHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccccchhHHHH
Confidence 321 123345688899999987654 899999999999999999999988654221 11 11111110 0
Q ss_pred --HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 --YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...... .......+++++.+||..||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNG----------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTC----------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccC----------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000 00111367888999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=370.17 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=205.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+ .++..||||+++.... ..+.+.+|+.+|+.++|||||++++++.. ..+|+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccEE
Confidence 47899999999999999999986 4578899999976543 35568899999999999999999998863 34899
Q ss_pred EEeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+.+ ++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999987 455554432 23689999999999999999999999999999999999999999999999999987653322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+......+.
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------------ 406 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------------ 406 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC------------
T ss_pred eccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 2223345678899999987644 8999999999999999999 9999999988888777655321111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...+|+++.+||.+||+.||.+|||+.++++
T Consensus 407 ----------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 ----------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1267888999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=345.76 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++. ..||+|+++.........+.+.+|+.+++.++||||++++++... ...++|
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~lv 97 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV 97 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEEE
Confidence 78999999999999999999743 359999998776667777889999999999999999999996543 347999
Q ss_pred EeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CC
Q 015247 196 FHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-KH 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 273 (410)
|||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999986 5555555666789999999999999999999999999999999999999999999999999998664321 22
Q ss_pred CCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 274 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.. ...++.++||||||+++|+|++|+.||.+....+.+..+.......+.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 246 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD----------- 246 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----------
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-----------
Confidence 2345678999999998862 344888999999999999999999999987777666555543211110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 247 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 ------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01112367888999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=365.43 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=208.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ........+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEE
Confidence 47899999999999999999999889999999998643 3445556788899999999999999999999774 34899
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+++ ++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999986 555555554557999999999999999999999999999999999999999999999999999865432211
Q ss_pred C-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 274 P-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 274 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
. .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP------------- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 1 12234578899999987644 8999999999999999998 999999988777665553321100
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 336 ---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 ---------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01256788999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=357.90 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=188.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHH-HHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+..|+. +++.++||||+++++++... ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceE
Confidence 3789999999999999999999999999999999986543 333344555655 67778999999999999874 4699
Q ss_pred EEEeeccCCHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 194 LVFHYMEHDLAGLAA----SPEVKFTEPQVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 194 lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
+||||+++++...+. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 999999998766553 2356899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCCcccccccccccccccc---CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHhh
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLL---GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 344 (410)
.... .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.... +.+..+..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 244 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK----------- 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC-----------
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc-----------
Confidence 3322 23457899999999883 2244889999999999999999999999865432 11111100
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+. ........+++.+.+||.+||+.||.+|||+.++|+||||.+
T Consensus 245 -~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 245 -GDPPQ------------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -SCCCC------------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -CCCCC------------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00000 000112357888999999999999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=359.26 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLD--HPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++.++ |+||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~- 120 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 120 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-
Confidence 378999999999999999999999999999999997654321 11234567999999996 59999999999874
Q ss_pred CceEEEEEeeccC--CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeecccc
Q 015247 189 SCSLYLVFHYMEH--DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLAS 265 (410)
Q Consensus 189 ~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~ 265 (410)
...+++||++.+ ++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.
T Consensus 121 -~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 121 -DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 459999999974 55554433 45799999999999999999999999999999999999999 78999999999998
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
...... .....||+.|+|||++.+...++.++||||||+++|||++|+.||..... +....
T Consensus 199 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~---------- 259 (320)
T 3a99_A 199 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ---------- 259 (320)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC----------
T ss_pred cccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc----------
Confidence 775332 34567899999999987655457899999999999999999999975321 11100
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
. .....+++++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 260 ~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 V-------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp C-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred c-------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0 011367888999999999999999999999999999997653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=350.66 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=197.6
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++..++||||+++++++... ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeE
Confidence 34789999999999999999999999999999999875433 344457788999999999999999999999874 469
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|++|||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999744444443445799999999999999999999999999999999999999999999999999987754443
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+ ......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-------------- 253 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR-------------- 253 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC--------------
T ss_pred ccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC--------------
Confidence 334556789999999988764 4899999999999999999999999887655333222 211100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-CHHHHhc
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-TATVALN 398 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~elL~ 398 (410)
.......+|+.+.+||.+||+.||.+|| |++++++
T Consensus 254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122247899999999999999999999 7877764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=360.95 Aligned_cols=263 Identities=20% Similarity=0.191 Sum_probs=201.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCC-----CceEEEEEEecCCCChH---------HHHHHHHHHHHHHhCCCCceeeE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPE---------SVKFMAREILILRRLDHPNVIKL 180 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l 180 (410)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ .......|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 36899999999999999999987654 58899999876531100 01123345666778899999999
Q ss_pred eeeEeecC--CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCCcE
Q 015247 181 EGLVTSRM--SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVL 256 (410)
Q Consensus 181 ~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~v 256 (410)
++++.... ..+.|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99987642 356899999997777777766667899999999999999999999999999999999999999 88999
Q ss_pred EEEeeccccccCCCCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 015247 257 KIADFGLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 330 (410)
Q Consensus 257 kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 330 (410)
||+|||+++.+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999876433221 123456999999999988754 89999999999999999999999986433332222
Q ss_pred HHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 331 IYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETF--KDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 331 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+.. ...+...+ ..+|+++.+||..||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENI--------------------ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCH--------------------HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhH--------------------HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2221100010 00111111 467899999999999999999999998874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.20 Aligned_cols=247 Identities=16% Similarity=0.218 Sum_probs=200.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 187 (410)
.++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 478999999999999999999988777 479999986533 34456788999999999999999999999874
Q ss_pred CCceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--------EEE
Q 015247 188 MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--------LKI 258 (410)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vkl 258 (410)
. ..++||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 85 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 85 D--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp T--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred C--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 3 47899999986 555555555555999999999999999999999999999999999999998887 999
Q ss_pred EeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Q 015247 259 ADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 259 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|..|+...........+.....
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~-- 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH-- 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC--
Confidence 99999865432 23456799999999998755689999999999999999996544444433333333322110
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......++++.+||.+||+.||.+|||+.++++|
T Consensus 236 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 ---------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112568899999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=358.57 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=209.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|++.. ++..||+|++... ........+.+|+++++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3789999999999999999998653 3357999999754 3455567788999999999 99999999999987
Q ss_pred cCCceEEEEEeeccC-CHHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 015247 187 RMSCSLYLVFHYMEH-DLAGLAASP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl 250 (410)
. ...++||||+++ +|...+... ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 147 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred C--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 4 348999999987 555544332 2469999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987754332 2234456789999999988754 8999999999999999999 99999998887776
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+....... ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 304 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6654321100 113678889999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.88 Aligned_cols=271 Identities=23% Similarity=0.262 Sum_probs=198.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC--CceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM--SCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~~ 192 (410)
.++|++.+.||+|+||.||+|++ .++.||||++.... .......+|+.++..++||||+++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 37899999999999999999985 48999999986432 33344556899999999999999999998743 3458
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCEEEcCCCcEEEEee
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN----------GVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----------~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
++||||++++ +...+.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999874 5444433 3599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-CCccccccccccccccccCC----cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Q 015247 262 GLASFFDPNHKH-PMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCG 336 (410)
Q Consensus 262 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~ 336 (410)
|+++........ ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+...............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999877543322 23446789999999998763 2356788999999999999999999987644222111111122
Q ss_pred CCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 337 SPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+....+.............. .... ....++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLR----DYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCC----GGGG--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCcc----cccc--ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222111111000000000000 0000 0012334899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=357.72 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=179.8
Q ss_pred CCCcceee-eeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCce
Q 015247 115 ADSFEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCS 191 (410)
Q Consensus 115 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 191 (410)
.++|++.+ .||+|+||.||+|++..+|+.||||++... .. ...+....++.++||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 37899965 699999999999999999999999999643 11 122233446677999999999998652 2445
Q ss_pred EEEEEeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccccc
Q 015247 192 LYLVFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASF 266 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~ 266 (410)
+++||||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 8999999987 5555554433 47999999999999999999999999999999999999986 45599999999987
Q ss_pred cCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 267 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+....... ..
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------~~ 250 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------QY 250 (336)
T ss_dssp C-------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ccccc---cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc------cc
Confidence 64322 3456789999999988664 48899999999999999999999998766544322221111000 00
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+ ....+..+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 251 ~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 GF---------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CC---------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cc---------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 011123678899999999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=340.46 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=210.1
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|++ +++.||+|++..........+.+.+|+.+++.++||||+++++++........+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 347899999999999999999986 488999999987766667777899999999999999999999999886556799
Q ss_pred EEEeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 194 LVFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
++|||+++ ++...+.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999987 5555554433 25999999999999999999999999 9999999999999999999999999875432
Q ss_pred CCCCCCccccccccccccccccCCcC--CCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.....||+.|+|||++.+... ++.++||||||+++|+|++|+.||.+.+..+....+......+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 234578999999999876431 2337999999999999999999999988877766665422111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111367888999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=355.25 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=207.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 478999999999999999999986 355899999987543 445567788999999999999999999998874
Q ss_pred ceEEEEEeeccC-CHHHHhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 015247 190 CSLYLVFHYMEH-DLAGLAASP-----------------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKG 245 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 245 (410)
...++||||+++ ++...+... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 458999999987 454444321 25799999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 015247 246 SNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 323 (410)
Q Consensus 246 ~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~ 323 (410)
+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999987643321 1223456799999999887644 8999999999999999999 999999988
Q ss_pred hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 324 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+....+...... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 87776666432110 0113678889999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=342.01 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=203.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHH-----HHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-----VKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++......... .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 37899999999999999999999999999999998765432221 156889999999999999999999986642
Q ss_pred ceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCc-----EEEEee
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGV-----LKIADF 261 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~-----vkl~DF 261 (410)
++||||+.+ ++...+......+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+||
T Consensus 97 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 ---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp ---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 699999985 666777777778999999999999999999999999 999999999999988876 999999
Q ss_pred ccccccCCCCCCCCccccccccccccccccC-CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCC
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ--LHKIYKLCGSP 338 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~--~~~i~~~~~~~ 338 (410)
|++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........ ...+... +..
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GLR 248 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CCC
Confidence 99975432 2345678999999998842 23478899999999999999999999987654332 2222221 110
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+ .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 P--------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp C--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 111367888999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.42 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=197.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.++.+++||||+++++++... ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cc
Confidence 368999999999999999999876 467789999987543 445567788999999999999999999998874 45
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.++||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 8999999976 566666666668999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.... .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-------- 271 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-------- 271 (373)
T ss_dssp -------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC--------
T ss_pred CccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 3221 1223457789999998764 48999999999999999998 9999999888777666543211110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...++..+.+||..||+.||.+|||+.++++
T Consensus 272 --------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 --------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1256788999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=353.16 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=203.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|++..+++. ||+|.+..... ......+.+|+.++..++||||+++++++.. ..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---Cc
Confidence 7899999999999999999998888876 67777643321 2223346679999999999999999998864 34
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.++||||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 8899999986 555666565668999999999999999999999999999999999999999999999999999987544
Q ss_pred CCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+....+....+.......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 237 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA---------- 237 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC----------
T ss_pred cccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC----------
Confidence 332 234456788999999987644 8999999999999999999 999999887766655554321000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.++.+||.+||+.||.+|||+.+++++
T Consensus 238 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 ------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012568889999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=346.59 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=210.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEEE
Confidence 478999999999999999999999999999999997543 3456688899999999999999999998774 45899
Q ss_pred EEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+++ ++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999986 55555433 345699999999999999999999999999999999999999999999999999988765443
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+.......+......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------- 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------
T ss_pred ccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC--------------
Confidence 3334456788999999987644 8999999999999999999 99999988776666555432110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 232 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 011367888999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=350.26 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=206.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 99 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--G 99 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--C
Confidence 78999999999999999999873 456899999987543 455567788999999999999999999998774 4
Q ss_pred eEEEEEeeccC-CHHHHhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASP-----------------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGS 246 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 246 (410)
..++||||+.+ ++...+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 58999999986 454444322 124899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCCh
Q 015247 247 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 324 (410)
Q Consensus 247 NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~ 324 (410)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+...
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543221 123345688999999987644 8999999999999999999 9999998877
Q ss_pred HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 325 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......+...... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRM----------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcCCcC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6665554331100 0113678889999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=355.03 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=198.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhC----CCCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRL----DHPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 378999999999999999999998999999999997654322 1223455689999888 89999999999877
Q ss_pred cCCceEEEEEee-ccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeecc
Q 015247 187 RMSCSLYLVFHY-MEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGL 263 (410)
Q Consensus 187 ~~~~~~~lv~e~-~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGl 263 (410)
. ...+++||+ +.+ ++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~--~~~~~v~e~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 Q--EGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred C--CeEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 4 348899998 555 4555443 344799999999999999999999999999999999999999 899999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 264 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 264 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
+....... .....||+.|+|||++.+....+.++||||||+++|+|++|+.||.... .+...
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--------- 248 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--------- 248 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT---------
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh---------
Confidence 98775432 3456789999999988765534568999999999999999999997532 11111
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... ....+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 249 -~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 -ELH-------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -CCC-------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -ccC-------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 000 1125788899999999999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=347.67 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=200.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc-
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC- 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 190 (410)
.++|++.+.||+|+||.||+|++.. ++..||+|++..........+.+.+|+.+++.++||||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4789999999999999999998754 456899999987766666677889999999999999999999998764332
Q ss_pred --eEEEEEeeccCCHH-HHhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 191 --SLYLVFHYMEHDLA-GLAA-----SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 191 --~~~lv~e~~~~~l~-~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
..+++|||++++.+ ..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 46999999997544 4331 344679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 015247 263 LASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSE 340 (410)
Q Consensus 263 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 340 (410)
++......... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 268 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred cceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence 99876543321 12334568899999998764 48999999999999999999 99999988877776665442111
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 269 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 -------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113678889999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=342.94 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=206.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.+++.++|++++..+..+... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 37899999999999999999999999999999998765432 2467899999999988877766655443 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 271 (410)
||||+++++.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999778887776556689999999999999999999999999999999999999 488999999999998775443
Q ss_pred CC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHHH
Q 015247 272 KH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 272 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 342 (410)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+. .+.+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 134567899999999988754 89999999999999999999999987432 233333333211111
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+|+++.+||..||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223478899999999999999999999998875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=370.41 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=195.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 193 (410)
..+|++.+.||+|+||+|+.. ...+|+.||||++...... ...+|+.+|+.+ +|||||++++++.+ ....|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKD--RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEec--CCEEE
Confidence 357999999999999997643 3578999999999654322 245699999999 79999999998877 45689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-----CCcEEEEeeccccccC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-----DGVLKIADFGLASFFD 268 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~~~~ 268 (410)
+||||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++...
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999999998888777767777778899999999999999999999999999999953 2368899999998775
Q ss_pred CCCC--CCCccccccccccccccccC--CcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHh
Q 015247 269 PNHK--HPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 269 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 343 (410)
.... ......+||+.|+|||++.+ ...++.++|||||||++|||++ |..||.......... + .+.....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~~-- 248 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSLD-- 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCCT--
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCcc--
Confidence 4321 22345679999999999874 2447789999999999999999 899996654433221 1 1111000
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+ ....+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 249 ---------~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 ---------CLHP-----------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ---------TSCT-----------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ---------ccCc-----------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0000 0112344789999999999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.45 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=208.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+++++.++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEE
Confidence 378999999999999999999974 7789999999765433 34678899999999999999999998874 45899
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+|||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999986 555555555567999999999999999999999999999999999999999999999999999876433222
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------------
T ss_pred ccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC--------------
Confidence 23345668899999998764 48999999999999999999 899999988877776664421100
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....++.+.+||.+||+.||.+|||+.+++++
T Consensus 226 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 --------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012467789999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.25 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=202.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 37899999999999999999999999999999987654332 2366799999999988877776666443 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999778887776556689999999999999999999999999999999999999 789999999999998775443
Q ss_pred CC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCHHH
Q 015247 272 KH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV---EQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 272 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 342 (410)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 21 223567899999999988754 899999999999999999999999875432 22333322111111
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+|+++.+||..||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 12223467899999999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=343.42 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=204.2
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
..++|++.+.||+|+||.||+|++.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---
Confidence 34789999999999999999998653 34469999987543 445567788999999999999999999998653
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
..+++|||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 36899999986 45555545555799999999999999999999999999999999999999999999999999987755
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
..........+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 235 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK--------- 235 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---------
T ss_pred ccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---------
Confidence 443333445678899999988754 48999999999999999998 9999988777766665544211110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 -------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12567889999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=340.39 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=194.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
.++|++.+.||+|+||.||+|++ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence 47899999999999999999985 4889999998764332 23356788899999999999999999998874 458
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEEcC--------CCcEEEEee
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG---VLHRDIKGSNLLIDD--------DGVLKIADF 261 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NILl~~--------~~~vkl~DF 261 (410)
++||||++++.+..+.. ...+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999998766555544 347999999999999999999999999 899999999999986 778999999
Q ss_pred ccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
|++....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+.......
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 233 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL--- 233 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC---
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC---
Confidence 9998764332 23557899999999987644 8999999999999999999999999988776655543311100
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 ------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0112577889999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.09 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=198.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIV----ALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 378999999999999999999988787754 777665332 2334567888999999999999999999988642
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+++++|+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 6788888876 55666655567899999999999999999999999999999999999999999999999999988754
Q ss_pred CCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred CcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---------
Confidence 4322 22334568899999998864 48999999999999999999 999999887766555443321111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....++.++.+||.+||+.||.+|||+.+++++
T Consensus 240 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 012567789999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=338.75 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=208.6
Q ss_pred CCcceee-eeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKID-KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|.+.+ .||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCc
Confidence 6788887 9999999999999853 467889999997643 44556778899999999999999999999843 348
Q ss_pred EEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||+++ ++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999987 5555555566679999999999999999999999999999999999999999999999999998775433
Q ss_pred CC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.. ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~----------- 232 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 232 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----------
T ss_pred ceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-----------
Confidence 21 123345689999999987644 8999999999999999998 99999998887776655432100
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
.....+++.+.+||..||+.||.+|||+.+++++.
T Consensus 233 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 233 -----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -----------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01136788999999999999999999999999763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=343.79 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=202.8
Q ss_pred CCcceee-eeccCCCeeEEEEE--EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKID-KIGQGTYSNVYKAK--DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+ .||+|+||.||+|. +..+++.||+|+++.........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 92 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 92 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---CCc
Confidence 6899998 99999999999995 45667899999997665555556788899999999999999999999843 348
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
++||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999998754444444455799999999999999999999999999999999999999999999999999987754332
Q ss_pred CC--CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 273 HP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 273 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.. .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 239 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------ 239 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred cccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 11 12234578899999987644 8899999999999999999 99999998877766555431100
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011367888999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=344.48 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
+.|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 579999999999999999998 56789999999997543 2334567889999999999999999999998866667
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+++||||+++ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999987 555555455567999999999999999999999999999999999999999999999999999887544
Q ss_pred CC--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH------
Q 015247 271 HK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY------ 342 (410)
Q Consensus 271 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 342 (410)
.. .......+|..|+|||++.+.. ++.++||||||+++|+|++|..|+..... ......+......
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHHHHH
Confidence 32 1233456788999999987654 88999999999999999999987643211 1111111111000
Q ss_pred --hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 343 --WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 343 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
..... .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGK----------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTC----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccC----------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000 00111367888999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=350.24 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=198.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIV----ALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 378999999999999999999988888765 666654332 3334567888999999999999999999988642
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+++++|+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 7788888876 56666666667899999999999999999999999999999999999999999999999999987653
Q ss_pred CCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred ccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 3222 223345688999999988644 8999999999999999999 999999887776655554321111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....++.++.+||.+||+.||.+|||+.++++
T Consensus 240 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 -------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01256778999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=369.42 Aligned_cols=250 Identities=21% Similarity=0.367 Sum_probs=208.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++..++..||||+++..... .+.+.+|+.+|++++|||||++++++... ..+|+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEE
Confidence 46899999999999999999999888999999998754432 45688899999999999999999999874 34899
Q ss_pred EEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+.+ +|...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999986 55555543 345699999999999999999999999999999999999999999999999999987754332
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------
T ss_pred eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2233445678999999987644 8999999999999999999 99999998877666555331110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 439 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011367888999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=345.88 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=207.5
Q ss_pred CCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 99 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence 7899999999999999999984 4577899999997543 344467788999999999 999999999999874
Q ss_pred ceEEEEEeeccC-CHHHHhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPE-----------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
...++||||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 348999999987 5555543322 2589999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||++......... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+......+.
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999877544322 12345578899999988764 48999999999999999999 999999877665555
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.+......+. ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 259 KMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5544221110 012577889999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=347.62 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=206.5
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 378999999999999999999875 457789999987543 445567788999999999 89999999999877
Q ss_pred cCCceEEEEEeeccC-CHHHHhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 015247 187 RMSCSLYLVFHYMEH-DLAGLAASPE---------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 250 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl 250 (410)
. ..+++||||+++ ++...+.... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 113 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 4 458999999987 5555444332 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 015247 251 DDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 328 (410)
Q Consensus 251 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 328 (410)
+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999876543221 123345688999999887644 8999999999999999999 99999998887776
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
..+....... ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMD----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6665421110 112577889999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=363.96 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=201.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.. ...++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 378999999999999999999874 4567999999765433 3467889999999999999999999865 34799
Q ss_pred EEeeccCC-HHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHD-LAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+.++ +.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999874 5554432 234699999999999999999999999999999999999999999999999999987754333
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+......+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 401 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 401 (452)
T ss_dssp -------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 223344568899999998764 48999999999999999999 999999998888777664421111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC--CCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS--EVIF 403 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h--p~~~ 403 (410)
....+|+.+.+||.+||+.||.+|||+.++++. .++.
T Consensus 402 ---------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 012678889999999999999999999998863 5554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.91 Aligned_cols=269 Identities=23% Similarity=0.281 Sum_probs=202.7
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
...++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--TCC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence 3458899999999999999999995 578999999876543 23456788999999999999999999998774 458
Q ss_pred EEEEeeccCCHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 193 YLVFHYMEHDLAGLAASPE----VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
++||||++++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999875554443222 359999999999999999999999999999999999999999999999999998754
Q ss_pred CCC-CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 269 PNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 269 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+... ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 264 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQ 264 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTTC
T ss_pred cccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcccccc
Confidence 322 22234456899999999987644 899999999999999999999999875432211111000 00000000
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+... ..+. .........+..+.+++.+||+.||.+|||+.+++++
T Consensus 265 ~~~~--~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQI--VDPN-----LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSS--SSSS-----CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh--cChh-----hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1100 0000 0000111345568899999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=347.90 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=187.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEee------cC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTS------RM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~------~~ 188 (410)
.+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.++..+. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 6899999999999999999999999999999998654 3445567888999999996 9999999998852 23
Q ss_pred CceEEEEEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeeccc
Q 015247 189 SCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLA 264 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla 264 (410)
...++++|||+++++...+.. ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 456899999999988776643 4457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCC-----------CCcccccccccccccccc--CCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 015247 265 SFFDPNHKH-----------PMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 331 (410)
Q Consensus 265 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 331 (410)
......... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 876543221 112456899999999883 2344888999999999999999999999765443222111
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.. . ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 266 ~~--------------~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 266 YS--------------I-----------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp CC--------------C-----------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc--------------C-----------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0 0012567779999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=361.78 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=191.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|..+ +|||||++++++.. ...+|+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEE
Confidence 567778899999999998764 578999999998743 234567899999876 89999999998876 456999
Q ss_pred EEeeccCCHHHHhcCCCCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-------------Cc
Q 015247 195 VFHYMEHDLAGLAASPEVK------FTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-------------GV 255 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-------------~~ 255 (410)
||||+++++.+.+...... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999998887776544321 1334567899999999999999999999999999999754 48
Q ss_pred EEEEeeccccccCCCCCC---CCccccccccccccccccC------CcCCCCccchHHHHHHHHHHHc-CCCCCCCCChH
Q 015247 256 LKIADFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 325 (410)
Q Consensus 256 vkl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 325 (410)
+||+|||+++........ .....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999987644322 1234679999999999865 2458899999999999999999 99999776544
Q ss_pred HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 326 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
+ ..+....... +..... ....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 247 ~--~~i~~~~~~~----------~~~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSL----------DEMKCL------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCC----------CCCTTC------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCc----------cccccc------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 2333211110 000000 00124567899999999999999999999999999964
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.63 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=204.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++ .++..||+|++...... .+.+.+|+++++.++||||+++++++... ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEE
Confidence 37899999999999999999986 46778999999765433 45678899999999999999999987643 3789
Q ss_pred EEeeccCCHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHDLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
+|||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999875444444332 2699999999999999999999999999999999999999999999999999988754433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--------------
Confidence 3334455688999999987544 8899999999999999999 99999998887776666432110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 230 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 001267888999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=363.12 Aligned_cols=276 Identities=21% Similarity=0.294 Sum_probs=205.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+++++.++||||+++++++........++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 689999999999999999999999999999999975432 2234567789999999999999999999988766678999
Q ss_pred EeeccCCHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEeeccccccC
Q 015247 196 FHYMEHDLAGLAASPE---VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFD 268 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~~ 268 (410)
|||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999875444443322 239999999999999999999999999999999999999 778889999999998775
Q ss_pred CCCCCCCccccccccccccccccCC-------cCCCCccchHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHHHhCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAGKPIMPGR----TEVEQLHKIYKLCGS 337 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGv~l~ell~g~~pf~~~----~~~~~~~~i~~~~~~ 337 (410)
.... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||... ...+.+.++...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--- 242 (396)
T 4eut_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--- 242 (396)
T ss_dssp CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS---
T ss_pred CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC---
Confidence 4332 3456789999999987641 34788999999999999999999999753 334444444432
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+...+................+. ........+++.+.+||.+||+.||++|||+.++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 221111110000000000000000 000011234456789999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.02 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=201.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--K 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--C
Confidence 368999999999999999999876543 459999997543 445566788999999999999999999998774 4
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
..++||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 59999999987 55555555556899999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 270 NHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 270 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~------- 271 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------- 271 (333)
T ss_dssp -----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------
T ss_pred ccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-------
Confidence 3221 12233457889999998764 48999999999999999999 9999998888777666643211110
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 272 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 ---------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12567889999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.49 Aligned_cols=265 Identities=21% Similarity=0.306 Sum_probs=205.2
Q ss_pred CCcceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+++++.++||||+++++++.......
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 789999999999999999998 5678999999998754 3455667889999999999999999999988766778
Q ss_pred EEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+++||||++++ +...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999764 55554444457999999999999999999999999999999999999999999999999999877543
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC--HHHhhhC
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWKKS 346 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 346 (410)
... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||............. ..... .......
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC--ERDVPALSRLLELL 257 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc--ccccccHHHHHHHh
Confidence 321 223456788899999987644 8899999999999999999999997643321110000 00000 0000000
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
. .. ........+++.+.+||.+||+.||.+|||+.++++
T Consensus 258 ~-~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 258 E-EG------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp H-TT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-cc------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00 000111367888999999999999999999999954
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=349.62 Aligned_cols=259 Identities=18% Similarity=0.154 Sum_probs=196.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC---CCceEEEEEEecCCCChH---------HHHHHHHHHHHHHhCCCCceeeEeee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPE---------SVKFMAREILILRRLDHPNVIKLEGL 183 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~ 183 (410)
++|++.+.||+|+||.||+|++.. ++..||+|++........ ....+.+|+.++..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 689999999999999999999876 788999999976532110 11235678889999999999999999
Q ss_pred Eeec--CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC--cEEEE
Q 015247 184 VTSR--MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG--VLKIA 259 (410)
Q Consensus 184 ~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--~vkl~ 259 (410)
+... .....|+||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 8762 3567999999995566655443 34899999999999999999999999999999999999999887 99999
Q ss_pred eeccccccCCCCC------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC--ChHHHHHHH
Q 015247 260 DFGLASFFDPNHK------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR--TEVEQLHKI 331 (410)
Q Consensus 260 DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~--~~~~~~~~i 331 (410)
|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+. +........
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 9999987643221 112455789999999998875 4899999999999999999999999653 222222222
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETF--KDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+.. +.... ..+++++.+||..||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 275 TNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2221111111 11111 168889999999999999999999998875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.07 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=203.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 378999999999999999999963 456789999997543 233456788999999999 899999999998874
Q ss_pred CceEEEEEeeccC-CHHHHhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 015247 189 SCSLYLVFHYMEH-DLAGLAASPE----------------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKG 245 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 245 (410)
...++||||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 122 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred -CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 458999999987 5555554433 2379999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 015247 246 SNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 323 (410)
Q Consensus 246 ~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~ 323 (410)
+|||++.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999876543322 123456788999999887644 8999999999999999998 999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 324 EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 324 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+..+......+. ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6665555544211110 012568889999999999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=348.18 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=202.9
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceE--EEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCc
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIV--ALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 190 (410)
..++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 99 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 99 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--C
Confidence 3478999999999999999999998888865 999987532 333455688899999999 899999999999874 4
Q ss_pred eEEEEEeeccC-CHHHHhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPE---------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
..|+||||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 69999999977 5555554332 4799999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYK 333 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~ 333 (410)
.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 99999999997543221 12334568899999998764 48999999999999999998 9999999887776655532
Q ss_pred HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 334 LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1100 0112567889999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=346.62 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=206.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEE-----cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 37899999999999999999984 3567899999997543 444556788999999999 799999999998764
Q ss_pred CceEEEEEeeccC-CHHHHhcCCCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC
Q 015247 189 SCSLYLVFHYMEH-DLAGLAASPEV---------------KFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD 252 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 252 (410)
...++++|||+++ ++...+..... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3458999999987 55555544322 2899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 015247 253 DGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHK 330 (410)
Q Consensus 253 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 330 (410)
++.+||+|||++......... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999876543322 123456789999999987644 8999999999999999998 9999988765544443
Q ss_pred HHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 331 IYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 331 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......... ....+++.+.++|..||+.||.+|||+.++++|
T Consensus 263 ~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333211110 012567889999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=346.87 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=202.9
Q ss_pred CCCcceeeeeccCCCeeEEEEE-----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|+ +..++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 3789999999999999999998 55678899999986432 4445567888999999999999999999988743
Q ss_pred ceEEEEEeeccC-CHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEE
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPE------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~ 259 (410)
..|+||||+++ ++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+
T Consensus 107 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 107 -PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred -CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 47999999965 5555544322 45899999999999999999999999999999999999994 4469999
Q ss_pred eeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 9999986533222 2223456789999999987644 8999999999999999998 99999988877766655432110
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
. ....+++.+.+||.+||+.||.+|||+.++++|.|+
T Consensus 265 ~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 265 D----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 0 113677889999999999999999999999998775
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.54 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=203.6
Q ss_pred CcCCCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 113 RRADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
....+|++.+.||+|+||.||+|++..+ ...||+|.+... ......+.+.+|+.++++++||||+++++++... .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-S
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-C
Confidence 3446799999999999999999986543 336899988643 3445567788999999999999999999986553 3
Q ss_pred ceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...+++|||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 458899999988 5666666666789999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhh
Q 015247 269 PNHK---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344 (410)
Q Consensus 269 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 344 (410)
.... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 253 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----- 253 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-----
T ss_pred ccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-----
Confidence 3321 1223456788999999987644 8999999999999999999 6677877776666555543211110
Q ss_pred hCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 -----------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1256778999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=339.46 Aligned_cols=253 Identities=32% Similarity=0.501 Sum_probs=193.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEE
Confidence 4789999999999999999999999999999999976443 455667788999999999999999999999874 4699
Q ss_pred EEEeeccCC-HHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 194 LVFHYMEHD-LAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 194 lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
++|||+.++ +...+. .....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999984 444332 2456799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHhhhCC
Q 015247 270 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+... ......+.. ..
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------- 254 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CD----------- 254 (310)
T ss_dssp -----------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TC-----------
T ss_pred CCc-cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-cc-----------
Confidence 322 23445789999999988764 489999999999999999999999976532 222222221 11
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
++. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 255 YPP---------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCC---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 001257888999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=336.22 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=202.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
...|++.+.||+|+||.||+|++..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CC
Confidence 3467788999999999999998765544 7999998643 34455677889999999999999999999987643 34
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 5899999965 566666666778999999999999999999999999999999999999999999999999999865432
Q ss_pred C---CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 271 H---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 271 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
. ........+|+.|+|||.+.+.. ++.++||||||+++|+|++| .+||...+..+....+......+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-------- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC--------
T ss_pred cccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC--------
Confidence 1 12233456789999999987654 89999999999999999995 55566555555554443321111
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+.+||..||+.||.+|||+.++++
T Consensus 249 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 --------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01256788999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.78 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=201.5
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
..++|++.+.||+|+||.||+|.. +|+.||||+++... ..+.+.+|+.+|++++||||+++++++.... ..+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceE
Confidence 347899999999999999999975 57899999997543 2456788999999999999999999987643 3589
Q ss_pred EEEeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 194 LVFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+||||+++ ++...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999987 5555554333 347999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.+....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 405 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------- 405 (450)
T ss_dssp -------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-------------
T ss_pred ----cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 2335688999999987754 9999999999999999998 99999988777766655432110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 406 ---------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 ---------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011367889999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.66 Aligned_cols=253 Identities=18% Similarity=0.262 Sum_probs=207.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 189 (410)
.++|++.+.||+|+||.||+|++. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 478999999999999999999876 457899999987543 344456788999999999999999999998774
Q ss_pred ceEEEEEeeccC-CHHHHhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 190 CSLYLVFHYMEH-DLAGLAAS---------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
...++||||+++ ++...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 458999999987 45444322 12467999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCC
Q 015247 260 DFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGS 337 (410)
Q Consensus 260 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 337 (410)
|||++......... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 99999866432211 123346688999999987644 8999999999999999999 89999998887776665432100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 260 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113678889999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.10 Aligned_cols=267 Identities=21% Similarity=0.295 Sum_probs=199.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++ .+|+.||+|++....... ....+.+|+.+++.++||||+++++++.... ..++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--CCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCC--ceEE
Confidence 47899999999999999999984 579999999987544221 1225778999999999999999999998743 4789
Q ss_pred EEeeccCC-HHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 195 VFHYMEHD-LAGLAASP---EVKFTEPQVKCYMHQLLSGLEHCHNN---GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
||||+.++ +...+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 99999874 44444332 23599999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCCHHHh
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT----EVEQLHKIYKLCGSPSEEYW 343 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 343 (410)
............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ...........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 254 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 254 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT---------
T ss_pred CcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH---------
Confidence 655544455567999999999987654 8999999999999999999999995211 10011111110
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp 400 (410)
............. ..........++.+.+|+..||+.||.+|||+.++|+|-
T Consensus 255 ---~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 255 ---LLKEKKLEALVDV--DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp ---TTSSCCSTTSSCT--TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred ---HhhchhhhhhcCh--hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 0000000000000 000000112345689999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=343.37 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=200.8
Q ss_pred CCc-ceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSF-EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y-~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++| ++++.||+|+||.||++. +..+++.||||++... ......+.+.+|+++++.++||||+++++++......
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 455 999999999999998875 3457899999999754 3445567788999999999999999999999887667
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++||||++++.+..+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999875444444332 5999999999999999999999999999999999999999999999999999887544
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH-----------HHHHHHHHhCC
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-----------QLHKIYKLCGS 337 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-----------~~~~i~~~~~~ 337 (410)
... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ....+....
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 264 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL-- 264 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH--
T ss_pred ccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH--
Confidence 321 123456788899999987654 8899999999999999999999997543221 011111100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.... .......+++++.+||.+||+.||.+|||+.++++
T Consensus 265 ------~~~~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ------ERGE----------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------HTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hccc----------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 00111367888999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=338.51 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=201.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee---------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS--------- 186 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 186 (410)
++|++.+.||+|+||.||+|++..+|+.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999998899999999997543 235679999999999999999998754
Q ss_pred -----cCCceEEEEEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 187 -----RMSCSLYLVFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 187 -----~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
.....+++||||+++ ++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 123458999999998 55554432 33579999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 015247 260 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS 339 (410)
Q Consensus 260 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 339 (410)
|||++........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||... ......+..
T Consensus 165 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~------ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD------ 233 (284)
T ss_dssp CCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT------
T ss_pred cchhheecccccc--ccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc------
Confidence 9999987754332 34557899999999987754 899999999999999999999887422 111111110
Q ss_pred HHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 340 EEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
... ...+++.+.+||.+||+.||.+|||+.++++|.|.-+
T Consensus 234 ------~~~-------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ------GII-------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ------TCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ------ccc-------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 001 1256778999999999999999999999999976543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.02 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=197.2
Q ss_pred CCCcCCCcceeeeeccCCCeeEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec
Q 015247 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (410)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 187 (410)
++.....|++.+.||+|+||.||+|++..++ ..||+|.++... .....+.+.+|+.++++++||||+++++++...
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 3344456899999999999999999865432 468999886432 345567788999999999999999999987553
Q ss_pred CCceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 188 MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
....++||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 163 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 163 -EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 3357899999987 56666666666799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC---CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 267 FDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 267 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+.......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---- 316 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---- 316 (373)
T ss_dssp ----------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC----
T ss_pred ccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 6433211 12334568899999998764 48999999999999999999 788888776665555443311000
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 317 ------------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 ------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012577889999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=345.24 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=206.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 188 (410)
.++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 3789999999999999999999876654 79999986543 445567788999999999 899999999998874
Q ss_pred CceEEEEEeeccC-CHHHHhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 015247 189 SCSLYLVFHYMEH-DLAGLAAS-------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 254 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 254 (410)
...++||||+++ ++...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 123 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 123 -GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred -CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 458999999987 55544432 134689999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 015247 255 VLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIY 332 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~ 332 (410)
.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999876433221 123455688999999887644 8999999999999999998 999999877666555554
Q ss_pred HHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 333 KLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.....+. .....++.+.+||..||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4321110 012467789999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=351.33 Aligned_cols=254 Identities=17% Similarity=0.202 Sum_probs=198.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC--------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee--------
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML--------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK-------- 179 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 179 (410)
++|++.+.||+|+||.||+|++.. +++.||+|++... +.+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 689999999999999999999877 4889999999754 24677999999999999988
Q ss_pred -------EeeeEeecCCceEEEEEeeccCCHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 180 -------LEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 180 -------l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
+++++... ....|+||||++++|...+... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 45555542 4579999999966777766543 36899999999999999999999999999999999999999
Q ss_pred CCC--cEEEEeeccccccCCCCCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 015247 252 DDG--VLKIADFGLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 323 (410)
Q Consensus 252 ~~~--~vkl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 323 (410)
.++ .+||+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 998 9999999999876533221 12345789999999998775 48999999999999999999999998764
Q ss_pred -hHHHHHHHHH-HhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 324 -EVEQLHKIYK-LCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 324 -~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
..+.+..... ....+.. . .. ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~-~------~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGP-F------VG-------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCC-E------EC-------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChhh-h------hh-------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3333332222 1111110 0 00 00011357889999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=372.58 Aligned_cols=245 Identities=20% Similarity=0.269 Sum_probs=200.7
Q ss_pred eeeccCCCeeEEEEEE--cCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
+.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+++|++++|||||++++++... ..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEcc
Confidence 4799999999999954 45678999999986655555667899999999999999999999998643 378999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--CCcc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH--PMTS 277 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~~~~ 277 (410)
.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 98655555455568999999999999999999999999999999999999999999999999999887543321 2233
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
..+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+
T Consensus 532 ~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 592 (635)
T 4fl3_A 532 GKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------ 592 (635)
T ss_dssp ---CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred CCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 4568899999998764 48999999999999999998 999999998888777665422111
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+|+++.+||..||+.||.+|||+.++++
T Consensus 593 ----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11267889999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.07 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=196.6
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCC-Ccee-------------
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH-PNVI------------- 178 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv------------- 178 (410)
....|...+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.++..++| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568999999999999999999999999999999874432 23335678889999999977 2211
Q ss_pred --eE------eeeEeecC---CceEEEEEeeccCCHHHHh------cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015247 179 --KL------EGLVTSRM---SCSLYLVFHYMEHDLAGLA------ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHR 241 (410)
Q Consensus 179 --~l------~~~~~~~~---~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHr 241 (410)
.+ ..++.... ...++++|+++.+++.+.+ ......+++..+..++.||+.||.|||++||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11 11111111 2347889999888887766 3445568899999999999999999999999999
Q ss_pred cCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCcccccccccccccccc---------CCcCCCCccchHHHHHHHHHH
Q 015247 242 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL---------GATDYGVGVDLWSAGCILAEL 312 (410)
Q Consensus 242 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwSlGv~l~el 312 (410)
||||+|||++.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999876433 345577 9999999983 334588899999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC
Q 015247 313 LAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT 392 (410)
Q Consensus 313 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 392 (410)
++|+.||.+.+..+....+ ......+|+.+.+||.+||+.||.+|||
T Consensus 311 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999876532221111 1112367889999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 015247 393 ATVALNSEVIFQ 404 (410)
Q Consensus 393 ~~elL~hp~~~~ 404 (410)
+.++|+||||++
T Consensus 358 ~~~~l~~~~~~~ 369 (413)
T 3dzo_A 358 PLQAMETPEYEQ 369 (413)
T ss_dssp HHHHTTSHHHHH
T ss_pred HHHHHhCHHHHH
Confidence 999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=335.89 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=193.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeEeeeEeec--CCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSR--MSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--~~~ 190 (410)
.++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 37899999999999999999975 7899999998643 23445557777766 7999999999987542 345
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
.+++||||++++.+..+.. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 6899999999754444443 347999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCC---CCccccccccccccccccCCc-----CCCCccchHHHHHHHHHHHcC----------CCCCCCCC-
Q 015247 263 LASFFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAG----------KPIMPGRT- 323 (410)
Q Consensus 263 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~ell~g----------~~pf~~~~- 323 (410)
++......... ......||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99776433221 123457899999999987653 245799999999999999999 88886532
Q ss_pred ---hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 324 ---EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 324 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.......+.......+. . +. .......++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-------~-------~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPN-------I-------PN-------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCC-------C-------CG-------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCC-------C-------Ch-------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22333332221110000 0 00 0001124567899999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.95 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=201.2
Q ss_pred CCcceee-eeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKID-KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
+++.+.+ .||+|+||.||+|... .++..||||+++... .....+.+.+|+++|+.++|||||++++++... .+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---Ce
Confidence 4566666 8999999999999865 356679999997653 333466788999999999999999999998752 38
Q ss_pred EEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999885 555555556679999999999999999999999999999999999999999999999999998775433
Q ss_pred CCCC--ccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 KHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---------- 559 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---------- 559 (613)
T ss_dssp -----------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC----------
T ss_pred ceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 2222 223456899999998764 49999999999999999998 999999998888777665421100
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++++.+||..||+.||.+|||+.++++
T Consensus 560 ------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 ------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11367889999999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.08 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=198.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcC-CCc--eEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDML-TGK--IVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|++.. +++ .||+|+++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 3789999999999999999998543 333 689999876543 3345677889999999999999999999987642
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+++|||+.+ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 7899999986 56655555456799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 270 NHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 270 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
.... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------- 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred cccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC-------
Confidence 3321 123345688899999987644 8899999999999999999 9999999988777766643211110
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 246 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 246 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 113678889999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.90 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=199.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCceE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSL 192 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~ 192 (410)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36899999999999999999999999999999998753 345566788999999999999999999988642 34578
Q ss_pred EEEEeeccC-CHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 193 YLVFHYMEH-DLAGLAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 193 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
++||||+.+ ++...+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999998 4444333 245689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--------CCccccccccccccccccCCc--CCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCC
Q 015247 269 PNHKH--------PMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGS 337 (410)
Q Consensus 269 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~ 337 (410)
..... ......||+.|+|||++.+.. .++.++||||||+++|+|++|+.||...... ..........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-- 263 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-- 263 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc--
Confidence 21110 012235699999999886532 3688999999999999999999999531110 0011111100
Q ss_pred CCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+ ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 --------~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 --------LSIP-----------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------CC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCC-----------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 013577889999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.93 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=204.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC-ceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP-NVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.++||+|+||.||+|++..+++.||||++....... .+.+|+++++.++|+ ++..+..++.. ....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE--GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEE
Confidence 378999999999999999999999999999999987654322 366799999999874 44455444444 45689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeeccccccCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~ 270 (410)
+||||+++++.+++......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999888888777666789999999999999999999999999999999999999 68899999999999877543
Q ss_pred CCC------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 015247 271 HKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 271 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 341 (410)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+... .+.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----
Confidence 321 123567899999999988754 89999999999999999999999987544 333444433211
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
...+......+++++.+||..||+.||.+||++.++++
T Consensus 234 -------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11123344578999999999999999999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.00 Aligned_cols=241 Identities=27% Similarity=0.410 Sum_probs=188.6
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++.+. .++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLNP----VCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT----TEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----cEE
Confidence 36899999999999999999985 5789999998532 3356788899999999999999999987642 689
Q ss_pred EEeeccC-CHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCEEEcCCCc-EEEEeecccccc
Q 015247 195 VFHYMEH-DLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHN---NGVLHRDIKGSNLLIDDDGV-LKIADFGLASFF 267 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~ 267 (410)
||||+++ ++...+.... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999987 4555444333 247899999999999999999999 89999999999999998887 799999999765
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHhhh
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVE--QLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 345 (410)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+.. +..
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~------- 222 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR------- 222 (307)
T ss_dssp ------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC-------
T ss_pred ccc----cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC-------
Confidence 432 2345689999999998764 48999999999999999999999998643322 2222211 000
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 223 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 223 -------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112367888999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=362.98 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=206.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|+.++||||+++++++.. ..+|+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence 478999999999999999999874 4567999999765433 3468889999999999999999999865 34899
Q ss_pred EEeeccC-CHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999987 55555432 234689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......++..|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+......+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 122334567889999988764 48999999999999999999 999999998888777664321111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC--CCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS--EVIF 403 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h--p~~~ 403 (410)
....+++.+.+||.+||+.||.+|||+.++++. .+|.
T Consensus 485 ---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 012678889999999999999999999998864 4444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=333.79 Aligned_cols=244 Identities=22% Similarity=0.381 Sum_probs=193.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++ +|+.||+|+++... ..+.+.+|+.+++.++||||+++++++... ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 47899999999999999999975 58899999986432 345688899999999999999999987653 335899
Q ss_pred EEeeccC-CHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEH-DLAGLAASPE-VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+++ ++...+.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999987 5555543322 238999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||...+..+....+.....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 232 (278)
T ss_dssp -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------------
T ss_pred ---cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 234568899999998764 48999999999999999998 9999998877665554432110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
......+++.+.++|.+||+.||.+|||+.++++
T Consensus 233 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 -------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0111367888999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=372.02 Aligned_cols=280 Identities=25% Similarity=0.312 Sum_probs=205.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee----cCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS----RMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 190 (410)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.+++.++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999999899999999998654 345556778899999999999999999998754 2245
Q ss_pred eEEEEEeeccC-CHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEeeccc
Q 015247 191 SLYLVFHYMEH-DLAGLAASPE--VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLA 264 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla 264 (410)
..++||||+++ ++...+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 68999999976 4555444322 36999999999999999999999999999999999999997765 999999999
Q ss_pred cccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHh-
Q 015247 265 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW- 343 (410)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~- 343 (410)
........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+............ .......
T Consensus 172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~ 245 (676)
T 3qa8_A 172 KELDQGEL--CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIV 245 (676)
T ss_dssp CBTTSCCC--CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CC
T ss_pred cccccccc--cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhhh
Confidence 88754432 3556889999999998764 489999999999999999999999987654432111100 0000000
Q ss_pred hhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
..........+.... .........+++.+.+||..||.+||.+|||+.++|+||||++
T Consensus 246 ~~~~l~g~~~~~~~l---p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVL---PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSS---CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhcccccccccc---CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000000000000 0001112235677899999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.23 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=201.9
Q ss_pred CCCcceeeeeccCCCeeEEEEE----EcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
.++|++.+.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3679999999999999999998 4568999999998754 344566788999999999999999999998776555
Q ss_pred eEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 015247 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 269 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 269 (410)
.+++||||+++ ++...+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 78999999987 56666655556799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH-------
Q 015247 270 NHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSE------- 340 (410)
Q Consensus 270 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 340 (410)
.... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... .+ .+..+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccchhhhHHH
Confidence 3321 122345678899999987644 88999999999999999999998864311 11 111111110
Q ss_pred --HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 341 --EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 341 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
........ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGR----------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCC----------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCC----------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000000 0011367888999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=338.05 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=200.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CceEE
Confidence 4789999999999999999998643 499999876554444445567799999999999999999999874 35999
Q ss_pred EEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC--
Q 015247 195 VFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-- 271 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 271 (410)
+|||+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999986 45555555555799999999999999999999999999999999999998 7899999999987653211
Q ss_pred --CCCCccccccccccccccccC--------CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 015247 272 --KHPMTSRVVTLWYRPPELLLG--------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341 (410)
Q Consensus 272 --~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 341 (410)
........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.........+........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 263 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-- 263 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC--
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC--
Confidence 122334568999999999864 23478899999999999999999999999887777665543211100
Q ss_pred HhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+.+||..||+.||.+|||+.++++
T Consensus 264 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 -------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01257889999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=334.89 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=187.2
Q ss_pred CCCccee-eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHH-HhCCCCceeeEeeeEee--cCCc
Q 015247 115 ADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL-RRLDHPNVIKLEGLVTS--RMSC 190 (410)
Q Consensus 115 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--~~~~ 190 (410)
.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3678888 7899999999999999999999999998632 2355688887 56699999999998865 3345
Q ss_pred eEEEEEeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeecccc
Q 015247 191 SLYLVFHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLAS 265 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 265 (410)
.+++||||+++ ++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 68999999987 555555433 347999999999999999999999999999999999999998 7899999999986
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
.... ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 169 ~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~---------- 214 (299)
T 3m2w_A 169 ETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------- 214 (299)
T ss_dssp ECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS----------
T ss_pred cccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH----------
Confidence 5421 237789999999999999999999998765433211110000
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.. .........+..+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 215 --------~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 --------RM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp --------CT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred --------hh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00 000011123357889999999999999999999999999999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.89 Aligned_cols=261 Identities=24% Similarity=0.286 Sum_probs=200.0
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCC--CChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN--LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.|...+.||+|+||.||+|.+ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 107 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCL 107 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEE
Confidence 355568999999999999974 78899999987543 2334566788999999999999999999998874 35899
Q ss_pred EEeeccC-CHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEH-DLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|||+++ ++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 9999976 45444432 23569999999999999999999999999999999999999999999999999998765432
Q ss_pred CC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC--HHHhhhCCC
Q 015247 272 KH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPS--EEYWKKSKL 348 (410)
Q Consensus 272 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 348 (410)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........+..+........ ...+-...+
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 22 2234578999999998865 388999999999999999999999987665443333333211111 000000000
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+ ......++.+.++|..||+.||.+|||+.+++++
T Consensus 266 ~----------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 N----------------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp S----------------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred c----------------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0001234568899999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=362.51 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=204.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 47899999999999999999987543 457999987643 244556778899999999999999999999854 34
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.|+||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 7999999986 455555545567999999999999999999999999999999999999999999999999999887544
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
.........+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+......+
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------- 612 (656)
T ss_dssp ---------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-----------
T ss_pred cceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 43333445668899999998764 48999999999999999997 999999998888877775532111
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 613 -----------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 -----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11367888999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=333.05 Aligned_cols=276 Identities=25% Similarity=0.271 Sum_probs=189.5
Q ss_pred cCCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHH--HHhCCCCceeeEeeeEee---cC
Q 015247 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI--LRRLDHPNVIKLEGLVTS---RM 188 (410)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~---~~ 188 (410)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 348999999999999999999974 78999999997532 2233344444 445899999999875532 23
Q ss_pred CceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEcCCCcEEE
Q 015247 189 SCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN---------GVLHRDIKGSNLLIDDDGVLKI 258 (410)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlkp~NILl~~~~~vkl 258 (410)
...+++||||+++ ++...+... ..++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4468999999977 455544332 458999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccCCCC-------CCCCccccccccccccccccCC------cCCCCccchHHHHHHHHHHHcCCCCCCC-CCh
Q 015247 259 ADFGLASFFDPNH-------KHPMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLAGKPIMPG-RTE 324 (410)
Q Consensus 259 ~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGv~l~ell~g~~pf~~-~~~ 324 (410)
+|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|||++|..||.. ...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764322 1122345789999999998763 2366789999999999999999766543 221
Q ss_pred HHHHHHHHHHhCC-CCHHHhhhCCCCCcccCCCCCchhhhhhhhh---CCCCCCcHHHHHhccCCCCCCCCCHHHH----
Q 015247 325 VEQLHKIYKLCGS-PSEEYWKKSKLPNATLFKPREPYKRCIQETF---KDFPPSSLPLIETLLAIDPAERLTATVA---- 396 (410)
Q Consensus 325 ~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~el---- 396 (410)
.+....+....+. +....+........ ..+ .+++.+ ..+++.+.+||.+||+.||.+|||+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREK--QRP------KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSC--CCC------CCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccc--cCC------CCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 1111111111111 11111000000000 000 000000 0123358999999999999999999999
Q ss_pred --hcCCCCCCCC
Q 015247 397 --LNSEVIFQDR 406 (410)
Q Consensus 397 --L~hp~~~~~~ 406 (410)
|-++|-+++.
T Consensus 314 ~~ll~~~~~~~~ 325 (336)
T 3g2f_A 314 AELMMIWERNKS 325 (336)
T ss_dssp HHHHHCCCC---
T ss_pred HHHHHHHHhccc
Confidence 5678877654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=337.63 Aligned_cols=243 Identities=18% Similarity=0.195 Sum_probs=188.3
Q ss_pred CCCcceeeeeccCCCeeEEEE-----EEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEee
Q 015247 115 ADSFEKIDKIGQGTYSNVYKA-----KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTS 186 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 186 (410)
.++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|++++..++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 478999999999999999999 467889999999986542 334667888888876 9999999999887
Q ss_pred cCCceEEEEEeeccCC-HHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---------
Q 015247 187 RMSCSLYLVFHYMEHD-LAGLAAS----PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--------- 252 (410)
Q Consensus 187 ~~~~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------- 252 (410)
.. ..|+||||++++ |...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 139 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 QN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred CC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 44 489999999865 4444432 4567999999999999999999999999999999999999998
Q ss_pred --CCcEEEEeeccccccCCC-CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 015247 253 --DGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH 329 (410)
Q Consensus 253 --~~~vkl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 329 (410)
++.+||+|||+|+.+... ........+||+.|+|||++.+.. |+.++|||||||++|||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 899999999999765321 222345568999999999998755 99999999999999999999999965432100
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.. . . .+.. ...++.+.+++..||+.+|.+|++..+.|.
T Consensus 294 --------------~~---~-----~---~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 --------------KP---E-----G---LFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp --------------EE---C-----S---CCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred --------------ee---c-----h---hccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 00 0 0 0000 022455778999999999999976544444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.62 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=188.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC--CCCceeeEeeeEeecCC--ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL--DHPNVIKLEGLVTSRMS--CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~--~~ 191 (410)
++|++.+.||+|+||.||+|++ +++.||||++.... .....+|.+++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 6899999999999999999985 48999999986432 23344566666654 89999999999877533 57
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEcCCCcEEEEeec
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
+++||||+++ ++...+.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999987 55554433 2699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---CCccccccccccccccccCCcCCCCc------cchHHHHHHHHHHHcC----------CCCCCCCC
Q 015247 263 LASFFDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVG------VDLWSAGCILAELLAG----------KPIMPGRT 323 (410)
Q Consensus 263 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~------~DiwSlGv~l~ell~g----------~~pf~~~~ 323 (410)
++..+...... ......||+.|+|||++.+.. ++.. +|||||||++|||++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99876543322 123557899999999987644 4443 8999999999999999 66665432
Q ss_pred ----hHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 324 ----EVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 324 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...............+ . .+. ......+++++.+||.+||+.||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~----------~----~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRP----------S----FPN-------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCC----------C----CCG-------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCc----------c----ccc-------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221110000 0 000 00011345668999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=340.51 Aligned_cols=249 Identities=17% Similarity=0.182 Sum_probs=192.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCC---------CCceeeE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLD---------HPNVIKL 180 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l 180 (410)
++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+++.++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6899999999999999999986 789999999987542 2233466788999988885 7777777
Q ss_pred eeeEeec----------------------------CCceEEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHH
Q 015247 181 EGLVTSR----------------------------MSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLE 231 (410)
Q Consensus 181 ~~~~~~~----------------------------~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~ 231 (410)
.+++... ....+|+||||+.++ ++..+.. ..+++..++.++.||+.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 6654311 145799999999875 5555543 47899999999999999999
Q ss_pred HHH-HCCceeccCCCCCEEEcCCC--------------------cEEEEeeccccccCCCCCCCCccccccccccccccc
Q 015247 232 HCH-NNGVLHRDIKGSNLLIDDDG--------------------VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290 (410)
Q Consensus 232 ~LH-~~~ivHrDlkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 290 (410)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||++
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhh
Confidence 999 99999999999999999887 899999999987643 245799999999998
Q ss_pred cCCcCCCCccchHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhh
Q 015247 291 LGATDYGVGVDLWSAGCI-LAELLAGKPIMPGRTE-VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETF 368 (410)
Q Consensus 291 ~~~~~~~~~~DiwSlGv~-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (410)
.+.. +.++||||||++ .+++++|..||.+... ......+........ .+ .....
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~-------~~~~~ 305 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---------------KC-------NTPAM 305 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---------------CC-------CSHHH
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---------------cc-------chhhh
Confidence 8643 789999998777 7889999999854321 112222222111000 00 01122
Q ss_pred CCCCCCcHHHHHhccCCCCCCCCCHHHHh-cCCCCC
Q 015247 369 KDFPPSSLPLIETLLAIDPAERLTATVAL-NSEVIF 403 (410)
Q Consensus 369 ~~~~~~~~~li~~~L~~dP~~Rpt~~elL-~hp~~~ 403 (410)
..+++++.+||.+||++| |+.|+| +||||+
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 356788999999999987 999999 999996
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=327.83 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=193.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeEeeeEeecCC--ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSRMS--CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~--~~ 191 (410)
++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 6799999999999999999986 6899999998632 23456778888887 799999999999877542 26
Q ss_pred EEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEcCCCcEEEEeec
Q 015247 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFG 262 (410)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DFG 262 (410)
.++||||+++ ++...+.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 8999999998 55554433 36899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCC---CCccccccccccccccccCCcC-----CCCccchHHHHHHHHHHHcC----------CCCCCCCCh
Q 015247 263 LASFFDPNHKH---PMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAG----------KPIMPGRTE 324 (410)
Q Consensus 263 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGv~l~ell~g----------~~pf~~~~~ 324 (410)
++......... ......||+.|+|||++.+... ++.++|||||||++|||++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99876543321 2345578999999999876422 33689999999999999999 778866432
Q ss_pred ----HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 325 ----VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 325 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.+.+..........+ ..+. .+ .....++.+.+||.+||+.||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~-------~~~~--------~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRP-------NIPN--------RW------QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCC-------CCCG--------GG------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCC-------CCcc--------cc------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 222222211000000 0000 00 001234568899999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=359.67 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=196.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC---ce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS---CS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 191 (410)
++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.++..++||||+++++++..... ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 789999999999999999999875 7899999988643 244556678899999999999999999999976433 22
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.|+||||++++.+...... .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 6999999998655544433 79999999999999999999999999999999999999875 9999999999876432
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+..... .+.
T Consensus 235 ----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------~~~- 286 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------LPE- 286 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------CCT-
T ss_pred ----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------ccc-
Confidence 456789999999988753 5889999999999999999998886521100 000
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.. .....++.+.+||.+||++||.+||+..++|.|+|+
T Consensus 287 -----~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 287 -----DD--------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -----TC--------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----cc--------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 001235678999999999999999998888888775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.63 Aligned_cols=227 Identities=19% Similarity=0.141 Sum_probs=181.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.++..++||||+++++++... ...|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEE
Confidence 689999999999999999999999999999999986654 345567788999999999999999999999874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
||||++++.+..+...+ ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 99999875444444332 4666788999999999999999999999999999999999999997443
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
|++ .++.++|||||||++|||++|+.||.+.+..+.+....+ ...
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~------------------~~~ 219 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER------------------DTA 219 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB------------------CTT
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH------------------Hhc
Confidence 333 278899999999999999999999987654321100000 000
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.. ..........+|+.+.+||.+||++||.+| |+.++++
T Consensus 220 ~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 220 GQ----PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SC----BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cC----CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00 011223345788999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=296.48 Aligned_cols=188 Identities=15% Similarity=0.072 Sum_probs=134.1
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCC----C----hHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCceE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----E----PESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 192 (410)
..++.|+.|.+..++....|+.||+|++.+... . +...+.+.+|+++|+++ .|+||+++++++++. ..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 346778888888888888999999999986532 1 23345788999999999 799999999999884 459
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||||++|+.+..+...++++++. .++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 9999999997777666666778765 478999999999999999999999999999999999999999998775433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 317 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 317 (410)
....+.+||+.|+|||++.+. +..++|+||+|+++++|.++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 234567899999999998763 6678999999999888766643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-28 Score=248.09 Aligned_cols=187 Identities=18% Similarity=0.139 Sum_probs=139.0
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
...+.||+|+||.||+|. ..+..+++|.......... ..+.+.+|+++|++++||||+++..++.... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 345689999999999994 6788999998755433211 2345789999999999999995544444433 36
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+||||++++.+..+... +..++.||+.||.|||++||+||||||+|||++. ++||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999986544444433 5689999999999999999999999999999998 999999999998754321
Q ss_pred CC------CccccccccccccccccCC-cCCCCccchHHHHHHHHHHHcCCCCC
Q 015247 273 HP------MTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIM 319 (410)
Q Consensus 273 ~~------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf 319 (410)
.. ....+||+.|+|||++.+. ..|+..+|+||..+-..+.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1356889999999998641 23778899999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=208.45 Aligned_cols=161 Identities=14% Similarity=0.107 Sum_probs=122.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----------------HHHHHHHHHHHHHHhCCCCceee
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----------------ESVKFMAREILILRRLDHPNVIK 179 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~ 179 (410)
..|++.+.||+|+||.||+|++ .+|+.||+|+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4577789999999999999998 889999999996543211 13456889999999999 4 66
Q ss_pred EeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 015247 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259 (410)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 259 (410)
+.+++.. ...|+||||++++.+..+ .. .....++.||+.||.|||++||+||||||+|||++ ++.+||+
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~l-~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYRV-RV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGGC-CC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec---cceEEEEEecCCCcHHHc-ch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 6665544 236999999988544433 11 23457999999999999999999999999999999 9999999
Q ss_pred eeccccccCCCCCCCCccccccccccccccccCC---------cCCCCccchHHH
Q 015247 260 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA---------TDYGVGVDLWSA 305 (410)
Q Consensus 260 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~DiwSl 305 (410)
|||+|... ..+.|||++... ..|+..+|+|.+
T Consensus 235 DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 235 DFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred ECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999643 346889876420 125556666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-22 Score=181.48 Aligned_cols=139 Identities=19% Similarity=0.262 Sum_probs=106.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCce--EEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhC
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEP----------------------ESVKFMAREILILRRL 172 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 172 (410)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999998778999 9999976542110 1123577899999999
Q ss_pred CCCce--eeEeeeEeecCCceEEEEEeeccC------CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccC
Q 015247 173 DHPNV--IKLEGLVTSRMSCSLYLVFHYMEH------DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH-NNGVLHRDI 243 (410)
Q Consensus 173 ~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDl 243 (410)
.|+++ +.+++. . ..++||||+++ .+...... .++..+..++.||+.||.||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 333322 1 35899999953 33332221 235577889999999999999 999999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccc
Q 015247 244 KGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 244 kp~NILl~~~~~vkl~DFGla~~~ 267 (410)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.1e-18 Score=164.28 Aligned_cols=140 Identities=19% Similarity=0.228 Sum_probs=99.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC---------------hHHH-----HHHHHHHHHHHhCCCCc
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---------------PESV-----KFMAREILILRRLDHPN 176 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------~~~~-----~~~~~E~~~l~~l~h~n 176 (410)
-|++...||.|+||.||+|.+ .+|+.||||+++..... .... ....+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 499999999999999999996 67999999998643110 0000 01234666777665444
Q ss_pred eeeEeeeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC--
Q 015247 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-- 254 (410)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-- 254 (410)
+....-+... . .++||||+++..+..+.. ...+..++.||+.+|.+||+.|||||||||.|||+++++
T Consensus 175 v~vp~p~~~~--~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS--R--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE--T--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc--C--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3211111111 1 379999999865543322 123467889999999999999999999999999998876
Q ss_pred --------cEEEEeecccccc
Q 015247 255 --------VLKIADFGLASFF 267 (410)
Q Consensus 255 --------~vkl~DFGla~~~ 267 (410)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=6.2e-12 Score=115.14 Aligned_cols=139 Identities=16% Similarity=0.111 Sum_probs=105.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l 194 (410)
+.|++...++.|+.+.||++. ..+..+++|+........ ...+.+|+.+++.+. +.++.++++++.. ....|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 468888999999999999997 347899999986422111 224777999999884 6677888887766 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN--------------------------------------- 235 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--------------------------------------- 235 (410)
||||++|..+..... +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999965544321 122234678899999999998
Q ss_pred --------------------CCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 236 --------------------NGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 236 --------------------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=4.8e-11 Score=108.64 Aligned_cols=134 Identities=11% Similarity=0.085 Sum_probs=95.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~ 193 (410)
..|.+....+.|..+.||++. ..+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++.... ...+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCE
Confidence 446555444566679999996 4667889999875431 134667888888885434 55677766553 4589
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG------------------------------------ 237 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~------------------------------------ 237 (410)
++|||++|..+. .. ... ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999985543 21 112 2356778888888888753
Q ss_pred ----------------------ceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 238 ----------------------VLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 238 ----------------------ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=111.19 Aligned_cols=144 Identities=13% Similarity=0.213 Sum_probs=103.4
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEe--cCCCChHHHHHHHHHHHHHHhCC--CCceeeEeeeEeecCC-ceEE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMS-CSLY 193 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~-~~~~ 193 (410)
..++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+... +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3467799999999999973 35678888765 32211 12345778999999886 4557788777665321 4578
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-------------------------------------- 235 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-------------------------------------- 235 (410)
+||||++|..+... .-..++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998543211 11246788889999999999999997
Q ss_pred --------------------CCceeccCCCCCEEEcCCCc--EEEEeecccccc
Q 015247 236 --------------------NGVLHRDIKGSNLLIDDDGV--LKIADFGLASFF 267 (410)
Q Consensus 236 --------------------~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~ 267 (410)
..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=7.7e-11 Score=110.37 Aligned_cols=185 Identities=17% Similarity=0.179 Sum_probs=116.5
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCc--eeeEeeeEeecC-CceEEEEE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPN--VIKLEGLVTSRM-SCSLYLVF 196 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~-~~~~~lv~ 196 (410)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+ .+.. +.+++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3558999999999873 4688997542 23456788899999887 3322 334433322211 12358899
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN----------------------------------------- 235 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~----------------------------------------- 235 (410)
++++|..+..... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999843321111 246777788888888888888886
Q ss_pred -----------------CCceeccCCCCCEEEcC--CCcEEEEeeccccccCCCCCCC-Cccc---cc---------ccc
Q 015247 236 -----------------NGVLHRDIKGSNLLIDD--DGVLKIADFGLASFFDPNHKHP-MTSR---VV---------TLW 283 (410)
Q Consensus 236 -----------------~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~-~~~~---~g---------t~~ 283 (410)
..++|+|++|.||+++. ...+.|+||+.+...++...-. .... .+ ..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999998 4567899999987643211000 0000 00 001
Q ss_pred ccc-cccccCCcCCCCccchHHHHHHHHHHHcCCCCC
Q 015247 284 YRP-PELLLGATDYGVGVDLWSAGCILAELLAGKPIM 319 (410)
Q Consensus 284 y~a-PE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 319 (410)
... |+.... ...-.+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221111 111258999999999999998655
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.2e-07 Score=83.78 Aligned_cols=136 Identities=15% Similarity=0.178 Sum_probs=92.2
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC---ceeeEeeeEeecCCceEEEEEe
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP---NVIKLEGLVTSRMSCSLYLVFH 197 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~lv~e 197 (410)
++.++.|....||+. |..+++|+-. .......+.+|..+|+.+.+. .+.+.+.+... .....|++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 456888988899988 5678889742 233456788999999998642 24555555442 2445789999
Q ss_pred eccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 015247 198 YMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNN----------------------------------------- 236 (410)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----------------------------------------- 236 (410)
+++|..+....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999854332110 1234555555666666666666642
Q ss_pred -------------------CceeccCCCCCEEEcC---CCcE-EEEeeccccccC
Q 015247 237 -------------------GVLHRDIKGSNLLIDD---DGVL-KIADFGLASFFD 268 (410)
Q Consensus 237 -------------------~ivHrDlkp~NILl~~---~~~v-kl~DFGla~~~~ 268 (410)
.++|+|++|.|||++. ++.+ .|+||+.+..-+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999987 4564 899999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.2e-06 Score=77.14 Aligned_cols=132 Identities=15% Similarity=0.128 Sum_probs=87.3
Q ss_pred eccCCCe-eEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEEEEeeccC
Q 015247 124 IGQGTYS-NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 124 LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.+. +-.+.++++++.+. ...|+||+++++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCC
Confidence 4445444 699987666778899998653 23456778999998774 33356677776664 458999999988
Q ss_pred CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 015247 202 DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN---------------------------------------------- 235 (410)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---------------------------------------------- 235 (410)
..+...... .......+..+++..|..||+
T Consensus 105 ~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 433221110 111223344555555555553
Q ss_pred -----C-------CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 236 -----N-------GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 236 -----~-------~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 278999999999999877777999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=6.3e-06 Score=79.70 Aligned_cols=78 Identities=17% Similarity=0.124 Sum_probs=47.4
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC--Ch---HHHHHHHHHHHHHHhCCC--C-ceeeEeeeEeecCCce
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EP---ESVKFMAREILILRRLDH--P-NVIKLEGLVTSRMSCS 191 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~ 191 (410)
..+.||.|..+.||++....+++.+++|....... .. ...+.+..|.++|+.+.. + .+.+++.+ +...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--
Confidence 35789999999999997655678899998653211 00 112345668888887632 3 34455433 2222
Q ss_pred EEEEEeeccC
Q 015247 192 LYLVFHYMEH 201 (410)
Q Consensus 192 ~~lv~e~~~~ 201 (410)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 4799999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.7e-05 Score=72.34 Aligned_cols=31 Identities=23% Similarity=0.409 Sum_probs=27.8
Q ss_pred CCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=4.5e-05 Score=72.44 Aligned_cols=83 Identities=8% Similarity=0.038 Sum_probs=50.3
Q ss_pred ceeeee-ccCCCeeEEEEEEc--C----CCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-C--CceeeEeeeEeec
Q 015247 119 EKIDKI-GQGTYSNVYKAKDM--L----TGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-H--PNVIKLEGLVTSR 187 (410)
Q Consensus 119 ~~~~~L-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~ 187 (410)
...+.| +.|....+|+.... . ++..+++|....... .......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88888999998642 1 266888997543220 0000123566888887773 2 3466676665443
Q ss_pred C-CceEEEEEeeccC
Q 015247 188 M-SCSLYLVFHYMEH 201 (410)
Q Consensus 188 ~-~~~~~lv~e~~~~ 201 (410)
. ....|++||+++|
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 1 1346899999987
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00016 Score=70.44 Aligned_cols=79 Identities=8% Similarity=0.045 Sum_probs=47.6
Q ss_pred HHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc--cccccccccccCCc--CCCCccchHHHHHHH
Q 015247 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT--DYGVGVDLWSAGCIL 309 (410)
Q Consensus 234 H~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~~DiwSlGv~l 309 (410)
+...++|+|++|.|||++.++ +.|+||+.+..-.+... ...... ...|++|+...... .-....++.+....+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 345799999999999998876 99999998875432111 011111 23466666443110 011234455777777
Q ss_pred HHHHcC
Q 015247 310 AELLAG 315 (410)
Q Consensus 310 ~ell~g 315 (410)
|+..++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00082 Score=62.56 Aligned_cols=75 Identities=16% Similarity=0.136 Sum_probs=55.2
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeEeeeEeecCCceEEEE
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv 195 (410)
.-.+.|+.|....+|+.. .++..+++|+.... ....+.+|...|+.+. ...+++++.+... ....+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIN--DEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEE
T ss_pred eeeEEeCCccceeeeEEE--ECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEE
Confidence 345779999999999997 35778899987632 2456778988888773 3567777766554 3468999
Q ss_pred EeeccCC
Q 015247 196 FHYMEHD 202 (410)
Q Consensus 196 ~e~~~~~ 202 (410)
|||+++.
T Consensus 110 me~l~G~ 116 (312)
T 3jr1_A 110 LEALNKS 116 (312)
T ss_dssp EECCCCC
T ss_pred EEeccCC
Confidence 9999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00097 Score=61.59 Aligned_cols=30 Identities=23% Similarity=0.266 Sum_probs=25.5
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
.++|+|+.+.||| ..++.+.|+||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3799999999999 56778999999988643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00059 Score=59.37 Aligned_cols=99 Identities=15% Similarity=0.015 Sum_probs=65.5
Q ss_pred CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCccccc
Q 015247 202 DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 280 (410)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 280 (410)
+|...+...+.++++.++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 4667777778899999999999999999877622 2212333457999999999998763 1110 01
Q ss_pred cccccccccccCCcCCCCccchHHHHHHHHHHHcCC
Q 015247 281 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 316 (410)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~ 316 (410)
...+.|||... ...+.+.=|||||+++|..+--.
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence 22366888653 22567889999999999988644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00085 Score=61.56 Aligned_cols=76 Identities=16% Similarity=0.239 Sum_probs=51.3
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC---CceeeEeeeEeecCCceEE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH---PNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~ 193 (410)
...-++.+|.|..+.||+.+ ..+|+.|++|+-...... ....+..|+..|+.|.. -.+++++++ . . -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ce
Confidence 35567889999999999998 578999999976533221 12346779888887742 223444432 2 1 36
Q ss_pred EEEeeccC
Q 015247 194 LVFHYMEH 201 (410)
Q Consensus 194 lv~e~~~~ 201 (410)
++|||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 88998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00045 Score=64.37 Aligned_cols=141 Identities=13% Similarity=0.103 Sum_probs=74.4
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeEeeeEe----ecCCceEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLVT----SRMSCSLY 193 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~----~~~~~~~~ 193 (410)
-++.|+.|....+|++.. .+| .+++|+..... . ...+..|+.++..+.... +.+++.... .......+
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 456788888899999974 344 68899886421 1 123445777776663211 233321100 00123468
Q ss_pred EEEeeccCCH----------------HHHhc-CCC--CC----CC---HHHHHH------------HHHHHHHHHHHHHH
Q 015247 194 LVFHYMEHDL----------------AGLAA-SPE--VK----FT---EPQVKC------------YMHQLLSGLEHCHN 235 (410)
Q Consensus 194 lv~e~~~~~l----------------~~~~~-~~~--~~----~~---~~~~~~------------~~~qi~~~L~~LH~ 235 (410)
+++++++|.. ...+. ... .. .. +..... +...+...+..|..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998631 01111 000 00 11 111000 00113344555553
Q ss_pred -------CCceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 236 -------NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 236 -------~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999998876668999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0013 Score=64.22 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=46.2
Q ss_pred eeeeeccCCCeeEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeEeeeEeecCCce
Q 015247 120 KIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCS 191 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 191 (410)
.++.|+.|....||++.... ++..+++|+..... . .+.+.+|..++..+...+ ..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 35678888889999997532 25789999874211 1 133456888888774322 3556655432
Q ss_pred EEEEEeeccC
Q 015247 192 LYLVFHYMEH 201 (410)
Q Consensus 192 ~~lv~e~~~~ 201 (410)
.++++|++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 278899875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0021 Score=61.52 Aligned_cols=148 Identities=14% Similarity=0.187 Sum_probs=83.7
Q ss_pred CCCCCcCCCcceeeeeccCCCeeEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeE
Q 015247 109 GWIPRRADSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKL 180 (410)
Q Consensus 109 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l 180 (410)
.|.....+.+++ +.|..|-...+|++.... ++..|++|+... .. .....+.+|..+++.+. +.-..++
T Consensus 44 ~W~~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~-~~~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 44 AWRRVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL-QGVDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp GGGGCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred cCCCCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc-chHHHHHHHHHHHHHHHhcCCCCeE
Confidence 354333344543 557778888899997532 357899997522 11 12345567988888773 2223556
Q ss_pred eeeEeecCCceEEEEEeeccCCHH-------------------HHhcC---CCCCC--CHHHHHHHHHHHHH--------
Q 015247 181 EGLVTSRMSCSLYLVFHYMEHDLA-------------------GLAAS---PEVKF--TEPQVKCYMHQLLS-------- 228 (410)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~~~l~-------------------~~~~~---~~~~~--~~~~~~~~~~qi~~-------- 228 (410)
++++.+ .+||||++|..+ .++.. -.... .+.++..+..++..
T Consensus 120 l~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~ 193 (379)
T 3feg_A 120 YGVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPE 193 (379)
T ss_dssp EEEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred EEEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccch
Confidence 555432 188999986211 01111 01112 24566666655422
Q ss_pred -----------HHHHHH----HC----CceeccCCCCCEEEcCC----CcEEEEeeccccc
Q 015247 229 -----------GLEHCH----NN----GVLHRDIKGSNLLIDDD----GVLKIADFGLASF 266 (410)
Q Consensus 229 -----------~L~~LH----~~----~ivHrDlkp~NILl~~~----~~vkl~DFGla~~ 266 (410)
.+..|. .. .++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 194 ~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 194 MNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 22 48999999999999876 7899999998854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.012 Score=54.77 Aligned_cols=74 Identities=12% Similarity=0.064 Sum_probs=45.0
Q ss_pred eeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeEeeeEee----cCCceEEEE
Q 015247 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTS----RMSCSLYLV 195 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----~~~~~~~lv 195 (410)
..|+ |....||++. ..+|+.+++|......... ..+..|..++..+.. -.+++++.. .. ...+..+++
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 8888999886 3467789999986433222 345567777776632 123444332 11 013456889
Q ss_pred EeeccC
Q 015247 196 FHYMEH 201 (410)
Q Consensus 196 ~e~~~~ 201 (410)
|++++|
T Consensus 106 ~~~i~G 111 (328)
T 1zyl_A 106 FPSVGG 111 (328)
T ss_dssp EECCCC
T ss_pred EEecCC
Confidence 999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0026 Score=59.57 Aligned_cols=32 Identities=28% Similarity=0.310 Sum_probs=27.7
Q ss_pred CCceeccCCCCCEEEcCC----CcEEEEeecccccc
Q 015247 236 NGVLHRDIKGSNLLIDDD----GVLKIADFGLASFF 267 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~ 267 (410)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 68999999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.012 Score=55.17 Aligned_cols=31 Identities=23% Similarity=0.399 Sum_probs=27.8
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
.++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998889999999887654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=57.91 Aligned_cols=73 Identities=21% Similarity=0.159 Sum_probs=44.7
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeEeeeEeecCCceEEEEEee
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHY 198 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~ 198 (410)
-++.|+.|-...+|++.....+..+++|+..... . ... ...+|..++..|...++ .++++++. . .++|+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EII-NREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCS-CHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 3567888888999999854335788999864321 1 111 12468888888854444 56666652 2 149999
Q ss_pred ccC
Q 015247 199 MEH 201 (410)
Q Consensus 199 ~~~ 201 (410)
+++
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0096 Score=56.52 Aligned_cols=72 Identities=7% Similarity=0.029 Sum_probs=39.9
Q ss_pred eeeeccCCCeeEEEEEEcC--------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeEeeeEeecCCce
Q 015247 121 IDKIGQGTYSNVYKAKDML--------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCS 191 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 191 (410)
+..|+.|....+|++.... .+..+++|+..... ........|..+++.+...+ ..++++.+ . .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N-G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C-C--
Confidence 4567888888999997532 13678888764321 11112345777777764223 34555433 1 2
Q ss_pred EEEEEeeccC
Q 015247 192 LYLVFHYMEH 201 (410)
Q Consensus 192 ~~lv~e~~~~ 201 (410)
+++|+|++|
T Consensus 110 -~~v~e~i~G 118 (369)
T 3c5i_A 110 -GRIEEWLYG 118 (369)
T ss_dssp -EEEEECCCS
T ss_pred -cEEEEEecC
Confidence 578999876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.73 E-value=0.14 Score=49.10 Aligned_cols=29 Identities=28% Similarity=0.551 Sum_probs=25.0
Q ss_pred ceeccCCCCCEEE------cCCCcEEEEeeccccc
Q 015247 238 VLHRDIKGSNLLI------DDDGVLKIADFGLASF 266 (410)
Q Consensus 238 ivHrDlkp~NILl------~~~~~vkl~DFGla~~ 266 (410)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998854
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.60 E-value=0.13 Score=49.80 Aligned_cols=29 Identities=21% Similarity=0.486 Sum_probs=25.9
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeeccccc
Q 015247 237 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 266 (410)
Q Consensus 237 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 266 (410)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7888999999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.50 E-value=0.026 Score=55.37 Aligned_cols=65 Identities=11% Similarity=0.169 Sum_probs=18.7
Q ss_pred ceeeeeccCCCeeEEEEEEcCCCceEEE------EEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 015247 119 EKIDKIGQGTYSNVYKAKDMLTGKIVAL------KKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS 186 (410)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 186 (410)
.+.+.|| ||.||+|....+..+||+ |..+......+....+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3445666 999999986554568888 7665444444555667789999999999999999887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 410 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-80 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-75 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-74 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-72 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-72 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-72 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-69 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-65 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-28 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-80
Identities = 135/305 (44%), Positives = 182/305 (59%), Gaps = 12/305 (3%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+EK+ KIGQGT+ V+KA+ TG+ VALKKV +N + REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 173 DHPNVIKLEGLVTSRMS------CSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQL 226
H NV+ L + ++ S S+YLVF + EHDLAGL ++ VKFT ++K M L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLW 283
L+GL + H N +LHRD+K +N+LI DGVLK+ADFGLA F + T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
YRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 344 KK-SKLPNATLFKPREPYKRCIQETFKDF--PPSSLPLIETLLAIDPAERLTATVALNSE 400
+ + KR +++ K + P +L LI+ LL +DPA+R+ + ALN +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 401 VIFQD 405
+ D
Sbjct: 307 FFWSD 311
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (599), Expect = 2e-75
Identities = 117/286 (40%), Positives = 170/286 (59%), Gaps = 9/286 (3%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHP 175
EK+D +G+G ++ VYKA+D T +IVA+KK++ + + + REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N+I L + ++ LVF +ME DL + + T +K YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
+ +LHRD+K +NLL+D++GVLK+ADFGLA F ++ T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARM 177
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK-SKLPNATLF 354
YGVGVD+W+ GCILAELL P +PG ++++QL +I++ G+P+EE W LP+ F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
K + F L LI+ L +P R+TAT AL +
Sbjct: 238 KSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 4e-74
Identities = 111/284 (39%), Positives = 165/284 (58%), Gaps = 4/284 (1%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++F+K++KIG+GTY VYKA++ LTG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++KL ++ + LYLVF ++ DL + AS P +K Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
++ VLHRD+K NLLI+ +G +K+ADFGLA F + T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 178
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y VD+WS GCI AE++ + + PG +E++QL +I++ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ ++ + L+ +L DP +R++A AL
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-72
Identities = 99/291 (34%), Positives = 153/291 (52%), Gaps = 10/291 (3%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ + IG+G Y V A D + VA+KK+ + + + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 175 PNVIKLEGLV---TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
N+I + ++ T +YLV H M DL L + + + +++Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWYRPPEL 289
+ H+ VLHRD+K SNLL++ LKI DFGLA DP+H H +T V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
+L + Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 350 NATLFKPREPYKRCI--QETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
A + P+K + F + +L L++ +L +P +R+ AL
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (578), Expect = 1e-72
Identities = 103/290 (35%), Positives = 162/290 (55%), Gaps = 5/290 (1%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + ++KIG+GTY VYKA++ G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N++KL ++ ++ L LVF +++ DL L E K ++ QLL+G+ +CH+
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
VLHRD+K NLLI+ +G LKIADFGLA F + +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
Y +D+WS GCI AE++ G P+ PG +E +QL +I+++ G+P+ + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405
+ K S + L+ +L +DP +R+TA AL F++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA-YFKE 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-72
Identities = 104/293 (35%), Positives = 150/293 (51%), Gaps = 16/293 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
S+ IG G++ VY+AK +G++VA+KKV D +F RE+ I+R+LDH
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHC 73
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLA---ASPEVKFTEPQVKCYMHQLLS 228
N+++L S L LV Y+ + +A + + VK YM+QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
L + H+ G+ HRDIK NLL+D D VLK+ DFG A P S + + +YR P
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAP 191
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
EL+ GATDY +D+WSAGC+LAELL G+PI PG + V+QL +I K+ G+P+ E ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
P+ + PP ++ L LL P RLT A
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-71
Identities = 109/284 (38%), Positives = 158/284 (55%), Gaps = 4/284 (1%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N+++L ++ S LVF + + DL S VK ++ QLL GL CH+
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
VLHRD+K NLLI+ +G LK+A+FGLA F + ++ VVTLWYRPP++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL 178
Query: 296 YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y +D+WSAGCI AEL P+ PG +QL +I++L G+P+EE W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P P + + L++ LL +P +R++A AL
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-71
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 30/286 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ + +G+G Y V A + +T + VA+K V + + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
NV+K G R YL Y P++ EP + + HQL++G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGAT 294
G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
+ VD+WS G +L +LAG+ ++ Q + +K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+K + L L+ +L +P+ R+T
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 1e-69
Identities = 69/301 (22%), Positives = 123/301 (40%), Gaps = 23/301 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G ++A K + + ++P + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
P ++ G S + + +M+ + E + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 234 HN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
+ ++HRD+K SN+L++ G +K+ DFG++ + S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCG----SPSEEYWKKSK 347
T Y V D+WS G L E+ G+ PI P + +L ++ G +P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLP----------LIETLLAIDPAERLTATVAL 397
L + + + + + PP LP + L +PAER +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 398 N 398
Sbjct: 297 V 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-67
Identities = 102/291 (35%), Positives = 150/291 (51%), Gaps = 12/291 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ + +G G Y +V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 176 NVIKLEGLVTSRMSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
NVI L + T S +YLV H M DL + K T+ V+ ++Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
+ H+ ++HRD+K SNL +++D LKI DFGLA D MT V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 191
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P E KK +A
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 352 TLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ K F P ++ L+E +L +D +R+TA AL
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 216 bits (551), Expect = 1e-67
Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ ++++G G + V++ + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+I L + + L+ ++ +L A+ + K +E +V YM Q GL+H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 235 NNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
+ ++H DIK N++ + +KI DFGLA+ +P+ +T T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
G D+W+ G + LL+G G ++E L + + E+ +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P + I+ LL +P +RLT AL
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-67
Identities = 97/289 (33%), Positives = 148/289 (51%), Gaps = 12/289 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +G G Y V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
NVI L + T + YLV +M DL L K E +++ ++Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
+ H G++HRD+K NL +++D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y VD+WS GCI+AE++ GK + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 352 TLFKPREPY--KRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ P K+ + P ++ L+E +L +D +R+TA AL
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (547), Expect = 2e-67
Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 37/294 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
PN I+ G + +LV Y + L + E ++ H L GL + H
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
++ ++HRD+K N+L+ + G++K+ DFG AS P S V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 295 D--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
+ Y VD+WS G EL KP + + L+ I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------- 228
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406
+ E F++ +++ L P +R T+ V L + ++R
Sbjct: 229 -NESPALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-67
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
RA+ +E + IG G+Y K + GKI+ K++ + ++ + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQVKCYMHQLLSG 229
HPN+++ + R + +LY+V Y E DLA + E V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 230 LEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
L+ CH + VLHRD+K +N+ +D +K+ DFGLA + + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYY 180
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE + Y D+WS GC+L EL A P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++P + +I +L + R + L
Sbjct: 231 FRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 108/294 (36%), Positives = 157/294 (53%), Gaps = 13/294 (4%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRR 171
R +E + +IG+G Y V+KA+D+ G+ VALK+VR E RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 172 L---DHPNVIKLEGLVT---SRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMH 224
L +HPNV++L + T + L LVF +++ D L PE +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 225 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 284
QLL GL+ H++ V+HRD+K N+L+ G +K+ADFGLA + TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 181
Query: 285 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
R PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ F + I++ D L+ L +PA+R++A AL+
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 214 bits (547), Expect = 5e-67
Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 35/286 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ +++G G + V++ + TG A K V + + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
++ L + +++ +M +L A K +E + YM Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 235 NNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
N +H D+K N++ LK+ DFGL + DP +T+ T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEG 199
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
G D+WS G + LL+G G + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG------- 251
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
I E KD I LL DP R+T AL
Sbjct: 252 -----------ISEDGKD-------FIRKLLLADPNTRMTIHQALE 279
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-67
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 36/288 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D +E I ++G G + VYKA++ T + A K + + E ++ EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++KL + L+++ + + + E TE Q++ Q L L + H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+N ++HRD+K N+L DG +K+ADFG+++ + S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCET 186
Query: 295 D----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
Y D+WS G L E+ +P + L KI K P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--SEP------------ 232
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
P FKD ++ L + R T + L
Sbjct: 233 -----PTLAQPSRWSSNFKD-------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-66
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 34/294 (11%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR 171
+R + F+ +G+G++S V A+++ T + A+K + ++ + V ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
LDHP +KL LY Y ++ F E + Y +++S LE
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELL 290
+ H G++HRD+K N+L+++D ++I DFG A P K + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
+ DLW+ GCI+ +L+AG P E KI KL E+++ K
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----- 236
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404
+D L+E LL +D +RL +
Sbjct: 237 -----------------ARD-------LVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-66
Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV-KFMAREILILRRLDH 174
+ FE +G+G + NVY A++ + I+ALK + LE V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
PN+++L G + +YL+ Y KF E + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ V+HRDIK NLL+ G LKIADFG + + + + TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRM 180
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
+ VDLWS G + E L GKP T E +I ++ + +
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ LI LL +P++R L
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-65
Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 33/285 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +KIGQG VY A D+ TG+ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNP 77
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN 235
N++ L++V Y+ E E Q+ + L LE H+
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 295
N V+HRDIK N+L+ DG +K+ DFG + P ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KA 192
Query: 296 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355
YG VD+WS G + E++ G+P + L+ I G+P + +K
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK---------- 241
Query: 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSE 400
+ F+D + L +D +R +A L +
Sbjct: 242 --------LSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQ 271
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 204 bits (520), Expect = 2e-63
Identities = 89/295 (30%), Positives = 155/295 (52%), Gaps = 23/295 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D ++ + K+G+G YS V++A ++ + V +K ++ P K + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
PN+I L +V +S + LVF ++ + D L T+ ++ YM+++L L++C
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 234 HNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
H+ G++HRD+K N++ID + L++ D+GLA F+ P ++ RV + +++ PELL+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 203
Query: 293 ATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPS-EEYWKKSKLPN 350
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ +Y K +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 351 ATLFK------PREPYKRCIQ-ETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
F R+ ++R + E P +L ++ LL D RLTA A+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 9e-63
Identities = 82/297 (27%), Positives = 125/297 (42%), Gaps = 36/297 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ D +G G +S V A+D T K+VA+K + LE + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++ L+ + S LYL+ + +L +TE + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 235 NNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
+ G++HRD+K NLL D+D + I+DFGL+ DP +++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y VD WS G I LL G P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408
D S+ I L+ DP +R T AL I D L
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 201 bits (511), Expect = 1e-62
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 44/297 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-------VKFMAREILI 168
+++E + +G+G S V + T K A+K + S + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
LR++ HPN+I+L+ + +LVF M+ +L +V +E + + M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
L + H ++HRD+K N+L+DDD +K+ DFG + DP K + T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 287 PELLLGATD-----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEE 341
PE++ + + YG VD+WS G I+ LLAG P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 342 YWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
W D+ + L+ L + P +R TA AL
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-62
Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 36/295 (12%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W IP +IG G++ VYK K VA+K + P+ ++ E+ +
Sbjct: 3 WEIPD--GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLL 227
LR+ H N++ G T+ L +V + E L E KF ++ Q
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP-NHKHPMTSRVVTLWYRP 286
G+++ H ++HRD+K +N+ + +D +KI DFGLA+ + H ++ +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 287 PELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE++ Y D+++ G +L EL+ G+ +Q+ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------- 223
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
R + + + P + L+ L ER L S
Sbjct: 224 ------------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-61
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 36/286 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G + V++ + + K K V+ + VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
N++ L S L ++F ++ D+ + + E ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 235 NNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 292
++ + H DI+ N++ +KI +FG A Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQH 177
Query: 293 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352
D+WS G ++ LL+G T + + I + EE +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
K+ ++ ++ LL + R+TA+ AL
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-60
Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE----SVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ + S + + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ HPNVI L + ++ + L+ + + + TE + ++ Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGV----LKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
+ H+ + H D+K N+++ D V +KI DFGLA D ++ + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E++ G+ D+WS G I LL+G G T+ E L + + +EY+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ + I LL DP +R+T +L
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 9e-59
Identities = 59/287 (20%), Positives = 106/287 (36%), Gaps = 37/287 (12%)
Query: 118 FEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
F K D +IG+G++ VYK D T VA +++ L + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 177 VIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+++ T + + LV M ++ + Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 235 NNG--VLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
++HRD+K N+ I G +KI D GLA+ + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE 186
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y VD+++ G + E+ + Q+++ P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------ 232
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ + K+ +IE + + ER + LN
Sbjct: 233 -------SFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 88/298 (29%), Positives = 149/298 (50%), Gaps = 23/298 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
I L + T + + +YLV M+ L +++ ++ ++Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G++HRD+K SN+++ D LKI DFGLA + MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 354 FKPREPYKR-------------CIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ R Y E K + L+ +L IDPA+R++ AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 186 bits (474), Expect = 3e-57
Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 31/293 (10%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD 173
+D +E + +G G S V+ A+D+ + VA+K +R D +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 174 HPNVIKLEGLVTSR--MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
HP ++ + + Y+V Y++ E T + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPEL 289
H NG++HRD+K +N++I +K+ DFG+A N + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 290 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349
G + D++S GC+L E+L G+P G + V ++ + P
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402
+ ++ LA +P R + ++++
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 187 bits (476), Expect = 2e-56
Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 35/290 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILRR 171
+ F IG+G + VY + TGK+ A+K + ++ + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
D P ++ + + L + M S F+E ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 291
H HN V++RD+K +N+L+D+ G ++I+D GLA F H T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG---THGYMAPEVLQ 178
Query: 292 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351
Y D +S GC+L +LL G ++ H+I ++ + + E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
F P L+E LL D RL EV
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-56
Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 35/292 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLD 173
+ F +G+G++ V+ A+ T + A+K ++ D + + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHC 233
HP + + ++ + L+ V Y+ KF + Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 234 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 293
H+ G+++RD+K N+L+D DG +KIADFG+ + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQ 178
Query: 294 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y VD WS G +L E+L G+ G+ E E H I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------------------- 216
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405
Y R +++ KD L+ L +P +RL + +F++
Sbjct: 217 -MDNPFYPRWLEKEAKD-------LLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 34/287 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
+ F+ + +G+GT+ V ++ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
P + L+ + L V Y S E FTE + + Y +++S LE+ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ V++RDIK NL++D DG +KI DFGL + M + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED-N 180
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
DYG VD W G ++ E++ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
+ R P + P + L+ LL DP +RL + EV
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (456), Expect = 6e-54
Identities = 61/287 (21%), Positives = 115/287 (40%), Gaps = 37/287 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
F+ + +G G++ V+ + G+ A+K ++ + + + V+ E L+L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
P +I++ G ++++ Y+E +F P K Y ++ LE+ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ +++RD+K N+L+D +G +KI DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y +D WS G ++ E+LAG ++ KI
Sbjct: 178 -YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------------------L 214
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
+ E KD L+ L+ D ++RL +V
Sbjct: 215 NAELRFPPFFNEDVKD-------LLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-53
Identities = 59/287 (20%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+PR ++ + ++++G G + V+ VA+K ++ ++ P++ E +++
Sbjct: 10 VPR--ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMK 63
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG--LAASPEVKFTEPQVKCYMHQLLS 228
+L H +++L +VT +Y++ YME+ L +K T ++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ +HRD++ +N+L+ D KIADFGLA + N + + PE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 289 LLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
+ T + + D+WS G +L E++ G+ PG T E + + +
Sbjct: 181 AINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------------- 225
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
++ P + P L+ P +R T
Sbjct: 226 -----GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFD 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-52
Identities = 66/291 (22%), Positives = 106/291 (36%), Gaps = 46/291 (15%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILR 170
++ +G G + +VY + VA+K V D + E + + E+++L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 171 RLD--HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLS 228
++ VI+L S L L DL E + + Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 121
Query: 229 GLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 287
+ HCHN GVLHRDIK N+LID + G LK+ DFG + T T Y PP
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPP 178
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
E + +G +WS G +L +++ G E+ + ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------------- 224
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+ LI LA+ P++R T N
Sbjct: 225 ---------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 62/299 (20%), Positives = 113/299 (37%), Gaps = 40/299 (13%)
Query: 116 DSFEKIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 174 HPNVIKLEGLVTSRMSC--SLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQLLSG 229
P+++++ + + + L +V ++ +L + + FTE + M +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 230 LEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
+++ H+ + HRD+K NLL + +LK+ DFG A ++ T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
PE+L Y D+WS G I+ LL G P + +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------- 233
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405
++ P + E K LI LL +P +R+T T +N I Q
Sbjct: 234 -------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPWIMQS 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-52
Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S K+GQG + V+ T + VA+K ++ + PE+ +E +++
Sbjct: 14 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMK 67
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLA--ASPEVKFTEPQVKCYMHQLLS 228
+L H +++L +V+ +Y+V YM PQ+ Q+ S
Sbjct: 68 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 229 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 288
G+ + +HRD++ +N+L+ ++ V K+ADFGLA + N + + PE
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 289 LLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
L + + D+WS G +L EL G+ PG E L ++ + P
Sbjct: 185 AALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP------ 237
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
+ P S L+ +P ER T
Sbjct: 238 ----------------------ECPESLHDLMCQCWRKEPEERPTF 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-52
Identities = 61/286 (21%), Positives = 102/286 (35%), Gaps = 37/286 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNL-EPESVKFMAREILILRR 171
++K+G G++ V + + VA+K ++ D L +PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
LDH N+I+L G+V + + +V L + F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPEL 289
+ + +HRD+ NLL+ ++KI DFGL N H M +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 290 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
L + D W G L E+ G+ G + LHKI K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP------- 237
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
+D P ++ A P +R T
Sbjct: 238 --------------------EDCPQDIYNVMVQCWAHKPEDRPTFV 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-52
Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 37/285 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +IG G + V+ L VA+K +R + E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+++L G+ + LVF +MEH L+ + F + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
V+HRD+ N L+ ++ V+K++DFG+ F + T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 295 DYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
Y D+WS G ++ E+ + GK R+ E + I L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------------GFRL 221
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+KPR Q ++ P +R + L
Sbjct: 222 YKPRLASTHVYQ------------IMNHCWKERPEDRPAFSRLLR 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 1e-51
Identities = 52/291 (17%), Positives = 95/291 (32%), Gaps = 36/291 (12%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R + + KIG G++ ++Y D+ G+ VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEH 232
I + +V + L L KF+ V Q++S +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 233 CHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFDPN------HKHPMTSRVVTLW 283
H+ +HRD+K N L+ ++ I DFGLA + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 284 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYW 343
Y LG + DL S G +L G G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 344 KKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
+ I+ K +P + ++ ++ +
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-51
Identities = 56/294 (19%), Positives = 110/294 (37%), Gaps = 46/294 (15%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ + + E
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEAS 52
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQVKCYMHQ 225
++ +L H N+++L G++ LY+V YM L L + + +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 285
+ +E+ N +HRD+ N+L+ +D V K++DFGL + + + +
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWT 167
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE L + D+WS G +L E+ + G+ P + + ++ K
Sbjct: 168 APEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
+K P PP+ +++ +D A R +
Sbjct: 216 --------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 2e-51
Identities = 56/270 (20%), Positives = 109/270 (40%), Gaps = 18/270 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
D F++I +G G++ V K +G A+K + + + + ++ E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
P ++KLE + + + + + L +F+EP + Y Q++ E+ H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH 158
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ +++RD+K NLLID G +++ DFG A K + T PE++L
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILS-K 213
Query: 295 DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354
Y VD W+ G ++ E+ AG P ++ KI + K
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK------- 266
Query: 355 KPREPYKRCIQETFKDFPPSSLPLIETLLA 384
+ + +Q + + +
Sbjct: 267 ---DLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 4e-51
Identities = 54/299 (18%), Positives = 114/299 (38%), Gaps = 34/299 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ R K+G G Y VY+ VA+K ++ D +E E +E +++
Sbjct: 14 MER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMK 68
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+ HPN+++L G+ T + F + L L + + + Q+ S +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 290
E+ +HRD+ N L+ ++ ++K+ADFGL+ + + + PE L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 291 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350
+ + D+W+ G +L E+ ++ Q++++ +
Sbjct: 189 AY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------------- 231
Query: 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS-EVIFQDRTL 408
R E + L+ +P++R + + E +FQ+ ++
Sbjct: 232 ----DYRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 5e-51
Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
++FE + +G G Y V+ + + TGK+ A+K ++ + + ++ + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 171 RLDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSG 229
+ P ++ L + L+L+ Y+ S +FTE +V+ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 230 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 289
LEH H G+++RDIK N+L+D +G + + DFGL+ F + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 290 LLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
+ G + + VD WS G ++ ELL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEV 401
++ + LI+ LL DP +RL E+
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-51
Identities = 58/289 (20%), Positives = 112/289 (38%), Gaps = 40/289 (13%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQL 226
+R+ DHP+++KL G++T ++++ +L + + Y +QL
Sbjct: 61 TMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 227 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 286
+ L + + +HRDI N+L+ + +K+ DFGL+ + + + + + + + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345
PE + + D+W G + E+L G G + + +I
Sbjct: 178 PESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------------ 224
Query: 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
R P T L+ A DP+ R T
Sbjct: 225 ---------GERLPMPPNCPPTLYS-------LMTKCWAYDPSRRPRFT 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-51
Identities = 53/302 (17%), Positives = 106/302 (35%), Gaps = 39/302 (12%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
++ R+ + E ++G G + V K + K VA+K ++ + +P + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLL 227
++++LD+P ++++ G+ + S LV E + + +HQ+
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 228 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYR 285
G+++ + +HRD+ N+L+ KI+DFGL+ + + + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 286 PPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWK 344
PE + + D+WS G ++ E + G+ G E + K
Sbjct: 178 APECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------- 225
Query: 345 KSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT-VALNSEVIF 403
R D L+ D R V L +
Sbjct: 226 ----------GERMGCPAGCPREMYD-------LMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 404 QD 405
D
Sbjct: 269 YD 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-50
Identities = 52/285 (18%), Positives = 111/285 (38%), Gaps = 37/285 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++G G + V K VA+K ++ ++ + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCH 234
+++L G+ T + ++++ YM + L +F Q+ + +E+
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 235 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 294
+ LHRD+ N L++D GV+K++DFGL+ + + + + PPE+L+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S 176
Query: 295 DYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
+ D+W+ G ++ E+ + GK T E I + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----------------GLRL 220
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
++P ++ ++ + ER T + L+
Sbjct: 221 YRPHLASEKVYT------------IMYSCWHEKADERPTFKILLS 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 7e-50
Identities = 62/293 (21%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRL 172
+ IG G + V L GK VA+K ++ E + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
DHPNVI LEG+VT S + ++ +ME+ L + +FT Q+ + + +G++
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV----TLWYRPP 287
+ + +HRD+ N+L++ + V K++DFGL+ F + + P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 288 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
E + + D+WS G ++ E+++ G+ T + ++ I +
Sbjct: 203 EAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------- 248
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399
R P L+ D R +N+
Sbjct: 249 --------DYRLPPPMDCPSALHQ-------LMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-49
Identities = 56/286 (19%), Positives = 107/286 (37%), Gaps = 40/286 (13%)
Query: 116 DSFEKID-KIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL 172
D+ D ++G G + +V + + K VA+K ++ E + M RE I+ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQL 66
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
D+P +++L G+ + +L LV L + V +HQ+ G++
Sbjct: 67 DNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPEL 289
+ +HRD+ N+L+ + KI+DFGL+ + + ++ L + PE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 290 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
+ + D+WS G + E L+ G+ E + I + K+ +
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMEC 233
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
P + PP L+ +R
Sbjct: 234 P-------------------PECPPELYALMSDCWIYKWEDRPDFL 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 165 bits (419), Expect = 8e-49
Identities = 46/284 (16%), Positives = 88/284 (30%), Gaps = 38/284 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ +IG+G++ +++ ++L + VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
I LV + L L KF+ V Q+L+ ++ H
Sbjct: 63 IPNVYYFGQEGLH-NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 238 VLHRDIKGSNLLIDD-----DGVLKIADFGLASFFDPN------HKHPMTSRVVTLWYRP 286
+++RDIK N LI ++ + DFG+ F+ + T Y
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 287 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346
LG + DL + G + L G G K ++
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------- 229
Query: 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAER 390
+ ++E FP + +
Sbjct: 230 ----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 67/296 (22%), Positives = 104/296 (35%), Gaps = 29/296 (9%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A + + IG+G + V++ K G+ VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 175 PNVIKLEGLVTSRMSC--SLYLVFHYMEH-DLA------GLAASPEVKFTEPQVKCYMHQ 225
N++ L+LV Y EH L + +K H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 226 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRVVTL 282
+ + + HRD+K N+L+ +G IAD GLA D RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 283 WYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGS 337
Y PE+L + + D+++ G + E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 338 PSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTA 393
PS E +K +P P + E + ++ + A RLTA
Sbjct: 236 PSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 285
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 4e-47
Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 48/321 (14%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ + K+G G +S V+ AKDM+ VA+K VR D + E+ + EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 178 IKLEGLVTSRMSCSLYLVFHYME--------------HDLAGLAASPEVKFTEPQVKCYM 223
K + + + + L H + LA + VK
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 224 HQLLSGLEHC-HNNGVLHRDIKGSNLLIDDDGV------LKIADFGLASFFDPNHKHPMT 276
QLL GL++ G++H DIK N+L++ +KIAD G A ++D ++ + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLHK 330
+R YR PE+LLGA +G G D+WS C++ EL+ G + + + + +
Sbjct: 192 TR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 331 IYKLCGSPSEEYWKKSKLPNATL-------------FKPREPYKRCIQETFKDFPPSSLP 377
I +L G + K F P E + KD
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 378 LIETLLAIDPAERLTATVALN 398
+ +L +DP +R A +N
Sbjct: 307 FLSPMLQLDPRKRADAGGLVN 327
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-47
Identities = 66/315 (20%), Positives = 113/315 (35%), Gaps = 64/315 (20%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-----VALKKVRFDNLEPESVKFMARE 165
PR ++ E +G G + V A K VA+K ++ E M E
Sbjct: 34 FPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SE 90
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKF--------- 214
+ ++ +L H N++ L G T S +YL+F Y + DL S KF
Sbjct: 91 LKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 215 -------------TEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261
T + C+ +Q+ G+E +HRD+ N+L+ V+KI DF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 262 GLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIM 319
GLA + + + + + + PE L Y + D+WS G +L E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 320 PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLI 379
PG +K+ + + E ++
Sbjct: 268 PGIPVDANFYKLIQN--------------------GFKMDQPFYATEEIYI-------IM 300
Query: 380 ETLLAIDPAERLTAT 394
++ A D +R +
Sbjct: 301 QSCWAFDSRKRPSFP 315
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-46
Identities = 53/286 (18%), Positives = 95/286 (33%), Gaps = 36/286 (12%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILR 170
+ F+KI +G G + VYK + G+ V + K + P++ K + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGL 230
+D+P+V +L G+ + + L + + + Q+ G+
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPEL 289
+ + ++HRD+ N+L+ +KI DFGLA K + + E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 290 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348
+L Y D+WS G + EL+ G G E + K
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------------- 228
Query: 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
R P ++ ID R
Sbjct: 229 ------GERLPQPPICTIDVYM-------IMVKCWMIDADSRPKFR 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 1e-46
Identities = 58/315 (18%), Positives = 119/315 (37%), Gaps = 65/315 (20%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMARE 165
PR ++ E + IG+G + V++A+ +VA+K ++ + F RE
Sbjct: 10 YPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 66
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH------------------------ 201
++ D+PN++KL G + + L+F YM +
Sbjct: 67 AALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 202 DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261
A +++ + + C Q+ +G+ + +HRD+ N L+ ++ V+KIADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 262 GLASFFDP-NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIM 319
GL+ ++ + + + + PPE + Y D+W+ G +L E+ + G
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 320 PGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLI 379
G E ++ + + + ++ P L+
Sbjct: 244 YGMAHEEVIYYV------------RDGNIL----------------ACPENCPLELYNLM 275
Query: 380 ETLLAIDPAERLTAT 394
+ PA+R +
Sbjct: 276 RLCWSKLPADRPSFC 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-43
Identities = 57/310 (18%), Positives = 100/310 (32%), Gaps = 59/310 (19%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMARE 165
PR + +G G + V +A VA+K ++ E M E
Sbjct: 20 FPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SE 76
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH------------------DLAGL 206
+ +L L +H N++ L G T ++ Y + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 207 AASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 266
E+ + + +Q+ G+ + +HRD+ N+L+ + KI DFGLA
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 267 FDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 324
+ + + + + PE + Y D+WS G L EL + G PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLA 384
+ +K+ K R D +++T
Sbjct: 254 DSKFYKMIK--------------------EGFRMLSPEHAPAEMYD-------IMKTCWD 286
Query: 385 IDPAERLTAT 394
DP +R T
Sbjct: 287 ADPLKRPTFK 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 60/310 (19%), Positives = 106/310 (34%), Gaps = 52/310 (16%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMARE 165
PR D + +G+G + V +A T + VA+K ++ E M+
Sbjct: 10 FPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDL---------------AGLAASP 210
+++ H NV+ L G T + +V +L
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 211 EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270
+ T + CY Q+ G+E + +HRD+ N+L+ + V+KI DFGLA +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 271 HKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQL 328
+ L + PE + Y + D+WS G +L E+ + PG E+
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 329 HKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPA 388
+ K + R P P + +P+
Sbjct: 247 CRRLK------------------EGTRMRAP---------DYTTPEMYQTMLDCWHGEPS 279
Query: 389 ERLTATVALN 398
+R T + +
Sbjct: 280 QRPTFSELVE 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-43
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 39/281 (13%)
Query: 122 DKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + VY + A+K + E +F+ E +I++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 179 KLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG 237
L G + R S +V YM+H DL + T + + Q+ G++ +
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 238 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLWYRPPELLLGAT 294
+HRD+ N ++D+ +K+ADFGLA H T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 295 DYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353
+ D+WS G +L EL+ G P P + + + L
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----------------GRRL 253
Query: 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT 394
+P + P ++ R + +
Sbjct: 254 LQP------------EYCPDPLYEVMLKCWHPKAEMRPSFS 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-43
Identities = 55/291 (18%), Positives = 111/291 (38%), Gaps = 40/291 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRR 171
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGL 230
H N+I+LEG+++ + ++ YME+ + +F+ Q+ + + +G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 231 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPE 288
++ N +HRD+ N+L++ + V K++DFGL+ DP + + + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 289 LLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347
+ D+WS G ++ E++ G+ + E + I
Sbjct: 184 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------------- 228
Query: 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398
R P L+ + A R ++
Sbjct: 229 -------GFRLPTPMDCPSAIYQ-------LMMQCWQQERARRPKFADIVS 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-42
Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 55/312 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL- 172
+ + D IG+G + V KA+ G A+K+++ + + + A E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH----------------DLAGLAASPEVKFTE 216
HPN+I L G LYL Y H +A S +
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 217 PQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276
Q+ + + G+++ +HRD+ N+L+ ++ V KIADFGL+ + K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLC 335
+ + + E L + Y D+WS G +L E+++ G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 336 GSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV 395
R + D L+ P ER +
Sbjct: 242 -------------------GYRLEKPLNCDDEVYD-------LMRQCWREKPYERPSFAQ 275
Query: 396 ALNS-EVIFQDR 406
L S + ++R
Sbjct: 276 ILVSLNRMLEER 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-41
Identities = 61/312 (19%), Positives = 109/312 (34%), Gaps = 58/312 (18%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMA 163
+PR D +G+G + V A+ + K VA+K ++ D E + ++
Sbjct: 10 LPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 67
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH----------------DLAGLA 207
++ H N+I L G T LY++ Y +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 208 ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267
+PE + + + +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 268 DPNHKHPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 325
+ T + + + + PE L Y D+WS G +L E+ G PG
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
Query: 326 EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAI 385
E + + R ++
Sbjct: 245 ELFKLLKE---------------------GHRMDKPSNCTNELYM-------MMRDCWHA 276
Query: 386 DPAERLTATVAL 397
P++R T +
Sbjct: 277 VPSQRPTFKQLV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-40
Identities = 49/322 (15%), Positives = 112/322 (34%), Gaps = 52/322 (16%)
Query: 96 PPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKV 149
P + +A + W + R + ++GQG++ VY+ VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58
Query: 150 RFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME--------- 200
E ++F+ E +++ + +V++L G+V+ ++ M
Sbjct: 59 NEAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLR 115
Query: 201 -HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 259
A + ++ ++ G+ + + N +HRD+ N ++ +D +KI
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 260 DFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KP 317
DFG+ + ++ ++ + + PE L + D+WS G +L E+ +
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQ 234
Query: 318 IMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLP 377
G + + L + + + +
Sbjct: 235 PYQGLSNEQVLRFVME---------------------GGLLDKPDNCPDMLFE------- 266
Query: 378 LIETLLAIDPAERLTATVALNS 399
L+ +P R + ++S
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISS 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 109 bits (272), Expect = 1e-28
Identities = 26/203 (12%), Positives = 65/203 (32%), Gaps = 30/203 (14%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFM--------AREILILRRLD 173
+G+G S V+ +K + + + VK + + R +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 174 HPNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLE 231
+ KL+G + ++ ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 232 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYRPPE 288
++ G++H D+ N+L+ ++G+ I DF + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 289 LLLGATDYGVGVDLWSAGCILAE 311
Y D+ SA + +
Sbjct: 174 -----RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 410 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=453.80 Aligned_cols=262 Identities=29% Similarity=0.425 Sum_probs=216.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... +..+.+.+|+.+|+.++|||||++++++.+. ..+|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEE
Confidence 37899999999999999999999999999999999865432 2345688999999999999999999999884 56999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-KH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 273 (410)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||+++++++||+|||+|+...... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999986555555666789999999999999999999999999999999999999999999999999998775332 22
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+...++.++|||||||++|||++|++||.+.................
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 34567899999999999876645788999999999999999999998766544333332211110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
...+..+|+++.+||.+||++||.+|||++|+|+||||++.
T Consensus 226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 226 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 01123678899999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-63 Score=454.20 Aligned_cols=256 Identities=31% Similarity=0.458 Sum_probs=221.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+... .....+.+.+|+++|+.++|||||++++++.++ ..+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence 4789999999999999999999999999999999975432 123345688899999999999999999999874 4699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999986665555555689999999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.++.+.... +
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------~----- 223 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----------F----- 223 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------C-----
T ss_pred -ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------C-----
Confidence 3567899999999999875 4899999999999999999999999999988888777542111 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.+.+|+++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 224 --------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 224 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 12578899999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-62 Score=457.55 Aligned_cols=286 Identities=39% Similarity=0.654 Sum_probs=238.2
Q ss_pred eeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh---HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP---ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
.+++||+|+||+||+|++..+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++..+ ..+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehh
Confidence 5789999999999999999999999999997654321 2234678899999999999999999999885 4599999
Q ss_pred eeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCCc
Q 015247 197 HYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 276 (410)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 276 (410)
||+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9999999888888888999999999999999999999999999999999999999999999999999987754332 234
Q ss_pred cccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 277 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
..+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++.+|.+.++.+....|.............
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 56899999999998876668999999999999999999999999999999999999999998876654432211111110
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
. .-..........+++++++||.+||++||++||||.|+|+||||++.+.|+
T Consensus 239 ~-~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 239 S-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp C-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred c-CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 0 011223444567889999999999999999999999999999999998876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-62 Score=448.50 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=211.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++++.||+|+||+||+|+++.+|+.||+|++......+...+.+.+|+++|++++|||||++++++.+.....+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999999888777777788999999999999999999999998766667999
Q ss_pred EEeeccCCHHH-Hhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 195 VFHYMEHDLAG-LAA---SPEVKFTEPQVKCYMHQLLSGLEHCHNNG-----VLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 195 v~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
||||++++.+. .+. .....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999875444 332 23457999999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
.+.... ......+||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..+...++......
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-------- 232 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-------- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 875433 224567899999999998764 4999999999999999999999999999888888777652111
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....+|+++.+||.+||++||.+|||+.|+|+|||+
T Consensus 233 --------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 --------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0112678899999999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-61 Score=449.23 Aligned_cols=291 Identities=38% Similarity=0.686 Sum_probs=240.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+++|++++.||+|+||+||+|++..+|+.||||+++.....+...+.+.+|+++|++++|||||++++++.+. ..+|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeE
Confidence 3789999999999999999999999999999999976654444456788999999999999999999999884 56999
Q ss_pred EEeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+++++.... ......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 9999999877755 4455679999999999999999999999999999999999999999999999999998875433 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......||+.|+|||.+.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....|..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34556899999999998877667899999999999999999999999999999999999999988876654432211111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
.................+++++++||.+||++||++|||+.|+|+||||++-..|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1111122223344556788999999999999999999999999999999875543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=446.34 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=220.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.+. ..+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEE
Confidence 5799999999999999999999999999999999865432 245688999999999999999999999884 469999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999998666555433 379999999999999999999999999999999999999999999999999999875433 234
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
...+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 174 ~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------------
T ss_pred cccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 567899999999999875 489999999999999999999999999988887777665321110
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.....+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 011367889999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-60 Score=449.37 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=224.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
+.|+.++.||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.+. ..+|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 3599999999999999999999999999999999876653 34556788999999999999999999999874 46999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||||.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988877666667899999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 275 MTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
....+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+..+.+..+......+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 234 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 234 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 2456899999999998642 3489999999999999999999999999988888777765321110
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
....+|+++.+||.+||++||.+|||+.|+|+||||.+...
T Consensus 235 --------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 235 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp --------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred --------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 01257889999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-60 Score=447.87 Aligned_cols=260 Identities=30% Similarity=0.441 Sum_probs=205.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|++.+.||+|+||+||+|++..+|+.||||++........ ...+.+|+.+|+.++|||||++++++.+ ...+|+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 679999999999999999999999999999999987654332 3457789999999999999999999987 4569999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||+. +++.+||+|||+|+.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 99999754444444456899999999999999999999999999999999999995 578999999999987754432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
..+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+.+....++.
T Consensus 166 --~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 230 (307)
T d1a06a_ 166 --LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------ 230 (307)
T ss_dssp ---------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT------------
T ss_pred --eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC------------
Confidence 3567899999999998875 4999999999999999999999999999988888877653222211
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
...+.+|+++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 231 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 231 -------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred -------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 11246888999999999999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-61 Score=447.50 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=218.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+++|++++|||||++++++.+. ..+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 689999999999999999999999999999999976432 223456788999999999999999999999874 56999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-KH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 273 (410)
||||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.+.... ..
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999986555455555689999999999999999999999999999999999999999999999999999875433 22
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+.+|.+... .+|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----------~~p---- 230 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY----------DFP---- 230 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----------CCC----
T ss_pred ccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC----------CCC----
Confidence 345678999999999998754 89999999999999999999999999998888888765211 111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHH------HhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATV------ALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------lL~hp~~~~ 404 (410)
..+++++++||.+||++||.+|||++| +++||||+.
T Consensus 231 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 231 ---------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp ---------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ---------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 267889999999999999999999988 588999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-60 Score=442.12 Aligned_cols=285 Identities=36% Similarity=0.648 Sum_probs=237.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+++++||+|+||+||+|++ .+|+.||||+++.........+.+.+|+.+|++++|||||++++++... ...+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEE
Confidence 7899999999999999999997 4889999999977655444466788999999999999999999999885 459999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
|+++.++++..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 99999999998888888999999999999999999999999999999999999999999999999999988754322 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFK 355 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 355 (410)
....+++.|+|||.+.+...++.++|||||||++|||++|+.||.+.+..+++.++.+..+.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 45578999999999987777899999999999999999999999999999999999999998886655432211111111
Q ss_pred CCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 356 PREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
.............+.+++++.|||++||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111112233445678889999999999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-60 Score=450.70 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=225.2
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
+++|++++.||+|+||+||+|++..+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 4789999999999999999999999999999999986532 223456788899999999999999999999884 5699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 999999987776666666789999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.++.+...... +
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~----------~----- 224 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----------F----- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------C-----
T ss_pred ccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC----------C-----
Confidence 345678999999999988754 999999999999999999999999999998888877653211 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
+..+|+++++||.+||++||.+|+ ++.|+++||||++
T Consensus 225 --------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 225 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred --------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 136889999999999999999999 4999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-59 Score=449.88 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=226.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+. ..+|+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 478999999999999999999999999999999997543 34456788999999999999999999999884 56999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--DGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 271 (410)
|||||+++ |...+....+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999875 55555566678999999999999999999999999999999999999964 6789999999999875443
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|.......+.
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred --ccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 245678999999999998754 899999999999999999999999999999999888764333221
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTL 408 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~ 408 (410)
..+..+|+++++||.+||++||++|||+.|+|+||||++...+
T Consensus 247 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp --------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1223688899999999999999999999999999999976544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=445.62 Aligned_cols=260 Identities=26% Similarity=0.367 Sum_probs=219.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
+.|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+. ..+|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEE
Confidence 57999999999999999999999999999999997653 33355688899999999999999999999884 459999
Q ss_pred EeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998655544 4455679999999999999999999999999999999999999999999999999997653221 11
Q ss_pred CccccccccccccccccC----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 275 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
....+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+.+..+.+.++.+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----------- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----------- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 345689999999999852 34488999999999999999999999999988888877765311100
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
.....+|+++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 236 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 236 ---------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred ---------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01136788999999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-60 Score=435.01 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=214.4
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec--CCceEEEE
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLYLV 195 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv 195 (410)
|++.++||+|+||+||+|++..+++.||+|++..........+.+.+|+++|++++|||||++++++... ....+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677789999999999999999999999999987766666677899999999999999999999998652 34568999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEc-CCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~ 272 (410)
|||++++.+..+......+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 999998766655555568999999999999999999999998 99999999999997 5789999999999865432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+.+.... +..+.
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~------------ 232 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA------------ 232 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG------------
T ss_pred -ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc------------
Confidence 2356789999999998875 3999999999999999999999999876655544332221 11111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIF 403 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~ 403 (410)
......++++.+||.+||++||++|||++|+|+||||+
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11235788899999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=438.56 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=224.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+|++++|||||++++++.+. ..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 67999999999999999999999999999999998765422 2356788999999999999999999999874 56
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEeecccccc
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFF 267 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~ 267 (410)
+|+|||||+++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999866555544456899999999999999999999999999999999999999776 5999999999887
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+.
T Consensus 168 ~~~~~--~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------- 237 (293)
T d1jksa_ 168 DFGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 237 (293)
T ss_dssp TTSCB--CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred CCCcc--ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-------
Confidence 54433 3566889999999998874 4899999999999999999999999999999988888664333332
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
...+.+|+.+++||.+||++||.+|||++|+|+||||+.
T Consensus 238 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 238 ------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp ------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred ------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 223478899999999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-59 Score=447.46 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=224.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+|++++|||||+++++|.+ ...+|+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 67999999999999999999999999999999998654 3334567889999999999999999999987 4569999
Q ss_pred EeeccCCHH-HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLA-GLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||+++.+ ..+.....++++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999997554 55566666899999999999999999999999999999999999998 67899999999999886543
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+......++.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 249 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 249 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------
T ss_pred -ceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence 24566889999999998775 4999999999999999999999999999999998888774433221
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
..+..+|+++.+||.+||++||.+|||+.|+|+||||+.+
T Consensus 250 -------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 -------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1123688999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=452.66 Aligned_cols=283 Identities=23% Similarity=0.327 Sum_probs=213.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++++.||+|+||+||+|++..+|+.||+|+++... .....+.+.+|+.+|++++|||||+++++|.+. ..+|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 478999999999999999999999999999999998654 334456788999999999999999999999884 45999
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
||||+.++.+..+....+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999986665555555689999999999999999999997 599999999999999999999999999998764322
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHh----hhCCC
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIYKLCGSPSEEYW----KKSKL 348 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~----~~~~~ 348 (410)
..+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+. ...+....+.+..... .....
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -cccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 34678999999999998854 99999999999999999999999988765432 2222222222111000 00000
Q ss_pred C-CcccCCCCCchhhhhhhhh---------CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 349 P-NATLFKPREPYKRCIQETF---------KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 349 ~-~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
. ......+............ ..+|.+++|||.+||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 0000001111111111110 135677999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-59 Score=443.63 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=223.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 3689999999999999999999999999999999976432 22335678899999999999999999999987 45699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999877777777778999999999999999999999999999999999999999999999999999887432
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
..+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.++.+..... |
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----------p---- 221 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----------P---- 221 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----------C----
T ss_pred -cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----------C----
Confidence 3467899999999998775 49999999999999999999999999999998888887632111 1
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+|+++.++|.+||++||.+|+ |++++|+||||++
T Consensus 222 ---------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 222 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 26788999999999999999996 9999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=437.79 Aligned_cols=295 Identities=45% Similarity=0.712 Sum_probs=238.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC------
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 188 (410)
.++|+++++||+|+||+||+|++..+|+.||||++......+.....+.+|+.+|+.++|||++++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47999999999999999999999999999999998776555555567888999999999999999999885532
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
...+|++|||+.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34589999999999998888888899999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC---CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 269 PNHK---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 269 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
.... ......+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+.+..+.+..+.+....+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3322 2234467999999999998776799999999999999999999999999999999999999999887655433
Q ss_pred CCCCCc-ccCCCCCchhhhhhhhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 015247 346 SKLPNA-TLFKPREPYKRCIQETF--KDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRTLC 409 (410)
Q Consensus 346 ~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~ 409 (410)
...... ................+ ...+++++|||.+||++||++|||++|+|+||||++++.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 221110 00000001111111111 13467789999999999999999999999999999999886
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=434.87 Aligned_cols=285 Identities=38% Similarity=0.640 Sum_probs=232.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeEeeeEee---cC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTS---RM 188 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---~~ 188 (410)
++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.+ +||||++++++|.. ..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 7899999999999999999998655 67799999976544333333455677776655 89999999999854 23
Q ss_pred CceEEEEEeeccCCHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 189 SCSLYLVFHYMEHDLAGLA-ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
...++++|||++++++... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 4578999999999876544 455668999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... .......||+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+..+++.++.+.++.+....|....
T Consensus 167 ~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 167 SFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 433 2345678999999999988754 9999999999999999999999999999999999999999998876664432
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.......... ...........+++.+++||.+||++||++|||+.|+|+||||++-
T Consensus 244 ~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 2211111110 1112334445788899999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-58 Score=427.94 Aligned_cols=260 Identities=29% Similarity=0.429 Sum_probs=222.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC-------hHHHHHHHHHHHHHHhCC-CCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-------PESVKFMAREILILRRLD-HPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 187 (410)
++|++.+.||+|+||+||+|++..+|+.||||++++.... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 7899999999999999999999999999999999876532 123346788999999997 9999999999987
Q ss_pred CCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeecccccc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 267 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 267 (410)
...+|+||||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 4569999999987544444444568999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCccccccccccccccccC-----CcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEY 342 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 342 (410)
..... ....+||+.|+|||.+.+ ...++.++||||+||++|||++|+.||.+.+..+....+.+....++.
T Consensus 161 ~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 236 (277)
T d1phka_ 161 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-- 236 (277)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred cCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence 65433 355789999999999853 334788999999999999999999999999998888888764222111
Q ss_pred hhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 343 WKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
....++|+++++||.+||++||++|||++|+|+||||++
T Consensus 237 -----------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 -----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 112368899999999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-59 Score=444.94 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=222.4
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.. ...++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 4789999999999999999999999999999999975432 22335678899999999999999999999987 44599
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||+.++.+.......+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999998766656555568999999999999999999999999999999999999999999999999999987532
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
....+||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+....+.++.......+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 258 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-------------- 258 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred -cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--------------
Confidence 3457899999999999875 489999999999999999999999999998888888876322111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
..+|+++.+||.+||++||.+|+ |++++|+||||+.
T Consensus 259 ---------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 259 ---------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ---------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ---------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 26788999999999999999995 9999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=433.99 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=224.1
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||+||+|++..+|+.||||+++... .....+.+|+++|+.++|||||+++++|.+. ..+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 378999999999999999999999999999999997643 2334577899999999999999999999884 56999
Q ss_pred EEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC--CcEEEEeeccccccCCCC
Q 015247 195 VFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--GVLKIADFGLASFFDPNH 271 (410)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 271 (410)
|||||+++ |...+...+..+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999975 555555555689999999999999999999999999999999999999854 589999999998875433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......+|+.|+|||.+.+.. |+.++|||||||++|+|++|..||.+.+..+.+.+|.+....++...
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 226 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------- 226 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH---------
T ss_pred --cccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh---------
Confidence 235567899999999887754 89999999999999999999999999999999999887554444332
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
++.+|+++++||.+||.+||.+|||+.|+|+||||++.
T Consensus 227 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 ----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 24688999999999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=437.86 Aligned_cols=281 Identities=36% Similarity=0.555 Sum_probs=233.5
Q ss_pred CcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEee----cCCceE
Q 015247 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS----RMSCSL 192 (410)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~~ 192 (410)
+|+.+++||+|+||+||+|++..+|+.||||++...... ..+|+++|++++|||||+++++|.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765422 2369999999999999999999854 335578
Q ss_pred EEEEeeccCCHHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccC
Q 015247 193 YLVFHYMEHDLAGLA---ASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFD 268 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~ 268 (410)
|+||||+++++...+ ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998865544 34556899999999999999999999999999999999999999775 89999999998875
Q ss_pred CCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... ..+.+||+.|+|||.+.+...|+.++||||+||++|||++|++||.+.+..+++..+.+.+|.+..+.+.....
T Consensus 175 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 4432 45578999999999988766799999999999999999999999999999999999999999999877765432
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
.......+............+..++++.+||.+||++||++|||+.|+|+||||++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222211111111112222334678899999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-58 Score=440.95 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=212.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
+++|++.+.||+|+||.||+|++..+|+.||||++.+.... ........+|+.+++.++|||||++++++.+. .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence 47899999999999999999999999999999999754321 11122233457777888999999999999874 4
Q ss_pred eEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 69999999998666655555668999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 271 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
. ....+||+.|+|||++.+...|+.++|||||||++|||+||+.||.+.+..+......... ....
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~---------- 226 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAV---------- 226 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCCC----------
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCC----------
Confidence 3 3566899999999999765669999999999999999999999998765443332221111 1110
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCC-----HHHHhcCCCCCC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLT-----ATVALNSEVIFQ 404 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~elL~hp~~~~ 404 (410)
.....+|+++.+||.+||++||.+||| |+|+|+||||+.
T Consensus 227 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 227 ---------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ---------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ---------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 111368889999999999999999999 899999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-57 Score=422.55 Aligned_cols=288 Identities=38% Similarity=0.642 Sum_probs=241.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++||||+++++++... ...+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeEE
Confidence 689999999999999999999999999999999987766666677889999999999999999999999884 458999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 275 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 275 (410)
++++.++.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++....... ..
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 99999988888777778999999999999999999999999999999999999999999999999999988754332 23
Q ss_pred ccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccC
Q 015247 276 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLF 354 (410)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 354 (410)
....+++.|+|||.+.+...++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4456789999999988766689999999999999999999987 567777888999999888887655443221111111
Q ss_pred CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 355 KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
................+++.+.+||.+||++||.+||||+|+|+||||++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 1111122223344456788899999999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-58 Score=433.80 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=219.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHH-hCCCCceeeEeeeEeecCCceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILR-RLDHPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 193 (410)
++|++.+.||+|+||+||+|++..+|+.||||++++... .....+.+.+|..++. .++|||||++++++.+. ..+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 789999999999999999999999999999999976432 1223445666777665 68999999999999884 5699
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999987666666666689999999999999999999999999999999999999999999999999998765433 2
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+.++.... + .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~--------~~----- 222 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P--------FY----- 222 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C--------CC-----
T ss_pred cccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C--------CC-----
Confidence 345568999999999998754 9999999999999999999999999999888888775421 1 11
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH-HHhcCCCCCC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT-VALNSEVIFQ 404 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-elL~hp~~~~ 404 (410)
.+.+|+++.+||.+||++||.+|||+. ++++||||++
T Consensus 223 --------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 223 --------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred --------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 136788999999999999999999995 8999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=435.96 Aligned_cols=283 Identities=34% Similarity=0.553 Sum_probs=233.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC----Cce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 191 (410)
++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+++|+.++|||||+++++|.... ...
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 7899999999999999999999999999999999876666666778889999999999999999999987643 235
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||++.++...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 98 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 799999997776665533 37999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.+...||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++..++........
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 35678999999999998766689999999999999999999999999999999999999999999877654332110
Q ss_pred ccC--CCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCC
Q 015247 352 TLF--KPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQ 404 (410)
Q Consensus 352 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~ 404 (410)
... .........+......+++++++||.+||.+||.+|||+.|+|+||||++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 000 00000011123344578889999999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=412.85 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=208.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||+||+|+. +..||||+++.........+.+.+|+.+|++++|||||++++++... .+++|
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---~~~lv 81 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIV 81 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc---EEEEE
Confidence 7899999999999999999973 23599999987766666778899999999999999999999987542 47999
Q ss_pred EeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-C
Q 015247 196 FHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-H 273 (410)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 273 (410)
|||+++ +|...+...+..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999996 55565656667899999999999999999999999999999999999999999999999999987653322 2
Q ss_pred CCccccccccccccccccCC--cCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 274 PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+......++.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~----------- 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------- 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----------
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----------
Confidence 34556899999999998643 34889999999999999999999999998877666555543222111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+.....++|+++.+||.+||+.||.+|||+.|++++
T Consensus 231 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112234688899999999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=418.08 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=207.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLD--HPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 189 (410)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-- 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence 68999999999999999999999999999999998654321 11223567999999986 89999999999874
Q ss_pred ceEEEEEeeccC-CHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEeecccccc
Q 015247 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFF 267 (410)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~ 267 (410)
...|+||||+.+ +++.........+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 459999999975 344434444558999999999999999999999999999999999999985 479999999999876
Q ss_pred CCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 268 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ..+...||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+ .+.+.. ..
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~----------~~ 222 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----------VF 222 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC----------CC
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc----------cC
Confidence 433 23567899999999998876556788999999999999999999997632 222210 00
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
....+|+++++||.+||++||++|||++|+|+||||++-..
T Consensus 223 -------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 223 -------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp -------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 11368899999999999999999999999999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=421.72 Aligned_cols=289 Identities=34% Similarity=0.548 Sum_probs=231.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC---CceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~ 192 (410)
++|++++.||+|+||+||+|++..+|+.||||+++... .....+.+.+|+++|+.++||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997644 3445667889999999999999999999986532 2357
Q ss_pred EEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 193 YLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
|+++++++++|...+... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 777777777777766433 799999999999999999999999999999999999999999999999999987644322
Q ss_pred --CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 273 --HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 273 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..++...+...+..+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 224556799999999998766668999999999999999999999999999999999999988888765443221111
Q ss_pred cc--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCCC
Q 015247 351 AT--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDRT 407 (410)
Q Consensus 351 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~~ 407 (410)
.. ..................+++++++||.+||++||.+|||+.|+|+||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 0000000111123344578889999999999999999999999999999996544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=427.09 Aligned_cols=285 Identities=31% Similarity=0.498 Sum_probs=226.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++|||||+++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999999999999999988776677777888999999999999999999998654 3467
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||+.++++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 999999999998887743 68999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC-
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN- 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 350 (410)
.....++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+...+..++....+.+..++|.......
T Consensus 174 --~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 24566789999999999875 59999999999999999999999999999999999999999998887775432110
Q ss_pred ----cccCCCCCchhhh--------hhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ----ATLFKPREPYKRC--------IQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ----~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
............. .......+++++++||++||.+||++||||+|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000000000000 0011123466789999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=427.01 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=207.9
Q ss_pred CCCcceee-eeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-CCCCceeeEeeeEee--cCCc
Q 015247 115 ADSFEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR-LDHPNVIKLEGLVTS--RMSC 190 (410)
Q Consensus 115 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~--~~~~ 190 (410)
.++|+++. .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.+ .+|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 47899886 599999999999999999999999999642 346679988765 589999999999865 3356
Q ss_pred eEEEEEeeccC-CHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeecccc
Q 015247 191 SLYLVFHYMEH-DLAGLAASP-EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLAS 265 (410)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 265 (410)
.+|+|||||++ +|...+... ...+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 79999999986 566655544 357999999999999999999999999999999999999985 5679999999998
Q ss_pred ccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhh
Q 015247 266 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKK 345 (410)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 345 (410)
....... ....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+........
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCCCc--cccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 8754433 4567899999999988764 499999999999999999999999988776665554443211110
Q ss_pred CCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCC
Q 015247 346 SKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQD 405 (410)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~ 405 (410)
...+ ...+..+|+++.+||.+||++||++|||+.|+|+||||.+.
T Consensus 234 -------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 -------YEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -------SSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -------CCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000 01123578899999999999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-55 Score=417.08 Aligned_cols=282 Identities=29% Similarity=0.510 Sum_probs=225.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 193 (410)
.++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++|+.++ ||||++++++|.......++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 378999999999999999999999999999999986432 456788999999995 99999999999876677899
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHK 272 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 272 (410)
+||||++++.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999999987765443 3699999999999999999999999999999999999998655 699999999988754433
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCHHHh-hhCCCCC
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIYKLCGSPSEEYW-KKSKLPN 350 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~-~~~~~~~ 350 (410)
....++|+.|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+.+.++.+....+ .......
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 456788999999999888777899999999999999999999999764 455677777777775543222 2211111
Q ss_pred ccc------CCCCCchhh-hhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 351 ATL------FKPREPYKR-CIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 351 ~~~------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
... ......... ........++++++|||++||++||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 100 001111111 11122235788899999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-55 Score=410.38 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=212.0
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecC--Cce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRM--SCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 191 (410)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... +......+.+|+++|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3789999999999999999999999999999999987654 4455667899999999999999999999987643 345
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
+|+||||++++.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999987666555556689999999999999999999999999999999999999999999999999987664332
Q ss_pred C--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCC
Q 015247 272 K--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLP 349 (410)
Q Consensus 272 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 349 (410)
. ......+||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.++......++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred ccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------
Confidence 2 234556899999999998775 4999999999999999999999999999988888777653222211
Q ss_pred CcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCC
Q 015247 350 NATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVI 402 (410)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~ 402 (410)
.....+|+++.+||.+||++||.+||+..+.|.|+|+
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 2224789999999999999999999954444455554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=418.56 Aligned_cols=285 Identities=36% Similarity=0.565 Sum_probs=229.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeec----CCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 191 (410)
++|++++.||+|+||+||+|++..+|+.||||+++....+....+.+.+|+++|++++|||+|++++++... ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 689999999999999999999999999999999987766666677888999999999999999999988643 2234
Q ss_pred EEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 192 LYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
.++++++.+++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 555555555566655533 3799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 235567899999999988776689999999999999999999999999999999999999998888765543221100
Q ss_pred c--cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcCCCCCCCC
Q 015247 352 T--LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNSEVIFQDR 406 (410)
Q Consensus 352 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~hp~~~~~~ 406 (410)
. ...........+......++++++|||.+||++||.+|||+.|+|+||||++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 000000011122334457889999999999999999999999999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=400.14 Aligned_cols=249 Identities=20% Similarity=0.327 Sum_probs=215.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.++||+|+||+||+|+. .+++.||||+++...... +.+.+|+.++++++|||||++++++.++ ..+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEE
Confidence 6899999999999999999996 578899999998765443 4588999999999999999999999874 449999
Q ss_pred EeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++ +..........+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.+.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999865 555556666789999999999999999999999999999999999999999999999999998876555554
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 222 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------- 222 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred ecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 55677899999999988654 8999999999999999998 8999999998888877765321111
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++.+.+||.+||++||++|||+.++|+|
T Consensus 223 --------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 --------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12567889999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=402.07 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=199.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++ .+++.||||+++..... .+.+.+|++++++++|||||++++++.... .+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEE-TTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEE
Confidence 6899999999999999999986 46788999999765433 345888999999999999999999998754 48999
Q ss_pred EeeccCCH-HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 015247 196 FHYMEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 274 (410)
Q Consensus 196 ~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 274 (410)
|||++++. ...+......+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.........
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99998754 45556666789999999999999999999999999999999999999999999999999998876554444
Q ss_pred CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 275 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
.....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+..+.+..+......+.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-------------- 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------- 223 (263)
T ss_dssp ------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC--------------
T ss_pred ecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Confidence 45567899999999988754 9999999999999999999 5777777777777777655321110
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++++.+||.+||++||++|||++|+|+|
T Consensus 224 --------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 --------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12567889999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-55 Score=408.59 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=206.4
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||+||+|++..+|+.||||+++.+... .+.+.+|+++|++++|||||++++++.+. ..+|++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 91 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 91 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEEE
Confidence 7899999999999999999999999999999998765433 45688999999999999999999999874 458999
Q ss_pred EeeccCCH-HHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDL-AGLAA-SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l-~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||++++. ...+. .....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+........
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 99999754 44433 44568999999999999999999999999999999999999999999999999999987655444
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCccc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATL 353 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 353 (410)
......||+.|+|||++.+.. |+.++|||||||++|||++|..||........+..+......+
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~--------------- 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------------- 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred eeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC---------------
Confidence 444556899999999987654 9999999999999999999766655444444333333211100
Q ss_pred CCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 354 FKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.....+|+++.+||.+||+.||.+|||+.++++
T Consensus 236 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111367889999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=407.15 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=210.2
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||.||+|++ .+++.||||+++..... .+.+.+|+.+|++++|||||++++++.+. .+|+|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEEE
Confidence 7899999999999999999996 46788999999765433 34688999999999999999999987653 36899
Q ss_pred EeeccCCHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 015247 196 FHYMEHDLAGLAASP--EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 273 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 273 (410)
|||++++.+...... ...+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+|+.+......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999998766544332 236999999999999999999999999999999999999999999999999999988655444
Q ss_pred CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcc
Q 015247 274 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNAT 352 (410)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 352 (410)
......||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.+....+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-------------- 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-------------- 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------------
T ss_pred cccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 45566789999999998764 489999999999999999995 56667777777666664321111
Q ss_pred cCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc--CCCCC
Q 015247 353 LFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN--SEVIF 403 (410)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~--hp~~~ 403 (410)
....+|+++.+||.+||+.||.+|||++++++ |+||+
T Consensus 231 --------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 --------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11367888999999999999999999999998 78875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-54 Score=405.49 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=198.7
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||+||+|++..+++ .||||.+.... .....+.+.+|+++|++++|||||++++++... ..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEE
Confidence 679999999999999999999876665 58888875433 445566789999999999999999999999774 448
Q ss_pred EEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
++||||++++.+. .+....+.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999986554 455556689999999999999999999999999999999999999999999999999998775433
Q ss_pred CCC----CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 272 KHP----MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 272 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
... .....||+.|+|||.+.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+.+....+.
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 254 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP------- 254 (299)
T ss_dssp -------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------
T ss_pred CcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 221 1224579999999998765 49999999999999999998 8999999988887777654221111
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+|+.+.+||.+||+.||.+|||+.|++++
T Consensus 255 ---------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ---------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12678889999999999999999999888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=407.24 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=202.9
Q ss_pred eeeccCCCeeEEEEEEc--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEEeec
Q 015247 122 DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (410)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~ 199 (410)
++||+|+||+||+|... .+++.||||+++....+....+.+.+|+.+|++++|||||++++++..+ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEEcC
Confidence 46999999999999754 4567899999976655556667899999999999999999999998653 378999999
Q ss_pred cCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC--Ccc
Q 015247 200 EHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTS 277 (410)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~~ 277 (410)
+++.+..+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 987665555556689999999999999999999999999999999999999999999999999998775443221 234
Q ss_pred ccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCcccCCC
Q 015247 278 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNATLFKP 356 (410)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (410)
..||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 170 ~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------------- 229 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 229 (277)
T ss_dssp -CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred cCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 56899999999987654 8999999999999999998 89999998887776666432110
Q ss_pred CCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH---hcCCCC
Q 015247 357 REPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA---LNSEVI 402 (410)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---L~hp~~ 402 (410)
.....+|+++.+||.+||+.||.+|||+.++ |+|+|+
T Consensus 230 ---------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 0113678899999999999999999999998 566664
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=402.77 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=211.3
Q ss_pred CCcceeee-eccCCCeeEEEEEEcC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDK-IGQGTYSNVYKAKDML--TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~-LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+++|++++|||||++++++..+ .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eE
Confidence 67888885 9999999999997653 45589999997543 455567889999999999999999999998653 38
Q ss_pred EEEEeeccCCH-HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|+||||++++. ...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999754 44556666789999999999999999999999999999999999999999999999999999876443
Q ss_pred C--CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 272 K--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 272 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
. .......||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~----------- 231 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 231 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----------
T ss_pred cccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2 223345689999999998765 49999999999999999998 99999998888777766542110
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHH---hcCCCC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVA---LNSEVI 402 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---L~hp~~ 402 (410)
+..+.+|+++.+||.+||+.||++|||+.++ |+|+|+
T Consensus 232 -----------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 -----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1113688899999999999999999999887 667765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=397.43 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=202.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.+|++++|||||++++++.+. ..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEE
Confidence 478999999999999999999874 4567999999765443 35688999999999999999999998542 3789
Q ss_pred EEeeccCCHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHDLAGLAAS--PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||++++.+..... ....+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999875443332 235799999999999999999999999999999999999999999999999999988765544
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.......||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+....+.+..+.+....+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~------------- 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 234 (285)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 4445567899999999987644 89999999999999999995 55566666666666664422111
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc--CCCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN--SEVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~--hp~~~~~ 405 (410)
....+|+++.+||.+||+.||++|||++++++ ++||+..
T Consensus 235 ---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11367888999999999999999999999998 8999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=407.90 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=205.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.++||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++ +|||||++++++.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 789999999999999999999765543 69999986543 233345678899999998 8999999999998754
Q ss_pred ceEEEEEeeccCC-HHHHhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 015247 190 CSLYLVFHYMEHD-LAGLAASPE----------------------VKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGS 246 (410)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 246 (410)
.+|+||||++++ +...+.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 489999999875 444443322 35899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCCh
Q 015247 247 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 324 (410)
Q Consensus 247 NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~ 324 (410)
|||++.++++||+|||+|+........ ...+..||+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876544332 223556899999999987644 9999999999999999997 8999999877
Q ss_pred HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 325 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
.+.+.++......++ ....+|+++.+||.+||+.||++|||++|+++|
T Consensus 273 ~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777766655321111 113678889999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=395.30 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=198.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 192 (410)
++|++.+.||+|+||+||+|++..+ +..||||.++.. ......+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 6899999999999999999987654 346888887543 345556778899999999999999999999864 348
Q ss_pred EEEEeeccCCH-HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 015247 193 YLVFHYMEHDL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 271 (410)
Q Consensus 193 ~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 271 (410)
|+||||++++. ..........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 99999999754 44455566689999999999999999999999999999999999999999999999999998876554
Q ss_pred CCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCC
Q 015247 272 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPN 350 (410)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 350 (410)
........||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+.+....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred ceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 44455667899999999987644 8999999999999999998 89999999888887777542111
Q ss_pred cccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 351 ATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
...+++|+.+.+||.+||+.||.+|||+.|+++|
T Consensus 229 ---------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1113688899999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=391.32 Aligned_cols=251 Identities=20% Similarity=0.328 Sum_probs=196.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
+.|++.++||+|+||.||+|....++ ..||||+++... .......+.+|+++|++++|||||++++++.... .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--P 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--c
Confidence 67999999999999999999876554 479999996543 4445567889999999999999999999998744 4
Q ss_pred EEEEEeeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++|||+.++.+. ........+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 89999999986554 44555568999999999999999999999999999999999999999999999999999877543
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ......||+.|+|||++.+. .++.++|||||||++|||++|. +||.+.+..+.+..+......+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------- 233 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--------- 233 (283)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---------
T ss_pred CccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC---------
Confidence 322 23345679999999998775 4999999999999999999965 5555566655555554321111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
....+|+.+.+||.+||+.||.+|||+.|+++
T Consensus 234 -------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 -------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11257788999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=410.00 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=216.3
Q ss_pred CCCcceeeeeccCCCeeEEEEEEc---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCC-CceeeEeeeEeecC
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDH-PNVIKLEGLVTSRM 188 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 188 (410)
.++|++++.||+|+||+||+|++. .+|+.||||++++... +....+.+.+|+++|++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 478999999999999999999874 4689999999865432 12223457789999999976 8999999999885
Q ss_pred CceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccC
Q 015247 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 268 (410)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 268 (410)
..++++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 4599999999987666666666688999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCccccccccccccccccCCc-CCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 269 PNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
...........||+.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+......
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--------
Confidence 55444455678999999999987543 478899999999999999999999988766555555544221110
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCC-----CHHHHhcCCCCCC
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERL-----TATVALNSEVIFQ 404 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~elL~hp~~~~ 404 (410)
......+|+++.+||.+||++||.+|| |++|+|+||||++
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 011136788999999999999999999 5899999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=399.06 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=202.6
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|+++++||+|+||+||+|++..+|+ .||+|.++... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 579999999999999999999888876 57888876433 3334567889999999999999999999998642
Q ss_pred EEEEEeecc-CCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYME-HDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
.+++++++. +++..........+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 566666665 5677777777778999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC-CccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCC
Q 015247 271 HKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKL 348 (410)
Q Consensus 271 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 348 (410)
.... .....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+.+....+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---------- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---------- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred cccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 4332 33456899999999988754 9999999999999999998 889998888777666554421111
Q ss_pred CCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 349 PNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
....+|+++.+||.+||+.||.+|||+.|++.|
T Consensus 234 ------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 ------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 113678889999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=385.73 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=199.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-CCC--ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCce
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-LTG--KIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 191 (410)
++|++++.||+|+||.||+|+.. .++ ..||||++..... ..+..+.+.+|+.+|++++|||||++++++.++ .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence 67999999999999999999854 333 3689999876544 344567789999999999999999999999753 3
Q ss_pred EEEEEeeccCC-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 015247 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 270 (410)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 270 (410)
+++||||++++ +..........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 68999999864 45455555567999999999999999999999999999999999999999999999999999987544
Q ss_pred CCC--CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCC
Q 015247 271 HKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSK 347 (410)
Q Consensus 271 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 347 (410)
... ......||..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--------- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---------
T ss_pred CCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---------
Confidence 332 12334578899999998874 48999999999999999998 899999999998888776521111
Q ss_pred CCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 348 LPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+....+|+.+.+||.+||++||.+|||+.++++
T Consensus 235 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111367889999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=387.56 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=206.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~ 89 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--K 89 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--C
Confidence 78999999999999999999864 356799999987543 445567789999999999999999999999874 4
Q ss_pred eEEEEEeeccCCHHH-HhcC-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 015247 191 SLYLVFHYMEHDLAG-LAAS-----------------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGS 246 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~-~~~~-----------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 246 (410)
..+++|||++++.+. .+.. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 489999999875433 3321 1235899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeeccccccCCCCC-CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCC-CCCCCCCh
Q 015247 247 NLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTE 324 (410)
Q Consensus 247 NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~-~pf~~~~~ 324 (410)
|||++.++.+||+|||+|+....... ...++..||+.|+|||.+.+.. |+.++|||||||++|||++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999987654332 2234567899999999988754 999999999999999999995 78998888
Q ss_pred HHHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 325 VEQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 325 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+.+..+.+.... .....+|+++.+||.+||+.||++|||+.|+++
T Consensus 249 ~e~~~~v~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8887776542111 111367889999999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=388.61 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=195.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEcC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.++||+|+||.||+|++.. +++.||||+++... .....+.+.+|..++.++ +|+|||.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 789999999999999999998653 45789999987544 334455677788887776 689999999887654 3
Q ss_pred ceEEEEEeeccCCHHHHhc-C---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 015247 190 CSLYLVFHYMEHDLAGLAA-S---------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 253 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~-~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 253 (410)
..+++|||||+++.+..+. . ....+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 4589999999975544332 1 12358999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHH
Q 015247 254 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKI 331 (410)
Q Consensus 254 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i 331 (410)
+++||+|||+|+........ ......||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999876544332 33456799999999998874 489999999999999999987 5688887766655555
Q ss_pred HHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 332 YKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
......+ .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4421111 1113578889999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=380.32 Aligned_cols=245 Identities=21% Similarity=0.360 Sum_probs=195.9
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEE
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l 194 (410)
.++|++.+.||+|+||.||+|+. +|+.||||+++.+. ..+.+.+|+.++++++|||||++++++.+.. ..+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEE
Confidence 47899999999999999999985 58899999996543 3456889999999999999999999886532 34799
Q ss_pred EEeeccCCHHH-HhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 015247 195 VFHYMEHDLAG-LAAS-PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 195 v~e~~~~~l~~-~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 272 (410)
||||++++.+. ++.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999875444 4332 2235899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 273 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
.....+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+....
T Consensus 157 --~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-------------- 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------- 219 (262)
T ss_dssp -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--------------
T ss_pred --CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2345678999999998765 49999999999999999998 78999888877777666431110
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
+....+++++.+||.+||+.||.+|||+.+++++
T Consensus 220 --------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 --------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1113678889999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=379.51 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=201.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeec
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-------KIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 187 (410)
++|++.+.||+|+||.||+|+...++ ..||||+++... .......+.+|...+.++ +|||||++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 79999999999999999999865543 479999997654 444556788899998888 899999999999874
Q ss_pred CCceEEEEEeeccCCHHHHhc-CC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 188 MSCSLYLVFHYMEHDLAGLAA-SP---------------EVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~-~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
..+++||||++++.+..+. .. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 92 --~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp --SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 4599999999976544433 22 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||+++........ ......+|+.|+|||.+.+. .|+.++|||||||++|||++ |.+||.+.+..+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999877543322 23456789999999998764 49999999999999999998 789998888877666
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
.+.+... + .....+|+++.+||.+||++||.+|||+.|+|+
T Consensus 249 ~i~~~~~-~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHR-M---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCC-C---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCC-C---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5543211 0 111367888999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=384.27 Aligned_cols=257 Identities=16% Similarity=0.215 Sum_probs=212.0
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCc
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 190 (410)
++|++.+.||+|+||+||+|.+. .+++.||||+++... .......+.+|++++++++|||||++++++....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 79999999999999999999864 246789999997543 4445567889999999999999999999997744
Q ss_pred eEEEEEeeccCCHHHHhc----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEe
Q 015247 191 SLYLVFHYMEHDLAGLAA----------SPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 260 (410)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~----------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~D 260 (410)
..++||||+.++.+..+. .....+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 489999999876444322 1224579999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCC
Q 015247 261 FGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIYKLCGSP 338 (410)
Q Consensus 261 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~ 338 (410)
||+|+.+...... ......||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+....+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999876433222 234457899999999988754 89999999999999999998 58888888888887775421111
Q ss_pred CHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc------CCCCCC
Q 015247 339 SEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN------SEVIFQ 404 (410)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~------hp~~~~ 404 (410)
..+.+|+.+.+||.+||+.||.+|||+.++++ +|+|++
T Consensus 256 ----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 256 ----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 11367888999999999999999999999998 777653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=383.57 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=202.8
Q ss_pred CCCcceeeeeccCCCeeEEEEEEcCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCCce
Q 015247 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (410)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 191 (410)
.++|++.++||+|+||+||+|++..+|.. ||||.++... ..+..+.+.+|+++|.++ +|||||++++++.+. ..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence 37999999999999999999998888774 6777775433 233455788999999998 799999999999874 45
Q ss_pred EEEEEeeccCCHHHHhc-C---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 015247 192 LYLVFHYMEHDLAGLAA-S---------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 255 (410)
Q Consensus 192 ~~lv~e~~~~~l~~~~~-~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 255 (410)
+++||||++++.+..+. . ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999975544433 2 2357999999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHH
Q 015247 256 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIYKL 334 (410)
Q Consensus 256 vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~-~pf~~~~~~~~~~~i~~~ 334 (410)
+||+|||+++....... .....||..|+|||.+.+.. |+.++|||||||++|||++|. +||.+.+..+.+..+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999987643322 23456899999999987654 899999999999999999975 678888877777666432
Q ss_pred hCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC
Q 015247 335 CGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS 399 (410)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h 399 (410)
... +....+++++.+||.+||++||++|||+.++|+|
T Consensus 243 ~~~----------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 1113678899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=378.29 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=207.5
Q ss_pred CCcceeeeeccCCCeeEEEEEEc-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeEeeeEeecCC
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 189 (410)
++|++.++||+|+||.||+|+.. .+++.||||+++... .......+.+|+.++..+ +|||||++++++....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 78999999999999999999853 567799999997654 344566788999999999 6999999999998754
Q ss_pred ceEEEEEeeccCCHHHHhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 015247 190 CSLYLVFHYMEHDLAGLAAS------------------PEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 251 (410)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 251 (410)
.++++|||++++.+..+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 101 -~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred -EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 4899999998754443321 223689999999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 015247 252 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 329 (410)
Q Consensus 252 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 329 (410)
.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987644332 23456789999999998764 48999999999999999998 677777777777776
Q ss_pred HHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 330 KIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 330 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
++.+....+. ....+|+++.+||.+||++||.+|||+.++|+
T Consensus 259 ~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665322111 11257888999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=373.23 Aligned_cols=255 Identities=19% Similarity=0.221 Sum_probs=201.6
Q ss_pred eeeeeccCCCeeEEEEEEcCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEEE
Q 015247 120 KIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (410)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~ 196 (410)
..++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+++|++++|||||+++|++... ....++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999976543 36899998643 3455667899999999999999999999998754 34689999
Q ss_pred eeccCCHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--
Q 015247 197 HYMEHDLAG-LAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-- 273 (410)
Q Consensus 197 e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-- 273 (410)
||++++.+. ........+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999986555 45566667889999999999999999999999999999999999999999999999999876543322
Q ss_pred -CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHhhhCCCCCc
Q 015247 274 -PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIYKLCGSPSEEYWKKSKLPNA 351 (410)
Q Consensus 274 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 351 (410)
......||+.|+|||.+.+.. ++.++||||||+++|||+||..||...... +....+.+.. . +
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--~----------~-- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R----------L-- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--C----------C--
T ss_pred eecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--C----------C--
Confidence 233457899999999887644 899999999999999999987777654433 3333332211 0 0
Q ss_pred ccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHhcC------CCCCCC
Q 015247 352 TLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVALNS------EVIFQD 405 (410)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL~h------p~~~~~ 405 (410)
...+.+++.+.+||.+||+.||++|||+.|+++| .|+.++
T Consensus 254 --------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 254 --------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred --------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 0013577889999999999999999999999998 666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-49 Score=373.90 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=205.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCCceEEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv 195 (410)
++|++.+.||+|+||+||+|++..+|+.||||++....... .+.+|+++++.++|+|++..+..+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 57999999999999999999999999999999987654322 366799999999877765554444332 4568999
Q ss_pred EeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeeccccccCCCCC
Q 015247 196 FHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASFFDPNHK 272 (410)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~~ 272 (410)
|||+++++..........+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999998888777778999999999999999999999999999999999999864 55799999999998754332
Q ss_pred C------CCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHhhhC
Q 015247 273 H------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSEEYWKKS 346 (410)
Q Consensus 273 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 346 (410)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.+....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--------- 231 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------- 231 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---------
T ss_pred ccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---------
Confidence 2 234567999999999988754 999999999999999999999999887665544433321100
Q ss_pred CCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHH---HHhcCCCCC
Q 015247 347 KLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTAT---VALNSEVIF 403 (410)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---elL~hp~~~ 403 (410)
......+...+++|+++.+||..||+.||.+||++. ++|+|+|.+
T Consensus 232 ------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 232 ------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000012233457899999999999999999999976 557777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-48 Score=372.17 Aligned_cols=282 Identities=28% Similarity=0.420 Sum_probs=216.8
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCceeeEeeeE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----------HPNVIKLEGLV 184 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 184 (410)
++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 46999999999999999999999999999999997542 33456778888888774 57899999988
Q ss_pred eecCCceEEEEEeeccC--CH-HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCC------
Q 015247 185 TSRMSCSLYLVFHYMEH--DL-AGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG------ 254 (410)
Q Consensus 185 ~~~~~~~~~lv~e~~~~--~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~------ 254 (410)
........++++.++.. +. ..........+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 77656667777776654 22 33344556689999999999999999999998 8999999999999998665
Q ss_pred cEEEEeeccccccCCCCCCCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCC------hHHHH
Q 015247 255 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQL 328 (410)
Q Consensus 255 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------~~~~~ 328 (410)
.++++|||.+...... ....+||+.|+|||++.+.. |+.++||||+||++++|++|+.||.... ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999865432 34668999999999988754 8999999999999999999999997543 44567
Q ss_pred HHHHHHhCCCCHHHhhhCCCCCc----------ccCCCCCchhhhhhhh---hCCCCCCcHHHHHhccCCCCCCCCCHHH
Q 015247 329 HKIYKLCGSPSEEYWKKSKLPNA----------TLFKPREPYKRCIQET---FKDFPPSSLPLIETLLAIDPAERLTATV 395 (410)
Q Consensus 329 ~~i~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e 395 (410)
..+...+|.++...+........ ................ ....+++++|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 77888888888766654332210 0011111122222221 1234677899999999999999999999
Q ss_pred HhcCCCCCCC
Q 015247 396 ALNSEVIFQD 405 (410)
Q Consensus 396 lL~hp~~~~~ 405 (410)
+|+||||++.
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999843
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.9e-48 Score=359.08 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=205.1
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC-CceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~l 194 (410)
++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.+.| +|++.+++++.. ....++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 6899999999999999999999999999999998754322 235678889998865 899999988877 456899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-----CCcEEEEeeccccccCC
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-----DGVLKIADFGLASFFDP 269 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~~~~~ 269 (410)
||||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999999988888777778999999999999999999999999999999999999974 57899999999987643
Q ss_pred CCC------CCCccccccccccccccccCCcCCCCccchHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 015247 270 NHK------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIYKLCGSPSE 340 (410)
Q Consensus 270 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 340 (410)
... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+... .+....+......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 221 123456799999999999875 499999999999999999999999986543 33333333321111
Q ss_pred HHhhhCCCCCcccCCCCCchhhhhhhhhCCCCCCcHHHHHhccCCCCCCCCCHHHHh
Q 015247 341 EYWKKSKLPNATLFKPREPYKRCIQETFKDFPPSSLPLIETLLAIDPAERLTATVAL 397 (410)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~elL 397 (410)
...+..+++|+++.+++..|+..+|.+||+...+.
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 12234457899999999999999999999866543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=361.42 Aligned_cols=254 Identities=25% Similarity=0.292 Sum_probs=186.3
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeEeeeEeecCC--ceEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSLY 193 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~ 193 (410)
.+|.+.+.||+|+||.||+|+ .+|+.||||+++... ........|+..+..++|||||++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEE--ECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 578999999999999999997 478999999986432 111122335555567899999999999976433 4689
Q ss_pred EEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 194 LVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN--------NGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
+||||++++.+..+.... .+++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999886555444333 68999999999999999999996 599999999999999999999999999998
Q ss_pred ccCCCCCC---CCccccccccccccccccCCc-----CCCCccchHHHHHHHHHHHcCCCCCCCCChH------------
Q 015247 266 FFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMPGRTEV------------ 325 (410)
Q Consensus 266 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~------------ 325 (410)
........ .....+||+.|+|||++.+.. .++.++|||||||++|||+||..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 87543321 234568999999999986532 2567899999999999999999887543211
Q ss_pred --HHHHHHHHHhCCCCHHHhhhCCCCCcccCCCCCchhhhhhhhh--CCCCCCcHHHHHhccCCCCCCCCCHHHHhc
Q 015247 326 --EQLHKIYKLCGSPSEEYWKKSKLPNATLFKPREPYKRCIQETF--KDFPPSSLPLIETLLAIDPAERLTATVALN 398 (410)
Q Consensus 326 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~elL~ 398 (410)
+......... .+ .+. ++..+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~-----------~~------~p~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 237 SVEEMRKVVCEQ-----------KL------RPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTS-----------CC------CCC------CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhcc-----------cc------CCC------CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111111000 00 000 00000 012234789999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.1e-26 Score=199.13 Aligned_cols=166 Identities=14% Similarity=0.101 Sum_probs=121.1
Q ss_pred cceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCC----------------hHHHHHHHHHHHHHHhCCCCceeeEe
Q 015247 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----------------PESVKFMAREILILRRLDHPNVIKLE 181 (410)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~ 181 (410)
+.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999987 57999999987643210 11123445688899999999999886
Q ss_pred eeEeecCCceEEEEEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEee
Q 015247 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 261 (410)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 261 (410)
++.. .+++|||+++.... .++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 5421 26999999985443 24455567899999999999999999999999999999865 5899999
Q ss_pred ccccccCCCCCCCCccccccccccc------cccccCCcCCCCccchHHHHHHH
Q 015247 262 GLASFFDPNHKHPMTSRVVTLWYRP------PELLLGATDYGVGVDLWSAGCIL 309 (410)
Q Consensus 262 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DiwSlGv~l 309 (410)
|+|......... .|.. .+.+. ..|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 999766422210 1111 12222 3488899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=2.4e-06 Score=75.27 Aligned_cols=139 Identities=16% Similarity=0.122 Sum_probs=85.9
Q ss_pred CCcceeeeeccCCCeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEeeeEeecCCceEEE
Q 015247 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (410)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l 194 (410)
..|+..+..+.++.+.||+.. .+++.+.+|+....... ....+.+|...+..+. +-.+.+++.+... ....++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 456766665555567899885 56667888887543221 1223566888877663 3334556655555 345899
Q ss_pred EEeeccCCHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015247 195 VFHYMEHDLAGLAASPEVKFTEPQVKCYMHQLLSGLEHCHN--------------------------------------- 235 (410)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--------------------------------------- 235 (410)
||+++++.......... .....++.+++..+..||+
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999885443222111 0112233344444444442
Q ss_pred --------------C------CceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 236 --------------N------GVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 236 --------------~------~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27899999999999877666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=5.2e-05 Score=65.99 Aligned_cols=70 Identities=14% Similarity=0.072 Sum_probs=44.7
Q ss_pred eccCC-CeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--CCceeeEeeeEeecCCceEEEEEeecc
Q 015247 124 IGQGT-YSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMSCSLYLVFHYME 200 (410)
Q Consensus 124 LG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~ 200 (410)
+..|. -+.||+.. ...+..+++|....... ..+.+|+..++.+. .-.+.+++++..+. ...+++|++++
T Consensus 18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCS
T ss_pred cCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeee
Confidence 34444 36789987 35677788897654332 12556777777663 23356666665553 45899999997
Q ss_pred C
Q 015247 201 H 201 (410)
Q Consensus 201 ~ 201 (410)
|
T Consensus 90 G 90 (255)
T d1nd4a_ 90 G 90 (255)
T ss_dssp S
T ss_pred c
Confidence 6
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=1.5e-05 Score=74.78 Aligned_cols=77 Identities=18% Similarity=0.132 Sum_probs=45.9
Q ss_pred eeeeccCCCeeEEEEEEcCCCceEEEEEEecCC-----CChHHHHHHHHHHHHHHhCC-C--CceeeEeeeEeecCCceE
Q 015247 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-----LEPESVKFMAREILILRRLD-H--PNVIKLEGLVTSRMSCSL 192 (410)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~ 192 (410)
.+.||.|....||++.+..+++.|++|.-.... ..+...++...|.++|+.+. + ..+++++.+ +... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC--C
Confidence 457899999999999876778889999753210 01112233456888777652 2 345566543 3222 4
Q ss_pred EEEEeeccC
Q 015247 193 YLVFHYMEH 201 (410)
Q Consensus 193 ~lv~e~~~~ 201 (410)
+++||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 689999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0017 Score=58.47 Aligned_cols=69 Identities=14% Similarity=0.122 Sum_probs=41.3
Q ss_pred CeeEEEEEEcCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-----eeEeeeEeecCCceEEEEEeeccC
Q 015247 129 YSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-----IKLEGLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 129 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~~~~~~~~~~~~lv~e~~~~ 201 (410)
--.||+++ ..+|..|++|+.+...... +.+..|...+..|....+ +..-+-.........+.++++++|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 45799997 4789999999987654433 345667777776632211 111110011124457888888875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0019 Score=59.91 Aligned_cols=81 Identities=16% Similarity=0.182 Sum_probs=49.4
Q ss_pred CCCCcCCCcceeeeeccCCCeeEEEEEEcC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeEe
Q 015247 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLE 181 (410)
Q Consensus 110 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 181 (410)
|-....+++++ +.|+.|-.-.+|++.... ..+.|.+++.- .. .. .....+|..+++.+. +.-..+++
T Consensus 37 W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~--~idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 37 WKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ET--ESHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp HHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CC--HHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred ccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-ch--hhHHHHHHHHHHHHHhCCCCCeEE
Confidence 43333345554 568878888999998542 23567777654 21 11 223556888888774 33345676
Q ss_pred eeEeecCCceEEEEEeeccC
Q 015247 182 GLVTSRMSCSLYLVFHYMEH 201 (410)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~ 201 (410)
+++.+ .+|++|+++
T Consensus 112 ~~~~~------g~I~efi~g 125 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPS 125 (395)
T ss_dssp EEETT------EEEECCCCE
T ss_pred EEcCC------ceEEEEecc
Confidence 66543 478888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.0033 Score=56.03 Aligned_cols=30 Identities=30% Similarity=0.479 Sum_probs=26.9
Q ss_pred CCceeccCCCCCEEEcCCCcEEEEeecccc
Q 015247 236 NGVLHRDIKGSNLLIDDDGVLKIADFGLAS 265 (410)
Q Consensus 236 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 265 (410)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999885
|